Citrus Sinensis ID: 015532
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 405 | 2.2.26 [Sep-21-2011] | |||||||
| P51566 | 467 | Serine/threonine-protein | yes | no | 0.965 | 0.837 | 0.759 | 0.0 | |
| P51567 | 427 | Serine/threonine-protein | no | no | 0.953 | 0.903 | 0.641 | 1e-158 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.879 | 0.89 | 0.575 | 1e-128 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.758 | 0.444 | 0.418 | 5e-77 | |
| O35491 | 499 | Dual specificity protein | yes | no | 0.743 | 0.603 | 0.425 | 1e-72 | |
| P49760 | 499 | Dual specificity protein | yes | no | 0.745 | 0.605 | 0.424 | 2e-72 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.750 | 0.365 | 0.416 | 9e-71 | |
| Q3SX21 | 490 | Dual specificity protein | no | no | 0.738 | 0.610 | 0.411 | 4e-69 | |
| Q63117 | 490 | Dual specificity protein | no | no | 0.743 | 0.614 | 0.408 | 6e-69 | |
| P49761 | 638 | Dual specificity protein | no | no | 0.743 | 0.471 | 0.408 | 7e-69 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 664 bits (1714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/429 (75%), Positives = 361/429 (84%), Gaps = 38/429 (8%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------------- 154
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+R
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202
YRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 262
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 263 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 322
NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376
Query: 323 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382
GA+LDWP+GATSRDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436
Query: 383 ALRHPFFTR 391
AL HPFFTR
Sbjct: 437 ALNHPFFTR 445
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 276/430 (64%), Positives = 330/430 (76%), Gaps = 44/430 (10%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WDV P +V ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------- 154
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG R
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201
YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 261
+P+YK SR +D Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct: 239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 262 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 321
W+YPCD+WSVGCI+VELC+GEALFQTHENLEHLAMMERVLGP P M+ + DR +EKY R
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356
Query: 322 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381
RG RLDWPDGATSRDS++AV KL RL NLIMQHVDHSAG+LI+++QGLLR+DP+ER+ AR
Sbjct: 357 RG-RLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITAR 415
Query: 382 EALRHPFFTR 391
EALRHPFF R
Sbjct: 416 EALRHPFFAR 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 237/412 (57%), Positives = 291/412 (70%), Gaps = 56/412 (13%)
Query: 12 KNMDK-RPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGS 70
++MDK R RKRPR+TWD P P K ++ G+ G R S
Sbjct: 7 ESMDKERVRKRPRMTWDEAPAEPEAKRA----VIKGHGSDG---------------RILS 47
Query: 71 PPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK 130
PP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VAIKI+RSI K
Sbjct: 48 PPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKK 107
Query: 131 YREAAMIEIDVLQRLARHDIGGTR---------------------------------YRS 157
YR+AAMIEIDVLQ+L + D G TR Y +
Sbjct: 108 YRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSA 167
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K RS+ + ++
Sbjct: 168 FPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK---RSAANETH 224
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 277
F+ LPKSSAIKLIDFGST +++ H +V TRHYR+PEVILGLGW+Y CDLWS+GCIL E
Sbjct: 225 FRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDLWSIGCILFE 284
Query: 278 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 337
LC+GEALFQTH+NLEHLAMMER LGPLP HM +A R AEKYFRRG RL+WP+GA SR+S
Sbjct: 285 LCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNWPEGANSRES 344
Query: 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+RAV +L RL +++ +HVD++ DLL GLL YDP+ERL A EAL HPFF
Sbjct: 345 IRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYDPSERLTANEALDHPFF 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 148/354 (41%), Positives = 210/354 (59%), Gaps = 47/354 (13%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGHY RY ++ +G GTFG+V++C+D AIK+ R+I KYREA+
Sbjct: 344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403
Query: 136 MIEIDVLQRLARHD----------------------------------IGGTRYRSFPID 161
+IE+ VLQ +A D + Y FP+
Sbjct: 404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463
Query: 162 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRSSKDGSYFK 219
++ L +QL +SVAF+H L L+HTDLKPEN+LLVS + +++P Y+ +Y +
Sbjct: 464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR---------NYSQ 513
Query: 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279
+ S I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL
Sbjct: 514 KVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELF 573
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
+G+ALFQTHE+ EHL MME++LGP +M+ R+ R ++++F+ ++ +P T + S+
Sbjct: 574 TGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSIN 633
Query: 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393
+ L L I L+DLL+ + YDP R+ A+EAL HPFFT+ +
Sbjct: 634 YLQSLQTL-EQIFAVSSPEVALLLDLLKKVFVYDPKRRITAKEALWHPFFTQPI 686
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 1e-72, Method: Compositional matrix adjust.
Identities = 149/350 (42%), Positives = 214/350 (61%), Gaps = 49/350 (14%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 144 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEA 203
Query: 135 AMIEIDVLQRLARHD----------------------------------IGGTRYRSFPI 160
A +EI+VL+++ D + Y +PI
Sbjct: 204 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 263
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y + L + + S
Sbjct: 264 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 316
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 317 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 375
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G LFQTH+N EHLAMMER+LGP+P M+ + R +KYF RG RLDW + ++ +R
Sbjct: 376 GFTLFQTHDNREHLAMMERILGPVPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 432
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
K LR L + DH L DL++ +L Y+PA+RL EAL+HPFF
Sbjct: 433 NCKPLR-RYLTSEAEDHHQ--LFDLIENMLEYEPAKRLTLGEALQHPFFA 479
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (698), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 149/351 (42%), Positives = 215/351 (61%), Gaps = 49/351 (13%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHD----------------------------------IGGTRYRSFPI 160
A +EI+VL+++ D + Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y + L + + S
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 317
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 318 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G LFQTH+N EHLAMMER+LGP+P M+ + R +KYF RG RLDW + ++ +R
Sbjct: 377 GFTLFQTHDNREHLAMMERILGPIPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 433
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 434 NCKPLR-RYLTSEAEEHHQ--LFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 9e-71, Method: Compositional matrix adjust.
Identities = 147/353 (41%), Positives = 210/353 (59%), Gaps = 49/353 (13%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGH ++ G+ L RY+I++ +GEGTFG+VV+ D E+ +A+KI++++ KYREAA
Sbjct: 461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520
Query: 136 MIEIDVLQRLARHD----------------------------------IGGTRYRSFPID 161
+EI+ L+++A+ D + Y +P+D
Sbjct: 521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580
Query: 162 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221
VR + QL SV F+H+ RL HTDLKPENIL V ++Y ++K ++R +
Sbjct: 581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHK-INREVRRV------ 633
Query: 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
K++ ++LIDFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL G
Sbjct: 634 -KNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFELYLG 692
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMV---IRADRRAEKYFRRGARLDWPDGATSRDSM 338
LFQTH+N EHLAMMER+LG +P+ M + KYF G +LDW + +++ +
Sbjct: 693 ITLFQTHDNREHLAMMERILGQIPYRMARNHTLYSKTKTKYFYHG-KLDWDEKSSAGRYV 751
Query: 339 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
R K L L L DH +L L++ +L Y+P+ R+ EAL HPFF R
Sbjct: 752 RDHCKPLFLCQL-SDSEDHC--ELFSLIKKMLEYEPSSRITLGEALHHPFFDR 801
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q3SX21|CLK3_BOVIN Dual specificity protein kinase CLK3 OS=Bos taurus GN=CLK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 145/352 (41%), Positives = 211/352 (59%), Gaps = 53/352 (15%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 138 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 197
Query: 135 AMIEIDVLQRLARHD----------------------------------IGGTRYRSFPI 160
A +EI+VL+++ D + ++ +P+
Sbjct: 198 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 257
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + + +S ++ S
Sbjct: 258 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN---EHKSCEEKSV--- 311
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 312 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 369
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G LFQTHEN EHL MME++LGP+P HM+ R R +KYF +G L W + ++ ++
Sbjct: 370 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSSDGRYVKE 426
Query: 341 VWKLLRLPNL--IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
K L+ L ++HV L DL++ +L +DPA+R+ EAL HPFF
Sbjct: 427 NCKPLKSYMLQDTLEHV-----QLFDLMRRMLEFDPAQRITLAEALLHPFFA 473
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q63117|CLK3_RAT Dual specificity protein kinase CLK3 OS=Rattus norvegicus GN=Clk3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 143/350 (40%), Positives = 211/350 (60%), Gaps = 49/350 (14%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 138 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 197
Query: 135 AMIEIDVLQRLARHD----------------------------------IGGTRYRSFPI 160
A +EI+VL+++ D + ++ +P+
Sbjct: 198 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 257
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + + +S ++ S
Sbjct: 258 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN---EHKSCEEKSV--- 311
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 312 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 369
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G LFQTHEN EHL MME++LGP+P HM+ R R +KYF +G L W + ++ ++
Sbjct: 370 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSSDGRYVKE 426
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
K L+ ++ ++H L DL++ +L +DPA+R+ EAL HPFF
Sbjct: 427 NCKPLK-SYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFA 473
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49761|CLK3_HUMAN Dual specificity protein kinase CLK3 OS=Homo sapiens GN=CLK3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 143/350 (40%), Positives = 211/350 (60%), Gaps = 49/350 (14%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 286 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 345
Query: 135 AMIEIDVLQRLARHD----------------------------------IGGTRYRSFPI 160
A +EI+VL+++ D + ++ +P+
Sbjct: 346 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 405
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + + +S ++ S
Sbjct: 406 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH---KSCEEKSV--- 459
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 460 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 517
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G LFQTHEN EHL MME++LGP+P HM+ R R +KYF +G L W + ++ ++
Sbjct: 518 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSSDGRYVKE 574
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
K L+ ++ ++H L DL++ +L +DPA+R+ EAL HPFF
Sbjct: 575 NCKPLK-SYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFA 621
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 405 | ||||||
| 225439856 | 429 | PREDICTED: serine/threonine-protein kina | 0.965 | 0.911 | 0.820 | 0.0 | |
| 147800314 | 448 | hypothetical protein VITISV_001943 [Viti | 0.960 | 0.868 | 0.819 | 0.0 | |
| 224138498 | 433 | predicted protein [Populus trichocarpa] | 0.960 | 0.898 | 0.806 | 0.0 | |
| 449439982 | 428 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.922 | 0.810 | 0.0 | |
| 449439980 | 433 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.912 | 0.810 | 0.0 | |
| 356505140 | 427 | PREDICTED: serine/threonine-protein kina | 0.958 | 0.908 | 0.771 | 0.0 | |
| 356505138 | 444 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.889 | 0.760 | 0.0 | |
| 255638456 | 444 | unknown [Glycine max] | 0.975 | 0.889 | 0.756 | 0.0 | |
| 15231839 | 467 | serine/threonine-protein kinase AFC1 [Ar | 0.965 | 0.837 | 0.759 | 0.0 | |
| 601787 | 467 | protein kinase [Arabidopsis thaliana] | 0.965 | 0.837 | 0.757 | 0.0 |
| >gi|225439856|ref|XP_002278124.1| PREDICTED: serine/threonine-protein kinase AFC1 [Vitis vinifera] gi|297741539|emb|CBI32671.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/428 (82%), Positives = 376/428 (87%), Gaps = 37/428 (8%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------------- 154
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTR
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207
YRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 267
LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296
Query: 268 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 327
LWSVGCIL+ELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFRRGARLD
Sbjct: 297 LWSVGCILIELCSGEALFQTHENLEHLAMMERVLGPLPQHMVLRADRRAEKYFRRGARLD 356
Query: 328 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 387
WP+GATSR+SMRAVWKL RL NL+MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP
Sbjct: 357 WPEGATSRESMRAVWKLPRLQNLVMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 416
Query: 388 FFTRDVRR 395
FFTRD RR
Sbjct: 417 FFTRDARR 424
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147800314|emb|CAN73108.1| hypothetical protein VITISV_001943 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/426 (81%), Positives = 375/426 (88%), Gaps = 37/426 (8%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------------- 154
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTR
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207
YRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 267
LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296
Query: 268 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 327
LWSVGCIL+ELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFRRGARLD
Sbjct: 297 LWSVGCILIELCSGEALFQTHENLEHLAMMERVLGPLPQHMVLRADRRAEKYFRRGARLD 356
Query: 328 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 387
WP+GATSR+SMRAVWKL RL NL+MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP
Sbjct: 357 WPEGATSRESMRAVWKLPRLQNLVMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 416
Query: 388 FFTRDV 393
FFTRD+
Sbjct: 417 FFTRDI 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138498|ref|XP_002322829.1| predicted protein [Populus trichocarpa] gi|222867459|gb|EEF04590.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/434 (80%), Positives = 372/434 (85%), Gaps = 45/434 (10%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPP----LPPPKVLPALYCVQEFGNGG--MPN 54
METQRI EFPHKNMDKRPRKR RLTWD+PPP L P KV+P ++C QEFGNG +PN
Sbjct: 1 METQRITEFPHKNMDKRPRKRQRLTWDIPPPPPPFLAPAKVVPGMFCGQEFGNGNGVIPN 60
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
Y +FY R GSPPWRPDDKDGHYVFAIG+NLTPRYRILSKMGEGTFGQV+ECFDN
Sbjct: 61 YG---LFYN---RNGSPPWRPDDKDGHYVFAIGDNLTPRYRILSKMGEGTFGQVLECFDN 114
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------- 154
EKKELVAIKIVRSI+KYREAAM EIDVLQRLARHDIG TR
Sbjct: 115 EKKELVAIKIVRSIHKYREAAMTEIDVLQRLARHDIGSTRCVQIRNWFDYRNHICIVFEK 174
Query: 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201
YRSFPIDLVRELGRQLLESVAFMH+L LIHTDLKPENILLVS+EY+K
Sbjct: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLHLIHTDLKPENILLVSSEYIK 234
Query: 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 261
VPDYKFLSRS+KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG
Sbjct: 235 VPDYKFLSRSTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
Query: 262 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 321
WNYPCD+WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFR
Sbjct: 295 WNYPCDIWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPQHMVVRADRRAEKYFR 354
Query: 322 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381
RG RLDWP+GATSR+SM+AV KL RLPNLIMQHVDHSAG+LIDLLQGLLR+DPAERLKAR
Sbjct: 355 RGMRLDWPEGATSRESMKAVMKLPRLPNLIMQHVDHSAGELIDLLQGLLRHDPAERLKAR 414
Query: 382 EALRHPFFTRDVRR 395
EALRHPFF+RD+RR
Sbjct: 415 EALRHPFFSRDLRR 428
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439982|ref|XP_004137764.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/428 (81%), Positives = 370/428 (86%), Gaps = 33/428 (7%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------------- 154
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTR
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207
YRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 267
LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300
Query: 268 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 327
LWSVGCILVELCSGEALFQTHENLEHLAMME+VLGPLP HMV+RADRRAEKYFRRG +LD
Sbjct: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMEKVLGPLPQHMVLRADRRAEKYFRRGMQLD 360
Query: 328 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 387
WP ATSR+SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ERL AREALRHP
Sbjct: 361 WPQSATSRESMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSERLMAREALRHP 420
Query: 388 FFTRDVRR 395
FFTRD+RR
Sbjct: 421 FFTRDLRR 428
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439980|ref|XP_004137763.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 685 bits (1767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/428 (81%), Positives = 370/428 (86%), Gaps = 33/428 (7%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------------- 154
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTR
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207
YRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 267
LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300
Query: 268 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 327
LWSVGCILVELCSGEALFQTHENLEHLAMME+VLGPLP HMV+RADRRAEKYFRRG +LD
Sbjct: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMEKVLGPLPQHMVLRADRRAEKYFRRGMQLD 360
Query: 328 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 387
WP ATSR+SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ERL AREALRHP
Sbjct: 361 WPQSATSRESMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSERLMAREALRHP 420
Query: 388 FFTRDVRR 395
FFTRD+RR
Sbjct: 421 FFTRDLRR 428
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505140|ref|XP_003521350.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/429 (77%), Positives = 362/429 (84%), Gaps = 41/429 (9%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPH+NMDKRPRK+ RLTWD+ VLP +YC QE GNG +PN+A S+
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDM-------HVLPTMYCKQEVGNGVVPNHAYPSL 53
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+EC DNEK+E+V
Sbjct: 54 FYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLECLDNEKEEIV 113
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------------- 154
AIK+VRSINKYREAA EI+VL RLARHD+ G
Sbjct: 114 AIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICIVFEKLGPSLY 173
Query: 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207
YRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+E++KVPDYKF
Sbjct: 174 DFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISSEFIKVPDYKF 233
Query: 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 267
LSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 234 LSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 293
Query: 268 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 327
LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYF+RG RL
Sbjct: 294 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVVRADRRAEKYFKRGTRLS 353
Query: 328 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 387
WPD +TSR+SMRAVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ERLKA+EALRHP
Sbjct: 354 WPDSSTSRESMRAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSERLKAKEALRHP 413
Query: 388 -FFTRDVRR 395
FFTRD +R
Sbjct: 414 FFFTRDTKR 422
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505138|ref|XP_003521349.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/439 (76%), Positives = 366/439 (83%), Gaps = 44/439 (10%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197
YRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 257
E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300
Query: 258 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 317
LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAE
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVVRADRRAE 360
Query: 318 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377
KYF+RG RL WPD +TSR+SMRAVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ER
Sbjct: 361 KYFKRGTRLSWPDSSTSRESMRAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSER 420
Query: 378 LKAREALRHP-FFTRDVRR 395
LKA+EALRHP FFTRD +R
Sbjct: 421 LKAKEALRHPFFFTRDTKR 439
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255638456|gb|ACU19537.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/439 (75%), Positives = 364/439 (82%), Gaps = 44/439 (10%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197
YRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNCYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 257
E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300
Query: 258 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 317
LGLGWNYPCDLWSVGCILVELCSGEALFQTHENL HLAMMERVLGPLP HMV+RADRRAE
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLGHLAMMERVLGPLPPHMVVRADRRAE 360
Query: 318 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377
KYF+RG RL WPD +TSR+SMRAVWKL RLPNLIMQHVDH AGDLIDLLQGLLRYDP+ER
Sbjct: 361 KYFKRGTRLSWPDSSTSRESMRAVWKLPRLPNLIMQHVDHFAGDLIDLLQGLLRYDPSER 420
Query: 378 LKAREALRHP-FFTRDVRR 395
LKA+EALRHP FFTRD +R
Sbjct: 421 LKAKEALRHPFFFTRDTKR 439
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231839|ref|NP_190925.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|42570490|ref|NP_850695.2| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|79314891|ref|NP_001030853.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|26454604|sp|P51566.2|AFC1_ARATH RecName: Full=Serine/threonine-protein kinase AFC1 gi|642132|dbj|BAA08215.1| protein kinase [Arabidopsis thaliana] gi|6729508|emb|CAB67664.1| protein kinase (AME2/AFC1) [Arabidopsis thaliana] gi|222424132|dbj|BAH20025.1| AT3G53570 [Arabidopsis thaliana] gi|332645589|gb|AEE79110.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645590|gb|AEE79111.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645591|gb|AEE79112.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/429 (75%), Positives = 361/429 (84%), Gaps = 38/429 (8%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------------- 154
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+R
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202
YRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 262
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 263 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 322
NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376
Query: 323 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382
GA+LDWP+GATSRDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436
Query: 383 ALRHPFFTR 391
AL HPFFTR
Sbjct: 437 ALNHPFFTR 445
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|601787|gb|AAA57117.1| protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/429 (75%), Positives = 361/429 (84%), Gaps = 38/429 (8%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY++LSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQMLSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------------- 154
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+R
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202
YRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 262
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 263 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 322
NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376
Query: 323 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382
GA+LDWP+GATSRDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436
Query: 383 ALRHPFFTR 391
AL HPFFTR
Sbjct: 437 ALNHPFFTR 445
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 405 | ||||||
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.651 | 0.618 | 0.704 | 6.7e-147 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.575 | 0.582 | 0.669 | 8.2e-122 | |
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.585 | 0.507 | 0.907 | 1.8e-119 | |
| UNIPROTKB|F1RLJ5 | 500 | CLK2 "Uncharacterized protein" | 0.550 | 0.446 | 0.497 | 2e-73 | |
| UNIPROTKB|E1B9Q2 | 500 | CLK2 "Uncharacterized protein" | 0.550 | 0.446 | 0.497 | 2.5e-73 | |
| UNIPROTKB|F1P919 | 612 | CLK2 "Uncharacterized protein" | 0.550 | 0.364 | 0.497 | 2.5e-73 | |
| UNIPROTKB|B1AVT0 | 497 | CLK2 "Dual-specificity protein | 0.550 | 0.448 | 0.497 | 2.5e-73 | |
| UNIPROTKB|P49760 | 499 | CLK2 "Dual specificity protein | 0.550 | 0.446 | 0.497 | 2.5e-73 | |
| MGI|MGI:1098669 | 499 | Clk2 "CDC-like kinase 2" [Mus | 0.545 | 0.442 | 0.502 | 4.1e-73 | |
| RGD|1359711 | 500 | Clk2 "CDC-like kinase 2" [Ratt | 0.545 | 0.442 | 0.502 | 4.1e-73 |
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 6.7e-147, Sum P(2) = 6.7e-147
Identities = 188/267 (70%), Positives = 221/267 (82%)
Query: 125 VRSINKYREAAMIEIDVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
+R+ YR I + L + YRSFPIDLVRE+G QLLE VAFMH+LR+IH
Sbjct: 162 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIH 221
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
TDLKPENILLVS++YVK+P+YK SR +D Y K +PKSSAIK+IDFGSTT+E QD +Y
Sbjct: 222 TDLKPENILLVSSDYVKIPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTY 279
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304
+VSTRHYRAPEVILGLGW+YPCD+WSVGCI+VELC+GEALFQTHENLEHLAMMERVLGP
Sbjct: 280 IVSTRHYRAPEVILGLGWSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPF 339
Query: 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364
P M+ + DR +EKY RRG RLDWPDGATSRDS++AV KL RL NLIMQHVDHSAG+LI+
Sbjct: 340 PQQMLKKVDRHSEKYVRRG-RLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELIN 398
Query: 365 LLQGLLRYDPAERLKAREALRHPFFTR 391
++QGLLR+DP+ER+ AREALRHPFF R
Sbjct: 399 MVQGLLRFDPSERITAREALRHPFFAR 425
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 8.2e-122, Sum P(3) = 8.2e-122
Identities = 158/236 (66%), Positives = 194/236 (82%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
+Y +FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K RS+
Sbjct: 164 KYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK---RSAA 220
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
+ ++F+ LPKSSAIKLIDFGST +++ H +V TRHYR+PEVILGLGW+Y CDLWS+GC
Sbjct: 221 NETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDLWSIGC 280
Query: 274 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 333
IL ELC+GEALFQTH+NLEHLAMMER LGPLP HM +A R AEKYFRRG RL+WP+GA
Sbjct: 281 ILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNWPEGAN 340
Query: 334 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
SR+S+RAV +L RL +++ +HVD++ DLL GLL YDP+ERL A EAL HPFF
Sbjct: 341 SRESIRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYDPSERLTANEALDHPFF 396
|
|
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1176 (419.0 bits), Expect = 1.8e-119, P = 1.8e-119
Identities = 215/237 (90%), Positives = 231/237 (97%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
YRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+PDYKFLSR +KD
Sbjct: 209 YRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKIPDYKFLSRPTKD 268
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
GSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GWNYPCDLWS+GCI
Sbjct: 269 GSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGWNYPCDLWSIGCI 328
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
LVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRRGA+LDWP+GATS
Sbjct: 329 LVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRRGAKLDWPEGATS 388
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
RDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KAREAL HPFFTR
Sbjct: 389 RDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKAREALNHPFFTR 445
|
|
| UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 2.0e-73, Sum P(2) = 2.0e-73
Identities = 118/237 (49%), Positives = 159/237 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 259 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 315
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 316 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 370
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 371 IFEYYVGFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 427
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+R K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 428 GRYVRENCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
Identities = 118/237 (49%), Positives = 159/237 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 259 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 315
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 316 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 370
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 371 IFEYYVGFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 427
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+R K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 428 GRYVRENCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
Identities = 118/237 (49%), Positives = 159/237 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 371 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 427
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 428 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 482
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 483 IFEYYVGFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 539
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+R K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 540 GRYVRENCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 593
|
|
| UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
Identities = 118/237 (49%), Positives = 159/237 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 257 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 313
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 314 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 368
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 369 IFEYYVGFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 425
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+R K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 426 GRYVRENCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 479
|
|
| UNIPROTKB|P49760 CLK2 "Dual specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
Identities = 118/237 (49%), Positives = 159/237 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 259 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 315
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 316 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 370
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 371 IFEYYVGFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 427
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+R K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 428 GRYVRENCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| MGI|MGI:1098669 Clk2 "CDC-like kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
Identities = 118/235 (50%), Positives = 158/235 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 258 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 314
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 315 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 369
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 370 IFEYYVGFTLFQTHDNREHLAMMERILGPVPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 426
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+R K LR L + DH L DL++ +L Y+PA+RL EAL+HPFF
Sbjct: 427 GRYVRENCKPLRR-YLTSEAEDHH--QLFDLIENMLEYEPAKRLTLGEALQHPFF 478
|
|
| RGD|1359711 Clk2 "CDC-like kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
Identities = 118/235 (50%), Positives = 158/235 (67%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
Y +PI VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + +
Sbjct: 259 YLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDE 315
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI
Sbjct: 316 RSV-----KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCI 370
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
+ E G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++
Sbjct: 371 IFEYYVGFTLFQTHDNREHLAMMERILGPVPSRM-IRKTRK-QKYFYRG-RLDWDENTSA 427
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+R K LR L + DH L DL++ +L Y+PA+RL EAL+HPFF
Sbjct: 428 GRYVRENCKPLRR-YLTSEAEDHH--QLFDLIENMLEYEPAKRLTLGEALQHPFF 479
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P51566 | AFC1_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.7599 | 0.9654 | 0.8372 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 405 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-60 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-45 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-41 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-40 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-37 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-33 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-33 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-31 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-28 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-27 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-22 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-21 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-20 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-07 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-05 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.002 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.003 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 4e-60
Identities = 92/328 (28%), Positives = 132/328 (40%), Gaps = 106/328 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD-I 150
Y IL K+GEG+FG+V D + +LVAIK+++ I K RE + EI +L++L +H I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 151 ---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLI 183
GG + D R RQ+L ++ ++H ++
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DLKPENILL +DG +KL DFG
Sbjct: 120 HRDLKPENILL-----------------DEDGH----------VKLADFGLARQLDPGEK 152
Query: 244 Y--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
V T Y APEV+LG G+ D+WS+G IL EL +G+ F + L + +++
Sbjct: 153 LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--ELFKKIG 210
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
P P P+ S +
Sbjct: 211 KPKPP-------------------FPPPEWDISP-------------------------E 226
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389
DL++ LL DP +RL A EAL+HPFF
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 119/353 (33%), Positives = 178/353 (50%), Gaps = 66/353 (18%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
++GH+ +GE++ T R++ILS +GEGTFG+VVE +D ++KE A+KIVR++ KY
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171
Query: 135 AMIEIDVLQRLARHD----------------------IGGTRYRSFPIDLVRELG----R 168
A IEI ++++ + D I +Y +D + + G R
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR 231
Query: 169 QLLESV--------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
L + + F EL L+HTDLKPENIL+ +++ + D +
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD------------TVVDPVTNRA 279
Query: 221 LPKSSA-IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279
LP +++ D G E + +VSTRHYR+PEV+LGLGW Y D+WS+GCI+ EL
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDW---PDGATSR 335
+G+ L+ TH+NLEHL +ME+ LG LP R A + +L P
Sbjct: 340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARI 399
Query: 336 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
R V +++R L DL+ GLL YD +RL AR+ HP+
Sbjct: 400 ARARPVREVIRDDL------------LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-47
Identities = 86/331 (25%), Positives = 129/331 (38%), Gaps = 106/331 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD- 149
Y +L K+G G+FG V + ++VA+KI+ RS K + A EI +L+RL H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 150 I---------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRL 182
I GG +R D +++ Q+L + ++H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQD 241
IH DLKPENILL +K+ DFG +
Sbjct: 120 IHRDLKPENILLDENGV---------------------------VKIADFGLAKKLLKSS 152
Query: 242 HSY--VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
S V T Y APEV+L G G+ D+WS+G IL EL +G+ F L+ L ++
Sbjct: 153 SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
R+LGP D P ++ +
Sbjct: 213 RILGPPLE-------------------FDEPKWSSGSE---------------------- 231
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ DL++ L DP++R A E L+HP+F
Sbjct: 232 --EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 93/333 (27%), Positives = 149/333 (44%), Gaps = 88/333 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH- 148
Y L K+GEGT+G V + D + E+VA+K +R ++ E A+ EI +L+ L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKEL-KHP 58
Query: 149 ------------------------DIGG---TRYRSFPIDLVRELGRQLLESVAFMHELR 181
D+ R +L++ + QLL +A+ H R
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
++H DLKP+NIL+ ++DG +KL DFG + F
Sbjct: 119 ILHRDLKPQNILI-----------------NRDGV----------LKLADFGLARAFGIP 151
Query: 241 DHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+Y V T YRAPE++LG ++ D+WSVGCI E+ +G+ LF ++ L +
Sbjct: 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211
Query: 298 ERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
++LG P WP G T + + P + + +
Sbjct: 212 FQILGTPTEE--------------------SWP-GVTKLPDYKPTFP-KFPPKDLEKVLP 249
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ IDLL +L+Y+PA+R+ A+EAL+HP+F
Sbjct: 250 RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 95/329 (28%), Positives = 147/329 (44%), Gaps = 74/329 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG +G V++C + E+VAIK ++ A+ E+ VL++L +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 150 I---------GGTRYRSF------------------PIDLVRELGRQLLESVAFMHELRL 182
I G Y F P D VR QLL+++A+ H +
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
IH D+KPENIL+ + +K+ D+ F + L A L D+
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFA----------RALRARPASPLTDY---------- 161
Query: 243 SYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300
V+TR YRAPE+++G NY P D+W++GCI+ EL GE LF +++ L ++++
Sbjct: 162 ---VATRWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC 217
Query: 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360
LGPLP F A + +S+ R P + +
Sbjct: 218 LGPLPPSHQELFSS--NPRFAGVAFPEPSQ----PESL-----ERRYPGKV-------SS 259
Query: 361 DLIDLLQGLLRYDPAERLKAREALRHPFF 389
+D L+ LR DP ERL E L+HP+F
Sbjct: 260 PALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 96/334 (28%), Positives = 143/334 (42%), Gaps = 84/334 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLAR-- 147
RY+IL ++GEG G V + D E E VA+K + R A+ EI LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 148 -------------------------HDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
++ R P V+ R LL+ VA+MH +
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H DLKP N+L+ + +K+ D+ L+R + + HQ
Sbjct: 121 MHRDLKPANLLISADGVLKIADFG-LARLFSEE-----------------EPRLYSHQ-- 160
Query: 243 SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
V+TR YRAPE++ G ++ DLW+VGCI EL +G LF ++E LA++ R L
Sbjct: 161 ---VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTL 217
Query: 302 G-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN----LIMQHVD 356
G P WP + D + + P + +
Sbjct: 218 GTPNEE--------------------TWPGLTSLPD-----YNKITFPESKPIPLEEIFP 252
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
++ + +DLL+GLL YDP++RL A EALRHP+FT
Sbjct: 253 DASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 88/333 (26%), Positives = 148/333 (44%), Gaps = 87/333 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA-AMIEIDVLQRLARHD-- 149
Y+++ ++G+GTFG V + E ELVAIK + + + E + E+ L++L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 150 ---------------------------IGGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
+ + + F ++R + Q+L+ +A +H+
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
H DLKPEN+L+ E VK+ D+ L+R + + T +
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFG-LAREIRSRPPY----------------TDY----- 158
Query: 243 SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
VSTR YRAPE++L + P D+W++GCI+ EL + LF ++ L + VL
Sbjct: 159 ---VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL-LRLPN----LIMQHVD 356
G P DWP+G + KL R P + Q +
Sbjct: 216 GT-PTKQ------------------DWPEG------YKLASKLGFRFPQFAPTSLHQLIP 250
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+++ + IDL++ +LR+DP +R A +AL+HP+F
Sbjct: 251 NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 95/333 (28%), Positives = 136/333 (40%), Gaps = 87/333 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDI 150
Y+ L K+GEGT+G V + D E+VAIK ++ + + A+ EI +L+ L +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 151 GG---------------------------TRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
R R P L++ QLL+ +AF H ++
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DLKPEN+L + +KL DFG
Sbjct: 121 HRDLKPENLL---------------------------INTEGVLKLADFGLARSFGSPVR 153
Query: 244 YV---VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
V TR YRAPE++LG G++ P D+WSVGCI EL S LF ++ L + R
Sbjct: 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213
Query: 300 VLG-PLPHHM-VIRADRRAEKY-FRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
LG P P + R K+ F + A + P PN
Sbjct: 214 TLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLP---------------KLFPNA------ 252
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ +DLL +L YDP +R+ A +AL HP+F
Sbjct: 253 --SPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 93/333 (27%), Positives = 142/333 (42%), Gaps = 88/333 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARH- 148
Y+IL K+GEGTF +V++ + + AIK ++ + EI L+RL+ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 149 -----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHE 179
++ R R P V+ QLL+S+ MH
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS--TTF 237
+ H D+KPENIL+ K +KL DFGS +
Sbjct: 119 NGIFHRDIKPENILI----------------------------KDDILKLADFGSCRGIY 150
Query: 238 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
++ +STR YRAPE +L G + D+W+VGC+ E+ S LF L+ +A
Sbjct: 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ VLG P D K FR+ ++ + + + + + KLL +
Sbjct: 211 IHDVLG-TP-------DAEVLKKFRKSRHMN-YNFPSKKGT--GLRKLL-------PNAS 252
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+DLL+ LL YDP ER+ A++ALRHP+F
Sbjct: 253 AEG---LDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-37
Identities = 92/345 (26%), Positives = 145/345 (42%), Gaps = 107/345 (31%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHD- 149
Y ++++GEGT+GQV + + + ELVA+K +R N+ A+ EI +LQ+L RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPN 59
Query: 150 -----------IGGTRYRSFPI---DL---------------VRELGRQLLESVAFMHEL 180
G+ Y F DL ++ +QLLE + ++H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTF 237
++H D+K NIL+ + DG +KL DFG T
Sbjct: 120 GILHRDIKGSNILI-----------------NNDGV----------LKLADFGLARPYTK 152
Query: 238 EH-QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
+ D++ V T YR PE++LG + D+WSVGCIL EL G+ +FQ LE L
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212
Query: 296 MMERVLGP-----------LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
+ + G LP ++ + ++ R+ + +
Sbjct: 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL--------------REFFKHL--- 255
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+D SA +DLL LL DP +R+ A +AL+H +F
Sbjct: 256 ----------IDPSA---LDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 94/337 (27%), Positives = 139/337 (41%), Gaps = 91/337 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMI-EIDVLQRLARH- 148
Y L+++GEG +G V + D VA+K VR E + + EI +L++L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFE 59
Query: 149 --------DI--GGTRYRSFPIDLVRE-------------------------LGRQLLES 173
D+ G R + LV E L RQLL
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
V F+H R++H DLKP+NIL+ S VK+ D+ L+R Y + +S
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG-LARI-----YSFEMALTS-------- 165
Query: 234 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
VV T YRAPEV+L + P D+WSVGCI EL LF+ +
Sbjct: 166 -----------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ 214
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP-DGATSRDSMRAVWKLLRLPNLIM 352
L + V+G LP + +WP + + R S + R +
Sbjct: 215 LDKIFDVIG-LP------------------SEEEWPRNVSLPRSSFPS--YTPRSFKSFV 253
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ DLL+ +L ++P +R+ A EAL+HP+F
Sbjct: 254 PEICEEGL---DLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 60/212 (28%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI-------- 150
GEG FG V D + + VAIKI++ + E + EI++L++L +I
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 151 -------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 190
GG+ D + + Q+LE + ++H +IH DLKPE
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 191 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--- 247
NILL S +KL DFG + D S + +
Sbjct: 122 NILLDSDNGK--------------------------VKLADFGLSKLLTSDKSLLKTIVG 155
Query: 248 TRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 278
T Y APEV+LG G ++ D+WS+G IL EL
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 93/339 (27%), Positives = 150/339 (44%), Gaps = 96/339 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---------IVRSINKYREAAM------- 136
+Y LSK+GEG++G V +C + E ++VAIK +++ I RE M
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI-ALREIRMLKQLKHP 60
Query: 137 -----IEI----------------DVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVA 175
IE+ VL L ++ R P L++++ Q L++V
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVN 114
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 234
F H+ IH D+KPENIL+ K IKL DFG +
Sbjct: 115 FCHKHNCIHRDVKPENILIT---------------------------KQGQIKLCDFGFA 147
Query: 235 TTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
Y V+TR YRAPE+++G + P D+W++GC+ EL +G+ L+ ++
Sbjct: 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207
Query: 292 EHLAMMERVLGPL-PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 350
+ L ++ + LG L P H I ++F +G + P +R+ + + + PN+
Sbjct: 208 DQLYLIRKTLGDLIPRHQQI---FSTNQFF-KGLSIPEP---ETREPLES-----KFPNI 255
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + L+G L+ DP ERL E L HP+F
Sbjct: 256 --------SSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 94/354 (26%), Positives = 139/354 (39%), Gaps = 111/354 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY K+GEGT+ V + D E +VAIK ++ + A+ EI +LQ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59
Query: 147 RHD-IGGTR----YRSFPIDLVRELGR------------------------QLLESVAFM 177
+H I G ++S I+LV E L + ++
Sbjct: 60 KHPNIIGLLDVFGHKSN-INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS--T 235
H ++H DLKP N+L+ S +K+ D+ L+RS FGS
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFG-LARS--------------------FGSPNR 157
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
HQ V TR YRAPE++ G + D+WSVGCI EL +++ L
Sbjct: 158 KMTHQ-----VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212
Query: 295 AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIM 352
+ LG P +WP + LP+ +
Sbjct: 213 GKIFEALGTPTEE--------------------NWPG-------------VTSLPDYVEF 239
Query: 353 QHVDH--------SAG-DLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+ +A D +DLLQ LL +P +R+ AR+AL HP+F+ D PT
Sbjct: 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP-APT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 84/346 (24%), Positives = 134/346 (38%), Gaps = 103/346 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQR 144
RY +L +G G +G V D VAIK + ++ RE I +L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKLLRH 55
Query: 145 LARHD--------IGGTRYRSF--------------------PIDLVRELGR----QLLE 172
L RH+ + F P L + + Q+L
Sbjct: 56 L-RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
+ ++H +IH DLKP NIL+ N + +K+ DF
Sbjct: 115 GLKYLHSANVIHRDLKPSNILV-------------------------N--SNCDLKICDF 147
Query: 233 G-----STTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEAL 284
G + + YVV TR YRAPE++L + D+WSVGCI EL + + L
Sbjct: 148 GLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
F + ++ L ++ VLG L + +R+ ++++ K
Sbjct: 207 FPGRDYIDQLNLIVEVLGTPSEED-----------------LKFITSEKARNYLKSLPKK 249
Query: 345 LRLP-NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ P + + A IDLL+ +L +DP +R+ A EAL HP+
Sbjct: 250 PKKPLSKLFPGASPEA---IDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 89/330 (26%), Positives = 153/330 (46%), Gaps = 77/330 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ +L +GEG +G V++C E KE+VAIK + + +E + E+ +L+ L + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 150 I---------GGTRYRSF------------------PIDLVRELGRQLLESVAFMHELRL 182
I G Y F P + VR QL++++ + H+ +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H D+KPEN+L+ + +K+ D+ F +R+ +GS + ++
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGS----------------------NANY 158
Query: 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302
+ V+TR YR+PE++LG + D+WSVGCIL EL G+ LF ++ L +++VLG
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG 218
Query: 303 PLPHHMVIRADRRAEKYFRRGAR---LDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
PLP + K F R L +P + R +L +
Sbjct: 219 PLPAEQM--------KLFYSNPRFHGLRFPAVNHPQSLERRYLGIL-------------S 257
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFF 389
G L+DL++ LL+ +P +R + L HP F
Sbjct: 258 GVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 73/327 (22%), Positives = 114/327 (34%), Gaps = 113/327 (34%)
Query: 101 GEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDI------- 150
G G+FG V D + EL+A+K + + EA EI +L L +I
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSE 68
Query: 151 ----------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 188
GG+ ++ P ++R+ RQ+LE +A++H ++H D+K
Sbjct: 69 RDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIK 128
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------STTFEHQDH 242
NIL+ S +KL DFG
Sbjct: 129 GANILVDS---------------------------DGVVKLADFGCAKRLGDIETGEGTG 161
Query: 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302
S V T ++ APEVI G + D+WS+GC ++E+ +G+
Sbjct: 162 S-VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP------------------- 201
Query: 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362
P + M A++K+ S +
Sbjct: 202 PWSELG---------------------------NPMAALYKIGSSGEPPEIPEHLSE-EA 233
Query: 363 IDLLQGLLRYDPAERLKAREALRHPFF 389
D L+ LR DP +R A E L+HPF
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 101/350 (28%), Positives = 150/350 (42%), Gaps = 94/350 (26%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----------RSINKYREA 134
I +++ +Y IL K+G+G +G V + D KE+VA+K + R+ +RE
Sbjct: 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FRE- 56
Query: 135 AMIEIDVLQRLARH----------------DIGGTRYRSFPI---DL------------- 162
I LQ L H DI Y F DL
Sbjct: 57 ----IMFLQELGDHPNIVKLLNVIKAENDKDI----YLVFEYMETDLHAVIRANILEDVH 108
Query: 163 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222
R + QLL+++ ++H +IH DLKP NILL S VK+ D+ L+RS
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG-LARS----------- 156
Query: 223 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSG 281
+ E+ + V+TR YRAPE++LG D+WSVGCIL E+ G
Sbjct: 157 -------LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
+ LF L L + V+GP D + + P AT DS+
Sbjct: 210 KPLFPGTSTLNQLEKIIEVIGPPS-----AEDIES---------IKSPFAATMLDSL--- 252
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
R + + + ++ D +DLL+ LL ++P +RL A EAL HP+ +
Sbjct: 253 --PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 92/340 (27%), Positives = 142/340 (41%), Gaps = 97/340 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLA--- 146
Y L+++ EGT+G V D + E+VA+K ++ + K +E ++ EI++L +L
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKLQHPN 65
Query: 147 -----------------------RHDIGG---TRYRSFPIDLVRELGRQLLESVAFMHEL 180
HD+ T + F V+ L QLL VA +H+
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
++H DLK N+L L +K+ DFG + +
Sbjct: 126 WILHRDLKTSNLL---------------------------LNNRGILKICDFGLAREYGS 158
Query: 240 QDHSY--VVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
Y +V T YRAPE++LG ++ D+WSVGCI EL + + LF ++ L
Sbjct: 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD-----GATSRDSMRAVWKLLR--LPN 349
+ ++LG P EK WP GA + + + LR P
Sbjct: 219 IFKLLG-TP----------TEK--------IWPGFSELPGAKKKTFTKYPYNQLRKKFPA 259
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
L + DLL LL YDPA+R+ A +AL+HP+F
Sbjct: 260 LSLSDNGF------DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 90/337 (26%), Positives = 143/337 (42%), Gaps = 95/337 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------------RSINKYREAAMIEI- 139
++ L K+GEGT+ V + + E+VA+K + R I+ +E I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 140 ---DVL--------------QRLARH-DIGGTRYRSFPIDLVRELGRQLLESVAFMHELR 181
DV+ + L ++ D G R + + V+ QLL+ +AF HE R
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-------- 233
++H DLKP+N+L+ +K G +KL DFG
Sbjct: 121 VLHRDLKPQNLLI-----------------NKRGE----------LKLADFGLARAFGIP 153
Query: 234 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
TF ++ V T YRAP+V+LG ++ D+WSVGCI+ E+ +G LF N +
Sbjct: 154 VNTFSNE-----VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
L + R++G P + +Y + +P P +
Sbjct: 209 QLLKIFRIMGT-PTESTWPGISQLPEY-----KPTFP---------------RYPPQDLQ 247
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
Q H+ IDLL LL+ +P R+ A +AL+HP+F
Sbjct: 248 QLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 83/338 (24%), Positives = 136/338 (40%), Gaps = 76/338 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRL--- 145
Y IL K+GEGTFG+V + + +VA+K + ++ ++ A+ EI +L++L
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHP 67
Query: 146 --------------ARHDIGGTRYRSFPI---DLVRELG---------------RQLLES 173
G+ Y P DL L QLLE
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEG 127
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ ++HE ++H D+K NIL+ + +K+ D+ L+R N G
Sbjct: 128 INYLHENHILHRDIKAANILIDNQGILKIADFG-LARPYDGPPP--NPKGGGG------G 178
Query: 234 STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENL 291
T ++ +V TR YR PE++LG Y D+W +GC+ E+ + + Q ++
Sbjct: 179 GTR----KYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
+ L ++ ++ G WP G S V P +
Sbjct: 234 DQLHLIFKLCGTPTEE-------------------TWP-GWRSLPGCEGVHSFTNYPRTL 273
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + +DLL LL DP +RL A +AL HP+F
Sbjct: 274 EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 88/332 (26%), Positives = 131/332 (39%), Gaps = 89/332 (26%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD--- 149
L+++GEGT+G V D E+VA+K VR ++ R+ I EI +L L RH
Sbjct: 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RHPNIV 69
Query: 150 -----IGGTRYRS----------------------FPIDLVRELGRQLLESVAFMHELRL 182
+ G S F V+ L QLL + ++HE +
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQD 241
IH DLK N+LL +K+ DFG + T+
Sbjct: 130 IHRDLKVSNLLLTD---------------------------KGCLKIADFGLARTYGLPA 162
Query: 242 HSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
V T YRAPE++LG + D+W+VGCIL EL + + L +E L ++
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDH 357
++LG P+ + WP S + + L + P N +
Sbjct: 223 QLLGT-PNESI------------------WPG--FSDLPLVGKFTLPKQPYNNLKHKFPW 261
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + LL LL YDP +R A EAL +F
Sbjct: 262 LSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 71/326 (21%), Positives = 123/326 (37%), Gaps = 105/326 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDI-- 150
+ IL K+G+G FG+V + + VAIK+++ + +E + EI +L++ +I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 151 -------------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
GG+ ++ + + ++LL+ + ++H +IH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH-QDH 242
D+K NILL + DG +KLIDFG S +
Sbjct: 122 RDIKAANILL-----------------TSDGE----------VKLIDFGLSAQLSDTKAR 154
Query: 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302
+ +V T ++ APEVI G ++Y D+WS+G +EL G+ + E A+ +
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKALFKIATN 212
Query: 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362
P L P + D
Sbjct: 213 GPP-------------------GLRNP----------------------EKWSDE----F 227
Query: 363 IDLLQGLLRYDPAERLKAREALRHPF 388
D L+ L+ +P +R A + L+HPF
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 42/227 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYR--EAAMIEIDVLQRLARH- 148
++ +GEG+F VV + E + AIKI+ R + K + + IE +VL RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 149 -------------------------DIGG--TRYRSFPIDLVRELGRQLLESVAFMHELR 181
++ +Y S R ++L ++ ++H
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 182 LIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+IH DLKPENILL ++K+ D+ K L +S S N ++ I +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES---NKGDATNIDSQIEKNRRR- 178
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
+ V T Y +PE++ DLW++GCI+ ++ +G+ F
Sbjct: 179 ---FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 92/333 (27%), Positives = 139/333 (41%), Gaps = 93/333 (27%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLAR------ 147
+ K+GEGT+G V + + E+VA+K +R A+ EI +L+ L
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 148 HDIGGTRYRSF----------------------PIDLVRELGRQLLESVAFMHELRLIHT 185
D+ T + + P+ L++ QLL+ +AF H R++H
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--------TF 237
DLKP+N+L+ + +G AIKL DFG T+
Sbjct: 125 DLKPQNLLI-----------------NTEG----------AIKLADFGLARAFGVPVRTY 157
Query: 238 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
H+ V T YRAPE++LG ++ D+WS+GCI E+ + ALF ++ L
Sbjct: 158 THE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ R LG P +V Y + + W R V +P L
Sbjct: 213 IFRTLGT-PDEVVWPGVTSLPDY--KPSFPKWA-----RQDFSKV-----VPPL------ 253
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
D DLL +L YDP +R+ A+ AL HPFF
Sbjct: 254 --DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 97/338 (28%), Positives = 151/338 (44%), Gaps = 94/338 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--IVRSINKY-REAAMIEIDVLQRLARHD 149
+Y L +GEG++G V++C E ++VAIK + +K ++ AM EI +L++L RH+
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60
Query: 150 -----IGGTRYR-------------------SFPIDL----VRELGRQLLESVAFMHELR 181
I R + +P L VR+ Q+L + F H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
+IH D+KPENIL VS +S +KL DFG + T
Sbjct: 121 IIHRDIKPENIL-VS--------------------------QSGVVKLCDFGFARTLAAP 153
Query: 241 DHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
Y V+TR YRAPE+++G + D+W+VGC++ E+ +GE LF +++ L +
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213
Query: 298 ERVLGPL-PHHMVIRADRRAEKYFRR-----GARLDWPDGATSRDSMRAVWKLLRLPNLI 351
+ LG L P H I F++ G RL P+ + + R P L
Sbjct: 214 IKCLGNLIPRHQEI---------FQKNPLFAGMRL--PE-VKEIEPLEK-----RFPKL- 255
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+G ++DL + LR DP +R + + L H FF
Sbjct: 256 -------SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 86/354 (24%), Positives = 145/354 (40%), Gaps = 81/354 (22%)
Query: 85 AIGENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------ 137
+ +++ RY +GEGT+G+V + +D ++VAIK V+ I +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVG 59
Query: 138 ----------EIDVLQRLARHDIGGTR----YRSFPIDLVRELG---------------- 167
E+ ++ + +I G F I+LV ++
Sbjct: 60 MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLKKVVDRKIRLTE 118
Query: 168 -------RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
Q+L + +H+ +H DL P NI + S K+ D+ L+R Y
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG-LARRYGYPPYSDT 177
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC 279
L K ++ ++ + V T YRAPE+++G +++ D+WSVGCI EL
Sbjct: 178 LSKDETMQR---------REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 280 SGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM 338
+G+ LF ++ L + +LG P +WP A
Sbjct: 229 TGKPLFPGENEIDQLGRIFELLGTPNED--------------------NWPQ-AKKLPLY 267
Query: 339 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
R P + +++ D IDLLQ LL+ +P ER+ A+EAL+H +F D
Sbjct: 268 TEFTP--RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 92/341 (26%), Positives = 140/341 (41%), Gaps = 103/341 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLAR-- 147
Y+ + K+GEGT+G V + D E+VA+K +R + E A+ EI +L+ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKELNHPN 59
Query: 148 ----HDIGGTRYR----------------------SFPIDLVRELGRQLLESVAFMHELR 181
D+ + + L++ QLL+ +A+ H R
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST------ 235
++H DLKP+N+L + + A+KL DFG
Sbjct: 120 VLHRDLKPQNLL---------------------------IDREGALKLADFGLARAFGVP 152
Query: 236 --TFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENL 291
T+ H+ V T YRAPE++LG Y P D+WS+GCI E+ + LF +
Sbjct: 153 VRTYTHE-----VVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI 206
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV---WKLLRLP 348
+ L + R LG P V WP G TS + W L
Sbjct: 207 DQLFRIFRTLGT-PDEDV------------------WP-GVTSLPDYKPTFPKWARQDLS 246
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
++ D +DLL +L YDPA+R+ A+ AL+HP+F
Sbjct: 247 KVVPNL-DEDG---LDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 83/344 (24%), Positives = 134/344 (38%), Gaps = 89/344 (25%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-------------------------- 123
+ RY+ + +G G +G V D + VAIK
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 124 ---IV--RSINKYREAAMIEIDVLQRLARHDIGGTRYRSFPI--DLVRELGRQLLESVAF 176
I+ R I + A ++ V+ L D+ + P+ + +R QLL + +
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+H +IH DLKP N+L+ +++ D+ + LS S + YF
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT------------- 169
Query: 234 STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLE 292
E+ V+TR YRAPE++L L + D+WSVGCI E+ LF +
Sbjct: 170 ----EY------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219
Query: 293 HLAMMERVLGPLPHHMV--IRADRRAEKY---FRRGARLDWPDGATSRDSMRAVWKLLRL 347
L ++ VLG ++ I +D R KY R + W
Sbjct: 220 QLKLILSVLGSPSEEVLNRIGSD-RVRKYIQNLPRKQPVPWSKIFPKASP---------- 268
Query: 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ +DLL +L++DP ER+ +AL+HPF +
Sbjct: 269 -------------EALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 96/340 (28%), Positives = 136/340 (40%), Gaps = 92/340 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y L K+GEGT+G+V + D +LVA+K R A+ EI +LQ L+ I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESI 61
Query: 151 --------------------------------------GGTRYRSFPIDLVRELGRQLLE 172
G R P ++ QLL+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 173 SVAFMHELRLIHTDLKPENILL-VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 231
VA H+ ++H DLKP+N+L+ +K+ D L R+ I
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG-LGRAFS----------------IP 164
Query: 232 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 290
S T E + T YRAPEV+LG ++ P D+WSVGCI E+ + LF
Sbjct: 165 VKSYTHE-------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217
Query: 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKLLRLPN 349
L+ L + ++LG P V WP + RD WK L
Sbjct: 218 LQQLLHIFKLLGT-PTEQV------------------WPGVSKLRDWHEFPQWKPQDLSR 258
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ +DLLQ +LRYDPA+R+ A+ AL HP+F
Sbjct: 259 AVPDLSPEG----LDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 88/335 (26%), Positives = 144/335 (42%), Gaps = 90/335 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y + K+GEGT+G V + + + ++VA+K +R ++ A+ EI +L+ L +I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 151 GG----------------------TRY-------RSFPIDLVRELGRQLLESVAFMHELR 181
+Y + +LV+ Q+L+ + F H R
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFE 238
++H DLKP+N+L+ IKL DFG +
Sbjct: 122 VLHRDLKPQNLLI---------------------------DNKGVIKLADFGLARAFGIP 154
Query: 239 HQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+ +++ V T YRAPEV+LG ++ P D+WS+G I E+ + + LF ++ L +
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV---WKLLRLPNLIMQH 354
R+LG P V WP G TS + WK +
Sbjct: 215 FRILGT-PTEDV------------------WP-GVTSLPDYKNTFPKWK----KGSLRSA 250
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
V + D +DLL+ +L YDPA+R+ A++AL HP+F
Sbjct: 251 VKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-26
Identities = 75/327 (22%), Positives = 126/327 (38%), Gaps = 116/327 (35%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMI--EIDVLQRL----------A 146
G+G+FG+V+ + +L A+K+++ I K +E E ++L R+ A
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61
Query: 147 RHD-----------IGG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 189
GG ++ F + R +++ ++ ++H L +I+ DLKP
Sbjct: 62 FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121
Query: 190 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS----TTFEHQDHSYV 245
ENILL DG IKL DFG ++ + +++
Sbjct: 122 ENILL-----------------DADGH----------IKLTDFGLAKELSSEGSRTNTF- 153
Query: 246 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 305
T Y APEV+LG G+ D WS+G +L E+ +G+ F + E + E++L
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKIL---- 206
Query: 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365
L +P+ + + DL
Sbjct: 207 -----------------KDPLRFPEFLSP--------------------------EARDL 223
Query: 366 LQGLLRYDPAERLKAREA---LRHPFF 389
+ GLL+ DP +RL + A HPFF
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 90/336 (26%), Positives = 138/336 (41%), Gaps = 77/336 (22%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRL 145
++ PRY+ LS +GEG +G V VAIK + + + + EI +L+R
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 146 ARHDIGGTR-------YRSF----------PIDLVRELGRQ-------------LLESVA 175
+I G + SF DL + + Q +L +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235
++H ++H DLKP N+LL + +K+ D+ L+R A D
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFG-LAR--------------IADPEHDHTGF 165
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
E+ V+TR YRAPE++L G+ D+WSVGCIL E+ S LF + L L
Sbjct: 166 LTEY------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219
Query: 295 AMMERVLGPLPHHMVIRA--DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
++ VLG P + RA Y + L + W L P
Sbjct: 220 NLILGVLGT-PSQEDLNCIISLRARNYIK---SLPFKPKVP--------WNKL-FP---- 262
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+ D A +DLL +L ++P +R+ EAL HP+
Sbjct: 263 -NADPKA---LDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 81/344 (23%), Positives = 118/344 (34%), Gaps = 113/344 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH- 148
YRIL K+GEG+FG+V D + VA+K++ S +K E + EI +L L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 149 --------------------DIGGT----------RYRSFPIDLVRELGRQLLESVAFMH 178
+ G R + Q+L ++ ++H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG----- 233
+IH D+KPENILL +KLIDFG
Sbjct: 119 SKGIIHRDIKPENILLD--------------------------RDGRVVKLIDFGLAKLL 152
Query: 234 ----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC---DLWSVGCILVELCSGEALFQ 286
ST+ S V T Y APEV+LGL Y D+WS+G L EL +G F+
Sbjct: 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
+N + +++ LP +
Sbjct: 213 GEKNSSATSQTLKIILELPTPSL------------------------------------- 235
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
L + + + DLL+ LL DP RL + L H
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 88/354 (24%), Positives = 146/354 (41%), Gaps = 113/354 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + K++VA+K V N+ +E A+ EI +LQ L
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHE 71
Query: 149 DI------------GGTRYRS-----------------------FPIDLVRELGRQLLES 173
++ RY+ F + ++++ + LL
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ ++H +++H D+K NIL+ +KDG +KL DFG
Sbjct: 132 LYYIHRNKILHRDMKAANILI-----------------TKDG----------ILKLADFG 164
Query: 234 -----STTFEHQDHSYV--VSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEAL 284
S + + + Y V T YR PE++LG +Y P D+W GCI+ E+ + +
Sbjct: 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPI 223
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
Q + L ++ ++ G + + WP G + ++K
Sbjct: 224 MQGNTEQHQLTLISQLCGSITPEV-------------------WP-GVDKLE----LFKK 259
Query: 345 LRLPNLIMQHV---------DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ LP + V D A DLID LL DPA+R+ A AL H FF
Sbjct: 260 MELPQGQKRKVKERLKPYVKDPHALDLIDK---LLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 91/359 (25%), Positives = 142/359 (39%), Gaps = 116/359 (32%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVL 142
G+ ++ I+ ++GEGT+GQV + D + ELVA+K VR N+ +E A+ EI +L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKIL 60
Query: 143 QRLAR----------------------------------HDIGG---TRYRSFPIDLVRE 165
++L HD+ G + F D ++
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 166 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225
+QLLE + + H+ +H D+K NILL
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILL---------------------------NNKG 153
Query: 226 AIKLIDFGSTTFEHQDHS--YV--VSTRHYRAPEVILGLGWNYPC-DLWSVGCILVELCS 280
IKL DFG + + S Y V T YR PE++LG P D+WS GCIL EL +
Sbjct: 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
Query: 281 GEALFQTHENLEHLAMMERVLGP-----------LPHHMVIRADRRAEKYFRRGARLDWP 329
+ +FQ ++ L L ++ R+ G LP+ + + +K +RR R ++
Sbjct: 214 KKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTM----KPKKQYRRRLREEF- 268
Query: 330 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+DLL +L DP++R A EAL P+
Sbjct: 269 --------------------------SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 74/325 (22%), Positives = 119/325 (36%), Gaps = 104/325 (32%)
Query: 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD--------- 149
G +G+V ++ AIK+++ + R+ + E D+L + A+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQ-AQSPYVVKLYYSF 62
Query: 150 -------------IGGTRYR------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 190
GG S D+ R +++ ++ ++H +IH DLKP+
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPD 122
Query: 191 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRH 250
NIL+ S ++K+ D+ SK G + + + K + +V T
Sbjct: 123 NILIDSNGHLKLTDFGL----SKVGLVRRQINLNDDEK------------EDKRIVGTPD 166
Query: 251 YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVI 310
Y APEVILG G + D WS+GCIL E G F
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH------------------------ 202
Query: 311 RADRRAEKYFR--RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368
E+ F+ +++WP+ D + IDL+
Sbjct: 203 --GETPEEIFQNILNGKIEWPEDVEVSD------------------------EAIDLISK 236
Query: 369 LLRYDPAERLKAR---EALRHPFFT 390
LL DP +RL A+ E HPFF
Sbjct: 237 LLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 93/335 (27%), Positives = 145/335 (43%), Gaps = 80/335 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMI--EIDVLQRLARH- 148
RY+I +G+G++G V D E VAIK + + ++ +A I EI +L RL RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLL-RLLRHP 59
Query: 149 DIGGTRYRSFP--------IDLVRELGR-----------------------QLLESVAFM 177
DI ++ P I +V EL QLL ++ ++
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H + H DLKP+NIL + +K+ D+ L+R + F + P +AI D+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFG-LARVA-----FNDTP--TAIFWTDY----- 166
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLA 295
V+TR YRAPE+ Y D+WS+GCI E+ +G+ LF + L
Sbjct: 167 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218
Query: 296 MMERVLGPLPHHMVIRA-DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
++ +LG + R + +A +Y SMR + P Q
Sbjct: 219 LITDLLGTPSPETISRVRNEKARRYL---------------SSMRK-----KQPVPFSQK 258
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
++ + LL+ LL +DP +R A EAL P+F
Sbjct: 259 FPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 87/365 (23%), Positives = 138/365 (37%), Gaps = 117/365 (32%)
Query: 93 RYRILSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINK---------YREAAMI-EID 140
+Y I +G GT+G+V + + + + AIK + + RE A++ E+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 141 -----VLQRL---------------ARHDIGG-------TRYRSFPIDLVRELGRQLLES 173
L + A HD+ + S P +V+ L Q+L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
V ++H ++H DLKP NIL++ +G P+ +K+ D G
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMG-----------------EG------PERGVVKIGDLG 157
Query: 234 STTFEHQ------DHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQ 286
+ D VV T YRAPE++LG + D+W++GCI EL + E +F+
Sbjct: 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
Query: 287 THE------NLEHLAMMER---VLGP-----------LPHHMVIRADRRAEKYFRRGARL 326
E N +ER VLG +P + + D + + Y
Sbjct: 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTY------- 270
Query: 327 DWPDGATSRDSMRAVWKLLRLPNLI--MQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 384
+L M+ DLL+ LL YDP +R+ A EAL
Sbjct: 271 -------------------PSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311
Query: 385 RHPFF 389
HP+F
Sbjct: 312 EHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-23
Identities = 76/335 (22%), Positives = 131/335 (39%), Gaps = 115/335 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y I+ ++G+G+FG+V +L +K + N K RE A+ E+ +L++L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 150 ----------------I------GGT----------RYRSFPIDLVRELGRQLLESVAFM 177
I GG + FP + + + QL ++ ++
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 236
H +++H D+KP+NI L + +G +KL DFG S
Sbjct: 120 HSRKILHRDIKPQNIFL-----------------TSNGL----------VKLGDFGISKV 152
Query: 237 FEH-QDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
D + VV T +Y +PE+ +NY D+WS+GC+L ELC+ + F+ ENL L
Sbjct: 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GENLLEL 211
Query: 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
A+ +++ +P+
Sbjct: 212 AL-----------KILKGQYPP------------------------------IPS----- 225
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ +L +L+ LL+ DP ER + L+ PF
Sbjct: 226 --QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 89/344 (25%), Positives = 138/344 (40%), Gaps = 107/344 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------SINKYREAAMIE------ 138
+Y L K+GEGT+G V + + E E+VA+K VR + RE +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 139 ----IDVL--------------QRLARH--DIGGTRYRSFPIDLVRELGRQLLESVAFMH 178
DVL Q L ++ G +V+ QLL+ +AF H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPE----IVKSFMFQLLKGLAFCH 116
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---ST 235
++H DLKP+N+L+ +K+G +KL DFG +
Sbjct: 117 SHNVLHRDLKPQNLLI-----------------NKNGE----------LKLADFGLARAF 149
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEH 293
+ +S V T YR P+V+ G ++ D+WS GCI EL +G LF ++ +
Sbjct: 150 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
L + R+L G + +S V KL M
Sbjct: 210 LKRIFRLL-----------------------------GTPTEESWPGVSKLPDYKPYPMY 240
Query: 354 HVDHSAGDLI--------DLLQGLLRYDPAERLKAREALRHPFF 389
S +++ DLLQ LL +P +R+ A EAL+HP+F
Sbjct: 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 83/336 (24%), Positives = 144/336 (42%), Gaps = 85/336 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMI------- 137
RY+ L+ +G G +G V +D ++ VA+K ++ + YRE ++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 138 ------------------EIDVLQRLARHDIGG-TRYRSFPIDLVRELGRQLLESVAFMH 178
E+ ++ L D+ + + + V+ L QLL + ++H
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+IH DLKP N+ + + ++++DFG
Sbjct: 136 SAGIIHRDLKPSNVAV---------------------------NEDCELRILDFGLARQA 168
Query: 239 HQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA-M 296
+ + V+TR YRAPE++L + +N D+WSVGCI+ EL G+ALF ++ ++ L +
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
ME V P P + + A KY + L +P ++ +
Sbjct: 229 MEVVGTPSPEVLKKISSEHARKYIQ---------------------SLPHMPQQDLKKIF 267
Query: 357 HSAGDL-IDLLQGLLRYDPAERLKAREALRHPFFTR 391
A L IDLL+ +L D +R+ A EAL HP+F++
Sbjct: 268 RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 80/335 (23%), Positives = 143/335 (42%), Gaps = 83/335 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIE------ 138
RY+ LS +G G +G V FD + VA+K I+ + YRE +++
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 139 ----IDVLQ-----------RLARHDIGG-----TRYRSFPIDLVRELGRQLLESVAFMH 178
+DV L H +G + + D V+ L Q+L + ++H
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+IH DLKP N+ + + +K++DFG
Sbjct: 138 SADIIHRDLKPSNLAV---------------------------NEDCELKILDFGLARHT 170
Query: 239 HQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+ + V+TR YRAPE++L + +N D+WSVGCI+ EL +G LF ++++ L ++
Sbjct: 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
R++G ++ + + + + + L ++P + +V
Sbjct: 231 LRLVGTPGAELLKKISSESARNY--------------------IQSLTQMPKMNFANVFI 270
Query: 358 SAGDL-IDLLQGLLRYDPAERLKAREALRHPFFTR 391
A L +DLL+ +L D +R+ A +AL H +F +
Sbjct: 271 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 86/333 (25%), Positives = 133/333 (39%), Gaps = 84/333 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK-------YREAAMIE------ 138
RY L ++G G +G V D E VAIK + R YRE +++
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 139 -IDVLQRLA------------------RHDIGGTRYRSFPIDLVRELGRQLLESVAFMHE 179
I +L + D+ D V+ L Q+L + ++H
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
+IH DLKP N+ + + +K++DFG
Sbjct: 136 AGIIHRDLKPGNLAV---------------------------NEDCELKILDFGLARHAD 168
Query: 240 QDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ + V TR YRAPEVIL + +N D+WSVGCI+ E+ +G+ LF+ + L+ L +
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 299 RVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
+V G P P + D+ A+ Y + L + P +
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIK---------------------SLPKYPRKDFSTLFP 267
Query: 358 SAGDL-IDLLQGLLRYDPAERLKAREALRHPFF 389
A +DLL+ +L D +RL A EAL HP+F
Sbjct: 268 KASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 83/342 (24%), Positives = 138/342 (40%), Gaps = 101/342 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIE------ 138
RY+ LS +G G +GQV FD + VAIK + + YRE +++
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 139 ----IDVLQR---------------LARHDIGGT-RYRSFPIDLVRELGRQLLESVAFMH 178
+DV L D+ + + D ++ L Q+L + ++H
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---ST 235
+IH DLKP NI + + +K++DFG T
Sbjct: 136 SAGIIHRDLKPSNI---------------------------AVNEDCELKILDFGLARHT 168
Query: 236 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
E + V+TR YRAPE++L + +N D+WSVGCI+ EL +G+ LF ++++ L
Sbjct: 169 DDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225
Query: 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
+ ++G ++ + + + + + LP M
Sbjct: 226 KRIMNLVGTPDEELLQKISSESARNYIQS-----------------------LP--QMPK 260
Query: 355 VD-------HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
D + IDLL+ +L DP +R+ A EAL HP+
Sbjct: 261 KDFKEVFSGANP-LAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 80/335 (23%), Positives = 124/335 (37%), Gaps = 86/335 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAA-MIEIDVLQRLARH 148
+ ++ +G G FG+V D + ++ A+K++R I + + A E D+L
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 149 DI---------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
I GG R FP + R +L+ ++ +H+L
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
IH D+KP+NIL+ + ++K+ D+ + +KD Y+ N + +
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 240 QDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
Q V T Y APEV+ G + CD WS+G IL E+ G F
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY---------- 231
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL-LRLPNLIMQHV 355
+D E Y + + WK LR P
Sbjct: 232 ---------------SDTLQETYNK---------------IIN--WKESLRFP----PDP 255
Query: 356 DHSAGDLIDLLQGLLRYDPAERLK-AREALRHPFF 389
S + IDL+ LL DP +RL E HPFF
Sbjct: 256 PVSP-EAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 6e-22
Identities = 89/328 (27%), Positives = 139/328 (42%), Gaps = 78/328 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLAR-- 147
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKNLKHAN 64
Query: 148 ----HDIGGTRY------RSFPIDLVRELGR---------------QLLESVAFMHELRL 182
HDI T DL + L QLL +++ H+ ++
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H DLKP+N+L+ +K+ D+ L+R+ K++P + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFG-LARA-------KSVPTKT----------------Y 160
Query: 243 SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
S V T YR P+V+LG ++ P D+W VGCIL E+ +G +F E L ++ R+L
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
G WP G TS + R+ ++ H D
Sbjct: 221 GTPTEE-------------------TWP-GITSNEEFRSYLFPQYRAQPLINHAPRLDTD 260
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389
IDLL LL Y+ R+ A ALRH +F
Sbjct: 261 GIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 8e-22
Identities = 89/345 (25%), Positives = 150/345 (43%), Gaps = 99/345 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLAR- 147
+Y + K+GEGT+G V + D E +A+K +R + + E A+ EI +L+ +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHG 61
Query: 148 -----HDIGGTRYRSFPI------DLVRELGR----------------QLLESVAFMHEL 180
D+ + R + + DL + + Q+L +A+ H
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST----- 235
R++H DLKP+N+L + R ++A+KL DFG
Sbjct: 122 RVLHRDLKPQNLL--------------IDRR------------TNALKLADFGLARAFGI 155
Query: 236 ---TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
TF H+ V T YRAPE++LG ++ P D+WSVGCI E+ + + LF +
Sbjct: 156 PVRTFTHE-----VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL- 350
+ L + R+LG WP G TS ++ + +L
Sbjct: 211 DELFKIFRILGTPNEET-------------------WP-GVTSLPDYKSAFPKWPPKDLA 250
Query: 351 -IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394
++ ++ + +DLL +LR DP++R+ AR AL H +F +D+
Sbjct: 251 TVVPTLEPAG---VDLLSKMLRLDPSKRITARAALEHEYF-KDLG 291
|
Length = 294 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 77/331 (23%), Positives = 128/331 (38%), Gaps = 109/331 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y+ L K+GEG G+V + D + VAIK +R + +E + EI +++ +I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI-VD 79
Query: 154 RYRSFPID----LVREL---G----------------------RQLLESVAFMHELRLIH 184
Y S+ + +V E G R++L+ + ++H +IH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIH 139
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFEHQD 241
D+K +NILL SKDGS +KL DFG T E
Sbjct: 140 RDIKSDNILL-----------------SKDGS----------VKLADFGFAAQLTKEKSK 172
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ VV T ++ APEVI + D+WS+G + +E+ GE
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE------------------- 213
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-MRAVWKLLRLPNLIMQHVDHSAG 360
P ++ R+ +RA++ + +++ + +
Sbjct: 214 ---PPYL--------------------------REPPLRALFLITTKGIPPLKNPEKWSP 244
Query: 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ D L L DP +R A E L+HPF +
Sbjct: 245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 62/252 (24%), Positives = 101/252 (40%), Gaps = 73/252 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARH 148
R++ +K+G GTFG+V + + EL+A+K +R I + E+ VL+ L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHP 59
Query: 149 DI---------------------GGT-----RY-RSFPIDLVRELGRQLLESVAFMHELR 181
++ GGT + R ++R QLLE +A++H
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS------- 234
++H D+KP NI L + IKL DFG
Sbjct: 120 IVHRDIKPANIFLD---------------------------HNGVIKLGDFGCAVKLKNN 152
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSG----EALFQT 287
TT ++ + T Y APEVI G G D+WS+GC+++E+ +G L
Sbjct: 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
Query: 288 HENLEHLAMMER 299
+ + H+ +
Sbjct: 213 FQIMFHVGAGHK 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 87/332 (26%), Positives = 143/332 (43%), Gaps = 83/332 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLAR--- 147
Y+ L K+GEG++ V + +LVA+K +R + A A+ E +L+ L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANI 65
Query: 148 ---HDIGGTRYRSFPI-------DL---------------VRELGRQLLESVAFMHELRL 182
HDI T+ ++ + DL VR QLL +A+ H+ R+
Sbjct: 66 VTLHDIIHTK-KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRV 124
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H DLKP+N+L+ +K+ D+ L+R+ K++P S T+ ++
Sbjct: 125 LHRDLKPQNLLISERGELKLADFG-LARA-------KSVP-----------SKTYSNE-- 163
Query: 243 SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN-LEHLAMMERV 300
V T YR P+V+LG ++ D+W VGCI E+ +G LF + + L + RV
Sbjct: 164 ---VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV 220
Query: 301 LG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-- 357
LG P WP G +S + P ++ H
Sbjct: 221 LGTPTEE--------------------TWP-GVSSNPEFKPYSFPFYPPRPLINHAPRLD 259
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+L L+Y+P +R+ A EA++HP+F
Sbjct: 260 RIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 65/223 (29%), Positives = 95/223 (42%), Gaps = 62/223 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLARHD 149
Y++ +G G FG V + + E + VAIK + EA M EID+L+ L +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 150 I---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRL 182
I G+ ++ FP LV Q+L+ +A++HE +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT----FE 238
IH D+K NIL +KDG +KL DFG T
Sbjct: 121 IHRDIKAANILT-----------------TKDGV----------VKLADFGVATKLNDVS 153
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
D S VV T ++ APEVI G + D+WS+GC ++EL +G
Sbjct: 154 KDDAS-VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 93/356 (26%), Positives = 137/356 (38%), Gaps = 92/356 (25%)
Query: 81 HYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSIN 129
Y +G++ + RY+ L +G G G V +D + VAIK + +
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 130 KYREAAMIEIDVLQRLARH-DIGG-----TRYRSFP----IDLVRELGR----------- 168
YRE VL +L H +I G T +S + LV EL
Sbjct: 62 AYREL------VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL 115
Query: 169 ----------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
Q+L + +H +IH DLKP NI++ S
Sbjct: 116 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------------- 153
Query: 219 KNLPKSSAIKLIDFG-----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
+K++DFG T+F YVV TR+YRAPEVILG+G+ D+WSVGC
Sbjct: 154 -----DCTLKILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 274 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR-RGARLDWPDGA 332
I+ E+ G LF ++++ + LG + R Y R +
Sbjct: 206 IMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEE 265
Query: 333 TSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
D + P H A DLL +L DP +R+ +AL+HP+
Sbjct: 266 LFPDVL--------FPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 87/350 (24%), Positives = 144/350 (41%), Gaps = 93/350 (26%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLAR 147
+L RY L +G G+ G V D++ + VA+K IV + + + A+ EI +++RL
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH 61
Query: 148 HDI---------GGTR----------YRSFPI-------DLVR--ELGR----------- 168
+I G+ S I DL E G
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
QLL + ++H ++H DLKP N+ + + + V +K
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLV--------------------------LK 155
Query: 229 LIDFG-----STTFEHQDH-SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSG 281
+ DFG + H+ + S + T+ YR+P ++L + D+W+ GCI E+ +G
Sbjct: 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
+ LF LE M+ +L +P V+R + R E DG R +R +
Sbjct: 216 KPLFAGAHELE---QMQLILESVP---VVREEDRNE-LLNVIPSFVRNDGGEPRRPLRDL 268
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
LP V+ A +D L+ +L ++P +RL A EAL HP+ +
Sbjct: 269 -----LPG-----VNPEA---LDFLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 84/337 (24%), Positives = 128/337 (37%), Gaps = 89/337 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------SINKYREAAMI------- 137
+Y ++++G G +G V + D VA+K VR ++ RE A++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 138 ------------------EIDVLQRLARHDIGGTRYRS------FPIDLVRELGRQLLES 173
E V D Y P + +++L RQ L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ F+H ++H DLKPENIL+ S VK+ D+ ++ S
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGL----ARIYSC---------------- 160
Query: 234 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ VV T YRAPEV+L + P D+WSVGCI E+ + LF + +
Sbjct: 161 -----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP-DGATSRDSMRAVWKLLRLPNLIM 352
L + ++G LP DWP D R + R P +
Sbjct: 216 LGKIFDLIG-LP------------------PEDDWPRDVTLPRGAFSP-----RGPRPVQ 251
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
V LL +L ++P +R+ A AL+HPFF
Sbjct: 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 84/334 (25%), Positives = 142/334 (42%), Gaps = 85/334 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RYR L ++G G +G V D VAIK + R + + A E+ +L+ + +H+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHE 74
Query: 150 --IG------------------------GT------RYRSFPIDLVRELGRQLLESVAFM 177
IG GT ++ D ++ L Q+L+ + ++
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H +IH DLKP N L V+ + +K++DFG
Sbjct: 135 HAAGIIHRDLKPGN-LAVNED--------------------------CELKILDFGLARQ 167
Query: 238 EHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ + V TR YRAPEVIL + + D+WSVGCI+ E+ +G+ LF+ H++L+ L
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227
Query: 297 MERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
+ +V G V + A+ Y ++ R D + ++ +
Sbjct: 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS-----------------LLPNA 270
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ A +++L+ +L D R+ A EAL HP+F
Sbjct: 271 NPLA---VNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 59/287 (20%)
Query: 111 CFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRYRSFPI--DLVREL 166
CF L A+ I++ I+ + E I V+ L + D+ P+ D V+
Sbjct: 54 CFFKHDNVLSALDILQPPHIDPFEE-----IYVVTELMQSDLHKIIVSPQPLSSDHVKVF 108
Query: 167 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226
Q+L + ++H ++H D+KP N+L+ S +
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNS---------------------------NCV 141
Query: 227 IKLIDFGSTTFEHQDHSYV----VSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSG 281
+K+ DFG E D S V T++YRAPE+++G + D+WSVGCI EL
Sbjct: 142 LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
LFQ ++ L ++ +LG + A A + RG P S +
Sbjct: 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG-----PHKPPSLPVLY-- 254
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+ H A + LL +L +DP +R+ A +AL HP+
Sbjct: 255 --------TLSSQATHEA---VHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 88/346 (25%), Positives = 143/346 (41%), Gaps = 92/346 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI---------------- 137
Y++ + +G G+FG V E + E VAIK V +Y+ ++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 138 ---------EIDVLQRLARHDIGGTRYR----------SFPIDLVRELGRQLLESVAFMH 178
E ++ + I T ++ + P+ LV+ QL ++A++H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 236
+ H DLKP+N+L+ P + +KL DFGS
Sbjct: 188 SKFICHRDLKPQNLLID--------------------------PNTHTLKLCDFGSAKNL 221
Query: 237 -FEHQDHSYVVSTRHYRAPEVILGLGWNYPC--DLWSVGCILVELCSGEALFQTHENLEH 293
+ SY+ S R YRAPE++LG NY DLWS+GCI+ E+ G +F +++
Sbjct: 222 LAGQRSVSYICS-RFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
Query: 294 LAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
L + +VLG P + A+ F PD +D ++ V+
Sbjct: 280 LVRIIQVLGTPTEDQLKEMNPNYADIKF--------PD-VKPKD-LKKVFP--------- 320
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+ D I+ + L+Y+P +RL EAL PFF D+R P +
Sbjct: 321 ---KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD-DLRDPCI 362
|
Length = 440 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 85/334 (25%), Positives = 139/334 (41%), Gaps = 86/334 (25%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQR 144
+T RY L +G G FG V D + VAIK + + + + E+ +L+
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 145 LARHD--IGGTRYRSFP---IDLVREL----------------------GRQLLESVAFM 177
L RH+ I + P I V EL Q+L + ++
Sbjct: 66 L-RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 236
H ++H DLKP NIL+ ++ +K+ DFG +
Sbjct: 125 HSAGVVHRDLKPSNILI---------------------------NENCDLKICDFGLARI 157
Query: 237 FEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
+ Q YV STR+YRAPE++L ++ D+WS GCI E+ G+ LF +++ +
Sbjct: 158 QDPQMTGYV-STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS 216
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL-LRLPNLIMQH 354
++ +LG P ++ S +++R V L R P +
Sbjct: 217 IITDLLGTPPDDVINTI--------------------CSENTLRFVQSLPKREPVPFSEK 256
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
++ IDLL+ +L +DP +R+ A EAL HP+
Sbjct: 257 FKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 73/326 (22%), Positives = 121/326 (37%), Gaps = 109/326 (33%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRYR 156
G G FG+V K A+K V R I + + I E ++L+ H YR
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLYR 60
Query: 157 SFP-----------------IDLVRELGR-----------QLLESVAFMHELRLIHTDLK 188
+F ++R+ G ++ + ++H +I+ DLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 248
PEN+LL S YVK+ D+ F K + G T+ T
Sbjct: 121 PENLLLDSNGYVKLVDFGF-------------------AKKLKSGQKTWT------FCGT 155
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM 308
Y APE+IL G+++ D WS+G +L EL +G F ++ + + + +L
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE-DDEDPMEIYNDIL------- 207
Query: 309 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368
+ +L++P ++D +A DLI
Sbjct: 208 ------------KGNGKLEFP-----------------------NYIDKAAKDLIK---Q 229
Query: 369 LLRYDPAERL-----KAREALRHPFF 389
LLR +P ERL ++ +H +F
Sbjct: 230 LLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 47/229 (20%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA---------------- 173
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288
T F YVV TR+YRAPEVILG+G+ D+WSVGCI+ EL G +FQ
Sbjct: 174 -----CTNFMMT--PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD-------WPDGATSRDSMRAV 341
++++ + LG + R Y + +PD +S
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSES---- 281
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+ DLL +L DP +R+ EALRHP+ T
Sbjct: 282 -----------ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 85/338 (25%), Positives = 140/338 (41%), Gaps = 82/338 (24%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
+ +Y + +G G +G V ++E E VAIK I + + +A + EI +L R
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLL-RHL 61
Query: 147 RHD--------IGGTRYRSFP-IDLVRELGR-----------------------QLLESV 174
H+ + +F + +V EL QLL +
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
++H ++H DLKP N+LL + +K+ D+ L+R++ + F
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARTTSEKGDFMT-------------- 166
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
YVV TR YRAPE++L + D+WSVGCI EL + LF + +
Sbjct: 167 --------EYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217
Query: 294 LAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
L ++ +LG P + + +A +Y R T R S ++
Sbjct: 218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPY-------TPRQSFARLFP--------- 261
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
H+ IDLL+ +L +DP++R+ EAL HP+
Sbjct: 262 ----HANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 71/335 (21%), Positives = 118/335 (35%), Gaps = 116/335 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARH 148
+ +L +G+G+FG+V + D ++VAIK++ E A EI+ +Q+ L++
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC 56
Query: 149 DI------------------------GGT-----RYRSFPIDLVRELGRQLLESVAFMHE 179
GG+ + + + R++L + ++HE
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHE 116
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST---T 236
IH D+K NILL S++G +KL DFG + T
Sbjct: 117 EGKIHRDIKAANILL-----------------SEEGD----------VKLADFGVSGQLT 149
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ V T + APEVI G++ D+WS+G +EL GE
Sbjct: 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP------------- 196
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
PL MR ++ + + ++
Sbjct: 197 ------PLSDL----------------------------HPMRVLFLIPKNNPPSLEGNK 222
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
S D + L DP ER A+E L+H F +
Sbjct: 223 FSK-PFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 67/252 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD 149
+++L K+G+G++G V + + A+K V S++ K RE A+ EI +L + +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 150 I-------------------------------GGTRYRSFPIDLVRELGRQLLESVAFMH 178
I + + P + + QLL + +H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
E +++H DLK NILLV+ + VK+ D +S+ K KN+ K+
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLG-ISKVLK-----KNMAKT-------------- 160
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ T HY APEV G ++Y D+WS+GC+L E+ + F+ +++ L
Sbjct: 161 ------QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRY-- 211
Query: 299 RVLG----PLPH 306
+V P+P
Sbjct: 212 KVQRGKYPPIPP 223
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 62/235 (26%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+L + ++H ++H DLKP N+L+ + +K+ D+ L+R F P +A
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG-LARG------FSENPGENAGF 165
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC----DLWSVGCILVELCSGEAL 284
+ ++ V+TR YRAPE++L D+WSVGCIL EL + +
Sbjct: 166 MTEY-------------VATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAELLGRKPV 209
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 343
F+ + ++ L + +VLG + R +A+ Y R
Sbjct: 210 FKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR---------------------- 247
Query: 344 LLRLPNL-------IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
LPN+ I + + A +DLL+ LL +DP +R+ EAL HP+
Sbjct: 248 --SLPNIPKKPFESIFPNANPLA---LDLLEKLLAFDPTKRISVEEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 82/328 (25%), Positives = 136/328 (41%), Gaps = 78/328 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLAR-- 147
Y L K+GEGT+ V + LVA+K +R ++ E A + E+ +L+ L
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 148 ----HDIGGTR------YRSFPIDLVRELGR---------------QLLESVAFMHELRL 182
HDI T + DL + L QLL + + H ++
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H DLKP+N+L+ +K+ D+ L+R+ K++P + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFG-LARA-------KSIPTKT----------------Y 161
Query: 243 SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
S V T YR P+++LG ++ D+W VGCI E+ +G LF E L + R+L
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
G WP G S + ++ + + H D
Sbjct: 222 GTPTEET-------------------WP-GILSNEEFKSYNYPKYRADCLHNHAPRLDSD 261
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389
+LL LL+++ +R+ A EA++HP+F
Sbjct: 262 GAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
P + ++++ QLL + F+H R++H DLKP+NIL+ S+ +K+ D+
Sbjct: 108 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL----------- 156
Query: 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
++ F + VV T YRAPEV+L + P DLWSVGCI E+
Sbjct: 157 --------ARIYSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
Query: 279 CSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 337
+ LF+ +++ L + V+G P DWP
Sbjct: 203 FRRKPLFRGSSDVDQLGKILDVIGLPGEE--------------------DWPRDVALPRQ 242
Query: 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + + DLL L ++PA+R+ A AL HP+F
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGK----DLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 7e-18
Identities = 72/325 (22%), Positives = 116/325 (35%), Gaps = 111/325 (34%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------EIDVLQRLARHDI--- 150
+G G+FG V E + + + A+K V + + EI +L +L +I
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 151 ------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTD 186
GG+ +Y SFP ++R RQ+L + ++H+ +H D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--TFEHQDHSY 244
+K NIL+ +G +KL DFG E
Sbjct: 128 IKGANILV-----------------DTNG----------VVKLADFGMAKQVVEFSFAKS 160
Query: 245 VVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303
+ ++ APEVI G + D+WS+GC ++E+ +G+ + LE +A +
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS---QLEGVAAV------ 211
Query: 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363
F+ G + P I H+ A D I
Sbjct: 212 ----------------FKIGRSKELP--------------------PIPDHLSDEAKDFI 235
Query: 364 DLLQGLLRYDPAERLKAREALRHPF 388
L+ DP+ R A E L HPF
Sbjct: 236 LK---CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 65/329 (19%), Positives = 117/329 (35%), Gaps = 109/329 (33%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMIEIDVLQRLARHDI-- 150
+ +G+G+ G V + ++ A+K V ++R+ + E+ L+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 151 -------------------GGT------RYRSFPIDLVRELGRQLLESVAFMH-ELRLIH 184
GG+ + P ++ + RQ+L+ + ++H + +IH
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH---Q 240
D+KP N+L+ + G +K+ DFG S E+ Q
Sbjct: 124 RDIKPSNLLI-----------------NSKGE----------VKIADFGISKVLENTLDQ 156
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300
+++V T Y +PE I G ++Y D+WS+G L+E G+ F +M+ +
Sbjct: 157 CNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215
Query: 301 L-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
GP P P S
Sbjct: 216 CDGPPP---------------------SLPAEEFSP------------------------ 230
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPF 388
+ D + L+ DP +R A E L+HPF
Sbjct: 231 -EFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 84/339 (24%), Positives = 126/339 (37%), Gaps = 120/339 (35%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI-----VRSINKYREAAMIEIDVLQR---- 144
++IL+++G+G +GQV + E+VA+K + +N+ R + E D+L
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTTTKSE 61
Query: 145 ----------------LARHDIGGTRYRSFPIDL-------VRELGRQLLESVAFMHELR 181
LA + G +R+ +L R ++ E+V +HEL
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
IH DLKPEN L+ G IKL DFG S
Sbjct: 122 YIHRDLKPENFLI-----------------DASGH----------IKLTDFGLSKGIVTY 154
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LC-----SGEALFQTHENLEHL 294
+S VV + Y APEV+ G G+++ D WS+GC+L E LC SG +T ENL++
Sbjct: 155 ANS-VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
Query: 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV-WKLLRLPNLIMQ 353
L P R ++ W L+ LI
Sbjct: 214 KET----------------------------LQRPVYDDPRFNLSDEAWDLIT--KLIN- 242
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALR-HPFFTR 391
DP+ R + E ++ HPFF
Sbjct: 243 -------------------DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 47/227 (20%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++ G+ F P
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 177
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288
YVV TR+YRAPEVILG+G+ D+WSVGCI+ E+ + LF
Sbjct: 178 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 289 ENLEHL-AMMERVLGPLPHHM------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
+ ++ ++E++ P P M V KY +PD DS
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS---- 277
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+H A DLL +L DPA+R+ EAL+HP+
Sbjct: 278 -----------EHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 61/221 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL K+GEG++G V + E ++VAIK+V + + + + EI +L++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPYIVK 62
Query: 154 RYRSF-----------------PIDLVRELGRQL------------LESVAFMHELRLIH 184
Y S+ D+++ + L L+ + ++H + IH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH--QD 241
D+K NILL +++G KL DFG S
Sbjct: 123 RDIKAGNILL-----------------NEEG----------QAKLADFGVSGQLTDTMAK 155
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
+ V+ T + APEVI +G+N D+WS+G +E+ G+
Sbjct: 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 85/330 (25%), Positives = 134/330 (40%), Gaps = 79/330 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIE-IDVLQRL 145
Y L K+GEG++ V + +LVA+K++ REA++++ + +
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 146 ARHDIGGTR------YRSFPIDL---------------VRELGRQLLESVAFMHELRLIH 184
HDI T+ + DL VR QLL +A++H ++H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFEHQD 241
DLKP+N+L+ SY L KL DFG + + Q
Sbjct: 127 RDLKPQNLLI---------------------SYLGEL------KLADFGLARAKSIPSQT 159
Query: 242 HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ-THENLEHLAMMER 299
+S V T YR P+V+LG ++ D+W GCI +E+ G+ F + E L +
Sbjct: 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
VLG +P + Y + +W + +R VWK L P
Sbjct: 220 VLG-VPTEDTWPGVSKLPNY-----KPEWFLPCKPQ-QLRVVWKRLSRPP---------- 262
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFF 389
DL +L P +R+ A++AL HP+F
Sbjct: 263 -KAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 94/358 (26%), Positives = 145/358 (40%), Gaps = 83/358 (23%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----- 125
R + Y IG++ + RY+ L +G G G V +D + VAIK +
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 126 ---RSINKYREAAMIEI-----------------------DVLQRLARHDIGGTRYRSFP 159
+ YRE +++ DV + D +
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 160 IDLVRE--LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
+D R L Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++ G+
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTS 179
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 277
F P YVV TR+YRAPEVILG+G+ D+WSVGCI+ E
Sbjct: 180 FMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 278 LCSGEALFQTHENLEHL-AMMERVLGPLPHHM------VIRADRRAEKYFRRGARLDWPD 330
+ G LF ++++ ++E++ P P M V KY +PD
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD 277
Query: 331 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
DS +H A DLL +L D ++R+ EAL+HP+
Sbjct: 278 VLFPADS---------------EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 84/328 (25%), Positives = 139/328 (42%), Gaps = 78/328 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLAR-- 147
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 148 ----HDIGGTR------YRSFPIDL---------------VRELGRQLLESVAFMHELRL 182
HDI T + DL V+ Q+L +A+ H ++
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H DLKP+N+L+ +K+ D+ L+R+ K++P + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFG-LARA-------KSVPTKT----------------Y 161
Query: 243 SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
S V T YR P+V+LG ++ D+W VGCI E+ SG LF + L ++ R+L
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
G WP G +S D + P ++ H +
Sbjct: 222 GT-------------------PTEETWP-GISSNDEFKNYNFPKYKPQPLINHAPRLDTE 261
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389
I+LL L+Y+ +R+ A EA++H +F
Sbjct: 262 GIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 86/335 (25%), Positives = 144/335 (42%), Gaps = 87/335 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIE-IDVLQRL 145
Y L K+GEG++ V + +LVA+K++R REA++++ + +
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 146 ARHDIGGTR------YRSFPIDLVRELGR---------------QLLESVAFMHELRLIH 184
HDI T+ + DL + + + QLL ++++H+ ++H
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DLKP+N+L+ +K+ D+ L+R+ K++P S T+ ++
Sbjct: 127 RDLKPQNLLISDTGELKLADFG-LARA-------KSVP-----------SHTYSNE---- 163
Query: 245 VVSTRHYRAPEVILGLGWNYPC-DLWSVGCILVELCSGEALFQTHENLE-HLAMMERVLG 302
V T YR P+V+LG C D+W VGCI VE+ G A F ++++ L + VLG
Sbjct: 164 -VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222
Query: 303 -------PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
P H + R Y S ++R W L +V
Sbjct: 223 TPNEDTWPGVHSLPHFKPERFTLY--------------SPKNLRQAWNKL-------SYV 261
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+H+ DL LL+ P RL A+ AL H +F+
Sbjct: 262 NHAE----DLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 78/343 (22%), Positives = 123/343 (35%), Gaps = 115/343 (33%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
N + I+ ++G+G FG+V + E A KI++ I E M+EID+L
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEEELEDFMVEIDILSEC 59
Query: 146 ARHDIGGTRYRSFPID-----------------LVREL------------GRQLLESVAF 176
+H Y ++ + ++ EL RQ+LE++ F
Sbjct: 60 -KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 235
+H ++IH DLK NILL DG +KL DFG +
Sbjct: 119 LHSHKVIHRDLKAGNILLTL-----------------DGD----------VKLADFGVSA 151
Query: 236 --TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH 288
Q + T ++ APEV+ ++Y D+WS+G L+EL E
Sbjct: 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP----- 206
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
PHH + + MR + K+L+
Sbjct: 207 ----------------PHHEL--------------------------NPMRVLLKILKSE 224
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ + D L+ L DP +R A E L+HPF +
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 54/212 (25%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLARHDI--- 150
+G+G FG+V C+D + +A+K V K A EI +L+ L I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 151 ------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTD 186
GG+ Y + + R+ RQ+LE V ++H ++H D
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV 246
+K NIL SA VK+ D+ +SK + I S T V
Sbjct: 130 IKGANILRDSAGNVKLGDFG----ASK---------RLQTICS----SGTGM----KSVT 168
Query: 247 STRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
T ++ +PEVI G G+ D+WSVGC +VE+
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 66/224 (29%)
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226
QLL ++++HE ++IH D+K N+L+ S + +++ D+ +A
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF------------------GAA 151
Query: 227 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
+L G+ E Q ++ T + APEV+ G + CD+WSVGC+++E+ + + +
Sbjct: 152 ARLAAKGTGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
++ HLA++ F+ + P
Sbjct: 210 AEKHSNHLALI----------------------FKIASATTAPS---------------- 231
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+P +H + L D+ L P +R +RE L+HP F
Sbjct: 232 IP-------EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 63/222 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++I K+G+G F V + +VA+K V+ K R+ + EID+L++L +
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 150 IGGTRYRSFPID-----LVREL----------------GR------------QLLESVAF 176
+ +Y + I+ +V EL R QL ++
Sbjct: 64 V--IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
MH R++H D+KP N+ + + VK+ D G +F SS TT
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGL-------GRFF-----SS--------KTT 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
H +V T +Y +PE I G+N+ D+WS+GC+L E+
Sbjct: 162 AAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 63/262 (24%), Positives = 107/262 (40%), Gaps = 62/262 (23%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMI-----EIDVLQRLARHD 149
+G G+FG V + EL+A+K V + +K R+ +M+ EI +L+ L +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 150 I---------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRL 182
I GG Y +F LVR RQ+L+ + ++H +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 183 IHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
IH D+K NIL+ + +K+ D+ K L +S P + F
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--------LQGSVF-- 177
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM-E 298
+ APEV+ + D+WS+GC++VE+ +G+ F L+ + + E
Sbjct: 178 -----------WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 299 RVLGPLPHHMVIRADRRAEKYF 320
+P ++ A EK F
Sbjct: 227 NASPEIPSNISSEAIDFLEKTF 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 50/240 (20%), Positives = 95/240 (39%), Gaps = 65/240 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
Y +L +G+G+FG V + +++ K + N K ++ + E+++L+ L +I
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 151 -----------------------GG------TRYR----SFPIDLVRELGRQLLESVAFM 177
GG + + + + + QLL ++
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 178 HEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
H ++H DLKP NI L + VK+ D+ L++ S F
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG-LAKILGHDSSF-------------- 166
Query: 233 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
+ T+ V T +Y +PE + + ++ D+WS+GC++ ELC+ F L+
Sbjct: 167 -AKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLIDFG 233
+H+L IH D+KP+N+LL + ++K+ D+ + + S +++ L + +DF
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 234 STTFEHQD--HSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
S + ++ V T Y APEV L G+N CD WS+G I+ E+ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 56/219 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
Y + +G+G FG+ E LV K V R K R A+ EI +L L +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 150 I---------------------GGTRYRS--------FPIDLVRELGRQLLESVAFMHEL 180
I GGT Y F ++V Q++ +V+++H+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
++H D+K NI L A +K+ D+ S GS + + T
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGI---SKILGSEYS-------------MAET---- 160
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279
VV T +Y +PE+ G+ +N+ D+W++GC+L EL
Sbjct: 161 ----VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 66/238 (27%), Positives = 97/238 (40%), Gaps = 65/238 (27%)
Query: 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
P+D+ R + + ++ ++H ++H DLKP+N+L+ S ++K+ D+ SK G
Sbjct: 99 PVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGL----SKIG--L 152
Query: 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
+L + I+ T E D V T Y APEVIL G+ P D W++G IL E
Sbjct: 153 MSLTTNLYEGHIE--KDTREFLDKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF 209
Query: 279 CSGEALFQTHENLEHLAMMERVLGPLPHHM---VIRADRRAEKYFRRGARLDWPDGATSR 335
G F G P + VI D ++WP+G +
Sbjct: 210 LVGCVPF---------------FGDTPEELFGQVISDD------------IEWPEGDEA- 241
Query: 336 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---KAREALRHPFFT 390
LP D DL+ LLR +P ERL A E +H FF
Sbjct: 242 -----------LPA-----------DAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 77/234 (32%)
Query: 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
P D ++ +++ V +H+ +IH D+KPEN+L+ ++K+ D+ LSR+ + F
Sbjct: 95 PEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFG-LSRNGLENKKF 153
Query: 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
V T Y APE ILG+G + D WS+GC++ E
Sbjct: 154 ---------------------------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 279 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM 338
G F P + R R++WP+ S
Sbjct: 187 LFGYPPFHAET---------------PDAVFDNILSR---------RINWPEEVKEFCSP 222
Query: 339 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA---REALRHPFF 389
AV DL+ LL DPA+RL A +E HPFF
Sbjct: 223 EAV----------------------DLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 47/246 (19%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
P +V+ L Q+L+ + ++H ++H DLKP NIL++
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------- 145
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWS 270
P+ +K+ D G + D VV T YRAPE++LG + D+W+
Sbjct: 146 ----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201
Query: 271 VGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGA 324
+GCI EL + E +F + N H ++R+ + M AD+ E +
Sbjct: 202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF----NVMGFPADKDWEDIKKM-- 255
Query: 325 RLDWPDGAT-SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 383
P+ +T +D R + L + +H LLQ LL DP +R+ + +A
Sbjct: 256 ----PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 311
Query: 384 LRHPFF 389
++ P+F
Sbjct: 312 MQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 79/343 (23%), Positives = 133/343 (38%), Gaps = 85/343 (24%)
Query: 99 KMGEGTFGQVVECFDNEKKEL------------VAIKIVRSINKYREAAMIEIDVLQRL- 145
K+G GT+G V + + K+ +++ R I RE + LQ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 146 --------------ARHDI-----------GGTRYRSFPIDLVRELGRQLLESVAFMHEL 180
A HD+ + P +V+ L Q+L+ + ++H
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
++H DLKP NIL++ P+ +K+ D G +
Sbjct: 128 WVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGFARLFNS 164
Query: 241 ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE---- 289
D VV T YRAPE++LG + D+W++GCI EL + E +F +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224
Query: 290 --NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT-SRDSMRAVWKLLR 346
N H ++R+ M AD+ E + P+ T +D R +
Sbjct: 225 TSNPFHHDQLDRIFSV----MGFPADKDWEDIRKM------PEYPTLQKDFRRTTYANSS 274
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
L + +H + LLQ LL DP +R+ + +AL+ P+F
Sbjct: 275 LIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 85/251 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
+ ++ +GEGT+G+V + + +LVAIKI+ I E E ++L++ + H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 149 DIGGTRYRSFP-------------------IDLVRELG---------------RQLLESV 174
G + P DLV+ L R+ L +
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 233
A++HE ++IH D+K +NILL K++ +KL+DFG
Sbjct: 127 AYLHENKVIHRDIKGQNILLT---------------------------KNAEVKLVDFGV 159
Query: 234 ---STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGE--- 282
+ + +++ + T ++ APEVI ++ D+WS+G +EL G+
Sbjct: 160 SAQLDSTLGRRNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
Query: 283 -------ALFQ 286
ALF+
Sbjct: 219 CDMHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 71/236 (30%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH-- 148
Y ++ ++G GT+G V + D ELVAIK++ + + +I EI +L+ RH
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKE-CRHPN 61
Query: 149 ---------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELR 181
DI + + R+ L+ +A++HE
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-----STT 236
IH D+K NILL ++DG +KL DFG + T
Sbjct: 122 KIHRDIKGANILL-----------------TEDGD----------VKLADFGVSAQLTAT 154
Query: 237 FEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSGE-ALFQTH 288
+ T ++ APEV G++ CD+W++G +EL + +F H
Sbjct: 155 I--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 65/259 (25%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVL 142
GE+ Y ++ K+G G FG+V +E K + R + K RE + +IE++V+
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVM 66
Query: 143 QRLARHDIGGTRY---------RSFPI--------DLVR------------------ELG 167
+ L +I RY + I DL R ++
Sbjct: 67 RELKHKNI--VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 168 RQLLESVAFMHEL-------RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
RQLL ++A+ H L R++H DLKP+NI L + + K + N
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG----------IRHIGKITAQANN 174
Query: 221 LPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCIL 275
L K+ DFG + E HS V T +Y +PE++L +Y D+W++GCI+
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 276 VELCSGEALFQTHENLEHL 294
ELCSG+ F N L
Sbjct: 234 YELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 74/274 (27%)
Query: 93 RYRILSKMGEGTFGQVV----------------------ECFDNEKKELVAIKIVRSIN- 129
+Y +L +GEG+FG+ + ++ +KE V + ++ N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 130 -KYREA--------AMIEI----DVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAF 176
++E+ ++E D++Q+ I R + FP D + + Q+ V
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQK-----IKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+HE R++H D+K +NI FL+++ K +KL DFGS
Sbjct: 116 IHEKRVLHRDIKSKNI--------------FLTQNGK-------------VKLGDFGSAR 148
Query: 237 FEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--ENL 291
+Y V T +Y PE+ + +N D+WS+GCIL ELC+ + FQ + +NL
Sbjct: 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGAR 325
L + + PLP H ++ F+R R
Sbjct: 209 I-LKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 72/332 (21%), Positives = 119/332 (35%), Gaps = 118/332 (35%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDVLQRLARHDI-- 150
+G+G +G V C + +L+A+K V + K E E+D+L+ L +I
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 151 -------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHT 185
GG+ R+ P + + +Q+L+ VA++H ++H
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-----TFEHQ 240
D+K N++L+ + IKLIDFG H
Sbjct: 127 DIKGNNVMLMP---------------------------NGIIKLIDFGCARRLAWVGLHG 159
Query: 241 DHSYVVSTRH----YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
HS ++ + H + APEVI G+ D+WS+GC + E+ +G+ + + L +
Sbjct: 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ G +P RLP D
Sbjct: 220 IGAHRGLMP----------------------------------------RLP-------D 232
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+ ID + L D ER A + LRH F
Sbjct: 233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 75/329 (22%), Positives = 118/329 (35%), Gaps = 116/329 (35%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDI----- 150
+G+GTFG+V+ + + A+KI++ I E A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG +R R F D R G +++ ++ ++H +++ DL
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
K EN++L ++K+ D+ K+G I G+T
Sbjct: 122 KLENLMLDKDGHIKITDFGL----CKEG--------------ISDGATM------KTFCG 157
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMERVLGPLP 305
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------ 211
Query: 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365
+R P + + L
Sbjct: 212 ---------------------------------------IRFPRTLSP-------EAKSL 225
Query: 366 LQGLLRYDPAERL-----KAREALRHPFF 389
L GLL+ DP +RL A+E + H FF
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 65/251 (25%), Positives = 99/251 (39%), Gaps = 63/251 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
+Y + +G G FG V C ++LV IK + + R AA E VL+ L+ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 150 I---------------------GGT-------RYRS-FPIDLVRELGRQLLESVAFMHEL 180
I GGT R S D + Q+L ++ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
++H DLK +NILL + V +K+ DFG S
Sbjct: 121 LILHRDLKTQNILLDKHKMV--------------------------VKIGDFGISKILSS 154
Query: 240 QDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM-- 296
+ +Y VV T Y +PE+ G +N D+W++GC+L EL S + F+ NL L +
Sbjct: 155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKI 213
Query: 297 MERVLGPLPHH 307
M P+
Sbjct: 214 MSGTFAPISDR 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 56/220 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLAR 147
+R+ +G+G FG+V C+D + +A+K V+ +K A EI +L+ L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 148 HDI-----------------------GGT------RYRSFPIDLVRELGRQLLESVAFMH 178
I GG+ Y + ++ R+ RQ+LE V+++H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
++H D+K NIL S VK+ D+ S ++ I T +
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFG----------------ASKRLQTICLSGTGMK 167
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
V T ++ +PEVI G G+ D+WSVGC +VE+
Sbjct: 168 S-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 64/223 (28%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKY-------REAAMI-----EIDVLQRLAR 147
+G+GT+G+V + E++A+K V + R+ M+ EI+ L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 148 HDI---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHEL 180
+I GG+ Y F LVR Q+LE +A++H
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
++H DLK +N+L+ + K+ D+ +S+ S D + N S + F
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFG-ISKKSDD--IYDNDQNMS------MQGSVF--- 175
Query: 241 DHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVELCSG 281
+ APEVI G++ D+WS+GC+++E+ +G
Sbjct: 176 ----------WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 68/228 (29%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDI-- 150
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EI++L I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 151 -------------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
GG R ++ + RQ+LE++ ++H +++IH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-----TFEH 239
DLK N+LL + DG IKL DFG + T +
Sbjct: 134 RDLKAGNVLL-----------------TLDGD----------IKLADFGVSAKNVKTLQR 166
Query: 240 QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 282
+D + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 167 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 73/340 (21%), Positives = 125/340 (36%), Gaps = 111/340 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDI-- 150
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EID+L +I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 151 ------------------GGTRYRSFPIDLVRELG--------RQLLESVAFMHELRLIH 184
G + ++L R L +Q LE++ ++HE ++IH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFEHQD 241
DLK NIL + DG IKL DFG T Q
Sbjct: 127 RDLKAGNILF-----------------TLDGD----------IKLADFGVSAKNTRTIQR 159
Query: 242 HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP------------- 206
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
PHH + + MR + K+ + +
Sbjct: 207 --------PHHEL--------------------------NPMRVLLKIAKSEPPTLAQPS 232
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ + D L+ L + R + L+HPF T + +P
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 72/233 (30%)
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
+L++++F+H +IH D+K ++ILL S VK+ D+ F ++ SK+ +P+ ++
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSL 175
Query: 228 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287
V T ++ APEVI L + D+WS+G +++E+ GE
Sbjct: 176 ------------------VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP---P 214
Query: 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347
+ N L M+R+ RD+ L
Sbjct: 215 YFNEPPLQAMKRI----------------------------------RDN---------L 231
Query: 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLLV 400
P + S L L +L DPA+R A E L HPF P+ +V
Sbjct: 232 PPKLKNLHKVSP-RLRSFLDRMLVRDPAQRATAAELLNHPFL-AKAGPPSSIV 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 58/221 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLAR 147
+R+ +G G FG+V C+D + +A+K V + +K A EI +L+ L R
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-R 62
Query: 148 HD------------------------IGGT------RYRSFPIDLVRELGRQLLESVAFM 177
HD GG+ Y + ++ R RQ+L+ V+++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H ++H D+K NIL SA VK+ D+ S I+ I T
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRIQTICMSGTGI 166
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
+ V T ++ +PEVI G G+ D+WSV C +VE+
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 78/326 (23%), Positives = 121/326 (37%), Gaps = 110/326 (33%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDI----- 150
+G+G+FG+V+ + A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG R RSFP R ++ ++ ++H L +I+ DL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
KPENILL S +V + D+ K+G I+ TT S
Sbjct: 123 KPENILLDSQGHVVLTDFGL----CKEG--------------IEHSKTT------STFCG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHH 307
T Y APEV+ ++ D W +G +L E+ G F + + E M + +L
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNILN----- 210
Query: 308 MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367
K LRL I H LL+
Sbjct: 211 -----------------------------------KPLRLKPNISVSARH-------LLE 228
Query: 368 GLLRYDPAERLKAREALR----HPFF 389
GLL+ D +RL A++ H FF
Sbjct: 229 GLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 66/231 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y + K+GEG+FG+ + E + IK I + K RE + E+ VL + +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 150 I---------------------GGTRYRS--------FPIDLVRELGRQLLESVAFMHEL 180
I GG Y+ FP D + + Q+ ++ +H+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-----ST 235
+++H D+K +NI L +KDG IKL DFG ++
Sbjct: 121 KILHRDIKSQNIFL-----------------TKDG----------TIKLGDFGIARVLNS 153
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
T E + T +Y +PE+ +N D+W++GC+L E+C+ + F+
Sbjct: 154 TVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 67/333 (20%), Positives = 120/333 (36%), Gaps = 115/333 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH- 148
+ + +G G+FG+V+ + A+KI+ I K ++ + E +LQ + RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 149 ----------D-----------IGGT------RYRSFPIDLVRELGRQLLESVAFMHELR 181
D GG + FP + R Q++ ++ ++H L
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+++ DLKPEN+LL S Y+K+ D+ F K + + T
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGF-------------------AKRVKGRTYT----- 157
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ T Y APE+IL G+ D W++G ++ E+ +G F + + E++L
Sbjct: 158 ---LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---NPIQIYEKIL 211
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
++ +P D
Sbjct: 212 ---------------------EGKVRFP-----------------------SFFS---PD 224
Query: 362 LIDLLQGLLRYDPAERL-----KAREALRHPFF 389
DL++ LL+ D +RL + HP+F
Sbjct: 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 77/334 (23%), Positives = 124/334 (37%), Gaps = 105/334 (31%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGTR 154
L ++G+G+FG+V + DN KE+VAIKI+ E I EI VL + I TR
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI--TR 66
Query: 155 Y--------------------------RSFPID--LVRELGRQLLESVAFMHELRLIHTD 186
Y + P++ + + R++L+ + ++H R IH D
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV 246
+K N+LL VK+ D+ G T + V
Sbjct: 127 IKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQIKRNTFV 162
Query: 247 STRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPH 306
T + APEVI +++ D+WS+G +EL GE + +L + RVL +P
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPM----RVLFLIPK 215
Query: 307 HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366
+ P L Q+ + + +
Sbjct: 216 N--------------------------------------SPPTLEGQY----SKPFKEFV 233
Query: 367 QGLLRYDPAERLKAREALRHPFFTRDVRRPTLLV 400
+ L DP R A+E L+H F TR ++ + L
Sbjct: 234 EACLNKDPRFRPTAKELLKHKFITRYTKKTSFLT 267
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 76/344 (22%), Positives = 119/344 (34%), Gaps = 133/344 (38%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREA--AMIEIDVLQRLA 146
RY + ++G+G+FG V D + +K+++ I E A E +L +L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 147 RHDIGG--------------TRY-----------------RSFPIDLVRELGRQLLESVA 175
I T Y ++ + V E QLL V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 233
+MH+ R++H DLK +NI L K++ +K+ DFG
Sbjct: 121 YMHQRRILHRDLKAKNIFL----------------------------KNNLLKIGDFGVS 152
Query: 234 ---------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
+TTF T +Y +PE + G++ D+WS+GCIL E+C
Sbjct: 153 RLLMGSCDLATTF--------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA 204
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
F+ L ++ V GP P
Sbjct: 205 FEGQNFLS--VVLRIVEGPTP--------------------------------------- 223
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
LP + + L ++Q +L DP+ R A E LR+PF
Sbjct: 224 -SLP-------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 63/229 (27%)
Query: 94 YRILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHD 149
++I K+G G F +V D + L ++I ++ K R+ + EID+L++L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 150 IGGTRY-RSF----PIDLVRELGR----------------------------QLLESVAF 176
+ +Y SF +++V EL QL +V
Sbjct: 64 V--IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
MH R++H D+KP N+ + + VK+ D G +F + TT
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS-------------KTT 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
H +V T +Y +PE I G+N+ D+WS+GC+L E+ + ++ F
Sbjct: 162 AAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 56/224 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHDI 150
+ IL+K+G+G+FG V + K + A+K + +N + RE A+ E VL +L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 151 ---------------------GGT--------RYRSFPIDLVRELGRQLLESVAFMHELR 181
G R R P D V Q+L +A +H +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
++H D+K N+ L + + VK+ D +++ D + F N
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLG-VAKLLSDNTNFANT-------------------- 160
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
+V T +Y +PE+ +N D+W++G +L E C+G+ F
Sbjct: 161 ---IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 31/162 (19%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 215
FP DL R +L +V +H++ IH D+KP+NIL+ ++K+ D+ + R + D
Sbjct: 98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 216 SYFK--NLPKSSAIKLIDFGS--------------------TTFEHQD---HSYVVSTRH 250
Y++ + + ++ DF + +HQ HS +V T +
Sbjct: 158 KYYQSGDHVRQDSM---DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHS-LVGTPN 213
Query: 251 YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
Y APEV+L G+ CD WSVG IL E+ G+ F LE
Sbjct: 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 21/148 (14%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 215
F DL R +L ++ +H++ IH D+KP+NIL+ ++K+ D+ + R + D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 216 SYFK--NLPKSSAIKLIDFGS-------TTFE------HQD---HSYVVSTRHYRAPEVI 257
Y++ + + +++ + S E HQ HS +V T +Y APEV+
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS-LVGTPNYIAPEVL 216
Query: 258 LGLGWNYPCDLWSVGCILVELCSGEALF 285
L G+ CD WSVG IL E+ G+ F
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 68/242 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY I+ K+GEG+FG++ E IK + + K +EA+ E+ +L ++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 150 IGGTRYRSFPI--------------DLVRELGRQLLESVAF------------------M 177
I T + SF DL++ + RQ V F +
Sbjct: 61 I-VTFFASFQENGRLFIVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHI 117
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H+ +++H D+K +NI FLS++ KL DFG
Sbjct: 118 HDRKILHRDIKSQNI--------------FLSKNGM------------VAKLGDFGIARQ 151
Query: 238 EHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
+ V T +Y +PE+ +N D+WS+GC+L ELC+ + F+ + NL L
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQL 210
Query: 295 AM 296
+
Sbjct: 211 VL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 58/246 (23%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLARHDI--- 150
+G+G FG+V C+D + +A K V+ +K A EI +L+ L I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 151 --------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
GG+ Y + + R+ RQ+LE ++++H ++H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K NIL SA VK+ D+ S ++ I T
Sbjct: 130 RDIKGANILRDSAGNVKLGDFG----------------ASKRLQTICMSGTGIRS----- 168
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM--ERVLG 302
V T ++ +PEVI G G+ D+WS+GC +VE+ + + + +E + + + +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228
Query: 303 PLPHHM 308
LP H+
Sbjct: 229 QLPSHI 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 61/228 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD 149
+RI K+G G F +V VA+K V+ + K R + EID+L++L +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 150 IGGTRYRSF----PIDLVRELGR----------------------------QLLESVAFM 177
+ Y SF +++V EL QL ++ M
Sbjct: 64 VI-KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H R++H D+KP N+ + + VK+ D G +F + TT
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS-------------KTTA 162
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
H +V T +Y +PE I G+N+ D+WS+GC+L E+ + ++ F
Sbjct: 163 AHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
+Y +F D+ R + + ++ +H+L IH D+KP+NIL+ ++K+ D+ + K
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
Query: 214 --DGSYFKNLPKSSAIK---------LIDFGSTTFEHQDH-----------SY-VVSTRH 250
D +Y++ L + + K +D + T +D +Y V T
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 251 YRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
Y APE+ L G+ CD WS+G I+ E G
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 66/240 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI- 150
Y+ L +G G +G V +VA+KI+ + + I E+ +L +L +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 151 -----------------------GG---TRYRSFPID--LVRELGRQLLESVAFMHELRL 182
GG T ++ PI + + R++L ++ ++H++ +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 183 IHTDLKPENILLVSAEYVKVPDY----KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
IH D+K NIL+ + VK+ D+ SSK +TF
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--------------------RSTF- 161
Query: 239 HQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
V T ++ APEVI G ++ D+WS+G + E+ +G + + AMM
Sbjct: 162 -------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMM 212
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 29/143 (20%)
Query: 169 QLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
Q++ ++ ++H E R++H DL P NI+L + V + D+ L++ + S +
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG-LAKQKQPESKLTS------- 172
Query: 228 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287
VV T Y PE++ + D+W+ GCIL ++C+ + F +
Sbjct: 173 -----------------VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
Query: 288 HENLEHLAM--MERVLGPLPHHM 308
N+ LA +E V PLP M
Sbjct: 216 -TNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 78/344 (22%), Positives = 133/344 (38%), Gaps = 115/344 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLAR 147
+ L ++G G+FG V D E+VAIK + +S K+++ + E+ LQ+L R
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQQL-R 73
Query: 148 H----DIGGTRYRSFPIDLVRE--LG----------------------RQLLESVAFMHE 179
H + G R LV E LG L+ +A++H
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
IH D+K NILL ++ G+ +KL DFGS +
Sbjct: 134 HERIHRDIKAGNILL-----------------TEPGT----------VKLADFGSASLVS 166
Query: 240 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 167 PANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------------------ 207
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
A+R+ F + ++M A++ + + + + D
Sbjct: 208 ---------------AERKP-PLF-------------NMNAMSALYHIAQNDSPTLSSND 238
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLLV 400
S + + L+ P +R + E L+H F R+ R PT+++
Sbjct: 239 WSD-YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE-RPPTVII 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 75/338 (22%), Positives = 124/338 (36%), Gaps = 115/338 (34%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVR------SINKYRE--AAM------- 136
Y ++ +G G V C N E VAIK + S+++ R+ AM
Sbjct: 3 YELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 137 --------IEIDVLQRLARHDIGGTRY----RSFPIDLVRE-----LGRQLLESVAFMHE 179
+ D L + + GG+ S+P + E + +++L+ + ++H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--STTF 237
IH D+K NILL +DGS +K+ DFG ++
Sbjct: 121 NGQIHRDIKAGNILL-----------------GEDGS----------VKIADFGVSASLA 153
Query: 238 EHQDHSY-----VVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
+ D + V T + APEV+ G+++ D+WS G +EL +G A +
Sbjct: 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS----- 208
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
M+ ++ L + D P T D + K R
Sbjct: 209 -KYPPMKVLMLTLQN--------------------DPPSLETGAD-YKKYSKSFR----- 241
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+I L L+ DP++R A E L+H FF
Sbjct: 242 ---------KMISL---CLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 25/156 (16%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RS 211
R FP L R +L ++ +H++ IH D+KP+NIL+ ++K+ D+ + R
Sbjct: 94 RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153
Query: 212 SKDGSYFK--NLPKSSAIKLIDF-----------------GSTTFEHQD---HSYVVSTR 249
+ + Y++ + + +++ D T +HQ HS +V T
Sbjct: 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS-LVGTP 212
Query: 250 HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
+Y APEV+L G+ CD WSVG IL E+ G+ F
Sbjct: 213 NYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 68/318 (21%), Positives = 122/318 (38%), Gaps = 98/318 (30%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRYRSF 158
K+GEG+ G V + VA+K++ + R + V+ R +H Y+S+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 159 PI-----------------DLVRE----------LGRQLLESVAFMHELRLIHTDLKPEN 191
+ D+V + + +L+++ ++H +IH D+K ++
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 192 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHY 251
ILL VK+ D+ F ++ SKD +PK ++ V T ++
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKD------VPKRKSL------------------VGTPYW 183
Query: 252 RAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIR 311
APEVI + D+WS+G +++E+ GE
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP---------------------------- 215
Query: 312 ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371
YF S ++A+ +L P +++ + L D L+ +L
Sbjct: 216 ------PYF-------------SDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 372 YDPAERLKAREALRHPFF 389
+P ER A+E L HPF
Sbjct: 257 REPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 66/256 (25%), Positives = 92/256 (35%), Gaps = 93/256 (36%)
Query: 142 LQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201
LQR R D+ R+ + +LL ++ +H+ +I+ DLKPENILL
Sbjct: 84 LQREGRFDLSRARFYT----------AELLCALENLHKFNVIYRDLKPENILL------- 126
Query: 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV---VSTRHYRAPEVIL 258
DY I L DFG +D T Y APE++L
Sbjct: 127 --DY------------------QGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 259 GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEK 318
G G+ D W++G +L E+ +G LP D +
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG----------------------LPPFY----DENVNE 200
Query: 319 YFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378
+R K+L+ P D A DLL GLL DP RL
Sbjct: 201 MYR---------------------KILQEPLRFPDGFDRDAK---DLLIGLLSRDPTRRL 236
Query: 379 ---KAREALRHPFFTR 391
A+E HPFF++
Sbjct: 237 GYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 65/244 (26%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDI----- 150
+G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTD 186
GG +R R F D R G +++ ++ ++H E +++ D
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV 246
LK EN++L ++K+ D+ KDG+ K TF
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------------TF--------C 157
Query: 247 STRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME-----R 299
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME R
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217
Query: 300 VLGP 303
L P
Sbjct: 218 TLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 53/240 (22%), Positives = 85/240 (35%), Gaps = 78/240 (32%)
Query: 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215
FP Q++ + +H+ R+++ DLKPEN+LL V++ D
Sbjct: 90 PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL-------- 141
Query: 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 275
A++L G T Y APEV+ G +++ D +++GC L
Sbjct: 142 ----------AVELKG-GKKI-----KGRA-GTPGYMAPEVLQGEVYDFSVDWFALGCTL 184
Query: 276 VELCSGEALFQTH-ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
E+ +G + F+ E +E + R L A +Y PD +
Sbjct: 185 YEMIAGRSPFRQRKEKVEKEELKRRTL------------EMAVEY---------PDKFSP 223
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
+ DL + LL+ DP +RL A E HP F
Sbjct: 224 --------------------------EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 5e-09
Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 30/133 (22%)
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
R+ L+++ F+H ++IH D+K +NILL DGS +
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILL-----------------GMDGS----------V 155
Query: 228 KLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
KL DFG T E S +V T ++ APEV+ + D+WS+G + +E+ GE
Sbjct: 156 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 285 FQTHENLEHLAMM 297
+ L L ++
Sbjct: 216 YLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 66/230 (28%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDI----- 150
+G G+FG+V E AIK ++ K + E +L L+ I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 151 ----------------GG---TRYRS---FPIDLVRELGRQLLESVAFMHELRLIHTDLK 188
GG T R FP D+ + +L+ + ++H +I+ DLK
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV-S 247
PEN+LL + +VKV D+ F + D ++ +
Sbjct: 146 PENLLLDNKGHVKVTDFGFAKKVP----------------------------DRTFTLCG 177
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG------EALFQTHENL 291
T Y APEVI G D W++G +L E +G + F+ +E +
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 59/221 (26%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD---IGG 152
+G+GTFGQV + + + + A+K++ + I +E A E ++L R + I G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 153 --------------TRYRS-------------FPIDLVRELGRQLLESVAFMHELRLIHT 185
T Y S F D + +L+ ++ +H+ +++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 245
DLKPENILL + ++ + D+ LS++ NL + + TF
Sbjct: 121 DLKPENILLDATGHIALCDFG-LSKA--------NLTDNKT-------TNTF-------- 156
Query: 246 VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 285
T Y APEV+L G+ D WS+G ++ E+C G + F
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 13/121 (10%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLIDFGS 234
+H+L IH D+KP+N+LL S +VK+ D+ + + + +++NL S F +
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT-FQN 175
Query: 235 TTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
+ + ++ V T Y APEV + G+N CD WS+G I+ E+ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 285 F 285
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 62/219 (28%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHD--- 149
L ++G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 150 --------IGGTRY----------------RSFPID--LVRELGRQLLESVAFMHELRLI 183
+ GT+ R+ P D + + +++L+ + ++H + I
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H D+K N+LL VK+ D+ + + + IK F T F
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLT-----------DTQIKRNTFVGTPF------ 166
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
+ APEVI ++ D+WS+G +EL GE
Sbjct: 167 -------WMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 71/225 (31%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-----RHDIG 151
LS++GEG G V +C + A+K + + ++ +L+ L +
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITT----DPNPDLQKQILRELEINKSCKSPYI 61
Query: 152 GTRYRSFPIDL----------------------VRELGRQLLESVA------------FM 177
Y +F + V++ G ++ E V ++
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 236
H ++IH D+KP NILL ++ G +KL DFG S
Sbjct: 122 HSRKIIHRDIKPSNILL-----------------TRKG----------QVKLCDFGVSGE 154
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
+ T Y APE I G ++ D+WS+G L+E+
Sbjct: 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 74/330 (22%), Positives = 115/330 (34%), Gaps = 116/330 (35%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDI----- 150
+G+GTFG+V+ + A+KI+R I K A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG +R R F + R G +++ ++ ++H +++ D+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
K EN++L ++K+ D+ DG+ K TF
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMK----------------TF--------CG 157
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMERVLGPLP 305
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME +
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----- 212
Query: 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365
R P + L
Sbjct: 213 ----------------------------------------RFPRTLSPEAK-------SL 225
Query: 366 LQGLLRYDPAERL-----KAREALRHPFFT 390
L GLL+ DP +RL A+E + H FF
Sbjct: 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 35/152 (23%)
Query: 140 DVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199
D+L L R++ F D+ + +L+ ++ +H++ +H D+KPEN+L+ +
Sbjct: 87 DLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH 140
Query: 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG 259
+K+ D+ +R + + LP V T Y APEV+
Sbjct: 141 IKLADFGSAARLTANKMVNSKLP-----------------------VGTPDYIAPEVLTT 177
Query: 260 LG------WNYPCDLWSVGCILVELCSGEALF 285
+ + CD WS+G I E+ G + F
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 7e-09
Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 30/133 (22%)
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
R+ L+++ F+H ++IH D+K +NILL DGS +
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILL-----------------GMDGS----------V 154
Query: 228 KLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
KL DFG T E S +V T ++ APEV+ + D+WS+G + +E+ GE
Sbjct: 155 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
Query: 285 FQTHENLEHLAMM 297
+ L L ++
Sbjct: 215 YLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 30/118 (25%)
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
R+ L+++ F+H ++IH D+K +NILL DGS +
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILL-----------------GMDGS----------V 154
Query: 228 KLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
KL DFG T E S +V T ++ APEV+ + D+WS+G + +E+ GE
Sbjct: 155 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 80/245 (32%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDI-------- 150
+G+GT+G V D + +AIK I ++Y + EI + L +I
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 151 -------------GGT-----RYRSFPI----DLVRELGRQLLESVAFMHELRLIHTDLK 188
GG+ R + P+ + +Q+LE + ++H+ +++H D+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-----------TF 237
+N+L V Y S +K+ DFG++ TF
Sbjct: 136 GDNVL--------VNTY------------------SGVVKISDFGTSKRLAGINPCTETF 169
Query: 238 EHQDHSYVVSTRHYRAPEVI-LGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
T Y APEVI G G+ P D+WS+GC +VE+ +G+ F E E A
Sbjct: 170 --------TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGEPQA 219
Query: 296 MMERV 300
M +V
Sbjct: 220 AMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 57/237 (24%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDI------ 150
+G+GTFG+V+ + + A+KI++ I K A + + + RH
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 151 ----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 188
GG +R R F D R G +++ ++ ++H ++++ DLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 248
EN++L ++K+ D+ D + K T
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGITDAATMKTF------------------------CGT 158
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMERVLGP 303
Y APEV+ + D W +G ++ E+ G F Q HE L L +ME + P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 24/146 (16%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H L +I+ DLKPENILL ++K+ D+ LS+ S D
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFG-LSKESIDH--------------------- 151
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
E + +S+ T Y APEV+ G D WS G ++ E+ +G FQ + E + M
Sbjct: 152 -EKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRR 322
+ + +P + A F+R
Sbjct: 210 ILKAKLGMPQFLSPEAQSLLRALFKR 235
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 38/136 (27%), Positives = 68/136 (50%), Gaps = 27/136 (19%)
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+L +++++H +IH D+K ++ILL S +K+ D+ F ++ SK+ +PK ++
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSL-- 178
Query: 230 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289
V T ++ APEVI L + D+WS+G +++E+ GE +
Sbjct: 179 ----------------VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYF 219
Query: 290 NLEHLAMMERVLGPLP 305
N L M R+ LP
Sbjct: 220 NEPPLQAMRRIRDNLP 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 52/214 (24%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQR---------- 144
L K+G+G+FG+V + DN +++VAIKI+ E I EI VL +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 145 ----------LARHDIGGTRYRSF----PID--LVRELGRQLLESVAFMHELRLIHTDLK 188
+ +GG P+D + + R++L+ + ++H + IH D+K
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 248
N+LL VK+ D+ G T + V T
Sbjct: 129 AANVLLSEHGEVKLADFGVA------------------------GQLTDTQIKRNTFVGT 164
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
+ APEVI ++ D+WS+G +EL GE
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 57/217 (26%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR-SIN-KYREAAMIEIDVLQR---------- 144
L ++G G G V + +++A+K +R IN ++ + E+D+L +
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 145 ----------LARHDIGGTR--------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHT 185
+ + G P ++ ++ +L+ + ++HE ++IH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 245
D+KP NIL+ S +K+ D+ +S +L++ + TF
Sbjct: 126 DVKPSNILVNSRGQIKLCDFG-VSG-----------------QLVNSLAKTF-------- 159
Query: 246 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
V T Y APE I G ++ D+WS+G L+EL +G
Sbjct: 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 73/223 (32%)
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+L++++ +H +IH D+K ++ILL VK+ D+ F ++ SK+ K+L
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-------- 176
Query: 230 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289
V T ++ APE+I L + D+WS+G +++E+ GE +
Sbjct: 177 ----------------VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220
Query: 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349
L+ + M+ L P +L N
Sbjct: 221 PLKAMKMIRDNLPP------------------------------------------KLKN 238
Query: 350 LIMQHVDHSAGDLID-LLQGLLRYDPAERLKAREALRHPFFTR 391
L H + L LL DPA+R A E L+HPF +
Sbjct: 239 L------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 13/121 (10%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLIDFGS 234
+H+L IH D+KP+N+LL + +VK+ D+ + + + +++NL + F +
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF-SFQN 175
Query: 235 TTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
+ + ++ V T Y APEV + G+N CD WS+G I+ E+ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 285 F 285
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 58/219 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMI--EIDVLQRL---- 145
+ +G GTFG+V D + A+K+ + + + ++ + E VL+ +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 146 ------ARHD-----------IGGTRY------RSFPIDLVRELGRQLLESVAFMHELRL 182
HD GG + F +++ ++ ++H +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
++ DLKPENILL ++K+ D+ F A KL D T
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGF------------------AKKLRDRTWT------- 157
Query: 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
+ T Y APEVI G N D W++G ++ E+ G
Sbjct: 158 --LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 24/130 (18%)
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
R+ L+++ F+H ++IH D+K +N+LL VK+ D+ F ++
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ----------------- 164
Query: 228 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287
T E S +V T ++ APEV+ + D+WS+G + +E+ GE +
Sbjct: 165 -------ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
Query: 288 HENLEHLAMM 297
L L ++
Sbjct: 218 ENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 73/244 (29%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD- 149
T + I+ +G+GT+G+V + + + L A+KI+ I+ E E ++LQ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 150 --------------IGGTRYRSFPI-------DLVREL---GRQLLESV----------- 174
+GG + + +LV+ L G++L E++
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 175 -AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+H R+IH D+K NILL + +KL+DFG
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTT---------------------------EGGVKLVDFG 173
Query: 234 ST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGE-AL 284
+ T + V T + APEVI ++ CD+WS+G +EL G+ L
Sbjct: 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
Query: 285 FQTH 288
F H
Sbjct: 234 FDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 58/229 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMI--EIDVLQRLARH- 148
+ +L +G+G FG+V + K++ A+K + + + E +LQ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 149 ----------DI------------GGTRY-----RSFPIDLVRELGRQLLESVAFMHELR 181
D G RY F + V+ +++ ++ ++H
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+IH D+KP+NILL +V + D+ N+ A K+ + T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDF--------------NI----ATKVTP-DTLTTS--- 158
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290
T Y APEV+ G++ D WS+G E G+ ++ H
Sbjct: 159 ---TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 59/239 (24%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---IN-KYREAAMIEIDVLQRLARHDI----- 150
+G+G+FG+V+ + A+K+++ +N K ++ M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG R RSFP R ++ ++ ++H + +++ DL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
KPENILL S +V + D+ K+G I D +TTF
Sbjct: 123 KPENILLDSQGHVVLTDFGL----CKEG-----------IAQSD-TTTTF--------CG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF---QTHENLEHLAMMERVLGP 303
T Y APEVI ++ D W +G +L E+ G F E +++ VL P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 51/232 (21%), Positives = 95/232 (40%), Gaps = 71/232 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ +G GT+GQV + + +L AIK++ E +EI++L++ + H T
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 154 RYRSF-----------------------PIDLVRE-------------LGRQLLESVAFM 177
Y +F DLV+ + R++L +A +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 236
H ++IH D+K +N+LL +++ +KL+DFG S
Sbjct: 138 HAHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQ 170
Query: 237 FEHQ--DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 281
+ + + T ++ APEVI ++Y D+WS+G +E+ G
Sbjct: 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 43/223 (19%), Positives = 77/223 (34%), Gaps = 62/223 (27%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH 148
+ K+GEG FG+V + + K+ VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IG-------------------------GTRYRSFPIDLVRELGRQLLESVAFMH 178
+G R + + + Q+ + ++
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
IH DL N L+ VK+ D F LSR D Y+K I+
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYKVKGGKLPIR--------- 169
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
+ APE + + D+WS G +L E+ +
Sbjct: 170 -------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 48/232 (20%), Positives = 95/232 (40%), Gaps = 71/232 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H T
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 154 RYRSF-----------------------PIDLVRE-------------LGRQLLESVAFM 177
Y +F DL++ + R++L ++ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H+ ++IH D+K +N+LL +++ +KL+DFG +
Sbjct: 128 HQHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQ 160
Query: 238 EHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 281
+ + + T ++ APEVI +++ DLWS+G +E+ G
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 66/329 (20%), Positives = 111/329 (33%), Gaps = 115/329 (34%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYR--EAAMIEIDVLQRLARHDI----- 150
+G+G+FG+V+ EL A+K+++ I + E M E VL +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG R F R +++ + F+HE +I+ DL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
K +N+LL S ++K+ D+ K+G I G TT S
Sbjct: 123 KLDNVLLDSEGHIKIADFGM----CKEG--------------ILGGVTT------STFCG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMERVLGPLP 305
T Y APE++ + D W++G +L E+ +G++ F + L + + V P
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YP 216
Query: 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365
+ A +
Sbjct: 217 RWLSKEA--------------------------------------------------KSI 226
Query: 366 LQGLLRYDPAERLKA-----REALRHPFF 389
L+ L +P +RL ++ HPFF
Sbjct: 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 51/234 (21%), Positives = 85/234 (36%), Gaps = 80/234 (34%)
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+ +++H D+KP NIL+ S +K+ D+ + +LID + +F
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF- 158
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG------------EALFQ 286
V TR Y +PE + G + D+WS+G LVE+ G EA+F
Sbjct: 159 -------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL- 345
+ R + P S M A+++LL
Sbjct: 212 RPVSEGEAKESHRPVSGHPP--------------------------DSPRPM-AIFELLD 244
Query: 346 --------RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+LP+ + + D + L+ +P ER +E +HPF R
Sbjct: 245 YIVNEPPPKLPS------GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 4e-07
Identities = 45/223 (20%), Positives = 78/223 (34%), Gaps = 63/223 (28%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + +KK VA+K ++ + + E + E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D---------IGGTRY------------RSF---------PIDLVRELGRQLLESVAFMH 178
S+ DL+ Q+ + ++
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLL-SFALQIARGMEYLE 119
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
IH DL N L+ VK+ D F LSR D Y++ I+
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYRKRGGKLPIR--------- 168
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
+ APE + + D+WS G +L E+ +
Sbjct: 169 -------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 34/129 (26%), Positives = 61/129 (47%), Gaps = 25/129 (19%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H+ R+++ DLKPENILL ++++ D ++P+ IK G
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAV----------HVPEGQTIK----GR-- 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
V T Y APEV+ + + D W++GC+L E+ +G++ FQ +
Sbjct: 162 ---------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
Query: 297 MERVLGPLP 305
+ER++ +
Sbjct: 213 VERLVKEVQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 24/132 (18%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
R R P + R ++ ++ F+HE +I+ DLK +N+LL + ++K+ DY K
Sbjct: 89 RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGM----CK 144
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
+G + G TT S T +Y APE++ G + + D W++G
Sbjct: 145 EG--------------LGPGDTT------STFCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 274 ILVELCSGEALF 285
++ E+ +G + F
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 24/132 (18%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
R R P + R ++ ++ ++HE +I+ DLK +N+LL S ++K+ DY K
Sbjct: 89 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CK 144
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
+G + G TT S T +Y APE++ G + + D W++G
Sbjct: 145 EG--------------LRPGDTT------STFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 274 ILVELCSGEALF 285
++ E+ +G + F
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 79/349 (22%), Positives = 127/349 (36%), Gaps = 110/349 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSI---NKYREAAMIEIDVLQRLAR 147
++ + +G+G G+V +L A+K++ + + NK + E ++L L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATL-D 59
Query: 148 HDIGGTRYRSFPI--------------DLVRELGRQ----LLESVA------------FM 177
H T Y SF +L R L RQ L E VA ++
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDY----------KFLSRSSKDGSYFKNLPKSS-- 225
H L +++ DLKPENILL + ++ + D+ +S++ + GS ++
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 226 -AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
+ F S +F V T Y APEVI G G D W++G +L E+ G
Sbjct: 180 TFSEEPSFRSNSF--------VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
F + R E + +
Sbjct: 232 F-------------------------KGSNRDETFSN----------------------I 244
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL----KAREALRHPFF 389
L+ S+ DL++ LL DP++RL A E +HPFF
Sbjct: 245 LKKEVTFPGSPPVSS-SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 34/140 (24%), Positives = 63/140 (45%), Gaps = 28/140 (20%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
P D+ R +++ ++ +H+L +H D+KP+N+LL ++++ D+ + ++DG+
Sbjct: 99 LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVG 272
S V T Y +PE++ G+G P CD WS+G
Sbjct: 159 -----------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 273 CILVELCSGEALFQTHENLE 292
+ E+ GE F +E
Sbjct: 196 VCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 6e-07
Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 64/217 (29%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARH---- 148
L ++G G+FG V D E+VAIK + + N+ + + E+ LQR+ +H
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 149 DIGGTRYRSFPIDLVRE------------------------LGRQLLESVAFMHELRLIH 184
+ G R LV E + L+ +A++H +IH
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K NILL + +KL DFGS + +S+
Sbjct: 149 RDIKAGNILLT---------------------------EPGQVKLADFGSASIASPANSF 181
Query: 245 VVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 278
V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 182 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 24/117 (20%)
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235
F+H +++ DLK +NILL + ++K+ D+ + L D +
Sbjct: 111 FLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN----------------MLGDAKTC 154
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
TF T Y APE++LG +N D WS G +L E+ G++ F H+ E
Sbjct: 155 TF--------CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 27/138 (19%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
R + FP D+ Q++ ++ L +++ DLKPEN+LL K
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL-----------------DK 166
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
DG IK+ DFG + T Y APE++L +G D W++G
Sbjct: 167 DG----------FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGI 216
Query: 274 ILVELCSGEALFQTHENL 291
+ E+ G F +E L
Sbjct: 217 FIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 55/250 (22%)
Query: 156 RSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
+ P +++ ++ +L +A++ E +++H D+KP NIL+ S +K+ D+
Sbjct: 98 KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDF--------- 148
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
+ +LID + +F V TR Y +PE + G ++ D+WS+G
Sbjct: 149 ---------GVSGQLIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 275 LVELCSGEALFQTHENLEHLAMMERVL----GPLPHHMVIRADRRAEKYFRRGARLDWPD 330
LVEL G + E A+ R + PH + R R R
Sbjct: 192 LVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP--------RPPGRPVSGH 243
Query: 331 GATSRDSMRAVWKLL---------RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381
G SR +M A+++LL +LPN + D + + L +PAER +
Sbjct: 244 GMDSRPAM-AIFELLDYIVNEPPPKLPNGVF------TPDFQEFVNKCLIKNPAERADLK 296
Query: 382 EALRHPFFTR 391
+ H F R
Sbjct: 297 MLMNHTFIKR 306
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 33/128 (25%), Positives = 54/128 (42%), Gaps = 28/128 (21%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
YR P ++ + +++ + ++ L+++H D+KP N+L+ + VK
Sbjct: 89 YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVK------------- 135
Query: 215 GSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
L DFG ST + V T Y APE I G + D+WS+G
Sbjct: 136 --------------LCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGI 181
Query: 274 ILVELCSG 281
+EL G
Sbjct: 182 SFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 61/261 (23%), Positives = 102/261 (39%), Gaps = 68/261 (26%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRY 155
+G+G+FG+V+ K E A+K ++ I+ E M+E VL + Y
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 156 RSFPI--------------DL---VRELGR-----------QLLESVAFMHELRLIHTDL 187
+F DL +++ GR +++ + F+H +I+ DL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFEHQDHSY 244
K +N++L +DG IK+ DFG F S
Sbjct: 123 KLDNVML-----------------DRDGH----------IKIADFGMCKENVFGDNRAST 155
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304
T Y APE++ GL + + D WS G +L E+ G++ F + E + E +
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRVDT 212
Query: 305 PHH---MVIRADRRAEKYFRR 322
PH+ + + EK F R
Sbjct: 213 PHYPRWITKESKDILEKLFER 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 56/225 (24%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDI----- 150
+G+G+FG+V+ +++ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG R R F R ++ ++ ++H L +++ DL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
KPENILL S ++ + D+ + I+ TT S
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKEN------------------IEHNGTT------STFCG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
T Y APEV+ ++ D W +G +L E+ G F + E
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 66/241 (27%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDI-- 150
+G+G FG+V C +L A K +NK R E AM+E +L ++ I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACK---KLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 151 --------------------GGTRYRSFPIDLVRE---------LGRQLLESVAFMHELR 181
G RY + +D Q++ + +H+ R
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLKPEN+LL + V++ D A++L D S T +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGL------------------AVELKDGQSKTKGY-- 157
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENLEHLAMMERV 300
T + APE++ G +++ D +++G L E+ + F+ E +E+ + +R+
Sbjct: 158 ----AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
Query: 301 L 301
L
Sbjct: 214 L 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 28/140 (20%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
P D+ R +++ ++ +H+L +H D+KP+NIL+ ++++ D+
Sbjct: 99 LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF------------ 146
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVG 272
S +KL++ G+ S V T Y +PE++ G G P CD WS+G
Sbjct: 147 ------GSCLKLMEDGTV-----QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG 195
Query: 273 CILVELCSGEALFQTHENLE 292
+ E+ GE F +E
Sbjct: 196 VCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 56/255 (21%), Positives = 89/255 (34%), Gaps = 67/255 (26%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
R R PID + +Q+LE + ++H R+IH D+K ENI +
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV---------------- 193
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSV 271
+ + D G+ F ++ + T APEV+ +N D+WS
Sbjct: 194 -----------DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 272 GCILVEL------------CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKY 319
G +L E+ + E ++ + HL + L P R +
Sbjct: 243 GIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS--HLLKIISTLKVHPEEFPRDPGSRLVRG 300
Query: 320 FRRGARLDWPDGATSRDSMRAVWKLLRLPNL---IMQHVD-HSAGDLIDLLQGLLRYDPA 375
F A L+ R P Q V+ G+ L+ +L +D A
Sbjct: 301 FIEYASLE------------------RQPYTRYPCFQRVNLPIDGEF--LVHKMLTFDAA 340
Query: 376 ERLKAREALRHPFFT 390
R A E L +P F
Sbjct: 341 MRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 64/217 (29%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARH---- 148
L ++G G+FG V D E+VAIK + + N+ + + E+ LQ+L RH
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 149 DIGGTRYRSFPIDLVRE------------------------LGRQLLESVAFMHELRLIH 184
G R LV E + L+ +A++H +IH
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K NILL + +KL DFGS + + +
Sbjct: 139 RDVKAGNILLS---------------------------EPGLVKLGDFGSASIMAPANXF 171
Query: 245 VVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 278
V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 172 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 30/121 (24%), Positives = 53/121 (43%), Gaps = 27/121 (22%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
+++ ++ +H + IH D+KP+N+LL + ++K+ D+ + +G
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV----------- 198
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL 284
D + V T Y +PEV+ G + CD WSVG L E+ G+
Sbjct: 199 ----------RCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 285 F 285
F
Sbjct: 247 F 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 32/132 (24%), Positives = 61/132 (46%), Gaps = 24/132 (18%)
Query: 154 RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
R R P + R ++ ++ F+HE +I+ DLK +N+LL + ++K+ DY +
Sbjct: 89 RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
G ++TF T +Y APE++ G + + D W++G
Sbjct: 149 PGDT----------------TSTF--------CGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 274 ILVELCSGEALF 285
++ E+ +G + F
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 28/121 (23%), Positives = 54/121 (44%), Gaps = 25/121 (20%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+ + +H + +++ D+KPEN+LL ++ D A++
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL------------------AVE 144
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288
L D + T T Y APE++ ++YP D +++GC + E+ +G F+ H
Sbjct: 145 LKDGKTITQR-------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197
Query: 289 E 289
+
Sbjct: 198 K 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 32/128 (25%), Positives = 62/128 (48%), Gaps = 27/128 (21%)
Query: 159 PIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
P++++ ++ ++E + +++ R++H D+KP NIL+ S +K+ D+
Sbjct: 101 PVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDF------------ 148
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 277
+ +LI+ + TF V T Y +PE I G + D+WS+G ++E
Sbjct: 149 ------GVSGELINSIADTF--------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 278 LCSGEALF 285
L G+ F
Sbjct: 195 LALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 25/114 (21%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H+ +I+ DLKPENILL + +VK+ D+ L K S I G+ T
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDF--------------GLCKES----IHEGTVT 157
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290
H++ T Y APE+++ G D WS+G ++ ++ +G F T EN
Sbjct: 158 -----HTF-CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 33/126 (26%)
Query: 164 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223
R + +QLL +V ++H+ +LIH D+K ENI L + DG
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-----------------NCDGK------- 305
Query: 224 SSAIKLIDFGS-TTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
I L DFG+ FE + D+ +V T +PE++ G G+ D+WS G IL+++
Sbjct: 306 ---IVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 279 CSGEAL 284
S +
Sbjct: 362 LSHDFC 367
|
Length = 501 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 45/162 (27%), Positives = 67/162 (41%), Gaps = 39/162 (24%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
F VR +++ ++ +H+L +I+ D+K ENILL +G
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL-----------------DSEGH- 143
Query: 218 FKNLPKSSAIKLIDFG-STTF----EHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWS 270
+ L DFG S F E + +S+ T Y APEVI G G + D WS
Sbjct: 144 ---------VVLTDFGLSKEFLAEEEERAYSF-CGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 271 VGCILVELCSGEALFQTH-ENLEHLAMMERVLG---PLPHHM 308
+G + EL +G + F E + R+L P P M
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 62/232 (26%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDI----- 150
+G+G+FG+V+ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG R R F R ++ ++ ++H L +I+ DL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
KPENILL S +V + D+ K+G ++ TT S
Sbjct: 123 KPENILLDSQGHVVLTDFGL----CKEG--------------VEPEETT------STFCG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF------QTHENLEH 293
T Y APEV+ ++ D W +G +L E+ G F Q ++N+ H
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 68/275 (24%)
Query: 93 RY-RILSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL 145
RY + + +GEG FG+V + C+D + E+VA+K ++ + EI++L+ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 146 ARHDIGGTRYRS----------------FPIDLVRE--------------LGRQLLESVA 175
+I +Y+ P+ +R+ +Q+ E +A
Sbjct: 64 YHENI--VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA 121
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235
++H IH DL N+LL + VK+ D+ L+++ +G + + + D S
Sbjct: 122 YLHSQHYIHRDLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRVRE-------DGDSP 173
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
F + A E + ++Y D+WS G L EL L
Sbjct: 174 VF-------------WYAVECLKENKFSYASDVWSFGVTLYEL-----LTHCDSKQSPPK 215
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 330
E ++GP M + R + RG RL P
Sbjct: 216 KFEEMIGPKQGQMTV---VRLIELLERGMRLPCPK 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 25/110 (22%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H R+++ DLKPENILL ++++ D L+ +G +
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLG-LAVEIPEGETIRGR--------------- 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
V T Y APEV+ + + D W +GC++ E+ G++ F+
Sbjct: 162 ---------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 61/224 (27%)
Query: 13 NMDKRPRKRPRLTWDVP---PPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
RPR+RP LT +P P L P LP P + SS +
Sbjct: 19 TTKSRPRRRPDLTLPLPQRDPSLAVPLPLP-------------PPSSSSSSSSSSSASGS 65
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK------ 123
+P +L+ R+ +++G G G V + L A+K
Sbjct: 66 APSAAK-------------SLSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 124 -------------IVRSINK---------YREAAMIEIDVLQRLARHDIGGTRYRSFPID 161
I+R +N + I++ +L+ + + GT
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV-LLEFMDGGSLEGTHIADEQ-- 168
Query: 162 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205
+ ++ RQ+L +A++H ++H D+KP N+L+ SA+ VK+ D+
Sbjct: 169 FLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
|
Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 53/246 (21%), Positives = 99/246 (40%), Gaps = 58/246 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDI 150
Y + +G+G++G+V + IK + + + R+AA E +L +L +I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 151 ----------------------GGTRYRSF--------PIDLVRELGRQLLESVAFMHEL 180
GG Y P + V E Q+ ++ ++HE
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
++H DLK +N+ L +KV D ++R ++ D ST
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLG-IARVLENQC--------------DMAST----- 161
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE-NLEHLAMMER 299
++ T +Y +PE+ +NY D+W++GC + E+ + + F + N ++E
Sbjct: 162 ----LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217
Query: 300 VLGPLP 305
L P+P
Sbjct: 218 KLPPMP 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 72/234 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH----D 149
+ I+ +G+GT+G+V + + + A+KI+ I+ E E ++L+ L+ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 150 IGGTRYRSFPID-----LVREL----------------GRQLLES-VAF----------- 176
G Y+ + LV EL G ++ E +A+
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 235
+H + IH D+K NILL + +KL+DFG +
Sbjct: 140 LHVNKTIHRDVKGNNILLTT---------------------------EGGVKLVDFGVSA 172
Query: 236 --TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGE 282
T + V T + APEVI L ++ CD+WS+G +EL G+
Sbjct: 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 28/113 (24%), Positives = 51/113 (45%), Gaps = 25/113 (22%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+ R+++ DLKPENILL ++++ D + +P+ ++ G
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ----------IPEGETVR----GR-- 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289
V T Y APEVI + + D W +GC++ E+ G++ F+ +
Sbjct: 162 ---------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 64/217 (29%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARH---- 148
L ++G G+FG V ++ E+VA+K + + N+ + + E+ LQ+L +H
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 149 DIGGTRYRSFPIDLVRE--LGRQ----------------------LLESVAFMHELRLIH 184
+ G + LV E LG L+ +A++H +IH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K NILL + +KL DFGS + +S+
Sbjct: 145 RDIKAGNILLT---------------------------EPGQVKLADFGSASKSSPANSF 177
Query: 245 VVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 278
V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 178 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 55/237 (23%), Positives = 90/237 (37%), Gaps = 64/237 (27%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRY 155
+G+G+FG+V+ E AIK ++ + E M+E VL H +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 156 RSFPI--------------DL---VRELGR-----------QLLESVAFMHELRLIHTDL 187
+F DL ++ GR +++ + F+H+ +I+ DL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSY 244
K +N+LL KDG IK+ DFG S
Sbjct: 123 KLDNVLL-----------------DKDGH----------IKIADFGMCKENMNGEGKAST 155
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMER 299
T Y APE++ G +N D WS G +L E+ G++ F + + L + +R
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 49/236 (20%), Positives = 80/236 (33%), Gaps = 76/236 (32%)
Query: 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215
V+++ RQL+E++ +H+ +IH D+K EN+L
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL---------------------- 141
Query: 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 275
Y + + I L D+G Y T Y +PE I G ++ D W+VG +
Sbjct: 142 -YDRAKDR---IYLCDYGLCKIIGTPSCY-DGTLDYFSPEKIKGHNYDVSFDWWAVGVLT 196
Query: 276 VELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
EL +G+ F+ E+ E L + + R
Sbjct: 197 YELLTGKHPFKEDEDEELDLESLLK-------------------------RQQKKLPFIK 231
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-KAREALRHPFF 389
S A D +Q +L+Y+ RL E ++HPF
Sbjct: 232 NVSKNAN----------------------DFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 35/150 (23%), Positives = 63/150 (42%), Gaps = 35/150 (23%)
Query: 140 DVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199
D++ ++ +D+ R + ++V L +H + IH D+KP+N+LL + +
Sbjct: 129 DLVNLMSNYDVPEKWARFYTAEVVLALDA--------IHSMGFIHRDVKPDNMLLDKSGH 180
Query: 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG 259
+K+ D+ + +K+G + V T Y +PEV+
Sbjct: 181 LKLADFGTCMKMNKEGMVRCDT-----------------------AVGTPDYISPEVLKS 217
Query: 260 LG----WNYPCDLWSVGCILVELCSGEALF 285
G + CD WSVG L E+ G+ F
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 51/222 (22%), Positives = 82/222 (36%), Gaps = 61/222 (27%)
Query: 97 LSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++GEG FG+V C + E VA+K + ++R EI++L+ L +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 151 GGTRYRSFP-----IDLVRE-------------------LGRQLLESV------AFMHEL 180
+ + L+ E L R LL S ++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
R IH DL NIL+ S + VK+ D+ L++ Y+ P S I
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFG-LAKVLPEDKDYYYVKEPGESPIF---------- 177
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
+ APE + ++ D+WS G L EL +
Sbjct: 178 ------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 51/219 (23%), Positives = 79/219 (36%), Gaps = 79/219 (36%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
MH +++ DLKP NILL +V++ D + K P +S
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS----------- 155
Query: 237 FEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
V T Y APEV+ G+ ++ D +S+GC+L +L G + F+ H+ +
Sbjct: 156 ---------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
+ DR ++ PD +
Sbjct: 207 I----------------DRMTLT-----MAVELPDSFSP--------------------- 224
Query: 356 DHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
+L LL+GLL+ D RL A+E HPFF
Sbjct: 225 -----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 46/217 (21%), Positives = 90/217 (41%), Gaps = 57/217 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI- 150
Y ++ ++G GT+G V + + EL A+KI++ + + ++I EI +++ +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 151 --------------------GGTRYRSFPID------LVRELGRQLLESVAFMHELRLIH 184
GG+ + + + + R+ L+ +A++H +H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K NILL VK+ D+ ++ + + K+
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF----------------------- 166
Query: 245 VVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 278
+ T ++ APEV G+N CD+W+VG +EL
Sbjct: 167 -IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 49/233 (21%), Positives = 93/233 (39%), Gaps = 53/233 (22%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINK--YREAAMIEIDVLQRLAR------- 147
++G G FG V + + KK++ VAIK++++ N+ R+ M E +++ +L
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 148 --------------------HDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
+ + + V EL Q+ + ++ +H DL
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
N+LLV+ Y K+ D+ D SY+K +S G +
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARS-------AGKWPLK--------- 163
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
+ APE I ++ D+WS G + E S G+ ++ + E ++ +E+
Sbjct: 164 ---WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 45/228 (19%), Positives = 94/228 (41%), Gaps = 58/228 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--------- 144
+ ++ ++G GT+G V + + EL AIK+++ + + A+++ +++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 145 ------LARHDI--------GGTRYRSFPID------LVRELGRQLLESVAFMHELRLIH 184
L R + GG+ + + + + R+ L+ + ++H +H
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K NILL +VK+ D+ ++ + + K+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF----------------------- 166
Query: 245 VVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGE-ALFQTH 288
+ T ++ APEV G+N CD+W+VG +EL + +F H
Sbjct: 167 -IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 4e-05
Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 64/225 (28%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + + VA+K ++ + + RE + E ++++L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60
Query: 149 D-----IG-----GTRY-----------RSF---------PIDLVRELGRQLLESVAFMH 178
+G Y F DL+ ++ Q+ + + ++
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL-QMALQIAKGMEYLE 119
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS-SAIKLIDFGSTT 236
+H DL N L+ VK+ D F LSR + Y++ IK
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISD--FGLSRDIYEDDYYRKRGGGKLPIK-------- 169
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
+ APE + + D+WS G +L E+ +
Sbjct: 170 --------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 54/254 (21%), Positives = 86/254 (33%), Gaps = 92/254 (36%)
Query: 147 RHDIGGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 200
+H GG ++ + P + V+ +++ ++ +H ++ DL P NILL ++
Sbjct: 65 QHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHI 124
Query: 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL 260
++ +YF + E V Y APEV
Sbjct: 125 QL-------------TYFSRW-------------SEVEDSCDGEAVE-NMYCAPEVGGIS 157
Query: 261 GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF 320
CD WS+G IL EL +G+ L + H
Sbjct: 158 EETEACDWWSLGAILFELLTGKTLVECH-------------------------------- 185
Query: 321 RRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380
P G + + L +P + V A L+ Q LL+++P ERL A
Sbjct: 186 --------PSGINTHTT-------LNIP----EWVSEEARSLL---QQLLQFNPTERLGA 223
Query: 381 REA-----LRHPFF 389
A HPFF
Sbjct: 224 GVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 24/110 (21%)
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235
++HE ++++ DLK +N+LL + +VK+ D+ K+G + FG
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL----CKEG--------------MGFGDR 157
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
T S T + APEV+ + D W +G ++ E+ GE+ F
Sbjct: 158 T------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 56/224 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLAR-- 147
+ L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 148 -----HDIGGTRYRSFPI-------DL---VRELGR-----------QLLESVAFMHELR 181
H T R + + DL ++++G+ ++ + F+H
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N++L + ++K+ D+ + G + TF
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----------------TF---- 161
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
T Y APE+I + D W+ G +L E+ +G+ F
Sbjct: 162 ----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 50/212 (23%)
Query: 93 RYRILSKMGEGTFGQVVEC--FDNEKKELVAIK----------------------IVRSI 128
+Y ILS + G+ G+V C +E+++ V +K I+ I
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLI 152
Query: 129 NKYREAAMIEIDVLQRLARHDIGGTRYRSFPIDL--VRELGRQLLESVAFMHELRLIHTD 186
+ YR + + + + + D+ RS P+ L + R+LLE++A++H +IH D
Sbjct: 153 HAYRWKSTVCM--VMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD 210
Query: 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV 246
+K ENI L E + D+ +A KL + Q + +
Sbjct: 211 VKTENIFLDEPENAVLGDF------------------GAACKL---DAHPDTPQCYGW-S 248
Query: 247 STRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
T +PE++ + D+WS G +L E+
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 35/119 (29%), Positives = 48/119 (40%), Gaps = 39/119 (32%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS-- 234
+H + LIH D+KP+N+LL K +KL DFG+
Sbjct: 158 IHSMGLIHRDVKPDNMLL---------------------------DKHGHLKLADFGTCM 190
Query: 235 ----TTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 285
T D + V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 191 KMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 30/132 (22%), Positives = 60/132 (45%), Gaps = 28/132 (21%)
Query: 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
P D+ R +++ ++ +H+L +H D+KP+N+LL ++++ D+
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF------------- 146
Query: 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGC 273
S ++L+ G+ + V T Y +PE++ + + CD WS+G
Sbjct: 147 -----GSCLRLLADGTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGV 196
Query: 274 ILVELCSGEALF 285
+ E+ GE F
Sbjct: 197 CMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 58/239 (24%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQRLARHDI----- 150
+G+G+FG+V+ E+ AIK+++ + + M E +L A+H
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG R R F R ++ ++ F+H +I+ DL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
K +NILL + + K+ D+ +G +TTF
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVT----------------TTTF--------CG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT--HENLEHLAMMERVLGPL 304
T Y APE++ L + D W++G ++ E+ +G+ F+ ++L + + VL P+
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 27/128 (21%)
Query: 163 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222
+R +++ + MH +++ DLKP NILL +V++ D SK P
Sbjct: 99 MRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------P 152
Query: 223 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSG 281
+S V T Y APEV+ G ++ D +S+GC+L +L G
Sbjct: 153 HAS--------------------VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
Query: 282 EALFQTHE 289
+ F+ H+
Sbjct: 193 HSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 25/110 (22%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H ++ DLKPENILL ++++ D + +P+ +I+ G
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVK----------IPEGESIR----GR-- 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
V T Y APEV+ + D W +GC++ E+ G++ F+
Sbjct: 162 ---------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 57/227 (25%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDI----- 150
+G+G+FG+V+ E L A+K+++ + E M E +L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 151 -----------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG + R F R ++ ++ F+H+ +I+ DL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
K +N+LL + K+ D+ +G ++TF
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKT----------------TSTF--------CG 158
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
T Y APE++ + + D W++G +L E+ G A F+ EN + L
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 39/133 (29%), Positives = 60/133 (45%), Gaps = 32/133 (24%)
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
F D VR +++ ++ +H+L +++ D+K ENILL S +V
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV---------------- 145
Query: 218 FKNLPKSSAIKLIDFG-STTF--EHQDHSY-VVSTRHYRAPEVILG-LGWNYPCDLWSVG 272
L DFG S F E ++ +Y T Y APE+I G G D WS+G
Sbjct: 146 -----------LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 273 CILVELCSGEALF 285
++ EL +G + F
Sbjct: 195 ILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 59/237 (24%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI---- 150
+++ K+G G FG+V N + VA+K ++ E+ + E ++++L RHD
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQL 66
Query: 151 ---------------------------GGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
G R P +LV ++ Q+ +A++ + I
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP-NLV-DMAAQVAAGMAYIERMNYI 124
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 125 HRDLRSANILVGDGLVCKIADFG-LARLIEDNEYTARQGAKFPIK--------------- 168
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
+ APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 169 -------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 75/335 (22%), Positives = 120/335 (35%), Gaps = 88/335 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI--- 150
+ IL G G C DN+ E V IK + R E +L+ + I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQL 148
Query: 151 GGT------------RYRS-----------FPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GT RY++ I + + R +L ++ ++HE R+IH D+
Sbjct: 149 KGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDI 208
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSY 244
K ENI F N P + L DFG+ F + + Y
Sbjct: 209 KAENI-------------------------FINHPGD--VCLGDFGAACFPVDINANKYY 241
Query: 245 -VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE-ALFQTH------ENLEHLAM 296
T APE++ + D+WS G +L E+ + +LF+ ++ + +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVW-KLLRLPNLIMQH 354
+ R G P+ I A ++ + A+ +SR R +W L LP
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAK------KSSRKPGSRPLWTNLYELPI----- 350
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
DL L+ +L +D R A L F
Sbjct: 351 ------DLEYLICKMLAFDAHHRPSAEALLDFAAF 379
|
Length = 391 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 56/221 (25%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLAR----- 147
L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 148 --HDIGGTRYRSFPI-------DL---VRELGR-----------QLLESVAFMHELRLIH 184
H T R + + DL ++++G+ ++ + F+H +I+
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DLK +N++L S ++K+ D+ DG + TF
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----------------VTTRTF------- 161
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
T Y APE+I + D W+ G +L E+ +G+ F
Sbjct: 162 -CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 56/231 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLAR-- 147
+ L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 148 -----HDIGGTRYRSFPI-------DL---VRELGR-----------QLLESVAFMHELR 181
H T R + + DL ++++GR ++ + F+H
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N++L S ++K+ D+ + DG K TF
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK----------------TF---- 161
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
T Y APE+I + D W+ G +L E+ +G+A F+ + E
Sbjct: 162 ----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 72/255 (28%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG--- 151
L ++G GT GQV + + ++A+K + R+ NK E I +D+ L HD
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIV 77
Query: 152 ---GTRYRSFPIDLVRE---------------------LGRQLLESVAFMHELR----LI 183
G + + E LG+ + V +H L+ +I
Sbjct: 78 KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI 137
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF--EHQD 241
H D+KP NILL S +KL DFG + + +
Sbjct: 138 HRDVKPSNILL---------------------------DASGNVKLCDFGISGRLVDSKA 170
Query: 242 HSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+ Y APE I ++ D+WS+G LVEL +G+ F ++
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVL 228
Query: 298 ERVLGP----LPHHM 308
++L LP +
Sbjct: 229 TKILQEEPPSLPPNE 243
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 57/236 (24%)
Query: 95 RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
R+ K+G+G FG+V + ++ K VAIK ++ EA + E ++++L RHD
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVP 65
Query: 154 RYRSF---PIDLVRE--------------------------LGRQLLESVAFMHELRLIH 184
Y PI +V E + Q+ + +A++ + IH
Sbjct: 66 LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 126 RDLRAANILVGDNLVCKIADFG-LARLIEDNEYTARQGAKFPIK---------------- 168
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
+ APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 169 ------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 58/235 (24%), Positives = 89/235 (37%), Gaps = 55/235 (23%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQL 66
Query: 155 YRSF---PIDLVRE--------------------------LGRQLLESVAFMHELRLIHT 185
Y PI +V E + Q+ +A++ + +H
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 245
DL+ NIL+ KV D+ L+R +D Y IK
Sbjct: 127 DLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK----------------- 168
Query: 246 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
+ APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 46/238 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRYR 156
L ++G G FG V + ++A+K +RS +E Q+ D+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE---------QKRLLMDLDVVMRS 59
Query: 157 SFPIDLVRELGRQLLESVAFM-HEL---------RLIHTDLK---PENIL-LVSAEYVKV 202
S +V+ G E ++ EL + ++ LK PE IL ++ VK
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 203 PDY-----KFLSRSSKDGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHY 251
+Y K + R K + L ++ IKL DFG + + +D R Y
Sbjct: 120 LNYLKEELKIIHRDVKPSNIL--LDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRPY 173
Query: 252 RAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENL-EHLAMMERVLGPLP 305
APE I G++ D+WS+G L E+ +G+ + ++ + L + V G P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--VKGDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 1/60 (1%)
Query: 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215
F I + + Q+ + ++ R IH DL NILL S + VK+ D+ L R+
Sbjct: 92 GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG-LMRALPQN 150
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 68/289 (23%), Positives = 108/289 (37%), Gaps = 92/289 (31%)
Query: 100 MGEGTFGQVVE--CFDNEKKEL---VAIKIVRSINKY--REAAMIEIDVLQRLARH---- 148
+G G FG+VVE + K + VA+K+++ REA M E+ ++ L H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 149 DIGGTRYRSFPI----------DLVRELGR----------------QLLESVAFMHELRL 182
++ G PI DL+ L R Q+ + +AF+
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
IH DL N+LL + VK+ D+ L+R + D
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFG-LARDIMN--------------------------DS 195
Query: 243 SYVV--STR---HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+YVV + R + APE I + + D+WS G +L E+ S
Sbjct: 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS----------------- 238
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWKL 344
LG P+ + D + K + G R+ P+ A + D M+ W
Sbjct: 239 ---LGSNPYPGMP-VDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDA 283
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 26/101 (25%)
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
+++H D+KP NIL+ S +K+ D+ + +LID + +F
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF--- 162
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
V TR Y +PE + G ++ D+WS+G LVE+ G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 63/224 (28%)
Query: 92 PR--YRILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLAR 147
PR + + K+G G FG+V E + N + VAIKI++S + ++ E+ L+RL R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-R 60
Query: 148 HD----IGGTRYRSFPIDLVREL--------------------------GRQLLESVAFM 177
H + P+ ++ EL Q+ E +A++
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 178 HELRLIHTDLKPENILLVSAEYV-KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
E IH DL NI LV + V KV D+ L+R K+ Y L I
Sbjct: 121 EEQNSIHRDLAARNI-LVGEDLVCKVADFG-LARLIKEDVY---LSSDKKIPY------- 168
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
+ APE ++ D+WS G +L E+ +
Sbjct: 169 -------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 36/129 (27%), Positives = 54/129 (41%), Gaps = 34/129 (26%)
Query: 156 RSFPIDL--VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213
R P+ L V + RQLL ++ ++H +IH D+K EN+L+
Sbjct: 253 RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV------------------- 293
Query: 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDL 268
N P+ I L DFG+ F S + T APEV+ G + D+
Sbjct: 294 ------NGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 269 WSVGCILVE 277
WS G ++ E
Sbjct: 346 WSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 79/238 (33%)
Query: 159 PIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
P D++ ++ +++++ ++H L +IH D+KP N+L+ VK+ D+
Sbjct: 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDF----------GI 150
Query: 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGC 273
L S A K ID G + Y APE I G++ D+WS+G
Sbjct: 151 SGYLVDSVA-KTIDAGC--------------KPYMAPERINPELNQKGYDVKSDVWSLGI 195
Query: 274 ILVELCSGEALFQT-HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA 332
++EL +G + + + L + V P P
Sbjct: 196 TMIELATGRFPYDSWKTPFQQLKQV--VEEPSP--------------------------- 226
Query: 333 TSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+LP + + + D + L+ + ER E L+HPFF
Sbjct: 227 -------------QLPA------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 29/141 (20%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+L +V +H +IH D+K NILL S VK+ D+ F K A
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF--------------SKMYAAT 196
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288
+ D TF T +Y APE+ ++ D++S+G +L EL + + F
Sbjct: 197 VSDDVGRTF--------CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247
Query: 289 ENLEHLAMMERVLG----PLP 305
EN+E + M + L PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266
|
Length = 496 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 37/142 (26%), Positives = 57/142 (40%), Gaps = 37/142 (26%)
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H+L +I+ D+K ENILL S + + L DFG +
Sbjct: 121 LHKLGIIYRDIKLENILLDS---------------------------NGHVVLTDFGLSK 153
Query: 237 FEHQDHSY----VVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTH-E 289
H+D T Y AP+++ G G + D WS+G ++ EL +G + F E
Sbjct: 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
Query: 290 NLEHLAMMERVLG---PLPHHM 308
+ R+L P P M
Sbjct: 214 KNSQAEISRRILKSEPPYPQEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 51/217 (23%), Positives = 81/217 (37%), Gaps = 61/217 (28%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N + VA+K ++ EA + E ++++L RHD
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQL 66
Query: 155 Y----RSFPIDLVREL--------------GRQLL------------ESVAFMHELRLIH 184
Y PI +V E G++L E +A++ IH
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA---IKLIDFGSTTFEHQD 241
DL NIL+ K+ D+ L+R +D Y + A IK
Sbjct: 127 RDLAARNILVGENLVCKIADFG-LARLIEDDEY---TAREGAKFPIK------------- 169
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278
+ APE + D+WS G +L E+
Sbjct: 170 ---------WTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 46/226 (20%), Positives = 87/226 (38%), Gaps = 67/226 (29%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI-- 150
+L ++G+G +G V + +A+K +R +K+ + M E+D+L + I
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVD 63
Query: 151 ----------------------------GGTRYRSFPIDLVRELGRQLLESVAFMHE-LR 181
GG P D++R + +++ + F+ E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+IH D+KP N+L+ VK+ D+ G+ +L K++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGV------SGNLVASLAKTN---------------- 161
Query: 242 HSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELCSG 281
+ + Y APE I G + D+WS+G ++E+ G
Sbjct: 162 ----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 38/151 (25%), Positives = 60/151 (39%), Gaps = 34/151 (22%)
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
R P+ ++EL Q+ +A++ +H DL N+LLV+ K+ D+ +SR+
Sbjct: 89 RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG-MSRALGA 147
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDL 268
GS Y +T R APE I ++ D+
Sbjct: 148 GS--------------------------DYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 269 WSVGCILVELCS-GEALFQTHENLEHLAMME 298
WS G L E S G + + E +AM+E
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 25/133 (18%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q++ ++ +H +++H DLK NI L+ +K+ D+ F + S S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS------------ 224
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288
+D S+ T +Y APE+ ++ D+WS+G IL EL + F+
Sbjct: 225 -LDVASS---------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274
Query: 289 ENLEHLAMMERVL 301
E +M++VL
Sbjct: 275 SQRE---IMQQVL 284
|
Length = 478 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 55/236 (23%), Positives = 89/236 (37%), Gaps = 56/236 (23%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++L K+G G FG+V E N VA+K ++ + + E ++++L RH
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQL 66
Query: 155 Y----RSFPIDLVRELGRQ--LLE------------------------SVAFMHELRLIH 184
Y PI +V EL + LLE +A++ IH
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL N+L+ KV D+ L+R K+ Y IK
Sbjct: 127 RDLAARNVLVGENNICKVADFG-LARVIKEDIYEAREGAKFPIK---------------- 169
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
+ APE L ++ D+WS G +L E+ + G + N E L +++
Sbjct: 170 ------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 63/284 (22%), Positives = 105/284 (36%), Gaps = 73/284 (25%)
Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI--- 150
+GEG FG+V C +D E E VA+K ++ + A + EI++L+ L +I
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 151 --------------------GGTRYRSFP-----IDLVREL--GRQLLESVAFMHELRLI 183
G+ P I+L ++L Q+ + + ++ + +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV 131
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DL N+L+ S VK+ D+ D Y+ +K D S F
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-------TVK-DDLDSPVF------ 177
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL---CSGEALFQTHENLEHLAMMERV 300
+ APE ++ + D+WS G L EL C E+ + + ++
Sbjct: 178 -------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES--------SPMTLFLKM 222
Query: 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVW 342
+GP M + R + G RL P MR W
Sbjct: 223 IGPTHGQMTV---TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCW 263
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 19/51 (37%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219
QL ++A++ R +H D+ N+L+ S + VK+ D+ LSR +D SY+K
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG-LSRYLEDESYYK 164
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 56/267 (20%), Positives = 95/267 (35%), Gaps = 104/267 (38%)
Query: 162 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221
+++ + RQ+L ++ +H ++H D+KP+NI+
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS-------------------------- 289
Query: 222 PKSSAIKLIDFGSTT-----FEHQDHSYVVSTRHYRAPE---------------VILGLG 261
S + K+ID G+ + +++ R Y APE V L
Sbjct: 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPR-YAAPEQYIMSTQTPSAPSAPVATALS 348
Query: 262 ---W--NYP--CDLWSVGCILVELC-----SGEALFQTHENLEH----LAMMERVLGPLP 305
W N P D++S G I +++ S L Q + L+ L +++ P
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-- 406
Query: 306 HHMVIRADRRAEKYFRRGAR-LDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364
RA RRG LD GA W +
Sbjct: 407 ---------RASPDLRRGFEVLDLDGGAG--------W---------------------E 428
Query: 365 LLQGLLRYDPAERLKAREALRHPFFTR 391
LL+ ++R+ +R+ A+ AL HP+F R
Sbjct: 429 LLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 31/138 (22%), Positives = 56/138 (40%), Gaps = 22/138 (15%)
Query: 163 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222
+ EL Q+ + ++ E +H DL N+LLV+ Y K+ D+ D +Y+K
Sbjct: 97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA-- 154
Query: 223 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-G 281
+ H + APE + ++ D+WS G ++ E S G
Sbjct: 155 -----------------KTHGK--WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 282 EALFQTHENLEHLAMMER 299
+ ++ + E M+E
Sbjct: 196 QKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 48/236 (20%), Positives = 94/236 (39%), Gaps = 56/236 (23%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----I 150
+++ K+G G FG+V + N + VA+K ++ +A + E ++++ L +HD +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRL 66
Query: 151 GGTRYRSFPIDLVRE--------------------------LGRQLLESVAFMHELRLIH 184
+ PI ++ E Q+ E +A++ IH
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL+ N+L+ + K+ D+ L+R +D Y IK
Sbjct: 127 RDLRAANVLVSESLMCKIADFG-LARVIEDNEYTAREGAKFPIK---------------- 169
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
+ APE I + D+WS G +L E+ + G+ + N + ++ ++R
Sbjct: 170 ------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 57/242 (23%), Positives = 93/242 (38%), Gaps = 61/242 (25%)
Query: 92 PR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL-----QR 144
PR +++ K+G G FG+V + N + VAIK ++ + EA + E +++ R
Sbjct: 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPR 62
Query: 145 LARHDIGGTRYRSFPIDLVRE--------------------------LGRQLLESVAFMH 178
L R T+ PI ++ E + Q+ E +AF+
Sbjct: 63 LVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFG-LARLIEDNEYTAREGAKFPIK---------- 168
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297
+ APE I + D+WS G +L E+ + G + N E + +
Sbjct: 169 ------------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
Query: 298 ER 299
ER
Sbjct: 217 ER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 405 | |||
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.62 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.51 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.38 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.32 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.99 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.93 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.61 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.56 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.46 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.14 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.77 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.18 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.77 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.68 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.98 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.96 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.87 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 95.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.41 | |
| PLN02236 | 344 | choline kinase | 95.29 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.27 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.2 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.76 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.87 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.84 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.83 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.79 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.6 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.31 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.5 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.47 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.62 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.55 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.15 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.45 | |
| PTZ00296 | 442 | choline kinase; Provisional | 89.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 86.46 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 85.91 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 85.04 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.0 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-59 Score=420.74 Aligned_cols=316 Identities=59% Similarity=1.005 Sum_probs=273.1
Q ss_pred CCCCCCCCCCCCCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH
Q 015532 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL 145 (405)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l 145 (405)
.....+++.+++..|++.+..|+.+.+||++++.||+|+||.|..|.+..++..||||+++...++++..+.|+++|+++
T Consensus 63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki 142 (415)
T KOG0671|consen 63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI 142 (415)
T ss_pred ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 55667788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCC----------------------------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 015532 146 ARHDIGG----------------------------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 191 (405)
Q Consensus 146 ~~~~~~~----------------------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 191 (405)
.+..-.+ ..+..|+...++.+++||+.++.|||+.+++|-||||+|
T Consensus 143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 7655211 124568999999999999999999999999999999999
Q ss_pred EEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHH
Q 015532 192 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 271 (405)
Q Consensus 192 Ili~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 271 (405)
||+.+....+..+.+-. ..+....++..++++|||.|++..+..++.+.|..|+|||++.+.+++.++||||+
T Consensus 223 ILfvss~~~~~~~~k~~-------~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKK-------VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred EEEeccceEEEeccCCc-------cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence 99988776665544321 12233456778999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 272 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 272 G~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
||||+|+.+|...|++.++.+++++|++++|++|..++.+.. ..+|+..+ +++|++...... .+..+...+.....
T Consensus 296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~--~~Kyf~~~-rldw~e~~~~~~-~k~v~~~ckpl~~~ 371 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR--KEKYFRRG-RLDWPEVSSKGK-SKYVFEPCKPLKKY 371 (415)
T ss_pred eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh--hHhhhhcc-cccCcccccccc-chhhhcCCccHHHH
Confidence 999999999999999999999999999999999999987765 67888888 999998777665 44444444444444
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
....+....++.|||++||.+||.+|+|+.|+|.||||+.-
T Consensus 372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 44444556679999999999999999999999999999874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-53 Score=407.11 Aligned_cols=291 Identities=40% Similarity=0.688 Sum_probs=236.5
Q ss_pred CCCCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCC---
Q 015532 75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG--- 151 (405)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~--- 151 (405)
.++.++.|.+..++.+..+|+|++.||+|+||.|.+|.+..|++.||||+++.......+...|+.||..|+.+...
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 55677789999999999999999999999999999999999999999999998888888899999999999943221
Q ss_pred -------------------------------CCccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccc
Q 015532 152 -------------------------------GTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 152 -------------------------------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~ 200 (405)
...+..|+...++.++.||+.||.+||+.||||+||||||||+...
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--- 325 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--- 325 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC---
Confidence 1224678999999999999999999999999999999999999764
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
....|||+|||+|.+......+.+.++.|+|||++.|.+|+.+.||||||||++||++
T Consensus 326 ----------------------~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t 383 (586)
T KOG0667|consen 326 ----------------------KRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT 383 (586)
T ss_pred ----------------------CcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhc
Confidence 3457999999999998887778899999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhc-CCcccCC------CCCCchhhHHHH---HHhccch--
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR-GARLDWP------DGATSRDSMRAV---WKLLRLP-- 348 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~---~~~~~~~-- 348 (405)
|.++|.|.+..++++.|.+++|.+|..++...... .+|+.. ......- .+.......... ......+
T Consensus 384 G~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~-~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~ 462 (586)
T KOG0667|consen 384 GEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA-HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPG 462 (586)
T ss_pred CccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc-ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCC
Confidence 99999999999999999999999999888777555 555555 3222211 111111111111 1111112
Q ss_pred --hhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 349 --NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 349 --~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
.............+.|||.+||.+||.+|+|+.|+|+||||++
T Consensus 463 ~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 463 SRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred CcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 1111111134567899999999999999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-53 Score=385.09 Aligned_cols=235 Identities=29% Similarity=0.472 Sum_probs=190.3
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh--------hhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++++... ......+|++||++|+||+++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 466789999999999999999999999999999999965321 123357899999999999984321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+.+...+.+++||+.||.|||++||+||||||+|||+..+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~--------------- 313 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA--------------- 313 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC---------------
Confidence 24567888899999999999999999999999999999997642
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCC---CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.+..+||+|||+|+..... ..++|||+.|.|||++.+.+ +..++||||+||++|.+++|.+||.+.
T Consensus 314 ---------e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 314 ---------EDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred ---------cceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 4567999999999987533 45689999999999998765 335889999999999999999999876
Q ss_pred ChHH-HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 289 ENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 289 ~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.... ...+|.+.- ..+ ....+..++++.++||.
T Consensus 385 ~~~~sl~eQI~~G~------------------------y~f----------------------~p~~w~~Iseea~dlI~ 418 (475)
T KOG0615|consen 385 YTDPSLKEQILKGR------------------------YAF----------------------GPLQWDRISEEALDLIN 418 (475)
T ss_pred cCCccHHHHHhcCc------------------------ccc----------------------cChhhhhhhHHHHHHHH
Confidence 5433 444443311 110 01123456889999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+||.+||++|||++|+|+||||+...
T Consensus 419 ~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 419 WMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=363.95 Aligned_cols=254 Identities=32% Similarity=0.613 Sum_probs=203.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|+.+.++|+|+||+||+|+++.||+.||||++...+ ...+-+++||.+|++|.|+|++...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46999999999999999999999999999999996433 4567789999999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
-..++.+.++.++.|++.|+.|||+++||||||||+||||+..|
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g----------------------- 138 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG----------------------- 138 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-----------------------
Confidence 24578899999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.+||||||+|+..... .+.++.|.+|+|||++.| ..|+..+||||+||++.||++|++.|++.++.+++..|
T Consensus 139 ----vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 139 ----VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred ----cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 5677777777665522 234689999999999998 57999999999999999999999999999999999999
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...+|.+++.-..-.. ...+| .|.+++-+. . +..........+.-+.||+.+||..||++|
T Consensus 215 ~ktLG~L~prhq~iF~--~N~~F-~Gv~lP~~~--~--------------~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 215 RKTLGNLIPRHQSIFS--SNPFF-HGVRLPEPE--H--------------PEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred HHHHcccCHHHHHHhc--cCCce-eeeecCCCC--C--------------ccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 9999998765432211 01111 111222111 0 111222234556788999999999999999
Q ss_pred CCHHHHHcCCCCCC
Q 015532 378 LKAREALRHPFFTR 391 (405)
Q Consensus 378 pta~elL~hp~f~~ 391 (405)
++.+|+|.||||++
T Consensus 276 ~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 276 LSCEQLLHHPYFDG 289 (396)
T ss_pred ccHHHHhcChHHHH
Confidence 99999999999954
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=387.20 Aligned_cols=226 Identities=31% Similarity=0.499 Sum_probs=198.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc----hhhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+|...+.||+|+|+.||.+++..+|+.||+|++.+ ....++...+||+|.+.|.|+||++..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 579999999999999999999999999999999976 456678889999999999999995432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...++|.+++.+++||+.||.|||+++|||||||..|++++.
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~------------------------ 153 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE------------------------ 153 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC------------------------
Confidence 367899999999999999999999999999999999999864
Q ss_pred CCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+.+|||+|||+|.... +...+.||||.|+|||++...+++..+||||+||+||.||+|++||+..+-.+.+..|
T Consensus 154 ---~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 154 ---NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred ---cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 4578889999887765 4456789999999999999999999999999999999999999999998887877777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....-.+| ...+.++++||.+||+.||.+|
T Consensus 231 k~~~Y~~P--------------------------------------------------~~ls~~A~dLI~~lL~~~P~~R 260 (592)
T KOG0575|consen 231 KLNEYSMP--------------------------------------------------SHLSAEAKDLIRKLLRPNPSER 260 (592)
T ss_pred HhcCcccc--------------------------------------------------cccCHHHHHHHHHHhcCCcccC
Confidence 65433333 2457789999999999999999
Q ss_pred CCHHHHHcCCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDVR 394 (405)
Q Consensus 378 pta~elL~hp~f~~~~~ 394 (405)
||+++||.|+||++..-
T Consensus 261 psl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 261 PSLDEVLDHPFFKSGFT 277 (592)
T ss_pred CCHHHHhcCHhhhCCCc
Confidence 99999999999966543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=347.56 Aligned_cols=251 Identities=32% Similarity=0.554 Sum_probs=202.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+|...++||+|.||+||+|++..+|+.||||.++..+ ...-..++||+.|+.+.|+++++..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47899999999999999999999999999999997543 2356788999999999999984421
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...++...++.++.++++||+|||++.|+||||||.|+||+++|.
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~---------------------- 139 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ---------------------- 139 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc----------------------
Confidence 234677889999999999999999999999999999999987774
Q ss_pred CCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+||+|||+|+...... ...+-|.+|+|||++.|. .|+..+||||.|||+.||+-|.+.|.|.++.+++..|
T Consensus 140 -----lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 140 -----LKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred -----EEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 5666666665544322 223789999999999986 5999999999999999999999999999999999999
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhh-cccCchHHHHHHHHHccccCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ-HVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
.+.+|++-++. ||+-..-.+.. .....+..... .....+.++.||+.+||.+||.+
T Consensus 215 f~~LGTP~~~~-------------------WP~~~~lpdY~----~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~ 271 (318)
T KOG0659|consen 215 FRALGTPTPDQ-------------------WPEMTSLPDYV----KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKK 271 (318)
T ss_pred HHHcCCCCccc-------------------CccccccccHH----HHhcCCCCccccccccccHHHHHHHHhhhccCchh
Confidence 99999876543 44322222221 11122222222 44566778899999999999999
Q ss_pred CCCHHHHHcCCCCCCC
Q 015532 377 RLKAREALRHPFFTRD 392 (405)
Q Consensus 377 Rpta~elL~hp~f~~~ 392 (405)
|+||.|+|+|+||++.
T Consensus 272 Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 272 RITASQALKHPYFKSL 287 (318)
T ss_pred cccHHHHhcchhhhcC
Confidence 9999999999999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=375.46 Aligned_cols=259 Identities=32% Similarity=0.533 Sum_probs=207.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHH--HHHHHHHHHHHh-hcCCCCC-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA--AMIEIDVLQRLA-RHDIGGT------------- 153 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~--~~~E~~il~~l~-~~~~~~~------------- 153 (405)
+.+||.++++||.|+||.||+|+.+.+++.||||.+++.-..-++ -++|+..|++|+ |+|++..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999999999999999999764332232 458999999999 8887431
Q ss_pred ---------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 154 ---------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 154 ---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
+...|++..++.|+.||++||+|+|.+|+.|||+||+||||..
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---------------------- 145 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---------------------- 145 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc----------------------
Confidence 1467899999999999999999999999999999999999963
Q ss_pred cCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+..+||+|||+|+...... +.++.|++|+|||++... -|+.++||||+|||++|+.+-++.|.|.++.+++.
T Consensus 146 -----~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 146 -----NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred -----cceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 3468999999998766544 447899999999998765 58999999999999999999999999999999999
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
+|++++|.+-...+..... ....-+..+|.-. +..........+.++.+||.+||.|||+
T Consensus 221 KIc~VLGtP~~~~~~eg~~-----La~~mnf~~P~~~---------------~~~l~~L~p~~s~~~~~li~~ll~WDP~ 280 (538)
T KOG0661|consen 221 KICEVLGTPDKDSWPEGYN-----LASAMNFRFPQVK---------------PSPLKDLLPNASSEAASLIERLLAWDPD 280 (538)
T ss_pred HHHHHhCCCccccchhHHH-----HHHHhccCCCcCC---------------CCChHHhCcccCHHHHHHHHHHhcCCCc
Confidence 9999999876543322211 1111122222210 1112223344688999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~~ 395 (405)
+||||.|+|+||||+.....
T Consensus 281 kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 281 KRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred cCccHHHHhcCccccccccc
Confidence 99999999999999976543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=356.87 Aligned_cols=258 Identities=28% Similarity=0.502 Sum_probs=210.0
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc---hhhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+..+|..++.||+|+||.|+.|.++.+|+.||||.+.. .....++..+|+.+|+.+.|+|++...
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 345678888999999999999999999999999999862 234557788999999999999984321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...++++.+..++.||+.||.|+|+.+|+||||||.|+|++.
T Consensus 99 ~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~------------------ 160 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA------------------ 160 (359)
T ss_pred ceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc------------------
Confidence 234888999999999999999999999999999999999865
Q ss_pred CCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
++.+||||||+|+.... ..+..+.|.+|+|||++.. ..|+.++||||+|||+.||++|++.|.|.
T Consensus 161 ---------~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 161 ---------DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred ---------CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 44678888888877632 2345788999999999875 47999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhh-HhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRAD-RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
+..+++..|...+|.++++.+.... .....|....... .+..........++.++|||.
T Consensus 232 d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~--------------------p~~~f~~~fp~a~p~AidLle 291 (359)
T KOG0660|consen 232 DYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQI--------------------PKQPFSSIFPNANPLAIDLLE 291 (359)
T ss_pred chHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCC--------------------CCCCHHHHcCCCCHHHHHHHH
Confidence 9999999999999999888776543 2233333222100 011112334567889999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+||.+||.+|+|++|+|+||||....
T Consensus 292 kmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 292 KMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHhccCccccCCHHHHhcChhhhhhc
Confidence 99999999999999999999998753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=356.40 Aligned_cols=229 Identities=24% Similarity=0.443 Sum_probs=190.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEec--chhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~--~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
...+.++.||+|+.|+||+|+|+.|++.+|+|++. .....+.+..+|++|++..+++++++..
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45778899999999999999999999999999993 3456678899999999999999885422
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.+.++|.....++.+|++||.|||+ ++||||||||+|||+++.|
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG---------------------- 216 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG---------------------- 216 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC----------------------
Confidence 2458899999999999999999995 9999999999999998766
Q ss_pred CCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--ENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~~~i 297 (405)
.|||||||.+...... ..+++||..|||||.+.+..|+.++||||||++++|+++|+.||... .....+..+
T Consensus 217 -----eVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll 291 (364)
T KOG0581|consen 217 -----EVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL 291 (364)
T ss_pred -----CEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH
Confidence 5677788877654433 35689999999999999999999999999999999999999999774 233444455
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc-CchHHHHHHHHHccccCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD-HSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~ll~~~L~~dP~~ 376 (405)
..++..+|+.+ +. .+++++++||..||++||.+
T Consensus 292 ~~Iv~~ppP~l----------------------------------------------P~~~fS~ef~~FV~~CL~Kdp~~ 325 (364)
T KOG0581|consen 292 CAIVDEPPPRL----------------------------------------------PEGEFSPEFRSFVSCCLRKDPSE 325 (364)
T ss_pred HHHhcCCCCCC----------------------------------------------CcccCCHHHHHHHHHHhcCCccc
Confidence 55444333211 12 36889999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDV 393 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~ 393 (405)
|+|+.|+++|||+++..
T Consensus 326 R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 326 RPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCHHHHhcCHHHhhcc
Confidence 99999999999999754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=360.06 Aligned_cols=228 Identities=29% Similarity=0.468 Sum_probs=190.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|+++++||+|+||+|++++.+.+++.||+|++++.. +.......|.+||.++.||.+++..
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 56999999999999999999999999999999997643 2345677899999999999885432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.+.|+|+.++.++.+|+.||.|||++|||||||||+|||++..|++
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi-------------------- 164 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHI-------------------- 164 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcE--------------------
Confidence 3578999999999999999999999999999999999999887765
Q ss_pred CCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+|+|||+++... ....+++||+.|||||++.+.+|+..+|+|||||++|+|++|.+||.+.+.......|
T Consensus 165 -------~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I 237 (357)
T KOG0598|consen 165 -------KLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI 237 (357)
T ss_pred -------EEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH
Confidence 555555554221 2334579999999999999999999999999999999999999999998887777766
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+.-...++ .-.+.++++||+++|+.||++|
T Consensus 238 ~~~k~~~~p-------------------------------------------------~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 238 LKGKLPLPP-------------------------------------------------GYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred hcCcCCCCC-------------------------------------------------ccCCHHHHHHHHHHhccCHHHh
Confidence 553211111 1246789999999999999999
Q ss_pred C----CHHHHHcCCCCCCCCCC
Q 015532 378 L----KAREALRHPFFTRDVRR 395 (405)
Q Consensus 378 p----ta~elL~hp~f~~~~~~ 395 (405)
. .++++-+||||..-.+.
T Consensus 269 Lg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred cCCCCChHHhhcCcccccCCHH
Confidence 6 79999999999986544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=369.48 Aligned_cols=258 Identities=31% Similarity=0.472 Sum_probs=208.4
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
+..-.+.|+.+++||+|.||.||+|++..+|+.||+|.++... .......+||.||++|.|+||+...
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3444567999999999999999999999999999999997543 3445678999999999999984321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
.-.|++.+++.|++||+.||+|||++||+|||||.+||||+.+|
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G---------------- 255 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG---------------- 255 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC----------------
Confidence 23689999999999999999999999999999999999998766
Q ss_pred CCcccCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
.+||+|||+|++.... .+..+-|.+|+|||++.|. .|+.++|+||+||||.||++|++.|.+.+
T Consensus 256 -----------~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 256 -----------VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred -----------CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 5677777777754432 2346789999999999987 59999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
+.+++..|.+++|.+.+..+... ++.+...... .........+.....+....+|+..|
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~------------kLP~~~~~kp---------~~~y~r~l~E~~~~~~~~~l~Ll~~l 383 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVS------------KLPHATIFKP---------QQPYKRRLRETFKDFPASALDLLEKL 383 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccc------------cCCcccccCC---------CCcccchHHHHhccCCHHHHHHHHHH
Confidence 99999999999999887664311 1111111100 01112223333556688899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
|..||++|.||.++|+|+||+..
T Consensus 384 L~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 384 LSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred hccCccccccHHHHhcCcccccC
Confidence 99999999999999999999544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=347.85 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=202.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCC---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGT--------------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~--------------- 153 (405)
+.|+.+++|++|+||.||+|+++.|++.||+|.++-.. ...-..++||++|.++.|+||+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56999999999999999999999999999999996432 334567899999999999998432
Q ss_pred --------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 154 --------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 154 --------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
....|...+++.++.|++.||+|||.+.|+|||||++|+|+...|
T Consensus 156 Me~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G--------------------- 214 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG--------------------- 214 (419)
T ss_pred HHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC---------------------
Confidence 135788999999999999999999999999999999999997766
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||+|+..... .+..+-|.+|+|||++.|. .|+.++|+||+|||+.||+++++.|.|....+++.
T Consensus 215 ------~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~ 288 (419)
T KOG0663|consen 215 ------ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD 288 (419)
T ss_pred ------cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence 5677888888766655 3456889999999999987 49999999999999999999999999999999999
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC--chHHHHHHHHHccccC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH--SAGDLIDLLQGLLRYD 373 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~~L~~d 373 (405)
+|.+.+|.+.+..+..... .+ ....+.......+.....+.. .++...+|+..+|.+|
T Consensus 289 ~If~llGtPte~iwpg~~~-------------------lp-~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~d 348 (419)
T KOG0663|consen 289 KIFKLLGTPSEAIWPGYSE-------------------LP-AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYD 348 (419)
T ss_pred HHHHHhCCCccccCCCccc-------------------cc-hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccC
Confidence 9999999887654322110 00 000000000000111111111 4578899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|.+|.||+|+|+|+||....
T Consensus 349 P~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 349 PGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccccccHHHhhcccccccCC
Confidence 99999999999999999843
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=361.59 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=197.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHH-hhcCCCC--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRL-ARHDIGG-------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l-~~~~~~~-------------- 152 (405)
..|.+.+.||.|+|++|++|+++.+++.||||++.+.-. ......+|-++|.+| .|+.++.
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 569999999999999999999999999999999965322 234466789999999 5555421
Q ss_pred -------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 153 -------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 153 -------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
..++.|++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||.++.+........
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 1157899999999999999999999999999999999999999999998888887765543321100
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.+-..........+++||..|.+||++.....+..+|||+||||+|+|+.|.+||.+.++.-.+..|..
T Consensus 233 -----------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 233 -----------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred -----------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 000011111223568999999999999999999999999999999999999999999999998888887
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
+.-.+|+ ..++.++|||.++|..||.+|+|
T Consensus 302 l~y~fp~--------------------------------------------------~fp~~a~dLv~KLLv~dp~~Rlt 331 (604)
T KOG0592|consen 302 LDYEFPE--------------------------------------------------GFPEDARDLIKKLLVRDPSDRLT 331 (604)
T ss_pred hcccCCC--------------------------------------------------CCCHHHHHHHHHHHccCcccccc
Confidence 6554443 34668899999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015532 380 AREALRHPFFTRDVR 394 (405)
Q Consensus 380 a~elL~hp~f~~~~~ 394 (405)
++||.+||||.+-.+
T Consensus 332 ~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 332 SQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHHhhCcccccCCh
Confidence 999999999987543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=345.47 Aligned_cols=316 Identities=31% Similarity=0.543 Sum_probs=238.4
Q ss_pred CCCCCCCCCCCceEeeCCccC-CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcC
Q 015532 71 PPWRPDDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149 (405)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~ 149 (405)
........+|++++.+|+.|. +||.+.++||.|.|++||+|.|..+.+.||+|+.+....+.+..+.||.+|+++...+
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 334456788999999999999 9999999999999999999999999999999999999999999999999999997755
Q ss_pred --CC--------------------------------------CCccccCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCC
Q 015532 150 --IG--------------------------------------GTRYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLK 188 (405)
Q Consensus 150 --~~--------------------------------------~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlk 188 (405)
.. ...|+.++...++.|++|||.||+||| ++||||-|||
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK 215 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK 215 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence 10 012677899999999999999999999 5799999999
Q ss_pred CCcEEEecccc-----------c------------cc--------------CCcc-------------------------
Q 015532 189 PENILLVSAEY-----------V------------KV--------------PDYK------------------------- 206 (405)
Q Consensus 189 p~NIli~~~~~-----------~------------k~--------------~df~------------------------- 206 (405)
|+|||+..... . +- .++-
T Consensus 216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~ 295 (590)
T KOG1290|consen 216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE 295 (590)
T ss_pred cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence 99999975410 0 00 0000
Q ss_pred -------------------ccccCCCC----------CCccc--------------------------------------
Q 015532 207 -------------------FLSRSSKD----------GSYFK-------------------------------------- 219 (405)
Q Consensus 207 -------------------~~~~~~~~----------~~~~~-------------------------------------- 219 (405)
.+.....+ ....+
T Consensus 296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~ 375 (590)
T KOG1290|consen 296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA 375 (590)
T ss_pred ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence 00000000 00000
Q ss_pred ----------CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 015532 220 ----------NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH- 288 (405)
Q Consensus 220 ----------~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~- 288 (405)
.......+||+|||-|.+....-+.-..|..|+|||++.|.+|+..+||||++|++|||+||..+|...
T Consensus 376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 376 SNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred cccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 001123589999999998877777778899999999999999999999999999999999999999642
Q ss_pred -----ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 289 -----ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 289 -----~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
.+.+++++|.+++|.+|..+...... .+.||.+.+.+.-..........+-+..... .....+.++.
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~-SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~-------~s~e~A~~fs 527 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKY-SRDFFNRRGELRHIRRLKPWPLYEVLIEKYE-------WSEEDAQQFS 527 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcc-hHhhhccccceecccccCCCcHHHHHHHHhC-------CCHHHHHHHH
Confidence 46789999999999999988766543 4455555444432221111111111111111 2234467899
Q ss_pred HHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 364 DLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
|||.-||+++|++|+||.++|+|||+.....
T Consensus 528 dFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 528 DFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999999999999996544
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=368.51 Aligned_cols=294 Identities=38% Similarity=0.665 Sum_probs=215.0
Q ss_pred CCceEeeCCcc---CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCC---
Q 015532 80 GHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT--- 153 (405)
Q Consensus 80 ~~~~~~~~~~~---~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~--- 153 (405)
+.+....++.+ .++|++.++||+|+||+||+|.+..+++.||||+++...........|+++++.+.+.+....
T Consensus 114 ~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred CceeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 34555556544 578999999999999999999999999999999997655555566779999999877653110
Q ss_pred ------------------------------ccccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEeccccccc
Q 015532 154 ------------------------------RYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 154 ------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~ 202 (405)
....+++..++.++.||+.||+|||+ .|||||||||+|||++..+...
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~- 272 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV- 272 (467)
T ss_pred eeeEEEEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccc-
Confidence 01347888999999999999999998 5999999999999998765321
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCC
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~ 282 (405)
++.... ........+||+|||.+..........+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 273 -~~~~~~---------~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 273 -DPVTNR---------ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred -cccccc---------ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 111100 0012334699999998876555555678999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHh-hHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
+||.+.+..+.+..+.+.+|.+|..+....... ...++.....+.. ................. . ...++.
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----~--~~~~~~ 413 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP---CTDPKHLARIARARPVR----E--VIRDDL 413 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccc---cCCHHHHHhhhcccchh----h--hhchHH
Confidence 999999999999999999999998876543211 1222222211110 00111111100000000 0 012457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+.|||.+||++||++||||+|+|+||||++..
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 88999999999999999999999999999843
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.01 Aligned_cols=251 Identities=30% Similarity=0.542 Sum_probs=201.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
=.|.-.+++|+|+||.||+|....+++.||||.+-..... ..+|+++|+.+.|+|++...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3589999999999999999999999999999988554443 34699999999999985422
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...++.-.++-+..||++||.|||+.||+||||||+|||++.
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-------------------- 160 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-------------------- 160 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--------------------
Confidence 134455567778999999999999999999999999999975
Q ss_pred cccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
.++.+||||||+|+...... .+...|+.|+|||++.|. .|+.+.||||.||++.||+-|++.|.|.+..++
T Consensus 161 ------~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ 234 (364)
T KOG0658|consen 161 ------DTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ 234 (364)
T ss_pred ------CCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH
Confidence 45679999999998765433 446789999999999986 599999999999999999999999999999999
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..|.+++|.+..+.+...+..... ..+|. .....| ..-.....++++.+|+.++|+++
T Consensus 235 L~eIik~lG~Pt~e~I~~mn~~y~~-------~~~p~------ik~~~~--------~~~~~~~~~~d~~dll~~~L~Y~ 293 (364)
T KOG0658|consen 235 LVEIIKVLGTPTREDIKSMNPNYTE-------FKFPQ------IKAHPW--------HKVFFKRLPPDALDLLSKLLQYS 293 (364)
T ss_pred HHHHHHHhCCCCHHHHhhcCccccc-------ccCcc------cccccc--------eeecccCCCHHHHHHHHHHhccC
Confidence 9999999999988766544322110 00110 000000 00122455789999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRD 392 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~ 392 (405)
|.+|.++.|+|+||||..-
T Consensus 294 P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 294 PSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhhcCCHHHHhcchhhHHh
Confidence 9999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=335.62 Aligned_cols=235 Identities=26% Similarity=0.405 Sum_probs=197.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++.. ....+...+|+.|.+.|.||+|+...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 4568899999999999999999999999999999998532 23457788999999999999985422
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...++|..+-.+++||+.||.|||.+||||||+||+|+|+-+..
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-------------------- 147 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-------------------- 147 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc--------------------
Confidence 12356777888999999999999999999999999999997642
Q ss_pred cCCCCCCCceeccCCCCccccCCcc--ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+...+||+|||+|........ ..+|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+.....++
T Consensus 148 ----~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~ 223 (355)
T KOG0033|consen 148 ----KGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ 223 (355)
T ss_pred ----CCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Confidence 455689999999987664332 26899999999999999999999999999999999999999999888787777
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
|.+.--.+|. ..++.+++++++|+++||..||.+
T Consensus 224 I~~g~yd~~~----------------------------------------------~~w~~is~~Ak~LvrrML~~dP~k 257 (355)
T KOG0033|consen 224 IKAGAYDYPS----------------------------------------------PEWDTVTPEAKSLIRRMLTVNPKK 257 (355)
T ss_pred HhccccCCCC----------------------------------------------cccCcCCHHHHHHHHHHhccChhh
Confidence 7653222211 234567889999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDV 393 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~ 393 (405)
|+||.|+|+|||+.+..
T Consensus 258 RIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 258 RITADEALKHPWICNRE 274 (355)
T ss_pred hccHHHHhCCchhcchH
Confidence 99999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=335.44 Aligned_cols=226 Identities=25% Similarity=0.382 Sum_probs=195.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|++++.||.|+||.|.+++++.+|..||+|++++.. +..+...+|..+|+.+.||.+....
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56999999999999999999999999999999997643 3446677899999999998763211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.+.|++..++.++.||+.||+|||+++|++|||||+|||++.+|
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G---------------------- 181 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG---------------------- 181 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC----------------------
Confidence 35799999999999999999999999999999999999998766
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||+|+......-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...+.......|...
T Consensus 182 -----~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~ 256 (355)
T KOG0616|consen 182 -----HIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG 256 (355)
T ss_pred -----cEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC
Confidence 467778888887777777789999999999999999999999999999999999999999999988888777664
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC--
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-- 378 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-- 378 (405)
--.+|. -.+.+++|||+++|++|-.+|.
T Consensus 257 ~v~fP~--------------------------------------------------~fs~~~kdLl~~LL~vD~t~R~gn 286 (355)
T KOG0616|consen 257 KVKFPS--------------------------------------------------YFSSDAKDLLKKLLQVDLTKRFGN 286 (355)
T ss_pred cccCCc--------------------------------------------------ccCHHHHHHHHHHHhhhhHhhhcC
Confidence 333332 3467899999999999999994
Q ss_pred ---CHHHHHcCCCCCCCCC
Q 015532 379 ---KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ---ta~elL~hp~f~~~~~ 394 (405)
...+|.+||||+...+
T Consensus 287 lknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 287 LKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred cCCCccccccCcccccccH
Confidence 5789999999997654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=342.59 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=201.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---hhHHHHHHHHHHHHHhhcC-CCC---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD-IGG--------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~-~~~--------------- 152 (405)
..|+.+++||+|+||+||+|+.+.+|+.||+|+++...+ ......+|+.+|+.|+|.+ ++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 458888999999999999999999999999999975433 5567899999999999999 421
Q ss_pred Cc------------------c---ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 153 TR------------------Y---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 153 ~~------------------~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
.. . ..++...++.+++||+.||+|||++||+||||||+||||+..|
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G------------- 157 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG------------- 157 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-------------
Confidence 00 1 2456678999999999999999999999999999999998766
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
.+||+|||+|+...- ..+..++|.+|+|||++.|. .|+..+||||+|||++||+++++.|.+
T Consensus 158 --------------~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 158 --------------VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred --------------cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 456666666654331 12345889999999999987 699999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.++.+++..|.+.+|.+.+.. ||.......... .+.....+..........+.+..+++.
T Consensus 224 ~se~~ql~~If~~lGtP~e~~-------------------Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~ 283 (323)
T KOG0594|consen 224 DSEIDQLFRIFRLLGTPNEKD-------------------WPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLS 283 (323)
T ss_pred CcHHHHHHHHHHHcCCCCccC-------------------CCCccccccccc-cCcCCCCccchHHhccccCccHHHHHH
Confidence 999999999999999876533 332221111100 111111122222333344568899999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
+||+++|.+|.||+.+|.||||+......
T Consensus 284 ~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 284 KLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred HHhccCcccCcCHHHHhcChhhcccccch
Confidence 99999999999999999999999875543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=351.18 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=199.2
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+.|++++.||+|+||.||+|+.+.||+.||+|++++... ..+.+..|-.||.....+.++...
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 3679999999999999999999999999999999987653 335566788899887777664322
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
.+.|++++++.++.+++.|++.||+.|+|||||||+|+||+..|++||+||||+.-.........
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 35789999999999999999999999999999999999999999999999999853332111110
Q ss_pred ------CCCCCCCceeccCCCC--cccc------------CC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 220 ------NLPKSSAIKLIDFGST--TFEH------------QD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 220 ------~~~~~~~~kl~Dfg~a--~~~~------------~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
.-......+..||... .... .. ....+|||.|||||++.+.+|+..+|+||||||+|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY 379 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence 0001112344555531 1100 00 11268999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc
Q 015532 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356 (405)
Q Consensus 277 ~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (405)
|||.|.+||.+.+..+....|...--. +.+|. ..
T Consensus 380 EmLvGyPPF~s~tp~~T~rkI~nwr~~----------------------l~fP~------------------------~~ 413 (550)
T KOG0605|consen 380 EMLVGYPPFCSETPQETYRKIVNWRET----------------------LKFPE------------------------EV 413 (550)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhhh----------------------ccCCC------------------------cC
Confidence 999999999999998888777543110 11111 12
Q ss_pred CchHHHHHHHHHccccCCCCCC---CHHHHHcCCCCCCCCC
Q 015532 357 HSAGDLIDLLQGLLRYDPAERL---KAREALRHPFFTRDVR 394 (405)
Q Consensus 357 ~~~~~l~~ll~~~L~~dP~~Rp---ta~elL~hp~f~~~~~ 394 (405)
..++++.|||.+||. ||++|. +++||.+||||++-.+
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 346789999999999 999998 4999999999998654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=341.51 Aligned_cols=240 Identities=27% Similarity=0.391 Sum_probs=186.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---------------hhhHHHHHHHHHHHHHhhcCCCCCc
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------------KYREAAMIEIDVLQRLARHDIGGTR 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------------~~~~~~~~E~~il~~l~~~~~~~~~ 154 (405)
..++|++.+.||+|.||.|.+|++..+++.||||++.+.. ...+...+||.||+++.|+|++...
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4478999999999999999999999999999999995422 1235788999999999999984321
Q ss_pred -----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 155 -----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 155 -----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
...+++.+++.|+++++.||+|||.+|||||||||+|+|++++|.+||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 123789999999999999999999999999999999999988776655555
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCC----CCCchhHHHHHHHHHHHHhC
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~~lltg 281 (405)
|.+-...... |- .........+|||.|+|||.+.+.. .+.+.||||+||+||+|+.|
T Consensus 255 GVs~~~~~~~---------------~~----~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 255 GVSNEFPQGS---------------DE----GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred ceeeecccCC---------------cc----ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 5432111000 00 0000112258999999999998732 34889999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
+.||-+....+....|....-.+| + ..++.+.
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP------------------------~------------------------~pe~~e~ 347 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFP------------------------E------------------------NPEINED 347 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCC------------------------C------------------------cccccHH
Confidence 999998887777777655322222 1 1234668
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
++|||.+||.+||++|++..+|..|||..+....+
T Consensus 348 ~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 348 LKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 99999999999999999999999999999875443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=358.53 Aligned_cols=230 Identities=28% Similarity=0.478 Sum_probs=196.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+-|++.+.||.|+-|.|.+|++..||+.+|||++.+. ........+||.||+.+.|||+....
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4599999999999999999999999999999999654 22345567899999999999983321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.+.+++.++.++++||+.|+.|||..+|+||||||+|+|++..+
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~---------------------- 149 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN---------------------- 149 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc----------------------
Confidence 36789999999999999999999999999999999999987543
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.+||+|||+|.....+. .+.||++.|.|||++.|.+|+ .++||||+|||||.||||..||.+++-...+.++
T Consensus 150 -----nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV 224 (786)
T KOG0588|consen 150 -----NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV 224 (786)
T ss_pred -----CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 48888888887655443 457999999999999999986 8899999999999999999999988777777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
++....+| ..++.++++||++||.+||++|
T Consensus 225 ~~G~f~MP--------------------------------------------------s~Is~eaQdLLr~ml~VDp~~R 254 (786)
T KOG0588|consen 225 QRGVFEMP--------------------------------------------------SNISSEAQDLLRRMLDVDPSTR 254 (786)
T ss_pred HcCcccCC--------------------------------------------------CcCCHHHHHHHHHHhccCcccc
Confidence 66444333 4568899999999999999999
Q ss_pred CCHHHHHcCCCCCCCCCCCcc
Q 015532 378 LKAREALRHPFFTRDVRRPTL 398 (405)
Q Consensus 378 pta~elL~hp~f~~~~~~~~~ 398 (405)
+|.+||++|||+++...-+..
T Consensus 255 iT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 255 ITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ccHHHHhhCchhhcCCCCChh
Confidence 999999999999998765544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=336.59 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=193.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.|++.++||.|.-++||+|++..+++.||||++...+ ...+...+|+..|..++|||+....
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 46999999999999999999999999999999996433 3356788999999999999995432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...++|..+..+++++++||.|||++|.||||||+.||||+++|.+||+|||...
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa----------- 174 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA----------- 174 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee-----------
Confidence 2357899999999999999999999999999999999999999999888888642
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.|.|-|...... - .+++||++|||||++.. .+|+.|+||||||++.+||++|..||........+.+
T Consensus 175 -------~l~~~G~R~~~r-f-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-- 243 (516)
T KOG0582|consen 175 -------SLFDSGDRQVTR-F-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-- 243 (516)
T ss_pred -------eecccCceeeEe-e-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--
Confidence 344444111111 1 45799999999999654 3799999999999999999999999998888776643
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
.+-+.+|...... ...+....++..+++++..||++||++||
T Consensus 244 tLqn~pp~~~t~~--------------------------------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 244 TLQNDPPTLLTSG--------------------------------------LDKDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred HhcCCCCCccccc--------------------------------------CChHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 3334443211000 00011123456899999999999999999
Q ss_pred CHHHHHcCCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVRR 395 (405)
Q Consensus 379 ta~elL~hp~f~~~~~~ 395 (405)
||+++|+|+||++....
T Consensus 286 tAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 286 TASKLLKHAFFKKAKSK 302 (516)
T ss_pred CHHHHhccHHHhhccch
Confidence 99999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=327.41 Aligned_cols=213 Identities=32% Similarity=0.507 Sum_probs=181.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc---hhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
..|+|+++||+|+||.||++.+..+|+.||.|.++. ..+.++....|+.+|++|+|+||+...
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 469999999999999999999999999999999864 335567788999999999999983211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHH--CC--cEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHE--LR--LIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~--~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
.+.++|..+++++.|++.||.+||+ .. |+||||||.||+++.+|
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g------------- 165 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG------------- 165 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-------------
Confidence 3568999999999999999999998 44 99999999999997655
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCcc---ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.+||+|||++++.....+ +++|||+||+||.+.+.+|+.++||||+||++|||+.-++||.+.
T Consensus 166 --------------vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 166 --------------VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred --------------ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 578888888877765543 479999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCC-CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
+-.+....|.+..-+ +|. +.+|.++..||.
T Consensus 232 n~~~L~~KI~qgd~~~~p~-------------------------------------------------~~YS~~l~~li~ 262 (375)
T KOG0591|consen 232 NLLSLCKKIEQGDYPPLPD-------------------------------------------------EHYSTDLRELIN 262 (375)
T ss_pred cHHHHHHHHHcCCCCCCcH-------------------------------------------------HHhhhHHHHHHH
Confidence 777777777664221 221 234778999999
Q ss_pred HccccCCCCCCCH
Q 015532 368 GLLRYDPAERLKA 380 (405)
Q Consensus 368 ~~L~~dP~~Rpta 380 (405)
.|+..||+.||+.
T Consensus 263 ~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 263 MCIAVDPEQRPDT 275 (375)
T ss_pred HHccCCcccCCCc
Confidence 9999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=335.08 Aligned_cols=237 Identities=28% Similarity=0.458 Sum_probs=196.5
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..+.|.+.++||+|+||+||+|+++.++..||||.+.+. .+..+....||.||+.++|+|+++..
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 346799999999999999999999999999999999653 45677788999999999999985432
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
.+.+++..++.++.||+.||++||+++||||||||+|||++....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~-------------------- 147 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR-------------------- 147 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC--------------------
Confidence 357899999999999999999999999999999999999976410
Q ss_pred CCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.+....+||+|||+|+...... .+.+|++.|||||++....|+.|+|+||+|+|+|+|++|++||...+..+.+..+
T Consensus 148 -~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 148 -NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI 226 (429)
T ss_pred -CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 0111578999999999877553 4579999999999999999999999999999999999999999998888877655
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+.-.-+|. .....+..+.+|+...|+.+|.+|
T Consensus 227 ~k~~~~~~~-----------------------------------------------~~~~~s~~~~~Ll~~ll~~~~~~~ 259 (429)
T KOG0595|consen 227 KKGNEIVPV-----------------------------------------------LPAELSNPLRELLISLLQRNPKDR 259 (429)
T ss_pred hccccccCc-----------------------------------------------hhhhccCchhhhhhHHHhcCcccc
Confidence 442211110 011234466789999999999999
Q ss_pred CCHHHHHcCCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDVR 394 (405)
Q Consensus 378 pta~elL~hp~f~~~~~ 394 (405)
.+..+-+.|+++..+..
T Consensus 260 ~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 260 ISFEDFFDHPFLAANPQ 276 (429)
T ss_pred CchHHhhhhhhcccCcc
Confidence 99999999999987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=347.50 Aligned_cols=230 Identities=25% Similarity=0.379 Sum_probs=190.2
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHh-hcCCCC-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGG------------- 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~-~~~~~~------------- 152 (405)
.+.|.++++||+|+||+|++|..+.+++.||||++++.. ..-+..+.|..|+.... ||.+..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 368999999999999999999999999999999998743 34567788999998888 444311
Q ss_pred --------Cc-----cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 153 --------TR-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 153 --------~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
.+ .+.|++..++.|+..|+.||+|||++|||+||||.+|||++.+|++||+|||+++...
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m------- 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM------- 519 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC-------
Confidence 11 2578999999999999999999999999999999999999888766555555443221
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
......++++||+.|||||++.+..|+.++|+|||||+|||||.|+.||.+++..++...|..
T Consensus 520 -----------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 520 -----------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred -----------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 122345668999999999999999999999999999999999999999999999998887765
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.....| ..++.++.++|+++|++||++|..
T Consensus 583 d~~~yP--------------------------------------------------~~ls~ea~~il~~ll~k~p~kRLG 612 (694)
T KOG0694|consen 583 DEVRYP--------------------------------------------------RFLSKEAIAIMRRLLRKNPEKRLG 612 (694)
T ss_pred CCCCCC--------------------------------------------------CcccHHHHHHHHHHhccCcccccC
Confidence 432222 344778999999999999999994
Q ss_pred -----HHHHHcCCCCCCCCC
Q 015532 380 -----AREALRHPFFTRDVR 394 (405)
Q Consensus 380 -----a~elL~hp~f~~~~~ 394 (405)
+++|.+||||+.-.+
T Consensus 613 ~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 613 SGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred CCCCCchhhhhCCccccCCH
Confidence 689999999997543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=347.18 Aligned_cols=227 Identities=31% Similarity=0.450 Sum_probs=187.4
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch-----h-hhhHHHHHHHHHHHHHh-hcCCCCCc-------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----N-KYREAAMIEIDVLQRLA-RHDIGGTR------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~-~~~~~~~~E~~il~~l~-~~~~~~~~------- 154 (405)
...++|.+.+.||+|+||+|++|++..+++.||||++++. . ...+...+|+.+++.+. |+||....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999987653 1 23455668999999999 88873211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
.+.+.|.+++.+++||+.|++|||++||+||||||+|||++.+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~----------------- 156 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGN----------------- 156 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCC-----------------
Confidence 2578899999999999999999999999999999999999764
Q ss_pred CCcccCCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLG-WN-YPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
...+||+|||++.... ....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+
T Consensus 157 ---------~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 157 ---------EGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ---------CCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 1467788888777652 2345579999999999999987 86 88999999999999999999999866
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc-hHHHHHHHHH
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS-AGDLIDLLQG 368 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~ll~~ 368 (405)
.......|.+..-.+| ..+ ++++++|+.+
T Consensus 228 ~~~l~~ki~~~~~~~p--------------------------------------------------~~~~S~~~~~Li~~ 257 (370)
T KOG0583|consen 228 VPNLYRKIRKGEFKIP--------------------------------------------------SYLLSPEARSLIEK 257 (370)
T ss_pred HHHHHHHHhcCCccCC--------------------------------------------------CCcCCHHHHHHHHH
Confidence 6555554433222221 233 7789999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
||..||.+|+|+.++++||||+.
T Consensus 258 mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 258 MLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=349.39 Aligned_cols=234 Identities=26% Similarity=0.412 Sum_probs=191.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
...|....+||+|+.|.||.|+...+++.||||.+..... .++..++|+.+|+.+.|+|++..+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4579999999999999999999999999999999976544 356678999999999999984322
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+||||+.+.....
T Consensus 352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-------- 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-------- 423 (550)
T ss_pred cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--------
Confidence 1346899999999999999999999999999999999999877755555554433222111
Q ss_pred CCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 015532 224 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
....+.+||++|||||++....|++++||||||+++.||+-|++||-..+....+..|...
T Consensus 424 ----------------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n--- 484 (550)
T KOG0578|consen 424 ----------------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--- 484 (550)
T ss_pred ----------------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---
Confidence 1345679999999999999999999999999999999999999999877776666555331
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHH
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 383 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~el 383 (405)
..+.....+.+|+.++|||.+||+.|+++|++|.|+
T Consensus 485 --------------------------------------------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eL 520 (550)
T KOG0578|consen 485 --------------------------------------------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKEL 520 (550)
T ss_pred --------------------------------------------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence 122234456779999999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q 015532 384 LRHPFFTRDVRR 395 (405)
Q Consensus 384 L~hp~f~~~~~~ 395 (405)
|+||||+.....
T Consensus 521 L~HpFl~~a~p~ 532 (550)
T KOG0578|consen 521 LEHPFLKMAKPE 532 (550)
T ss_pred hcChhhhhcCCH
Confidence 999999765443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=348.41 Aligned_cols=225 Identities=30% Similarity=0.517 Sum_probs=187.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.. +......+|++|++.|.|+||+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46889999999999999999999999999999996543 3445678899999999999985422
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
.+.++|+.++.++.|++.||.|||+++|+|||+||.|||++..|
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~------------------------ 137 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG------------------------ 137 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC------------------------
Confidence 36789999999999999999999999999999999999987655
Q ss_pred CCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.+|+||||+|+...... +...|||.|||||++.+.+|+..+|+|||||++||+++|++||...+-.+....|..
T Consensus 138 ---~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~ 214 (808)
T KOG0597|consen 138 ---TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK 214 (808)
T ss_pred ---ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence 56666666666544433 235799999999999999999999999999999999999999987665555555543
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
..-+.| ...+..+++||..+|.+||.+|.|
T Consensus 215 d~v~~p--------------------------------------------------~~~S~~f~nfl~gLL~kdP~~Rlt 244 (808)
T KOG0597|consen 215 DPVKPP--------------------------------------------------STASSSFVNFLQGLLIKDPAQRLT 244 (808)
T ss_pred CCCCCc--------------------------------------------------ccccHHHHHHHHHHhhcChhhccc
Confidence 222111 234678999999999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 015532 380 AREALRHPFFTRDV 393 (405)
Q Consensus 380 a~elL~hp~f~~~~ 393 (405)
+.+++.|||+++..
T Consensus 245 W~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 245 WTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHhcChHHhhhh
Confidence 99999999998753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=332.97 Aligned_cols=251 Identities=31% Similarity=0.502 Sum_probs=191.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.++||+|+||+||+|++..+++.||+|+++... .....+.+|+.+++.+.|+++....
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999999999999999986432 2345677899999999999873311
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~----------------------- 141 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE----------------------- 141 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-----------------------
Confidence 123678889999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
+||+|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 142 ----~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 142 ----LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred ----EEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 555556555432211 122468899999999876 468999999999999999999999999998888888888
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+..+.++...+....... .+. ...++. . ............+.+++|||.+||++||.+|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~-~~~----~~~~~~--------------~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~ 277 (288)
T cd07871 218 RLLGTPTEETWPGITSNE-EFR----SYLFPQ--------------Y-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRI 277 (288)
T ss_pred HHhCCCChHHhhccccch-hhh----ccccCc--------------c-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCC
Confidence 888887766543221100 000 000000 0 00011122234577899999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|++|+|+||||
T Consensus 278 t~~~~l~hp~f 288 (288)
T cd07871 278 SAEAALRHSYF 288 (288)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.11 Aligned_cols=253 Identities=32% Similarity=0.609 Sum_probs=194.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.+.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999999999999999986532 2345677899999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~---------------------- 138 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV---------------------- 138 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----------------------
Confidence 135788899999999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+
T Consensus 139 -----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 139 -----LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred -----EEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 555566555433211 12346899999999999988999999999999999999999999998888888888
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+..+++|............ + ....++..... ...........+.++.+||.+||++||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~-------------~~~~~~~~~~~s~~~~dll~~~L~~~P~~R 275 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPR-F----HGLRFPAVNHP-------------QSLERRYLGILSGVLLDLMKNLLKLNPTDR 275 (287)
T ss_pred HHhhCCCCHHHHHhhhccch-h----cccccCcccCc-------------ccHHHhhhcccCHHHHHHHHHHccCCcccC
Confidence 89999988765433211100 0 00111110000 000111223457789999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||++|+|+||||
T Consensus 276 ~s~~~~l~hp~f 287 (287)
T cd07848 276 YLTEQCLNHPAF 287 (287)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.43 Aligned_cols=255 Identities=26% Similarity=0.360 Sum_probs=200.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCC---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGG--------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~--------------- 152 (405)
+.|++++.||+|.-|+||+|+.+.++..+|+|++.+.. +...++..|-+||+.++||.+..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 67999999999999999999999999999999997533 23355677999999999997621
Q ss_pred --------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 153 --------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 153 --------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
.....|++..++.|+.+|+.||+|||-.|||.|||||+||||.++|++.++||.|+.++.......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 124678999999999999999999999999999999999999999999999999987764322211
Q ss_pred cCCC-----CCCC---cee----------------ccCCC--------CccccCCccceecCCCcchhHHHhCCCCCCch
Q 015532 219 KNLP-----KSSA---IKL----------------IDFGS--------TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC 266 (405)
Q Consensus 219 ~~~~-----~~~~---~kl----------------~Dfg~--------a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 266 (405)
...+ .... +.+ .|++. |.........++||-.|+|||++.|.+++.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 1100 0000 001 12221 11111223457999999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhcc
Q 015532 267 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346 (405)
Q Consensus 267 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (405)
|+|+|||++|||+.|..||.|.++.+.+..|....-.+|.
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------------------------------------- 356 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------------------------------------- 356 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC----------------------------------------
Confidence 9999999999999999999999998888776543222221
Q ss_pred chhhhhhcccCchHHHHHHHHHccccCCCCCCC----HHHHHcCCCCCCCCC
Q 015532 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK----AREALRHPFFTRDVR 394 (405)
Q Consensus 347 ~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt----a~elL~hp~f~~~~~ 394 (405)
...++.+++|||+++|.+||++|.. |.||-+||||++-.+
T Consensus 357 --------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 357 --------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred --------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 1144678999999999999999998 999999999998643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=339.01 Aligned_cols=288 Identities=32% Similarity=0.573 Sum_probs=228.4
Q ss_pred CCCCCCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCC
Q 015532 73 WRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~ 152 (405)
..+++..|||.+.+|+.+..+|.+....|+|-|++|..|.+...|+.||||+|+.++.....-+.|++||++|....-..
T Consensus 413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchh
Confidence 34678899999999999999999999999999999999999999999999999988877888899999999987543211
Q ss_pred C------------------c-----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 153 T------------------R-----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 153 ~------------------~-----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
. . .-.|....++.|+.|+..||..|-.+||+|.||||+|||++..
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 0 0 1235567788899999999999999999999999999999763
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-cceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
...+||||||.|.+...+. +.+.-+..|.|||++.|.+|+...|+||+||+||
T Consensus 573 --------------------------k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLY 626 (752)
T KOG0670|consen 573 --------------------------KNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLY 626 (752)
T ss_pred --------------------------cceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeE
Confidence 3468999999998776554 3355678899999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCC---------------CCCCchhhHHHH
Q 015532 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP---------------DGATSRDSMRAV 341 (405)
Q Consensus 277 ~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 341 (405)
||.||+..|+|.++.+++..+..+-|++|..|+.+.......|- ..-+.-+. ...........+
T Consensus 627 ElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD-~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l 705 (752)
T KOG0670|consen 627 ELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD-QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSEL 705 (752)
T ss_pred EeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc-cccceEEEeccccccceeEEEecccCcchhHHHHH
Confidence 99999999999999999999999999999999887654444332 22111110 001111111222
Q ss_pred HHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
...++++... ...-.+|++||.+||..||++|.|..|+|+||||+.
T Consensus 706 ~~~q~~~deq----~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 706 IAVQRLPDEQ----PKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccCCCCchh----HHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 2222222211 122457999999999999999999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=338.31 Aligned_cols=278 Identities=28% Similarity=0.457 Sum_probs=206.5
Q ss_pred CCCceEeeCC---ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCC
Q 015532 79 DGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 79 ~~~~~~~~~~---~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~ 152 (405)
.++|.+..++ .+.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+.|+++..
T Consensus 5 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (359)
T cd07876 5 SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS 84 (359)
T ss_pred CCcceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEee
Confidence 3456666665 4568999999999999999999999999999999998642 233456778999999999998743
Q ss_pred Cc------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 153 TR------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 153 ~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--- 161 (359)
T cd07876 85 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--- 161 (359)
T ss_pred eeeeeccCCCccccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---
Confidence 11 123577888999999999999999999999999999999977654
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 162 ------------------------~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 217 (359)
T cd07876 162 ------------------------LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217 (359)
T ss_pred ------------------------EEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh
Confidence 555666655432211 123478999999999999899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+.+..+.+..+.+.++.++..+..........+........ . . .....+.....+. ........++
T Consensus 218 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~----~~~~~~~~~~~~~-~~~~~~~~~~ 289 (359)
T cd07876 218 GSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYP--G-I----SFEELFPDWIFPS-ESERDKLKTS 289 (359)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCC--C-c----chhhhcccccccc-ccccccccch
Confidence 99999998888888888888888887766555444444433221111 0 0 0000000000000 0011122356
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
.+++||.+||++||++|||+.|+|+||||+.
T Consensus 290 ~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 290 QARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 8899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=347.56 Aligned_cols=254 Identities=29% Similarity=0.490 Sum_probs=194.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
....+|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+|+.+.|++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345689999999999999999999999999999998854322 234699999999999885310
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~------------ 207 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT------------ 207 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC------------
Confidence 12466778889999999999999999999999999999996432
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
..+||+|||++...... .....||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+
T Consensus 208 --------------~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 208 --------------HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred --------------CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 24677777777644322 2235789999999998765 689999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
....+.+..+.+.+|.++............ ...++... ...+....+...++++++||.
T Consensus 274 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~-------~~~~~~~~--------------~~~l~~~~p~~~~~~~~~li~ 332 (440)
T PTZ00036 274 QSSVDQLVRIIQVLGTPTEDQLKEMNPNYA-------DIKFPDVK--------------PKDLKKVFPKGTPDDAINFIS 332 (440)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhchhhh-------cccCCccC--------------chhHHHHhccCCCHHHHHHHH
Confidence 998899999988888877654432211100 11111100 000111122345678999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+||++||++|+|+.|+|+||||..-
T Consensus 333 ~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 333 QFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHCCCChhHCcCHHHHhCChhHHhh
Confidence 9999999999999999999999753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=336.41 Aligned_cols=278 Identities=28% Similarity=0.417 Sum_probs=205.1
Q ss_pred CCceEeeCC---ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCC
Q 015532 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (405)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~ 153 (405)
++|++..|+ .+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+++...
T Consensus 2 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 81 (355)
T cd07874 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_pred cceeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhce
Confidence 345566665 3568999999999999999999999999999999998642 2234567789999999999987432
Q ss_pred c------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 154 R------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 154 ~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~---- 157 (355)
T cd07874 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---- 157 (355)
T ss_pred eeeeeccccccccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC----
Confidence 1 123567788899999999999999999999999999999976554
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 158 -----------------------~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 214 (355)
T cd07874 158 -----------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_pred -----------------------EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 566666665443222 1234789999999999998999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
..||.+.+..+....+...++.....+..........+........- ... ....... ............+..
T Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~-~~~~~~~~~~~~~~~ 286 (355)
T cd07874 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG---LTF----PKLFPDS-LFPADSEHNKLKASQ 286 (355)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcccc---ccc----hhhcccc-ccccccccccccchH
Confidence 99999988888887777777776666655554444444433221110 000 0000000 000001112234567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 287 ~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 287 ARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 8999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=333.80 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=193.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.++||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+.|+++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998642 12234577899999999999874211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~------------------ 142 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKL------------------ 142 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcE------------------
Confidence 1247888999999999999999999999999999999999876655
Q ss_pred cCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 143 ---------kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 143 ---------KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred ---------EEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 55555544322111 122478999999999876 5789999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhh-HHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
...+..+....|.++........... ..+.... . ...+..........++.+.+||.+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~------------------~--~~~~~~~~~~~~~~~~~~~~li~~~ 273 (338)
T cd07859 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSM------------------R--KKQPVPFSQKFPNADPLALRLLERL 273 (338)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhh------------------c--ccCCCchHHhcCCCChHHHHHHHHH
Confidence 88888888888887776554332111 1111000 0 0000111112234567889999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
|+.||++|||++|+|+||||++-..
T Consensus 274 l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 274 LAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred cCcCcccCCCHHHHhcCchhhhcCc
Confidence 9999999999999999999987433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=334.30 Aligned_cols=276 Identities=28% Similarity=0.457 Sum_probs=204.8
Q ss_pred CceEeeCC---ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc
Q 015532 81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR 154 (405)
Q Consensus 81 ~~~~~~~~---~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~ 154 (405)
.+.+..++ .+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 10 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~ 89 (364)
T cd07875 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89 (364)
T ss_pred ceeeecCcchhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 34444444 3468999999999999999999999999999999998642 23345677899999999999885321
Q ss_pred ------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCC
Q 015532 155 ------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 204 (405)
Q Consensus 155 ------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~d 204 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------ 163 (364)
T cd07875 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------ 163 (364)
T ss_pred eeecccccccccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC------
Confidence 11356778889999999999999999999999999999997655
Q ss_pred ccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCC
Q 015532 205 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 205 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~ 282 (405)
.+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 164 ---------------------~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 222 (364)
T cd07875 164 ---------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222 (364)
T ss_pred ---------------------cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCC
Confidence 45666666665433221 2347899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||.+.+..+....+....+.++..+..........+........-. ...........+ .........+..+
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~ 294 (364)
T cd07875 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY-------SFEKLFPDVLFP-ADSEHNKLKASQA 294 (364)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCC-------ChHhhCcccccc-ccccccccccHHH
Confidence 99999998888888888888877766655554444443322111000 000000000000 0001112235688
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
++||.+||+.||++|||+.|+|+||||..
T Consensus 295 ~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 295 RDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 99999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=330.22 Aligned_cols=228 Identities=32% Similarity=0.498 Sum_probs=178.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhh-hHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.+|...+.||+|+||.||++.+..+|+.+|||.+...+.. .+...+|+.+|.+|.|++|+...
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4588889999999999999999999999999998654221 35578899999999998874221
Q ss_pred -------------cc-cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-ccccccCCccccccCCCCCCccc
Q 015532 155 -------------YR-SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 -------------~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~-~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
++ .+++..++.+.+||++||.|||++|||||||||+|||++. ++
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~--------------------- 155 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG--------------------- 155 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC---------------------
Confidence 12 5899999999999999999999999999999999999976 34
Q ss_pred CCCCCCCceeccCCCCccccC------CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-ChH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH-ENL 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~ 291 (405)
.+||+|||++..... ......||+.|||||++... ....++|||||||++.||+||.+||... ...
T Consensus 156 ------~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~ 229 (313)
T KOG0198|consen 156 ------DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA 229 (313)
T ss_pred ------eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH
Confidence 466666666654331 12346899999999999953 2335999999999999999999999763 222
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+.+..+... .. ....+..+++++++||.+||.
T Consensus 230 ~~~~~ig~~-~~-----------------------------------------------~P~ip~~ls~~a~~Fl~~C~~ 261 (313)
T KOG0198|consen 230 EALLLIGRE-DS-----------------------------------------------LPEIPDSLSDEAKDFLRKCFK 261 (313)
T ss_pred HHHHHHhcc-CC-----------------------------------------------CCCCCcccCHHHHHHHHHHhh
Confidence 222111110 00 012334568899999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
+||++||||+++|+|||.++...
T Consensus 262 ~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 262 RDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999988654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=336.06 Aligned_cols=240 Identities=32% Similarity=0.502 Sum_probs=200.4
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHh-hcCCCCCc-------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLA-RHDIGGTR------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~-~~~~~~~~------- 154 (405)
.+.+...|++.+.||+|.||+||+|+++.+|+.||+|++.+... ..+...+|++||+++. |++++...
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45567889999999999999999999999999999999965432 3467889999999999 88873211
Q ss_pred ------------------cc-cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 ------------------YR-SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 ------------------~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
.. .+++..+..++.||+.++.|||+.||+||||||+|+|+....
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~----------------- 172 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD----------------- 172 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc-----------------
Confidence 11 299999999999999999999999999999999999997532
Q ss_pred CcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
..+..++++|||++..... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+....
T Consensus 173 ------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~ 246 (382)
T KOG0032|consen 173 ------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI 246 (382)
T ss_pred ------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence 1235799999999988776 33457999999999999999999999999999999999999999999887776
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+.+.-. ......++.++..+++||++||..|
T Consensus 247 ~~~i~~~~~----------------------------------------------~f~~~~w~~is~~akd~i~~ll~~d 280 (382)
T KOG0032|consen 247 FLAILRGDF----------------------------------------------DFTSEPWDDISESAKDFIRKLLEFD 280 (382)
T ss_pred HHHHHcCCC----------------------------------------------CCCCCCccccCHHHHHHHHHhcccC
Confidence 665443211 1122344567889999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~~ 395 (405)
|.+|+||.++|+|||++.....
T Consensus 281 p~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 281 PRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred cccCCCHHHHhcCccccCCccc
Confidence 9999999999999999986433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=341.34 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=187.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
..+|+++++||+|+||.||+|.+..+++.||||.... ..+.+|+++++.+.|++++...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 3679999999999999999999999999999997542 3467899999999999985421
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~------------------------- 220 (391)
T PHA03212 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD------------------------- 220 (391)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC-------------------------
Confidence 134678889999999999999999999999999999999976554
Q ss_pred CCceeccCCCCccccC----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------ChHHH
Q 015532 225 SAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-------ENLEH 293 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~-------~~~~~ 293 (405)
++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ....+
T Consensus 221 --vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 298 (391)
T PHA03212 221 --VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQ 298 (391)
T ss_pred --EEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHH
Confidence 56666666543211 112357999999999999989999999999999999999999887542 23456
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+.+..|..|..+...........+........ ... .....+......+.++.+||.+||++|
T Consensus 299 l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~--------------~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 299 IKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS-RKP--------------GSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred HHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC-CCC--------------CCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 67777777877655432211111111100000000 000 000001111234568899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRD 392 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~ 392 (405)
|++||||+|+|+||||+..
T Consensus 364 P~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 364 AHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhhCCCHHHHhcChhhccC
Confidence 9999999999999999874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=328.49 Aligned_cols=224 Identities=26% Similarity=0.329 Sum_probs=182.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36999999999999999999999999999999986432 2345577899999999999873311
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~---------------------- 138 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG---------------------- 138 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----------------------
Confidence 13468888999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.++|+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 139 -----~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 139 -----HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred -----CEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 467777777665544444567999999999999988999999999999999999999999887665554443221
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC-
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK- 379 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt- 379 (405)
. ..+ ....+..+++||.+||+.||.+|++
T Consensus 214 ~------------------------~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~~~ 243 (291)
T cd05612 214 K------------------------LEF--------------------------PRHLDLYAKDLIKKLLVVDRTRRLGN 243 (291)
T ss_pred C------------------------cCC--------------------------CccCCHHHHHHHHHHcCCCHHHccCC
Confidence 1 011 1233568899999999999999995
Q ss_pred ----HHHHHcCCCCCCC
Q 015532 380 ----AREALRHPFFTRD 392 (405)
Q Consensus 380 ----a~elL~hp~f~~~ 392 (405)
++++++||||+.-
T Consensus 244 ~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 244 MKNGADDVKNHRWFKSV 260 (291)
T ss_pred ccCCHHHHhcCccccCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.14 Aligned_cols=257 Identities=28% Similarity=0.516 Sum_probs=196.8
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999999999999999986432 2234567899999999998874211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~----------------- 155 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC----------------- 155 (343)
T ss_pred CcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-----------------
Confidence 13478899999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+||+|||++...........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 156 ----------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 225 (343)
T cd07878 156 ----------ELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL 225 (343)
T ss_pred ----------CEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 4566666666555444445678999999999987 46889999999999999999999999998888888
Q ss_pred HHHHHHhCCCChHHHHHhhHhhH-HhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAE-KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
..+....+..+............ .+...... .+ ...........++.+.+||.+||+.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------------------~~~~~~~~~~~~~~~~~li~~mL~~d 285 (343)
T cd07878 226 KRIMEVVGTPSPEVLKKISSEHARKYIQSLPH--MP------------------QQDLKKIFRGANPLAIDLLEKMLVLD 285 (343)
T ss_pred HHHHHHhCCCCHHHHHhcchhhHHHHhhcccc--cc------------------chhHHHhccCCCHHHHHHHHHHcCCC
Confidence 88888777766655433211111 11100000 00 00001112234567899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|++|||+.|+|+||||.+..
T Consensus 286 p~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 286 SDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhCCCHHHHhcCcchhccC
Confidence 99999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=334.07 Aligned_cols=224 Identities=27% Similarity=0.406 Sum_probs=183.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56999999999999999999999999999999997532 2345677899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---------------------- 155 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG---------------------- 155 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC----------------------
Confidence 13568889999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 156 -----~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 156 -----HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred -----CEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 467777777665544444568999999999999989999999999999999999999999877665544433221
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC-
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK- 379 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt- 379 (405)
. ..+ +...+..+.+||.+||+.||++|++
T Consensus 231 ~------------------------~~~--------------------------p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 231 R------------------------LKF--------------------------PNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred C------------------------cCC--------------------------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 011 1224567899999999999999997
Q ss_pred ----HHHHHcCCCCCCC
Q 015532 380 ----AREALRHPFFTRD 392 (405)
Q Consensus 380 ----a~elL~hp~f~~~ 392 (405)
++++++||||++.
T Consensus 261 ~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 261 LKGGVADVKNHPYFHGA 277 (329)
T ss_pred CCCCHHHHhcCCccCCC
Confidence 7999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=332.65 Aligned_cols=231 Identities=28% Similarity=0.423 Sum_probs=185.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..|..++.||+|+||.||+|.+..+++.||||++.... ..-+....|+.+|..+.++++....
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35888899999999999999999999999999996532 3446788899999999998873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+.+.++..++++++.||.|||.++.+|||||+.|||+...|
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g------------------------ 148 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG------------------------ 148 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC------------------------
Confidence 22347888888999999999999999999999999999997655
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.+||+|||.+...... ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+...+..|-+
T Consensus 149 ---~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk 225 (467)
T KOG0201|consen 149 ---DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK 225 (467)
T ss_pred ---cEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC
Confidence 4667777766543322 2458999999999999988999999999999999999999999988766333322211
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
. .| ......+++.+++|+..||.+||+.|||
T Consensus 226 ~---~P----------------------------------------------P~L~~~~S~~~kEFV~~CL~k~P~~Rps 256 (467)
T KOG0201|consen 226 S---AP----------------------------------------------PRLDGDFSPPFKEFVEACLDKNPEFRPS 256 (467)
T ss_pred C---CC----------------------------------------------CccccccCHHHHHHHHHHhhcCcccCcC
Confidence 0 00 0111256788999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcc
Q 015532 380 AREALRHPFFTRDVRRPTL 398 (405)
Q Consensus 380 a~elL~hp~f~~~~~~~~~ 398 (405)
|.++|+|+|++...+.+.+
T Consensus 257 A~~LLKh~FIk~a~k~s~L 275 (467)
T KOG0201|consen 257 AKELLKHKFIKRAKKTSEL 275 (467)
T ss_pred HHHHhhhHHHHhcCCchHH
Confidence 9999999999996555443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=330.66 Aligned_cols=230 Identities=23% Similarity=0.398 Sum_probs=173.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..|+++++||+|+||.||+|++..+++.||||++... ....+.+.+|+++++.+.|+++....
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4588899999999999999999999999999998543 23456688999999999999874321
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
.....+..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--------------------------- 206 (353)
T PLN00034 154 MDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--------------------------- 206 (353)
T ss_pred CCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---------------------------
Confidence 122467788899999999999999999999999999999976654
Q ss_pred ceeccCCCCccccCC---ccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 227 IKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
+||+|||++...... ....+||..|+|||++.. ...+.++|||||||++|+|++|+.||......+....+.
T Consensus 207 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~ 286 (353)
T PLN00034 207 VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286 (353)
T ss_pred EEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence 556666655433221 123578999999998743 224568999999999999999999997433222111111
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
...... ........+.++.+||.+||+.||++||
T Consensus 287 ~~~~~~----------------------------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rp 320 (353)
T PLN00034 287 AICMSQ----------------------------------------------PPEAPATASREFRHFISCCLQREPAKRW 320 (353)
T ss_pred HHhccC----------------------------------------------CCCCCCccCHHHHHHHHHHccCChhhCc
Confidence 110000 0011124467899999999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ta~elL~hp~f~~~~~ 394 (405)
|+.|+|+||||.+...
T Consensus 321 t~~ell~hp~~~~~~~ 336 (353)
T PLN00034 321 SAMQLLQHPFILRAQP 336 (353)
T ss_pred CHHHHhcCcccccCCc
Confidence 9999999999998743
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=324.47 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=185.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.++||+|+||.||+|++..+++.||||+++... .......+|+.+++.+.|+++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 67999999999999999999999999999999986432 2234567899999999999984321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~----------------------- 141 (303)
T cd07869 85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE----------------------- 141 (303)
T ss_pred CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-----------------------
Confidence 134788899999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccC---CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN-LEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i 297 (405)
+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+ .+.+..+
T Consensus 142 ----~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 217 (303)
T cd07869 142 ----LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217 (303)
T ss_pred ----EEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 55555655543221 11224688999999998764 588999999999999999999999987644 3455556
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....+.+....+...... ..+. . ..+. ..........+. ....++.+.+||.+||++||++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~-~~~~-~---~~~~--~~~~~~~~~~~~-----------~~~~~~~~~dli~~mL~~dp~~R 279 (303)
T cd07869 218 FLVLGTPNEDTWPGVHSL-PHFK-P---ERFT--LYSPKNLRQAWN-----------KLSYVNHAEDLASKLLQCFPKNR 279 (303)
T ss_pred HHHhCCCChhhccchhhc-cccc-c---cccc--ccCCccHHHHhh-----------ccCCChHHHHHHHHHhccCchhc
Confidence 665555443221111000 0000 0 0000 000011111111 01235678999999999999999
Q ss_pred CCHHHHHcCCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDVR 394 (405)
Q Consensus 378 pta~elL~hp~f~~~~~ 394 (405)
+|++|+|+||||++-..
T Consensus 280 ~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 280 LSAQAALSHEYFSDLPP 296 (303)
T ss_pred cCHHHHhcCcccccCCh
Confidence 99999999999988543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=321.26 Aligned_cols=248 Identities=32% Similarity=0.523 Sum_probs=182.6
Q ss_pred CCeEEEeeeecccceeEEEEEecC-CCcEEEEEEecchh---hhhHHHHHHHHHHHHH---hhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l---~~~~~~~~~---------- 154 (405)
++|++.+.||+|+||+||+|++.. +++.||||+++... .......+|+.+++.+ .|+++....
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 46889999986432 2234556788887776 588764311
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~------------ 148 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ------------ 148 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC------------
Confidence 123678899999999999999999999999999999999976654
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus 149 ---------------~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 149 ---------------IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ---------------EEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 555666655433221 223568999999999998899999999999999999999999999998
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+.+..+....+.++........ ..+.. .+. ..............+..+.+||.+|
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~-------------~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~li~~~ 270 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDV-------------ALPRQ---------AFH-SKSAQPIEKFVTDIDELGKDLLLKC 270 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhh-------------cccch---------hcc-CCCCCCHHHHccCCCHHHHHHHHHH
Confidence 888888887766644332111000 00000 000 0000111112234577899999999
Q ss_pred cccCCCCCCCHHHHHcCCCC
Q 015532 370 LRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f 389 (405)
|+.||++|||+.|+|+||||
T Consensus 271 l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 271 LTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hccCchhcCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=303.15 Aligned_cols=224 Identities=28% Similarity=0.458 Sum_probs=191.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCC--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGT-------------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~-------------- 153 (405)
+.|++.+.||+|.||.||+|+.+.++-.||+|++-+.. ....++.+|++|-..|.|+||...
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56999999999999999999999999999999996543 234667789999999999998332
Q ss_pred ---------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 154 ---------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 154 ---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
....|++.....++.|++.||.|||.++||||||||+|+|++..|
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-------------------- 161 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-------------------- 161 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--------------------
Confidence 134588899999999999999999999999999999999998766
Q ss_pred cCCCCCCCceeccCCCCccc-cCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.+|++|||.+... .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+....|
T Consensus 162 -------~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI 234 (281)
T KOG0580|consen 162 -------ELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI 234 (281)
T ss_pred -------CeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence 4677777776655 34456789999999999999999999999999999999999999999988877777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.++--..| ..++..+.|||.+||.++|.+|
T Consensus 235 ~k~~~~~p--------------------------------------------------~~is~~a~dlI~~ll~~~p~~r 264 (281)
T KOG0580|consen 235 RKVDLKFP--------------------------------------------------STISGGAADLISRLLVKNPIER 264 (281)
T ss_pred HHccccCC--------------------------------------------------cccChhHHHHHHHHhccCcccc
Confidence 66533333 3457789999999999999999
Q ss_pred CCHHHHHcCCCCCCC
Q 015532 378 LKAREALRHPFFTRD 392 (405)
Q Consensus 378 pta~elL~hp~f~~~ 392 (405)
.+..|++.|||+...
T Consensus 265 ~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 265 LALTEVMDHPWIVAN 279 (281)
T ss_pred ccHHHHhhhHHHHhc
Confidence 999999999999764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=327.18 Aligned_cols=234 Identities=25% Similarity=0.416 Sum_probs=200.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.+-|.+.+.||+|.|++|-+|++.-||+.||||++.+.. .....+..|+..|+.++|+||+...
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 45677999999999999999999999999999999997643 2345678899999999999985422
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+.|+.+++|++||+.|+.|||+..+|||||||+||.+-.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--------------------- 153 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--------------------- 153 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---------------------
Confidence 245789999999999999999999999999999999998743
Q ss_pred ccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
+-+.|||.|||++...... ..+.||+..|-|||++.|..|+ +++||||||||||.|++|++||...++.+.+
T Consensus 154 -----KlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL 228 (864)
T KOG4717|consen 154 -----KLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL 228 (864)
T ss_pred -----ecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence 3446788888888654433 3567999999999999999998 7899999999999999999999999999999
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
.+|..+--..|. .++.+++|||..||..||
T Consensus 229 TmImDCKYtvPs--------------------------------------------------hvS~eCrdLI~sMLvRdP 258 (864)
T KOG4717|consen 229 TMIMDCKYTVPS--------------------------------------------------HVSKECRDLIQSMLVRDP 258 (864)
T ss_pred hhhhcccccCch--------------------------------------------------hhhHHHHHHHHHHHhcCc
Confidence 888776544443 447899999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCCCcc
Q 015532 375 AERLKAREALRHPFFTRDVRRPTL 398 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~~~~ 398 (405)
.+|.|.++|..|+|++...+.+..
T Consensus 259 kkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 259 KKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred hhhccHHHHhccccccCCCCCccc
Confidence 999999999999999987766544
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.72 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=193.2
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 78899999999999999999999999999998642 12335677899999999999874211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 v~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~------------------- 142 (372)
T cd07853 82 VTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVL------------------- 142 (372)
T ss_pred EeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCE-------------------
Confidence 1346888999999999999999999999999999999999876654
Q ss_pred CCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 143 --------kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 143 --------KICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214 (372)
T ss_pred --------EeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 55555554432211 1123678999999999875 4789999999999999999999999999999999
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+...+|..+.............+........ + . ...........++++.+||.+||++||
T Consensus 215 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~-------~----------~~~~~~~~~~~~~~~~~li~~mL~~dP 276 (372)
T cd07853 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKP-P-------S----------LPVLYTLSSQATHEAVHLLCRMLVFDP 276 (372)
T ss_pred HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCC-C-------c----------hHHhcccCCCCCHHHHHHHHHhCCCCh
Confidence 999999888776554433332222222111000 0 0 000011123446789999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRD 392 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~ 392 (405)
++|||+.|+|+||||++.
T Consensus 277 ~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 277 DKRISAADALAHPYLDEG 294 (372)
T ss_pred hhCcCHHHHhcCHhhCCC
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=318.80 Aligned_cols=247 Identities=33% Similarity=0.545 Sum_probs=182.8
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHH---hhcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l---~~~~~~~~~------------ 154 (405)
+|++.+.||+|+||+||+|+++.+++.||+|+++... .......+|+.+++.+ .|+++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5999999999999999999999999999999986432 2223456788877776 577753210
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-------------- 146 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ-------------- 146 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--------------
Confidence 123688899999999999999999999999999999999976654
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|.+||.+....
T Consensus 147 -------------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 147 -------------VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred -------------EEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 556666655443222 12346889999999999889999999999999999999999999988888
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+.+..+....+......+... ...+..... .............++..+.+||.+||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~ 270 (288)
T cd07863 214 DQLGKIFDLIGLPPEDDWPRD-------------VTLPRGAFS----------PRGPRPVQSVVPEIEESGAQLLLEMLT 270 (288)
T ss_pred HHHHHHHHHhCCCChhhCccc-------------ccccccccC----------CCCCCchHHhCcCcCHHHHHHHHHHhc
Confidence 877777776654432211000 000000000 000011112223456788999999999
Q ss_pred cCCCCCCCHHHHHcCCCC
Q 015532 372 YDPAERLKAREALRHPFF 389 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f 389 (405)
+||++|||+.|+++||||
T Consensus 271 ~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 271 FNPHKRISAFRALQHPFF 288 (288)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.98 Aligned_cols=218 Identities=26% Similarity=0.407 Sum_probs=173.8
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+.||+|+||.||+|++..+++.||||+++... .....+..|+.+++.+.|+++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2234567899999999999874321
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--------------------------- 133 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--------------------------- 133 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---------------------------
Confidence 235688899999999999999999999999999999999976654
Q ss_pred ceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 015532 227 IKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 227 ~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 134 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~- 212 (323)
T cd05571 134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI- 212 (323)
T ss_pred EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-
Confidence 5566666554321 112335799999999999998999999999999999999999999987665444433321100
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC-----
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL----- 378 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp----- 378 (405)
..+...++++.+||.+||+.||++|+
T Consensus 213 -------------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (323)
T cd05571 213 -------------------------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPE 243 (323)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 01123467899999999999999999
Q ss_pred CHHHHHcCCCCCCC
Q 015532 379 KAREALRHPFFTRD 392 (405)
Q Consensus 379 ta~elL~hp~f~~~ 392 (405)
++.++++||||+..
T Consensus 244 ~~~~ll~h~~f~~~ 257 (323)
T cd05571 244 DAKEIMEHRFFASI 257 (323)
T ss_pred CHHHHHcCCCcCCC
Confidence 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=324.30 Aligned_cols=280 Identities=28% Similarity=0.451 Sum_probs=209.6
Q ss_pred CCceEeeCC---ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCC
Q 015532 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (405)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~ 153 (405)
|++++..|+ .+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+++...
T Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 80 (353)
T cd07850 1 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80 (353)
T ss_pred CceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcce
Confidence 466777777 4678999999999999999999999999999999998642 2233456789999999999987432
Q ss_pred c------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 154 R------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 154 ~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~---- 156 (353)
T cd07850 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---- 156 (353)
T ss_pred eeeeccCCCccccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC----
Confidence 1 113677888899999999999999999999999999999976654
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|
T Consensus 157 -----------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 213 (353)
T cd07850 157 -----------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213 (353)
T ss_pred -----------------------EEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHC
Confidence 5555555554332221 224678899999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
..||...+.......+...++.++..+..........+.......... ...........+..........+..
T Consensus 214 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
T cd07850 214 TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGY-------SFEELFPDVLFPPDSESHNKLKASQ 286 (353)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCc-------chhhhCcccccCcccccccccchhH
Confidence 999999888888888888899888887766655554444332211100 0000000000111111112234667
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+.+||.+||++||++|||+.|+|+||||+.+.
T Consensus 287 ~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 287 ARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 89999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.85 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=193.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.++||+|+||.||+|++..+++.||||+++... .....+.+|+++++++.|+++....
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999999999999999986432 2334567899999999999874321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~----------------------- 142 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE----------------------- 142 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-----------------------
Confidence 123678889999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||++...... .....+|..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 143 ----~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 143 ----LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred ----EEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 556666655432211 1224678999999998764 58899999999999999999999999988888888888
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.++.++...+.......... ....+. ..+..........+.++++||.+||++||++|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 278 (309)
T cd07872 219 RLLGTPTEETWPGISSNDEFK-----NYNFPK---------------YKPQPLINHAPRLDTEGIELLTKFLQYESKKRI 278 (309)
T ss_pred HHhCCCCHHHHhhhcchhhhh-----hhhcCc---------------cCCCchhhhccCCCHHHHHHHHHhccCChhhCC
Confidence 888877765443221110000 000000 000111112234577899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
|+.|+|+||||+...
T Consensus 279 t~~e~l~h~~~~~~~ 293 (309)
T cd07872 279 SAEEAMKHAYFRSLG 293 (309)
T ss_pred CHHHHhcChhhhhcc
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.99 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=179.1
Q ss_pred EeeeecccceeEEEEEec--CCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------------
Q 015532 97 LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------- 154 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------------- 154 (405)
.++||+|+||+||+|+++ .+++.||+|.++... ......+|+.+++.+.|+++....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 368999999999999975 467889999986533 234567899999999999984321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~------------------- 145 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------- 145 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC-------------------
Confidence 01377888999999999999999999999999999999995421
Q ss_pred ccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+.+..+||+|||++...... .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||.....
T Consensus 146 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 146 ----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred ----CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 13446788888887654322 1235789999999999874 588999999999999999999999975432
Q ss_pred ---------HHHHHHHHHHhCCCChHHHHHhhHhhH--HhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 291 ---------LEHLAMMERVLGPLPHHMVIRADRRAE--KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 291 ---------~~~~~~i~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
.+.+..+...+|.++...+........ ..........+ ................+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~ 287 (317)
T cd07868 222 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY--------------TNCSLIKYMEKHKVKPD 287 (317)
T ss_pred cccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhcccc--------------CcccccchHHhcCCCCC
Confidence 345566667677655443322110000 00000000000 00000000111112234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
..+.+||.+||++||++|+|++|+|+||||
T Consensus 288 ~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 288 SKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 578999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.87 Aligned_cols=228 Identities=24% Similarity=0.348 Sum_probs=177.1
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+.|+++....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3889999999999999999999999999999986432 2234567899999999998762210
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~--------------------- 139 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG--------------------- 139 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---------------------
Confidence 12478889999999999999999999999999999999997655
Q ss_pred CCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+
T Consensus 140 ------~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 140 ------HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred ------CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 4566666666543221 12347899999999999989999999999999999999999999876543222222
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...... .........+.++.+||.+||+.||++|
T Consensus 214 ~~~~~~----------------------------------------------~~~~~~~~~s~~~~~li~~~l~~~P~~R 247 (285)
T cd05631 214 DRRVKE----------------------------------------------DQEEYSEKFSEDAKSICRMLLTKNPKER 247 (285)
T ss_pred HHHhhc----------------------------------------------ccccCCccCCHHHHHHHHHHhhcCHHHh
Confidence 111100 0011223457789999999999999999
Q ss_pred CC-----HHHHHcCCCCCCCC
Q 015532 378 LK-----AREALRHPFFTRDV 393 (405)
Q Consensus 378 pt-----a~elL~hp~f~~~~ 393 (405)
+| ++++++||||++..
T Consensus 248 ~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 248 LGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred cCCCCCCHHHHhcCHhhcCCC
Confidence 97 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=327.13 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=181.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCC-cEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.|++.+.||+|+||.||+|.+..++ ..||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999876654 689999986432 2345677899999999999884321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-------------------- 168 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-------------------- 168 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--------------------
Confidence 23578889999999999999999999999999999999997655
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.++|+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 169 -------~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 241 (340)
T PTZ00426 169 -------FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241 (340)
T ss_pred -------CEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 4667777776655444445689999999999999889999999999999999999999998876655444432
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
..... .+...++.+.++|++||+.||++|+
T Consensus 242 ~~~~~--------------------------------------------------~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 242 EGIIY--------------------------------------------------FPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred cCCCC--------------------------------------------------CCCCCCHHHHHHHHHHcccCHHHcC
Confidence 21111 1123466889999999999999996
Q ss_pred -----CHHHHHcCCCCCCC
Q 015532 379 -----KAREALRHPFFTRD 392 (405)
Q Consensus 379 -----ta~elL~hp~f~~~ 392 (405)
|++++++||||.+.
T Consensus 272 ~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 272 GNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCCHHHHHcCCCcCCC
Confidence 89999999999864
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=330.32 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=174.0
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++|++|.|++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 4579999999999999999999999999999996432 2356799999999999984322
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~------------------------ 298 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED------------------------ 298 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC------------------------
Confidence 134788999999999999999999999999999999999976654
Q ss_pred CCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hH
Q 015532 224 SSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE-------NL 291 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~ 291 (405)
++|+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|..++.... ..
T Consensus 299 ---vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~ 375 (461)
T PHA03211 299 ---ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375 (461)
T ss_pred ---EEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcH
Confidence 455555555432211 112469999999999999899999999999999999999876543211 12
Q ss_pred HHHHHHHHHhCCCChHHHHHh-hHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 292 EHLAMMERVLGPLPHHMVIRA-DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
..+..+.+..+.....+.... ......+........ ........+......+..+.+||.+||
T Consensus 376 ~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~dli~~mL 439 (461)
T PHA03211 376 AQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNR----------------RPAYTRPAWTRYYKLDLDVEYLVCRAL 439 (461)
T ss_pred HHHHHHHHhhccccccCCCCcchHHHHHHHhhhhccc----------------CCccCCcchhhhccccchHHHHHHHHc
Confidence 233333332221110000000 000000000000000 000000011111234567899999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~ 391 (405)
++||++|||+.|+|+||||+.
T Consensus 440 ~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 440 TFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ccChhhCcCHHHHhhCcccCC
Confidence 999999999999999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.92 Aligned_cols=262 Identities=31% Similarity=0.545 Sum_probs=199.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC----cEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~----~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..|++++.||+|.||.||+|..+.++ +.+|||.++... .....+.+|+.+++.+.|+|++...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46999999999999999999765543 378999996542 3345678999999999999973211
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...++...++.++.||+.|+.|||++-|+||||||.|||+..+|
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg-------------- 169 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG-------------- 169 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC--------------
Confidence 24577889999999999999999999999999999999998765
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
++.+.|||+|||+++...... ..++-|.+|+|||++.|. .|+.+.||||+|||+.||+|-++.|
T Consensus 170 ---------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 170 ---------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ---------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 457789999999998765443 236789999999999987 4999999999999999999999999
Q ss_pred CCCC---------hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhh---HHHHHHhcc----chh
Q 015532 286 QTHE---------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVWKLLR----LPN 349 (405)
Q Consensus 286 ~~~~---------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~----~~~ 349 (405)
.+.. ..+++.+|.+++|.+... +||.-..-++. +........ +.+
T Consensus 241 ~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~-------------------~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~ 301 (438)
T KOG0666|consen 241 KGREEKIKTKNPFQHDQLDRIFEVLGTPTDK-------------------DWPDLKKMPEYQTLLSDFRRHYYDNVSLHK 301 (438)
T ss_pred cchhhhcccCCCchHHHHHHHHHHcCCCccc-------------------cchhhhhCcchHHHHHHhHHhhcCcchHHH
Confidence 7642 246788888999887543 23332222211 111110100 111
Q ss_pred hhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 350 ~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
.. +.....++...+||.+||++||-+|.|++|+|+|+||+.....|
T Consensus 302 ~~-~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 302 YY-HKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred HH-HHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence 11 11122345688999999999999999999999999999986654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=303.83 Aligned_cols=226 Identities=31% Similarity=0.472 Sum_probs=180.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc---------hhhhhHHHHHHHHHHHHHhhcC-CCCC--------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---------INKYREAAMIEIDVLQRLARHD-IGGT-------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~---------~~~~~~~~~~E~~il~~l~~~~-~~~~-------- 153 (405)
.+|.-.+.||.|..++|.+|.++.+++.+|+|++.. ....++....|+.||+++..|. |+..
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 568888999999999999999999999999999842 1234567778999999986554 4211
Q ss_pred -------------c------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 154 -------------R------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 154 -------------~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
+ .-.+++...+.+++|++.|++|||.++||||||||+|||+++
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd------------------ 158 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD------------------ 158 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc------------------
Confidence 1 124688999999999999999999999999999999999864
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhC------CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
+.+++|+|||++....... ...||||+|+|||.+.. .+|+..+|+||+|||+|.|+.|.+||.
T Consensus 159 ---------n~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 159 ---------NMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ---------ccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 4567888888887665544 34799999999999864 358889999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
.....-.+.+|.+.- ..+ ....+.+++...+|||
T Consensus 230 HRkQmlMLR~ImeGk------------------------yqF----------------------~speWadis~~~KdLI 263 (411)
T KOG0599|consen 230 HRKQMLMLRMIMEGK------------------------YQF----------------------RSPEWADISATVKDLI 263 (411)
T ss_pred HHHHHHHHHHHHhcc------------------------ccc----------------------CCcchhhccccHHHHH
Confidence 655544444443311 010 1122356678899999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
.+||++||.+|.|++|+|+||||.
T Consensus 264 srlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 264 SRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHeeCchhcccHHHHhcChHHH
Confidence 999999999999999999999994
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.38 Aligned_cols=232 Identities=28% Similarity=0.393 Sum_probs=184.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||+++... .....+..|+.++..+.|+++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999997532 2335577899999999999874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------------------- 138 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG---------------------- 138 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----------------------
Confidence 23468889999999999999999999999999999999997654
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 139 -----~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 139 -----HIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred -----CEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence 467777777765544444568999999999999989999999999999999999999999887766555444321
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
...+ ..+.. .......++++.+||.+||..+|++|+|+
T Consensus 214 ~~~~----------------------~~~~~--------------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 214 KETL----------------------QRPVY--------------------DDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred cccc----------------------cCCCC--------------------CccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 1000 00000 00002346789999999999999999999
Q ss_pred HHHHcCCCCCCC
Q 015532 381 REALRHPFFTRD 392 (405)
Q Consensus 381 ~elL~hp~f~~~ 392 (405)
+++++||||...
T Consensus 252 ~~ll~h~~~~~~ 263 (333)
T cd05600 252 EDIKNHPFFKEV 263 (333)
T ss_pred HHHHhCcccCCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.40 Aligned_cols=223 Identities=26% Similarity=0.370 Sum_probs=177.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++.+.||+|+||.||+|++..+++.||||+++... ...+.+..|+.++..+.|+++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4899999999999999999999999999999997532 2345677899999999887642111
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--------------------- 139 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--------------------- 139 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC---------------------
Confidence 134688899999999999999999999999999999999977654
Q ss_pred CCCCCCceeccCCCCccc---cCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 140 ------~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 140 ------IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred ------EEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 555566655321 11122357999999999999989999999999999999999999999887766555444
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...... .+...+.++.+||.+||..||++|
T Consensus 214 ~~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~~P~~R 243 (324)
T cd05587 214 MEHNVS--------------------------------------------------YPKSLSKEAVSICKGLLTKHPAKR 243 (324)
T ss_pred HcCCCC--------------------------------------------------CCCCCCHHHHHHHHHHhhcCHHHc
Confidence 321111 112346688999999999999999
Q ss_pred CCH-----HHHHcCCCCCCC
Q 015532 378 LKA-----REALRHPFFTRD 392 (405)
Q Consensus 378 pta-----~elL~hp~f~~~ 392 (405)
+++ +++++||||+..
T Consensus 244 ~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 244 LGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.16 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=184.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||||++++.. .....+..|+.++..+.|+++....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999997532 2234567899999999998874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 245788999999999999999999999999999999999999999999999987644321110000
Q ss_pred CCCCCCceeccCCCCccc------------cCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 221 LPKSSAIKLIDFGSTTFE------------HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.........|+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 161 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 -RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred -ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 00000011122111100 00112357999999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
+..+....+...... ..+|. ....++++++||.+
T Consensus 240 ~~~~~~~~i~~~~~~----------------------~~~p~------------------------~~~~s~~~~~li~~ 273 (363)
T cd05628 240 TPQETYKKVMNWKET----------------------LIFPP------------------------EVPISEKAKDLILR 273 (363)
T ss_pred CHHHHHHHHHcCcCc----------------------ccCCC------------------------cCCCCHHHHHHHHH
Confidence 766655544321110 00000 01246688999999
Q ss_pred ccccCCCC---CCCHHHHHcCCCCCCC
Q 015532 369 LLRYDPAE---RLKAREALRHPFFTRD 392 (405)
Q Consensus 369 ~L~~dP~~---Rpta~elL~hp~f~~~ 392 (405)
|+. +|++ ||+++|+++||||++.
T Consensus 274 l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 274 FCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred HcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 775 5554 5899999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.80 Aligned_cols=218 Identities=27% Similarity=0.414 Sum_probs=173.3
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2335667899999999999874321
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--------------------------- 133 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--------------------------- 133 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc---------------------------
Confidence 235788899999999999999999999999999999999976654
Q ss_pred ceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 015532 227 IKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 134 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~- 212 (328)
T cd05593 134 IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI- 212 (328)
T ss_pred EEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc-
Confidence 56666665543211 11235799999999999988999999999999999999999999987665544333211100
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC-----
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL----- 378 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp----- 378 (405)
..+...+.++.+||.+||+.||++|+
T Consensus 213 -------------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (328)
T cd05593 213 -------------------------------------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPD 243 (328)
T ss_pred -------------------------------------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCC
Confidence 11123467899999999999999997
Q ss_pred CHHHHHcCCCCCCC
Q 015532 379 KAREALRHPFFTRD 392 (405)
Q Consensus 379 ta~elL~hp~f~~~ 392 (405)
++.|+++||||...
T Consensus 244 ~~~~il~h~~~~~~ 257 (328)
T cd05593 244 DAKEIMRHSFFTGV 257 (328)
T ss_pred CHHHHhcCCCcCCC
Confidence 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=318.55 Aligned_cols=216 Identities=31% Similarity=0.475 Sum_probs=172.1
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
||+|+||.||+|++..+++.||+|+++... .....+..|+.+++.+.|+++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999996432 2335567899999999999874321
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 155 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 155 ------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~---------------------------~k 133 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH---------------------------IA 133 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc---------------------------EE
Confidence 235788899999999999999999999999999999999976554 56
Q ss_pred eccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 015532 229 LIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 305 (405)
Q Consensus 229 l~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p 305 (405)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 134 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---- 209 (312)
T cd05585 134 LCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---- 209 (312)
T ss_pred EEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC----
Confidence 666666543211 1223579999999999999899999999999999999999999998766554443322110
Q ss_pred hHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC---CHHH
Q 015532 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---KARE 382 (405)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp---ta~e 382 (405)
. ..+...++.+.+||.+||+.||++|+ ++.|
T Consensus 210 --------------------~--------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 210 --------------------L--------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred --------------------C--------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 0 11123467899999999999999997 5899
Q ss_pred HHcCCCCCCC
Q 015532 383 ALRHPFFTRD 392 (405)
Q Consensus 383 lL~hp~f~~~ 392 (405)
+|+||||++.
T Consensus 244 ~l~hp~~~~~ 253 (312)
T cd05585 244 IKNHPFFSQL 253 (312)
T ss_pred HHcCCCcCCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=323.87 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=186.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36999999999999999999999999999999997532 2334567899999999999874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc--
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF-- 218 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~-- 218 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++..........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 2357899999999999999999999999999999999999999999999999876543221100
Q ss_pred cCCCCCCCceeccCCCCccccC------------CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQ------------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.........-..++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0000000000011111100000 1112479999999999999899999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.+..+....+..... ....+ .....++++.+||
T Consensus 241 ~~~~~~~~~~i~~~~~----------------------~~~~~------------------------~~~~~s~~~~~li 274 (364)
T cd05599 241 SDNPQETYRKIINWKE----------------------TLQFP------------------------DEVPLSPEAKDLI 274 (364)
T ss_pred CCCHHHHHHHHHcCCC----------------------ccCCC------------------------CCCCCCHHHHHHH
Confidence 8776554433321100 00000 0113467889999
Q ss_pred HHccccCCCCCCC---HHHHHcCCCCCCC
Q 015532 367 QGLLRYDPAERLK---AREALRHPFFTRD 392 (405)
Q Consensus 367 ~~~L~~dP~~Rpt---a~elL~hp~f~~~ 392 (405)
.+||. +|.+|++ ++|+++||||+..
T Consensus 275 ~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 275 KRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred HHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99997 9999998 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=322.41 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=185.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||||+++... .....+..|+.++..+.|+++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46999999999999999999999999999999997532 2345677899999999998874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 135788999999999999999999999999999999999999888888888876544322211000
Q ss_pred CCCCCCce-eccCC----CCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 221 LPKSSAIK-LIDFG----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 221 ~~~~~~~k-l~Dfg----~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
........ ..... .............||+.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 00000000 00000 00000011123579999999999999999999999999999999999999998877655444
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+...... ...+ ....+++.+.+||.+||. ||+
T Consensus 241 ~i~~~~~~----------------------~~~p------------------------~~~~~~~~~~~li~~ll~-dp~ 273 (350)
T cd05573 241 KIINWKES----------------------LRFP------------------------PDPPVSPEAIDLICRLLC-DPE 273 (350)
T ss_pred HHhccCCc----------------------ccCC------------------------CCCCCCHHHHHHHHHHcc-Chh
Confidence 43321100 0000 011246789999999998 999
Q ss_pred CCCC-HHHHHcCCCCCCC
Q 015532 376 ERLK-AREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpt-a~elL~hp~f~~~ 392 (405)
+|++ ++++++||||+..
T Consensus 274 ~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 274 DRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred hcCCCHHHHhcCCCcCCC
Confidence 9999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.66 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=182.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++++.||+|+||+||+|++..+++.||||+++... ...+.+..|+.+++.+.|+++....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5899999999999999999999999999999996532 2345577899999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc--cc
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY--FK 219 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~--~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++......... ..
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 235788899999999999999999999999999999999999999999999986532111000 00
Q ss_pred C------CCCC-----CCceeccCCCC-------cc---ccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 220 N------LPKS-----SAIKLIDFGST-------TF---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 220 ~------~~~~-----~~~kl~Dfg~a-------~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
. .... .....+.++.. .. ........+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0 0000 00001111100 00 00011235799999999999998999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc
Q 015532 279 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358 (405)
Q Consensus 279 ltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (405)
++|..||...+..+....+...... ..+ .....+
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~------------------------~~~~~~ 275 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENT----------------------LHI------------------------PPQVKL 275 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccc----------------------cCC------------------------CCCCCC
Confidence 9999999877655443333211000 000 011235
Q ss_pred hHHHHHHHHHcccc--CCCCCCCHHHHHcCCCCCCC
Q 015532 359 AGDLIDLLQGLLRY--DPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 359 ~~~l~~ll~~~L~~--dP~~Rpta~elL~hp~f~~~ 392 (405)
++++++||.+||.. ++..|++++++++||||++.
T Consensus 276 s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 276 SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 67899999996654 44559999999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.84 Aligned_cols=243 Identities=28% Similarity=0.453 Sum_probs=188.8
Q ss_pred cCCCeEEE-eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-hcCCCCC--------------
Q 015532 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGT-------------- 153 (405)
Q Consensus 90 ~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~-~~~~~~~-------------- 153 (405)
+++.|.+- ++||-|-.|.|..|.++.|++.+|+|++....+ +.+|+++.-..+ |++++..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 55667774 689999999999999999999999999875444 456777655544 4444211
Q ss_pred -----------c--------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 154 -----------R--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 154 -----------~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
+ ...|+|.++..|++||..|+.|||+.+|.||||||+|+|+...+
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~---------------- 198 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS---------------- 198 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC----------------
Confidence 0 24589999999999999999999999999999999999997654
Q ss_pred CCcccCCCCCCCceeccCCCCcccc--CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
.+..+||+|||+|+... ....+.+-|++|.|||++....|+..+|+||+||++|.|++|.+||.......
T Consensus 199 --------~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 199 --------PNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred --------CCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 56679999999998766 33455788999999999998899999999999999999999999997654321
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
+ ++.|..+. ..+...+|+ +.|+.+|+..+|+|+++|..
T Consensus 271 i-----------spgMk~rI---------~~gqy~FP~----------------------pEWs~VSe~aKdlIR~LLkt 308 (400)
T KOG0604|consen 271 I-----------SPGMKRRI---------RTGQYEFPE----------------------PEWSCVSEAAKDLIRKLLKT 308 (400)
T ss_pred C-----------ChhHHhHh---------hccCccCCC----------------------hhHhHHHHHHHHHHHHHhcC
Confidence 1 11111110 011122222 23345688999999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCCCCcchhcc
Q 015532 373 DPAERLKAREALRHPFFTRDVRRPTLLVAT 402 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~~~~~~~~~~ 402 (405)
+|.+|.|++|+++|||+.+...-|...+.|
T Consensus 309 ~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 309 EPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred CchhheeHHHhhcCchhcccccCCCCCchh
Confidence 999999999999999999987766655544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.56 Aligned_cols=254 Identities=27% Similarity=0.368 Sum_probs=184.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+|+++++||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+.|++++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5999999999999999999999999999999997532 2345677899999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc-ccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY-FKN 220 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~-~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......... ...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 134688899999999999999999999999999999999999999999999986432211000 000
Q ss_pred CCCCCCceeccCCC---------------------Ccc-ccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGS---------------------TTF-EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~---------------------a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
..........+|.. ... ........+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00000000001100 000 00011235799999999999998999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc
Q 015532 279 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358 (405)
Q Consensus 279 ltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (405)
++|.+||.+.+..+....+...... ... ......
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~------------------------p~~~~~ 275 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTS----------------------LHI------------------------PPQAKL 275 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCC----------------------cCC------------------------CCcccC
Confidence 9999999887765544433221100 000 011235
Q ss_pred hHHHHHHHHHccccCCCCCCC---HHHHHcCCCCCCCC
Q 015532 359 AGDLIDLLQGLLRYDPAERLK---AREALRHPFFTRDV 393 (405)
Q Consensus 359 ~~~l~~ll~~~L~~dP~~Rpt---a~elL~hp~f~~~~ 393 (405)
++++.+||.+|+ .||++|++ ++++++||||+...
T Consensus 276 s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 276 SPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred CHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 678899999987 59999997 99999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.24 Aligned_cols=222 Identities=24% Similarity=0.372 Sum_probs=174.2
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHH---HHHhhcCCCCCc------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVL---QRLARHDIGGTR------------ 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il---~~l~~~~~~~~~------------ 154 (405)
|++++.||+|+||.||+|.+..+++.||||+++... ...+.+..|+.++ +.+.|+++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999997532 2234455666655 456688773321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--------------------- 139 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--------------------- 139 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc---------------------
Confidence 235789999999999999999999999999999999999987664
Q ss_pred CCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 140 ------~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i 213 (324)
T cd05589 140 ------VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213 (324)
T ss_pred ------EEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4555555543211 1123457999999999999989999999999999999999999999887766555443
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...... .+..++..+.+||.+||+.||++|
T Consensus 214 ~~~~~~--------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R 243 (324)
T cd05589 214 VNDEVR--------------------------------------------------YPRFLSREAISIMRRLLRRNPERR 243 (324)
T ss_pred HhCCCC--------------------------------------------------CCCCCCHHHHHHHHHHhhcCHhHc
Confidence 221111 112346688999999999999999
Q ss_pred C-----CHHHHHcCCCCCCC
Q 015532 378 L-----KAREALRHPFFTRD 392 (405)
Q Consensus 378 p-----ta~elL~hp~f~~~ 392 (405)
| ++.++++||||+..
T Consensus 244 ~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 244 LGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CCCCCCCHHHHhhCCCcCCC
Confidence 9 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=317.56 Aligned_cols=219 Identities=25% Similarity=0.391 Sum_probs=172.8
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+.||+|+||.||+|++..+++.||+|+++... .....+..|+.+++.+.|+++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2234566799999999999884321
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k------------------------- 135 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK------------------------- 135 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEE-------------------------
Confidence 13478899999999999999999999999999999999998766554
Q ss_pred ceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 015532 227 IKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 136 --L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~- 212 (323)
T cd05595 136 --ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI- 212 (323)
T ss_pred --ecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-
Confidence 455554432111 11234689999999999988999999999999999999999999987665544433321100
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC-----
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL----- 378 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp----- 378 (405)
..+..+++++.+||.+||+.||++|+
T Consensus 213 -------------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (323)
T cd05595 213 -------------------------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 243 (323)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCC
Confidence 01123467899999999999999998
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
++.++++||||.+..
T Consensus 244 ~~~~~l~h~~~~~~~ 258 (323)
T cd05595 244 DAKEVMEHRFFLSIN 258 (323)
T ss_pred CHHHHHcCCCcCCCC
Confidence 999999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.09 Aligned_cols=223 Identities=25% Similarity=0.360 Sum_probs=175.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++.+.||+|+||.||+|++..+++.||||++++.. ...+....|..++..+.++++....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3889999999999999999999999999999997532 2234456788888887665542110
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--------------------- 139 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--------------------- 139 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc---------------------
Confidence 235788899999999999999999999999999999999977664
Q ss_pred CCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 140 ------~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 140 ------IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred ------EEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5556666554321 1122357999999999999999999999999999999999999999987766655544
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....... +...+.++.+|+.+||+.||++|
T Consensus 214 ~~~~~~~--------------------------------------------------p~~~s~~~~~li~~~l~~~p~~R 243 (323)
T cd05616 214 MEHNVAY--------------------------------------------------PKSMSKEAVAICKGLMTKHPGKR 243 (323)
T ss_pred HhCCCCC--------------------------------------------------CCcCCHHHHHHHHHHcccCHHhc
Confidence 3321111 12346688999999999999999
Q ss_pred CC-----HHHHHcCCCCCCC
Q 015532 378 LK-----AREALRHPFFTRD 392 (405)
Q Consensus 378 pt-----a~elL~hp~f~~~ 392 (405)
++ ..++++||||+.-
T Consensus 244 ~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 244 LGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 97 4899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=314.34 Aligned_cols=274 Identities=23% Similarity=0.287 Sum_probs=183.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.+.||+|+||.||+|++..++..||+|+++.. ....+.+.+|+++++.+.|+++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46899999999999999999999999999999998643 23456788999999999999884321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--------------------- 142 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--------------------- 142 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc---------------------
Confidence 13467888999999999999999985 6999999999999987664
Q ss_pred CCCCCCceeccCCCCccccC-CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||++..... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..
T Consensus 143 ------~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 216 (331)
T cd06649 143 ------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216 (331)
T ss_pred ------EEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 45555555543322 12234789999999999998899999999999999999999999987655443222211
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCC--CchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA--TSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.............. ............... .........................+++++++||.+||++||++|
T Consensus 217 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~R 292 (331)
T cd06649 217 PVVDGEEGEPHSIS----PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAER 292 (331)
T ss_pred cccccccCCccccC----cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccC
Confidence 00000000000000 000000000000000 000000000000000000001112357789999999999999999
Q ss_pred CCHHHHHcCCCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDVRR 395 (405)
Q Consensus 378 pta~elL~hp~f~~~~~~ 395 (405)
||++|+|+||||+.....
T Consensus 293 pt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 293 ADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred CCHHHHhcChHHhhcccc
Confidence 999999999999876443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=319.62 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=185.3
Q ss_pred CccCCCeEEEeeeecccceeEEEEEec--CCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..+..+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+++|+.+.|+++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 345678999999999999999999764 35678999988643 2345799999999999885421
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 164 v~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~-------------------- 223 (392)
T PHA03207 164 VMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN-------------------- 223 (392)
T ss_pred EehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--------------------
Confidence 245788899999999999999999999999999999999976664
Q ss_pred CCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE---NL 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~ 291 (405)
++|+|||++...... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. ..
T Consensus 224 -------~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 224 -------AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred -------EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 455555555432211 123579999999999999899999999999999999999999997654 34
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcC---CcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRG---ARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
..+..+.+.++..|..+...........+... .+..+. .+... .....+.++.+||.+
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~--~~~~~~~~~~~li~~ 357 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT-----------------IPPVI--RKYGMHMDVEYLIAK 357 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc-----------------ccchh--hccCcchhHHHHHHH
Confidence 55566666666544332211111111111000 000000 00000 011335678999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
||++||++|||+.|+|+||||+....
T Consensus 358 ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 358 MLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HhccChhhCCCHHHHhhCchhhccch
Confidence 99999999999999999999988544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.09 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=184.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|+++++||+|+||+||+|++..+++.||||++.+.. ...+.+.+|+++++.+.|+++....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36999999999999999999999999999999986532 2235567899999999999874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc--c
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY--F 218 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~--~ 218 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++......... .
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 245788899999999999999999999999999999999999999999999987543221100 0
Q ss_pred cC----------CCCCCCc-------------eeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHH
Q 015532 219 KN----------LPKSSAI-------------KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 275 (405)
Q Consensus 219 ~~----------~~~~~~~-------------kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 275 (405)
.. .+....+ ++.+++..... .....+||+.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00 0000000 01111111000 01124799999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 276 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 276 ~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
|||++|.+||.+.+..+.+..+..... ...++. .
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~----------------------~~~~p~------------------------~ 272 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRE----------------------TLYFPD------------------------D 272 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCC----------------------ccCCCC------------------------C
Confidence 999999999988776555444322100 001110 1
Q ss_pred cCchHHHHHHHHHccccCCCCC---CCHHHHHcCCCCCCC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAER---LKAREALRHPFFTRD 392 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~R---pta~elL~hp~f~~~ 392 (405)
...+.++.+||.+||. +|.+| +|+.|+++||||++.
T Consensus 273 ~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 273 IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 1346789999999998 77776 599999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=308.39 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=189.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.++||+|+||.||+|++..+++.||+|.++... .....+.+|+.+++.+.|+++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999999999999999986432 2334567899999999999874321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~----------------------- 142 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE----------------------- 142 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc-----------------------
Confidence 134678889999999999999999999999999999999977664
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||++...... .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.+..+.
T Consensus 143 ----~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 143 ----LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred ----EEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 455555554432211 1123568899999998764 47889999999999999999999999988888887777
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.++.++...+........ + ....++. .............++.+.+||.+||+.||++||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~-~----~~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~ 278 (301)
T cd07873 219 RILGTPTEETWPGILSNEE-F----KSYNYPK---------------YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278 (301)
T ss_pred HHcCCCChhhchhhhcccc-c----cccccCc---------------cccccHHhhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 7777665443221100000 0 0000000 000011112234577899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
|++|+|+||||+.-.
T Consensus 279 t~~eil~h~~f~~~~ 293 (301)
T cd07873 279 SAEEAMKHPYFHCLG 293 (301)
T ss_pred CHHHHhcCccccccc
Confidence 999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.41 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=182.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++++.||+|+||.||+|++..+++.||||++.+.. .....+.+|+.+|+.+.|+++....
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6999999999999999999999999999999996532 2345577899999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC--CCccc
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD--GSYFK 219 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~--~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 234678889999999999999999999999999999999999999999999986432110 00000
Q ss_pred CCCCCCCceeccCCCC---------------c---cccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 220 NLPKSSAIKLIDFGST---------------T---FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a---------------~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
.. ........+.... . .........+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 162 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 162 KG-DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred cc-cccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 0000000000000 0 000011235799999999999998999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
..||.+.+..+....+...... .. ......++..
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~----------------------~~------------------------~~~~~~~s~~ 274 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETT----------------------LH------------------------IPSQAKLSRE 274 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCcc----------------------cc------------------------CCCCCCCCHH
Confidence 9999887665544332211000 00 0011235678
Q ss_pred HHHHHHHccccCCCCCC---CHHHHHcCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERL---KAREALRHPFFTRD 392 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rp---ta~elL~hp~f~~~ 392 (405)
+.+||.+|+ .+|++|+ |+.|+++||||++.
T Consensus 275 ~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 275 ASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 899999977 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.94 Aligned_cols=230 Identities=26% Similarity=0.397 Sum_probs=192.0
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++..||++.+.||+|.||.|-+|.+...|+.||||.|++... ..-...+||+||..|+|++|+...
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 456789999999999999999999999999999999976543 223456899999999999984322
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
.+.+++.+++.+++||..|+.|||.++++|||||.+|||++.+
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-------------------- 189 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-------------------- 189 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC--------------------
Confidence 2578999999999999999999999999999999999998654
Q ss_pred ccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.++||+|||++....... +++||++-|.+||++.|.+|. +.+|-|||||+||.|+.|..||++.+....+
T Consensus 190 -------~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv 262 (668)
T KOG0611|consen 190 -------NNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV 262 (668)
T ss_pred -------CCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH
Confidence 467888888887665543 568999999999999999986 7899999999999999999999999887777
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
.+|.+..-.- ...+.++.-||+.||.+||
T Consensus 263 rQIs~GaYrE---------------------------------------------------P~~PSdA~gLIRwmLmVNP 291 (668)
T KOG0611|consen 263 RQISRGAYRE---------------------------------------------------PETPSDASGLIRWMLMVNP 291 (668)
T ss_pred HHhhcccccC---------------------------------------------------CCCCchHHHHHHHHHhcCc
Confidence 7665422111 1123467789999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~~ 396 (405)
++|.|+++|..|=|+.=....+
T Consensus 292 ~RRATieDiAsHWWvNwgy~~~ 313 (668)
T KOG0611|consen 292 ERRATIEDIASHWWVNWGYNMP 313 (668)
T ss_pred ccchhHHHHhhhheeecccccc
Confidence 9999999999998887555444
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.49 Aligned_cols=218 Identities=26% Similarity=0.380 Sum_probs=171.2
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||+||+|+++.+++.||||++++.. ...+....|+.++..+ .|+++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997532 2334566788888876 466663211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~-------------------------- 134 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH-------------------------- 134 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--------------------------
Confidence 235788899999999999999999999999999999999987664
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 135 -~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 135 -CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred -EEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 4555555543321 112235799999999999988899999999999999999999999988776665544432111
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH--
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-- 380 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-- 380 (405)
. .+...+.++.+||.+||+.||++|+++
T Consensus 214 ~--------------------------------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 214 V--------------------------------------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred C--------------------------------------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1 112346688999999999999999998
Q ss_pred ----HHHHcCCCCCCC
Q 015532 381 ----REALRHPFFTRD 392 (405)
Q Consensus 381 ----~elL~hp~f~~~ 392 (405)
+++++||||+.-
T Consensus 244 ~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 244 LGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.00 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=176.1
Q ss_pred eEeeCCccCCCeEEEeeeecccceeEEEEEecCCC-cEEEEE------------------EecchhhhhHHHHHHHHHHH
Q 015532 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIK------------------IVRSINKYREAAMIEIDVLQ 143 (405)
Q Consensus 83 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~-~~vAiK------------------~~~~~~~~~~~~~~E~~il~ 143 (405)
.+..++.+.++|+++++||+|+||+||+|..+... ..+++| .++........+.+|+.+|+
T Consensus 139 ~~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~ 218 (501)
T PHA03210 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218 (501)
T ss_pred hcccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHH
Confidence 34455667789999999999999999998764322 222222 22222233456778999999
Q ss_pred HHhhcCCCCCcc-------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 015532 144 RLARHDIGGTRY-------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 192 (405)
Q Consensus 144 ~l~~~~~~~~~~-------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 192 (405)
++.|++++.... .......++.++.||+.||.|||++|||||||||+||
T Consensus 219 ~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 219 RLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred hCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 999999854220 0112456778999999999999999999999999999
Q ss_pred EEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhH
Q 015532 193 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDL 268 (405)
Q Consensus 193 li~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di 268 (405)
|++.++. +||+|||++....... ...+||..|+|||++.+..++.++||
T Consensus 299 Ll~~~~~---------------------------vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 351 (501)
T PHA03210 299 FLNCDGK---------------------------IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDI 351 (501)
T ss_pred EECCCCC---------------------------EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHH
Confidence 9976554 5666666665433221 22579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCC-CCC--ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhc
Q 015532 269 WSVGCILVELCSGEALF-QTH--ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345 (405)
Q Consensus 269 wSlG~il~~lltg~~pf-~~~--~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (405)
|||||++|||++|..++ ... .....+..+...++..+..+..... ....+... ..+.... .
T Consensus 352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~i~~---~~~~~~~---~--------- 415 (501)
T PHA03210 352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPC-KLFDYIDS---AEIDHAG---H--------- 415 (501)
T ss_pred HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHH-HHHHHhhh---hhcccCc---c---------
Confidence 99999999999987544 322 2334444444443332221110000 00011000 0000000 0
Q ss_pred cchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCC
Q 015532 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 346 ~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
..+.... ....+.++.++|.+||++||++||||.|+|+||||+....+
T Consensus 416 ~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 416 SVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred chhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence 0000000 01245678899999999999999999999999999886544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=319.78 Aligned_cols=230 Identities=24% Similarity=0.388 Sum_probs=178.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||++++.. .....+..|+.+++.+.|+++....
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 367999999999999999999999999999999996532 2234466899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--------------------- 180 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--------------------- 180 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC---------------------
Confidence 124678889999999999999999999999999999999977664
Q ss_pred CCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+...
T Consensus 181 ------~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 254 (370)
T cd05596 181 ------LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (370)
T ss_pred ------EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH
Confidence 555555555433211 1235799999999999754 37899999999999999999999998876655
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+..... ...++. ...++.++.+||.+||+.
T Consensus 255 ~~~~i~~~~~----------------------~~~~~~------------------------~~~~s~~~~~li~~~L~~ 288 (370)
T cd05596 255 TYSKIMDHKN----------------------SLTFPD------------------------DIEISKQAKDLICAFLTD 288 (370)
T ss_pred HHHHHHcCCC----------------------cCCCCC------------------------cCCCCHHHHHHHHHHccC
Confidence 4443322100 011111 113477899999999999
Q ss_pred CCCC--CCCHHHHHcCCCCCCCC
Q 015532 373 DPAE--RLKAREALRHPFFTRDV 393 (405)
Q Consensus 373 dP~~--Rpta~elL~hp~f~~~~ 393 (405)
+|++ |+|++|+++||||++..
T Consensus 289 ~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 289 REVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred hhhccCCCCHHHHhcCcccCCCC
Confidence 9998 99999999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.89 Aligned_cols=218 Identities=26% Similarity=0.406 Sum_probs=172.6
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+.||+|+||.||+|++..+++.||+|+++... .....+..|+++++.+.|+++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2234567799999999999874321
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~-------------------------- 134 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-------------------------- 134 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--------------------------
Confidence 2357889999999999999999997 79999999999999976654
Q ss_pred CceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 135 -~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 135 -IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred -EEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 56666665543211 11235799999999999998999999999999999999999999987665544433321100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC----
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---- 378 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp---- 378 (405)
..+...++++.+||.+||+.||++|+
T Consensus 214 --------------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (325)
T cd05594 214 --------------------------------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGP 243 (325)
T ss_pred --------------------------------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCC
Confidence 01123467899999999999999997
Q ss_pred -CHHHHHcCCCCCCC
Q 015532 379 -KAREALRHPFFTRD 392 (405)
Q Consensus 379 -ta~elL~hp~f~~~ 392 (405)
++.++++||||.+.
T Consensus 244 ~~~~~il~h~~~~~~ 258 (325)
T cd05594 244 DDAKEIMQHKFFAGI 258 (325)
T ss_pred CCHHHHhcCCCcCCC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=311.81 Aligned_cols=218 Identities=26% Similarity=0.378 Sum_probs=168.9
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|+++.+++.||||+++... ...+....|..++..+ .|+++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999997532 2334556788887764 666653211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~-------------------------- 134 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-------------------------- 134 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--------------------------
Confidence 135788899999999999999999999999999999999977664
Q ss_pred CceeccCCCCccc---cCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 135 -~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 135 -IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred -EEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 455555554321 1122345799999999999998999999999999999999999999988766554443322110
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH-H
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-R 381 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-~ 381 (405)
. .....+.++.+||.+||+.||++|+++ +
T Consensus 214 ~--------------------------------------------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~ 243 (316)
T cd05620 214 H--------------------------------------------------YPRWITKESKDILEKLFERDPTRRLGVVG 243 (316)
T ss_pred C--------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 0 112246688999999999999999997 5
Q ss_pred HHHcCCCCCCC
Q 015532 382 EALRHPFFTRD 392 (405)
Q Consensus 382 elL~hp~f~~~ 392 (405)
++++||||+..
T Consensus 244 ~~~~h~~f~~~ 254 (316)
T cd05620 244 NIRGHPFFKTI 254 (316)
T ss_pred HHHcCCCcCCC
Confidence 89999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=310.84 Aligned_cols=223 Identities=25% Similarity=0.360 Sum_probs=175.8
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++.+.||+|+||.||+|+++.+++.||||++++.. ...+....|+.++..+.|+++....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3788899999999999999999999999999997532 2234567788899888876642211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--------------------- 139 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--------------------- 139 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---------------------
Confidence 135788999999999999999999999999999999999976654
Q ss_pred CCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+
T Consensus 140 ------ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 140 ------IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred ------EEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55566665543211 122356899999999999888999999999999999999999999887765554444
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...... .+...+.++.+|+.+||+.||++|
T Consensus 214 ~~~~~~--------------------------------------------------~p~~~~~~~~~li~~~l~~~p~~R 243 (323)
T cd05615 214 MEHNVS--------------------------------------------------YPKSLSKEAVSICKGLMTKHPSKR 243 (323)
T ss_pred HhCCCC--------------------------------------------------CCccCCHHHHHHHHHHcccCHhhC
Confidence 321111 112346688999999999999999
Q ss_pred CC-----HHHHHcCCCCCCC
Q 015532 378 LK-----AREALRHPFFTRD 392 (405)
Q Consensus 378 pt-----a~elL~hp~f~~~ 392 (405)
++ .+++++||||+.-
T Consensus 244 ~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 244 LGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CCCCCCCHHHHhcCcccCCC
Confidence 97 5899999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=272.15 Aligned_cols=253 Identities=33% Similarity=0.526 Sum_probs=194.4
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|.-.++||+|.||+|++|+.+.+++.||+|.++..+ ......++||-+|+.+.|.|++...
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4777899999999999999999999999999997533 3457789999999999999985421
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
.+.+..+.++.++.|++.||.|+|++++.||||||+|+||+.+|.
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge----------------------- 139 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE----------------------- 139 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc-----------------------
Confidence 356778899999999999999999999999999999999987765
Q ss_pred CCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
+|++|||+++...-.. +..+-|.+|++|.++.|.. |+...|+||.|||+.|+.. |++.|++.+..+++.+|
T Consensus 140 ----lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 140 ----LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred ----EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 5555555554433222 1236789999999999875 8999999999999999986 99999999999999999
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+.+|.+.++. ||.-..-+.... .........-.+........-+||+.++|.-+|.+|
T Consensus 216 f~~lg~p~ed~-------------------wps~t~lpdyk~--yp~ypattswsqivp~lns~grdllqkll~cnp~qr 274 (292)
T KOG0662|consen 216 FRLLGTPTEDQ-------------------WPSMTKLPDYKP--YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQR 274 (292)
T ss_pred HHHhCCCcccc-------------------CCccccCCCCcc--cCCccccchHHHHhhhhcchhHHHHHHHhccCcccc
Confidence 99999876543 222111000000 000000000011223345567899999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDV 393 (405)
Q Consensus 378 pta~elL~hp~f~~~~ 393 (405)
++|+++|+||||....
T Consensus 275 isaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 275 ISAEAALQHPYFSDFS 290 (292)
T ss_pred cCHHHHhcCccccccC
Confidence 9999999999998753
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=325.27 Aligned_cols=230 Identities=27% Similarity=0.468 Sum_probs=190.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc-hhhhhHHHHHHHHHHHHHhhcCCCCC-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGT----------------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~il~~l~~~~~~~~----------------- 153 (405)
+.|+|+..||.|+||.||+|..+.++-..|-|+|.. .....+.++.||+||..+.||++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 568999999999999999999999999999999864 34567889999999999999987432
Q ss_pred -----------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 154 -----------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 154 -----------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
+...+.+.++..+++|++.||.|||+++|||||||..|||++.+|
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG------------------------ 167 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG------------------------ 167 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC------------------------
Confidence 245789999999999999999999999999999999999998776
Q ss_pred CCCCceeccCCCCcccc---CCccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 223 KSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.++|+|||.+.... ....++.|||+|||||+... .+|++++||||||++|.||..+.+|....+....+
T Consensus 168 ---dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl 244 (1187)
T KOG0579|consen 168 ---DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 244 (1187)
T ss_pred ---cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence 46777777664332 23456899999999999864 57999999999999999999999999888777766
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..|.+... | ..-.+..++..|.|||.+||..||
T Consensus 245 lKiaKSeP--P---------------------------------------------TLlqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 245 LKIAKSEP--P---------------------------------------------TLLQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred HHHhhcCC--C---------------------------------------------cccCcchhhhHHHHHHHHHHhcCC
Confidence 65544211 1 111234557789999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~ 395 (405)
+.||++.++|+||||+...+.
T Consensus 278 ~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 278 RNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred ccCCCHHHHhhCcccccCCcc
Confidence 999999999999999976543
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.35 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=175.1
Q ss_pred EeeeecccceeEEEEEecC--CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------------
Q 015532 97 LSKMGEGTFGQVVECFDNE--KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------------- 154 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------------- 154 (405)
..+||+|+||+||+|++.. ++..||+|.++... ....+.+|+++++.+.|+++....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3689999999999999754 56889999986543 234567899999999999873210
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~------------------- 145 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------- 145 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC-------------------
Confidence 11367888999999999999999999999999999999995322
Q ss_pred ccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+.+..+||+|||++...... .....||..|+|||++.+. .++.++|||||||++|+|++|.+||.....
T Consensus 146 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~ 221 (317)
T cd07867 146 ----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred ----CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence 13445778888877644322 1235789999999999874 588999999999999999999999975432
Q ss_pred ---------HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 291 ---------LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 291 ---------~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
...+..+...+|......+....... .+.... ..+.... .................+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07867 222 DIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMP-EYPTLQ--KDFRRTT---------YANSSLIKYMEKHKVKPDSK 289 (317)
T ss_pred cccccccccHHHHHHHHHhcCCCChhhhhhhhhcc-cchhhh--hhhcccc---------cCCchhhhhhhcccCCCChH
Confidence 23445555555544433222111000 000000 0000000 00000000011111233567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
+.+||.+||+.||.+|||++|+|+||||
T Consensus 290 ~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 290 VFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=315.68 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=175.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
.+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.+++.+.|+++....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 5799999999999999999999999999999986432 235689999999999985432
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-------------------------- 194 (357)
T PHA03209 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-------------------------- 194 (357)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--------------------------
Confidence 23478899999999999999999999999999999999997655
Q ss_pred CCceeccCCCCccccC--CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCh---------HH
Q 015532 225 SAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA-LFQTHEN---------LE 292 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~-pf~~~~~---------~~ 292 (405)
.++|+|||++..... ......||..|+|||++.+..++.++|||||||++|+|+++.. +|..... ..
T Consensus 195 -~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~ 273 (357)
T PHA03209 195 -QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273 (357)
T ss_pred -CEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHH
Confidence 456666666653222 1223578999999999999899999999999999999998544 4443211 12
Q ss_pred HHHHHHHHhCCCChHHHHHhh-HhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 293 HLAMMERVLGPLPHHMVIRAD-RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.+..+...++..|..+..... .....+.........+ ............+.++.+||.+||+
T Consensus 274 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~mL~ 336 (357)
T PHA03209 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQP-----------------YTRYPCFQRVNLPIDGEFLVHKMLT 336 (357)
T ss_pred HHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCc-----------------ccccHHHhccCCCchHHHHHHHHHc
Confidence 233333444443332210000 0000110000000000 0000000112345678899999999
Q ss_pred cCCCCCCCHHHHHcCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~ 391 (405)
+||++||||.|+|+||||++
T Consensus 337 ~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 337 FDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCcccCcCHHHHhcCchhcc
Confidence 99999999999999999986
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=312.95 Aligned_cols=218 Identities=23% Similarity=0.344 Sum_probs=170.9
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..+++.||||+++... ...+.+..|..++..+ .|+++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997532 2234566788888876 566652211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~-------------------------- 134 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-------------------------- 134 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--------------------------
Confidence 235678889999999999999999999999999999999977664
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 135 -~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 135 -CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred -EEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 5555665554321 112235789999999999998999999999999999999999999998877665554432110
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC----
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---- 378 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp---- 378 (405)
. .+...+.++.+||.+||+.||++|+
T Consensus 214 ~--------------------------------------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~ 243 (321)
T cd05591 214 L--------------------------------------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVA 243 (321)
T ss_pred C--------------------------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 0 0112356889999999999999999
Q ss_pred ---CHHHHHcCCCCCCC
Q 015532 379 ---KAREALRHPFFTRD 392 (405)
Q Consensus 379 ---ta~elL~hp~f~~~ 392 (405)
+++++++||||...
T Consensus 244 ~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 244 SQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCCCHHHHhcCCccCCC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=314.26 Aligned_cols=227 Identities=27% Similarity=0.403 Sum_probs=177.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||||+++.... ..+.+..|+.+++.+.|+++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 369999999999999999999999999999999975432 345567899999999998873321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~-------------------- 140 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH-------------------- 140 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--------------------
Confidence 135788899999999999999999999999999999999976654
Q ss_pred CCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHh------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 141 -------~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 141 -------IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred -------EEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 5666666654432221 1246899999999987 4567899999999999999999999998876
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
....+..+..... ...++ .....+.++.+||.+|
T Consensus 214 ~~~~~~~i~~~~~----------------------~~~~~------------------------~~~~~~~~~~~li~~l 247 (330)
T cd05601 214 SAKTYNNIMNFQR----------------------FLKFP------------------------EDPKVSSDFLDLIQSL 247 (330)
T ss_pred HHHHHHHHHcCCC----------------------ccCCC------------------------CCCCCCHHHHHHHHHH
Confidence 6554443322100 00111 0123467899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
|+ ||++|+|++++++||||+..
T Consensus 248 l~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 248 LC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred cc-ChhhCCCHHHHhCCCCcCCC
Confidence 98 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=312.59 Aligned_cols=227 Identities=28% Similarity=0.399 Sum_probs=169.2
Q ss_pred CeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHh-hcCCCCCc---------
Q 015532 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTR--------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~-~~~~~~~~--------- 154 (405)
+|++.+.||+|+||+||+|++. .+++.||+|++++.. ...+....|+++++.+. |+++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 478999999996432 22345678999999996 45442210
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~----------------- 143 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH----------------- 143 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC-----------------
Confidence 235788999999999999999999999999999999999976654
Q ss_pred cccCCCCCCCceeccCCCCccccC----CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
++|+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 144 ----------~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 144 ----------VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred ----------EEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 55666665543211 11235799999999999875 4789999999999999999999999653321
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+...... ........++..+.+||.+||+
T Consensus 214 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~li~~~l~ 247 (332)
T cd05614 214 NTQSEVSRRILK----------------------------------------------CDPPFPSFIGPEAQDLLHKLLR 247 (332)
T ss_pred CCHHHHHHHHhc----------------------------------------------CCCCCCCCCCHHHHHHHHHHcC
Confidence 111111100000 0001112356789999999999
Q ss_pred cCCCCCC-----CHHHHHcCCCCCCC
Q 015532 372 YDPAERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~Rp-----ta~elL~hp~f~~~ 392 (405)
.||++|+ +++++++||||+..
T Consensus 248 ~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 248 KDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=308.04 Aligned_cols=264 Identities=28% Similarity=0.479 Sum_probs=191.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.++|++.++||+|+||.||+|++..+++.||||+++.. ......+..|+.+++.+.|+++....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 457899999999999999999999999999999998642 23345677899999999998874321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-- 160 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc--
Confidence 1247888999999999999999999999999999999999877665555555432211000
Q ss_pred ccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
..........||..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......
T Consensus 161 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 161 -------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred -------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00001112468899999998765 4688999999999999999999999998887777777
Q ss_pred HHHHhCCCChHHHHHhh-HhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 297 MERVLGPLPHHMVIRAD-RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
+...++..+.+...... .....+.... ... ............+..+.+||.+||+.||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 281 (336)
T cd07849 222 ILGVLGTPSQEDLNCIISLRARNYIKSL---PFK-----------------PKVPWNKLFPNADPKALDLLDKMLTFNPH 281 (336)
T ss_pred HHHHcCCCCHHHHHHhhchhhhhHHhhc---CcC-----------------CcccHHHHhcccCcHHHHHHHHHcCCChh
Confidence 77777765543322111 1111111000 000 00000011123467899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~ 394 (405)
+|||+.|+++||||.+...
T Consensus 282 ~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 282 KRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hCcCHHHHhcCccccccCC
Confidence 9999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=316.81 Aligned_cols=230 Identities=23% Similarity=0.386 Sum_probs=177.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..++|++.+.||+|+||.||+|++..+++.||+|++.+.. .....+..|+.+++.+.|+++....
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3468999999999999999999999999999999986422 2234567899999999999874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~-------------------- 180 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------------------- 180 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--------------------
Confidence 124678899999999999999999999999999999999976654
Q ss_pred CCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..
T Consensus 181 -------~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~ 253 (370)
T cd05621 181 -------LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253 (370)
T ss_pred -------EEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence 566666655443221 12357999999999997643 788999999999999999999999887765
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+..... ...++. ....+..+++++.+||+
T Consensus 254 ~~~~~i~~~~~----------------------~~~~p~------------------------~~~~s~~~~~li~~~L~ 287 (370)
T cd05621 254 GTYSKIMDHKN----------------------SLNFPE------------------------DVEISKHAKNLICAFLT 287 (370)
T ss_pred HHHHHHHhCCc----------------------ccCCCC------------------------cccCCHHHHHHHHHHcc
Confidence 55444332110 111111 11346788999999998
Q ss_pred cCCCC--CCCHHHHHcCCCCCCC
Q 015532 372 YDPAE--RLKAREALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~--Rpta~elL~hp~f~~~ 392 (405)
.++.+ |+|++|+++||||+..
T Consensus 288 ~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 288 DREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CchhccCCCCHHHHhcCcccCCC
Confidence 65544 8899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=312.34 Aligned_cols=218 Identities=25% Similarity=0.373 Sum_probs=171.0
Q ss_pred eeeecccceeEEEEEec---CCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 98 SKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.||+|+||.||+|++. .+++.||||+++... .....+..|+.+|+.+.|+++....
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999874 468899999997532 2234566899999999999984321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----------------------- 138 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH----------------------- 138 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-----------------------
Confidence 134577888899999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 139 ----~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 139 ----VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred ----EEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 55556665542211 11234789999999999988899999999999999999999999988766554443322
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC-
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL- 378 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp- 378 (405)
... ..+...++.+.+||.+||+.||++|+
T Consensus 215 ~~~--------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 215 GKL--------------------------------------------------NLPPYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCC--------------------------------------------------CCCCCCCHHHHHHHHHHcccCHhHcCC
Confidence 110 11123466889999999999999999
Q ss_pred ----CHHHHHcCCCCCCC
Q 015532 379 ----KAREALRHPFFTRD 392 (405)
Q Consensus 379 ----ta~elL~hp~f~~~ 392 (405)
+++++++||||+..
T Consensus 245 ~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 245 AGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=309.51 Aligned_cols=218 Identities=27% Similarity=0.368 Sum_probs=168.8
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..+++.||||+++... ...+....|..++..+ .|+++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997532 2234455677777654 676663211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--------------------------- 133 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--------------------------- 133 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC---------------------------
Confidence 23578889999999999999999999999999999999997655
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 134 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 134 HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 45666666654321 122335799999999999998999999999999999999999999998776555544322111
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH-H
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-R 381 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-~ 381 (405)
. ....++.++.+||.+||+.||++|+++ .
T Consensus 214 ~--------------------------------------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 214 H--------------------------------------------------FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred C--------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 1 112346688999999999999999985 5
Q ss_pred HHHcCCCCCCC
Q 015532 382 EALRHPFFTRD 392 (405)
Q Consensus 382 elL~hp~f~~~ 392 (405)
++++||||...
T Consensus 244 ~l~~h~~~~~~ 254 (316)
T cd05592 244 DIRQHPFFRGI 254 (316)
T ss_pred HHHcCcccCCC
Confidence 88999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=303.28 Aligned_cols=228 Identities=25% Similarity=0.366 Sum_probs=177.1
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+|++.++||+|+||+||++.+..+++.||||++.... .....+.+|+.+++.++|+++....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999999999999999986432 1234467899999999998873211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-------------------- 140 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH-------------------- 140 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--------------------
Confidence 134788899999999999999999999999999999999976554
Q ss_pred CCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++....... ....|+..|+|||++.+..++.++||||+||++|+|++|..||.+.........+
T Consensus 141 -------~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 141 -------IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred -------EEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 5566666554432211 2247899999999999888999999999999999999999999876543333222
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.......+ ......++..+.+||.+||..||++|
T Consensus 214 ~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05605 214 ERRVKEDQ----------------------------------------------EEYSEKFSEAARSICRQLLTKDPGFR 247 (285)
T ss_pred HHHhhhcc----------------------------------------------cccCcccCHHHHHHHHHHccCCHHHh
Confidence 21110000 01112356788999999999999999
Q ss_pred C-----CHHHHHcCCCCCCCC
Q 015532 378 L-----KAREALRHPFFTRDV 393 (405)
Q Consensus 378 p-----ta~elL~hp~f~~~~ 393 (405)
| +++++++||||....
T Consensus 248 ~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 248 LGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred cCCCCCCHHHHhcCcCccCCC
Confidence 9 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.45 Aligned_cols=219 Identities=26% Similarity=0.380 Sum_probs=169.8
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||+||+|++..+++.||||+++... ...+....|..++..+ .|+++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997532 2234556688888764 777763211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~-------------------------- 134 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH-------------------------- 134 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--------------------------
Confidence 135788899999999999999999999999999999999976654
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 135 -~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 135 -IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred -EEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 5566666554321 112335789999999999998999999999999999999999999988766554443321100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH-
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR- 381 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~- 381 (405)
. .....+.++.+||.+||+.||++|+++.
T Consensus 214 ~--------------------------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 243 (316)
T cd05619 214 C--------------------------------------------------YPRWLTREAKDILVKLFVREPERRLGVKG 243 (316)
T ss_pred C--------------------------------------------------CCccCCHHHHHHHHHHhccCHhhcCCChH
Confidence 0 0112356789999999999999999996
Q ss_pred HHHcCCCCCCCC
Q 015532 382 EALRHPFFTRDV 393 (405)
Q Consensus 382 elL~hp~f~~~~ 393 (405)
++++||||+...
T Consensus 244 ~l~~h~~~~~~~ 255 (316)
T cd05619 244 DIRQHPFFREID 255 (316)
T ss_pred HHHcCcccCCCC
Confidence 899999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.07 Aligned_cols=218 Identities=25% Similarity=0.354 Sum_probs=171.3
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||+||+|++..+++.||||++++.. ...+....|+.++..+ .|+++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997532 2334566788898888 466663211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-------------------------- 134 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-------------------------- 134 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--------------------------
Confidence 235789999999999999999999999999999999999976654
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++.... ......+||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 135 -~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 135 -IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred -EEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 5556666553311 112235789999999999999999999999999999999999999987765554433321100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH--
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-- 380 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-- 380 (405)
......+..+.+||.+||+.||++|||+
T Consensus 214 --------------------------------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~ 243 (318)
T cd05570 214 --------------------------------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLP 243 (318)
T ss_pred --------------------------------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCC
Confidence 0112346688999999999999999999
Q ss_pred ---HHHHcCCCCCCC
Q 015532 381 ---REALRHPFFTRD 392 (405)
Q Consensus 381 ---~elL~hp~f~~~ 392 (405)
.++++||||+..
T Consensus 244 ~~~~~ll~~~~~~~~ 258 (318)
T cd05570 244 TGEQDIKGHPFFREI 258 (318)
T ss_pred CCHHHHhcCCCcCCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.26 Aligned_cols=227 Identities=24% Similarity=0.260 Sum_probs=178.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCC-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT------------- 153 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~------------- 153 (405)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.++..+.|+++...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 357899999999999999999999999999999998643 2334556789999998888765310
Q ss_pred ----------------c----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 154 ----------------R----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 154 ----------------~----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~-------- 181 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-------- 181 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--------
Confidence 0 124678889999999999999999999999999999999987664
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCC
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~ 282 (405)
+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 182 -------------------vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 182 -------------------VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred -------------------EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 55555655543221 123357999999999999989999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||.+.+..+.+..+... .. .......++++
T Consensus 243 ~Pf~~~~~~~~~~~~~~~--~~-----------------------------------------------~~~~~~~~~~l 273 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAG--RY-----------------------------------------------DPLPPSISPEM 273 (496)
T ss_pred CCCCCCCHHHHHHHHhcC--CC-----------------------------------------------CCCCCCCCHHH
Confidence 999877655544332210 00 00113456789
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
.+|+.+||+.||++|||+.++++|||++..
T Consensus 274 ~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 274 QEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 999999999999999999999999998753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.43 Aligned_cols=262 Identities=27% Similarity=0.510 Sum_probs=197.7
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.+++++.|+++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 45688999999999999999999999999999999986432 2245577899999999999874321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---------------- 157 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---------------- 157 (345)
T ss_pred cccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC----------------
Confidence 02467889999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
.++|+|||++...........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+....
T Consensus 158 -----------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 158 -----------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred -----------CEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4566666666554444344578899999999877 4688999999999999999999999998887777
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhh-hhhcccCchHHHHHHHHHcccc
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL-IMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
+..+.+..+..+..+...........+. .. ....+.. ........++.+++||.+||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 286 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYI-----------------QS---LTQMPKMNFANVFIGANPLAVDLLEKMLVL 286 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHH-----------------HH---hcccCCcchhhhcCCCCHHHHHHHHHHcCC
Confidence 7777777777666554332211110000 00 0000000 0011123467899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCCCCc
Q 015532 373 DPAERLKAREALRHPFFTRDVRRPT 397 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~~~~~ 397 (405)
||++|+|+.++++||||++......
T Consensus 287 dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 287 DSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred ChhhcCCHHHHhcChhhhhcCCCCc
Confidence 9999999999999999997655433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=315.92 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=184.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|++.+.||+|+||+||+|++..+++.||||+++... .....+..|+.++..+.|+++....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35899999999999999999999999999999997532 2334567799999999998773211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc--c
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY--F 218 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~--~ 218 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||++......... .
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 235788999999999999999999999999999999999999999999999987643221100 0
Q ss_pred cCCCCCCCceeccCCCCcc------------ccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTF------------EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.... .....++.+... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 161 RNLT---HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccc---cCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0000 000011111000 0001123579999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.+.......+..... ...++. ....+.++++||
T Consensus 238 ~~~~~~~~~~i~~~~~----------------------~~~~p~------------------------~~~~s~~~~~li 271 (360)
T cd05627 238 SETPQETYRKVMNWKE----------------------TLVFPP------------------------EVPISEKAKDLI 271 (360)
T ss_pred CCCHHHHHHHHHcCCC----------------------ceecCC------------------------CCCCCHHHHHHH
Confidence 8776555443322100 000110 012467889999
Q ss_pred HHccccCCCCCC---CHHHHHcCCCCCCC
Q 015532 367 QGLLRYDPAERL---KAREALRHPFFTRD 392 (405)
Q Consensus 367 ~~~L~~dP~~Rp---ta~elL~hp~f~~~ 392 (405)
.+|+. ||++|+ +++|+++||||++.
T Consensus 272 ~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 272 LRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 99874 999998 58999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.34 Aligned_cols=262 Identities=30% Similarity=0.566 Sum_probs=201.5
Q ss_pred ceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-hcCCCCC-------
Q 015532 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGT------- 153 (405)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~-~~~~~~~------- 153 (405)
+.+..| -.+.|++.+++|+|-|+.|+.|....+++.++||+++...+ ....+|+.||+.|. ++||+..
T Consensus 30 ~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 30 LVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 444555 34789999999999999999999999999999999976443 44778999999998 6676321
Q ss_pred -------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 154 -------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 154 -------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
++..++...++.++.|++.||+|||++||+|||+||.|++|+.
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh------------------ 167 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH------------------ 167 (338)
T ss_pred cccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech------------------
Confidence 2567788899999999999999999999999999999999975
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCccc--eecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCC-CCCCh
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF-QTHEN 290 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf-~~~~~ 290 (405)
....++|+|+|+|.+......+ .+.+..|--||++..- .|+..-|+|||||++..|+..+-|| .|.++
T Consensus 168 --------~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 168 --------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred --------hhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 3456899999999988776544 5678899999999875 4889999999999999999977765 78899
Q ss_pred HHHHHHHHHHhCCCCh-HHHHH----hhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhh-hcccCchHHHHH
Q 015532 291 LEHLAMMERVLGPLPH-HMVIR----ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM-QHVDHSAGDLID 364 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 364 (405)
.+++..|.+++|.-.- .++.+ .+...........+..|. .+.. +...-.++++.|
T Consensus 240 ~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~-------------------~Fi~~~n~hl~~peaiD 300 (338)
T KOG0668|consen 240 YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS-------------------RFINSENQHLVSPEAID 300 (338)
T ss_pred HHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHH-------------------HhCCccccccCChHHHH
Confidence 9999999999986210 00000 011111111122222221 1111 111234689999
Q ss_pred HHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 365 LLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
||.++|.+|.++|+||.|++.||||..-
T Consensus 301 lldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 301 LLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHhhccccccchHHHhcCchHHHH
Confidence 9999999999999999999999999753
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=309.72 Aligned_cols=221 Identities=24% Similarity=0.397 Sum_probs=166.7
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..+++.||||++++.. .....+..|+.++..+ .|+++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997532 2234567899999988 577763211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~-------------------------- 134 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH-------------------------- 134 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--------------------------
Confidence 235789999999999999999999999999999999999976654
Q ss_pred CceeccCCCCccc---cCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Q 015532 226 AIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-----HLAMM 297 (405)
Q Consensus 226 ~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----~~~~i 297 (405)
++|+|||++... .......+||..|+|||++.+..++.++|||||||++|+|++|..||......+ ....+
T Consensus 135 -~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 135 -IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred -EEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 555556555421 112233579999999999999899999999999999999999999996321100 00000
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+ .+. ......+..++..+.+||.+||+.||++|
T Consensus 214 ~~----------------------------------------~~~------~~~~~~p~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 214 FQ----------------------------------------VIL------EKQIRIPRSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred HH----------------------------------------HHH------cCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 00 000 00001123456789999999999999999
Q ss_pred CC------HHHHHcCCCCCC
Q 015532 378 LK------AREALRHPFFTR 391 (405)
Q Consensus 378 pt------a~elL~hp~f~~ 391 (405)
+| ++++++||||..
T Consensus 248 ~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 97 799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=299.22 Aligned_cols=249 Identities=31% Similarity=0.491 Sum_probs=181.0
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCC----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGT---------------- 153 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~---------------- 153 (405)
+|++.+.||+|+||.||+|++..+|+.||+|.++... .....+.+|+.+++.+.|+++...
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999999999999986432 223456789999999999987321
Q ss_pred -----------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 154 -----------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 154 -----------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.++++||
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~df----------------- 143 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADF----------------- 143 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECcc-----------------
Confidence 0234788999999999999999999999999999999999987665555554
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALF-QTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i 297 (405)
|++...... .....++..|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..+.+..+
T Consensus 144 ----------g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 144 ----------GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred ----------chhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 444322211 11235688999999987754 789999999999999999988774 555556666667
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+.++..+............ + ..++... ......+.....++++.+||.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07839 214 FRLLGTPTEESWPGVSKLPD-Y------KPYPMYP--------------ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR 272 (284)
T ss_pred HHHhCCCChHHhHHhhhccc-c------cccCCCC--------------CcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence 66666655433221110000 0 0000000 0000011223467789999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||++++++||||
T Consensus 273 ~t~~~il~h~~f 284 (284)
T cd07839 273 ISAEEALQHPYF 284 (284)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=302.11 Aligned_cols=221 Identities=23% Similarity=0.340 Sum_probs=168.7
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCC----------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGT---------------------- 153 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~---------------------- 153 (405)
||+|+||+||+|.+..+++.||+|++..... ..+.+..|+.+++.+.|+++...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999864321 22456789999999998876321
Q ss_pred ---------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 154 ---------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 154 ---------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~------------------------- 135 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN------------------------- 135 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-------------------------
Confidence 0134788899999999999999999999999999999999976554
Q ss_pred CCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 136 --~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 136 --VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred --EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 556666655432221 123468999999999999999999999999999999999999997654321111111100
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC---
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL--- 378 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp--- 378 (405)
.. ........++..+.+|+.+||+.||++|+
T Consensus 214 ~~----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 214 LN----------------------------------------------DSVTYPDKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred cc----------------------------------------------cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 00 00011234577899999999999999999
Q ss_pred --CHHHHHcCCCCCCCC
Q 015532 379 --KAREALRHPFFTRDV 393 (405)
Q Consensus 379 --ta~elL~hp~f~~~~ 393 (405)
|++++++||||++..
T Consensus 248 ~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 248 DGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CCCHHHHhcChhhhcCC
Confidence 899999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=315.57 Aligned_cols=234 Identities=29% Similarity=0.443 Sum_probs=192.1
Q ss_pred cCCCeEE--EeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCC-----------
Q 015532 90 LTPRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT----------- 153 (405)
Q Consensus 90 ~~~~y~~--~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~----------- 153 (405)
+..-|+| .++||+|.||+||-|+++.+|+.||||+|.+. .+..+...+|+.||+.+.||.++..
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 4445776 47999999999999999999999999999653 3445778889999999999987421
Q ss_pred -----------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 154 -----------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 154 -----------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
-.+.+++...+.++.||+.||.|||.++|+|+||||+|||+.+.
T Consensus 640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~------------------- 700 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA------------------- 700 (888)
T ss_pred EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC-------------------
Confidence 13678999999999999999999999999999999999999763
Q ss_pred cccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
+.-.++||||||+|+.+.... .+++||+.|+|||++.+.+|+..-|+||.|||+|.-++|..||..+.+. -
T Consensus 701 -----~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--n 773 (888)
T KOG4236|consen 701 -----SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--N 773 (888)
T ss_pred -----CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--h
Confidence 244579999999999877653 4579999999999999999999999999999999999999999765443 2
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
.+|.....- +|. +-+.+++..++|||.++|++.=
T Consensus 774 dQIQNAaFM------------------------yPp----------------------~PW~eis~~AidlIn~LLqVkm 807 (888)
T KOG4236|consen 774 DQIQNAAFM------------------------YPP----------------------NPWSEISPEAIDLINNLLQVKM 807 (888)
T ss_pred HHhhccccc------------------------cCC----------------------CchhhcCHHHHHHHHHHHHHHH
Confidence 333322111 111 1224567899999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~ 395 (405)
++|+|.++.|.|||+++...+
T Consensus 808 ~kRysvdk~lsh~Wlq~yq~w 828 (888)
T KOG4236|consen 808 RKRYSVDKSLSHPWLQDYQTW 828 (888)
T ss_pred HHhcchHhhccchhhhcchHH
Confidence 999999999999999986543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.25 Aligned_cols=271 Identities=22% Similarity=0.317 Sum_probs=182.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.++||+|+||.||+|.+..++..||+|+++.. ....+.+.+|+++++.+.|+++....
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46899999999999999999999999999999998643 23346688999999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--------------------- 142 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--------------------- 142 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC---------------------
Confidence 12467788899999999999999975 7999999999999976654
Q ss_pred CCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+..
T Consensus 143 ------~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (333)
T cd06650 143 ------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216 (333)
T ss_pred ------EEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcC
Confidence 566666665433221 2234789999999999988899999999999999999999999987654333222211
Q ss_pred H-hCCCChHHHHHhhHhhHHhhhcCCcccC-CCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 300 V-LGPLPHHMVIRADRRAEKYFRRGARLDW-PDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 300 ~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
. .+..+........... ......+ +..... .......................+.++.+||.+||++||++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 290 (333)
T cd06650 217 PVEGDPAESETSPRPRPP-----GRPLSSYGPDSRPP-MAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAER 290 (333)
T ss_pred cccCCccccccCcccCCc-----cchhhhhccccccc-ccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccC
Confidence 1 1111000000000000 0000000 000000 000000000000000000112346789999999999999999
Q ss_pred CCHHHHHcCCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDVR 394 (405)
Q Consensus 378 pta~elL~hp~f~~~~~ 394 (405)
||++|+++||||+....
T Consensus 291 pt~~ell~h~~~~~~~~ 307 (333)
T cd06650 291 ADLKQLMVHAFIKRSEA 307 (333)
T ss_pred cCHHHHhhCHHHhcCcc
Confidence 99999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.10 Aligned_cols=258 Identities=31% Similarity=0.534 Sum_probs=194.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|.+.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 457899999999999999999999999999999998642 22334577899999999999874211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~------------------ 154 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC------------------ 154 (342)
T ss_pred ceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------------------
Confidence 12578889999999999999999999999999999999997655
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.++|+|||++...........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 155 ---------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~ 225 (342)
T cd07879 155 ---------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225 (342)
T ss_pred ---------CEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4566666666554433344577889999999876 458899999999999999999999999888777777
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccch-hhhhhcccCchHHHHHHHHHccccCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
.+....+..+..+...........+.... ...+ ..........+..+.+||.+||+.||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSL--------------------PKYPRKDFSTLFPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhc--------------------CCcccchHHHHhcCCCHHHHHHHHHHcCCCh
Confidence 77777776665554333211110000000 0000 00001112346688999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~ 394 (405)
++|||+++++.||||+....
T Consensus 286 ~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 286 DKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hhCcCHHHHhcCcchhhccc
Confidence 99999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=294.86 Aligned_cols=226 Identities=33% Similarity=0.570 Sum_probs=175.8
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhH---HHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~---~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
|++.+.||+|+||+||+|++..+++.||+|++........ ...+|+.+++.+.|+++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999976543332 234599999999998874211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++.++..++.||+.||.+||++||+|+||||+||+++.++.
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~------------------------ 136 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE------------------------ 136 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE------------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------------------
Confidence 245788999999999999999999999999999999999976554
Q ss_pred CCCceeccCCCCccc---cCCccceecCCCcchhHHHh-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+... ........++..|+|||++. +..++.++||||||+++|+|++|..||......+....+.+
T Consensus 137 ---~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~ 213 (260)
T PF00069_consen 137 ---VKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK 213 (260)
T ss_dssp ---EEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH
T ss_pred ---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 566666666431 12223357899999999998 77899999999999999999999999988754444444433
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
....... ............+.++|.+||+.||++|||
T Consensus 214 ~~~~~~~-------------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~ 250 (260)
T PF00069_consen 214 ILKRPLP-------------------------------------------SSSQQSREKSEELRDLIKKMLSKDPEQRPS 250 (260)
T ss_dssp HHHTHHH-------------------------------------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTT
T ss_pred ccccccc-------------------------------------------ccccccchhHHHHHHHHHHHccCChhHCcC
Confidence 2211000 000001112368999999999999999999
Q ss_pred HHHHHcCCCC
Q 015532 380 AREALRHPFF 389 (405)
Q Consensus 380 a~elL~hp~f 389 (405)
+.++++||||
T Consensus 251 ~~~l~~~~~~ 260 (260)
T PF00069_consen 251 AEELLKHPWF 260 (260)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.32 Aligned_cols=222 Identities=23% Similarity=0.384 Sum_probs=166.1
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..+++.||+|++++.. .....+..|+.++..+ .|+++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997532 2234566788888877 677764321
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~-------------------------- 134 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-------------------------- 134 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--------------------------
Confidence 235788899999999999999999999999999999999976654
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-----HLAMM 297 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----~~~~i 297 (405)
++|+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..||....... ....+
T Consensus 135 -~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 135 -IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred -EEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 5566666554321 11233579999999999999899999999999999999999999995321100 00000
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+. +. ......+...+..+.+||.+||+.||++|
T Consensus 214 ~~~----------------------------------------i~------~~~~~~p~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 214 FQV----------------------------------------IL------EKQIRIPRSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred HHH----------------------------------------Hh------cCCCCCCCCCCHHHHHHHHHHhcCCHHHc
Confidence 000 00 00001123456788999999999999999
Q ss_pred CC------HHHHHcCCCCCCC
Q 015532 378 LK------AREALRHPFFTRD 392 (405)
Q Consensus 378 pt------a~elL~hp~f~~~ 392 (405)
+| +.++++||||+..
T Consensus 248 ~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 248 LGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCCC
Confidence 98 5899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=308.97 Aligned_cols=218 Identities=28% Similarity=0.413 Sum_probs=168.4
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHH-HHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~-il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||+||+|++..+++.||||++.... .....+..|.. +++.+.|+++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999996432 12233445544 56778898874321
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~-------------------------- 134 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH-------------------------- 134 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--------------------------
Confidence 135678899999999999999999999999999999999976654
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 135 -~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 135 -VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred -EEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 5556666554321 112235799999999999998999999999999999999999999988765554443322100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH--
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-- 380 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-- 380 (405)
......+..+.+||.+||+.||++|+++
T Consensus 214 --------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 214 --------------------------------------------------RLKPNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred --------------------------------------------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 0112346689999999999999999987
Q ss_pred --HHHHcCCCCCCC
Q 015532 381 --REALRHPFFTRD 392 (405)
Q Consensus 381 --~elL~hp~f~~~ 392 (405)
.++++||||...
T Consensus 244 ~~~~il~~~~~~~~ 257 (323)
T cd05575 244 DFLEIKNHVFFSSI 257 (323)
T ss_pred CHHHHHcCCCcCCC
Confidence 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=289.12 Aligned_cols=269 Identities=26% Similarity=0.467 Sum_probs=196.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc---hhhhhHHHHHHHHHHHHHhhcCCCC---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGG--------------- 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~il~~l~~~~~~~--------------- 152 (405)
.+.|+-..+||+|.||.||+|+.+.+++.||+|++-- ........++|+.+|+.|.|+++..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4568888999999999999999999999999997632 3456678899999999999998621
Q ss_pred --------------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 153 --------------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 153 --------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
.....|+..++++++.+++.||.|+|++.|+|||+|++|+||+.+|.+|++|||++..++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 112457889999999999999999999999999999999999877755555444432211
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
.... ......+..+-|.+|++||.+.|. .|+++.|||..|||+.||+++.+.|.+.++.
T Consensus 176 ~~~n--------------------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 176 TSKN--------------------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred cccc--------------------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 1100 000112234679999999999986 5999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.++..|..++|....+.+...+....... ....+.+. ...+. ..+....+. ..+++.||+.+||.
T Consensus 236 qql~~Is~LcGs~tkevWP~~d~lpL~~s--ie~ePl~~-----~~~rk------v~n~~kp~~--kd~~a~dLle~ll~ 300 (376)
T KOG0669|consen 236 QQLHLISQLCGSITKEVWPNVDNLPLYQS--IELEPLPK-----GQKRK------VKNRLKPYV--KDDEALDLLEKLLK 300 (376)
T ss_pred HHHHHHHHHhccCCcccCCCcccchHHHh--ccCCCCCc-----chhhh------hhhhccccc--CChhHHHHHHHHhc
Confidence 99999999999877655433221111000 00000111 00010 111111111 14578899999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
+||.+|++++++|+|.||..+..
T Consensus 301 ~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 301 LDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred cCcccCcchHhhhchhhhhcCCc
Confidence 99999999999999999988643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.07 Aligned_cols=249 Identities=30% Similarity=0.513 Sum_probs=183.2
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4899999999999999999999999999999986432 2335677899999999998873211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg-------------- 146 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFG-------------- 146 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECccc--------------
Confidence 1357889999999999999999999999999999999999877655555555
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
++...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....
T Consensus 147 -------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 147 -------------LARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred -------------ceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 43322111 1123568889999998764 478999999999999999999999998887777766
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+..+......+..... ...+... ..... ..........+++++.+||.+||+.||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~-~~~~~~~-------------------~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 272 (285)
T cd07861 214 IFRILGTPTEDVWPGVTS-LPDYKNT-------------------FPKWK-KGSLRSAVKNLDEDGLDLLEKMLIYDPAK 272 (285)
T ss_pred HHHHhCCCChhhhhcchh-hHHHHhh-------------------ccccC-cchhHHhcCCCCHHHHHHHHHHhcCChhh
Confidence 666666544333211110 0011000 00000 00011122346788999999999999999
Q ss_pred CCCHHHHHcCCCC
Q 015532 377 RLKAREALRHPFF 389 (405)
Q Consensus 377 Rpta~elL~hp~f 389 (405)
|||+.++++||||
T Consensus 273 Rpt~~~ll~~~~~ 285 (285)
T cd07861 273 RISAKKALNHPYF 285 (285)
T ss_pred CCCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=303.59 Aligned_cols=257 Identities=29% Similarity=0.523 Sum_probs=196.9
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999999999999999998542 22345677899999999999874211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~---------------- 155 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC---------------- 155 (343)
T ss_pred cceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----------------
Confidence 13578889999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
.++|+|||.+...........+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+....
T Consensus 156 -----------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 224 (343)
T cd07880 156 -----------ELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224 (343)
T ss_pred -----------CEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4566666666554444444567889999999876 3588999999999999999999999998887777
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhH-HhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAE-KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
...+....+..|..+......... .+....... ............++.+.++|.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~l~~ 284 (343)
T cd07880 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF--------------------RKKDFRSLLPNANPLAVNVLEKMLVL 284 (343)
T ss_pred HHHHHHhcCCCCHHHHHhhcchhHHHHHHhcccc--------------------CcchHHHhccCCChHHHHHHHHHcCC
Confidence 777777777777665443321111 110000000 00011122345677899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~ 392 (405)
||++|||+.++++||||+..
T Consensus 285 dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 285 DAESRITAAEALAHPYFEEF 304 (343)
T ss_pred ChhhCCCHHHHhcCccHhhh
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=311.46 Aligned_cols=225 Identities=26% Similarity=0.389 Sum_probs=187.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
..|.-++.||.|+||.||-|++..+.+.||||.+.... ..-.+++.|+.+|+++.|||.+...
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45788899999999999999999999999999996432 2235678899999999999986543
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+.+.++..|+.+.+.||.|||+++.||||||..|||++..|
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g---------------------- 163 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG---------------------- 163 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC----------------------
Confidence 24567788889999999999999999999999999999987655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.|||+|||+|..... ..+++|||+|||||++.. +.|+-++|||||||+..||...++|+-..+....+..|
T Consensus 164 -----~VKLaDFGSAsi~~P-AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI 237 (948)
T KOG0577|consen 164 -----LVKLADFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 237 (948)
T ss_pred -----eeeeccccchhhcCc-hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence 578888888766543 345799999999999974 46999999999999999999999999888887777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+...|. + ....++..|++|+..||+.-|++|
T Consensus 238 AQNesPt---------------------------------------------L---qs~eWS~~F~~Fvd~CLqKipqeR 269 (948)
T KOG0577|consen 238 AQNESPT---------------------------------------------L---QSNEWSDYFRNFVDSCLQKIPQER 269 (948)
T ss_pred HhcCCCC---------------------------------------------C---CCchhHHHHHHHHHHHHhhCcccC
Confidence 6532211 0 013457799999999999999999
Q ss_pred CCHHHHHcCCCCCCC
Q 015532 378 LKAREALRHPFFTRD 392 (405)
Q Consensus 378 pta~elL~hp~f~~~ 392 (405)
||.+++|.|+|+...
T Consensus 270 ptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 270 PTSEELLKHRFVLRE 284 (948)
T ss_pred CcHHHHhhcchhccC
Confidence 999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=310.84 Aligned_cols=231 Identities=23% Similarity=0.387 Sum_probs=177.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..++|++.+.||+|+||.||+|+++.+++.||+|++.... .....+..|+.+++.+.|+++....
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3478999999999999999999999999999999986422 2234466899999999999874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 121 v~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~-------------------- 180 (371)
T cd05622 121 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-------------------- 180 (371)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--------------------
Confidence 124678889999999999999999999999999999999976554
Q ss_pred CCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..
T Consensus 181 -------ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 253 (371)
T cd05622 181 -------LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (371)
T ss_pred -------EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence 566666665433221 12357999999999997643 789999999999999999999999887765
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+...... ..++ ....++..+.+||.+||+
T Consensus 254 ~~~~~i~~~~~~----------------------~~~~------------------------~~~~~s~~~~~li~~~L~ 287 (371)
T cd05622 254 GTYSKIMNHKNS----------------------LTFP------------------------DDNDISKEAKNLICAFLT 287 (371)
T ss_pred HHHHHHHcCCCc----------------------ccCC------------------------CcCCCCHHHHHHHHHHcC
Confidence 544443321100 0111 112457789999999998
Q ss_pred cCCCC--CCCHHHHHcCCCCCCCC
Q 015532 372 YDPAE--RLKAREALRHPFFTRDV 393 (405)
Q Consensus 372 ~dP~~--Rpta~elL~hp~f~~~~ 393 (405)
.++.+ |++++|+++|+||++..
T Consensus 288 ~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 288 DREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ChhhhcCCCCHHHHhcCcccCCCC
Confidence 44433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=301.47 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=187.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---hhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+|+.+++++.|+++....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3579999999999999999999999999999999864321 223456799999999998873211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~------------------ 147 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCL------------------ 147 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE------------------
Confidence 1346788999999999999999999999999999999999876654
Q ss_pred cCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
+|+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+
T Consensus 148 ---------kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~ 218 (309)
T cd07845 148 ---------KIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218 (309)
T ss_pred ---------EECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 55555544432211 112345778999999876 45789999999999999999999999998888888
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+....+..+..++........ ......+... .. .........++.+.+||.+||++||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~~li~~ml~~dp 278 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPL-----VGKFTLPKQP--------------YN-NLKHKFPWLSEAGLRLLNFLLMYDP 278 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccc-----cccccccCCC--------------CC-chHHhccccCHHHHHHHHHHhcCCh
Confidence 88888777655443221110000 0000000000 00 0001112346788999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRD 392 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~ 392 (405)
++|||++|+++||||++.
T Consensus 279 ~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 279 KKRATAEEALESSYFKEK 296 (309)
T ss_pred hhCcCHHHHhcChhhccC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=310.15 Aligned_cols=223 Identities=31% Similarity=0.537 Sum_probs=192.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|.+++.+|+|+||.+++++++..+..|++|.++.. ...+..+..|+.+++++.||+|+...
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5799999999999999999999999999999999643 34455788999999999999984322
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...|+++.+..++.||+.||.|||+++|+|||||+.||+++.++
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-------------------- 143 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-------------------- 143 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC--------------------
Confidence 24689999999999999999999999999999999999986544
Q ss_pred cCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.|+|.|||+|+...... .+++||+.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+......
T Consensus 144 -------~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ 216 (426)
T KOG0589|consen 144 -------KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL 216 (426)
T ss_pred -------ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH
Confidence 56888888887665543 45799999999999999999999999999999999999999999988888887
Q ss_pred HHHHHh-CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 296 MMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 296 ~i~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
.|.+.. .++| ..++.+++.+|..||..+|
T Consensus 217 ki~~~~~~Plp--------------------------------------------------~~ys~el~~lv~~~l~~~P 246 (426)
T KOG0589|consen 217 KINRGLYSPLP--------------------------------------------------SMYSSELRSLVKSMLRKNP 246 (426)
T ss_pred HHhhccCCCCC--------------------------------------------------ccccHHHHHHHHHHhhcCC
Confidence 776654 2332 3457789999999999999
Q ss_pred CCCCCHHHHHcCCCCCC
Q 015532 375 AERLKAREALRHPFFTR 391 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~ 391 (405)
+.||+|.++|.+|.+..
T Consensus 247 ~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 247 EHRPSALELLRRPHLLR 263 (426)
T ss_pred ccCCCHHHHhhChhhhh
Confidence 99999999999988873
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=300.25 Aligned_cols=227 Identities=27% Similarity=0.405 Sum_probs=173.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|++.+.||+|+||.||+|.+..+++.||||.+.... .....+..|+.+++.++|+++....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3788899999999999999999999999999986432 1234466899999999998773211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~-------------------- 140 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH-------------------- 140 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--------------------
Confidence 124778889999999999999999999999999999999976554
Q ss_pred CCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++....... ....|+..|+|||++.+..++.++||||+||++|+|++|..||............
T Consensus 141 -------~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~ 213 (285)
T cd05630 141 -------IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213 (285)
T ss_pred -------EEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 5666666554332211 1246899999999999888999999999999999999999999765432111111
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....... ........++.+.+|+.+||+.||++|
T Consensus 214 ~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (285)
T cd05630 214 ERLVKEV----------------------------------------------QEEYSEKFSPDARSLCKMLLCKDPKER 247 (285)
T ss_pred Hhhhhhh----------------------------------------------hhhcCccCCHHHHHHHHHHhhcCHHHc
Confidence 1100000 001123456788999999999999999
Q ss_pred CC-----HHHHHcCCCCCCC
Q 015532 378 LK-----AREALRHPFFTRD 392 (405)
Q Consensus 378 pt-----a~elL~hp~f~~~ 392 (405)
+| ++|+++||||++-
T Consensus 248 ~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 248 LGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred cCCCCCchHHHHcChhhhcc
Confidence 99 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.26 Aligned_cols=218 Identities=29% Similarity=0.425 Sum_probs=172.6
Q ss_pred eeeecccceeEEEEEec---CCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 98 SKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.||+|+||.||++++. .+++.||+|+++... ........|+++++++.|+++....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999999863 578999999997533 2334566799999999999884321
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~------------------------- 136 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH------------------------- 136 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc-------------------------
Confidence 134788999999999999999999999999999999999976554
Q ss_pred CCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.+..
T Consensus 137 --~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~ 214 (318)
T cd05582 137 --IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214 (318)
T ss_pred --EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 566666665433222 123578999999999998889999999999999999999999998877655554443211
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC--
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK-- 379 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt-- 379 (405)
.. .+...++.+.+||.+||+.||++|||
T Consensus 215 ~~--------------------------------------------------~p~~~~~~~~~li~~~l~~~P~~R~~a~ 244 (318)
T cd05582 215 LG--------------------------------------------------MPQFLSPEAQSLLRALFKRNPANRLGAG 244 (318)
T ss_pred CC--------------------------------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 11 11234668899999999999999999
Q ss_pred ---HHHHHcCCCCCCC
Q 015532 380 ---AREALRHPFFTRD 392 (405)
Q Consensus 380 ---a~elL~hp~f~~~ 392 (405)
++++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 245 PDGVEEIKRHPFFSTI 260 (318)
T ss_pred CCCHHHHhCCCCcCCC
Confidence 7889999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=293.54 Aligned_cols=229 Identities=28% Similarity=0.439 Sum_probs=187.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCC-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDI----------------- 150 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~----------------- 150 (405)
+.|..+++||+|.||+|.+|+.+.+++.||||++++.-. ....-+.|-.+|+...||.+
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 568999999999999999999999999999999976432 22334568889999999865
Q ss_pred ----CCCc------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 151 ----GGTR------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 151 ----~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
++.+ ...|+++.++.+..+|+.||.|||+++||.||||.+|+|++.+|++||+|||+++.....
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~------ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY------ 321 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc------
Confidence 1222 356889999999999999999999999999999999999988887766666655433221
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.....++||||.|+|||++....|+.++|+|.+||++|||++|+.||...+....+..|...
T Consensus 322 ------------------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e 383 (516)
T KOG0690|consen 322 ------------------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME 383 (516)
T ss_pred ------------------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh
Confidence 12334579999999999999999999999999999999999999999988877776665432
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC--
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-- 378 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-- 378 (405)
.-.+ +..++++++.||..+|..||.+|.
T Consensus 384 d~kF--------------------------------------------------Pr~ls~eAktLLsGLL~kdP~kRLGg 413 (516)
T KOG0690|consen 384 DLKF--------------------------------------------------PRTLSPEAKTLLSGLLKKDPKKRLGG 413 (516)
T ss_pred hccC--------------------------------------------------CccCCHHHHHHHHHHhhcChHhhcCC
Confidence 2222 234578999999999999999998
Q ss_pred ---CHHHHHcCCCCCCCCC
Q 015532 379 ---KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ---ta~elL~hp~f~~~~~ 394 (405)
.|.||.+|+||..-.+
T Consensus 414 GpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 414 GPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred CchhHHHHHhhhhhccCCH
Confidence 5899999999987654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=303.39 Aligned_cols=229 Identities=26% Similarity=0.403 Sum_probs=173.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||||++++.. ...+.+..|+.++..+.|+++....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999996532 2234567899999999998873211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--------------------- 139 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--------------------- 139 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC---------------------
Confidence 23578889999999999999999999999999999999997655
Q ss_pred CCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.++|+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 140 ------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 140 ------HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ------CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 45666666654332211 12469999999999973 3578899999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+....+..... ....+ ......+..+++||.+||
T Consensus 214 ~~~~~~i~~~~~----------------------~~~~~-----------------------~~~~~~~~~~~~li~~ll 248 (331)
T cd05597 214 VETYGKIMNHKE----------------------HFQFP-----------------------PDVTDVSEEAKDLIRRLI 248 (331)
T ss_pred HHHHHHHHcCCC----------------------cccCC-----------------------CccCCCCHHHHHHHHHHc
Confidence 554443321100 00000 011235678999999999
Q ss_pred ccCCCC--CCCHHHHHcCCCCCCC
Q 015532 371 RYDPAE--RLKAREALRHPFFTRD 392 (405)
Q Consensus 371 ~~dP~~--Rpta~elL~hp~f~~~ 392 (405)
..++++ |++++++++||||.+.
T Consensus 249 ~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 249 CSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred cCcccccCCCCHHHHhcCCCCCCC
Confidence 765544 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.50 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=188.9
Q ss_pred EeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 84 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
+..++.+.++|+++++||+|+||+||+|++..+++.||+|++... ......+..|+.+|+.|.|++++...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 455677788999999999999999999999999999999998642 23456678899999999999874311
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHC-------CcEecCCCCCcEEEeccccc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHEL-------RLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~-------givHrDlkp~NIli~~~~~~ 200 (405)
...+++..++.|+.||+.||.|||+. +||||||||+||||+....
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~- 163 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR- 163 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc-
Confidence 13478889999999999999999984 4999999999999975321
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCC--CCCCchhHHHHHHHHH
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILV 276 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ 276 (405)
.+.+... .....+....+||+|||++....... ....||+.|+|||++.+. .++.++||||||||+|
T Consensus 164 ~lg~i~~---------~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 164 HIGKITA---------QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred ccccccc---------cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 1111000 00112334568999999987653322 235799999999999753 4889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc
Q 015532 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356 (405)
Q Consensus 277 ~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (405)
+|++|..||........+.........+ ...
T Consensus 235 ELLTGk~PF~~~~~~~qli~~lk~~p~l-------------------------------------------------pi~ 265 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQLISELKRGPDL-------------------------------------------------PIK 265 (1021)
T ss_pred HHHHCCCCCCcCCcHHHHHHHHhcCCCC-------------------------------------------------CcC
Confidence 9999999998665544332221110000 011
Q ss_pred CchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 357 ~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
..+.++.+||..||..+|++|||+.|+|.|+||+..
T Consensus 266 ~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 266 GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 235689999999999999999999999999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.50 Aligned_cols=228 Identities=25% Similarity=0.354 Sum_probs=177.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.|+..+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+++++.+.|+++....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3788899999999999999999999999999986532 2234467899999999998873211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--------------------- 139 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--------------------- 139 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC---------------------
Confidence 12478889999999999999999999999999999999997654
Q ss_pred CCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.++|+|||++...... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+
T Consensus 140 ------~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 140 ------HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred ------CEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4566666665433221 12346899999999999888999999999999999999999999876654433333
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
........ .......+..+.+|+.+||+.||++|
T Consensus 214 ~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 214 DRRVLETE----------------------------------------------EVYSAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred HHhhhccc----------------------------------------------cccCccCCHHHHHHHHHHccCCHhHc
Confidence 22111000 01112346678999999999999999
Q ss_pred CC-----HHHHHcCCCCCCCC
Q 015532 378 LK-----AREALRHPFFTRDV 393 (405)
Q Consensus 378 pt-----a~elL~hp~f~~~~ 393 (405)
|| +.++++|+||+.-.
T Consensus 248 ~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 248 LGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred CCCcccChHHHHcChhhhcCC
Confidence 99 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.88 Aligned_cols=255 Identities=29% Similarity=0.506 Sum_probs=191.5
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+..+|++.+.||+|+||+||+|++..+++.||||.++.. .........|+.+++.+.|+++....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 456899999999999999999999999999999998642 22334567899999999999874211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~---------------- 146 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---------------- 146 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----------------
Confidence 145788999999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 147 -----------~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 147 -----------LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred -----------EEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence 455555555433221 122467889999999875 46889999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCChHHHHHh-hHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh-hhhhcccCchHHHHHHHHHc
Q 015532 292 EHLAMMERVLGPLPHHMVIRA-DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~ 369 (405)
.....+....+..+....... ......+..... .... .........+..+.+||.+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~ 274 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLP---------------------YTPRQSFARLFPHANPLAIDLLEKM 274 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcC---------------------cccccCHHHHcccCCHHHHHHHHHH
Confidence 778888888877665432111 001111110000 0000 00111234677899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
|+.||++|||++|+++||||..-
T Consensus 275 l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 275 LVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCChhhccCHHHHHcCcchhhh
Confidence 99999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=305.24 Aligned_cols=218 Identities=28% Similarity=0.407 Sum_probs=167.9
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHH-HHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEID-VLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~-il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||+||+|++..+++.||+|++..... .......|.. +++.+.|+++....
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999965321 1223334443 56778898874321
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~-------------------------- 134 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-------------------------- 134 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--------------------------
Confidence 134678888999999999999999999999999999999976554
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 135 -~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~- 212 (325)
T cd05602 135 -IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP- 212 (325)
T ss_pred -EEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-
Confidence 5666666654321 11233579999999999999899999999999999999999999998876655444332210
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH-
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR- 381 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~- 381 (405)
.......+..+.++|.+||+.||.+|+++.
T Consensus 213 -------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 213 -------------------------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred -------------------------------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 011124567899999999999999999876
Q ss_pred ---HHHcCCCCCCC
Q 015532 382 ---EALRHPFFTRD 392 (405)
Q Consensus 382 ---elL~hp~f~~~ 392 (405)
++++|+||...
T Consensus 244 ~~~~i~~~~~~~~~ 257 (325)
T cd05602 244 DFMEIKNHIFFSPI 257 (325)
T ss_pred CHHHHhcCcccCCC
Confidence 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.40 Aligned_cols=227 Identities=25% Similarity=0.431 Sum_probs=185.7
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
-|.++++||+|+||.||+|.++.+|+.+|||.+.. +...++.+.||.|++++..+.++...
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 48889999999999999999999999999999864 34456688999999999888764322
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++.++..+++..+.||+|||...-||||||..|||++.+|.
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~------------------------- 167 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI------------------------- 167 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch-------------------------
Confidence 356889999999999999999999999999999999999987765
Q ss_pred CCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
.||+|||.|....+ ...++.||+.|||||++..-+|+.++||||||++..||..|++||....+...+.+|
T Consensus 168 --AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---- 241 (502)
T KOG0574|consen 168 --AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---- 241 (502)
T ss_pred --hhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----
Confidence 45566665544332 335578999999999999999999999999999999999999999876554333222
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
...+......++.+++++-||+++||..+|++|.||.
T Consensus 242 -------------------------------------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~ 278 (502)
T KOG0574|consen 242 -------------------------------------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTAL 278 (502)
T ss_pred -------------------------------------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHH
Confidence 1112222233445688999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 015532 382 EALRHPFFTRDVR 394 (405)
Q Consensus 382 elL~hp~f~~~~~ 394 (405)
++++|||++....
T Consensus 279 ~L~~H~FiknA~g 291 (502)
T KOG0574|consen 279 RLCEHTFIKNAPG 291 (502)
T ss_pred HHhhhhhhcCCCc
Confidence 9999999998654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=300.88 Aligned_cols=266 Identities=27% Similarity=0.491 Sum_probs=195.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+.|+++....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999999999999999986432 2345567899999999999874311
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 162 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT- 162 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc-
Confidence 23478899999999999999999999999999999999998776555555554321110000
Q ss_pred ccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
..........|+..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....+..
T Consensus 163 -------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 163 -------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred -------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence 00000112468889999999876 4588999999999999999999999999888888888
Q ss_pred HHHHhCCCChHHHHHhhH-hhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 297 MERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
+....|.+|......... ....+.... +. .............+..+.++|.+||+.||+
T Consensus 224 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~-----~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 283 (334)
T cd07855 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNL-----PR---------------KQPVPWSKIFPKASPEALDLLSQMLQFDPE 283 (334)
T ss_pred HHHHhCCChhHhhhhhchhhHHHHHhhc-----cc---------------CCCCCHHHHcccCCHHHHHHHHHHccCChh
Confidence 888888887766433211 111111100 00 000000111234577899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~~~ 396 (405)
+|||++++++||||.+.....
T Consensus 284 ~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 284 ERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hCcCHHHHHhChhhhhccCCc
Confidence 999999999999998765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=306.85 Aligned_cols=218 Identities=27% Similarity=0.389 Sum_probs=168.3
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHH-HHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~-il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||+||+|++..+++.||||++.... .....+..|.. +++.+.|+++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999996532 22234445554 46778898874321
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~-------------------------- 134 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH-------------------------- 134 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--------------------------
Confidence 235788999999999999999999999999999999999977664
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 135 -~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~- 212 (325)
T cd05604 135 -VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP- 212 (325)
T ss_pred -EEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-
Confidence 5556666554321 11233579999999999999899999999999999999999999998876555443332210
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH--
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-- 380 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-- 380 (405)
.......+..+.++|.+||+.||++||++
T Consensus 213 -------------------------------------------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 -------------------------------------------------LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -------------------------------------------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 00112346688899999999999999976
Q ss_pred --HHHHcCCCCCCC
Q 015532 381 --REALRHPFFTRD 392 (405)
Q Consensus 381 --~elL~hp~f~~~ 392 (405)
.++++||||+..
T Consensus 244 ~~~~i~~h~~f~~~ 257 (325)
T cd05604 244 DFLEIQEHPFFESL 257 (325)
T ss_pred CHHHHhcCCCcCCC
Confidence 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=307.52 Aligned_cols=217 Identities=28% Similarity=0.451 Sum_probs=164.9
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHH---hhcCCCCCc------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRL---ARHDIGGTR------------------ 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l---~~~~~~~~~------------------ 154 (405)
||+|+||+||+|++..+++.||||++.+... .......|..++..+ .|+++....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999964322 122344577777766 466653211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~-------------------------- 134 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH-------------------------- 134 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--------------------------
Confidence 235788999999999999999999999999999999999976554
Q ss_pred CceeccCCCCccccC---CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 226 AIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
++|+|||++..... .....+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 135 -~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 135 -IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred -EEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 56666665543211 12235799999999999765 48899999999999999999999998876554443332110
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC---
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL--- 378 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp--- 378 (405)
. .++ ....++.+.+||.+||+.||++|+
T Consensus 214 ~------------------------~~~-------------------------~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 214 V------------------------RFP-------------------------KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred C------------------------CCC-------------------------CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 0 000 012466889999999999999998
Q ss_pred -CHHHHHcCCCCCCC
Q 015532 379 -KAREALRHPFFTRD 392 (405)
Q Consensus 379 -ta~elL~hp~f~~~ 392 (405)
+++++++||||...
T Consensus 245 ~~~~~ll~h~~~~~~ 259 (330)
T cd05586 245 RDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHHhcCccccCC
Confidence 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=300.55 Aligned_cols=258 Identities=29% Similarity=0.532 Sum_probs=195.5
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999999999999999998642 22335567899999999998762110
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~----------------- 155 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----------------- 155 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----------------
Confidence 12578889999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.++|+|||.+...........++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+....+.+
T Consensus 156 ----------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 225 (343)
T cd07851 156 ----------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225 (343)
T ss_pred ----------CEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 35666666665444333445678899999998763 6789999999999999999999999988888888
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccch-hhhhhcccCchHHHHHHHHHccccC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
..+....+.+++.+..+........+... ..... ..........+..+.+||.+||..|
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~ 285 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQS--------------------LPQMPKKDFKEVFSGANPLAIDLLEKMLVLD 285 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHh--------------------ccccCCCCHHHHhccCCHHHHHHHHHhCCCC
Confidence 88888777777665443321111000000 00000 0001111234778999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~ 394 (405)
|++|||+.++++||||++...
T Consensus 286 P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 286 PDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred hhhCCCHHHHhcCCCccccCC
Confidence 999999999999999987543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.74 Aligned_cols=227 Identities=25% Similarity=0.366 Sum_probs=175.2
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCC----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGT---------------- 153 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~---------------- 153 (405)
..+.+..||+|+-|+||+++.+.+|...|||.+++.. ...++.+..+.++..-. .+.|+..
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4567889999999999999999999999999997533 33455666666655543 2333221
Q ss_pred -----------ccccCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 154 -----------RYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 154 -----------~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
.++.++|..+-++...++.||.||. .+||+|||+||+|||++..|
T Consensus 173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G----------------------- 229 (391)
T KOG0983|consen 173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG----------------------- 229 (391)
T ss_pred HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-----------------------
Confidence 1466888888899999999999999 57999999999999997655
Q ss_pred CCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHE-NLEHLA 295 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~ 295 (405)
.+||||||++....+.. +...|.+.|||||.+.-. .|+.++||||||++++||+||+.||.+.+ +.+.+.
T Consensus 230 ----niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 230 ----NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred ----CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 56777777776544332 335799999999998643 59999999999999999999999999854 445555
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.. ..|+.+ ......|+++++|+..||++|+.
T Consensus 306 kvln---~ePP~L--------------------------------------------~~~~gFSp~F~~fv~~CL~kd~r 338 (391)
T KOG0983|consen 306 KVLN---EEPPLL--------------------------------------------PGHMGFSPDFQSFVKDCLTKDHR 338 (391)
T ss_pred HHHh---cCCCCC--------------------------------------------CcccCcCHHHHHHHHHHhhcCcc
Confidence 5443 222110 11123688999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDV 393 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~ 393 (405)
+||.-.++|+|||+....
T Consensus 339 ~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 339 KRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred cCcchHHHhcCcceeecc
Confidence 999999999999998653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.34 Aligned_cols=230 Identities=26% Similarity=0.395 Sum_probs=184.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCC--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGT-------------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~-------------- 153 (405)
+.|...++||+|+||.||-|+.+.||+-||.|.+.+. .+.....++|-.||++++.+.++..
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688899999999999999999999999999988542 2334557789999999988866211
Q ss_pred ---------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 154 ---------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 154 ---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
....|++..+..++.+|+.||++||+.+||.|||||+|||+++.|
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-------------------- 324 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-------------------- 324 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC--------------------
Confidence 124789999999999999999999999999999999999997766
Q ss_pred cCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+++|+|+|+|....... ...+||.+|||||++.+..|+...|+|||||++|||+.|+.||........-..
T Consensus 325 -------hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE 397 (591)
T KOG0986|consen 325 -------HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE 397 (591)
T ss_pred -------CeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH
Confidence 46677777776554433 335899999999999999999999999999999999999999976544332222
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+.. .+...++.+..|+++++|.+.+|+.||++
T Consensus 398 vdrr~----------------------------------------------~~~~~ey~~kFS~eakslc~~LL~Kdp~~ 431 (591)
T KOG0986|consen 398 VDRRT----------------------------------------------LEDPEEYSDKFSEEAKSLCEGLLTKDPEK 431 (591)
T ss_pred HHHHH----------------------------------------------hcchhhcccccCHHHHHHHHHHHccCHHH
Confidence 22211 11223344677899999999999999999
Q ss_pred CC-----CHHHHHcCCCCCCCCC
Q 015532 377 RL-----KAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rp-----ta~elL~hp~f~~~~~ 394 (405)
|. +++++.+||||+.-..
T Consensus 432 RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 432 RLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred hccCCCcCcchhhhCcccccCCH
Confidence 98 6889999999998544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.76 Aligned_cols=216 Identities=26% Similarity=0.351 Sum_probs=171.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcE-EEEEEecchhh---hhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~-vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..+.+.||+|+||+||+|.++ |+. ||||++..... ..+.+.+|+.+|.+++|+|++...
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 455667999999999999987 444 99999975332 256899999999999999984311
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...++...+..++.||+.||+|||+++ ||||||||+|||++.++
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-------------------- 180 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-------------------- 180 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--------------------
Confidence 356888999999999999999999999 99999999999997543
Q ss_pred cCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
.++||+|||+++.... ..+...||..|||||++. ...|+.|+||||||+++|||+||+.||.+....+.
T Consensus 181 ------~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~ 254 (362)
T KOG0192|consen 181 ------KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV 254 (362)
T ss_pred ------CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 2577888888765543 233368999999999999 55899999999999999999999999999887444
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+... +.+...| ..+++.+..||.+||..|
T Consensus 255 ~~~v~~~----------------------~~Rp~~p--------------------------~~~~~~l~~l~~~CW~~d 286 (362)
T KOG0192|consen 255 ASAVVVG----------------------GLRPPIP--------------------------KECPPHLSSLMERCWLVD 286 (362)
T ss_pred HHHHHhc----------------------CCCCCCC--------------------------ccCCHHHHHHHHHhCCCC
Confidence 4333221 1111111 224668899999999999
Q ss_pred CCCCCCHHHHHc
Q 015532 374 PAERLKAREALR 385 (405)
Q Consensus 374 P~~Rpta~elL~ 385 (405)
|++||+..+++.
T Consensus 287 p~~RP~f~ei~~ 298 (362)
T KOG0192|consen 287 PSRRPSFLEIVS 298 (362)
T ss_pred CCcCCCHHHHHH
Confidence 999999998874
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.20 Aligned_cols=235 Identities=22% Similarity=0.391 Sum_probs=176.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+++++++.|+++....
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 588999999999999999999999999999998643 23345678899999999999874321
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCc
Q 015532 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227 (405)
Q Consensus 155 -------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~ 227 (405)
+..+++..+..++.|++.||.|||++||+|+||||+|||++.++. +
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~---------------------------~ 134 (279)
T cd06619 82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ---------------------------V 134 (279)
T ss_pred CCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC---------------------------E
Confidence 234678889999999999999999999999999999999976654 5
Q ss_pred eeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 015532 228 KLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPH 306 (405)
Q Consensus 228 kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~ 306 (405)
+|+|||++...... .....||..|+|||++.+..++.++|+|||||++|+|++|..||......+... .+.
T Consensus 135 ~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~ 206 (279)
T cd06619 135 KLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPL 206 (279)
T ss_pred EEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chH
Confidence 66666655433222 233578999999999998889999999999999999999999996532111000 000
Q ss_pred HHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 307 HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.... . ......+. ......+.++.+|+.+||+.||++||+++|+++|
T Consensus 207 ~~~~--------~----------------------~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 207 QLLQ--------C----------------------IVDEDPPV---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHH--------H----------------------HhccCCCC---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 0 00000000 0012346688999999999999999999999999
Q ss_pred CCCCCCCCC
Q 015532 387 PFFTRDVRR 395 (405)
Q Consensus 387 p~f~~~~~~ 395 (405)
|||+.....
T Consensus 254 ~~~~~~~~~ 262 (279)
T cd06619 254 PFIVQYNDG 262 (279)
T ss_pred cccccccCc
Confidence 999876443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=291.04 Aligned_cols=252 Identities=33% Similarity=0.601 Sum_probs=184.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+..|+.+++.+.|+++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999999999999999985432 2335577899999999998863211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~---------------------- 138 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---------------------- 138 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc----------------------
Confidence 235788999999999999999999999999999999999977664
Q ss_pred CCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+
T Consensus 139 -----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 139 -----IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred -----EEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4555555554332211 12357888999999876 45789999999999999999999999988887777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+..+............ ..++. ....+.... ...........+..+.+||.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd07847 214 RKTLGDLIPRHQQIFST--NQFFK---GLSIPEPET--------------REPLESKFPNISSPALSFLKGCLQMDPTER 274 (286)
T ss_pred HHHhCCCChHHhhhccc--ccccc---cccCCCccc--------------ccCHHHHhccCCHHHHHHHHHHhcCCcccc
Confidence 76666544321111000 00000 000000000 000011123456789999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||+.|++.||||
T Consensus 275 p~~~eil~~~~f 286 (286)
T cd07847 275 LSCEELLEHPYF 286 (286)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=303.40 Aligned_cols=218 Identities=28% Similarity=0.387 Sum_probs=167.5
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHH-HHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~-il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..+++.||+|++.+.. .....+..|+. +++.+.|+++....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999996532 12233445554 67888998885422
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~-------------------------- 134 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH-------------------------- 134 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--------------------------
Confidence 134678889999999999999999999999999999999976664
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....-
T Consensus 135 -~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 135 -VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred -EEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 5556666554321 112235789999999999988899999999999999999999999988765544433321100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH--
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-- 380 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-- 380 (405)
......+..+.++|.+||+.||++|+++
T Consensus 214 --------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (321)
T cd05603 214 --------------------------------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKA 243 (321)
T ss_pred --------------------------------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCC
Confidence 1112345688999999999999999975
Q ss_pred --HHHHcCCCCCCC
Q 015532 381 --REALRHPFFTRD 392 (405)
Q Consensus 381 --~elL~hp~f~~~ 392 (405)
.++++|+||...
T Consensus 244 ~~~~~~~~~~~~~~ 257 (321)
T cd05603 244 DFLEIKNHVFFSPI 257 (321)
T ss_pred CHHHHhCCCCcCCC
Confidence 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.64 Aligned_cols=225 Identities=25% Similarity=0.454 Sum_probs=178.2
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc----------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR---------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~---------------------- 154 (405)
-+||+|.||+||-|+|..+....|||-+... ....+-...||.+.++|.|.||+..+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3699999999999999999999999998543 33445577899999999999984322
Q ss_pred ------cccC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 ------YRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 ------~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
.+.+ +|..+-.+.+||++||.|||++.|||||||-+||||+.. .+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy--------------------------SGv 714 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY--------------------------SGV 714 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec--------------------------cce
Confidence 2344 678889999999999999999999999999999999752 345
Q ss_pred ceeccCCCCcccc---CCccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-H--HH
Q 015532 227 IKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA-M--ME 298 (405)
Q Consensus 227 ~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~--i~ 298 (405)
+||+|||.++... .-..++.||..|||||++..+ +|+.++|||||||++.||.||++||......+... + |.
T Consensus 715 lKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy 794 (1226)
T KOG4279|consen 715 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY 794 (1226)
T ss_pred EEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce
Confidence 7778888775433 233457899999999999765 59999999999999999999999997654433211 0 11
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.-.++| +..+.++++||.+|+..||.+||
T Consensus 795 KvHP~iP--------------------------------------------------eelsaeak~FilrcFepd~~~R~ 824 (1226)
T KOG4279|consen 795 KVHPPIP--------------------------------------------------EELSAEAKNFILRCFEPDPCDRP 824 (1226)
T ss_pred ecCCCCc--------------------------------------------------HHHHHHHHHHHHHHcCCCcccCc
Confidence 1112222 34477899999999999999999
Q ss_pred CHHHHHcCCCCCCCCCCCcc
Q 015532 379 KAREALRHPFFTRDVRRPTL 398 (405)
Q Consensus 379 ta~elL~hp~f~~~~~~~~~ 398 (405)
+|.++|..||++.+.+.+..
T Consensus 825 sA~~LL~DpFlq~~~kk~r~ 844 (1226)
T KOG4279|consen 825 SAKDLLQDPFLQHNNKKPRP 844 (1226)
T ss_pred cHHHhccCcccccCCCCCCC
Confidence 99999999999988655443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=291.11 Aligned_cols=249 Identities=33% Similarity=0.521 Sum_probs=184.0
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||.|+||.||+|++..+++.||||+++... .....+..|++++++++|+++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4899999999999999999999999999999986432 2235677899999999999873321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~--------------------- 139 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI--------------------- 139 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE---------------------
Confidence 1346788999999999999999999999999999999999876654
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+|+|||++...... .....++..|+|||++.+.. ++.++|||||||++|+|+||..||.+.+..+.+..+
T Consensus 140 ------~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 140 ------KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred ------EEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 55555544332211 11235678899999887654 688999999999999999999999988888777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+..+..+..+....... ..+.. .++.. ............+..+.++|.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSL-PDYKP-----SFPKW---------------ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272 (284)
T ss_pred HHHhCCCChhhhhhhhHH-HHHHh-----hcccc---------------cccCHHHHcccCCHHHHHHHHHhcCCCcccC
Confidence 777776654432211110 00000 00000 0000011122356788999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||++++++||||
T Consensus 273 pt~~~~l~~~~f 284 (284)
T cd07860 273 ISAKAALAHPFF 284 (284)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.24 Aligned_cols=219 Identities=24% Similarity=0.376 Sum_probs=166.4
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHh-hcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~-~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..+++.||||++++.. ...+.+..|+.++.++. |+++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997532 23345678999998885 55542110
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~-------------------------- 134 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH-------------------------- 134 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--------------------------
Confidence 245789999999999999999999999999999999999987664
Q ss_pred CceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH
Q 015532 226 AIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN------LEHLAM 296 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~------~~~~~~ 296 (405)
++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+..
T Consensus 135 -~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 135 -IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred -EEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 5556666554311 112335799999999999998999999999999999999999999964321 111111
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
... . .....+...+..+.++|.+||+.||++
T Consensus 214 ~~~--~-----------------------------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~ 244 (327)
T cd05617 214 VIL--E-----------------------------------------------KPIRIPRFLSVKASHVLKGFLNKDPKE 244 (327)
T ss_pred HHH--h-----------------------------------------------CCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 000 0 000112234678899999999999999
Q ss_pred CCC------HHHHHcCCCCCCC
Q 015532 377 RLK------AREALRHPFFTRD 392 (405)
Q Consensus 377 Rpt------a~elL~hp~f~~~ 392 (405)
|++ .+++++||||+.-
T Consensus 245 R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 245 RLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred cCCCCCCCCHHHHHcCCCCCCC
Confidence 998 5799999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=292.65 Aligned_cols=225 Identities=22% Similarity=0.411 Sum_probs=173.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~-------------- 154 (405)
..++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.++.++ .|+++....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 45679999999999999999999999999999999976555556778899999998 576652110
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~-------------- 149 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------------- 149 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--------------
Confidence 124678889999999999999999999999999999999976554
Q ss_pred CCCcccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
++|+|||++..... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 150 -------------~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~ 216 (272)
T cd06637 150 -------------VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216 (272)
T ss_pred -------------EEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 56666666543321 1223578999999999863 35888999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
...........+.... . ........+.++.+|
T Consensus 217 ~~~~~~~~~~~~~~~~-----------------------~-------------------------~~~~~~~~~~~~~~l 248 (272)
T cd06637 217 CDMHPMRALFLIPRNP-----------------------A-------------------------PRLKSKKWSKKFQSF 248 (272)
T ss_pred cccCHHHHHHHHhcCC-----------------------C-------------------------CCCCCCCcCHHHHHH
Confidence 7654332222111000 0 000012345688999
Q ss_pred HHHccccCCCCCCCHHHHHcCCCC
Q 015532 366 LQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~hp~f 389 (405)
|.+||..||.+|||+.++++||||
T Consensus 249 i~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 249 IESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHcCCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.81 Aligned_cols=229 Identities=27% Similarity=0.411 Sum_probs=173.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.++||+|+||.||+++++.+++.||+|++.+.. .....+..|+.++..+.|+++....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999996422 2233466788999999888762210
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~-------------------- 140 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-------------------- 140 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--------------------
Confidence 135788899999999999999999999999999999999976654
Q ss_pred CCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
++|+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 141 -------~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 141 -------IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred -------EEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 555666655432111 122479999999999873 3588999999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+....+..... +..++. ....+++++.+||.+||
T Consensus 214 ~~~~~~i~~~~~----------------------~~~~p~-----------------------~~~~~s~~~~~li~~ll 248 (332)
T cd05623 214 VETYGKIMNHKE----------------------RFQFPA-----------------------QVTDVSEDAKDLIRRLI 248 (332)
T ss_pred HHHHHHHhCCCc----------------------cccCCC-----------------------ccccCCHHHHHHHHHHc
Confidence 555544322100 001110 11235778999999999
Q ss_pred ccCCCC--CCCHHHHHcCCCCCCC
Q 015532 371 RYDPAE--RLKAREALRHPFFTRD 392 (405)
Q Consensus 371 ~~dP~~--Rpta~elL~hp~f~~~ 392 (405)
..++++ |++++|+++||||++-
T Consensus 249 ~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 249 CSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred cChhhhcCCCCHHHHhCCCCcCCC
Confidence 765555 6899999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.83 Aligned_cols=260 Identities=27% Similarity=0.514 Sum_probs=185.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.++||+|+||.||+|.+..+++.||||++.... .......+|+++++++.|+++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56999999999999999999999999999999885422 2234456799999999999873221
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++++|||++.....
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 01468889999999999999999999999999999999998776655555554322211
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
... . .........++..|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+...
T Consensus 172 ~~~-------------------~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 172 SKN-------------------S-KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred Ccc-------------------c-CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 000 0 00011123578889999998765 47889999999999999999999999988888
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.+..|.+|..+......... +. ....+..... .. ... ......+..+.+||.+||..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~-----~~------~~~--l~~~~~~~~~~dli~~~l~~ 293 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLEL--FK---KMELPQGQKR-----KV------KER--LKPYVKDPHALDLIDKLLVL 293 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhh--hh---hccCCCccch-----hh------HHh--cccccCCHHHHHHHHHHhcC
Confidence 8888888888877654322210000 00 0000100000 00 000 00011245788999999999
Q ss_pred CCCCCCCHHHHHcCCCC
Q 015532 373 DPAERLKAREALRHPFF 389 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f 389 (405)
||++|||++|+|+||||
T Consensus 294 ~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 294 DPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhccCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=293.34 Aligned_cols=225 Identities=26% Similarity=0.407 Sum_probs=181.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++++.|+++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999999999986432 2345678899999999999873321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+|+||+|+||+++.++
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~---------------------- 138 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG---------------------- 138 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC----------------------
Confidence 24578889999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.++|+|||++...........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...
T Consensus 139 -----~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (290)
T cd05580 139 -----YIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213 (290)
T ss_pred -----CEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 456666666655444444457899999999998888899999999999999999999999876644433333211
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC--
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-- 378 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-- 378 (405)
... .....+..+.++|.+||+.||++|+
T Consensus 214 ~~~--------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 214 KVR--------------------------------------------------FPSFFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred Ccc--------------------------------------------------CCccCCHHHHHHHHHHccCCHHHccCc
Confidence 000 1122356889999999999999999
Q ss_pred ---CHHHHHcCCCCCCCC
Q 015532 379 ---KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ---ta~elL~hp~f~~~~ 393 (405)
+++|+++||||+...
T Consensus 244 ~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 244 LKNGVNDIKNHPWFAGID 261 (290)
T ss_pred ccCCHHHHHcCcccccCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=297.28 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=182.8
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.+.|+++....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 3578999999999999999999999999999999985433 3345677899999999999874211
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++..+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~----------- 151 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED----------- 151 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-----------
Confidence 12468889999999999999999999999999999999996432
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~ 282 (405)
..++|+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 152 ---------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 216 (342)
T cd07854 152 ---------------LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216 (342)
T ss_pred ---------------ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCC
Confidence 23566666665433211 112357889999998765 45889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||.+....+....+.......................... . ..............+.++
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----------------~~~~~~~~~~~~~~~~~~ 276 (342)
T cd07854 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRND---G-----------------GEPRRPLRDLLPGVNPEA 276 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc---c-----------------cccCCCHHHHccCCCHHH
Confidence 99988777665554443332222111110000000000000 0 000001111223456789
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
.+||.+||+.||++|||+.|+|+||||+.
T Consensus 277 ~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 277 LDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=292.38 Aligned_cols=251 Identities=37% Similarity=0.613 Sum_probs=185.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999999899999999986432 3346688899999999998873221
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~---------------------- 138 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVL---------------------- 138 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcE----------------------
Confidence 1347888999999999999999999999999999999999876655
Q ss_pred CCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+|+|||.+...... .....|+..|+|||++.+. .++.++|||||||++|+|++|.++|.+..+...+..+
T Consensus 139 -----~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 139 -----KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred -----EEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence 45555544332221 1224688999999998764 4689999999999999999999999888887777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....+.+....+...... ..+ ....++... ...........+..+.+||.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 273 (286)
T cd07832 214 FRTLGTPNEETWPGLTSL-PDY----NKITFPESK---------------PIPLEEIFPDASPEALDLLKGLLVYDPSKR 273 (286)
T ss_pred HHHcCCCChHHHhhccCc-chh----hcccCCCCC---------------cchHHHhCCCccHHHHHHHHHHhccChhhC
Confidence 766665543222111000 000 000111000 000112223456789999999999999999
Q ss_pred CCHHHHHcCCCCC
Q 015532 378 LKAREALRHPFFT 390 (405)
Q Consensus 378 pta~elL~hp~f~ 390 (405)
||++++|+||||.
T Consensus 274 ~~~~~~l~h~~~~ 286 (286)
T cd07832 274 LSAAEALRHPYFT 286 (286)
T ss_pred CCHHHHhhCcCcC
Confidence 9999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.62 Aligned_cols=275 Identities=20% Similarity=0.254 Sum_probs=180.9
Q ss_pred EEeeeecc--cceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 96 ILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 96 ~~~~LG~G--~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
++++||+| +|++||++.++.+++.||||+++.. ....+.+.+|+.+++.++|+++....
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999999999999999999653 23345567799999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~------------ 149 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL------------ 149 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh------------
Confidence 1247888999999999999999999999999999999999998888888876431
Q ss_pred CCCCCceeccCCCCccc-cCCccceecCCCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.+.++|..... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 150 ------~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-- 221 (327)
T cd08227 150 ------SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-- 221 (327)
T ss_pred ------ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH--
Confidence 22233222111 111122356778999999976 3589999999999999999999999987554433222
Q ss_pred HHhCCCChHHHHHhhHhhHHhh----hcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
...+..|........ ...... ..+....+........ .................++.+.+||.+||++||
T Consensus 222 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 295 (327)
T cd08227 222 KLNGTVPCLLDTTTI-PAEELTMKPSRSGANSGLGESTTVST-----PRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNP 295 (327)
T ss_pred HhcCCccccccccch-hhhhcccCCcccCCcCCCCcccccCC-----cCccccCCcccccccccCHHHHHHHHHHHhhCc
Confidence 222322211100000 000000 0000000000000000 000000000011223456789999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~~ 396 (405)
++|||++|+++||||++-...+
T Consensus 296 ~~Rpt~~ell~~p~f~~~~~~~ 317 (327)
T cd08227 296 DARPSASTLLNHSFFKQIKRRA 317 (327)
T ss_pred hhcCCHHHHhcChhhhhcchhh
Confidence 9999999999999998755444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.93 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=190.5
Q ss_pred CeEEEeeeecccceeEEEEEecCC--CcEEEEEEecch---hhhhHHHHHHHHHHHHHh-hcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEK--KELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~--~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~-~~~~~~~~------------ 154 (405)
+|++.+.||+|+||.||+|++..+ +..||||++... ......+.+|+.+++++. |+++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 889999998642 123456778999999995 77653211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 13467889999999999999999999999999999999998776655555554332211000
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
..........||..|+|||++.+ ..++.++||||+||++|+|++|.+||...+....+.
T Consensus 161 --------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~ 220 (332)
T cd07857 161 --------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220 (332)
T ss_pred --------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH
Confidence 00001122468999999998876 468999999999999999999999999988888899
Q ss_pred HHHHHhCCCChHHHHHhhHhhHH-hhhcCCcccCCCCCCchhhHHHHHHhccchh-hhhhcccCchHHHHHHHHHccccC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEK-YFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
.+...+|.++............. +..... ..+. .........+..+.+|+.+||+.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLP---------------------NIPKKPFESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHHHhCCCCHHHHHhhhhhhHHHHHHhcc---------------------ccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence 99999988777654433221111 100000 0000 000111234678999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|++|||+.|+++||||+...
T Consensus 280 P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 280 PTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred cccCCCHHHHhcChhhhhhc
Confidence 99999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.08 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=191.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.++||+|+||.||+|++..+++.||||++.... .......+|+++++.++|+++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999985422 2234567899999999999874321
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 1257889999999999999999999999999999999999988888888887654332
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
...... ..+.. ..........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 167 ~~~~~~------------~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 167 GPPPNP------------KGGGG-GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred CCCccc------------ccCCc-ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 211000 00000 000111234678999999998764 5889999999999999999999999998888
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+....+.+++.....+..... ...+.. ....+..........+..+.+||.+||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 293 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPG-------CEGVHS-------------FTNYPRTLEERFGKLGPEGLDLLSKLLS 293 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhccc-------cccccc-------------CCCCCccHHHHcccCChhHHHHHHHHcc
Confidence 88887777766655432211100000 000000 0000111111223345688999999999
Q ss_pred cCCCCCCCHHHHHcCCCC
Q 015532 372 YDPAERLKAREALRHPFF 389 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f 389 (405)
.||++|||+.|+++||||
T Consensus 294 ~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 294 LDPYKRLTASDALEHPYF 311 (311)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=294.75 Aligned_cols=259 Identities=28% Similarity=0.498 Sum_probs=197.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|++.+.||.|+||.||+|.+..+++.||||++... ....+.+..|+.+++.+.|+++....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 568899999999999999999999999999999987532 22345677899999999999873311
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 88 v~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~---------------------- 145 (328)
T cd07856 88 VTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC---------------------- 145 (328)
T ss_pred EeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC----------------------
Confidence 13457778888999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.++|+|||.+...........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.+
T Consensus 146 -----~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 146 -----DLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred -----CEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4566666666544433334567889999998766 5689999999999999999999999999888888888888
Q ss_pred HhCCCChHHHHHhhHhh-HHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
.+|.+|..+........ ..++.... ...+..........+..+.++|.+||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLP--------------------KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhcc--------------------ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 88988877654321111 11110000 0000011112234567899999999999999999
Q ss_pred CHHHHHcCCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVRR 395 (405)
Q Consensus 379 ta~elL~hp~f~~~~~~ 395 (405)
|+++++.||||......
T Consensus 281 t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 281 SAAEALAHPYLAPYHDP 297 (328)
T ss_pred CHHHHhcCCccccccCC
Confidence 99999999999876443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.06 Aligned_cols=259 Identities=31% Similarity=0.513 Sum_probs=181.3
Q ss_pred CeEEEeeeecccceeEEEEEecC--CCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~--~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+|++.++||+|+||.||+|.+.. +++.||||++... ....+...+|+.+++.+.|+++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8899999998752 23345677899999999999873211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~--------------- 145 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG--------------- 145 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC---------------
Confidence 02567888999999999999999999999999999999998722
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
+.+..+||+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 146 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 146 --------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred --------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 12345666666665543221 1224678899999998774 57899999999999999999999997
Q ss_pred CCChH---------HHHHHHHHHhCCCChHHHHHhhHhhHH--hhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 287 THENL---------EHLAMMERVLGPLPHHMVIRADRRAEK--YFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 287 ~~~~~---------~~~~~i~~~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
+.... ..+..+...++..+............. .........++. ..... ..+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----------~~~~~ 282 (316)
T cd07842 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-----NSLAK----------WMEKH 282 (316)
T ss_pred CCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC-----ccHHH----------HHHhc
Confidence 65432 234444555554443322211110000 000000000000 00000 00111
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcCCCC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
...+..+.++|.+||+.||++|||+.|+++||||
T Consensus 283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 2456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.51 Aligned_cols=225 Identities=31% Similarity=0.504 Sum_probs=169.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc---hhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
..|+++++||+||.+.||++... +.+.||+|.+.. .......+..||..|.+|..+..+-.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 45999999999999999999874 445677776532 344567789999999999876431110
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
....+.-.++.+..||+.|+.++|++||||.||||.|+|+..
T Consensus 440 E~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk------------------------ 495 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK------------------------ 495 (677)
T ss_pred ecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe------------------------
Confidence 122333488999999999999999999999999999999853
Q ss_pred CCCCCCceeccCCCCccccCCccc-----eecCCCcchhHHHhCCC-----------CCCchhHHHHHHHHHHHHhCCCC
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLG-----------WNYPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~~lltg~~p 284 (405)
+.+||+|||+|.....+.+. -+||+.||+||.+.... .+.++||||||||||+|+.|++|
T Consensus 496 ----G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP 571 (677)
T KOG0596|consen 496 ----GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP 571 (677)
T ss_pred ----eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence 46899999999877665543 48999999999996432 56889999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
|....+ .++++..+..+ +....+|+ ... ..++++
T Consensus 572 f~~~~n--~~aKl~aI~~P-------------------~~~Iefp~-----------------------~~~--~~~li~ 605 (677)
T KOG0596|consen 572 FGQIIN--QIAKLHAITDP-------------------NHEIEFPD-----------------------IPE--NDELID 605 (677)
T ss_pred hHHHHH--HHHHHHhhcCC-------------------CccccccC-----------------------CCC--chHHHH
Confidence 964322 22333222211 11222221 001 124899
Q ss_pred HHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 365 LLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
+++.||.+||.+|||+.++|+|||++-
T Consensus 606 ~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 606 VMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHhcCcccCCCcHHHhcCccccc
Confidence 999999999999999999999999987
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.61 Aligned_cols=251 Identities=30% Similarity=0.485 Sum_probs=180.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.+.||+|+||.||+|.++.+++.||||.+.... .....+.+|+++++.+.|+++....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999999899999999986432 2234567899999999999873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~---------------------- 142 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGEL---------------------- 142 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCE----------------------
Confidence 1246788999999999999999999999999999999999876655
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE-NLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i 297 (405)
+|+|||++...... .....++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.. ..+.+..+
T Consensus 143 -----kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 217 (291)
T cd07844 143 -----KLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217 (291)
T ss_pred -----EECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 55555544322111 112246788999999876 458899999999999999999999997765 45556666
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch--HHHHHHHHHccccCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA--GDLIDLLQGLLRYDPA 375 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~ll~~~L~~dP~ 375 (405)
.+.++.+............... ...+.. .. ...........+ ..+.++|.+||+.||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 277 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFK-----PYSFPF--YP-------------PRPLINHAPRLDRIPHGEELALKFLQYEPK 277 (291)
T ss_pred HHhcCCCChhhhhhhhhccccc-----cccccc--cC-------------ChhHHHhCcCCCCchhHHHHHHHHhccCcc
Confidence 6666655443322221100000 000000 00 000011111222 6788999999999999
Q ss_pred CCCCHHHHHcCCCC
Q 015532 376 ERLKAREALRHPFF 389 (405)
Q Consensus 376 ~Rpta~elL~hp~f 389 (405)
+|||+.++++||||
T Consensus 278 ~Rps~~e~l~~~~f 291 (291)
T cd07844 278 KRISAAEAMKHPYF 291 (291)
T ss_pred cccCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=300.45 Aligned_cols=229 Identities=26% Similarity=0.401 Sum_probs=173.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||++++..+++.||||++.+.. .....+..|+.++..+.|+++....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999986532 2234466788999999888763210
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~-------------------- 140 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH-------------------- 140 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--------------------
Confidence 235788899999999999999999999999999999999976654
Q ss_pred CCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 141 -------~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 141 -------IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred -------EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 5556666554332211 22469999999999976 4578899999999999999999999987766
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+....+..... +..++ .....++..+.+||.+||
T Consensus 214 ~~~~~~i~~~~~----------------------~~~~p-----------------------~~~~~~~~~~~~li~~ll 248 (331)
T cd05624 214 VETYGKIMNHEE----------------------RFQFP-----------------------SHITDVSEEAKDLIQRLI 248 (331)
T ss_pred HHHHHHHHcCCC----------------------cccCC-----------------------CccccCCHHHHHHHHHHc
Confidence 554443322100 00111 011234678999999999
Q ss_pred ccCCCC--CCCHHHHHcCCCCCCC
Q 015532 371 RYDPAE--RLKAREALRHPFFTRD 392 (405)
Q Consensus 371 ~~dP~~--Rpta~elL~hp~f~~~ 392 (405)
..++++ |++++++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 249 CSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred cCchhhcCCCCHHHHhcCCCcCCC
Confidence 976655 5699999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=284.26 Aligned_cols=221 Identities=25% Similarity=0.430 Sum_probs=173.1
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+..|+++++++.|+++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4899999999999999999999999999999986432 2345677899999999998763211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~------------------- 141 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNII------------------- 141 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcE-------------------
Confidence 1236788899999999999999999999999999999999876654
Q ss_pred CCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+|+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......
T Consensus 142 --------~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~ 213 (257)
T cd08223 142 --------KVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR 213 (257)
T ss_pred --------EEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 5555554433221 11234688899999999998899999999999999999999999987665443332
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.. +.+| ......++.+.+|+.+||+.||++
T Consensus 214 ~~~--~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd08223 214 IIE--GKLP-----------------------------------------------PMPKDYSPELGELIATMLSKRPEK 244 (257)
T ss_pred HHh--cCCC-----------------------------------------------CCccccCHHHHHHHHHHhccCccc
Confidence 211 1110 011234668999999999999999
Q ss_pred CCCHHHHHcCCCC
Q 015532 377 RLKAREALRHPFF 389 (405)
Q Consensus 377 Rpta~elL~hp~f 389 (405)
|||+.++++||||
T Consensus 245 Rp~~~~~l~~~~~ 257 (257)
T cd08223 245 RPSVKSILRQPYI 257 (257)
T ss_pred CCCHHHHhcCCCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.74 Aligned_cols=253 Identities=34% Similarity=0.643 Sum_probs=190.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+++++.+.|+++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4699999999999999999999999999999998643 23346788999999999998873321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~---------------------- 138 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV---------------------- 138 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC----------------------
Confidence 134778899999999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
++|+|||.+....... ....++..|+|||++.+. .++.++||||||+++|+|++|.+||.+....+.+..
T Consensus 139 -----~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 139 -----LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred -----EEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5555555554332221 234678899999999888 789999999999999999999999998888888888
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+.++............ + ....++... .. ..........++.++.+||.+||..||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~-~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPR--F---AGVAFPEPS-QP------------ESLERRYPGKVSSPALDFLKACLRMDPKE 275 (288)
T ss_pred HHHHhCCCCHHHhhhcccCcc--c---cccccCCCC-Cc------------HHHHHhcCCccchHHHHHHHHHhccCchh
Confidence 888887777644322110000 0 000000000 00 00011112234778999999999999999
Q ss_pred CCCHHHHHcCCCC
Q 015532 377 RLKAREALRHPFF 389 (405)
Q Consensus 377 Rpta~elL~hp~f 389 (405)
|||++++++||||
T Consensus 276 Rps~~~il~~~~f 288 (288)
T cd07833 276 RLTCDELLQHPYF 288 (288)
T ss_pred cccHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=288.98 Aligned_cols=250 Identities=34% Similarity=0.548 Sum_probs=181.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhh-cCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~-~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+++.+.| +++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46999999999999999999999999999999886432 123567789999999976 4542100
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-ccccccCCcccccc
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSR 210 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~-~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~------------ 148 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG------------ 148 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC------------
Confidence 123688899999999999999999999999999999999976 44
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.++|+|||.+...... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 149 ---------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 149 ---------------LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred ---------------eEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 4566666655432211 1123567889999998764 57899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.+..+.+..+.+.++..+........... .+. ..+. ..+..........+..+.+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------~~~~---------------~~~~~~~~~~~~~~~~~~~~i 271 (295)
T cd07837 214 GDSELQQLLHIFKLLGTPTEQVWPGVSKLR-DWH------EFPQ---------------WKPQDLSRAVPDLSPEGLDLL 271 (295)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCcchhhcc-chh------hcCc---------------ccchhHHHhccccCHHHHHHH
Confidence 888877776666655544332211000000 000 0000 000011112234677899999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
.+||..||++|||+.|+|+||||+
T Consensus 272 ~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 272 QKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHccCChhhcCCHHHHhcCCCcC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=312.16 Aligned_cols=224 Identities=24% Similarity=0.252 Sum_probs=176.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCC-CcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~-~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+..|+.+|+.+.|++++...
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4599999999999999999998877 7889999775433 3334567799999999999883211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~------------------- 207 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI------------------- 207 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc-------------------
Confidence 124678889999999999999999999999999999999976654
Q ss_pred cCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 208 --------~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~ 279 (478)
T PTZ00267 208 --------IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI 279 (478)
T ss_pred --------EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 555566655433221 2235799999999999998999999999999999999999999987766554
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+... ..+ .....++..+.+||.+||..|
T Consensus 280 ~~~~~~~--~~~-----------------------------------------------~~~~~~s~~~~~li~~~L~~d 310 (478)
T PTZ00267 280 MQQVLYG--KYD-----------------------------------------------PFPCPVSSGMKALLDPLLSKN 310 (478)
T ss_pred HHHHHhC--CCC-----------------------------------------------CCCccCCHHHHHHHHHHhccC
Confidence 4433211 000 011234668999999999999
Q ss_pred CCCCCCHHHHHcCCCCCC
Q 015532 374 PAERLKAREALRHPFFTR 391 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~ 391 (405)
|++|||+++++.|+|++.
T Consensus 311 P~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 311 PALRPTTQQLLHTEFLKY 328 (478)
T ss_pred hhhCcCHHHHHhCHHHHH
Confidence 999999999999999863
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.93 Aligned_cols=254 Identities=31% Similarity=0.475 Sum_probs=185.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh------hhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+|++.+.||+|+||.||+|.+..+++.||||.++.... ....+..|+++++.+.|+++....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 58899999999999999999998999999999965322 234566799999999998873211
Q ss_pred --------------c-ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 --------------Y-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 --------------~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~------------------ 142 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLK------------------ 142 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEE------------------
Confidence 1 2578899999999999999999999999999999999998766554
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.+.+..+.+.
T Consensus 143 ---------l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~ 213 (298)
T cd07841 143 ---------LADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG 213 (298)
T ss_pred ---------EccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH
Confidence 4555544332211 112346778999999865 357899999999999999999999998888777777
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.+..+.+........... ..+.. + ...............+..+.+||.+||++||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~-~~~~~------~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 271 (298)
T cd07841 214 KIFEALGTPTEENWPGVTSL-PDYVE------F---------------KPFPPTPLKQIFPAASDDALDLLQRLLTLNPN 271 (298)
T ss_pred HHHHHcCCCchhhhhhcccc-ccccc------c---------------cccCCcchhhhcccccHHHHHHHHHHhcCCcc
Confidence 66665554443322111000 00000 0 00000001112234567899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~~ 395 (405)
+|||+.|+|+||||++....
T Consensus 272 ~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 272 KRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cCcCHHHHhhCccccCCCCC
Confidence 99999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=291.88 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=178.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.++||+|+||.||++.+..++..||+|.++.. ......+.+|+++++++.|+++....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3599999999999999999999999999999998643 23345678899999999999874321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---------------------- 138 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---------------------- 138 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc----------------------
Confidence 1346788999999999999999997 69999999999999987664
Q ss_pred CCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
++|+|||++...... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 139 -----~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (308)
T cd06615 139 -----IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213 (308)
T ss_pred -----EEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc
Confidence 455555554432211 22357889999999998888999999999999999999999999765533322211111
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
....+... .. .. .................................++.++.+|+.+||..||++|||+
T Consensus 214 ~~~~~~~~----~~------~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 281 (308)
T cd06615 214 VSEGEAKE----SH------RP--VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281 (308)
T ss_pred cccccccC----Cc------cc--ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence 00000000 00 00 00000000000000000000000000000011256789999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 015532 381 REALRHPFFTRDV 393 (405)
Q Consensus 381 ~elL~hp~f~~~~ 393 (405)
.|+++||||.+..
T Consensus 282 ~~ll~~~~~~~~~ 294 (308)
T cd06615 282 KELTKHPFIKRAE 294 (308)
T ss_pred HHHhcChhhhhcc
Confidence 9999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.21 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=193.0
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|+||.||+|++..+++.||||++.... ...+.+..|+.+++.+.|+++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999999889999999986532 2345678899999999988762111
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~--------------- 145 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC--------------- 145 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc---------------
Confidence 1246788889999999999999999999999999999999876655554
Q ss_pred cCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
|||.+...... .....++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..
T Consensus 146 ------------dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 146 ------------DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred ------------ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 55444332221 1224678899999999887 7899999999999999999999999999888
Q ss_pred HHHHHHHHHhCCCChHHHHHhh-HhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 292 EHLAMMERVLGPLPHHMVIRAD-RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
+.+..+....+.++........ .....+.... ...............+..+.+||.+||
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~li~~~l 273 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL--------------------PKKPKKPLSKLFPGASPEAIDLLEKML 273 (330)
T ss_pred HHHHHHHHhcCCCChhHhhhccccchhhHHhhc--------------------ccCCcchhHHhcccCCHHHHHHHHHHc
Confidence 8888888888777655432111 0000110000 000000111122345778999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
++||++|||++++++||||++....+
T Consensus 274 ~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 274 VFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred cCChhhCCCHHHHHhCccHHhhcccc
Confidence 99999999999999999998765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.05 Aligned_cols=228 Identities=26% Similarity=0.427 Sum_probs=174.9
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCC--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGT-------------- 153 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~-------------- 153 (405)
...++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+..|+.+++++ .|+++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 456889999999999999999999999999999999976555556677899999999 67765210
Q ss_pred ----------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 154 ----------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 154 ----------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
....+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~------------ 166 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG------------ 166 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC------------
Confidence 0134678889999999999999999999999999999999976554
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-----CCCCchhHHHHHHHHHHHHhCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~~lltg~~ 283 (405)
++|+|||++...... .....|+..|+|||++... .++.++|||||||++|+|++|++
T Consensus 167 ---------------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 167 ---------------VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred ---------------EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 556666655432211 1224678899999998643 36789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||........+..+.+. ..+ .....+..+..+.
T Consensus 232 p~~~~~~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~l~ 264 (291)
T cd06639 232 PLFDMHPVKTLFKIPRN--PPP---------------------------------------------TLLHPEKWCRSFN 264 (291)
T ss_pred CCCCCcHHHHHHHHhcC--CCC---------------------------------------------CCCcccccCHHHH
Confidence 99876554433322110 000 0001123355789
Q ss_pred HHHHHccccCCCCCCCHHHHHcCCCCC
Q 015532 364 DLLQGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
+||.+||+.||++||++.|+++||||+
T Consensus 265 ~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 265 HFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=269.96 Aligned_cols=223 Identities=26% Similarity=0.329 Sum_probs=170.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..||++.+.||+|||+.||+++...+++.||+|++.... +..+..++|++..++++|+++....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 368999999999999999999999999999999986544 5678889999999999998872210
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++.++..++.+|++||++||+.. ++||||||.|||++..+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~------------- 166 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG------------- 166 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-------------
Confidence 235789999999999999999999998 99999999999987654
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCc------------cceecCCCcchhHHHhC---CCCCCchhHHHHHHHHH
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------------SYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILV 276 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------------~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ 276 (405)
.++|.|||++....-.. ..-..|..|+|||++.- ...+.++|||||||++|
T Consensus 167 --------------~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 167 --------------LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred --------------ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 46777777765332110 11356889999999864 34679999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc
Q 015532 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356 (405)
Q Consensus 277 ~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (405)
.|+.|..||..... .-|.+ .+....+...||. ..
T Consensus 233 a~mf~~sPfe~~~~---------~GgSl-------------aLAv~n~q~s~P~------------------------~~ 266 (302)
T KOG2345|consen 233 AMMFGESPFERIYQ---------QGGSL-------------ALAVQNAQISIPN------------------------SS 266 (302)
T ss_pred HHHHcCCcchHHhh---------cCCeE-------------EEeeeccccccCC------------------------CC
Confidence 99999999953110 00000 0000011222222 12
Q ss_pred CchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 357 HSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 357 ~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+++.+.+||+.||+.||.+||++.+++.+
T Consensus 267 ~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 267 RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 367889999999999999999999999864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=290.27 Aligned_cols=220 Identities=22% Similarity=0.392 Sum_probs=164.5
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
||+|+||.||+++++.+++.||+|++..... .......|+++++.+.|+++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864221 223455699999999999873211
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--------------------------- 133 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--------------------------- 133 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC---------------------------
Confidence 123677788899999999999999999999999999999976654
Q ss_pred ceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCC
Q 015532 227 IKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER-VLGP 303 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~-~~g~ 303 (405)
++|+|||++....... ....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.+ ....
T Consensus 134 ~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 213 (277)
T cd05607 134 CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED 213 (277)
T ss_pred EEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc
Confidence 4555555554332211 124688999999999988899999999999999999999999976432111111100 0000
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH---
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA--- 380 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta--- 380 (405)
. . ......++.++.+||.+||+.||++||++
T Consensus 214 -----------------------~-------------------~----~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~ 247 (277)
T cd05607 214 -----------------------E-------------------V----KFEHQNFTEESKDICRLFLAKKPEDRLGSREK 247 (277)
T ss_pred -----------------------c-------------------c----ccccccCCHHHHHHHHHHhccCHhhCCCCccc
Confidence 0 0 00012346789999999999999999999
Q ss_pred -HHHHcCCCCCCC
Q 015532 381 -REALRHPFFTRD 392 (405)
Q Consensus 381 -~elL~hp~f~~~ 392 (405)
++++.||||+.-
T Consensus 248 ~~~~~~h~~f~~~ 260 (277)
T cd05607 248 NDDPRKHEFFKTI 260 (277)
T ss_pred hhhhhcChhhcCC
Confidence 778899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.92 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=185.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||||.+.... .....+..|+++++.+.|+++....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36999999999999999999999999999999986532 2335677899999999998873221
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++++|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 1357888999999999999999999999999999999999999999999998765443221110
Q ss_pred cCCCCCCC-----ce-eccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 219 KNLPKSSA-----IK-LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~-----~k-l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
........ .+ ...+. ............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETF-SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhh-cccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 00000000 00 00000 0000111123578999999999998889999999999999999999999998776554
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.... ..++ .....+..+.++|.+||..
T Consensus 240 ~~~~~~~~~------------------------~~~~------------------------~~~~~~~~~~~li~~~l~~ 271 (316)
T cd05574 240 TFSNILKKE------------------------VTFP------------------------GSPPVSSSARDLIRKLLVK 271 (316)
T ss_pred HHHHHhcCC------------------------ccCC------------------------CccccCHHHHHHHHHHccC
Confidence 443322110 0000 0112467899999999999
Q ss_pred CCCCCCC----HHHHHcCCCCCCCC
Q 015532 373 DPAERLK----AREALRHPFFTRDV 393 (405)
Q Consensus 373 dP~~Rpt----a~elL~hp~f~~~~ 393 (405)
||++||| ++|+|+||||++..
T Consensus 272 ~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 272 DPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CHhHCCCchhhHHHHHcCchhhcCC
Confidence 9999999 99999999999853
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=286.16 Aligned_cols=223 Identities=30% Similarity=0.432 Sum_probs=172.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+++++++.|+++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 45899999999999999999999999999999986422 1234577899999999999873321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~------------------ 143 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNV------------------ 143 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE------------------
Confidence 1246778889999999999999999999999999999999876655
Q ss_pred cCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+|+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 144 ---------~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 144 ---------KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred ---------EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 55555544322111 022457889999999999889999999999999999999999997654443
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+..... ........+..+.+||.+||..
T Consensus 215 ~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~~l~~ 246 (263)
T cd06625 215 AIFKIATQPT------------------------------------------------NPQLPSHVSPDARNFLRRTFVE 246 (263)
T ss_pred HHHHHhccCC------------------------------------------------CCCCCccCCHHHHHHHHHHhhc
Confidence 3322211000 0011234466889999999999
Q ss_pred CCCCCCCHHHHHcCCCC
Q 015532 373 DPAERLKAREALRHPFF 389 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f 389 (405)
||++|||+.|+++|+||
T Consensus 247 ~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 247 NAKKRPSAEELLRHFFV 263 (263)
T ss_pred CcccCCCHHHHhhCCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.55 Aligned_cols=231 Identities=27% Similarity=0.470 Sum_probs=178.2
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
-|++.++||+|+||.||+|.+..++..+|+|.+... ....+.+.+|+++++.+.|+++....
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 378899999999999999999999999999998643 23456678899999999999873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~----------------------- 142 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDI----------------------- 142 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCE-----------------------
Confidence 1347888999999999999999999999999999999999776654
Q ss_pred CCCceeccCCCCccccC---CccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+|+|||++..... ......|+..|+|||++. +..++.++|||||||++|+|++|.+||...+..+...
T Consensus 143 ----kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 218 (282)
T cd06643 143 ----KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL 218 (282)
T ss_pred ----EEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH
Confidence 5555555433211 112346889999999984 3457789999999999999999999998766544433
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.....+. ......++.++.+||.+||+.||+
T Consensus 219 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~ 251 (282)
T cd06643 219 KIAKSEPPT-----------------------------------------------LAQPSRWSSEFKDFLKKCLEKNVD 251 (282)
T ss_pred HHhhcCCCC-----------------------------------------------CCCccccCHHHHHHHHHHccCChh
Confidence 332211000 001123456899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCCCCc
Q 015532 376 ERLKAREALRHPFFTRDVRRPT 397 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~~~~ 397 (405)
+|||++++++||||+.....+.
T Consensus 252 ~Rp~~~~il~~~~~~~~~~~~~ 273 (282)
T cd06643 252 ARWTTTQLLQHPFVTVNSNKPI 273 (282)
T ss_pred hCcCHHHHhcCCCEeccCCCCH
Confidence 9999999999999998766654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=286.16 Aligned_cols=247 Identities=34% Similarity=0.557 Sum_probs=183.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~~---------------- 154 (405)
|++.++||+|+||.||+|.+..+++.||+|+++... ........|+.++.++. |+++....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678999999999999999999999999999986532 22233457888999886 76652211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++. +.
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~---------------------- 137 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI---------------------- 137 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC----------------------
Confidence 134788899999999999999999999999999999999976 54
Q ss_pred CCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||.+....... ....++..|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 138 -----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 138 -----LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212 (282)
T ss_pred -----eEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHH
Confidence 5566666554332211 22457889999998754 457889999999999999999999999988888888888
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
...+..+..+....... ......++..... .........+..+.+||.+||++||++||
T Consensus 213 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 271 (282)
T cd07831 213 DVLGTPDAEVLKKFRKS------RHMNYNFPSKKGT---------------GLRKLLPNASAEGLDLLKKLLAYDPDERI 271 (282)
T ss_pred HHcCCCCHHHHHhhccc------ccccccCcccccc---------------cHHHHcccccHHHHHHHHHHhccCccccc
Confidence 88887776552211000 0011111111000 00111234577999999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|++++++||||
T Consensus 272 ~~~~~l~~~~~ 282 (282)
T cd07831 272 TAKQALRHPYF 282 (282)
T ss_pred CHHHHhhCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=286.87 Aligned_cols=252 Identities=30% Similarity=0.520 Sum_probs=184.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.++||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.+.|+++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46999999999999999999999899999999885432 2345677899999999999873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~---------------------- 138 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV---------------------- 138 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc----------------------
Confidence 124788999999999999999999999999999999999977664
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||......+....+
T Consensus 139 -----~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 139 -----VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred -----EEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 455555554432211 1224578899999998764 4788999999999999999999999888777777777
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....+.++........... ... ....+.. .............+..+.+|+.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 274 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNP--LFA---GMRLPEV--------------KEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274 (286)
T ss_pred HHHhCCCchhhHHHhccch--Hhh---ccccccc--------------cCcchHHHhCCCcCHHHHHHHHHHhcCCcccc
Confidence 7666655432211100000 000 0000000 00001111233567789999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||+.++++||||
T Consensus 275 p~~~~il~~~~~ 286 (286)
T cd07846 275 PSSSQLLHHEFF 286 (286)
T ss_pred hhHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.97 Aligned_cols=219 Identities=23% Similarity=0.349 Sum_probs=162.6
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
++|++.++||+|+||.||+|.+. .+++.||||+++... .....+.+|+.++..+ .|+++....
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 67999999999999999999752 345789999986432 2345688899999999 787763211
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCC
Q 015532 155 -YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233 (405)
Q Consensus 155 -~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 233 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~---------------------------~kl~DfG 219 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---------------------------VKICDFG 219 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc---------------------------EEEeecc
Confidence 012556677889999999999999999999999999999976654 4555555
Q ss_pred CCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChH
Q 015532 234 STTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHH 307 (405)
Q Consensus 234 ~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~ 307 (405)
++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...... +.
T Consensus 220 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~---- 294 (338)
T cd05102 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT---- 294 (338)
T ss_pred cccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC----
Confidence 554322111 12345678999999999899999999999999999997 99999875433222111100 00
Q ss_pred HHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 308 MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
. .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 295 -----------------~--------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 295 -----------------R--------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----------------C--------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 0011234668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=287.60 Aligned_cols=256 Identities=31% Similarity=0.491 Sum_probs=187.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.+.||+|+||+||+|.+..+++.||||.++... ...+.+..|+++++.+.|+++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46999999999999999999999999999999986432 2335677899999999998873211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+||+++..+
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~---------------------- 139 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT---------------------- 139 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC----------------------
Confidence 11246778889999999999999999999999999999997432
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
..+||+|||++...... .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||......+.+..
T Consensus 140 ----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 140 ----NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred ----CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 24677777766543221 1223578899999998764 578999999999999999999999998887777777
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+.+....+..... ...+.... ..| ............+..+.+++.+||+.||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~------------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 274 (294)
T PLN00009 216 IFRILGTPNEETWPGVTS-LPDYKSAF--PKW------------------PPKDLATVVPTLEPAGVDLLSKMLRLDPSK 274 (294)
T ss_pred HHHHhCCCChhhcccccc-chhhhhhc--ccC------------------CCCCHHHhCcCCChHHHHHHHHHccCChhh
Confidence 666666544433211100 00000000 000 000111112345778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~ 394 (405)
||++.++++||||+....
T Consensus 275 Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 275 RITARAALEHEYFKDLGD 292 (294)
T ss_pred CcCHHHHhcCchHhHHhc
Confidence 999999999999987543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=289.28 Aligned_cols=228 Identities=27% Similarity=0.415 Sum_probs=178.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.+|++.+.||.|+||.||+|.+..+++.||||.+.... ...+.+.+|+.+++.+.|+++....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 57999999999999999999999999999999986432 2345678899999999999874321
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++.++..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~------------------------- 153 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS------------------------- 153 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-------------------------
Confidence 124788999999999999999999999999999999999977664
Q ss_pred CCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
++|+|||++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 154 --~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~- 230 (296)
T cd06655 154 --VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN- 230 (296)
T ss_pred --EEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-
Confidence 455555544332211 12246888999999999888999999999999999999999999877654443322110
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
..+ .......+++.+.+||.+||..||++|||+.
T Consensus 231 -~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~ 264 (296)
T cd06655 231 -GTP---------------------------------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAK 264 (296)
T ss_pred -CCc---------------------------------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHH
Confidence 000 0011234566889999999999999999999
Q ss_pred HHHcCCCCCCCC
Q 015532 382 EALRHPFFTRDV 393 (405)
Q Consensus 382 elL~hp~f~~~~ 393 (405)
++++||||+...
T Consensus 265 ~il~~~~~~~~~ 276 (296)
T cd06655 265 ELLQHPFLKLAK 276 (296)
T ss_pred HHhhChHhhhcc
Confidence 999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.26 Aligned_cols=254 Identities=29% Similarity=0.468 Sum_probs=179.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.+.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 367999999999999999999999999999999986432 2234567899999999999873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---------------------- 141 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---------------------- 141 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc----------------------
Confidence 123567788899999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN-LEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~ 296 (405)
++|+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..
T Consensus 142 -----~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 216 (291)
T cd07870 142 -----LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216 (291)
T ss_pred -----EEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Confidence 555566555432111 1223578899999998764 578899999999999999999999976543 355555
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+.+++........ ...+.. .+.... ........+. . ...+..+.+++.+||+.||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~-~~~~~~~~~~----------~-~~~~~~~~~ll~~~l~~dp~~ 278 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSK-LPNYKP-----EWFLPC-KPQQLRVVWK----------R-LSRPPKAEDLASQMLMMFPKD 278 (291)
T ss_pred HHHHcCCCChhhhhhhhh-cccccc-----hhcccc-CCcchhhhcc----------c-cCCChHHHHHHHHHhCcCccc
Confidence 666666554443222110 000000 000000 0000011110 0 012567889999999999999
Q ss_pred CCCHHHHHcCCCC
Q 015532 377 RLKAREALRHPFF 389 (405)
Q Consensus 377 Rpta~elL~hp~f 389 (405)
|||++|++.||||
T Consensus 279 R~t~~~~l~h~~~ 291 (291)
T cd07870 279 RISAQDALLHPYF 291 (291)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=289.06 Aligned_cols=225 Identities=26% Similarity=0.481 Sum_probs=172.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCC---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGT--------------- 153 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~--------------- 153 (405)
..+.|++.+.||+|+||.||+|++..+++.||+|++.........+..|+.+++++ .|+++...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 34679999999999999999999999999999999876555556678899999998 46654210
Q ss_pred --------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 154 --------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 154 --------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
....+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~-------------- 159 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE-------------- 159 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--------------
Confidence 0123677788999999999999999999999999999999976554
Q ss_pred CCCcccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
++|+|||.+..... ......|+..|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 160 -------------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 160 -------------VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred -------------EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 56666666543221 122356899999999986 345888999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
...........+.+.. + .. .....++.++.+|
T Consensus 227 ~~~~~~~~~~~~~~~~---~------------------------------------------~~---~~~~~~~~~~~~l 258 (282)
T cd06636 227 CDMHPMRALFLIPRNP---P------------------------------------------PK---LKSKKWSKKFIDF 258 (282)
T ss_pred cccCHHhhhhhHhhCC---C------------------------------------------CC---CcccccCHHHHHH
Confidence 7655433222111100 0 00 0012346689999
Q ss_pred HHHccccCCCCCCCHHHHHcCCCC
Q 015532 366 LQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~hp~f 389 (405)
|.+||+.||++|||+.|+|+||||
T Consensus 259 i~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 259 IEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=287.34 Aligned_cols=228 Identities=27% Similarity=0.413 Sum_probs=179.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.+.||.|+||.||+|++..+++.||+|++.... .....+.+|+++++.+.|+++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46899999999999999999999999999999986432 2335577899999999999873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~------------------------ 136 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD------------------------ 136 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC------------------------
Confidence 125788999999999999999999999999999999999977654
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
++|+|||.+...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 137 ---~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 213 (274)
T cd06609 137 ---VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213 (274)
T ss_pred ---EEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc
Confidence 556666655443321 22346888999999999888999999999999999999999999766544333222211
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC-chHHHHHHHHHccccCCCCCCC
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
..+ ..... ++..+.++|.+||..||++|||
T Consensus 214 ~~~-------------------------------------------------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt 244 (274)
T cd06609 214 NPP-------------------------------------------------SLEGNKFSKPFKDFVSLCLNKDPKERPS 244 (274)
T ss_pred CCC-------------------------------------------------CCcccccCHHHHHHHHHHhhCChhhCcC
Confidence 000 00011 4567899999999999999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 015532 380 AREALRHPFFTRDVRR 395 (405)
Q Consensus 380 a~elL~hp~f~~~~~~ 395 (405)
++++++||||+...+.
T Consensus 245 ~~~il~~~~~~~~~~~ 260 (274)
T cd06609 245 AKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhChhhcCCCcc
Confidence 9999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=288.79 Aligned_cols=229 Identities=27% Similarity=0.407 Sum_probs=177.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..+|++.+.||+|+||.||+|++..+++.||+|.+.... ...+.+.+|+.+++.+.|+++....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 368999999999999999999999999999999986433 2345677899999999999873221
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++.++..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~------------------------ 154 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS------------------------ 154 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC------------------------
Confidence 123677889999999999999999999999999999999976554
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
++|+|||.+...... .....|++.|+|||.+.+..++.++|||||||++|+|++|..||........+..+...
T Consensus 155 ---~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~ 231 (296)
T cd06654 155 ---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (296)
T ss_pred ---EEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC
Confidence 556666655432211 12246889999999999888999999999999999999999999876553332221110
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
+. + .......++..+.+||.+||..||++|||+
T Consensus 232 -~~-~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 264 (296)
T cd06654 232 -GT-P---------------------------------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSA 264 (296)
T ss_pred -CC-C---------------------------------------------CCCCccccCHHHHHHHHHHCcCCcccCcCH
Confidence 00 0 001112345678999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 015532 381 REALRHPFFTRDV 393 (405)
Q Consensus 381 ~elL~hp~f~~~~ 393 (405)
.++++||||....
T Consensus 265 ~eil~~~~~~~~~ 277 (296)
T cd06654 265 KELLQHQFLKIAK 277 (296)
T ss_pred HHHhhChhhhccC
Confidence 9999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.08 Aligned_cols=216 Identities=31% Similarity=0.424 Sum_probs=170.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc-hhhhhHHHHHHHHHHHHHh-hcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLA-RHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~il~~l~-~~~~~~~~--------------- 154 (405)
.+++|.+.|.+|||+.||+|++...+..||+|++-. .+...+...+||++|+.|. |+||+...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 478999999999999999999998888999998744 3445677889999999998 77763211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...|++.++++|+.|+++|+.+||... |||||||-|||||+.+|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g------------- 183 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG------------- 183 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-------------
Confidence 235899999999999999999999987 99999999999998766
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCc------------cceecCCCcchhHHHh---CCCCCCchhHHHHHHHHH
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------------SYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------------~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ 276 (405)
..||||||++....... -....|+.|+|||++. +.+.+.|+|||+|||+||
T Consensus 184 --------------~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 184 --------------NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred --------------CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence 45667777664322111 1135799999999984 668999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc
Q 015532 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356 (405)
Q Consensus 277 ~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (405)
-|+....||++.....++. ++..+|. ..
T Consensus 250 kLCy~t~PFe~sg~laIln----------------------------g~Y~~P~------------------------~p 277 (738)
T KOG1989|consen 250 KLCYFTTPFEESGKLAILN----------------------------GNYSFPP------------------------FP 277 (738)
T ss_pred HHHHhCCCcCcCcceeEEe----------------------------ccccCCC------------------------Cc
Confidence 9999999998753322111 1122221 24
Q ss_pred CchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 357 HSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 357 ~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.++..+.+||+.||+.||++||++-|++.+
T Consensus 278 ~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 278 NYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 568899999999999999999999998853
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.29 Aligned_cols=234 Identities=26% Similarity=0.391 Sum_probs=178.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+..|+.+++.+.|+++....
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3478999999999999999999999999999999986433 2345677899999999999873321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||+.||+||||||+|||++.++.
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~----------------------- 153 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS----------------------- 153 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-----------------------
Confidence 124677889999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 154 ----~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~ 229 (297)
T cd06656 154 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (297)
T ss_pred ----EEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc
Confidence 455555554432211 1224688899999999988899999999999999999999999976544322211100
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.+.. ........+..+.+|+.+||+.||++|||
T Consensus 230 -~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 230 -NGTP----------------------------------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred -CCCC----------------------------------------------CCCCccccCHHHHHHHHHHccCChhhCcC
Confidence 0000 00111234567889999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCc
Q 015532 380 AREALRHPFFTRDVRRPT 397 (405)
Q Consensus 380 a~elL~hp~f~~~~~~~~ 397 (405)
++++++||||+.....+.
T Consensus 263 ~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 263 AKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHhcCchhcccccccc
Confidence 999999999987654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=283.66 Aligned_cols=249 Identities=32% Similarity=0.511 Sum_probs=182.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
+|++.++||.|++|.||+|++..+++.||||+++... ...+.+..|+.+++.+.|+++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4899999999999999999999999999999986532 2345667899999999998863211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~--------------------- 139 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL--------------------- 139 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcE---------------------
Confidence 1247889999999999999999999999999999999999776654
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+|+|||++...... .....++..|++||++.+. .++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 140 ------~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 140 ------KLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred ------EEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 55555544322211 1123578899999998764 5789999999999999999999999988877777776
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+....+......... ....+. ...+.. .. ..........+..++++|.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~--~~-------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 272 (284)
T cd07836 214 FRIMGTPTESTWPGIS-QLPEYK-----PTFPRY--PP-------------QDLQQLFPHADPLGIDLLHRLLQLNPELR 272 (284)
T ss_pred HHHhCCCChhhHHHHh-cCchhc-----ccccCC--Ch-------------HHHHHHhhhcCcHHHHHHHHHhcCCcccC
Confidence 6665554443322211 000000 000000 00 00011112346789999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||+.|+++||||
T Consensus 273 ~~~~~~l~~~~f 284 (284)
T cd07836 273 ISAHDALQHPWF 284 (284)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.16 Aligned_cols=252 Identities=31% Similarity=0.509 Sum_probs=184.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.|++.+.||.|+||.||+|.+..+++.||+|.++... .....+.+|+.+++++.|+++....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46999999999999999999999999999999996432 2233466899999999998863210
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-------------------- 144 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-------------------- 144 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--------------------
Confidence 123788899999999999999999999999999999999987664
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
++|+|||++...... .....++..|+|||.+.+.. ++.++|||||||++|+|++|.+||......+.+.
T Consensus 145 -------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~ 217 (293)
T cd07843 145 -------LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217 (293)
T ss_pred -------EEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 455555554432221 12235788999999987654 6899999999999999999999999988888877
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC-chHHHHHHHHHccccCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~~L~~dP 374 (405)
.+....+.++...+........ .....+.. ............. .++.+.+||.+||+.||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 278 (293)
T cd07843 218 KIFKLLGTPTEKIWPGFSELPG-----AKKKTFTK--------------YPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278 (293)
T ss_pred HHHHHhCCCchHHHHHhhccch-----hccccccc--------------ccchhhhccccccCCChHHHHHHHHHhccCc
Confidence 7777776655443322110000 00000000 0000000111111 46789999999999999
Q ss_pred CCCCCHHHHHcCCCC
Q 015532 375 AERLKAREALRHPFF 389 (405)
Q Consensus 375 ~~Rpta~elL~hp~f 389 (405)
++|||+.|+|+||||
T Consensus 279 ~~R~t~~ell~~~~f 293 (293)
T cd07843 279 AKRISAEDALKHPYF 293 (293)
T ss_pred cccCCHHHHhcCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=281.48 Aligned_cols=223 Identities=27% Similarity=0.457 Sum_probs=175.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .+.+.+|+.+++.+.|+++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 569999999999999999999998899999999976544 67788999999999998873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~------------------------ 137 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ------------------------ 137 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc------------------------
Confidence 235688999999999999999999999999999999999976654
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 138 ---~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (256)
T cd06612 138 ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK 214 (256)
T ss_pred ---EEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC
Confidence 555666655433221 12245788999999999988999999999999999999999999765443322211000
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
. .........++..+.++|.+||+.||++|||+
T Consensus 215 ---~--------------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 247 (256)
T cd06612 215 ---P--------------------------------------------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSA 247 (256)
T ss_pred ---C--------------------------------------------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCH
Confidence 0 00000112345688999999999999999999
Q ss_pred HHHHcCCCC
Q 015532 381 REALRHPFF 389 (405)
Q Consensus 381 ~elL~hp~f 389 (405)
.|+|+||||
T Consensus 248 ~~il~~~~~ 256 (256)
T cd06612 248 IQLLQHPFI 256 (256)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.29 Aligned_cols=232 Identities=26% Similarity=0.458 Sum_probs=177.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.+.|+++++||+|+||.||+|++..+++.||+|++.... ...+.+..|+.+++.+.|+++....
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999999999999999986533 3456677899999999998873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~---------------------- 148 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---------------------- 148 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC----------------------
Confidence 134688899999999999999999999999999999999976554
Q ss_pred CCCCCceeccCCCCccccC---CccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
++|+|||.+..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+....
T Consensus 149 -----~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 223 (292)
T cd06644 149 -----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223 (292)
T ss_pred -----EEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH
Confidence 55666665543211 1123467889999999853 3478899999999999999999999977654433
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+.+. ..| .......++.++.+||.+||..|
T Consensus 224 ~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~ 256 (292)
T cd06644 224 LLKIAKS--EPP---------------------------------------------TLSQPSKWSMEFRDFLKTALDKH 256 (292)
T ss_pred HHHHhcC--CCc---------------------------------------------cCCCCcccCHHHHHHHHHHhcCC
Confidence 3222110 000 00011234567899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~~~ 396 (405)
|++||+++++++||||..-...+
T Consensus 257 p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 257 PETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cccCcCHHHHhcCccccccccch
Confidence 99999999999999998744433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.84 Aligned_cols=221 Identities=27% Similarity=0.419 Sum_probs=174.1
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.|++.+.||+|+||.||+|.+..+++.|++|.+... ......+..|+++++.+.|+++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 388899999999999999999999999999998642 34456788899999999999873321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~-------------------- 140 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNV-------------------- 140 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCE--------------------
Confidence 1346778889999999999999999999999999999999876644
Q ss_pred CCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+|+|||++....... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+
T Consensus 141 -------~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 141 -------KIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred -------EEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 555555544322211 2246788999999999888999999999999999999999999877654433332
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+. ..+ .....++..+.++|.+||+.+|++|
T Consensus 214 ~~~--~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R 244 (256)
T cd08529 214 IRG--VFP-----------------------------------------------PVSQMYSQQLAQLIDQCLTKDYRQR 244 (256)
T ss_pred HcC--CCC-----------------------------------------------CCccccCHHHHHHHHHHccCCcccC
Confidence 211 000 0011345688999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
|++.++++|||+
T Consensus 245 p~~~~ll~~~~~ 256 (256)
T cd08529 245 PDTFQLLRNPSL 256 (256)
T ss_pred cCHHHHhhCCCC
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.81 Aligned_cols=229 Identities=24% Similarity=0.412 Sum_probs=173.4
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc-----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR----------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~----------- 154 (405)
-....++|++.+.||+|+||.||+|.+..+++.||+|+++......+.+..|+.+++.+ .|+++....
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 34566899999999999999999999999999999999876544456677899999999 587763210
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---------- 162 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---------- 162 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC----------
Confidence 123567778889999999999999999999999999999977654
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg 281 (405)
++|+|||++..... ......|+..|+|||++.. ..++.++|||||||++|+|++|
T Consensus 163 -----------------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g 225 (286)
T cd06638 163 -----------------VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225 (286)
T ss_pred -----------------EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence 55556665543221 1122468999999999853 3578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
..||........+..+... ..+ ........+..
T Consensus 226 ~~p~~~~~~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~ 258 (286)
T cd06638 226 DPPLADLHPMRALFKIPRN--PPP---------------------------------------------TLHQPELWSNE 258 (286)
T ss_pred CCCCCCCchhHHHhhcccc--CCC---------------------------------------------cccCCCCcCHH
Confidence 9999765543322211100 000 00011223567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
+.+||.+||+.||++|||+.|+++|+||
T Consensus 259 ~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 259 FNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 8999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=285.79 Aligned_cols=230 Identities=22% Similarity=0.372 Sum_probs=175.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++++.||+|+||.||+|.+..+++.||+|.++.. ......+.+|+++++++.|+++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3689999999999999999999989999999988642 23345678899999999998772211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||+ +||+||||||+||+++.++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-------------------- 140 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-------------------- 140 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--------------------
Confidence 1267889999999999999999996 5999999999999997655
Q ss_pred cCCCCCCCceeccCCCCccccC-CccceecCCCcchhHHHhCC------CCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
.++|+|||.+..... ......++..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 141 -------~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 141 -------QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred -------CEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 456666666543322 12234678899999998653 3578999999999999999999999765443
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+.......+. .....++.++.+||.+||+
T Consensus 214 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~ 247 (286)
T cd06622 214 NIFAQLSAIVDGDPP----------------------------------------------TLPSGYSDDAQDFVAKCLN 247 (286)
T ss_pred hHHHHHHHHhhcCCC----------------------------------------------CCCcccCHHHHHHHHHHcc
Confidence 333333222111110 0112346788999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.+|++||+++++++||||.....
T Consensus 248 ~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 248 KIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred cCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999977543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=277.44 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=179.4
Q ss_pred CCeEEE-eeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCC----------------
Q 015532 92 PRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGT---------------- 153 (405)
Q Consensus 92 ~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~---------------- 153 (405)
+-|++. +.||+|+|+.|--|....++..||||++.+.. ..+....+|++++.....|..+-.
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 345554 67999999999999999999999999997653 457788999999998865543110
Q ss_pred ------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 154 ------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 154 ------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
....|++.++..++++|+.||+|||.+||.||||||+|||....+
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn----------------------- 213 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN----------------------- 213 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-----------------------
Confidence 024689999999999999999999999999999999999987644
Q ss_pred CCCCCceeccCCCCcccc----------CCccceecCCCcchhHHHh---C--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 222 PKSSAIKLIDFGSTTFEH----------QDHSYVVSTRHYRAPEVIL---G--LGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~----------~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.-..+|||||.+..-.. ....+.+|+..|||||+.. + ..|+.++|.||||+|+|.||+|.+||.
T Consensus 214 -~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 214 -KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred -CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 23457888876653221 1223468999999999874 2 358999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.-..+.-..- |.. .+.+....--..+.+...+|+ ..|..+|.+.+||+
T Consensus 293 G~Cg~dCGWdr----Ge~-----Cr~CQ~~LFesIQEGkYeFPd----------------------kdWahIS~eakdli 341 (463)
T KOG0607|consen 293 GHCGADCGWDR----GEV-----CRVCQNKLFESIQEGKYEFPD----------------------KDWAHISSEAKDLI 341 (463)
T ss_pred CccCCcCCccC----CCc-----cHHHHHHHHHHHhccCCcCCh----------------------hhhHHhhHHHHHHH
Confidence 75322100000 000 000000000001122333333 22345688999999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
+.+|..|+.+|.+|.++++|||++....
T Consensus 342 snLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 342 SNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHhccHHhhhhhhhccCCccccccch
Confidence 9999999999999999999999987643
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=293.07 Aligned_cols=273 Identities=29% Similarity=0.487 Sum_probs=191.0
Q ss_pred cCCCeEE-EeeeecccceeEEEEEecCCCcEEEEEEecchhhhh---------------HHHHHHHHHHHHHhhcCCCCC
Q 015532 90 LTPRYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------------EAAMIEIDVLQRLARHDIGGT 153 (405)
Q Consensus 90 ~~~~y~~-~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---------------~~~~~E~~il~~l~~~~~~~~ 153 (405)
+.++|.. .+.||.|+||+||+|.+..+++.||||+++...... ..+.+|+++++.+.|+++...
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4577875 467999999999999999999999999986432211 246789999999999887332
Q ss_pred c--------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 154 R--------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 154 ~--------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred eEEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 1 13468889999999999999999999999999999999999888888888876
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
+.......... ..-.+.+. ..........++..|+|||.+.+. .++.++|||||||++|+|++|.+||.
T Consensus 166 ~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 166 ARRYGYPPYSD--------TLSKDETM--QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred eeecccccccc--------cccccccc--cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 64332111000 00000000 000111223568899999998764 47899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.+..+.+..+....+.++...+..... ...+ ..+.. ..+..........+..+.+||
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~------~~~~~---------------~~~~~~~~~~~~~~~~~~~li 293 (335)
T PTZ00024 236 GENEIDQLGRIFELLGTPNEDNWPQAKK-LPLY------TEFTP---------------RKPKDLKTIFPNASDDAIDLL 293 (335)
T ss_pred CCCHHHHHHHHHHHhCCCchhhCcchhh-cccc------cccCc---------------CCcccHHHhCcCCChHHHHHH
Confidence 9888887777777666554321110000 0000 00000 000011112234467899999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.+||+.||++|||++|+|.||||+....
T Consensus 294 ~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 294 QSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999999999999999999999997643
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=282.49 Aligned_cols=230 Identities=26% Similarity=0.442 Sum_probs=172.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----------hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++++.|+++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999998889999999885321 1225577899999999998873211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||++.....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 2356788899999999999999999999999999999999877766666665443221100
Q ss_pred CcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
. ............|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+......
T Consensus 161 ~------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (267)
T cd06628 161 L------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222 (267)
T ss_pred c------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence 0 0000011122458889999999998889999999999999999999999998765433332
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.... . .......+..+.++|.+||+.||+
T Consensus 223 ~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~ 253 (267)
T cd06628 223 KIGENA--S-----------------------------------------------PEIPSNISSEAIDFLEKTFEIDHN 253 (267)
T ss_pred HHhccC--C-----------------------------------------------CcCCcccCHHHHHHHHHHccCCch
Confidence 221100 0 001123466889999999999999
Q ss_pred CCCCHHHHHcCCCC
Q 015532 376 ERLKAREALRHPFF 389 (405)
Q Consensus 376 ~Rpta~elL~hp~f 389 (405)
+||++.|+++||||
T Consensus 254 ~Rp~~~~il~~~~~ 267 (267)
T cd06628 254 KRPTAAELLKHPFL 267 (267)
T ss_pred hCcCHHHHhhCCCC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.72 Aligned_cols=249 Identities=35% Similarity=0.579 Sum_probs=184.6
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---hhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
|++.+.||+|++|.||+|.+..+++.+|+|.++.... ....+..|+++++.+.|+++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6778999999999999999998999999999864322 345677899999999998763211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~------------------------ 136 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV------------------------ 136 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc------------------------
Confidence 135788899999999999999999999999999999999976654
Q ss_pred CCCceeccCCCCccccCCc---cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+....... ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+..+..
T Consensus 137 ---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 213 (283)
T cd05118 137 ---LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213 (283)
T ss_pred ---EEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4555555543332221 123577889999999876 688999999999999999999999998888887777776
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.++.................. ...+.. ......+.....+..+.+||.+||+.||.+||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 273 (283)
T cd05118 214 TLGTPDPEVWPKFTSLARNYK-----FSFPKK---------------AGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273 (283)
T ss_pred HcCCCchHhcccchhhhhhhh-----hhhccc---------------cccCHHHhhhhhCHHHHHHHHHHhccCcccCcC
Confidence 666544333222211111000 000000 000001122345778999999999999999999
Q ss_pred HHHHHcCCCC
Q 015532 380 AREALRHPFF 389 (405)
Q Consensus 380 a~elL~hp~f 389 (405)
+.++++||||
T Consensus 274 ~~~ll~~~~~ 283 (283)
T cd05118 274 AEQALAHPYF 283 (283)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=282.24 Aligned_cols=222 Identities=31% Similarity=0.452 Sum_probs=168.2
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.|++.+.||+|+||.||+|.+..++..||+|+++... ...+.+.+|+.+++.+.|+++....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5889999999999999999999999999999885321 2234577899999999998873211
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~----------------- 145 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNV----------------- 145 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCE-----------------
Confidence 1246778888999999999999999999999999999999766544
Q ss_pred ccCCCCCCCceeccCCCCccccC------CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
+|+|||++..... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......
T Consensus 146 ----------~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~ 215 (266)
T cd06651 146 ----------KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215 (266)
T ss_pred ----------EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH
Confidence 5555554432211 111245788999999999888999999999999999999999999765443
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+... +.. .......++.+.+|| +||.
T Consensus 216 ~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~~~li-~~~~ 246 (266)
T cd06651 216 AAIFKIATQ-PTN-----------------------------------------------PQLPSHISEHARDFL-GCIF 246 (266)
T ss_pred HHHHHHhcC-CCC-----------------------------------------------CCCchhcCHHHHHHH-HHhc
Confidence 332221110 000 001122355778888 6777
Q ss_pred cCCCCCCCHHHHHcCCCCC
Q 015532 372 YDPAERLKAREALRHPFFT 390 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~ 390 (405)
.||++|||++|+++||||+
T Consensus 247 ~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 247 VEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CChhhCcCHHHHhcCcccc
Confidence 8999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.97 Aligned_cols=252 Identities=29% Similarity=0.476 Sum_probs=197.9
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
.+.||.|+||+||.+.|..+|+.||+|.+.... .....+.+|+.+|..+.|.|+...+
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 468999999999999999999999999885321 2346677899999998888763211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
-..++.+.++-++.||+.||+|||+.||.||||||.|+|+++
T Consensus 138 LmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS-------------------------- 191 (449)
T KOG0664|consen 138 LMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS-------------------------- 191 (449)
T ss_pred HHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--------------------------
Confidence 245677889999999999999999999999999999999975
Q ss_pred CCCCceeccCCCCccccCCcc----ceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+..+||||||+++..+.+.. ..+-|.+|+|||++.|. .|+.++||||.|||+.||+..+..|...+..+++..|
T Consensus 192 -NCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 192 -NCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred -CceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 45678888888876654432 24678899999999987 4999999999999999999999999999999999999
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhh-hhhcccCchHHHHHHHHHccccCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL-IMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
..++|++..+-....++..+....+++... |+ .+.+ .........-+..+++.+||.+||++
T Consensus 271 tdLLGTPs~EaMr~ACEGAk~H~LR~~~k~-Ps----------------~~vLYtlsS~~~~~heav~~~~~~l~~d~dk 333 (449)
T KOG0664|consen 271 IDLLGTPSQEAMKYACEGAKNHVLRAGLRA-PD----------------TQRLYKIASPDDKNHEAVDLLQKLLHFDPDK 333 (449)
T ss_pred HHHhCCCcHHHHHHHhhhhHHHhhccCCCC-CC----------------ccceeeecCCcccchHHHHHHHHHhCCCCcc
Confidence 999999987776666666655544432110 00 0000 00111122346778999999999999
Q ss_pred CCCHHHHHcCCCCCCC
Q 015532 377 RLKAREALRHPFFTRD 392 (405)
Q Consensus 377 Rpta~elL~hp~f~~~ 392 (405)
|.+.++++.|++..+.
T Consensus 334 ris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 334 RISVEEALQHRYLEEG 349 (449)
T ss_pred cccHhhhccccccccc
Confidence 9999999999998764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=288.14 Aligned_cols=232 Identities=24% Similarity=0.389 Sum_probs=178.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
+.|.....||+|+||.||++.+..+++.||||.+.... ...+.+.+|+.+++.+.|+++....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44666788999999999999999899999999986432 3445678899999999998862210
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~------------------------ 157 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI------------------------ 157 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCE------------------------
Confidence 1346888999999999999999999999999999999999776654
Q ss_pred CCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
+|+|||++..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...+....+..+....
T Consensus 158 ---kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (292)
T cd06658 158 ---KLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234 (292)
T ss_pred ---EEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 5555554432211 1123468899999999988889999999999999999999999998766554443332211
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
.... ......+..+.+||.+||..||++|||++
T Consensus 235 ~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 267 (292)
T cd06658 235 PPRV-----------------------------------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQ 267 (292)
T ss_pred CCcc-----------------------------------------------ccccccCHHHHHHHHHHccCChhHCcCHH
Confidence 1000 00112456789999999999999999999
Q ss_pred HHHcCCCCCCCCCCCc
Q 015532 382 EALRHPFFTRDVRRPT 397 (405)
Q Consensus 382 elL~hp~f~~~~~~~~ 397 (405)
|+++||||........
T Consensus 268 ~il~~~~~~~~~~~~~ 283 (292)
T cd06658 268 ELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHhhChhhhccCCccc
Confidence 9999999997654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.23 Aligned_cols=248 Identities=33% Similarity=0.538 Sum_probs=183.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
|++.+.||.|++|.||+|.+..+|+.||||++.... ...+.+.+|+++++.++|+++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999999999999999986432 2235677899999999999874211
Q ss_pred ----------c--ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ----------Y--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ----------~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
. ..+++..+..++.||+.||.|||+++++||||+|+||+++.++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~----------------------- 137 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA----------------------- 137 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc-----------------------
Confidence 1 24788999999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||.+...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||...+....+..+.
T Consensus 138 ----~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 138 ----LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred ----EEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 455555554332211 1123568889999988764 47899999999999999999999999888877777777
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+..+.+....+...... ..+... .+. .. ..........++..+.++|.+||+.||++||
T Consensus 214 ~~~~~~~~~~~~~~~~~-~~~~~~-----~~~--------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 272 (283)
T cd07835 214 RTLGTPDEDVWPGVTSL-PDYKPT-----FPK--------------WA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272 (283)
T ss_pred HHhCCCChHHhhhhhhc-hhhhhh-----ccc--------------cc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCc
Confidence 76666554432221110 000000 000 00 0001112344567899999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|++|+++||||
T Consensus 273 t~~~il~~~~~ 283 (283)
T cd07835 273 SAKAALQHPYF 283 (283)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=286.38 Aligned_cols=229 Identities=30% Similarity=0.488 Sum_probs=177.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
++|++++.||.|+||.||+|.+..+++.||+|+++... ...+.+..|+++++++.|+++....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56999999999999999999998899999999986433 3345678899999999998873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~----------------------- 141 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD----------------------- 141 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC-----------------------
Confidence 135788999999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccC---CccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
++|+|||.+..... ......|+..|+|||++.. ..++.++|||||||++|+|++|..||...+....+
T Consensus 142 ----~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~ 217 (280)
T cd06611 142 ----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217 (280)
T ss_pred ----EEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH
Confidence 55566665433221 1223568999999999853 34778999999999999999999999876554433
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+... ..| .......++..+.+||.+||+.||
T Consensus 218 ~~~~~~--~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p 250 (280)
T cd06611 218 LKILKS--EPP---------------------------------------------TLDQPSKWSSSFNDFLKSCLVKDP 250 (280)
T ss_pred HHHhcC--CCC---------------------------------------------CcCCcccCCHHHHHHHHHHhccCh
Confidence 322211 000 001112346688999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~ 394 (405)
++|||++++++||||.....
T Consensus 251 ~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 251 DDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred hhCcCHHHHhcChhhcccch
Confidence 99999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.10 Aligned_cols=227 Identities=27% Similarity=0.488 Sum_probs=173.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-------hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
+|+..+.||+|+||.||+|.+..+++.||+|+++... ...+.+..|+.+++.+.|+++....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999986422 2346678899999999998873221
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++|++|+||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~------------------- 141 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ------------------- 141 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-------------------
Confidence 235678899999999999999999999999999999999975431
Q ss_pred cCCCCCCCceeccCCCCccccCC-------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||+||++|+|++|..||......
T Consensus 142 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 142 -------RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred -------EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 3566666665433221 12246788999999998888999999999999999999999999754432
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+.+.... . .........++++.+++.+||+
T Consensus 215 ~~~~~~~~~~~~-------------------~--------------------------~~~~~~~~~~~~~~~~i~~~l~ 249 (268)
T cd06630 215 NHLALIFKIASA-------------------T--------------------------TAPSIPEHLSPGLRDVTLRCLE 249 (268)
T ss_pred chHHHHHHHhcc-------------------C--------------------------CCCCCchhhCHHHHHHHHHHcC
Confidence 222221111000 0 0001112346789999999999
Q ss_pred cCCCCCCCHHHHHcCCCCC
Q 015532 372 YDPAERLKAREALRHPFFT 390 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~ 390 (405)
.||++|||+.++++||||+
T Consensus 250 ~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 250 LQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCcccCcCHHHHhcCcccC
Confidence 9999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.60 Aligned_cols=221 Identities=30% Similarity=0.442 Sum_probs=173.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc-CCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~-~~~~~~-------------- 154 (405)
+.+.|++...+|.|+|+.|-.|.+..+++.+++|++.+.. ....+|+.++....++ +++...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4577999999999999999999999999999999997642 2234577666665544 442211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cccccccCCccccccCCCCCCcccCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~-~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
.......++..+++||+.|+.|||++|||||||||+|||++ +.
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~------------------------ 452 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA------------------------ 452 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC------------------------
Confidence 11122256778999999999999999999999999999994 43
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
.+++|+|||.+........+.+-|..|.|||++....|+.++||||||++||+||+|+.||........+ ...+
T Consensus 453 ---g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i 526 (612)
T KOG0603|consen 453 ---GHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRI 526 (612)
T ss_pred ---CcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH---HHhh
Confidence 3578888888877766655557788999999999999999999999999999999999999876554111 1111
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
+..+. ...+|+.++|||.+||++||.+|+++.
T Consensus 527 ~~~~~------------------------------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~ 558 (612)
T KOG0603|consen 527 QMPKF------------------------------------------------SECVSDEAKDLLQQLLQVDPALRLGAD 558 (612)
T ss_pred cCCcc------------------------------------------------ccccCHHHHHHHHHhccCChhhCcChh
Confidence 11110 135688999999999999999999999
Q ss_pred HHHcCCCCCC
Q 015532 382 EALRHPFFTR 391 (405)
Q Consensus 382 elL~hp~f~~ 391 (405)
+++.||||.+
T Consensus 559 ~i~~h~w~~~ 568 (612)
T KOG0603|consen 559 EIGAHPWFLS 568 (612)
T ss_pred hhccCcchhc
Confidence 9999999933
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=287.53 Aligned_cols=230 Identities=26% Similarity=0.413 Sum_probs=172.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~~--------------- 154 (405)
.|+..+.||+|+||.||++.+..+++.||||.+.... .....+..|+.++.++. |+++....
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4677789999999999999999999999999986432 33456788999999997 77763211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~------------------ 146 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN------------------ 146 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc------------------
Confidence 1346788899999999999999997 49999999999999976554
Q ss_pred ccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
++|+|||++...... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 147 ---------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-- 215 (288)
T cd06616 147 ---------IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-- 215 (288)
T ss_pred ---------EEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--
Confidence 566666655432221 1223678899999999876 688999999999999999999999976542
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.+.....+. .........++.++.+||.+||+.
T Consensus 216 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~l~~li~~~l~~ 253 (288)
T cd06616 216 VFDQLTQVVKGDPP------------------------------------------ILSNSEEREFSPSFVNFINLCLIK 253 (288)
T ss_pred HHHHHhhhcCCCCC------------------------------------------cCCCcCCCccCHHHHHHHHHHccC
Confidence 22222221111000 000011123567899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~ 393 (405)
||++|||++++++||||+...
T Consensus 254 ~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 254 DESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ChhhCcCHHHHhcChhhhchh
Confidence 999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.81 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=178.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc---hhhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..+...+...||+|.||+||+|++. | .||||+++- .....+.|.+|+.++++-+|.||.-.+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeee
Confidence 3345678899999999999999986 3 499999964 234567899999999999999983221
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...|.......|++||++|+.|||.++|||||||..||++.+++.+
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kV------------------- 527 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKV------------------- 527 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcE-------------------
Confidence 2346677888999999999999999999999999999999876655
Q ss_pred CCCCCCCceeccCCCCcccc-----CCccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 220 NLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
||.|||++.... .......|...|||||++.. .+|++.+|||||||++|||++|..||......
T Consensus 528 --------kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 528 --------KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred --------EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 555555443211 11122467888999999974 46999999999999999999999999955555
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+++.++-+..+.+ . ......+...++++|+..||.
T Consensus 600 qIifmVGrG~l~p-d--------------------------------------------~s~~~s~~pk~mk~Ll~~C~~ 634 (678)
T KOG0193|consen 600 QIIFMVGRGYLMP-D--------------------------------------------LSKIRSNCPKAMKRLLSDCWK 634 (678)
T ss_pred heEEEecccccCc-c--------------------------------------------chhhhccCHHHHHHHHHHHHh
Confidence 5554443321110 0 001113456689999999999
Q ss_pred cCCCCCCCHHHHHc--------CCCCCCCCCCCcchhccC
Q 015532 372 YDPAERLKAREALR--------HPFFTRDVRRPTLLVATG 403 (405)
Q Consensus 372 ~dP~~Rpta~elL~--------hp~f~~~~~~~~~~~~~~ 403 (405)
+++++||+..+||. -|=+..-.+.|.++.++.
T Consensus 635 ~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~~~~~ 674 (678)
T KOG0193|consen 635 FDREERPLFPQLLSKLEELLPSLPKINRSASEPVLLRSSA 674 (678)
T ss_pred cCcccCccHHHHHHHHHHhhhcccccccCcCccchhhhhh
Confidence 99999999999887 355566666676665544
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.97 Aligned_cols=230 Identities=21% Similarity=0.443 Sum_probs=170.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHH-HHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDV-LQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~i-l~~l~~~~~~~~~-------------- 154 (405)
+.|++.+.||+|+||.||+|++..+++.||||+++... ........|+.+ ++.+.|+++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36999999999999999999999999999999986532 223445556665 5556677763210
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++ +++||||||+||+++.++.
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~------------------ 142 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ------------------ 142 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC------------------
Confidence 12478899999999999999999997 9999999999999976654
Q ss_pred ccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-h
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSGEALFQTHE-N 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~ 290 (405)
+||+|||.+...... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.... .
T Consensus 143 ---------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (283)
T cd06617 143 ---------VKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213 (283)
T ss_pred ---------EEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC
Confidence 556666655433221 122467889999999865 356889999999999999999999996432 2
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+.+..+.. +..+ .. ....++.++.+||.+||
T Consensus 214 ~~~~~~~~~--~~~~---------------------~~-------------------------~~~~~~~~l~~li~~~l 245 (283)
T cd06617 214 FQQLKQVVE--EPSP---------------------QL-------------------------PAEKFSPEFQDFVNKCL 245 (283)
T ss_pred HHHHHHHHh--cCCC---------------------CC-------------------------CccccCHHHHHHHHHHc
Confidence 222221111 0000 00 00124678999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
..||++|||++++++||||.....+.
T Consensus 246 ~~~p~~Rp~~~~il~~~~~~~~~~~~ 271 (283)
T cd06617 246 KKNYKERPNYPELLQHPFFELHLSKN 271 (283)
T ss_pred cCChhhCcCHHHHhcCchhhhccccc
Confidence 99999999999999999999976553
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.70 Aligned_cols=225 Identities=27% Similarity=0.446 Sum_probs=173.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~--------------- 154 (405)
.++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+..|+.+++++ .|+++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5789999999999999999999998999999999976655567788999999999 577652110
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~------------- 151 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE------------- 151 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe-------------
Confidence 135678888999999999999999999999999999999976654
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-----CCCCchhHHHHHHHHHHHHhCCCC
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~~lltg~~p 284 (405)
++|+|||.+...... .....|+..|+|||++... .++.++|||||||++|+|++|..|
T Consensus 152 --------------~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 152 --------------VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred --------------EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 555555555432211 1224688999999998642 467899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
|........+..+... ..+ .......++..+.+
T Consensus 218 ~~~~~~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~~~~ 250 (275)
T cd06608 218 LCDMHPMRALFKIPRN--PPP---------------------------------------------TLKSPENWSKKFND 250 (275)
T ss_pred ccccchHHHHHHhhcc--CCC---------------------------------------------CCCchhhcCHHHHH
Confidence 9765544433332211 000 00011124568899
Q ss_pred HHHHccccCCCCCCCHHHHHcCCCC
Q 015532 365 LLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
||.+||..||++|||++|+++|||+
T Consensus 251 li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 251 FISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=284.35 Aligned_cols=225 Identities=24% Similarity=0.381 Sum_probs=170.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.+.|+++....
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57999999999999999999999999999999986543 2234567899999999999873221
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++.+++.++.|++.||.|||++||+|+||||+||+++.++.+
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~----------------------- 145 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHV----------------------- 145 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE-----------------------
Confidence 2357889999999999999999999999999999999999776654
Q ss_pred CCCceeccCCCCccccC---CccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+|+|||++..... ......|+..|+|||++. ...++.++|+|||||++|+|++|..||...........+
T Consensus 146 ----~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 146 ----KLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred ----EECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 5555554432211 112346899999999985 445889999999999999999999999665433322211
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.......+ .......++..+.+||.+||+.||++|
T Consensus 222 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R 256 (267)
T cd06645 222 TKSNFQPP---------------------------------------------KLKDKMKWSNSFHHFVKMALTKNPKKR 256 (267)
T ss_pred hccCCCCC---------------------------------------------cccccCCCCHHHHHHHHHHccCCchhC
Confidence 11000000 000011245678999999999999999
Q ss_pred CCHHHHHcCCC
Q 015532 378 LKAREALRHPF 388 (405)
Q Consensus 378 pta~elL~hp~ 388 (405)
||++++++|||
T Consensus 257 ~~~~~ll~~~~ 267 (267)
T cd06645 257 PTAEKLLQHPF 267 (267)
T ss_pred cCHHHHhcCCC
Confidence 99999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.19 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=186.8
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
|+...++|++.+.||+|+||.||+|.+..+++.||||+++... .....+..|+++++.+.|+++....
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 4556678999999999999999999999999999999996432 2334567899999999998774310
Q ss_pred ----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcc
Q 015532 155 ----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 155 ----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~------- 154 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ------- 154 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc-------
Confidence 124688899999999999999999999999999999999976664
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhC
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg 281 (405)
++|+|||.+....... ....++..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus 155 --------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 155 --------------------IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred --------------------EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 4555555554322211 113467789999998754 478999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
++||...+..+.+..+.+..+..+.......... . .+..... ...............+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~----------~~~~~~~~~~~~~~~~~~ 274 (302)
T cd07864 215 KPIFQANQELAQLELISRLCGSPCPAVWPDVIKL-P---------YFNTMKP----------KKQYRRRLREEFSFIPTP 274 (302)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhccccccc-c---------ccccccc----------ccccccchhhhcCCCCHH
Confidence 9999988888888777777665543221110000 0 0000000 000000011112234678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
+.+||.+||+.||++|||+.++++||||
T Consensus 275 ~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 275 ALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=272.59 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=205.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCcc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRY------------ 155 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~~------------ 155 (405)
..||.-++.+|.|.- .|..|-|.-.++.||+|.+... ........+|..++..+.|.|+++...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 468999999999998 8888999889999999987432 222355778999999999999865331
Q ss_pred ------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 156 ------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 156 ------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
-.+.-+.+..++.|++.|++|||+.||+||||||+||++..++
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~------------------- 155 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC------------------- 155 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-------------------
Confidence 1233457788999999999999999999999999999987654
Q ss_pred ccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||.|||+|+..... .+..+.|..|.|||++.+..|...+||||+||++.||++|...|.|.+..++..
T Consensus 156 --------~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 156 --------TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred --------heeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 5677777777654443 234688999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
++.+.+|.+-+.+..........|+........ .. .........++. ..+.....+..++||+.+||..||+
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~---~~----f~~~fpD~~f~~-~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQA---IS----FSELFPDSLFPV-VLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhc---cc----hhhhCCcccccc-cccCCccchHHHHHHHHHhhccChh
Confidence 999999999999998888888887763211110 00 000000000111 1112223456789999999999999
Q ss_pred CCCCHHHHHcCCCCC
Q 015532 376 ERLKAREALRHPFFT 390 (405)
Q Consensus 376 ~Rpta~elL~hp~f~ 390 (405)
+|.+++++|+||||+
T Consensus 300 ~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 300 KRISVDDALRHPYIK 314 (369)
T ss_pred hcccHHHHhcCCeee
Confidence 999999999999997
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=280.02 Aligned_cols=221 Identities=24% Similarity=0.412 Sum_probs=172.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++++.|+++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999996432 3346678899999999999873210
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~---------------------- 138 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH---------------------- 138 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC----------------------
Confidence 125788899999999999999999999999999999999987664
Q ss_pred CCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL--EHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--~~~~~i 297 (405)
++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.. ..+...
T Consensus 139 -----~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (258)
T cd05578 139 -----VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213 (258)
T ss_pred -----EEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH
Confidence 455555554433221 12245788999999999888999999999999999999999999876542 111111
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.. .. ....+...+..+.++|.+||+.||++|
T Consensus 214 ~~--~~-----------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (258)
T cd05578 214 QE--TA-----------------------------------------------DVLYPATWSTEAIDAINKLLERDPQKR 244 (258)
T ss_pred hc--cc-----------------------------------------------cccCcccCcHHHHHHHHHHccCChhHc
Confidence 00 00 001112345688999999999999999
Q ss_pred CCH--HHHHcCCCC
Q 015532 378 LKA--REALRHPFF 389 (405)
Q Consensus 378 pta--~elL~hp~f 389 (405)
+++ +|+++||||
T Consensus 245 ~~~~~~~l~~~~~~ 258 (258)
T cd05578 245 LGDNLKDLKNHPYF 258 (258)
T ss_pred CCccHHHHhcCCCC
Confidence 999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.57 Aligned_cols=214 Identities=24% Similarity=0.359 Sum_probs=175.3
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+.+++.||+|.||.||+|.++.+. .||+|.++......+.+.+|+++|++|+|++++...
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 456789999999999999997443 599999988777778899999999999999984321
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+...+...++.||++|++||+++++|||||-..|||++.+.
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-------------------------- 340 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-------------------------- 340 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--------------------------
Confidence 24567788899999999999999999999999999999998765
Q ss_pred CCceeccCCCCccccCCccc----eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 015532 225 SAIKLIDFGSTTFEHQDHSY----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (405)
.+||+|||+|+...++... ..-...|.|||.+....++.|+|||||||+||||+| |+.||.+.++.+.+.++.+
T Consensus 341 -~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~ 419 (468)
T KOG0197|consen 341 -VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER 419 (468)
T ss_pred -eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 4566666666643332221 122557999999999999999999999999999999 9999999999988877755
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
- -+++-| +.+++++.+++..||..+|++|||
T Consensus 420 G-----------------------yRlp~P--------------------------~~CP~~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 420 G-----------------------YRLPRP--------------------------EGCPDEVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred c-----------------------CcCCCC--------------------------CCCCHHHHHHHHHHhhCCcccCCC
Confidence 2 233322 456789999999999999999999
Q ss_pred HHHHH
Q 015532 380 AREAL 384 (405)
Q Consensus 380 a~elL 384 (405)
.+.+.
T Consensus 451 F~~L~ 455 (468)
T KOG0197|consen 451 FETLR 455 (468)
T ss_pred HHHHH
Confidence 98765
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=276.80 Aligned_cols=221 Identities=27% Similarity=0.450 Sum_probs=174.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|+||.||++++..+++.||+|.+... ......+.+|+.+++++.|+++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 599999999999999999999999999999998642 23345678899999999998863211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--------------------- 139 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--------------------- 139 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---------------------
Confidence 124678888999999999999999999999999999999976554
Q ss_pred CCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||.+....... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+
T Consensus 140 ------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 140 ------IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred ------EEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 5666666554332211 1245788999999999888999999999999999999999999876655444332
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.. +..+ ......+.++.++|.+||+.+|++|
T Consensus 214 ~~--~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08218 214 IR--GSYP-----------------------------------------------PVSSHYSYDLRNLVSQLFKRNPRDR 244 (256)
T ss_pred hc--CCCC-----------------------------------------------CCcccCCHHHHHHHHHHhhCChhhC
Confidence 21 1100 0112346688999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
|++.++++||||
T Consensus 245 p~~~~vl~~~~~ 256 (256)
T cd08218 245 PSVNSILEKNFI 256 (256)
T ss_pred cCHHHHhhCcCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=278.93 Aligned_cols=231 Identities=26% Similarity=0.418 Sum_probs=171.8
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-------hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
+|++.+.||+|+||.||+|.+ .+++.+|||.++... .....+.+|+++++.+.|+++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999987 478889999886321 1234577899999999998763211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++++|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG--- 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc---
Confidence 1346888999999999999999999999999999999999877766666665433211000
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.............|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 157 ---------------~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 157 ---------------LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred ---------------ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 00000011122468899999999998889999999999999999999999997655443332222
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
...+..| .....++..+.+||.+||..||++||
T Consensus 222 ~~~~~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp 254 (265)
T cd06631 222 AHRGLMP-----------------------------------------------RLPDSFSAAAIDFVTSCLTRDQHERP 254 (265)
T ss_pred hccCCCC-----------------------------------------------CCCCCCCHHHHHHHHHHhcCCcccCC
Confidence 1111110 11123467889999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|+.|+++||||
T Consensus 255 ~~~~~l~~~~~ 265 (265)
T cd06631 255 SALQLLRHDFL 265 (265)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=276.03 Aligned_cols=222 Identities=27% Similarity=0.389 Sum_probs=175.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|+||.||+|.+..+++.||||.+... ......+..|+++++.+.|+++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 599999999999999999999999999999998643 22345678899999999998863211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||++||+|+||||+||+++.++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~---------------------- 138 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK---------------------- 138 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----------------------
Confidence 12368889999999999999999999999999999999996432
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
..++|+|||.+....... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 139 ----~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 139 ----MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred ----CEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 235777777765443222 22468889999999998888999999999999999999999998765544332221
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
.... .......+..+.+++.+||..||++||
T Consensus 215 ~~~~-------------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (256)
T cd08220 215 SGTF-------------------------------------------------APISDRYSPDLRQLILSMLNLDPSKRP 245 (256)
T ss_pred hcCC-------------------------------------------------CCCCCCcCHHHHHHHHHHccCChhhCC
Confidence 1000 001123466899999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|+.|+++||||
T Consensus 246 t~~~ll~~p~~ 256 (256)
T cd08220 246 QLSQIMAQPIC 256 (256)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=289.74 Aligned_cols=267 Identities=31% Similarity=0.458 Sum_probs=191.9
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHH-hhcCCCCCc----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l-~~~~~~~~~---------- 154 (405)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+... ......+.+|+.++.++ .|+++....
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4668899999999999999999999989999999988432 22334566899999999 898873321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++........
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~- 162 (337)
T cd07852 84 IYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE- 162 (337)
T ss_pred EEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc-
Confidence 01467788888999999999999999999999999999998777665555554322211000
Q ss_pred ccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
...........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....
T Consensus 163 ------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~ 224 (337)
T cd07852 163 ------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224 (337)
T ss_pred ------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 000011122468999999998865 4578999999999999999999999998888888888
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+..+..............+... . ...... .........+.++.+||.+||+.||++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----------------~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~ 285 (337)
T cd07852 225 IIEVIGPPSAEDIESIKSPFAATMLDS--L----------------PSRPRK-PLDELLPKASDDALDLLKKLLVFNPNK 285 (337)
T ss_pred HHHHhCCCCHHHHHHHHhhhHHHhhhh--c----------------cccccc-chhhhccCCCHHHHHHHHHhccCCccc
Confidence 877777666544333221111100000 0 000000 011122335778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDV 393 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~ 393 (405)
|||+.++++||||++-.
T Consensus 286 Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 286 RLTAEEALEHPYVAQFH 302 (337)
T ss_pred ccCHHHHhhChhhhhhc
Confidence 99999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=281.65 Aligned_cols=226 Identities=24% Similarity=0.361 Sum_probs=169.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+.|+++....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 356999999999999999999999999999999986432 2334567899999999999874321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~----------------------- 144 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD----------------------- 144 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-----------------------
Confidence 134678889999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
++|+|||++...... .....|+..|+|||.+. ...++.++|+|||||++|+|++|..||......+....
T Consensus 145 ----~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~ 220 (267)
T cd06646 145 ----VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred ----EEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence 455555555432211 12346888999999985 33578899999999999999999999965443222111
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.... ...+ .......++..+.+||.+||+.||++
T Consensus 221 ~~~~~------------------------~~~~---------------------~~~~~~~~~~~~~~li~~~l~~~P~~ 255 (267)
T cd06646 221 MSKSN------------------------FQPP---------------------KLKDKTKWSSTFHNFVKISLTKNPKK 255 (267)
T ss_pred eecCC------------------------CCCC---------------------CCccccccCHHHHHHHHHHhhCChhh
Confidence 11000 0000 00001234668999999999999999
Q ss_pred CCCHHHHHcCCC
Q 015532 377 RLKAREALRHPF 388 (405)
Q Consensus 377 Rpta~elL~hp~ 388 (405)
|||++++|+|+|
T Consensus 256 Rp~~~~il~~l~ 267 (267)
T cd06646 256 RPTAERLLTHLF 267 (267)
T ss_pred CcCHHHHhcCCC
Confidence 999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=277.03 Aligned_cols=229 Identities=28% Similarity=0.427 Sum_probs=169.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|++.+.||+|+||.||+|.+..+++.||||.+.... ...+.+.+|+.+++.+.|+++....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 35899999999999999999999999999999885321 2235677899999999998863211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~- 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC- 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-
Confidence 1235777888999999999999999999999999999999877655555555432110000
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
..........|+..|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 161 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 220 (265)
T cd06652 161 --------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220 (265)
T ss_pred --------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence 000111224588899999999988899999999999999999999999976544333222
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.. ... ....+...+..+.++|.+|+. +|++
T Consensus 221 ~~~---~~~---------------------------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~ 251 (265)
T cd06652 221 IAT---QPT---------------------------------------------NPVLPPHVSDHCRDFLKRIFV-EAKL 251 (265)
T ss_pred Hhc---CCC---------------------------------------------CCCCchhhCHHHHHHHHHHhc-Chhh
Confidence 111 000 000112335678899999995 9999
Q ss_pred CCCHHHHHcCCCCC
Q 015532 377 RLKAREALRHPFFT 390 (405)
Q Consensus 377 Rpta~elL~hp~f~ 390 (405)
|||++|+++|||+.
T Consensus 252 Rp~~~~il~~~~~~ 265 (265)
T cd06652 252 RPSADELLRHTFVH 265 (265)
T ss_pred CCCHHHHhcCcccC
Confidence 99999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.53 Aligned_cols=228 Identities=24% Similarity=0.407 Sum_probs=176.2
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
|.....||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.++..+.|+++....
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 455668999999999999999899999999986432 3345677899999999998863211
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--------------------------- 155 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--------------------------- 155 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc---------------------------
Confidence 134678899999999999999999999999999999999977664
Q ss_pred ceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 015532 227 IKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
++|+|||++..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......+.+..+...
T Consensus 156 ~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 232 (297)
T cd06659 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS--- 232 (297)
T ss_pred EEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---
Confidence 45555555432221 112356899999999999888999999999999999999999999876655544332210
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHH
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 383 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~el 383 (405)
.+. ........+..+.++|.+||+.||++|||++++
T Consensus 233 ~~~--------------------------------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 233 PPP--------------------------------------------KLKNAHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred CCC--------------------------------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000 001112345678999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q 015532 384 LRHPFFTRDVRR 395 (405)
Q Consensus 384 L~hp~f~~~~~~ 395 (405)
++||||.+..-.
T Consensus 269 l~~~~~~~~~~~ 280 (297)
T cd06659 269 LDHPFLLQTGLP 280 (297)
T ss_pred hhChhhccCCCc
Confidence 999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=275.95 Aligned_cols=221 Identities=24% Similarity=0.435 Sum_probs=173.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||.|+||.||+|.+..+++.||+|++... ....+.+..|+++++.+.|+++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 489999999999999999999999999999998642 23445677899999999999874311
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHH-----HCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMH-----ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH-----~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~------------ 148 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN------------ 148 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC------------
Confidence 134677889999999999999999 899999999999999987665
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
++|+|||++....... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 149 ---------------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 149 ---------------VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ---------------EEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 4555555544332221 2246889999999999888999999999999999999999999876
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
+.......+.... . .......+..+.+++.+
T Consensus 214 ~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~l~~~ 244 (265)
T cd08217 214 NQLQLASKIKEGK--F-----------------------------------------------RRIPYRYSSELNEVIKS 244 (265)
T ss_pred CHHHHHHHHhcCC--C-----------------------------------------------CCCccccCHHHHHHHHH
Confidence 6433332221100 0 00112345688999999
Q ss_pred ccccCCCCCCCHHHHHcCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f 389 (405)
||+.+|++|||+.++++|||+
T Consensus 245 ~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 245 MLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=278.06 Aligned_cols=234 Identities=22% Similarity=0.351 Sum_probs=173.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.+.||.|+||+||+|....++..||+|++.... .....+.+|+++++.+.|+++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36999999999999999999998899999999986432 2446678899999999998762211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~--- 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD--- 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc---
Confidence 13478889999999999999999999999999999999998766555555544322111000
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
..........|+..|+|||++... .++.++|+|||||++|+|++|..||...+.........
T Consensus 158 -----------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 220 (267)
T cd06610 158 -----------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220 (267)
T ss_pred -----------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh
Confidence 000011234688999999999876 68899999999999999999999997665543332221
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+. .+.. +.. .......+..+.+|+.+||..||++||
T Consensus 221 ~~---~~~~--------------------~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06610 221 QN---DPPS--------------------LET---------------------GADYKKYSKSFRKMISLCLQKDPSKRP 256 (267)
T ss_pred cC---CCCC--------------------cCC---------------------ccccccccHHHHHHHHHHcCCChhhCc
Confidence 10 0000 000 000124567889999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|++++++||||
T Consensus 257 ~~~~ll~~p~~ 267 (267)
T cd06610 257 TAEELLKHKFF 267 (267)
T ss_pred CHHHHhhCCCC
Confidence 99999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=283.34 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=180.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|++.+.||+|+||.||++.+..+++.||||.+.... ...+.+..|+++++.+.|+++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 35999999999999999999999999999999986532 2334567899999999998773211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++..+.++++|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~----- 155 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL----- 155 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc-----
Confidence 1346788899999999999999999999999999999999988877777777643211100
Q ss_pred CCCCCCceeccCCCCccc-cCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
...+.+....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+....+....+..
T Consensus 156 -----~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~ 230 (305)
T cd05609 156 -----TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230 (305)
T ss_pred -----cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 0000000000000 0011124578899999999888899999999999999999999999987665544433322
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.... ++. .....+..+.+||.+||+.||++||+
T Consensus 231 ~~~~------------------------~~~-----------------------~~~~~~~~~~~li~~~l~~~P~~R~~ 263 (305)
T cd05609 231 DDIE------------------------WPE-----------------------GDEALPADAQDLISRLLRQNPLERLG 263 (305)
T ss_pred cccC------------------------CCC-----------------------ccccCCHHHHHHHHHHhccChhhccC
Confidence 1100 000 00134668899999999999999997
Q ss_pred ---HHHHHcCCCCCCCC
Q 015532 380 ---AREALRHPFFTRDV 393 (405)
Q Consensus 380 ---a~elL~hp~f~~~~ 393 (405)
+.++|+||||....
T Consensus 264 ~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 264 TGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCHHHHHhCccccCCC
Confidence 89999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.40 Aligned_cols=233 Identities=26% Similarity=0.443 Sum_probs=176.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhh------------cCC-----
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLAR------------HDI----- 150 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~------------~~~----- 150 (405)
+.|+|+++||+|+||.|.+++++.+++.||+|++++... ....|..|-.||..-+. .+.
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 579999999999999999999999999999999976332 23445556555543221 111
Q ss_pred ----CCC------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 151 ----GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 151 ----~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
+|. .+..++++.+++|+..|+.||+-||+.|+|||||||+||||+..|++|++|||.+-.+..+
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d------ 228 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD------ 228 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC------
Confidence 111 1457999999999999999999999999999999999999998887666666543222211
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
|.. .....+|||.|++||++.. +.|+..+|+||+||++|||+.|..||..++-.+...
T Consensus 229 ------------G~V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~ 291 (1317)
T KOG0612|consen 229 ------------GTV-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG 291 (1317)
T ss_pred ------------CcE-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH
Confidence 111 1123589999999999973 358899999999999999999999998877666665
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.|..-- -.+.+|+ ...+|.++++||.++|. +|+
T Consensus 292 KIm~hk----------------------~~l~FP~------------------------~~~VSeeakdLI~~ll~-~~e 324 (1317)
T KOG0612|consen 292 KIMNHK----------------------ESLSFPD------------------------ETDVSEEAKDLIEALLC-DRE 324 (1317)
T ss_pred HHhchh----------------------hhcCCCc------------------------ccccCHHHHHHHHHHhc-Chh
Confidence 554320 0111211 12468899999999776 899
Q ss_pred CCCC---HHHHHcCCCCCCCCC
Q 015532 376 ERLK---AREALRHPFFTRDVR 394 (405)
Q Consensus 376 ~Rpt---a~elL~hp~f~~~~~ 394 (405)
.|.. ++++.+||||.+..+
T Consensus 325 ~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 325 VRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hhcccccHHHHHhCccccCCCh
Confidence 9998 999999999998765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.17 Aligned_cols=229 Identities=25% Similarity=0.390 Sum_probs=181.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCC----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIG---------------- 151 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~---------------- 151 (405)
..|..+.+||+|+||.|.+|..+.+.+.||||++++.- ...+.-+.|-.+|.....+...
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46899999999999999999999999999999997632 2234445566665544444321
Q ss_pred ------C------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 152 ------G------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 152 ------~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
+ ..++.|.|..+..++.+|+.||-|||++|||.||||.+|||++.+|++||+|||+++....
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~------ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF------ 502 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc------
Confidence 1 1146788999999999999999999999999999999999998888665555554332111
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
......+++||+.|+|||++.-.+|+..+|+||+||+||||+.|++||++.+..+.+..|..
T Consensus 503 ------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 503 ------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred ------------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11223458999999999999999999999999999999999999999999999988887765
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
-.-..| ...|.++.++.+..|...|.+|..
T Consensus 565 hnvsyP--------------------------------------------------KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 HNVSYP--------------------------------------------------KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccCcCc--------------------------------------------------ccccHHHHHHHHHHhhcCCccccC
Confidence 332222 345778999999999999999984
Q ss_pred -----HHHHHcCCCCCCCCC
Q 015532 380 -----AREALRHPFFTRDVR 394 (405)
Q Consensus 380 -----a~elL~hp~f~~~~~ 394 (405)
-.+|-.||||+.-.+
T Consensus 595 cg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 595 CGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred CCCccccchhhCcchhhccH
Confidence 368999999987543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=280.03 Aligned_cols=249 Identities=31% Similarity=0.514 Sum_probs=181.5
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+.|+++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999754 23345677899999999998763211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~--------------------- 139 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVL--------------------- 139 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCE---------------------
Confidence 1357888999999999999999999999999999999999876655
Q ss_pred CCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+|+|||.+...... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...+....+..
T Consensus 140 ------~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 140 ------KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred ------EEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 45555544332221 1223567889999987654 578999999999999999999999998887777777
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC-chHHHHHHHHHccccCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~~L~~dP~ 375 (405)
+....+.++.......... .+.. .............+.... .+..+.+++.+||..||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~-----------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 273 (287)
T cd07840 214 IFELCGSPTDENWPGVSKL-----------PWFE---------NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPK 273 (287)
T ss_pred HHHHhCCCchhhccccccc-----------hhhh---------hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChh
Confidence 7666655443221111000 0000 000000001111111122 377899999999999999
Q ss_pred CCCCHHHHHcCCCC
Q 015532 376 ERLKAREALRHPFF 389 (405)
Q Consensus 376 ~Rpta~elL~hp~f 389 (405)
+|||+.++++||||
T Consensus 274 ~Rp~~~~~l~~~~~ 287 (287)
T cd07840 274 KRISADQALQHEYF 287 (287)
T ss_pred hCcCHHHHhhCcCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=275.72 Aligned_cols=225 Identities=27% Similarity=0.420 Sum_probs=175.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
++|++.+.||.|+||.||+|.+..+++.+|+|++.... ...+.+..|+++++.+.|+++....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57999999999999999999999899999999986532 2346678899999999999873321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----------------------- 139 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD----------------------- 139 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC-----------------------
Confidence 145788899999999999999999999999999999999987654
Q ss_pred CCCCceeccCCCCccccC---CccceecCCCcchhHHHhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
++|+|||.+..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...+.......
T Consensus 140 ----~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~ 215 (262)
T cd06613 140 ----VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL 215 (262)
T ss_pred ----EEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45555555543222 11234678899999999876 788999999999999999999999987665544333
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.......+ ........+.++.+||.+||..||++
T Consensus 216 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~ 250 (262)
T cd06613 216 ISKSNFPPP---------------------------------------------KLKDKEKWSPVFHDFIKKCLTKDPKK 250 (262)
T ss_pred HHhccCCCc---------------------------------------------cccchhhhhHHHHHHHHHHcCCChhh
Confidence 221100000 00001123567899999999999999
Q ss_pred CCCHHHHHcCCC
Q 015532 377 RLKAREALRHPF 388 (405)
Q Consensus 377 Rpta~elL~hp~ 388 (405)
|||+.+++.|+|
T Consensus 251 Rpt~~~il~~~~ 262 (262)
T cd06613 251 RPTATKLLQHPF 262 (262)
T ss_pred CCCHHHHhcCCC
Confidence 999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=277.52 Aligned_cols=244 Identities=27% Similarity=0.374 Sum_probs=182.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHh-hcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~-~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+++++++. |+++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3699999999999999999999999999999998652 223456778999999998 88763211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++|||+............
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 13578899999999999999999999999999999999999988888888887654432221000
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.. .....++..............++..|+|||++.+..++.++|||||||+++++++|..||........+..+..
T Consensus 161 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 161 NK----GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred CC----CCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 00 00001111111111222335688999999999888899999999999999999999999987664443333221
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
... .....+++.+.+||.+||+.||++|||
T Consensus 237 ~~~--------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 237 LEY--------------------------------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred cCC--------------------------------------------------CCCCccCHHHHHHHHHHhcCCHhhCCC
Confidence 111 111233568899999999999999999
Q ss_pred H----HHHHcCCCC
Q 015532 380 A----REALRHPFF 389 (405)
Q Consensus 380 a----~elL~hp~f 389 (405)
+ +++++||||
T Consensus 267 ~~~~~~~ll~~~~~ 280 (280)
T cd05581 267 VNEGYDELKAHPFF 280 (280)
T ss_pred cccCHHHHhcCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=283.72 Aligned_cols=229 Identities=27% Similarity=0.397 Sum_probs=176.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.++|++.+.||+|+||.||++.+..++..||+|.+... ....+.+.+|+.+++.+.|+++....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999999888999999998643 23345678899999999998863311
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~------------------------ 153 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS------------------------ 153 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC------------------------
Confidence 124678889999999999999999999999999999999976554
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
++|+|||++...... .....|++.|+|||.+.+..++.++|+|||||++|++++|..||...+....+..+..
T Consensus 154 ---~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~- 229 (293)
T cd06647 154 ---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT- 229 (293)
T ss_pred ---EEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-
Confidence 455555554332211 1224688899999999888899999999999999999999999977654332221110
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
+.. .........+..+.+||.+||..||++||++
T Consensus 230 -~~~---------------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 263 (293)
T cd06647 230 -NGT---------------------------------------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 263 (293)
T ss_pred -CCC---------------------------------------------CCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 000 0001112345678999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 015532 381 REALRHPFFTRDV 393 (405)
Q Consensus 381 ~elL~hp~f~~~~ 393 (405)
.+++.|+||+...
T Consensus 264 ~~il~h~~~~~~~ 276 (293)
T cd06647 264 KELLQHPFLKIAK 276 (293)
T ss_pred HHHhcCHHHhcCc
Confidence 9999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.62 Aligned_cols=246 Identities=27% Similarity=0.364 Sum_probs=175.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
....|+.++.||+||||.||+++.+-+|+.||||+|... .+......+|+.+|.+|+|+|+++..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 345688899999999999999999999999999999654 44456678899999999999871110
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ----------------------------------------------------cccC--CHHHHHHHHHHHHHHHHHHHHC
Q 015532 155 ----------------------------------------------------YRSF--PIDLVRELGRQLLESVAFMHEL 180 (405)
Q Consensus 155 ----------------------------------------------------~~~l--~~~~~~~~~~qi~~aL~~LH~~ 180 (405)
...+ .....+++++||+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0111 1456788999999999999999
Q ss_pred CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCcccc-CCccceecCCCcchhHHHhC
Q 015532 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILG 259 (405)
Q Consensus 181 givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~ 259 (405)
|||||||||.||++++.+.+||+|||++........ .......+.+.-.... ...+..+||.-|+|||++.+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~-------~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLE-------SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhh-------hHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999999999999999999999999998754221110 0011111111111111 13455799999999999987
Q ss_pred CC---CCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCch
Q 015532 260 LG---WNYPCDLWSVGCILVELCSGEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 335 (405)
Q Consensus 260 ~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (405)
.. |+.|+||||||||+|||+. ||...-+. ..+..+. -|.+|..
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~---------------------------- 836 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEP---------------------------- 836 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCC----------------------------
Confidence 54 9999999999999999984 46543221 2222222 1222211
Q ss_pred hhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 336 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
.......-+.-..+|+.||+.||.+||||.|+|++.||-.
T Consensus 837 ----------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 837 ----------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred ----------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 0011111234468999999999999999999999999985
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=273.65 Aligned_cols=222 Identities=27% Similarity=0.424 Sum_probs=173.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|+||.||+|.++.++..||+|.+.... ...+.+.+|+++++.++|+++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5899999999999999999999999999999986431 3345677899999999998873211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||+++|+|+||||+||+++.++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--------------------- 139 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--------------------- 139 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC---------------------
Confidence 123678889999999999999999999999999999999976432
Q ss_pred CCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.++|+|||.+....... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+
T Consensus 140 -----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (257)
T cd08225 140 -----VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI 214 (257)
T ss_pred -----eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 35667776665433221 1235888999999998888999999999999999999999999766544433221
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.. +..+ ......+.++.++|.+||..+|++|
T Consensus 215 ~~--~~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R 245 (257)
T cd08225 215 CQ--GYFA-----------------------------------------------PISPNFSRDLRSLISQLFKVSPRDR 245 (257)
T ss_pred hc--ccCC-----------------------------------------------CCCCCCCHHHHHHHHHHhccChhhC
Confidence 11 0000 0012345689999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||+.++++||||
T Consensus 246 pt~~~ll~~~~~ 257 (257)
T cd08225 246 PSITSILKRPFL 257 (257)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.14 Aligned_cols=220 Identities=21% Similarity=0.338 Sum_probs=163.4
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
++|++.+.||+|+||.||+|.+.. +++.||+|+++... ...+.+..|++++.++ .|+++....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 579999999999999999997543 45789999986432 2335577899999999 666652110
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCC
Q 015532 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234 (405)
Q Consensus 155 ~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 234 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~---------------------------vkL~DfG~ 219 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---------------------------VKICDFGL 219 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc---------------------------EEEecccc
Confidence 014677888999999999999999999999999999999986654 45555555
Q ss_pred CccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHH
Q 015532 235 TTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHM 308 (405)
Q Consensus 235 a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~ 308 (405)
+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+......
T Consensus 220 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-------- 291 (337)
T cd05054 220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-------- 291 (337)
T ss_pred chhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc--------
Confidence 54332111 12345678999999999999999999999999999998 99999764433222111100
Q ss_pred HHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 309 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
+.. .......++++.+++.+||+.+|++|||+.|+++|
T Consensus 292 --------------~~~--------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 --------------GTR--------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --------------cCC--------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 00112345688999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=280.58 Aligned_cols=239 Identities=16% Similarity=0.203 Sum_probs=158.4
Q ss_pred eCCccCCCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecchhhh--hH----------HHHHHHHHHHHHhhcCC
Q 015532 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--RE----------AAMIEIDVLQRLARHDI 150 (405)
Q Consensus 86 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~~~--~~----------~~~~E~~il~~l~~~~~ 150 (405)
+.+...++|++.++||+|+||+||+|.+..+ +..+|+|+....... .+ ....+...+..+.|.++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3455668899999999999999999998877 677888865322111 00 11122233344455554
Q ss_pred CCCc------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccc
Q 015532 151 GGTR------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 151 ~~~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~ 200 (405)
.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 2210 1134677788999999999999999999999999999999776655
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
+++|||++.....++.. ............||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 166 ~l~DFGla~~~~~~~~~-----------------~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 166 YIIDYGIASHFIIHGKH-----------------IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred EEEEcCCceeeccCCcc-----------------cccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 44444443222111000 0000011122469999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHH--HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc
Q 015532 281 GEALFQTHENLEHLAMMER--VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~--~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (405)
|..||.+............ ....+ .... ......
T Consensus 229 g~~P~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~---~~~~~~ 264 (294)
T PHA02882 229 IKLPWKGFGHNGNLIHAAKCDFIKRL-----------------------------------------HEGK---IKIKNA 264 (294)
T ss_pred CCCCCCccccchHHHHHhHHHHHHHh-----------------------------------------hhhh---hccCCC
Confidence 9999987643222211111 00000 0000 011233
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 359 AGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 359 ~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
++.+.+++..|+..+|++||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 265 NKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 568999999999999999999999975
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=280.38 Aligned_cols=228 Identities=27% Similarity=0.464 Sum_probs=175.2
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
+|++.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+++++.+.|+++....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 588899999999999999999999999999998653 23456678899999999998873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~----------------------- 138 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG----------------------- 138 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-----------------------
Confidence 1456888899999999999999999 9999999999999997655
Q ss_pred CCCCCceeccCCCCccccCCc-cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--LEHLAMME 298 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~ 298 (405)
.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 139 ----~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (265)
T cd06605 139 ----QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214 (265)
T ss_pred ----CEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Confidence 46667777664432211 125688899999999998999999999999999999999999965421 11111111
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
......+. .. ....++..+.+||.+||..||++||
T Consensus 215 ~~~~~~~~------------------------------------------~~---~~~~~~~~~~~li~~~l~~~p~~Rp 249 (265)
T cd06605 215 YIVNEPPP------------------------------------------RL---PSGKFSPDFQDFVNLCLIKDPRERP 249 (265)
T ss_pred HHhcCCCC------------------------------------------CC---ChhhcCHHHHHHHHHHcCCCchhCc
Confidence 11110000 00 0011466899999999999999999
Q ss_pred CHHHHHcCCCCCCC
Q 015532 379 KAREALRHPFFTRD 392 (405)
Q Consensus 379 ta~elL~hp~f~~~ 392 (405)
|+.+++.||||++.
T Consensus 250 t~~~ll~~~~~~~~ 263 (265)
T cd06605 250 SYKELLEHPFIKKY 263 (265)
T ss_pred CHHHHhhCchhhcc
Confidence 99999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.47 Aligned_cols=118 Identities=22% Similarity=0.372 Sum_probs=102.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.++||+|+||+||+|++..+++.||||+++... .....+..|+.++..+.|+++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997532 2335677899999999999874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 2346788899999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=276.71 Aligned_cols=226 Identities=26% Similarity=0.440 Sum_probs=169.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-----------hhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------KYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
+|.+.+.||+|+||.||+|.+..+++.||||.++... ...+.+..|+.+++.+.|+++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5889999999999999999998899999999885311 1124567799999999998763211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++|++||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~--------- 152 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF--------- 152 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeec---------
Confidence 135788899999999999999999999999999999999987665555554
Q ss_pred CCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCC--CCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
|.+..... ......|+..|+|||.+.+.. ++.++|+||||+++|++++|..||..
T Consensus 153 ------------------~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 153 ------------------GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ------------------cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 44432211 112246788999999988754 78999999999999999999999975
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
......+..+... .....+ .......++..+.+||.
T Consensus 215 ~~~~~~~~~~~~~----------------------~~~~~~----------------------~~~~~~~~~~~~~~li~ 250 (272)
T cd06629 215 EEAIAAMFKLGNK----------------------RSAPPI----------------------PPDVSMNLSPVALDFLN 250 (272)
T ss_pred cchHHHHHHhhcc----------------------ccCCcC----------------------CccccccCCHHHHHHHH
Confidence 5443322211100 000000 00111234678999999
Q ss_pred HccccCCCCCCCHHHHHcCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f 389 (405)
+||..||++|||++++|+||||
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 251 ACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHhcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=278.33 Aligned_cols=228 Identities=27% Similarity=0.431 Sum_probs=175.4
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
.|...+.||+|++|.||++.+..+++.||+|+++... ...+.+.+|+.+++.+.|+++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4566689999999999999998899999999886433 2345577899999999998863321
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~------------------------- 154 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRV------------------------- 154 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcE-------------------------
Confidence 1346788899999999999999999999999999999999776654
Q ss_pred CceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
+|+|||.+...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 155 --~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~- 231 (285)
T cd06648 155 --KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL- 231 (285)
T ss_pred --EEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-
Confidence 55555544322211 122468889999999988889999999999999999999999998765544443332210
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
.+ .......++..+.+||.+||+.||++|||+.+
T Consensus 232 -~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 232 -PP---------------------------------------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred -CC---------------------------------------------CCcccccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 00 00001124568999999999999999999999
Q ss_pred HHcCCCCCCCCC
Q 015532 383 ALRHPFFTRDVR 394 (405)
Q Consensus 383 lL~hp~f~~~~~ 394 (405)
+++||||+....
T Consensus 266 il~~~~~~~~~~ 277 (285)
T cd06648 266 LLNHPFLAKAGP 277 (285)
T ss_pred HccCcccccCCC
Confidence 999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.74 Aligned_cols=276 Identities=18% Similarity=0.215 Sum_probs=173.3
Q ss_pred eeeecc--cceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G--~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
..||+| +||+||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 99999999999999999999986432 2345677899999999999984311
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~-------- 155 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG-------- 155 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC--------
Confidence 1236788888999999999999999999999999999999988888887776432111110
Q ss_pred CCCceeccCCCCccccCCccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 224 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
+.............++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 156 ---------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 226 (328)
T cd08226 156 ---------QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP 226 (328)
T ss_pred ---------ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC
Confidence 0000000011112356679999999764 47899999999999999999999998766544333222211
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
...|....... ......... ...+..............................++.+.+||++||++||++|||+.
T Consensus 227 ~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~ 303 (328)
T cd08226 227 PYSPLDITTFP-CEESRMKNS--QSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS 303 (328)
T ss_pred CCCCccccccc-hhhhhhccc--hhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence 11111000000 000000000 000000000000000000000000001111234567899999999999999999999
Q ss_pred HHHcCCCCCCCC
Q 015532 382 EALRHPFFTRDV 393 (405)
Q Consensus 382 elL~hp~f~~~~ 393 (405)
|+|+||||++..
T Consensus 304 e~l~~~~~~~~~ 315 (328)
T cd08226 304 SLLSHAFFKQVK 315 (328)
T ss_pred HHhhCHHHHHHH
Confidence 999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=276.82 Aligned_cols=246 Identities=34% Similarity=0.587 Sum_probs=176.7
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHh---hcCCCCCc-------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA---RHDIGGTR------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~---~~~~~~~~------------- 154 (405)
|++.+.||+|+||.||+|++..+++.||||+++... .....+..|+.+++++. |+++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 688999999999999999998889999999996422 22345667888887774 77652110
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--------------- 145 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--------------- 145 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC---------------
Confidence 124788899999999999999999999999999999999987654
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
++|+|||.+....... ....++..|+|||++.+..++.++|+|||||++|+|++|.+||.+....+
T Consensus 146 ------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 146 ------------VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred ------------EEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH
Confidence 5555555554332211 12357888999999998889999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+....+..... .|+....... .... ..............+..+.+||.+||+.
T Consensus 214 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~ 270 (287)
T cd07838 214 QLDKIFDVIGLPSEE-------------------EWPRNVSLPR---SSFP-SYTPRSFKSFVPEICEEGLDLLKKMLTF 270 (287)
T ss_pred HHHHHHHHcCCCChH-------------------hcCCCcccch---hhcc-cccccchhhhhhhhhHHHHHHHHHHhcc
Confidence 776665544322111 1110000000 0000 0000000111223467889999999999
Q ss_pred CCCCCCCHHHHHcCCCC
Q 015532 373 DPAERLKAREALRHPFF 389 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f 389 (405)
||++||+++|+++||||
T Consensus 271 dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 271 NPHKRISAFEALQHPYF 287 (287)
T ss_pred CCccCCCHHHHhcCcCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=300.86 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=153.4
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC----CcEEEEEEecchhhhhHHHHHHH----------HHHHHHhhcCC------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSINKYREAAMIEI----------DVLQRLARHDI------ 150 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~----~~~vAiK~~~~~~~~~~~~~~E~----------~il~~l~~~~~------ 150 (405)
.++|++.++||+|+||.||+|++..+ +..||||++..... .+....|. ..+..+.+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 46899999999999999999999988 89999998854221 11111110 00001000000
Q ss_pred ---------CCCcc--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 151 ---------GGTRY--------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 151 ---------~~~~~--------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
.+.++ ....+..+..++.||+.||.|||++||+||||||+|||++
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe
Confidence 00000 0112345678999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC-----------
Q 015532 196 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----------- 260 (405)
Q Consensus 196 ~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----------- 260 (405)
.+ +..+||+|||++...... .....+|+.|+|||.+...
T Consensus 290 ~~--------------------------~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~ 343 (566)
T PLN03225 290 EG--------------------------SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 343 (566)
T ss_pred CC--------------------------CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccc
Confidence 42 234677777777543221 2345789999999976532
Q ss_pred -----------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCC
Q 015532 261 -----------GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 329 (405)
Q Consensus 261 -----------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (405)
.++.++|||||||++|||+++..++. +....+..+....+.....+.... ...
T Consensus 344 ~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~--------~~~------ 407 (566)
T PLN03225 344 ATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLV--------EPR------ 407 (566)
T ss_pred cccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhh--------ccc------
Confidence 23456799999999999998765543 333233222222221111110000 000
Q ss_pred CCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCC
Q 015532 330 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
... ... ...+..+.....+.|||.+||++||++|||+.|+|+||||++....
T Consensus 408 ---~~~-~~~----------~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 408 ---ASP-DLR----------RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred ---cch-hhh----------hhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 000 000 0011112234467799999999999999999999999999886543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.08 Aligned_cols=226 Identities=22% Similarity=0.273 Sum_probs=165.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecC----------------CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCC
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~ 152 (405)
.++|++.++||+|+||.||+|.+.. ++..||||+++.. ......+.+|+.++.++.|+++..
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3679999999999999999998632 3457999998653 234566889999999999998732
Q ss_pred Cc----------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 015532 153 TR----------------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTD 186 (405)
Q Consensus 153 ~~----------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 186 (405)
.. ...+++..+..++.||+.||.|||++||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 11 01245667889999999999999999999999
Q ss_pred CCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCC
Q 015532 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLG 261 (405)
Q Consensus 187 lkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~ 261 (405)
|||+|||++.++. +||+|||++....... ....++..|+|||++.+..
T Consensus 164 lkp~Nill~~~~~---------------------------~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 164 LATRNCLVGENLT---------------------------IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred cchhheEEcCCcc---------------------------EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 9999999976654 5555555554322111 1234577899999999888
Q ss_pred CCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHH
Q 015532 262 WNYPCDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339 (405)
Q Consensus 262 ~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (405)
++.++|||||||++|+|++ +..||...+..+.+..+....... ...
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~------------- 264 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQ-------------------GRQ------------- 264 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhc-------------------ccc-------------
Confidence 9999999999999999986 667887766555444332211000 000
Q ss_pred HHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
........++..+.+|+.+||+.||++|||++||.+
T Consensus 265 ----------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 265 ----------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ----------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 000011234668999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=273.29 Aligned_cols=230 Identities=28% Similarity=0.454 Sum_probs=171.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---hhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
||++.+.||+|+||.||+|.+..+++.||+|+++.... ....+..|+++++.+.|+++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988999999999875433 456778899999999998863211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~----- 155 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT----- 155 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc-----
Confidence 123678889999999999999999999999999999999987665555555543222111000
Q ss_pred CCCCceeccCCCCccccCCccceecCCCcchhHHHhCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQTHENLEHL-AMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~i~ 298 (405)
.........++..|+|||++.+.. ++.++|||||||++|++++|..||......... ..+.
T Consensus 156 ---------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~ 220 (264)
T cd06626 156 ---------------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220 (264)
T ss_pred ---------------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh
Confidence 000011235788999999998766 889999999999999999999999765332221 1111
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
. +..+ ..+ .....+..+.+||.+||+.||++||
T Consensus 221 ~--~~~~---------------------~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 221 A--GHKP---------------------PIP------------------------DSLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred c--CCCC---------------------CCC------------------------cccccCHHHHHHHHHHccCCcccCC
Confidence 1 1100 000 0112356788999999999999999
Q ss_pred CHHHHHcCCCC
Q 015532 379 KAREALRHPFF 389 (405)
Q Consensus 379 ta~elL~hp~f 389 (405)
|+.+++.|||+
T Consensus 254 ~~~~i~~~~~~ 264 (264)
T cd06626 254 TASELLQHPFV 264 (264)
T ss_pred CHHHHhcCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.19 Aligned_cols=237 Identities=22% Similarity=0.378 Sum_probs=174.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|+..++||.|++|.||+|.+..+++.||+|++.... .....+.+|+++++.+.|+++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46999999999999999999999999999999986432 3456688999999999999873311
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~----------------- 143 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ----------------- 143 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe-----------------
Confidence 122567778899999999999999999999999999999976654
Q ss_pred cccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--LEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~ 293 (405)
++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ...
T Consensus 144 ----------~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (287)
T cd06621 144 ----------VKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213 (287)
T ss_pred ----------EEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh
Confidence 555566555432211 1224578889999999988899999999999999999999999976522 000
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...........+. ..+. ........++.+.+||.+||..|
T Consensus 214 ~~~~~~~~~~~~~--------------------~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~ 253 (287)
T cd06621 214 IELLSYIVNMPNP--------------------ELKD--------------------EPGNGIKWSEEFKDFIKQCLEKD 253 (287)
T ss_pred HHHHHHHhcCCch--------------------hhcc--------------------CCCCCCchHHHHHHHHHHHcCCC
Confidence 1111110000000 0000 00000123568899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~~ 395 (405)
|++|||+.|+++||||+...+.
T Consensus 254 p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 254 PTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred cccCCCHHHHHhCccccccccc
Confidence 9999999999999999776543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=283.58 Aligned_cols=219 Identities=21% Similarity=0.271 Sum_probs=165.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc----EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|++.+.||+|+||.||+|++..+++ .||||+++.. ....+.+..|+.+++.+.|+++....
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 469999999999999999999866655 3899998643 23456788899999999999884321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~------------------- 147 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH------------------- 147 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc-------------------
Confidence 123567788899999999999999999999999999999976654
Q ss_pred cCCCCCCCceeccCCCCccccCCcc-----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+||+|||++........ ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 148 --------~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 148 --------VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred --------EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 55555555544322111 1124567999999999899999999999999999997 999998765443
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+ .....+ . ....++.++.+++.+||..
T Consensus 220 ~~~~~-~~~~~~----------------------~--------------------------~~~~~~~~~~~li~~cl~~ 250 (316)
T cd05108 220 ISSIL-EKGERL----------------------P--------------------------QPPICTIDVYMIMVKCWMI 250 (316)
T ss_pred HHHHH-hCCCCC----------------------C--------------------------CCCCCCHHHHHHHHHHccC
Confidence 32211 110000 0 0122355788999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++|||+.+++.+
T Consensus 251 ~p~~Rps~~~l~~~ 264 (316)
T cd05108 251 DADSRPKFRELIIE 264 (316)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=279.51 Aligned_cols=230 Identities=26% Similarity=0.412 Sum_probs=177.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..|+.+++||.|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45888999999999999999999899999999986432 3345677899999999998773211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~----------------------- 140 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV----------------------- 140 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCE-----------------------
Confidence 1346788889999999999999999999999999999999876654
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
+|+|||++...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 141 ----~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06640 141 ----KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN 216 (277)
T ss_pred ----EEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC
Confidence 55555554332211 12245788999999999888999999999999999999999999876544333221110
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.. .......+..+.+|+.+||+.||++||++
T Consensus 217 --~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (277)
T cd06640 217 --NP-----------------------------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTA 247 (277)
T ss_pred --CC-----------------------------------------------CCCchhhhHHHHHHHHHHcccCcccCcCH
Confidence 00 00112235678899999999999999999
Q ss_pred HHHHcCCCCCCCCCCCc
Q 015532 381 REALRHPFFTRDVRRPT 397 (405)
Q Consensus 381 ~elL~hp~f~~~~~~~~ 397 (405)
.++++|+||........
T Consensus 248 ~~il~~~~~~~~~~~~~ 264 (277)
T cd06640 248 KELLKHKFIVKNAKKTS 264 (277)
T ss_pred HHHHhChHhhhcchhhh
Confidence 99999999988766543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=275.31 Aligned_cols=248 Identities=33% Similarity=0.564 Sum_probs=185.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
|++.+.||+|+||.||+|++..+++.||+|++... ....+.+..|+.+++.+.|+++....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67788999999999999999999999999999753 33345677899999999988763211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.|++.||.|||++||+||||+|+||+++.++.
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~------------------------ 136 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV------------------------ 136 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC------------------------
Confidence 135788999999999999999999999999999999999977654
Q ss_pred CCCceeccCCCCccccCCc---cceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+....... ....++..|+|||.+.+. .++.++|||||||++|+|++|.+||......+.+..+.+
T Consensus 137 ---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 137 ---LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred ---EEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 4555555554332211 123457789999999876 788999999999999999999999999888888888877
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.++...+..+....... ++ ...++... ...........+..+.++|.+||..||++||+
T Consensus 214 ~~~~~~~~~~~~~~~~~--~~----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 272 (282)
T cd07829 214 ILGTPTEESWPGVTKLP--DY----KPTFPKFP---------------PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272 (282)
T ss_pred HhCCCcHHHHHhhcccc--cc----cccccccC---------------ccchHHhcccccHHHHHHHHHhhccCcccCCC
Confidence 77766554433221110 00 00000000 00001112234678999999999999999999
Q ss_pred HHHHHcCCCC
Q 015532 380 AREALRHPFF 389 (405)
Q Consensus 380 a~elL~hp~f 389 (405)
++++++||||
T Consensus 273 ~~~~l~~p~~ 282 (282)
T cd07829 273 AKEALKHPYF 282 (282)
T ss_pred HHHHhhCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=273.26 Aligned_cols=218 Identities=19% Similarity=0.315 Sum_probs=169.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
..|.+.++||+|+||.||+|.+..+++.||+|+++........+.+|+++++.+.|+++....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 358999999999999999999999999999999876555556788999999999998763211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~---------------------- 143 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV---------------------- 143 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcE----------------------
Confidence 1246788889999999999999999999999999999999776654
Q ss_pred CCCCceeccCCCCccccCCcc----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
+|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 144 -----kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~ 218 (263)
T cd05052 144 -----KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218 (263)
T ss_pred -----EeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 5555554443322111 1123567999999998899999999999999999998 99999876654443332
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.... . .......+.++.++|.+||+.||++|
T Consensus 219 ~~~~-----------------------~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~R 249 (263)
T cd05052 219 EKGY-----------------------R--------------------------MERPEGCPPKVYELMRACWQWNPSDR 249 (263)
T ss_pred HCCC-----------------------C--------------------------CCCCCCCCHHHHHHHHHHccCCcccC
Confidence 2110 0 01112346789999999999999999
Q ss_pred CCHHHHHc
Q 015532 378 LKAREALR 385 (405)
Q Consensus 378 pta~elL~ 385 (405)
||+.++++
T Consensus 250 p~~~~l~~ 257 (263)
T cd05052 250 PSFAEIHQ 257 (263)
T ss_pred CCHHHHHH
Confidence 99999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=290.47 Aligned_cols=229 Identities=26% Similarity=0.347 Sum_probs=185.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
-.+.|.+.++||+|.|+.|.+|++..++..||||++.+.. ..+....+|+++|+.|.||||+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467999999999999999999999999999999997643 2334478899999999999995432
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
.+...+..++.++.|++.|++|||+++|||||||.+|||++
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~------------------------ 189 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD------------------------ 189 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc------------------------
Confidence 24556789999999999999999999999999999999975
Q ss_pred CCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+..+||+|||++.+.... ..+.+|++.|.|||++.+..|+ +.+|+||+|+++|.|+.|..||++.+-.+.-..
T Consensus 190 ---~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r 266 (596)
T KOG0586|consen 190 ---ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR 266 (596)
T ss_pred ---cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence 4456888888888766543 3457999999999999998876 889999999999999999999998654332221
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
..... .+ .+.-.+.++.++|++||..+|.+
T Consensus 267 vl~gk-------------------------------------------~r-------Ip~~ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 267 VLRGK-------------------------------------------YR-------IPFYMSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeee-------------------------------------------ec-------ccceeechhHHHHHHhhccCccc
Confidence 11100 00 11123568899999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~~ 395 (405)
|++.+++++|.|.......
T Consensus 297 r~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 297 RGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cCCHHHhhhhcccchhhhh
Confidence 9999999999999876544
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=282.50 Aligned_cols=230 Identities=25% Similarity=0.369 Sum_probs=177.2
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
....+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.+.|+++....
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34567999999999999999999999899999999985322 2234577899999999999863211
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||+|+||+++.++.
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~------------------ 153 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT------------------ 153 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC------------------
Confidence 234788899999999999999999999999999999999976554
Q ss_pred ccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
++|+|||++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||...+.....
T Consensus 154 ---------~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~ 223 (307)
T cd06607 154 ---------VKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (307)
T ss_pred ---------EEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence 566666655443322 2346788999999875 345889999999999999999999999776554433
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+... ..|. . ....++..+.+||.+||..||
T Consensus 224 ~~~~~~--~~~~---------------------~-------------------------~~~~~~~~~~~li~~~l~~~p 255 (307)
T cd06607 224 YHIAQN--DSPT---------------------L-------------------------SSNDWSDYFRNFVDSCLQKIP 255 (307)
T ss_pred HHHhcC--CCCC---------------------C-------------------------CchhhCHHHHHHHHHHhcCCh
Confidence 222110 0000 0 001235678999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~ 394 (405)
++|||+.+++.||||.....
T Consensus 256 ~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 256 QDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred hhCcCHHHHhcChhhcccCC
Confidence 99999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.92 Aligned_cols=230 Identities=28% Similarity=0.430 Sum_probs=176.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3577889999999999999999989999999998643 23345678899999999998873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~----------------------- 140 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV----------------------- 140 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCE-----------------------
Confidence 1346788999999999999999999999999999999999876644
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
+|+|||++...... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 141 ----~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06642 141 ----KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 216 (277)
T ss_pred ----EEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC
Confidence 55555554432221 12245788999999999888999999999999999999999999765433322211000
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.. .......+..+.++|.+||+.+|++|||+
T Consensus 217 --~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (277)
T cd06642 217 --SP-----------------------------------------------PTLEGQYSKPFKEFVEACLNKDPRFRPTA 247 (277)
T ss_pred --CC-----------------------------------------------CCCCcccCHHHHHHHHHHccCCcccCcCH
Confidence 00 00112345678999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCc
Q 015532 381 REALRHPFFTRDVRRPT 397 (405)
Q Consensus 381 ~elL~hp~f~~~~~~~~ 397 (405)
.++++||||......++
T Consensus 248 ~~il~~~~~~~~~~~~~ 264 (277)
T cd06642 248 KELLKHKFITRYTKKTS 264 (277)
T ss_pred HHHHHhHHHHHHhhhHH
Confidence 99999999987655543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=290.05 Aligned_cols=219 Identities=22% Similarity=0.328 Sum_probs=161.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
++|++.+.||+|+||.||+|++..+ ++.||||+++.. ....+.+.+|+++++.+ .|++++...
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4699999999999999999986543 357999999643 23345678899999999 788763211
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~D---------------------- 255 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICD---------------------- 255 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEee----------------------
Confidence 01256778899999999999999999999999999999998766555555
Q ss_pred ceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 227 IKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 256 -----fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~ 330 (374)
T cd05106 256 -----FGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330 (374)
T ss_pred -----ceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence 44443221111 11234567999999998899999999999999999997 99999765433322221110
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.. .. ......++++.+++.+||+.||++|||+
T Consensus 331 ~~----------------------~~--------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~ 362 (374)
T cd05106 331 GY----------------------QM--------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTF 362 (374)
T ss_pred cc----------------------Cc--------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 00 00 0011235689999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
.++++
T Consensus 363 ~~l~~ 367 (374)
T cd05106 363 SQISQ 367 (374)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.42 Aligned_cols=221 Identities=30% Similarity=0.478 Sum_probs=174.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++++.||.|+||.||.+++..+++.|++|.+... ......+.+|+++++++.|+++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 599999999999999999999999999999987542 23345678899999999998873211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~-------------------- 140 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLI-------------------- 140 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCE--------------------
Confidence 1247888999999999999999999999999999999999876654
Q ss_pred CCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
||+|||.+....... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||......+....+
T Consensus 141 -------kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 141 -------KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred -------EECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 555555543322211 2346889999999998888899999999999999999999999876655544433
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.. +..+ ......+..+.++|.+||..||++|
T Consensus 214 ~~--~~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R 244 (256)
T cd08221 214 VQ--GNYT-----------------------------------------------PVVSVYSSELISLVHSLLQQDPEKR 244 (256)
T ss_pred Hc--CCCC-----------------------------------------------CCccccCHHHHHHHHHHcccCcccC
Confidence 21 1100 0012345688999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||+.++|+|+|+
T Consensus 245 ~s~~~ll~~~~l 256 (256)
T cd08221 245 PTADEVLDQPLL 256 (256)
T ss_pred CCHHHHhhCcCC
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=275.02 Aligned_cols=218 Identities=29% Similarity=0.424 Sum_probs=169.5
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
||.|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999999999999999986432 3346678899999999999873311
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 155 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 155 ------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
...+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~---------------------------~~ 133 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY---------------------------VK 133 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC---------------------------EE
Confidence 134688899999999999999999999999999999999976654 56
Q ss_pred eccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCC
Q 015532 229 LIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE--NLEHLAMMERVLGPL 304 (405)
Q Consensus 229 l~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~--~~~~~~~i~~~~g~~ 304 (405)
|+|||.+...... .....|+..|++||.+.+..++.++|+|||||++|+|++|..||.... ..+....+.....
T Consensus 134 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 211 (262)
T cd05572 134 LVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-- 211 (262)
T ss_pred EeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC--
Confidence 6666655443322 122467889999999988889999999999999999999999997765 2222222111000
Q ss_pred ChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC-----
Q 015532 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK----- 379 (405)
Q Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt----- 379 (405)
.. ..+...+.++.++|.+||+.||++|+|
T Consensus 212 --------------------~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 212 --------------------KL--------------------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred --------------------CC--------------------------CCCcccCHHHHHHHHHHccCChhhCcCCcccC
Confidence 00 111223568899999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 015532 380 AREALRHPFFTRD 392 (405)
Q Consensus 380 a~elL~hp~f~~~ 392 (405)
++|+++||||+.-
T Consensus 246 ~~~l~~~~~~~~~ 258 (262)
T cd05572 246 IKDIKKHKWFNGF 258 (262)
T ss_pred HHHHhcChhhhCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=271.69 Aligned_cols=222 Identities=29% Similarity=0.479 Sum_probs=171.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+|+..+.||+|+||+||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999998889999999986432 2345678899999999998873211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~-------------------- 140 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-------------------- 140 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--------------------
Confidence 123678888999999999999999999999999999999976654
Q ss_pred CCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
++|+|||.+...... .....|+..|++||.+.... ++.++|+|||||++|+|++|..||......+....
T Consensus 141 -------~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~ 213 (258)
T cd06632 141 -------VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213 (258)
T ss_pred -------EEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence 455555554432221 12346888999999998766 89999999999999999999999976554333222
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.... .. ......+++.+.+|+.+||+.||++
T Consensus 214 ~~~~~-~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 245 (258)
T cd06632 214 IGRSK-EL-----------------------------------------------PPIPDHLSDEAKDFILKCLQRDPSL 245 (258)
T ss_pred HHhcc-cC-----------------------------------------------CCcCCCcCHHHHHHHHHHhhcCccc
Confidence 21100 00 0111234678899999999999999
Q ss_pred CCCHHHHHcCCCC
Q 015532 377 RLKAREALRHPFF 389 (405)
Q Consensus 377 Rpta~elL~hp~f 389 (405)
|||+.+++.|||+
T Consensus 246 Rp~~~~~l~~~~~ 258 (258)
T cd06632 246 RPTAAELLEHPFV 258 (258)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=293.41 Aligned_cols=226 Identities=27% Similarity=0.437 Sum_probs=182.2
Q ss_pred CCCe-EEEeeeecccceeEEEEEecCCCcEEEEEEec-----chhhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~-----~~~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|| +...+||+|+|-+||+|.|..+|..||--.++ +.....+.+..|+.+|+.|.|+||+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3455 44679999999999999999999888855443 2234457889999999999999995432
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
++.++...++.+++||++||.|||++ -|||||||.+||+|+.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG----------------- 180 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG----------------- 180 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-----------------
Confidence 34567889999999999999999988 5999999999999964
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCcc-ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
..+.|||+|+|+|........ .++|||.|||||++. ..|+..+||||||..++||+|+.+||....+..
T Consensus 181 ---------~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 181 ---------NLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred ---------CcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 456799999999987665543 368999999999998 589999999999999999999999998877655
Q ss_pred HHHHHHHH-hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 293 HLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 293 ~~~~i~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
++.+ ++ .|..|..+. .-..+++++||.+||.
T Consensus 251 QIYK--KV~SGiKP~sl~----------------------------------------------kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 251 QIYK--KVTSGIKPAALS----------------------------------------------KVKDPEVREFIEKCLA 282 (632)
T ss_pred HHHH--HHHcCCCHHHhh----------------------------------------------ccCCHHHHHHHHHHhc
Confidence 4432 22 233332221 0014689999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~ 392 (405)
. .++|+||.|+|+||||..+
T Consensus 283 ~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 283 T-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred C-chhccCHHHHhhChhhccc
Confidence 9 9999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=273.94 Aligned_cols=249 Identities=32% Similarity=0.561 Sum_probs=183.0
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh--hhHHHHHHHHHHHHHh-hcCCCCC-----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA-RHDIGGT----------------- 153 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~-~~~~~~~----------------- 153 (405)
|++.+.||+|+||+||+|+...+++.||||.+..... ......+|+..+.++. |+++...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6788999999999999999998999999999864322 2233456899999998 8766211
Q ss_pred ---c--------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 154 ---R--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 154 ---~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
. ...+++..+..++.|++.+|.|||++|++|+||||+||+++.++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~----------------------- 137 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV----------------------- 137 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC-----------------------
Confidence 0 125688999999999999999999999999999999999976554
Q ss_pred CCCCceeccCCCCccccCCc--cceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+....... ....++..|+|||++.+ ..++.++|+||||+++++|++|.+||......+....+..
T Consensus 138 ----~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 138 ----VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred ----EEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 5566666554333211 22467889999998854 4578999999999999999999999999888888888888
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.++.++............ .....++... ...........+..+.+||.+||+.||++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 214 VLGTPTKQDWPEGYKLAS-----KLGFRFPQFA---------------PTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred hcCCCChhhhhhHhhhhc-----cccccccccc---------------cccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 887766543322111000 0000000000 00001111223568999999999999999999
Q ss_pred HHHHHcCCCC
Q 015532 380 AREALRHPFF 389 (405)
Q Consensus 380 a~elL~hp~f 389 (405)
++|++.||||
T Consensus 274 ~~ei~~~~~~ 283 (283)
T cd07830 274 ASQALQHPYF 283 (283)
T ss_pred HHHHhhCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.82 Aligned_cols=218 Identities=27% Similarity=0.417 Sum_probs=170.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
+|++.++||+|+||.||++.+..+++.||+|.++.. ....+.+..|+.+++.+.|+++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 489999999999999999999999999999998532 23446677899999999999873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~---------------------- 138 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK---------------------- 138 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc----------------------
Confidence 124678889999999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
++++|||.+...... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 139 -----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 213 (255)
T cd08219 139 -----VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213 (255)
T ss_pred -----EEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh
Confidence 555566655433221 123468889999999998889999999999999999999999998765544433322
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+. ..+ .....++..+.+||.+||+.||++||
T Consensus 214 ~~--~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp 244 (255)
T cd08219 214 QG--SYK-----------------------------------------------PLPSHYSYELRSLIKQMFKRNPRSRP 244 (255)
T ss_pred cC--CCC-----------------------------------------------CCCcccCHHHHHHHHHHHhCCcccCC
Confidence 11 000 00123456789999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|+.++++-
T Consensus 245 ~~~~il~~ 252 (255)
T cd08219 245 SATTILSR 252 (255)
T ss_pred CHHHHhhc
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=278.53 Aligned_cols=239 Identities=24% Similarity=0.360 Sum_probs=175.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.+.||+|+||+||++.+..+++.||+|++... ....+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5699999999999999999999999999999988643 33456788999999999998873221
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.|++.||.|||+ +||+||||||+||+++.++
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----------------------- 141 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG----------------------- 141 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-----------------------
Confidence 1346788999999999999999996 6999999999999997655
Q ss_pred CCCCCceeccCCCCccccC-CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.++|+|||++..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......+.....
T Consensus 142 ----~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--- 214 (284)
T cd06620 142 ----QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD--- 214 (284)
T ss_pred ----cEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---
Confidence 456666665543211 122357899999999998888999999999999999999999999865432110000
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
+.... .. ...+.... .+.. .....+..+.+|+.+||+.||++|||+
T Consensus 215 ----~~~~~--------~~------------------~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~ 260 (284)
T cd06620 215 ----PMGIL--------DL------------------LQQIVQEP-PPRL---PSSDFPEDLRDFVDACLLKDPTERPTP 260 (284)
T ss_pred ----hhHHH--------HH------------------HHHHhhcc-CCCC---CchhcCHHHHHHHHHHhcCCcccCcCH
Confidence 00000 00 00000000 0000 001245678999999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015532 381 REALRHPFFTRDVR 394 (405)
Q Consensus 381 ~elL~hp~f~~~~~ 394 (405)
.|+++|+||.+...
T Consensus 261 ~e~~~~~~~~~~~~ 274 (284)
T cd06620 261 QQLCAMPPFIQALR 274 (284)
T ss_pred HHHhcCcccccccc
Confidence 99999999987644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=276.61 Aligned_cols=221 Identities=26% Similarity=0.374 Sum_probs=158.7
Q ss_pred eeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH---hhcCCCCC------------------
Q 015532 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL---ARHDIGGT------------------ 153 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l---~~~~~~~~------------------ 153 (405)
.||+|+||.||++.+..+++.||+|++.... ........|..+++.+ .|+++...
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999986432 1122334455444444 34444210
Q ss_pred ---c------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 154 ---R------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 154 ---~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~------------------------- 135 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH------------------------- 135 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC-------------------------
Confidence 0 134788999999999999999999999999999999999976654
Q ss_pred CCceeccCCCCccccCC-ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 225 SAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++...... .....||..|+|||.+.+ ..++.++||||+||++|+|++|..||......... .+.+...
T Consensus 136 --~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~ 212 (279)
T cd05633 136 --VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL 212 (279)
T ss_pred --EEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh
Confidence 455555555332211 122468999999999874 56899999999999999999999999754321111 0111000
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC----
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---- 378 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp---- 378 (405)
. .........+..+.++|.+||..||++|+
T Consensus 213 ~----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 246 (279)
T cd05633 213 T----------------------------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLG 246 (279)
T ss_pred c----------------------------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 0 00011233567899999999999999999
Q ss_pred -CHHHHHcCCCCCCCC
Q 015532 379 -KAREALRHPFFTRDV 393 (405)
Q Consensus 379 -ta~elL~hp~f~~~~ 393 (405)
|++++++||||+...
T Consensus 247 ~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 247 RGAQEVKEHVFFKGID 262 (279)
T ss_pred CCHHHHHhCccccCCC
Confidence 699999999998843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=274.58 Aligned_cols=218 Identities=22% Similarity=0.275 Sum_probs=166.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc----EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+|++.++||+|+||+||+|++..+++ .||+|+++.. ......+.+|+.+++.+.|+++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 579999999999999999999876665 4899998642 23355677899999999998874210
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~------------------- 147 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH------------------- 147 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc-------------------
Confidence 134788899999999999999999999999999999999976554
Q ss_pred cCCCCCCCceeccCCCCccccCCcc-----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
++|+|||++........ ...++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 148 --------~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 148 --------VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred --------EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 56666665544322111 1134568999999998889999999999999999998 999997765444
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+... ... ......+.++.+++.+||..
T Consensus 220 ~~~~~~~~-~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~ 250 (279)
T cd05109 220 IPDLLEKG-ERL------------------------------------------------PQPPICTIDVYMIMVKCWMI 250 (279)
T ss_pred HHHHHHCC-CcC------------------------------------------------CCCccCCHHHHHHHHHHcCC
Confidence 33222110 000 00123456889999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
||++|||+.+++.
T Consensus 251 dp~~Rp~~~~l~~ 263 (279)
T cd05109 251 DSECRPRFRELVD 263 (279)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=273.26 Aligned_cols=218 Identities=18% Similarity=0.239 Sum_probs=167.1
Q ss_pred CCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+|++.+.||+|+||.||+|.++ ..+..||+|+++... .....+.+|+.++..+.|+++....
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56999999999999999999875 346789999987542 3345678899999999999874311
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg------------ 152 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR------------ 152 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCc------------
Confidence 1357889999999999999999999999999999999999876655555555
Q ss_pred cCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 293 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 293 (405)
.+...... .....++..|+|||.+.+..++.++|||||||++|++++ |..||......+.
T Consensus 153 ---------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~ 217 (266)
T cd05064 153 ---------------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV 217 (266)
T ss_pred ---------------ccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 33221111 011234678999999999899999999999999999775 9999987766554
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+.+.... ..+..++..+.+++.+||+.+
T Consensus 218 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~c~~~~ 248 (266)
T cd05064 218 IKAVEDGFRL-------------------------------------------------PAPRNCPNLLHQLMLDCWQKE 248 (266)
T ss_pred HHHHHCCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcCCC
Confidence 4433221100 011234568899999999999
Q ss_pred CCCCCCHHHHHc
Q 015532 374 PAERLKAREALR 385 (405)
Q Consensus 374 P~~Rpta~elL~ 385 (405)
|++|||++++++
T Consensus 249 p~~RP~~~~i~~ 260 (266)
T cd05064 249 RGERPRFSQIHS 260 (266)
T ss_pred chhCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=271.97 Aligned_cols=218 Identities=24% Similarity=0.329 Sum_probs=167.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.++||+|+||.||+|++..++ .||+|+++......+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 367999999999999999999987664 599999976555556788999999999998873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~---------------------- 141 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---------------------- 141 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcE----------------------
Confidence 1235778899999999999999999999999999999999776644
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
+|+|||.+....... ....++..|+|||+..+..++.++|||||||++|+|++ |..||.+....+....+
T Consensus 142 -----~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~ 216 (262)
T cd05071 142 -----KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216 (262)
T ss_pred -----EeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence 555555544322111 11245678999999988889999999999999999999 89999876655444332
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.... .. ......+..+.+|+.+||+.||++|
T Consensus 217 ~~~~-~~------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~R 247 (262)
T cd05071 217 ERGY-RM------------------------------------------------PCPPECPESLHDLMCQCWRKEPEER 247 (262)
T ss_pred hcCC-CC------------------------------------------------CCccccCHHHHHHHHHHccCCcccC
Confidence 2110 00 0012345678999999999999999
Q ss_pred CCHHHHHc
Q 015532 378 LKAREALR 385 (405)
Q Consensus 378 pta~elL~ 385 (405)
||+.++++
T Consensus 248 p~~~~~~~ 255 (262)
T cd05071 248 PTFEYLQA 255 (262)
T ss_pred CCHHHHHH
Confidence 99999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=272.04 Aligned_cols=219 Identities=24% Similarity=0.343 Sum_probs=170.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..+.|++.++||+|+||.||+|... +++.||+|.+.......+.+.+|+.+++++.|+++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence 3467999999999999999999865 567899999976665567788999999999998872211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.++..++.|++.||+|||++|++||||||+||+++.++.
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---------------------- 140 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC---------------------- 140 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC----------------------
Confidence 124678888999999999999999999999999999999987664
Q ss_pred CCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....
T Consensus 141 -----~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05067 141 -----CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215 (260)
T ss_pred -----EEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 4555555554332111 11245678999999988889999999999999999999 9999987766554443
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+.... ......+.++.+++.+||..||++
T Consensus 216 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05067 216 LERGYRM-------------------------------------------------PRPDNCPEELYELMRLCWKEKPEE 246 (260)
T ss_pred HHcCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccCChhh
Confidence 3221100 011234568999999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
|||++++++
T Consensus 247 Rp~~~~l~~ 255 (260)
T cd05067 247 RPTFEYLRS 255 (260)
T ss_pred CCCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=271.71 Aligned_cols=221 Identities=24% Similarity=0.397 Sum_probs=165.0
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------------------
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------------------- 154 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------------------- 154 (405)
....||+|+||.||+|++..++..||+|.+.... ...+.+.+|+.+++.+.|+++....
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 3468999999999999999999999999886433 3445678899999999999874321
Q ss_pred --------cccC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 --------YRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 --------~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+ ++..+..++.||+.||.|||++||+||||||+||+++.. .
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--------------------------~ 145 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--------------------------S 145 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--------------------------C
Confidence 1223 667788899999999999999999999999999999642 2
Q ss_pred CCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 225 SAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
..++|+|||.+...... .....|+..|+|||++.+.. ++.++|+||||+++|+|++|..||..............
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~ 225 (268)
T cd06624 146 GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225 (268)
T ss_pred CeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh
Confidence 24667777766443211 12245788999999987643 78999999999999999999999965432211100000
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
... .........++++.+|+.+||..+|++|||
T Consensus 226 ~~~-----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 258 (268)
T cd06624 226 MFK-----------------------------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRAS 258 (268)
T ss_pred hhc-----------------------------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCC
Confidence 000 000111234668999999999999999999
Q ss_pred HHHHHcCCCC
Q 015532 380 AREALRHPFF 389 (405)
Q Consensus 380 a~elL~hp~f 389 (405)
+.|++.||||
T Consensus 259 ~~~ll~~~~~ 268 (268)
T cd06624 259 AHDLLQDPFL 268 (268)
T ss_pred HHHHHhCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=273.48 Aligned_cols=222 Identities=20% Similarity=0.300 Sum_probs=171.2
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... ......+..|+.+++.+.|+++....
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 569999999999999999999977 6788999988643 22345688899999999998763211
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------------ 153 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------------ 153 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------------
Confidence 01477888999999999999999999999999999999997643
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCcc-----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 284 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~p 284 (405)
....++|+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 154 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~p 221 (277)
T cd05036 154 ------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred ------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 223467888887765422211 1223567999999998889999999999999999997 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
|.+.+..+....+.... ... .....+..+.+
T Consensus 222 f~~~~~~~~~~~~~~~~-----------------------~~~--------------------------~~~~~~~~~~~ 252 (277)
T cd05036 222 YPGRTNQEVMEFVTGGG-----------------------RLD--------------------------PPKGCPGPVYR 252 (277)
T ss_pred CCCCCHHHHHHHHHcCC-----------------------cCC--------------------------CCCCCCHHHHH
Confidence 98766554433221100 000 11234568899
Q ss_pred HHHHccccCCCCCCCHHHHHcC
Q 015532 365 LLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~h 386 (405)
++.+||+.||++|||+.++++|
T Consensus 253 ~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 253 IMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.49 Aligned_cols=218 Identities=23% Similarity=0.343 Sum_probs=168.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.++||+|+||.||+|.+. ++..||+|.++......+.+.+|+.+++++.|+++....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 467999999999999999999875 556699999976555566788999999999998862110
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~---------------------- 141 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVC---------------------- 141 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceE----------------------
Confidence 1246888899999999999999999999999999999999876654
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 142 -----~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 142 -----KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred -----EeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 455555543322111 11234567999999988889999999999999999999 99999876655544433
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.... . .......+..+.+|+.+||..||++|
T Consensus 217 ~~~~-~------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05070 217 ERGY-R------------------------------------------------MPCPQDCPISLHELMLQCWKKDPEER 247 (260)
T ss_pred HcCC-C------------------------------------------------CCCCCcCCHHHHHHHHHHcccCcccC
Confidence 2110 0 00112345689999999999999999
Q ss_pred CCHHHHHc
Q 015532 378 LKAREALR 385 (405)
Q Consensus 378 pta~elL~ 385 (405)
||+.++++
T Consensus 248 pt~~~l~~ 255 (260)
T cd05070 248 PTFEYLQS 255 (260)
T ss_pred cCHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.34 Aligned_cols=220 Identities=25% Similarity=0.378 Sum_probs=163.0
Q ss_pred CCeEEEeeeecccceeEEEEEe-----cCCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
++|++.++||+|+||.||+|++ ..++..||||+++... ...+.+.+|+.++..+ .|+++....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 3456789999986432 3345678899999999 788773211
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~---------------------- 252 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI---------------------- 252 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc----------------------
Confidence 013567788899999999999999999999999999999986654
Q ss_pred CCCCCceeccCCCCccccCCcc-----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 295 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 295 (405)
++|+|||++........ ...++..|+|||++.+..++.++|||||||++|+|++ |..||........+.
T Consensus 253 -----~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 253 -----TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred -----EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 45555555543221111 1234567999999999899999999999999999998 899997654433222
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+... +.+. ..+...+.++.+||.+||+.||+
T Consensus 328 ~~~~~----------------------~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~ 359 (375)
T cd05104 328 KMIKE----------------------GYRM--------------------------LSPECAPSEMYDIMKSCWDADPL 359 (375)
T ss_pred HHHHh----------------------CccC--------------------------CCCCCCCHHHHHHHHHHccCChh
Confidence 11110 0000 00112356889999999999999
Q ss_pred CCCCHHHHHcC
Q 015532 376 ERLKAREALRH 386 (405)
Q Consensus 376 ~Rpta~elL~h 386 (405)
+|||+.|+++.
T Consensus 360 ~RPs~~eil~~ 370 (375)
T cd05104 360 KRPTFKQIVQL 370 (375)
T ss_pred HCcCHHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.33 Aligned_cols=231 Identities=25% Similarity=0.423 Sum_probs=174.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHh---hcCCCCCc-------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA---RHDIGGTR------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~---~~~~~~~~------------- 154 (405)
.|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+.+++.+. |+++....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 488899999999999999999999999999998643 233456778999999997 77652210
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.|++.||.|||+.||+|+||+|+||+++..+.
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~---------------------- 139 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN---------------------- 139 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC----------------------
Confidence 135678899999999999999999999999999999999987654
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||.+...... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+
T Consensus 140 -----~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 140 -----VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred -----EEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 555566555433221 1224688899999998754 5789999999999999999999999765443222111
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
... .+ +.. .....+.++.+++.+||+.||++|
T Consensus 215 ~~~---~~------------------------------------------~~~---~~~~~~~~~~~~i~~~l~~~p~~R 246 (277)
T cd06917 215 PKS---KP------------------------------------------PRL---EDNGYSKLLREFVAACLDEEPKER 246 (277)
T ss_pred ccC---CC------------------------------------------CCC---CcccCCHHHHHHHHHHcCCCcccC
Confidence 000 00 000 001245688999999999999999
Q ss_pred CCHHHHHcCCCCCCCCCCCcc
Q 015532 378 LKAREALRHPFFTRDVRRPTL 398 (405)
Q Consensus 378 pta~elL~hp~f~~~~~~~~~ 398 (405)
||+.++++|+||++....+..
T Consensus 247 ~~~~~il~~~~~~~~~~~~~~ 267 (277)
T cd06917 247 LSAEELLKSKWIKAHSKTPVS 267 (277)
T ss_pred cCHHHHhhChHhhccccCchh
Confidence 999999999999887665543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=271.53 Aligned_cols=227 Identities=24% Similarity=0.432 Sum_probs=176.0
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.|++.+.||+|++|.||+|++..+++.||||++.... .....+..|+.++..+.|+++....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5899999999999999999999999999999986543 3456788999999999998873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~----------------------- 138 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE----------------------- 138 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC-----------------------
Confidence 1457888999999999999999999 99999999999999976654
Q ss_pred CCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 139 ----~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (264)
T cd06623 139 ----VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214 (264)
T ss_pred ----EEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH
Confidence 5555665554332211 134678899999999988899999999999999999999999977642111111111
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC-chHHHHHHHHHccccCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~~L~~dP~~Rp 378 (405)
...... ...... ++..+.++|.+||..+|++||
T Consensus 215 ~~~~~~----------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 215 ICDGPP----------------------------------------------PSLPAEEFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred HhcCCC----------------------------------------------CCCCcccCCHHHHHHHHHHccCChhhCC
Confidence 110000 001112 467899999999999999999
Q ss_pred CHHHHHcCCCCCCC
Q 015532 379 KAREALRHPFFTRD 392 (405)
Q Consensus 379 ta~elL~hp~f~~~ 392 (405)
|+.|+++||||+.-
T Consensus 249 ~~~~ll~~~~~~~~ 262 (264)
T cd06623 249 SAAELLQHPFIKKA 262 (264)
T ss_pred CHHHHHhCHHHHhc
Confidence 99999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=271.34 Aligned_cols=217 Identities=20% Similarity=0.338 Sum_probs=167.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||.||+|.+. ++..||+|.+.......+.+..|+.+++.+.|+++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56999999999999999999975 556799999876555567788999999999999873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~---------------------- 142 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMC---------------------- 142 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcE----------------------
Confidence 1235677888899999999999999999999999999999876654
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
+|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 143 -----~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05072 143 -----KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217 (261)
T ss_pred -----EECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 555555544332211 11235678999999988889999999999999999998 99999876655544333
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+... .......+.++.+++.+||..||++|
T Consensus 218 ~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 248 (261)
T cd05072 218 QRGYR-------------------------------------------------MPRMENCPDELYDIMKTCWKEKAEER 248 (261)
T ss_pred HcCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHccCCcccC
Confidence 22100 00112345688999999999999999
Q ss_pred CCHHHHHc
Q 015532 378 LKAREALR 385 (405)
Q Consensus 378 pta~elL~ 385 (405)
||++++++
T Consensus 249 p~~~~i~~ 256 (261)
T cd05072 249 PTFDYLQS 256 (261)
T ss_pred cCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.33 Aligned_cols=220 Identities=26% Similarity=0.410 Sum_probs=166.4
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
||+|+||+||+|.+..+++.||+|++.... .....+..|+++++.+.|+++....
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999986422 2234556899999999998763211
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..+..++.|++.||.|||++||+||||+|+||+++.++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--------------------------- 133 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--------------------------- 133 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---------------------------
Confidence 125788899999999999999999999999999999999976654
Q ss_pred ceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 015532 227 IKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~ 304 (405)
++|+|||.+...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...........+.+..-
T Consensus 134 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 211 (277)
T cd05577 134 VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-- 211 (277)
T ss_pred EEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--
Confidence 455555555432211 1223577889999999888899999999999999999999999976543211111111000
Q ss_pred ChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC-----C
Q 015532 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-----K 379 (405)
Q Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-----t 379 (405)
..........++.+.++|.+||+.||++|| +
T Consensus 212 --------------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 247 (277)
T cd05577 212 --------------------------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGS 247 (277)
T ss_pred --------------------------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCccc
Confidence 000011233467899999999999999999 9
Q ss_pred HHHHHcCCCCCCC
Q 015532 380 AREALRHPFFTRD 392 (405)
Q Consensus 380 a~elL~hp~f~~~ 392 (405)
+.++++||||..-
T Consensus 248 ~~~ll~h~~~~~~ 260 (277)
T cd05577 248 ADEVREHPLFKDL 260 (277)
T ss_pred HHHHHhChhhhcC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=275.05 Aligned_cols=230 Identities=26% Similarity=0.409 Sum_probs=177.4
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
-|++.++||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+.|+++....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3788899999999999999998899999999985432 3345677899999999999863211
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~------------------------- 139 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE------------------------- 139 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC-------------------------
Confidence 134678899999999999999999999999999999999976664
Q ss_pred CCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
++|+|||++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 140 --~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 216 (277)
T cd06641 140 --VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN- 216 (277)
T ss_pred --EEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-
Confidence 455555554332211 12246788999999998888899999999999999999999999765543333222110
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
.. ......++.++.+++.+||+.||++||++.
T Consensus 217 -~~-----------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 248 (277)
T cd06641 217 -NP-----------------------------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAK 248 (277)
T ss_pred -CC-----------------------------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 00 001123456889999999999999999999
Q ss_pred HHHcCCCCCCCCCCCcc
Q 015532 382 EALRHPFFTRDVRRPTL 398 (405)
Q Consensus 382 elL~hp~f~~~~~~~~~ 398 (405)
++++||||.+....++.
T Consensus 249 ~~l~~~~~~~~~~~~~~ 265 (277)
T cd06641 249 ELLKHKFIVRFAKKTSY 265 (277)
T ss_pred HHHhCHHHhhhhhccch
Confidence 99999999987665543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=269.36 Aligned_cols=222 Identities=28% Similarity=0.443 Sum_probs=170.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch------hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+++++.+.|+++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3699999999999999999999999999999987421 12335677899999999998873211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg---------- 151 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG---------- 151 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccc----------
Confidence 1236778889999999999999999999999999999999876655555555
Q ss_pred cccCCCCCCCceeccCCCCccccC------CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
++..... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 152 -----------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 152 -----------------ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred -----------------cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 4432211 11224688899999999988899999999999999999999999976544
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
......+.. .+.+ ...+...++.+.++|.+||
T Consensus 215 ~~~~~~~~~--~~~~----------------------------------------------~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 215 MAAIFKIAT--QPTK----------------------------------------------PMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred HHHHHHHHc--CCCC----------------------------------------------CCCCcccCHHHHHHHHHHh
Confidence 433322211 0000 0112345678999999999
Q ss_pred ccCCCCCCCHHHHHcCCCC
Q 015532 371 RYDPAERLKAREALRHPFF 389 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f 389 (405)
+ +|.+|||+.+++.|||.
T Consensus 247 ~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 247 V-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred c-CcccCccHHHHhcCCCC
Confidence 9 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=275.16 Aligned_cols=219 Identities=22% Similarity=0.299 Sum_probs=168.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC-----cEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
+.|++.+.||+|+||.||+|.+...+ +.||+|.++... .....+.+|+.++..+.|+++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46899999999999999999976554 689999986432 3345678899999999998873211
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 155 ---------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 155 ---------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~- 163 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV- 163 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE-
Confidence 0335677888999999999999999999999999999999876654
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
+|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|
T Consensus 164 --------------------------~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ 217 (283)
T cd05048 164 --------------------------KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217 (283)
T ss_pred --------------------------EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence 55555554332111 11235678899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 277 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 277 ~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
||++ |..||.+....+....+.... . ....
T Consensus 218 el~~~g~~p~~~~~~~~~~~~i~~~~--~-----------------------------------------------~~~~ 248 (283)
T cd05048 218 EIFSYGLQPYYGFSNQEVIEMIRSRQ--L-----------------------------------------------LPCP 248 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCC--c-----------------------------------------------CCCc
Confidence 9998 999998876655444332110 0 0112
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
..++.++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 249 EDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=274.57 Aligned_cols=211 Identities=14% Similarity=0.134 Sum_probs=163.6
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhhh----hHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
..||+|++|.||+|.. +|+.||||+++..... .+.+.+|+.+|.++.|+++....
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 4799999999999997 5889999999754332 35667999999999999873211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.....++.|++.||.|||+ .+++||||||+|||++.++.
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---------------------- 161 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---------------------- 161 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc----------------------
Confidence 1346777889999999999999998 59999999999999976554
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
+||+|||++...........|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+..
T Consensus 162 -----~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 162 -----LKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred -----EEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 566666665543333334468899999999976 5799999999999999999999999988766554443322
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
....+ . .....++.+.+|+.+||+.||++|||
T Consensus 237 ~~~~~----------------------~--------------------------~~~~~~~~l~~li~~cl~~dp~~Rps 268 (283)
T PHA02988 237 KNNSL----------------------K--------------------------LPLDCPLEIKCIVEACTSHDSIKRPN 268 (283)
T ss_pred cCCCC----------------------C--------------------------CCCcCcHHHHHHHHHHhcCCcccCcC
Confidence 11100 0 11134668999999999999999999
Q ss_pred HHHHHc
Q 015532 380 AREALR 385 (405)
Q Consensus 380 a~elL~ 385 (405)
++|+++
T Consensus 269 ~~ell~ 274 (283)
T PHA02988 269 IKEILY 274 (283)
T ss_pred HHHHHH
Confidence 999985
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=271.54 Aligned_cols=216 Identities=19% Similarity=0.276 Sum_probs=163.0
Q ss_pred EEEeeeecccceeEEEEEecCCCc--EEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 95 RILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~~--~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.+.++||+|+||.||+|++..++. .||+|.++.. ....+.+..|+.+++.++|+++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467899999999999999877765 6999988643 23356678899999999998874311
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----------- 150 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN----------- 150 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC-----------
Confidence 012567888999999999999999999999999999999976654
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 284 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~p 284 (405)
++|+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.|
T Consensus 151 ----------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 151 ----------------VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred ----------------EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 4555555554332211 11245678999999998889999999999999999999 8999
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
|.+....+....+... . .. ......+..+.+
T Consensus 215 ~~~~~~~~~~~~~~~~--~---------------------~~--------------------------~~~~~~~~~~~~ 245 (272)
T cd05075 215 YPGVENSEIYDYLRQG--N---------------------RL--------------------------KQPPDCLDGLYS 245 (272)
T ss_pred CCCCCHHHHHHHHHcC--C---------------------CC--------------------------CCCCCCCHHHHH
Confidence 9876654433322210 0 00 011234567899
Q ss_pred HHHHccccCCCCCCCHHHHHcC
Q 015532 365 LLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~h 386 (405)
+|.+||+.||++|||+.+++++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 246 LMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=275.18 Aligned_cols=237 Identities=27% Similarity=0.436 Sum_probs=183.2
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+...+.|++.+.||+|+||.||+|.+..+++.||+|+++......+.+..|+++++.+.|+++....
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456779999999999999999999998899999999976544456788899999999998763211
Q ss_pred --------------cc-cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 --------------YR-SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 --------------~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
.. .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+++
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l----------------- 157 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKL----------------- 157 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEE-----------------
Confidence 11 6788899999999999999999999999999999999987665544
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+|||.+...... .....++..|++||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 158 ----------~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~ 227 (286)
T cd06614 158 ----------ADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL 227 (286)
T ss_pred ----------CccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 455443322111 1223578899999999888899999999999999999999999987655443332
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+... ..+. ......++..+.+||.+||+.+|.+
T Consensus 228 ~~~~--~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 228 ITTK--GIPP---------------------------------------------LKNPEKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred HHhc--CCCC---------------------------------------------CcchhhCCHHHHHHHHHHhccChhh
Confidence 2110 0000 0001124568899999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCCCcc
Q 015532 377 RLKAREALRHPFFTRDVRRPTL 398 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~~~~~ 398 (405)
|||+.++++|+||++...++.+
T Consensus 261 Rpt~~~il~~~~~~~~~~~~~~ 282 (286)
T cd06614 261 RPSAEELLQHPFLKKACPKEEF 282 (286)
T ss_pred CcCHHHHhhChHhhccCchHhh
Confidence 9999999999999996665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=267.02 Aligned_cols=221 Identities=31% Similarity=0.472 Sum_probs=174.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||+|++|.||++++..+++.||+|.+.... ...+.+.+|++++.++.|+++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5899999999999999999999899999999996544 3456788999999999998763211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~----------------------- 137 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV----------------------- 137 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC-----------------------
Confidence 135788899999999999999999999999999999999976554
Q ss_pred CCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..
T Consensus 138 ----~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (254)
T cd06627 138 ----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213 (254)
T ss_pred ----EEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 5555665554433222 224678899999999887889999999999999999999999976554333222211
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
... .......+..+.+++.+||..+|++|||
T Consensus 214 --~~~-----------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 244 (254)
T cd06627 214 --DDH-----------------------------------------------PPLPEGISPELKDFLMQCFQKDPNLRPT 244 (254)
T ss_pred --cCC-----------------------------------------------CCCCCCCCHHHHHHHHHHHhCChhhCcC
Confidence 000 0111234668899999999999999999
Q ss_pred HHHHHcCCCC
Q 015532 380 AREALRHPFF 389 (405)
Q Consensus 380 a~elL~hp~f 389 (405)
+.+++.||||
T Consensus 245 ~~~~l~~~~~ 254 (254)
T cd06627 245 AKQLLKHPWI 254 (254)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=266.64 Aligned_cols=221 Identities=30% Similarity=0.513 Sum_probs=174.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.+.||.|+||.||++.+..+++.||+|++.... .....+..|+++++.+.|+++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999999899999999986532 3456678899999999998863211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~------------------- 141 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL------------------- 141 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc-------------------
Confidence 145788899999999999999999999999999999999976654
Q ss_pred cCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
++|+|||.+...... .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+...
T Consensus 142 --------~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 213 (258)
T cd08215 142 --------VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213 (258)
T ss_pred --------EEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence 455555555433222 122468889999999988889999999999999999999999997765444333
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.+.. . .......+..+.+++.+||..||+
T Consensus 214 ~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~ 244 (258)
T cd08215 214 KILKGQ--Y-----------------------------------------------PPIPSQYSSELRNLVSSLLQKDPE 244 (258)
T ss_pred HHhcCC--C-----------------------------------------------CCCCCCCCHHHHHHHHHHcCCChh
Confidence 221110 0 001123456889999999999999
Q ss_pred CCCCHHHHHcCCCC
Q 015532 376 ERLKAREALRHPFF 389 (405)
Q Consensus 376 ~Rpta~elL~hp~f 389 (405)
+|||+.++|+||||
T Consensus 245 ~Rp~~~~ll~~~~~ 258 (258)
T cd08215 245 ERPSIAQILQSPFI 258 (258)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=274.63 Aligned_cols=218 Identities=20% Similarity=0.318 Sum_probs=167.2
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
+.|.+.+.||+|+||.||+|.+.. +++.||||+++.... ..+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468999999999999999998753 357899999865432 356788999999999998863211
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.++++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 1235778889999999999999999999999999999999876655555
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
|| |++...... .....++..|+|||++.+..++.++|||||||++|+|
T Consensus 165 d~---------------------------g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 165 DF---------------------------GMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred Cc---------------------------ccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 55 444322111 1122456789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
++ |..||.+.+..+....+.+.... .....
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~ 248 (280)
T cd05049 218 FTYGKQPWYGLSNEEVIECITQGRLL-------------------------------------------------QRPRT 248 (280)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCcC-------------------------------------------------CCCCC
Confidence 98 99999877665544433211000 00123
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+..+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 249 CPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=275.81 Aligned_cols=228 Identities=26% Similarity=0.415 Sum_probs=175.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
|....+||+|+||.||++....+++.||||.+.... .....+.+|+.+++.+.|+++....
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 444578999999999999999999999999985422 3455678899999999998863221
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..+..++.|++.||.|||++||+|+||||+||+++.++.+
T Consensus 102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~-------------------------- 155 (292)
T cd06657 102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV-------------------------- 155 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE--------------------------
Confidence 1346888999999999999999999999999999999999876655
Q ss_pred ceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 015532 227 IKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
+|+|||.+...... .....|+..|+|||.+.+..++.++|+||+||++|+|++|..||.+....+....+.....
T Consensus 156 -~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~- 233 (292)
T cd06657 156 -KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP- 233 (292)
T ss_pred -EEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-
Confidence 45555544322111 1224688899999999888889999999999999999999999987665544433322110
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHH
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 383 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~el 383 (405)
. ........+..+.+++.+||+.||.+||++.++
T Consensus 234 --~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~l 267 (292)
T cd06657 234 --P--------------------------------------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267 (292)
T ss_pred --c--------------------------------------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence 0 000112345678899999999999999999999
Q ss_pred HcCCCCCCCCCC
Q 015532 384 LRHPFFTRDVRR 395 (405)
Q Consensus 384 L~hp~f~~~~~~ 395 (405)
++||||......
T Consensus 268 l~~~~~~~~~~~ 279 (292)
T cd06657 268 LKHPFLAKAGPP 279 (292)
T ss_pred hcChHHhccCCC
Confidence 999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.31 Aligned_cols=241 Identities=21% Similarity=0.259 Sum_probs=171.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.++||+|+||.||+|++..+++.||||+++.. ....+.+.+|+++++.+.|+++....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998642 23456788999999999999874321
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 0112345667889999999999999999999999999999998888888888775
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
......... .......-+............+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 162 ~i~~~~~~~------~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 162 FKKLEEEDL------LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ecccccccc------cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 442211100 00000000000000011123579999999999999999999999999999999999999997644
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
....... ..... |. .......+++.+.+++.+|
T Consensus 236 ~~ki~~~--~~i~~-P~--------------------------------------------~~~p~~~iP~~L~~LI~rc 268 (932)
T PRK13184 236 GRKISYR--DVILS-PI--------------------------------------------EVAPYREIPPFLSQIAMKA 268 (932)
T ss_pred hhhhhhh--hhccC-hh--------------------------------------------hccccccCCHHHHHHHHHH
Confidence 3222111 00000 00 0000123466889999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|+.||++|++..+.+.
T Consensus 269 L~~DP~kR~ss~eeLl 284 (932)
T PRK13184 269 LAVDPAERYSSVQELK 284 (932)
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999987655553
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=277.25 Aligned_cols=229 Identities=25% Similarity=0.371 Sum_probs=176.0
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..+.|...++||+|+||+||+|++..+++.||+|++.... .....+..|+++++.+.|+++....
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3345888899999999999999999999999999986422 2234567899999999998873211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.++..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~------------------- 159 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ------------------- 159 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC-------------------
Confidence 234678889999999999999999999999999999999976554
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
++|+|||.+..... .....|+..|+|||++. +..++.++|||||||++|+|++|..||...+......
T Consensus 160 --------~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 160 --------VKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred --------EEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 56666665543222 22346888999999985 3458889999999999999999999998766544443
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+... ..|. .....++..+.+|+.+||+.+|+
T Consensus 231 ~~~~~--~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~~P~ 262 (313)
T cd06633 231 HIAQN--DSPT----------------------------------------------LQSNEWTDSFRGFVDYCLQKIPQ 262 (313)
T ss_pred HHHhc--CCCC----------------------------------------------CCccccCHHHHHHHHHHccCChh
Confidence 33211 0000 00122345789999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~ 394 (405)
+||++.++++||||+....
T Consensus 263 ~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 263 ERPASAELLRHDFVRRDRP 281 (313)
T ss_pred hCcCHHHHhcCcccCCCch
Confidence 9999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=269.94 Aligned_cols=219 Identities=27% Similarity=0.417 Sum_probs=167.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||.++.. ......+..|+.+++.+.|+++....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4699999999999999999999999999999987532 23345678899999999999873211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~----------------- 144 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV----------------- 144 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC-----------------
Confidence 123677888999999999999999999999999999999976654
Q ss_pred cccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--H
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--L 291 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~ 291 (405)
++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 145 ----------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 145 ----------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred ----------EEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 5566666554432211 124688899999999988899999999999999999999999965432 1
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.. .+..| ......+..+.++|.+||.
T Consensus 215 ~~~~~~~~-~~~~~-----------------------------------------------~~~~~~~~~~~~li~~cl~ 246 (267)
T cd08228 215 SLCQKIEQ-CDYPP-----------------------------------------------LPTEHYSEKLRELVSMCIY 246 (267)
T ss_pred HHHHHHhc-CCCCC-----------------------------------------------CChhhcCHHHHHHHHHHCC
Confidence 21111111 00000 0011235678999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.+|++|||+.++++
T Consensus 247 ~~p~~Rp~~~~vl~ 260 (267)
T cd08228 247 PDPDQRPDIGYVHQ 260 (267)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=266.02 Aligned_cols=221 Identities=29% Similarity=0.511 Sum_probs=175.3
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
|++.+.||+|++|.||++.+..+++.|++|++..... ....+.+|+++++.+.|+++....
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 7889999999999999999998999999999976443 456788899999999988762110
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..+..++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-------------------------- 135 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-------------------------- 135 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--------------------------
Confidence 13578899999999999999999999999999999999997654
Q ss_pred CCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 225 SAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
.++|+|||.+....... ....++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 136 -~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 212 (253)
T cd05122 136 -EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-- 212 (253)
T ss_pred -eEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--
Confidence 46677777665544332 3457889999999999888899999999999999999999999876544433322210
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
..+. . .....++..+.++|.+||+.||++|||+.|
T Consensus 213 ~~~~---------------------~------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 213 GPPG---------------------L------------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCC---------------------c------------------------CcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 0000 0 000112568899999999999999999999
Q ss_pred HHcCCC
Q 015532 383 ALRHPF 388 (405)
Q Consensus 383 lL~hp~ 388 (405)
+++|||
T Consensus 248 ~l~~~~ 253 (253)
T cd05122 248 LLKHPF 253 (253)
T ss_pred HhcCCC
Confidence 999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=268.59 Aligned_cols=217 Identities=23% Similarity=0.328 Sum_probs=167.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.|++.+.||+|+||.||++..+. +..+|+|.++......+.+..|+++++++.|+++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 358999999999999999998754 45799999876555556788899999999999873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~----------------------- 139 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV----------------------- 139 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeE-----------------------
Confidence 1246788899999999999999999999999999999999766544
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
+|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+.+..+.
T Consensus 140 ----kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 140 ----KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred ----EECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 555555544322111 11234567999999988889999999999999999999 999998877655554443
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+... .. .....+..+.+|+.+||..||++||
T Consensus 216 ~~~~-----------------------~~--------------------------~~~~~~~~~~~li~~c~~~~p~~Rp 246 (256)
T cd05114 216 RGFR-----------------------LY--------------------------RPKLASMTVYEVMYSCWHEKPEGRP 246 (256)
T ss_pred CCCC-----------------------CC--------------------------CCCCCCHHHHHHHHHHccCCcccCc
Confidence 2100 00 0112345789999999999999999
Q ss_pred CHHHHHc
Q 015532 379 KAREALR 385 (405)
Q Consensus 379 ta~elL~ 385 (405)
|++++++
T Consensus 247 s~~~l~~ 253 (256)
T cd05114 247 TFAELLR 253 (256)
T ss_pred CHHHHHH
Confidence 9999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=268.09 Aligned_cols=217 Identities=24% Similarity=0.337 Sum_probs=167.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||.||+|.+..++ .||+|.+.......+.+.+|+++++.+.|+++....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 57999999999999999999986554 599999876555567788999999999998863210
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~------------------------ 140 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV------------------------ 140 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe------------------------
Confidence 123577888999999999999999999999999999999976654
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 141 ---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05069 141 ---CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217 (260)
T ss_pred ---EEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 4555555554332111 11245678999999988889999999999999999999 999998776655444332
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
... .. ......+..+.+++.+||..||++||
T Consensus 218 ~~~-~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05069 218 RGY-RM------------------------------------------------PCPQGCPESLHELMKLCWKKDPDERP 248 (260)
T ss_pred cCC-CC------------------------------------------------CCCcccCHHHHHHHHHHccCCcccCc
Confidence 210 00 00123456889999999999999999
Q ss_pred CHHHHHc
Q 015532 379 KAREALR 385 (405)
Q Consensus 379 ta~elL~ 385 (405)
+++++++
T Consensus 249 ~~~~i~~ 255 (260)
T cd05069 249 TFEYIQS 255 (260)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=269.68 Aligned_cols=222 Identities=27% Similarity=0.457 Sum_probs=164.3
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHH-HHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQ-RLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~-~l~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|.+..+++.||||++++... .......|..++. ...|+++....
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999865321 1122334444433 34666653211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||+|+||+++.++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~-------------------------- 135 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH-------------------------- 135 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--------------------------
Confidence 135788999999999999999999999999999999999976554
Q ss_pred CceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 015532 226 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 305 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p 305 (405)
++|+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus 136 -~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---- 209 (260)
T cd05611 136 -LKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR---- 209 (260)
T ss_pred -EEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc----
Confidence 56666665543322 223468889999999998888999999999999999999999998766554433322110
Q ss_pred hHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH---HH
Q 015532 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA---RE 382 (405)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta---~e 382 (405)
..++. .....++..+.++|.+||+.||++|||+ +|
T Consensus 210 --------------------~~~~~----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 210 --------------------INWPE----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred --------------------cCCCC----------------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 01110 0112346789999999999999999954 79
Q ss_pred HHcCCCCCCCC
Q 015532 383 ALRHPFFTRDV 393 (405)
Q Consensus 383 lL~hp~f~~~~ 393 (405)
+|+||||+...
T Consensus 248 ~l~~~~~~~~~ 258 (260)
T cd05611 248 IKSHPFFKSIN 258 (260)
T ss_pred HHcChHhhcCC
Confidence 99999998743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=276.42 Aligned_cols=234 Identities=25% Similarity=0.378 Sum_probs=178.9
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
+.....|...+.||+|+||.||+|++..+++.||+|++.... .....+..|+++++.+.|+++....
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 334455889999999999999999999999999999986422 2234677899999999998763211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||+|+||+++.++.
T Consensus 101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~----------------- 163 (317)
T cd06635 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ----------------- 163 (317)
T ss_pred EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC-----------------
Confidence 234678889999999999999999999999999999999976554
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
++|+|||++..... .....|+..|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 164 ----------~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 164 ----------VKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ----------EEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 56666665543322 22346888999999984 34688999999999999999999999977655444
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+.....+. ......++.+.+||.+||+.+
T Consensus 233 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~~ 264 (317)
T cd06635 233 LYHIAQNESPT------------------------------------------------LQSNEWSDYFRNFVDSCLQKI 264 (317)
T ss_pred HHHHHhccCCC------------------------------------------------CCCccccHHHHHHHHHHccCC
Confidence 43332211000 001234567899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCCCCc
Q 015532 374 PAERLKAREALRHPFFTRDVRRPT 397 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~~~~ 397 (405)
|++|||+.++++|+|+........
T Consensus 265 p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 265 PQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred cccCcCHHHHHhChhhhccCcccc
Confidence 999999999999999988655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=267.83 Aligned_cols=220 Identities=30% Similarity=0.492 Sum_probs=168.7
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHhhcCCCCC-------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGT------------- 153 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~~~~~~~~------------- 153 (405)
||.+.++||+|+||.||++++..++..+++|+++... .....+..|+.+++.+.|+++...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998877777788775321 223346678999999999886211
Q ss_pred ------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 154 ------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 154 ------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
....+++..++.++.|++.||.|||++|++|+||||+||+++. +
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~----------------- 142 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N----------------- 142 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-----------------
Confidence 1134778899999999999999999999999999999999963 2
Q ss_pred CcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 143 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 143 ----------LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred ----------CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 2566676665443221 122457889999999988888999999999999999999999997655443
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.. +..|. .....+.++.++|.+||+.
T Consensus 213 ~~~~~~~--~~~~~-----------------------------------------------~~~~~~~~~~~li~~~l~~ 243 (260)
T cd08222 213 VVLRIVE--GPTPS-----------------------------------------------LPETYSRQLNSIMQSMLNK 243 (260)
T ss_pred HHHHHHc--CCCCC-----------------------------------------------CcchhcHHHHHHHHHHhcC
Confidence 3322211 11110 0123456889999999999
Q ss_pred CCCCCCCHHHHHcCCCC
Q 015532 373 DPAERLKAREALRHPFF 389 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f 389 (405)
||++||++.|+++||||
T Consensus 244 ~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 244 DPSLRPSAAEILRNPFI 260 (260)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=274.87 Aligned_cols=219 Identities=20% Similarity=0.248 Sum_probs=166.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..|++.++||+|+||.||+|.+..+ ++.||||+++... ...+.+..|+.++..+.|+++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3588899999999999999987543 5789999987432 2345677899999999999874211
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 155 ---------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 155 ---------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-- 162 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-- 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence 123677788899999999999999999999999999999976554
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|
T Consensus 163 -------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 217 (283)
T cd05091 163 -------------------------VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW 217 (283)
T ss_pred -------------------------eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHH
Confidence 4555555544322111 1124567899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 277 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 277 ~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
||++ |..||.+....+....+...... ...
T Consensus 218 el~~~g~~p~~~~~~~~~~~~i~~~~~~-------------------------------------------------~~~ 248 (283)
T cd05091 218 EVFSYGLQPYCGYSNQDVIEMIRNRQVL-------------------------------------------------PCP 248 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcC-------------------------------------------------CCC
Confidence 9998 89999887665554443321100 011
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
...+..+.+|+.+||+.||++||++.++++.
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 249 DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 3456688999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=269.43 Aligned_cols=228 Identities=29% Similarity=0.489 Sum_probs=170.7
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
||.|+||.||+|++..+++.||+|++.... ...+.+.+|+++++++.|+++....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999899999999986532 2445677899999999998873211
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 155 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 155 ------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++++|||++......... .
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~ 150 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI----------N 150 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc----------c
Confidence 135788899999999999999999999999999999999987776666665543322111000 0
Q ss_pred eccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Q 015532 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM 308 (405)
Q Consensus 229 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~ 308 (405)
. ...........++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+...
T Consensus 151 ~------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------- 216 (265)
T cd05579 151 L------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-------- 216 (265)
T ss_pred c------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------
Confidence 0 00000112346788999999998888899999999999999999999999877655544333220
Q ss_pred HHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH---HHHHc
Q 015532 309 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA---REALR 385 (405)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta---~elL~ 385 (405)
...++. ....+..+.+|+.+||+.+|++|||+ .++|+
T Consensus 217 ----------------~~~~~~------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 ----------------KIEWPE------------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----------------CcCCCc------------------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 011111 01135688999999999999999999 99999
Q ss_pred CCCCCC
Q 015532 386 HPFFTR 391 (405)
Q Consensus 386 hp~f~~ 391 (405)
||||+.
T Consensus 257 ~~~~~~ 262 (265)
T cd05579 257 HPFFKG 262 (265)
T ss_pred CccccC
Confidence 999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.53 Aligned_cols=231 Identities=30% Similarity=0.433 Sum_probs=179.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.++-|++...+||.|.||.||-|.+..+|+..|+|-++-.. +......+|..+|..+.|+|++...
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34567888999999999999999999999999999885432 2334566899999999999986543
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
.+..++...+.+..|++.||.|||++|||||||||+||+++.+|.+
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~i------------------ 1373 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLI------------------ 1373 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcE------------------
Confidence 1234566777889999999999999999999999999999887754
Q ss_pred cCCCCCCCceeccCCCCccccCCc-------cceecCCCcchhHHHhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
|+.|||.|....... ...+||+.|||||++.+. +...++|||||||++.||+||+.||...
T Consensus 1374 ---------K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1374 ---------KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred ---------EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 555555554433322 236899999999999864 4668999999999999999999999776
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
++.-++..-. ..|..| . .++..+.+.+|||..
T Consensus 1445 dne~aIMy~V-~~gh~P---------------------q--------------------------~P~~ls~~g~dFle~ 1476 (1509)
T KOG4645|consen 1445 DNEWAIMYHV-AAGHKP---------------------Q--------------------------IPERLSSEGRDFLEH 1476 (1509)
T ss_pred cchhHHHhHH-hccCCC---------------------C--------------------------CchhhhHhHHHHHHH
Confidence 5543332111 112111 1 123357789999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
||+.||++|+++.|+|+|-|-+....
T Consensus 1477 Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1477 CLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHhcCchhhhHHHHHHHhhccccccc
Confidence 99999999999999999999876543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=267.15 Aligned_cols=218 Identities=22% Similarity=0.343 Sum_probs=167.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||.||+|.+.. ++.||||.++......+.+.+|+.+++++.|+++....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3679999999999999999999754 56799999976555566788999999999998873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--------------------- 142 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNIC--------------------- 142 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCE---------------------
Confidence 1247788999999999999999999999999999999999876655
Q ss_pred CCCCCceeccCCCCccccCCc-cc---eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH-SY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~-~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
+|+|||++....... .. ...+..|+|||++.+..++.++|||||||++|+|++ |+.||.+......+..
T Consensus 143 ------~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05068 143 ------KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216 (261)
T ss_pred ------EECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 455555443322111 01 122457999999998889999999999999999999 9999988766554443
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+... . ......+..+.+++.+||+.||++
T Consensus 217 ~~~~~~-~------------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~ 247 (261)
T cd05068 217 VDQGYR-M------------------------------------------------PCPPGCPKELYDIMLDCWKEDPDD 247 (261)
T ss_pred HHcCCC-C------------------------------------------------CCCCcCCHHHHHHHHHHhhcCccc
Confidence 322110 0 011234568899999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
||++.++++
T Consensus 248 Rp~~~~l~~ 256 (261)
T cd05068 248 RPTFETLQW 256 (261)
T ss_pred CCCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=269.93 Aligned_cols=217 Identities=19% Similarity=0.278 Sum_probs=163.7
Q ss_pred eEEEeeeecccceeEEEEEecCC---CcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
|++.+.||+|+||.||+|....+ +..||||+++... ...+.+..|+.+++.+.|+++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987653 4789999986432 2345678899999999999863210
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~-------- 152 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTV-------- 152 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeE--------
Confidence 0246778889999999999999999999999999999999766554
Q ss_pred ccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CC
Q 015532 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 282 (405)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~ 282 (405)
+|+|||++....... ....++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 153 -------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~ 213 (273)
T cd05035 153 -------------------CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213 (273)
T ss_pred -------------------EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCC
Confidence 555555544322111 11234667999999988889999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||.+....+....+... . .. ......+..+
T Consensus 214 ~p~~~~~~~~~~~~~~~~--~---------------------~~--------------------------~~~~~~~~~~ 244 (273)
T cd05035 214 TPYPGVENHEIYDYLRHG--N---------------------RL--------------------------KQPEDCLDEL 244 (273)
T ss_pred CCCCCCCHHHHHHHHHcC--C---------------------CC--------------------------CCCcCCCHHH
Confidence 999876654443322110 0 00 0112346689
Q ss_pred HHHHHHccccCCCCCCCHHHHHcC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+++.+||+.||++|||+.|++++
T Consensus 245 ~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 245 YDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.66 Aligned_cols=226 Identities=22% Similarity=0.350 Sum_probs=168.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
.++|++.++||+|+||.||+|.++. .+..||+|.++... .....+.+|+.+++.+.|+++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4689999999999999999997652 34579999886433 2334567899999999998873211
Q ss_pred ----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcc
Q 015532 155 ----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 155 ----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
...++...+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~------- 157 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT------- 157 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc-------
Confidence 011234567889999999999999999999999999999977654
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
++|+|||+++...... ....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 158 --------------------~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~ 217 (288)
T cd05061 158 --------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217 (288)
T ss_pred --------------------EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhC
Confidence 4555555554322111 11235677999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+....+....+.. +. .. ......++
T Consensus 218 ~~~p~~~~~~~~~~~~~~~--~~---------------------~~--------------------------~~~~~~~~ 248 (288)
T cd05061 218 AEQPYQGLSNEQVLKFVMD--GG---------------------YL--------------------------DQPDNCPE 248 (288)
T ss_pred CCCCCCCCCHHHHHHHHHc--CC---------------------CC--------------------------CCCCCCCH
Confidence 7899987665443332211 00 00 01123356
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHc------CCCCCCC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALR------HPFFTRD 392 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~------hp~f~~~ 392 (405)
.+.+++.+||+.||++|||+.++++ ||||+.-
T Consensus 249 ~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 249 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 8999999999999999999999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=272.25 Aligned_cols=222 Identities=27% Similarity=0.361 Sum_probs=159.2
Q ss_pred eeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHH---HhhcCCCCCc-----------------
Q 015532 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQR---LARHDIGGTR----------------- 154 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~---l~~~~~~~~~----------------- 154 (405)
.||+|+||.||+|.+..+++.||||++.... ........|..+++. ..|+++....
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999986432 111223344444433 3455552110
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..++.++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~------------------------- 135 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH------------------------- 135 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC-------------------------
Confidence 134788999999999999999999999999999999999976654
Q ss_pred CCceeccCCCCccccC-CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 225 SAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||.+..... ......|+..|+|||++.+. .++.++||||+||++|+|++|..||.................
T Consensus 136 --~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 213 (278)
T cd05606 136 --VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213 (278)
T ss_pred --EEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc
Confidence 45555555432221 11234689999999999754 689999999999999999999999976532211110000000
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC----
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---- 378 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp---- 378 (405)
. . ...+...+.++.+++.+||..||++|+
T Consensus 214 ~---------------------~--------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~ 246 (278)
T cd05606 214 M---------------------A--------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLG 246 (278)
T ss_pred c---------------------C--------------------------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCC
Confidence 0 0 011123467899999999999999999
Q ss_pred -CHHHHHcCCCCCCCCC
Q 015532 379 -KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 -ta~elL~hp~f~~~~~ 394 (405)
++.++++||||+....
T Consensus 247 ~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 247 RGAQEVKEHPFFRSLDW 263 (278)
T ss_pred CCHHHHHhCccccCCCc
Confidence 9999999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=275.62 Aligned_cols=227 Identities=26% Similarity=0.381 Sum_probs=174.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
....|...+.||+|+||.||+|++..+++.||||.+... ......+..|+++++.+.|+++....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 345688899999999999999999999999999998532 22334567899999999998863321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~------------------- 153 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL------------------- 153 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc-------------------
Confidence 124678889999999999999999999999999999999976554
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
++|+|||++...... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+...
T Consensus 154 --------~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 224 (308)
T cd06634 154 --------VKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (308)
T ss_pred --------EEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH
Confidence 556666655433222 23468889999999853 457889999999999999999999997655443333
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.+.. .|. ......+..+.+||.+||..+|+
T Consensus 225 ~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~cl~~~P~ 256 (308)
T cd06634 225 HIAQNE--SPA----------------------------------------------LQSGHWSEYFRNFVDSCLQKIPQ 256 (308)
T ss_pred HHhhcC--CCC----------------------------------------------cCcccccHHHHHHHHHHhhCCcc
Confidence 222110 000 00123456789999999999999
Q ss_pred CCCCHHHHHcCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~ 392 (405)
+||+++++++|||+...
T Consensus 257 ~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 257 DRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cCCCHHHHhhCcccccc
Confidence 99999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=267.31 Aligned_cols=218 Identities=21% Similarity=0.308 Sum_probs=167.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.|++.+.||+|+||+||+|.+.. +..||||.++......+.+.+|+.+++.+.|+++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 358999999999999999998754 44599999876555556788999999999998873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~----------------------- 139 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV----------------------- 139 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCE-----------------------
Confidence 1247888999999999999999999999999999999999766544
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
+|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 140 ----kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05113 140 ----KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215 (256)
T ss_pred ----EECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh
Confidence 555555443322111 11234567999999998889999999999999999998 999998766554443332
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.... ......+..+.+++.+||+.||++||
T Consensus 216 ~~~~~-------------------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05113 216 QGLRL-------------------------------------------------YRPHLASEKVYAIMYSCWHEKAEERP 246 (256)
T ss_pred cCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 21100 00112356889999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|+.+++++
T Consensus 247 ~~~~ll~~ 254 (256)
T cd05113 247 TFQQLLSS 254 (256)
T ss_pred CHHHHHHh
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=263.74 Aligned_cols=221 Identities=28% Similarity=0.463 Sum_probs=172.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|++.++||+|+||.||++.+..+++.||+|.+.... .....+..|+.+++.+.|+++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999986432 3345667899999999998873211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~------------------- 141 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL------------------- 141 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc-------------------
Confidence 134677888999999999999999999999999999999987654
Q ss_pred cCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
++|+|||++...... .....++..|++||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 142 --------~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08530 142 --------VKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213 (256)
T ss_pred --------EEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 455555555433222 11235788999999999888999999999999999999999999876654433222
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
... ..+ ......+.++.++|.+||+.+|++|
T Consensus 214 ~~~--~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08530 214 QRG--KYP-----------------------------------------------PIPPIYSQDLQNFIRSMLQVKPKLR 244 (256)
T ss_pred hcC--CCC-----------------------------------------------CCchhhCHHHHHHHHHHcCCCcccC
Confidence 110 000 0011235678999999999999999
Q ss_pred CCHHHHHcCCCC
Q 015532 378 LKAREALRHPFF 389 (405)
Q Consensus 378 pta~elL~hp~f 389 (405)
||+.++++||++
T Consensus 245 p~~~~~l~~p~~ 256 (256)
T cd08530 245 PNCDKILASPAV 256 (256)
T ss_pred CCHHHHhcCCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.31 Aligned_cols=221 Identities=20% Similarity=0.310 Sum_probs=165.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
..++|++.+.||+|+||.||+|.+.. ++..||||+++... .....+.+|+.+++.+.|+++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998753 35679999986432 2345678899999999999873211
Q ss_pred -----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 155 -----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 155 -----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
...+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~------ 157 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT------ 157 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC------
Confidence 011345677889999999999999999999999999999986654
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 158 ---------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 158 ---------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred ---------------------EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence 4555555544322111 11245678999999998889999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 281 -GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 281 -g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
|..||.+....+....+... ..+ ......+
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~--~~~-----------------------------------------------~~~~~~~ 247 (277)
T cd05062 217 LAEQPYQGMSNEQVLRFVMEG--GLL-----------------------------------------------DKPDNCP 247 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC--CcC-----------------------------------------------CCCCCCC
Confidence 78999876655444332211 000 0112345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
..+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 248 DMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.62 Aligned_cols=223 Identities=31% Similarity=0.480 Sum_probs=173.1
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+|.+.+.||+|++|.||+|.+..+++.|++|++.... ...+.+.+|+.+++++.|+++....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4888999999999999999999899999999986544 3456788899999999998763211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~-------------------- 140 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVV-------------------- 140 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCE--------------------
Confidence 1256788899999999999999999999999999999999876544
Q ss_pred CCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+|+|||.+...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....+...
T Consensus 141 -------~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 211 (260)
T cd06606 141 -------KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-- 211 (260)
T ss_pred -------EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--
Confidence 55555554433222 1234688899999999888899999999999999999999999987652111
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+..... ...........+..+.+||.+||+.||+
T Consensus 212 ~~~~~~~---------------------------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~ 246 (260)
T cd06606 212 ALYKIGS---------------------------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPK 246 (260)
T ss_pred HHHhccc---------------------------------------------cCCCcCCCcccCHHHHHHHHHhCcCChh
Confidence 1111000 0000011223366899999999999999
Q ss_pred CCCCHHHHHcCCCC
Q 015532 376 ERLKAREALRHPFF 389 (405)
Q Consensus 376 ~Rpta~elL~hp~f 389 (405)
+||++.++++||||
T Consensus 247 ~Rp~~~~ll~~~~~ 260 (260)
T cd06606 247 KRPTADELLQHPFL 260 (260)
T ss_pred hCCCHHHHhhCCCC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=272.78 Aligned_cols=229 Identities=26% Similarity=0.396 Sum_probs=168.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~~-------------- 154 (405)
+.|++.+.||+|+||.||+|.+..+++.||||+++... .....+..|+.++..+. |+++....
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56999999999999999999999889999999996532 23344566777666665 66652211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.
T Consensus 95 ~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--------------------- 153 (296)
T cd06618 95 LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--------------------- 153 (296)
T ss_pred ccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC---------------------
Confidence 1347788889999999999999997 69999999999999976654
Q ss_pred CCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALFQTHEN-LEH 293 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~ 293 (405)
++|+|||.+...... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .+.
T Consensus 154 ------~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 227 (296)
T cd06618 154 ------VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227 (296)
T ss_pred ------EEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH
Confidence 455555555432211 11235778899999987653 78899999999999999999999965322 122
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+ ..... ..+ .....++.++.+|+.+||..|
T Consensus 228 ~~~~---~~~~~--------------------~~~------------------------~~~~~~~~~l~~li~~~l~~~ 260 (296)
T cd06618 228 LTKI---LQEEP--------------------PSL------------------------PPNEGFSPDFCSFVDLCLTKD 260 (296)
T ss_pred HHHH---hcCCC--------------------CCC------------------------CCCCCCCHHHHHHHHHHccCC
Confidence 2111 11000 000 001124568899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~ 394 (405)
|++|||++++++||||+...+
T Consensus 261 p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 261 HRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred hhhCCCHHHHhcChhhhccch
Confidence 999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.40 Aligned_cols=219 Identities=20% Similarity=0.265 Sum_probs=163.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc--EEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|.+..++. .+|+|.++.. ....+.+..|+.++.++ .|+++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 469999999999999999999877664 4788888642 23345678899999999 577653210
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---- 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA---- 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe----
Confidence 013677888999999999999999999999999999999976554
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccc--eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
+||+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++
T Consensus 158 -----------------------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~ 214 (297)
T cd05089 158 -----------------------SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSL 214 (297)
T ss_pred -----------------------EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 555666655432211111 123457999999998889999999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||......+....+.+... ......++.
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~ 245 (297)
T cd05089 215 GGTPYCGMTCAELYEKLPQGYR-------------------------------------------------MEKPRNCDD 245 (297)
T ss_pred CCCCCCCCCHHHHHHHHhcCCC-------------------------------------------------CCCCCCCCH
Confidence 9999987765554433221100 001123466
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+.+|+.+||+.||.+|||++++++.
T Consensus 246 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 246 EVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=265.68 Aligned_cols=215 Identities=20% Similarity=0.292 Sum_probs=165.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
.+|++.+.||+|+||.||++... +..||+|.++... ..+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46899999999999999999864 6779999986533 345688899999999998763211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---------------------- 140 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV---------------------- 140 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc----------------------
Confidence 113677888999999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
++|+|||++...........++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.+.
T Consensus 141 -----~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 215 (256)
T cd05082 141 -----AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215 (256)
T ss_pred -----EEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 566666655443333333345668999999988889999999999999999997 99999766554433332211
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.. .......++.+.+++.+||+.||++|||+
T Consensus 216 ~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 246 (256)
T cd05082 216 YK-------------------------------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSF 246 (256)
T ss_pred CC-------------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 00 01112346789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
.++++
T Consensus 247 ~~l~~ 251 (256)
T cd05082 247 LQLRE 251 (256)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=269.20 Aligned_cols=218 Identities=22% Similarity=0.322 Sum_probs=166.5
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|.+.+.||+|+||.||++.+. .++..||+|.++... ...+.+.+|+.+++++.|+++....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46999999999999999999853 345679999986533 3455688999999999998873211
Q ss_pred -----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 155 -----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 155 -----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~----- 159 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV----- 159 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE-----
Confidence 0137888999999999999999999999999999999999876654
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
+|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 160 ----------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 160 ----------------------KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ----------------------EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 555555444322111 11245678999999998889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 281 -GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 281 -g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
|..||......+.+..+... ..+ ......+
T Consensus 218 ~g~~p~~~~~~~~~~~~i~~~--~~~-----------------------------------------------~~~~~~~ 248 (288)
T cd05093 218 YGKQPWYQLSNNEVIECITQG--RVL-----------------------------------------------QRPRTCP 248 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcC--CcC-----------------------------------------------CCCCCCC
Confidence 99999877655544333221 000 0012345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.++.+|+.+||+.||.+|||+.++++
T Consensus 249 ~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 249 KEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 68999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=284.99 Aligned_cols=207 Identities=26% Similarity=0.359 Sum_probs=165.3
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------------
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------------- 154 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------------- 154 (405)
++-||+|+.|.||+|+.. ++.||||.++. .-..+|+-|++|.|+||+...
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 677999999999999975 78899997753 233588999999999995432
Q ss_pred -----cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCcee
Q 015532 155 -----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229 (405)
Q Consensus 155 -----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl 229 (405)
...+.......+..+|+.|+.|||.+.|||||||.-||||..+. .|||
T Consensus 201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---------------------------~VKI 253 (904)
T KOG4721|consen 201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---------------------------VVKI 253 (904)
T ss_pred HHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---------------------------eEEe
Confidence 23456677788999999999999999999999999999997654 4677
Q ss_pred ccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Q 015532 230 IDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHH 307 (405)
Q Consensus 230 ~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~ 307 (405)
+|||.++...... ..++||..|||||+|.+.+.+.|+|||||||+|||||||..||..-+...++.-+ |
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----G----- 324 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----G----- 324 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec----c-----
Confidence 7777776554432 3479999999999999999999999999999999999999999765432222111 0
Q ss_pred HHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 308 MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
...+....+..+++-|+=||++||+-.|..||++.++|.|
T Consensus 325 ---------------------------------------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 325 ---------------------------------------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ---------------------------------------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0112223345667789999999999999999999999998
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.39 Aligned_cols=212 Identities=19% Similarity=0.301 Sum_probs=160.4
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
+.||+|+||.||+|++..+++.||+|.+... ......+.+|+++++.+.|+++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999999999999999987542 23456688999999999999873211
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCc
Q 015532 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227 (405)
Q Consensus 155 -------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~ 227 (405)
...+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg--------------------- 139 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFG--------------------- 139 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccc---------------------
Confidence 1246788999999999999999999999999999999999876655555555
Q ss_pred eeccCCCCccccCCcc-----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 015532 228 KLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 228 kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 301 (405)
.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+....
T Consensus 140 ------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 140 ------MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred ------cCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 4332211110 0123456999999998889999999999999999998 999997655443322221100
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
.. ......+..+.+|+.+||+.||++|||+.
T Consensus 214 -----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 244 (252)
T cd05084 214 -----------------------RL--------------------------PCPELCPDAVYRLMERCWEYDPGQRPSFS 244 (252)
T ss_pred -----------------------CC--------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 00 01123466889999999999999999999
Q ss_pred HHHc
Q 015532 382 EALR 385 (405)
Q Consensus 382 elL~ 385 (405)
++++
T Consensus 245 ~~~~ 248 (252)
T cd05084 245 TVHQ 248 (252)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=264.05 Aligned_cols=218 Identities=23% Similarity=0.318 Sum_probs=169.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||.||+|.+. +++.||||.+.......+.+..|+.+++.+.|+++....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 468999999999999999999975 457799999976555567788999999999998873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~--------------------- 142 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVC--------------------- 142 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCE---------------------
Confidence 1246788899999999999999999999999999999999876654
Q ss_pred CCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+......+..
T Consensus 143 ------~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05034 143 ------KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216 (261)
T ss_pred ------EECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 555555544322111 11234567999999998889999999999999999998 9999988766555544
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+...... ......+..+.+++.+||+.||++
T Consensus 217 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~ 247 (261)
T cd05034 217 VERGYRM-------------------------------------------------PRPPNCPEELYDLMLQCWDKDPEE 247 (261)
T ss_pred HHcCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcccCccc
Confidence 3221100 001123567899999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
||+++++++
T Consensus 248 Rp~~~~l~~ 256 (261)
T cd05034 248 RPTFEYLQS 256 (261)
T ss_pred CCCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=266.16 Aligned_cols=219 Identities=22% Similarity=0.281 Sum_probs=166.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||+||+|.+..+ ...||||+++.. ......+..|+.+++.+.|+++....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4699999999999999999998644 457999998643 23345678899999999999873311
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++||
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~df------------- 150 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDF------------- 150 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECcc-------------
Confidence 125788899999999999999999999999999999999987665555554
Q ss_pred cCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
|++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 151 --------------g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~ 216 (266)
T cd05033 151 --------------GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216 (266)
T ss_pred --------------chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence 4443332110 01234578999999998889999999999999999998 999997766554
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.+... . ......+..+.+|+.+||+.
T Consensus 217 ~~~~~~~~~~-~------------------------------------------------~~~~~~~~~l~~li~~cl~~ 247 (266)
T cd05033 217 VIKAVEDGYR-L------------------------------------------------PPPMDCPSALYQLMLDCWQK 247 (266)
T ss_pred HHHHHHcCCC-C------------------------------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 4433322100 0 00123466889999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++||+++|++++
T Consensus 248 ~p~~Rp~~~ei~~~ 261 (266)
T cd05033 248 DRNERPTFSQIVST 261 (266)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=266.63 Aligned_cols=219 Identities=28% Similarity=0.431 Sum_probs=166.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||.+... ......+.+|+.+++.+.|+++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688999999999999999999989999999987542 23345678899999999998873211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~----------------- 144 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----------------- 144 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-----------------
Confidence 124678889999999999999999999999999999999977664
Q ss_pred cccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL-- 291 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-- 291 (405)
++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+....
T Consensus 145 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 145 ----------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred ----------EEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 4555555544322211 1246888999999999888999999999999999999999999754321
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+... .++. ......+..+.+||.+||.
T Consensus 215 ~~~~~~~~~--------------------------~~~~----------------------~~~~~~~~~~~~li~~~l~ 246 (267)
T cd08229 215 SLCKKIEQC--------------------------DYPP----------------------LPSDHYSEELRQLVNMCIN 246 (267)
T ss_pred HHhhhhhcC--------------------------CCCC----------------------CCcccccHHHHHHHHHhcC
Confidence 111111100 0000 0012346689999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.||++|||+.++++
T Consensus 247 ~~p~~Rpt~~~i~~ 260 (267)
T cd08229 247 PDPEKRPDITYVYD 260 (267)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=269.06 Aligned_cols=219 Identities=20% Similarity=0.299 Sum_probs=165.3
Q ss_pred CCeEEEeeeecccceeEEEEEec----CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~----~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|++.+.||+|+||+||+|... .+++.||+|.++... .....+.+|+.+++.+.|+++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45899999999999999999853 456789999986422 2235677899999999998873211
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 155 ---------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 155 ---------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-- 162 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-- 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence 012567778889999999999999999999999999999987654
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
++|+|||++...... .....++..|+|||++.+..++.++|||||||++|
T Consensus 163 -------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 163 -------------------------VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW 217 (283)
T ss_pred -------------------------EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence 455555555432111 11234567799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 277 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 277 ~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
+|++ |..||.+.........+.... . . ...
T Consensus 218 el~~~g~~p~~~~~~~~~~~~~~~~~-~----------------------~--------------------------~~~ 248 (283)
T cd05090 218 EIFSFGLQPYYGFSNQEVIEMVRKRQ-L----------------------L--------------------------PCS 248 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCC-c----------------------C--------------------------CCC
Confidence 9998 999998766544443332110 0 0 011
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
...++.+.+++.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 249 EDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2346688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=264.86 Aligned_cols=211 Identities=24% Similarity=0.358 Sum_probs=161.3
Q ss_pred eeecccceeEEEEEe--cCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 99 KMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+||+|+||.||+|.+ ..++..||+|+++... ...+.+..|+.+++.+.|+++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 699999999999965 4567899999986432 2356678899999999999874211
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCc
Q 015532 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227 (405)
Q Consensus 155 -------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~ 227 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++. +
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~---------------------------~ 134 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY---------------------------A 134 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe---------------------------E
Confidence 134688899999999999999999999999999999999976554 5
Q ss_pred eeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 228 KLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 228 kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.+.
T Consensus 135 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~ 214 (257)
T cd05116 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214 (257)
T ss_pred EECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 556666554332211 11234578999999988889999999999999999998 99999876665544433221
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
. .. ..+...+.++.+||.+||+.||++||++
T Consensus 215 ~-----------------------~~--------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~ 245 (257)
T cd05116 215 E-----------------------RM--------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGF 245 (257)
T ss_pred C-----------------------CC--------------------------CCCCCCCHHHHHHHHHHhccCchhCcCH
Confidence 0 00 0112346789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
++|.+
T Consensus 246 ~~i~~ 250 (257)
T cd05116 246 AVVEL 250 (257)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=266.46 Aligned_cols=217 Identities=19% Similarity=0.292 Sum_probs=166.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
.|++.+.||+|+||.||+|.++ ++..+|+|++.......+.+..|+++++.+.|+++....
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4889999999999999999886 466799999876555556788899999999998873210
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~------------------------- 138 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV------------------------- 138 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc-------------------------
Confidence 124678889999999999999999999999999999999987664
Q ss_pred CCceeccCCCCccccCCcc----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 015532 225 SAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (405)
++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 139 --~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05059 139 --VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216 (256)
T ss_pred --EEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc
Confidence 45555555443222111 1123457999999998889999999999999999999 8999987666554433321
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
... .......+..+.+++.+||..+|++|||
T Consensus 217 ~~~-------------------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 217 GYR-------------------------------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred CCc-------------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 100 0011234668999999999999999999
Q ss_pred HHHHHcC
Q 015532 380 AREALRH 386 (405)
Q Consensus 380 a~elL~h 386 (405)
+.|+++.
T Consensus 248 ~~~~l~~ 254 (256)
T cd05059 248 FKKLLSQ 254 (256)
T ss_pred HHHHHHH
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=259.62 Aligned_cols=230 Identities=23% Similarity=0.410 Sum_probs=175.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCC-CC--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDI-GG-------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~-~~-------------- 152 (405)
+.|.++++||+|+|++|.++++++|.+.||+|++++. +...+-.+.|-.+....+.+.+ ++
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999999999999999999753 2222334556666666544332 11
Q ss_pred -------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 153 -------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 153 -------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+.++++.++.+..+|+.||.|||++|||.||||.+|+|++..|++|++|||+.+....++
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g---- 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG---- 405 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC----
Confidence 113578999999999999999999999999999999999999999988887777655433222
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT-------HENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~-------~~~~~ 292 (405)
...++++||+.|+|||++.|..|+..+|+|+||++++||+.|+.||.- .+..+
T Consensus 406 --------------------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted 465 (593)
T KOG0695|consen 406 --------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED 465 (593)
T ss_pred --------------------cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH
Confidence 233567999999999999999999999999999999999999999952 11222
Q ss_pred HHHH-HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 293 HLAM-MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 293 ~~~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.+.+ |.+..-.+| ...+-.+..+++..|.
T Consensus 466 ylfqvilekqirip--------------------------------------------------rslsvkas~vlkgfln 495 (593)
T KOG0695|consen 466 YLFQVILEKQIRIP--------------------------------------------------RSLSVKASHVLKGFLN 495 (593)
T ss_pred HHHHHHhhhccccc--------------------------------------------------ceeehhhHHHHHHhhc
Confidence 2222 111111111 2234456688999999
Q ss_pred cCCCCCC------CHHHHHcCCCCCCCCCC
Q 015532 372 YDPAERL------KAREALRHPFFTRDVRR 395 (405)
Q Consensus 372 ~dP~~Rp------ta~elL~hp~f~~~~~~ 395 (405)
+||.+|. ...++..|+||+.-.+.
T Consensus 496 kdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 496 KDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred CCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 9999997 47899999999965443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=268.36 Aligned_cols=222 Identities=27% Similarity=0.394 Sum_probs=162.8
Q ss_pred CCeEEEeee--ecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc--------------
Q 015532 92 PRYRILSKM--GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~L--G~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~-------------- 154 (405)
+.|++.+.+ |+|+||.||+++++.+++.+|+|++....... .|+.+...+ .|+++....
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 457776666 99999999999999999999999986532211 133232222 466552110
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.++..++.||+.||.|||+.|++||||||+||+++.++
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----------------------- 146 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK----------------------- 146 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-----------------------
Confidence 13678999999999999999999999999999999999997654
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH-LAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~ 300 (405)
..++|+|||.+...... ....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ...+...
T Consensus 147 ---~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T PHA03390 147 ---DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222 (267)
T ss_pred ---CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh
Confidence 14667777766544322 224688999999999988899999999999999999999999975433221 1111110
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC-
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK- 379 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt- 379 (405)
... ........+..+.+||.+||+.||++|++
T Consensus 223 ~~~-----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 223 QQK-----------------------------------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred hcc-----------------------------------------------cCCcccccCHHHHHHHHHHhccChhhCCch
Confidence 000 00111245778999999999999999996
Q ss_pred HHHHHcCCCCCC
Q 015532 380 AREALRHPFFTR 391 (405)
Q Consensus 380 a~elL~hp~f~~ 391 (405)
++|+|+||||+.
T Consensus 256 ~~~~l~h~~~~~ 267 (267)
T PHA03390 256 YNEIIKHPFLKI 267 (267)
T ss_pred HHHHhcCCcccC
Confidence 599999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=280.77 Aligned_cols=227 Identities=26% Similarity=0.404 Sum_probs=184.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCC---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGG--------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~--------------- 152 (405)
..++++..||-|+||.|-++..+.....+|+|++++.. +..+....|-+||.....+.|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45788899999999999999887666679999997643 45566778889999887766522
Q ss_pred ------C------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 153 ------T------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 153 ------~------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
. ..+.|.+..++.++..+++|++|||++|||.|||||+|+|++.+|.+
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~-------------------- 559 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYL-------------------- 559 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCce--------------------
Confidence 1 13678899999999999999999999999999999999999888765
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
||.|||+|+...... -+++||+.|.|||++.+.+++.++|.||||+++|||++|.+||.+.+.......|.
T Consensus 560 -------KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 560 -------KLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred -------EEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 555555555444333 34799999999999999999999999999999999999999999999888777775
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.+.. + ..+..+...+.+||+++...+|.+|.
T Consensus 633 kGid~----------------------i--------------------------~~Pr~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 633 KGIDK----------------------I--------------------------EFPRRITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred hhhhh----------------------h--------------------------hcccccchhHHHHHHHHHhcCcHhhh
Confidence 53211 1 12234466788999999999999998
Q ss_pred C-----HHHHHcCCCCCCCC
Q 015532 379 K-----AREALRHPFFTRDV 393 (405)
Q Consensus 379 t-----a~elL~hp~f~~~~ 393 (405)
. +.+|-+|-||.+-.
T Consensus 665 G~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 665 GYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ccccCChHHHHhhhhhhcCC
Confidence 5 89999999998754
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=272.05 Aligned_cols=219 Identities=21% Similarity=0.259 Sum_probs=162.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc--EEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
+.|++.+.||+|+||.||+|.+..++. .+|+|.++.. ......+.+|+.++.++ .|+++....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 469999999999999999999877765 4577776532 23345677899999999 777763211
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~---- 162 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---- 162 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc----
Confidence 013678889999999999999999999999999999999976554
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 163 -----------------------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 163 -----------------------AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred -----------------------EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 5555555553221111 11123567999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+.+..+....+.... . .......+.
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~ 250 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQGY-----------------------R--------------------------LEKPLNCDD 250 (303)
T ss_pred CCCCcccCChHHHHHHHhcCC-----------------------c--------------------------CCCCCCCCH
Confidence 999997765544332221100 0 001122456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+.+|+.+||+.||++|||+++++++
T Consensus 251 ~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 251 EVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=269.52 Aligned_cols=234 Identities=22% Similarity=0.299 Sum_probs=163.5
Q ss_pred CCCe-EEEeeeecccceeEEEEEe----cCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 91 TPRY-RILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y-~~~~~LG~G~fg~V~~a~~----~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
.+|| ++.+.||+|+||+||++.. ..+++.||+|+++... ...+.+.+|+++++.+.|+++....
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 4566 9999999999999988653 3567889999987532 2456678899999999998863211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.|++.||.|||++||+||||||+|||++.++.+++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l------------- 148 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKI------------- 148 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEE-------------
Confidence 124688899999999999999999999999999999999987665544
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 149 --------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 149 --------------GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred --------------eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 4555443322111 11235667999999988889999999999999999999999986533
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
... ...+....+.... ......... ..........+..+.+++.+|
T Consensus 215 ~~~-~~~~~~~~~~~~~-----------------------------~~~~~~~~~----~~~~~~~~~~~~~~~~li~~c 260 (283)
T cd05080 215 KKF-EEMIGPKQGQMTV-----------------------------VRLIELLER----GMRLPCPKNCPQEVYILMKNC 260 (283)
T ss_pred chh-hhhhcccccccch-----------------------------hhhhhhhhc----CCCCCCCCCCCHHHHHHHHHH
Confidence 210 0000000000000 000000000 000011234567899999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|+.||++|||++++++
T Consensus 261 l~~~p~~Rps~~~i~~ 276 (283)
T cd05080 261 WETEAKFRPTFRSLIP 276 (283)
T ss_pred hccChhhCCCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=266.43 Aligned_cols=218 Identities=22% Similarity=0.327 Sum_probs=169.0
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
...|++.++||.|+||.||+|.+.. ++.+|+|++..... ..+.+..|+.+++.++|+++....
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3569999999999999999999977 88899999976543 456688899999999998873311
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g-------------- 149 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG-------------- 149 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEcccc--------------
Confidence 1246788899999999999999999999999999999999876655555554
Q ss_pred CCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+..
T Consensus 150 -------------~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~ 216 (261)
T cd05148 150 -------------LARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ 216 (261)
T ss_pred -------------chhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 443222111 11235667999999988889999999999999999998 8999987765555443
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+..... .......+..+.+++.+||+.||++
T Consensus 217 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~ 247 (261)
T cd05148 217 ITAGYR-------------------------------------------------MPCPAKCPQEIYKIMLECWAAEPED 247 (261)
T ss_pred HHhCCc-------------------------------------------------CCCCCCCCHHHHHHHHHHcCCCchh
Confidence 322100 0011234668899999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
|||+.++++
T Consensus 248 Rpt~~~l~~ 256 (261)
T cd05148 248 RPSFKALRE 256 (261)
T ss_pred CcCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=262.49 Aligned_cols=213 Identities=31% Similarity=0.517 Sum_probs=167.9
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
||.|+||.||++.+..+++.||+|+++.... ..+.+..|+.+++.+.|+++....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 7999999999999988899999999865332 345678899999999998762210
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 155 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 155 ------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~---------------------------~~~ 133 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG---------------------------HIK 133 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC---------------------------cEE
Confidence 12578899999999999999999999999999999999997655 456
Q ss_pred eccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 015532 229 LIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 305 (405)
Q Consensus 229 l~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p 305 (405)
|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.+.
T Consensus 134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----- 208 (250)
T cd05123 134 LTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD----- 208 (250)
T ss_pred EeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----
Confidence 6666665543322 23346788999999998888899999999999999999999999776653333322210
Q ss_pred hHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH---HH
Q 015532 306 HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA---RE 382 (405)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta---~e 382 (405)
.. ......+..+.++|.+||..||++|||+ ++
T Consensus 209 -------------------~~--------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~ 243 (250)
T cd05123 209 -------------------PL--------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEE 243 (250)
T ss_pred -------------------CC--------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHH
Confidence 00 1112235688999999999999999999 99
Q ss_pred HHcCCCC
Q 015532 383 ALRHPFF 389 (405)
Q Consensus 383 lL~hp~f 389 (405)
+++||||
T Consensus 244 l~~~~~f 250 (250)
T cd05123 244 IKAHPFF 250 (250)
T ss_pred HHhCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=262.93 Aligned_cols=216 Identities=19% Similarity=0.304 Sum_probs=168.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.|++.+.||.|+||.||+|... ++.||||.++......+.+..|+.+++.+.|+++....
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46899999999999999999875 78899999976555566788999999999998863211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~----------------------- 140 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV----------------------- 140 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC-----------------------
Confidence 114788899999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 015532 223 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 301 (405)
++|+|||.+...........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+....
T Consensus 141 ----~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05039 141 ----AKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY 216 (256)
T ss_pred ----EEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 566666655544332222334567999999988889999999999999999997 999997765544332221100
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
. .......++.+.++|.+||..+|++|||+.
T Consensus 217 -----------------------~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 247 (256)
T cd05039 217 -----------------------R--------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFK 247 (256)
T ss_pred -----------------------C--------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHH
Confidence 0 001123467899999999999999999999
Q ss_pred HHHc
Q 015532 382 EALR 385 (405)
Q Consensus 382 elL~ 385 (405)
++++
T Consensus 248 ~l~~ 251 (256)
T cd05039 248 QLRE 251 (256)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=267.09 Aligned_cols=218 Identities=22% Similarity=0.265 Sum_probs=162.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc----EEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
+.|++.+.||+|+||+||+|.+..+++ .|++|.+.... .....+..|+.++..+.|+++....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 468999999999999999999877765 47777775322 2234566788889999999873311
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~------------------- 147 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI------------------- 147 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-------------------
Confidence 134678899999999999999999999999999999999976654
Q ss_pred cCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+||+|||.+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....
T Consensus 148 --------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 148 --------VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred --------EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 455555555432211 112346778999999998889999999999999999998 999998765443
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.. +.... .....+.++.+++.+||..
T Consensus 220 ~~~~~~~-----------------------~~~~~--------------------------~~~~~~~~~~~li~~c~~~ 250 (279)
T cd05111 220 VPDLLEK-----------------------GERLA--------------------------QPQICTIDVYMVMVKCWMI 250 (279)
T ss_pred HHHHHHC-----------------------CCcCC--------------------------CCCCCCHHHHHHHHHHcCC
Confidence 3222211 00000 0112345778999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
||++|||+.|+++
T Consensus 251 ~p~~Rps~~el~~ 263 (279)
T cd05111 251 DENVRPTFKELAN 263 (279)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=269.83 Aligned_cols=225 Identities=22% Similarity=0.344 Sum_probs=166.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC----------------cEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCC
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK----------------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~----------------~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~ 153 (405)
++|++.++||+|+||.||+|.+..++ ..||+|++.... ...+.+.+|+++++.+.|+++...
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 57999999999999999999876543 568999986532 345677889999999999986321
Q ss_pred c---------------------------c-----------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 154 R---------------------------Y-----------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 154 ~---------------------------~-----------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
. . ..+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence 0 0 1478889999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHH
Q 015532 196 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWS 270 (405)
Q Consensus 196 ~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 270 (405)
.++.+ +|+|||.+...... .....++..|+|||++.+..++.++||||
T Consensus 165 ~~~~~---------------------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (296)
T cd05051 165 KNYTI---------------------------KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217 (296)
T ss_pred CCCce---------------------------EEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence 76655 45555544322111 11234577899999999888999999999
Q ss_pred HHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccch
Q 015532 271 VGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348 (405)
Q Consensus 271 lG~il~~llt--g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (405)
|||++|+|++ |..||......+.+..+...... ...
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~-------------------~~~----------------------- 255 (296)
T cd05051 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD-------------------DGR----------------------- 255 (296)
T ss_pred hHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccc-------------------ccc-----------------------
Confidence 9999999998 77888766555544333221100 000
Q ss_pred hhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 349 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 256 QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 0000011234568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=261.95 Aligned_cols=219 Identities=24% Similarity=0.359 Sum_probs=166.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..++|++.++||+|+||.||++.+. .+..||+|.+.......+.+.+|+++++.+.|+++....
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeC
Confidence 3578999999999999999999865 445699999876555567788999999999998873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||+.|++|+||||+||+++..+.++++|
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d----------------- 145 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD----------------- 145 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECC-----------------
Confidence 12356778889999999999999999999999999999997766555555
Q ss_pred CCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
||.+....... ....++..|+|||++.+..++.++|+|||||++|++++ |..||.+.+..+....
T Consensus 146 ----------~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05073 146 ----------FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215 (260)
T ss_pred ----------CcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 44443221111 11235567999999988889999999999999999998 9999987665444333
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+... .......+.++.+++.+||+.||++
T Consensus 216 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~ 246 (260)
T cd05073 216 LERGYR-------------------------------------------------MPRPENCPEELYNIMMRCWKNRPEE 246 (260)
T ss_pred HhCCCC-------------------------------------------------CCCcccCCHHHHHHHHHHcccCccc
Confidence 221100 0011234568999999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
||++.++++
T Consensus 247 Rp~~~~l~~ 255 (260)
T cd05073 247 RPTFEYIQS 255 (260)
T ss_pred CcCHHHHHH
Confidence 999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=262.59 Aligned_cols=213 Identities=22% Similarity=0.335 Sum_probs=166.3
Q ss_pred eeeecccceeEEEEEecCC---CcEEEEEEecchhhh--hHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~~~--~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|.+... +..||+|+++..... .+.+..|+.++..+.|+++....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999865 889999999754332 56788899999999988763211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~---------------- 144 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVV---------------- 144 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcE----------------
Confidence 1557899999999999999999999999999999999999876654
Q ss_pred cccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 290 (405)
+|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 145 -----------~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 145 -----------KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred -----------EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 55555554433221 122457888999999998889999999999999999999 6999988765
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+....+... . . ......++.++.+++.+||
T Consensus 214 ~~~~~~~~~~--~---------------------~--------------------------~~~~~~~~~~~~~li~~~l 244 (262)
T cd00192 214 EEVLEYLRKG--Y---------------------R--------------------------LPKPEYCPDELYELMLSCW 244 (262)
T ss_pred HHHHHHHHcC--C---------------------C--------------------------CCCCccCChHHHHHHHHHc
Confidence 5544433220 0 0 0112234678999999999
Q ss_pred ccCCCCCCCHHHHHcC
Q 015532 371 RYDPAERLKAREALRH 386 (405)
Q Consensus 371 ~~dP~~Rpta~elL~h 386 (405)
..||++|||+.|++++
T Consensus 245 ~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 245 QLDPEDRPTFSELVER 260 (262)
T ss_pred cCCcccCcCHHHHHHh
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=270.06 Aligned_cols=262 Identities=20% Similarity=0.249 Sum_probs=169.1
Q ss_pred eeecc--cceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 99 KMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 99 ~LG~G--~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+||+| ++|.||++++..+++.||||+++.. ....+.+..|+++++.+.|+++....
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34444 4566677777778999999998653 23445688899999999999873211
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.++++||+.+......+..
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~------- 157 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR------- 157 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc-------
Confidence 124678889999999999999999999999999999999998887777777654322111000
Q ss_pred CCceeccCCCCccccCCccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
. ...........++..|+|||++.+. .++.++|||||||++|+|++|..||........+ +.+..+
T Consensus 158 -~---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~ 225 (314)
T cd08216 158 -Q---------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRG 225 (314)
T ss_pred -c---------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhc
Confidence 0 0000011223577889999999763 5889999999999999999999999876544332 222223
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
..+..+.... +...... ............ .............+.++.+|+.+||++||++|||++|
T Consensus 226 ~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 226 TVPCLLDKST------YPLYEDS--MSQSRSSNEHPN------NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred cCccccccCc------hhhhcCC--cCcccccccccc------hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 2221110000 0000000 000000000000 0000001111234668999999999999999999999
Q ss_pred HHcCCCCCCCC
Q 015532 383 ALRHPFFTRDV 393 (405)
Q Consensus 383 lL~hp~f~~~~ 393 (405)
+|+||||++..
T Consensus 292 ll~~p~~~~~~ 302 (314)
T cd08216 292 LLNHSFFKQCK 302 (314)
T ss_pred HhcCchHhhhc
Confidence 99999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=262.84 Aligned_cols=212 Identities=24% Similarity=0.338 Sum_probs=161.4
Q ss_pred eeeecccceeEEEEEecCCC---cEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKK---ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~---~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
++||+|+||.||+|.+..++ ..||+|.+..... ..+.+..|+++++.+.|+++....
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 47999999999999876554 7899999875443 456788899999999998863211
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..+..++.|++.||.|||.+|++|+||||+|||++.++.++++|||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~-------------------- 140 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG-------------------- 140 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccc--------------------
Confidence 1247888999999999999999999999999999999999877655555554
Q ss_pred ceeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 015532 227 IKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (405)
.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+.+
T Consensus 141 -------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 141 -------MSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred -------ccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 4432221111 1123567999999998889999999999999999998 9999987665444333321
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.. . .......+..+.++|.+||..||++|||
T Consensus 214 ~~-----------------------~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~ 244 (257)
T cd05060 214 GE-----------------------R--------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPT 244 (257)
T ss_pred CC-----------------------c--------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 10 0 0111234668899999999999999999
Q ss_pred HHHHHc
Q 015532 380 AREALR 385 (405)
Q Consensus 380 a~elL~ 385 (405)
+.++++
T Consensus 245 ~~~l~~ 250 (257)
T cd05060 245 FSELES 250 (257)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=286.79 Aligned_cols=174 Identities=29% Similarity=0.423 Sum_probs=149.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..+...+.||+|+||.||+++++.+|+.||||.++.. ....+...+|+++|++|+|+||+...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4477789999999999999999999999999999753 34568888999999999999984321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++.++..++.++..||.|||++|||||||||.||++-...
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge--------------- 157 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE--------------- 157 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC---------------
Confidence 23579999999999999999999999999999999999985422
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
+.....||+|||.|+..+++. .+++||..|.+||++.. ..|+..+|.|||||++|+++||..||...
T Consensus 158 --------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 158 --------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred --------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 234568999999999877665 45799999999999995 78999999999999999999999999643
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=268.05 Aligned_cols=219 Identities=20% Similarity=0.335 Sum_probs=164.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCC----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGT---------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~---------- 153 (405)
++|++.+.||+|+||.||++.+... ...||+|+++... .....+.+|+++++.+ .|+++...
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 6799999999999999999998643 3789999986432 2335577899999999 68876321
Q ss_pred ---------------------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccc
Q 015532 154 ---------------------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 154 ---------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~ 200 (405)
....+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~- 170 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV- 170 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe-
Confidence 0134677888999999999999999999999999999999977664
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHH
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 275 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 275 (405)
++|+|||.+....... ....++..|+|||++.+..++.++|||||||++
T Consensus 171 --------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 224 (293)
T cd05053 171 --------------------------MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224 (293)
T ss_pred --------------------------EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHH
Confidence 4555555554332211 112345679999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhc
Q 015532 276 VELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354 (405)
Q Consensus 276 ~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (405)
|+|++ |..||.+....+....+.... .. ..
T Consensus 225 ~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~~--------------------------~~ 255 (293)
T cd05053 225 WEIFTLGGSPYPGIPVEELFKLLKEGY-----------------------RM--------------------------EK 255 (293)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------------cC--------------------------CC
Confidence 99997 999998766544433221100 00 01
Q ss_pred ccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 355 ~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
....+..+.+|+.+||..||++|||+.|++++
T Consensus 256 ~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 256 PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 12335688999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=264.22 Aligned_cols=219 Identities=22% Similarity=0.343 Sum_probs=165.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .....+.+|+.+++.+.|+++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 36799999999999999999998643 3789999986432 2345677899999999998873211
Q ss_pred ----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcc
Q 015532 155 ----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 155 ----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~------ 158 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV------ 158 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE------
Confidence 0124567888899999999999999999999999999999876655
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
+|+|||++...... .....++..|+|||.+.+..++.++|||||||++|++++
T Consensus 159 ---------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 217 (277)
T cd05032 159 ---------------------KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217 (277)
T ss_pred ---------------------EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhcc
Confidence 45555544322111 112346778999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+.+..+....+.. +. .. ..+...+.
T Consensus 218 g~~p~~~~~~~~~~~~~~~--~~---------------------~~--------------------------~~~~~~~~ 248 (277)
T cd05032 218 AEQPYQGLSNEEVLKFVID--GG---------------------HL--------------------------DLPENCPD 248 (277)
T ss_pred CCCCCccCCHHHHHHHHhc--CC---------------------CC--------------------------CCCCCCCH
Confidence 9999987665554433221 00 00 01123356
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHc
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+.+|+.+||+.+|++|||+.++++
T Consensus 249 ~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 249 KLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=275.04 Aligned_cols=220 Identities=23% Similarity=0.350 Sum_probs=160.0
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~~--------- 154 (405)
++|++.+.||+|+||.||+|.+. .+++.||||+++... .....+.+|+.++.++. |+++....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 67999999999999999999853 457889999996532 23456778999999995 45542110
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 155 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 155 ------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~---------------------------~k 219 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV---------------------------VK 219 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc---------------------------EE
Confidence 012456677889999999999999999999999999999976654 45
Q ss_pred eccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 015532 229 LIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 229 l~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g 302 (405)
|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||........+.....
T Consensus 220 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--- 296 (343)
T cd05103 220 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--- 296 (343)
T ss_pred EEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---
Confidence 55555544321111 11235667999999998889999999999999999997 9999976543222111100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
.+.... .....++.+.+++.+||+.||++|||+.|
T Consensus 297 -------------------~~~~~~--------------------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 297 -------------------EGTRMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred -------------------ccCCCC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 000000 01123557899999999999999999999
Q ss_pred HHcC
Q 015532 383 ALRH 386 (405)
Q Consensus 383 lL~h 386 (405)
+++|
T Consensus 332 il~~ 335 (343)
T cd05103 332 LVEH 335 (343)
T ss_pred HHHH
Confidence 9976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=267.38 Aligned_cols=227 Identities=28% Similarity=0.424 Sum_probs=167.5
Q ss_pred CeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHh-hcCCCCCc---------
Q 015532 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTR--------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~-~~~~~~~~--------- 154 (405)
.|++.+.||+|+||.||+|++. .+|+.||+|+++... ...+.+..|+++++.+. |+++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478899999986432 23456778999999996 55542211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~----------------- 143 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH----------------- 143 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC-----------------
Confidence 124678888999999999999999999999999999999976654
Q ss_pred cccCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
++|+|||++...... .....|+..|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus 144 ----------~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 144 ----------VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred ----------EEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 455555554432211 1124688899999998753 467899999999999999999999964332
Q ss_pred HHHHHHHHH-HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 LEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 ~~~~~~i~~-~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
......+.+ ..... .......+..+.+|+.+|
T Consensus 214 ~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~ll~~~ 246 (290)
T cd05613 214 KNSQAEISRRILKSE-----------------------------------------------PPYPQEMSALAKDIIQRL 246 (290)
T ss_pred cccHHHHHHHhhccC-----------------------------------------------CCCCccCCHHHHHHHHHH
Confidence 211111111 00000 001123466889999999
Q ss_pred cccCCCCCC-----CHHHHHcCCCCCCCC
Q 015532 370 LRYDPAERL-----KAREALRHPFFTRDV 393 (405)
Q Consensus 370 L~~dP~~Rp-----ta~elL~hp~f~~~~ 393 (405)
|+.||++|+ +++++++||||+...
T Consensus 247 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 247 LMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred hcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999997 899999999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=264.27 Aligned_cols=219 Identities=20% Similarity=0.266 Sum_probs=166.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecC----CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~----~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3679999999999999999999876 3578999988643 23356678899999999999873210
Q ss_pred ---------------------c-----ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccc
Q 015532 155 ---------------------Y-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 155 ---------------------~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~-------- 156 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV-------- 156 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcE--------
Confidence 0 346788899999999999999999999999999999999766544
Q ss_pred ccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CC
Q 015532 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 282 (405)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~ 282 (405)
+|+|||+++...... ....++..|+|||++.+..++.++|||||||++|++++ |.
T Consensus 157 -------------------kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 157 -------------------KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred -------------------EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 555555544321111 11235667999999998889999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||...+..+....+.... .. .....+++++
T Consensus 218 ~p~~~~~~~~~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~~ 248 (280)
T cd05043 218 TPYVEIDPFEMAAYLKDGY-----------------------RL--------------------------AQPINCPDEL 248 (280)
T ss_pred CCcCcCCHHHHHHHHHcCC-----------------------CC--------------------------CCCCcCCHHH
Confidence 9998765544332221100 00 0112335688
Q ss_pred HHHHHHccccCCCCCCCHHHHHc
Q 015532 363 IDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+++.+||..||++|||+.++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 249 FAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=266.26 Aligned_cols=218 Identities=22% Similarity=0.336 Sum_probs=165.4
Q ss_pred eeeecccceeEEEEEecCCCc-------EEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKE-------LVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~-------~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.||+|+||.||+|.+...+. .||+|.+.... ...+.+..|+.+++.+.|+++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999999865543 48888875433 3345677899999999999873321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++..++.+++
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~--------------- 145 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPP--------------- 145 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCc---------------
Confidence 1246888899999999999999999999999999999999988766666554
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG-EALFQTHENLEHLAMMER 299 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~ 299 (405)
.++++|||.+..... .....++..|+|||++.+. .++.++|||||||++|+|++| ..||...+..........
T Consensus 146 ----~~~l~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 220 (258)
T cd05078 146 ----FIKLSDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED 220 (258)
T ss_pred ----eEEecccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc
Confidence 378999998865443 2335788999999999874 578999999999999999998 566655443322111100
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
+. ..+...+.++.+||.+||+.||++|||
T Consensus 221 -------------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 249 (258)
T cd05078 221 -------------------------RH--------------------------QLPAPKWTELANLINQCMDYEPDFRPS 249 (258)
T ss_pred -------------------------cc--------------------------cCCCCCcHHHHHHHHHHhccChhhCCC
Confidence 00 011122457889999999999999999
Q ss_pred HHHHHcC
Q 015532 380 AREALRH 386 (405)
Q Consensus 380 a~elL~h 386 (405)
++++++.
T Consensus 250 ~~~il~~ 256 (258)
T cd05078 250 FRAIIRD 256 (258)
T ss_pred HHHHHHh
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=267.51 Aligned_cols=225 Identities=22% Similarity=0.291 Sum_probs=165.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC--------------cEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK--------------ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~--------------~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~- 154 (405)
++|++.++||+|+||.||+|++..++ ..||||+++.. ....+.+.+|+++++++.|+++....
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 57999999999999999999875432 35999998653 23345688899999999999873211
Q ss_pred --------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec
Q 015532 155 --------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 196 (405)
Q Consensus 155 --------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~ 196 (405)
...+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 012567788899999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHH
Q 015532 197 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSV 271 (405)
Q Consensus 197 ~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 271 (405)
++. +||+|||++....... ....++..|+|||++.+..++.++|||||
T Consensus 165 ~~~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 165 HYT---------------------------IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred CCc---------------------------EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 654 4555555543321111 11245678999999998889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh
Q 015532 272 GCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349 (405)
Q Consensus 272 G~il~~llt--g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (405)
||++|+|++ |..||...+..+.+..+.+.... .....
T Consensus 218 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~---------------------- 256 (295)
T cd05097 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN-------------------QGRQI---------------------- 256 (295)
T ss_pred HHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhh-------------------ccccc----------------------
Confidence 999999988 67888876665544433221100 00000
Q ss_pred hhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 350 ~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
........++.+.+|+.+||+.||++|||++++++
T Consensus 257 -~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 257 -YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00111234568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=267.53 Aligned_cols=220 Identities=24% Similarity=0.395 Sum_probs=164.6
Q ss_pred CCCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ....+.+..|+++++++ .|+++....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999853 34568999998653 23345678899999999 688874211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++.++..++.||+.||.|||++||+|+||||+|||++.++.+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~------------- 180 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV------------- 180 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeE-------------
Confidence 1126888999999999999999999999999999999999766544
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 287 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~ 287 (405)
+|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 181 --------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 181 --------------KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred --------------EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 555555544322111 11245678999999998889999999999999999998 9999977
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
....+........ +.. .......++.+.+|+.
T Consensus 247 ~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~~~li~ 278 (302)
T cd05055 247 MPVDSKFYKLIKE----------------------GYR--------------------------MAQPEHAPAEIYDIMK 278 (302)
T ss_pred CCchHHHHHHHHc----------------------CCc--------------------------CCCCCCCCHHHHHHHH
Confidence 5543322211110 000 0011233568999999
Q ss_pred HccccCCCCCCCHHHHHc
Q 015532 368 GLLRYDPAERLKAREALR 385 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~ 385 (405)
+||..+|++|||+.|+++
T Consensus 279 ~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 279 TCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=261.21 Aligned_cols=218 Identities=22% Similarity=0.329 Sum_probs=166.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
..|++.+.||+|+||.||+|.+. .+..+|+|+++........+..|+++++.+.|+++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35899999999999999999885 466799999876554456788899999999998873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~----------------------- 139 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVV----------------------- 139 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeE-----------------------
Confidence 1246788899999999999999999999999999999999766544
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+.
T Consensus 140 ----~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05112 140 ----KVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215 (256)
T ss_pred ----EECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence 555555443221111 11234568999999998889999999999999999998 999998766554443332
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
..... ......+..+.+|+.+||+.+|++||
T Consensus 216 ~~~~~-------------------------------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp 246 (256)
T cd05112 216 AGFRL-------------------------------------------------YKPRLASQSVYELMQHCWKERPEDRP 246 (256)
T ss_pred CCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcccChhhCC
Confidence 11000 00112356889999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|+.+++++
T Consensus 247 ~~~~~l~~ 254 (256)
T cd05112 247 SFSLLLHQ 254 (256)
T ss_pred CHHHHHHh
Confidence 99999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.45 Aligned_cols=219 Identities=28% Similarity=0.445 Sum_probs=165.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+.+|+++++++.|+++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999999989999999988532 22356678899999999998762211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~---------------- 145 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV---------------- 145 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcE----------------
Confidence 1236788899999999999999999999999999999999876654
Q ss_pred cccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL-- 291 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-- 291 (405)
+|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 146 -----------~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 146 -----------KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -----------EEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 55555544332211 12246788999999999888999999999999999999999999654311
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.. +..+ .. .....+..+.++|.+||.
T Consensus 215 ~~~~~~~~--~~~~---------------------~~-------------------------~~~~~~~~~~~~i~~cl~ 246 (267)
T cd08224 215 SLCKKIEK--CDYP---------------------PL-------------------------PADHYSEELRDLVSRCIN 246 (267)
T ss_pred HHHhhhhc--CCCC---------------------CC-------------------------ChhhcCHHHHHHHHHHcC
Confidence 11111110 0000 00 001335678999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.+|++|||+.++++
T Consensus 247 ~~p~~Rp~~~~il~ 260 (267)
T cd08224 247 PDPEKRPDISYVLQ 260 (267)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=261.43 Aligned_cols=215 Identities=20% Similarity=0.299 Sum_probs=165.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.|++.+.||+|+||.||++.. +++.||+|+++.. ...+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 4699999999999999999874 6778999998653 2346788899999999999873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~------------------------ 138 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV------------------------ 138 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc------------------------
Confidence 123678888999999999999999999999999999999976554
Q ss_pred CCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 015532 224 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g 302 (405)
++|+|||++............+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.+..
T Consensus 139 ---~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 214 (254)
T cd05083 139 ---AKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY- 214 (254)
T ss_pred ---EEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-
Confidence 556666655433222222334567999999988889999999999999999997 999998766544333222110
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
.. .....++..+.+|+.+||+.+|++||++++
T Consensus 215 ----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 215 ----------------------RM--------------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred ----------------------CC--------------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 011234668899999999999999999999
Q ss_pred HHc
Q 015532 383 ALR 385 (405)
Q Consensus 383 lL~ 385 (405)
+++
T Consensus 247 l~~ 249 (254)
T cd05083 247 LRE 249 (254)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=266.26 Aligned_cols=217 Identities=18% Similarity=0.330 Sum_probs=163.3
Q ss_pred CeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... .....+.+|+++++.+.|+++....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47889999999999999998753 23579999886432 2345678899999999999873311
Q ss_pred ----------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 015532 155 ----------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 194 (405)
Q Consensus 155 ----------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli 194 (405)
...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 0135677889999999999999999999999999999999
Q ss_pred ecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHH
Q 015532 195 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLW 269 (405)
Q Consensus 195 ~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (405)
+.++. ++|+|||++....... ....++..|+|||.+.+..++.++|||
T Consensus 161 ~~~~~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 161 AEGRK---------------------------MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred cCCCc---------------------------EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 76554 4555555554322111 112456789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccch
Q 015532 270 SVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348 (405)
Q Consensus 270 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (405)
||||++|+|++ |..||.+.........+.+.. .
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------~----------------------- 247 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY-----------------------R----------------------- 247 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-----------------------C-----------------------
Confidence 99999999998 999998765544333221100 0
Q ss_pred hhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 349 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.......+.++.+|+.+||+.||++||++.++++
T Consensus 248 ---~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 248 ---MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0011234668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.42 Aligned_cols=218 Identities=22% Similarity=0.312 Sum_probs=165.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc---EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|+..+.||+|+||.||+|++..+++ .||+|.++.. ....+.+..|+++++.+.|+++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468999999999999999999876554 7999998643 23356678899999999999862211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~------------------ 146 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLEC------------------ 146 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcE------------------
Confidence 1346788999999999999999999999999999999999766554
Q ss_pred cCCCCCCCceeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 291 (405)
+|+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 147 ---------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 147 ---------KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred ---------EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 5555554433221110 0123457999999998889999999999999999997 99999876655
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.... ..| .....+..+.+|+.+||+
T Consensus 218 ~~~~~i~~~~-~~~------------------------------------------------~~~~~~~~~~~li~~c~~ 248 (268)
T cd05063 218 EVMKAINDGF-RLP------------------------------------------------APMDCPSAVYQLMLQCWQ 248 (268)
T ss_pred HHHHHHhcCC-CCC------------------------------------------------CCCCCCHHHHHHHHHHcC
Confidence 5444432210 100 012345688999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.||++||++.++++
T Consensus 249 ~~p~~Rp~~~~i~~ 262 (268)
T cd05063 249 QDRARRPRFVDIVN 262 (268)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=264.35 Aligned_cols=226 Identities=22% Similarity=0.307 Sum_probs=163.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecC----------------CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCC
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~ 152 (405)
.++|++.++||+|+||.||+|.+.. ++..||+|+++.. ......+.+|+++++.+.|+++..
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986532 3457999998643 234567889999999999998732
Q ss_pred Cc--------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 015532 153 TR--------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 194 (405)
Q Consensus 153 ~~--------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli 194 (405)
.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 11 0124566899999999999999999999999999999999
Q ss_pred ecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHH
Q 015532 195 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLW 269 (405)
Q Consensus 195 ~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (405)
+.++. ++|+|||++....... ....++..|++||...+..++.++|||
T Consensus 164 ~~~~~---------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 164 GKNYT---------------------------IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred cCCCC---------------------------EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 76554 4555555554322111 112346789999999888899999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc
Q 015532 270 SVGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347 (405)
Q Consensus 270 SlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (405)
||||++|||++ |..||...+..+......... ........
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~~-------------------- 258 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF------------------RDQGRQVY-------------------- 258 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHH------------------hhcccccc--------------------
Confidence 99999999998 778997665544433221110 00000000
Q ss_pred hhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 348 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
......+++.+.+|+.+||+.||++|||+.++++
T Consensus 259 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 259 ----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0011234568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=267.86 Aligned_cols=220 Identities=20% Similarity=0.317 Sum_probs=163.4
Q ss_pred CCCeEEEeeeecccceeEEEEEecC-------CCcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------ 154 (405)
.++|.+.+.||+|+||.||+|++.. +...||+|+++.. ......+..|+++++.+ .|+++....
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999998643 2356999999753 23345677899999999 677752210
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 -------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
...+++.++..++.||+.||+|||++|++||||||+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 0236778899999999999999999999999999999999766
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+. ++|+|||.+....... ....++..|+|||++.+..++.++||||||
T Consensus 177 ~~---------------------------~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 229 (307)
T cd05098 177 NV---------------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229 (307)
T ss_pred Cc---------------------------EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHH
Confidence 54 4555555554322111 111235679999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++ |..||.+....+....+.... .
T Consensus 230 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~-------------------------- 260 (307)
T cd05098 230 VLLWEIFTLGGSPYPGVPVEELFKLLKEGH-----------------------R-------------------------- 260 (307)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-----------------------C--------------------------
Confidence 99999998 899997765443333221100 0
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.......+.++.+|+.+||..+|++|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 261 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 01112346688999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=264.09 Aligned_cols=218 Identities=21% Similarity=0.327 Sum_probs=165.3
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+|.+.+.||+|+||.||+|++. .++..+++|.++... ...+.+.+|+++++++.|+++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45899999999999999999864 345679999986533 2345678899999999999873211
Q ss_pred --------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 155 --------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 155 --------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~-- 162 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV-- 162 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE--
Confidence 0226788899999999999999999999999999999999876654
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHH
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 277 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 277 (405)
+|+|||++...... .....++..|+|||++.+..++.++|||||||++|+
T Consensus 163 -------------------------~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 163 -------------------------KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred -------------------------EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 55555554332211 112346788999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc
Q 015532 278 LCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356 (405)
Q Consensus 278 llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (405)
|++ |..||......+....+... ..+ ....
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~--~~~-----------------------------------------------~~~~ 248 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQG--RVL-----------------------------------------------ERPR 248 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCC--CCC-----------------------------------------------CCCc
Confidence 998 99999776665543322110 000 0011
Q ss_pred CchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 357 HSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 357 ~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
..+..+.+|+.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 249 VCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 23567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=264.02 Aligned_cols=228 Identities=28% Similarity=0.387 Sum_probs=165.9
Q ss_pred CeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHh-hcCCCCCc---------
Q 015532 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTR--------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~-~~~~~~~~--------- 154 (405)
.|++.+.||+|+||.||+|++. .+++.||||+++... ...+.+..|+.++.++. |+++....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3889999999999999999864 467889999986432 23345678999999995 55542110
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~----------------- 143 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH----------------- 143 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-----------------
Confidence 134678889999999999999999999999999999999976554
Q ss_pred cccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
++|+|||++....... ....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||.....
T Consensus 144 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 213 (288)
T cd05583 144 ----------VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213 (288)
T ss_pred ----------EEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence 5556666554322111 1245888999999987754 78899999999999999999999964322
Q ss_pred HHHHHHHHH-HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 LEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 ~~~~~~i~~-~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
......+.+ .... ........+..+.++|.+|
T Consensus 214 ~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~l~~li~~~ 246 (288)
T cd05583 214 QNSQSEISRRILKS-----------------------------------------------KPPFPKTMSAEARDFIQKL 246 (288)
T ss_pred cchHHHHHHHHHcc-----------------------------------------------CCCCCcccCHHHHHHHHHH
Confidence 111111111 0000 0001123456889999999
Q ss_pred cccCCCCCCC---HHHHHcCCCCCCCCC
Q 015532 370 LRYDPAERLK---AREALRHPFFTRDVR 394 (405)
Q Consensus 370 L~~dP~~Rpt---a~elL~hp~f~~~~~ 394 (405)
|+.||++||| +.++|+||||+...+
T Consensus 247 l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 247 LEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred hcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999999998 577899999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.17 Aligned_cols=218 Identities=21% Similarity=0.328 Sum_probs=165.2
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+|.+.++||+|+||.||+|... .++..+|+|.++... ...+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46889999999999999999753 356789999886433 3456788899999999999873211
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~--- 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV--- 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE---
Confidence 0236788899999999999999999999999999999999766554
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
+|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|
T Consensus 162 ------------------------kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 162 ------------------------KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred ------------------------EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 55555544322111 1122456789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
++ |.+||......+....+..... ......
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~ 248 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIECITQGRE-------------------------------------------------LERPRT 248 (280)
T ss_pred HcCCCCCCccCCHHHHHHHHHcCcc-------------------------------------------------CCCCCC
Confidence 98 9999977665544332221100 001123
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
+++.+.+||.+||+.||++||+++++++
T Consensus 249 ~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 249 CPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4568899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=260.65 Aligned_cols=218 Identities=24% Similarity=0.321 Sum_probs=166.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+|.+.++||+|+||.||+|.+... ...||||..... ....+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 5689999999999999999987544 356999988643 33456788899999999999874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||+|||++|++||||||+||+++.++.+
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~------------------- 146 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV------------------- 146 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCe-------------------
Confidence 1246888999999999999999999999999999999999876654
Q ss_pred CCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 294 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 294 (405)
+|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 147 --------~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~ 218 (270)
T cd05056 147 --------KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218 (270)
T ss_pred --------EEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 555555443322211 11234567999999988889999999999999999986 99999887665544
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.+.. .. ......+..+.++|.+||..+|
T Consensus 219 ~~~~~~~-----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~~P 249 (270)
T cd05056 219 GRIENGE-----------------------RL--------------------------PMPPNCPPTLYSLMTKCWAYDP 249 (270)
T ss_pred HHHHcCC-----------------------cC--------------------------CCCCCCCHHHHHHHHHHcCCCh
Confidence 3332110 00 0112346689999999999999
Q ss_pred CCCCCHHHHHc
Q 015532 375 AERLKAREALR 385 (405)
Q Consensus 375 ~~Rpta~elL~ 385 (405)
++|||+.++++
T Consensus 250 ~~Rpt~~~~~~ 260 (270)
T cd05056 250 SKRPRFTELKA 260 (270)
T ss_pred hhCcCHHHHHH
Confidence 99999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.66 Aligned_cols=219 Identities=22% Similarity=0.271 Sum_probs=164.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc----EEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.+++.+.|+++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 568999999999999999999877775 57889886432 2234577899999999999874321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~------------------- 147 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH------------------- 147 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc-------------------
Confidence 124677888999999999999999999999999999999976554
Q ss_pred cCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 148 --------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~ 219 (303)
T cd05110 148 --------VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219 (303)
T ss_pred --------eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 4555555554332111 11235678999999998889999999999999999997 999997755433
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+... . ... .....+..+.+++.+||..
T Consensus 220 ~~~~~~~~-~----------------------~~~--------------------------~~~~~~~~~~~li~~c~~~ 250 (303)
T cd05110 220 IPDLLEKG-E----------------------RLP--------------------------QPPICTIDVYMVMVKCWMI 250 (303)
T ss_pred HHHHHHCC-C----------------------CCC--------------------------CCCCCCHHHHHHHHHHcCC
Confidence 32221110 0 000 0112345788999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++||++.++++.
T Consensus 251 ~p~~Rp~~~~l~~~ 264 (303)
T cd05110 251 DADSRPKFKELAAE 264 (303)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=258.96 Aligned_cols=211 Identities=25% Similarity=0.364 Sum_probs=159.1
Q ss_pred eeecccceeEEEEEec--CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCC---------------------
Q 015532 99 KMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT--------------------- 153 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~--------------------- 153 (405)
.||+|+||.||+|.+. .++..||+|++.... ...+.+.+|+.+++++.|+++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999765 445679999986532 334668899999999999887321
Q ss_pred ------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCc
Q 015532 154 ------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227 (405)
Q Consensus 154 ------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~ 227 (405)
....+++..++.++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~--------------------------- 134 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA--------------------------- 134 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcE---------------------------
Confidence 12357889999999999999999999999999999999999766544
Q ss_pred eeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 228 KLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 228 kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
+|+|||++........ ...++..|+|||++.+..++.++|||||||++|++++ |..||......+....+.+.
T Consensus 135 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred EeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 5555555443221111 1123568999999988889999999999999999996 99999876655443332211
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.+.. .....++++.++|.+||..||++||++
T Consensus 215 -----------------------~~~~--------------------------~~~~~~~~l~~li~~c~~~~~~~Rp~~ 245 (257)
T cd05115 215 -----------------------KRLD--------------------------CPAECPPEMYALMKDCWIYKWEDRPNF 245 (257)
T ss_pred -----------------------CCCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 0000 112346789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
.++++
T Consensus 246 ~~i~~ 250 (257)
T cd05115 246 AKVEE 250 (257)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=258.00 Aligned_cols=215 Identities=22% Similarity=0.315 Sum_probs=165.1
Q ss_pred EEEeeeecccceeEEEEEecCCC----cEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 95 RILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~----~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++.+.||.|+||.||+|++...+ ..||+|+++.... ..+.+..|+.+++.+.|+++....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 56789999999999999998766 8999999975443 456788899999999888763211
Q ss_pred -------------cc-c-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 -------------YR-S-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 -------------~~-~-l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
.. . +++..+..++.||+.||.|||++|++|+||||+||+++.++.++++|
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~d--------------- 146 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--------------- 146 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcc---------------
Confidence 01 1 78889999999999999999999999999999999998766555554
Q ss_pred CCCCCCCceeccCCCCccccCCcc----ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 294 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 294 (405)
||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+..
T Consensus 147 ------------fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~ 214 (258)
T smart00219 147 ------------FGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL 214 (258)
T ss_pred ------------cCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 444433222111 1126788999999988889999999999999999998 89999876655544
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+..... . ......+.++.+++.+||..||
T Consensus 215 ~~~~~~~~-----------------------~--------------------------~~~~~~~~~~~~~i~~~l~~~p 245 (258)
T smart00219 215 EYLKKGYR-----------------------L--------------------------PKPENCPPEIYKLMLQCWAEDP 245 (258)
T ss_pred HHHhcCCC-----------------------C--------------------------CCCCcCCHHHHHHHHHHCcCCh
Confidence 43322100 0 0112246689999999999999
Q ss_pred CCCCCHHHHHc
Q 015532 375 AERLKAREALR 385 (405)
Q Consensus 375 ~~Rpta~elL~ 385 (405)
++|||+.|+++
T Consensus 246 ~~Rpt~~~ll~ 256 (258)
T smart00219 246 EDRPTFSELVE 256 (258)
T ss_pred hhCcCHHHHHh
Confidence 99999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=264.61 Aligned_cols=220 Identities=18% Similarity=0.298 Sum_probs=164.0
Q ss_pred CCCeEEEeeeecccceeEEEEEec-------CCCcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------ 154 (405)
.++|.+.+.||+|+||.||+|++. ..+..||+|.++.. ......+.+|+.+++.+ .|+++....
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467999999999999999999753 23457999998643 23345678899999999 788763211
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 -------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 0135667788899999999999999999999999999999766
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+. ++|+|||.+...... .....++..|+|||++.+..++.++||||||
T Consensus 174 ~~---------------------------~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (304)
T cd05101 174 NV---------------------------MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226 (304)
T ss_pred Cc---------------------------EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHH
Confidence 64 455555555432211 1112356789999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++ |..||.+....+....+.... .
T Consensus 227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~-------------------------- 257 (304)
T cd05101 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGH-----------------------R-------------------------- 257 (304)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCC-----------------------c--------------------------
Confidence 99999998 889997766544443321100 0
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.......+..+.+|+.+||..+|++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 258 MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 00112346689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.08 Aligned_cols=220 Identities=21% Similarity=0.301 Sum_probs=162.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~~-------- 154 (405)
.++|++.++||+|+||.||+|.+... +..||||+++... ...+.+.+|+++|+++. |+++....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 35788999999999999999987533 3579999996432 33467889999999996 88873211
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence
Q ss_pred -----------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccc
Q 015532 155 -----------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199 (405)
Q Consensus 155 -----------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~ 199 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 012566777889999999999999999999999999999987654
Q ss_pred cccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHH
Q 015532 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274 (405)
Q Consensus 200 ~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 274 (405)
++|+|||++...... .....++..|+|||++.+..++.++|||||||+
T Consensus 276 ---------------------------~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvi 328 (400)
T cd05105 276 ---------------------------VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328 (400)
T ss_pred ---------------------------EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHH
Confidence 455555555432211 112356778999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhh
Q 015532 275 LVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353 (405)
Q Consensus 275 l~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (405)
+|+|++ |..||........+...... +... .
T Consensus 329 l~ellt~g~~P~~~~~~~~~~~~~~~~----------------------~~~~--------------------------~ 360 (400)
T cd05105 329 LWEIFSLGGTPYPGMIVDSTFYNKIKS----------------------GYRM--------------------------A 360 (400)
T ss_pred HHHHHHCCCCCCcccchhHHHHHHHhc----------------------CCCC--------------------------C
Confidence 999997 99999765432222111110 0000 0
Q ss_pred cccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 354 ~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.....+..+.+++.+||+.||++|||+.++.+
T Consensus 361 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 361 KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 11234668899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.14 Aligned_cols=218 Identities=24% Similarity=0.324 Sum_probs=165.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc---EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.|++.+.||+|+||.||+|.+..+++ .||||+++.. ......+..|+.+++.+.|+++....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 358999999999999999999877654 6999998653 33456788999999999999873211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~------------------ 145 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVC------------------ 145 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcE------------------
Confidence 1346788899999999999999999999999999999999766544
Q ss_pred cCCCCCCCceeccCCCCccccCCcc------ce--ecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHS------YV--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~------~~--~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
+|+|||++........ .. ..+..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 146 ---------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 146 ---------KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ---------EECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 5555554433221110 01 12347999999998889999999999999999886 999998766
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+.... .. ......+..+.+++.+|
T Consensus 217 ~~~~~~~i~~~~-~~------------------------------------------------~~~~~~~~~~~~li~~~ 247 (269)
T cd05065 217 NQDVINAIEQDY-RL------------------------------------------------PPPMDCPTALHQLMLDC 247 (269)
T ss_pred HHHHHHHHHcCC-cC------------------------------------------------CCcccCCHHHHHHHHHH
Confidence 554444332110 00 00123456788999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|..+|++||+++++++
T Consensus 248 l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 248 WQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=264.47 Aligned_cols=218 Identities=21% Similarity=0.320 Sum_probs=162.9
Q ss_pred CCeEEEeeeecccceeEEEEEecC-------CCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc-------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~------- 154 (405)
++|.+.++||+|+||.||+|++.. ....||+|+++... .....+..|+++++.+ .|+++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 579999999999999999998642 34579999987432 2345577899999999 487762211
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 ------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 ------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 02367778889999999999999999999999999999997665
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
. ++|+|||.++...... ....++..|+|||++.+..++.++|||||||
T Consensus 172 ~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 172 V---------------------------MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred c---------------------------EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 4 4555555554332111 1112345799999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhh
Q 015532 274 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352 (405)
Q Consensus 274 il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (405)
++|+|++ |..||.+....+....+.... . .
T Consensus 225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~--------------------------~ 255 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPVEELFKLLREGH-----------------------R--------------------------M 255 (314)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------------C--------------------------C
Confidence 9999999 899998766544443322100 0 0
Q ss_pred hcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 353 ~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
......+.++.+|+.+||..||++|||+.++++
T Consensus 256 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 256 DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111234568899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=267.83 Aligned_cols=220 Identities=20% Similarity=0.308 Sum_probs=163.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-------CcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-------~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------ 154 (405)
..+|++.+.||+|+||.||+|++... +..||+|+++.. ....+.+.+|+++++++ .|+++....
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986432 236999988643 23345678899999999 688773211
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 -------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 0125567788899999999999999999999999999999776
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+.+ +|+|||+++...... ....++..|+|||++.+..++.++||||||
T Consensus 171 ~~~---------------------------kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 223 (334)
T cd05100 171 NVM---------------------------KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223 (334)
T ss_pred CcE---------------------------EECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHH
Confidence 644 555555544322111 112345679999999998899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++ |..||.+.+..+....+.... .
T Consensus 224 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~-------------------------- 254 (334)
T cd05100 224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGH-----------------------R-------------------------- 254 (334)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------------C--------------------------
Confidence 99999998 899998766554443322100 0
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.......+..+.+|+.+||+.+|++|||+.|++++
T Consensus 255 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 255 MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 00112345688999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.80 Aligned_cols=218 Identities=19% Similarity=0.257 Sum_probs=163.9
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.+++.+.|+++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 579999999999999999998753 57889999986432 3345678899999999998873211
Q ss_pred ---------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 155 ---------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 155 ---------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
...+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 01256777889999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHH
Q 015532 196 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWS 270 (405)
Q Consensus 196 ~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 270 (405)
.++.+ +|+|||.+...... .....++..|+|||.+.+..++.++||||
T Consensus 165 ~~~~~---------------------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (288)
T cd05050 165 ENMVV---------------------------KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA 217 (288)
T ss_pred CCCce---------------------------EECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence 76655 45555544322111 11123456799999999889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh
Q 015532 271 VGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349 (405)
Q Consensus 271 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (405)
|||++|+|++ |..||.+....+....+... . ..
T Consensus 218 lG~il~el~~~~~~p~~~~~~~~~~~~~~~~--~---------------------~~----------------------- 251 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG--N---------------------VL----------------------- 251 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--C---------------------CC-----------------------
Confidence 9999999997 88899776554443322110 0 00
Q ss_pred hhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 350 ~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
......+.++.+||.+||+.||++|||+.|+++
T Consensus 252 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 252 ---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011234568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=259.08 Aligned_cols=218 Identities=22% Similarity=0.289 Sum_probs=165.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC---cEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~---~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|++..++ ..||+|.++.. ....+.+..|+.+++.+.|+++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57999999999999999999986444 37999998643 23456788899999999999874311
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.++..++.|++.||.|||++|++||||||+|||++.++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~------------------ 145 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC------------------ 145 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeE------------------
Confidence 1246788899999999999999999999999999999999766554
Q ss_pred cCCCCCCCceeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 291 (405)
+|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|++++ |..||......
T Consensus 146 ---------~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 146 ---------KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred ---------EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 5555555443222111 1123467999999998889999999999999999886 99999876655
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.+... . ......++.+.+++.+||+
T Consensus 217 ~~~~~~~~~~~-~------------------------------------------------~~~~~~~~~~~~li~~~l~ 247 (267)
T cd05066 217 DVIKAIEEGYR-L------------------------------------------------PAPMDCPAALHQLMLDCWQ 247 (267)
T ss_pred HHHHHHhCCCc-C------------------------------------------------CCCCCCCHHHHHHHHHHcc
Confidence 44433322100 0 0012345688999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.+|++|||+.++++
T Consensus 248 ~~p~~Rp~~~~i~~ 261 (267)
T cd05066 248 KDRNERPKFEQIVS 261 (267)
T ss_pred cCchhCCCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=260.17 Aligned_cols=217 Identities=17% Similarity=0.244 Sum_probs=162.1
Q ss_pred eEEEeeeecccceeEEEEEec---CCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 94 YRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
|.+.+.||+|+||.||+|.+. .+++.||||++... ....+.+.+|+++++.+.|+++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 35789999998642 23345678899999999998862110
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
...+++..++.++.||+.||+|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--------- 151 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--------- 151 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC---------
Confidence 013566788999999999999999999999999999999976654
Q ss_pred ccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CC
Q 015532 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 282 (405)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~ 282 (405)
++|+|||++....... ....++..|++||.+.+..++.++|||||||++|+|++ |.
T Consensus 152 ------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~ 213 (273)
T cd05074 152 ------------------VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213 (273)
T ss_pred ------------------EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCC
Confidence 4555555554322111 11235678999999998889999999999999999999 89
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
+||.+.+..+....+... .... .....+..+
T Consensus 214 ~p~~~~~~~~~~~~~~~~-----------------------~~~~--------------------------~~~~~~~~~ 244 (273)
T cd05074 214 TPYAGVENSEIYNYLIKG-----------------------NRLK--------------------------QPPDCLEDV 244 (273)
T ss_pred CCCCCCCHHHHHHHHHcC-----------------------CcCC--------------------------CCCCCCHHH
Confidence 999876554333222110 0000 012345688
Q ss_pred HHHHHHccccCCCCCCCHHHHHcC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+++.+||..+|++|||+.+++++
T Consensus 245 ~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 245 YELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=263.00 Aligned_cols=233 Identities=21% Similarity=0.345 Sum_probs=162.8
Q ss_pred CeEEEeeeecccceeEEEEEe----cCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~----~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.|++++.||+|+||.||+|+. ..+++.||+|.++.. ....+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478999999999999999984 456889999998643 23345688899999999998863210
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~--------------- 149 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK--------------- 149 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEE---------------
Confidence 12367888999999999999999999999999999999998766554
Q ss_pred cccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|+++..|+.....
T Consensus 150 ------------l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 150 ------------IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred ------------ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 45555443322111 123467789999999888899999999999999999998776533111
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
. .....++........ ........+. .......++..+.+|+.+||
T Consensus 218 --~---~~~~~~~~~~~~~~~---~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l 263 (284)
T cd05079 218 --L---FLKMIGPTHGQMTVT---RLVRVLEEGK--------------------------RLPRPPNCPEEVYQLMRKCW 263 (284)
T ss_pred --h---hhhhcccccccccHH---HHHHHHHcCc--------------------------cCCCCCCCCHHHHHHHHHHc
Confidence 0 111111111100000 0000000000 00112345778999999999
Q ss_pred ccCCCCCCCHHHHHcC
Q 015532 371 RYDPAERLKAREALRH 386 (405)
Q Consensus 371 ~~dP~~Rpta~elL~h 386 (405)
+.||++|||+++++++
T Consensus 264 ~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 264 EFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCCcccCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.26 Aligned_cols=232 Identities=24% Similarity=0.407 Sum_probs=174.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhh-cCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLAR-HDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~-~~~~~~~-------------- 154 (405)
+..+-+..||.|+||+|++-.++.+|+..|||.++... +.+.+++.|.+...+-+. ++|+...
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34566788999999999999999999999999997644 455667778776555433 3332111
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...++|..+-.+....+.||+||-. ..|||||+||+|||++..|
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G------------------ 205 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG------------------ 205 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC------------------
Confidence 2356777777788888999999995 6899999999999998766
Q ss_pred cccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
.+||||||++....... +.-.|...|||||.+... +|+.++|+||||++|||++||..|+.+.+.
T Consensus 206 ---------~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-- 274 (361)
T KOG1006|consen 206 ---------DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-- 274 (361)
T ss_pred ---------CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--
Confidence 56777777765443322 224788999999999743 599999999999999999999999987554
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
++.++.++...-|+.+.. + ..--+++..++.||.-||.+
T Consensus 275 vfeql~~Vv~gdpp~l~~------------------~-----------------------~~~~~~s~~~~~fintCl~K 313 (361)
T KOG1006|consen 275 VFEQLCQVVIGDPPILLF------------------D-----------------------KECVHYSFSMVRFINTCLIK 313 (361)
T ss_pred HHHHHHHHHcCCCCeecC------------------c-----------------------ccccccCHHHHHHHHHHhhc
Confidence 566666654332221100 0 00023577899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~ 393 (405)
|-.+||...+++++||++...
T Consensus 314 d~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 314 DRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccccCcchhhhhcCchhhhhh
Confidence 999999999999999998754
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=255.57 Aligned_cols=219 Identities=20% Similarity=0.291 Sum_probs=162.8
Q ss_pred eeeecccceeEEEEEecC-CC--cEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~-~~--~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|.+.. .+ ..||||.++.... ..+.+..|+.+++++.|+++....
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999999865 33 3699999975433 456788899999999998874321
Q ss_pred ---------c-ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ---------Y-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ---------~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+|++|||++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~--------- 151 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------- 151 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc---------
Confidence 1 246788999999999999999999999999999999999877766555555432221100
Q ss_pred CCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 015532 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGP 303 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~ 303 (405)
+. ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 152 --------~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05040 152 --------DH----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219 (257)
T ss_pred --------cc----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc
Confidence 00 000112346778999999998889999999999999999998 99999876665544433221000
Q ss_pred CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHH
Q 015532 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 383 (405)
Q Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~el 383 (405)
.......+..+.+++.+||+.+|++|||+.++
T Consensus 220 ------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 220 ------------------------------------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred ------------------------------------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 00112345688999999999999999999999
Q ss_pred Hc
Q 015532 384 LR 385 (405)
Q Consensus 384 L~ 385 (405)
++
T Consensus 252 ~~ 253 (257)
T cd05040 252 RE 253 (257)
T ss_pred HH
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=259.38 Aligned_cols=218 Identities=22% Similarity=0.285 Sum_probs=165.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc----EEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+|++.+.||+|+||.||+|.++.+++ .||+|.++... .....+.+|+.+++.+.|+++....
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 579999999999999999999876654 58999886543 3346678899999999999874221
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~------------------ 148 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV------------------ 148 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeE------------------
Confidence 1247788999999999999999999999999999999999766644
Q ss_pred cCCCCCCCceeccCCCCccccCCccc-----eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+|+|||.+......... ..++..|+|||.+.+..++.++|+|||||++|++++ |..||.+....+
T Consensus 149 ---------kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 149 ---------KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred ---------EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 55555555433221111 123567999999988889999999999999999998 999998766544
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+... ... ......+..+.+++.+||..
T Consensus 220 ~~~~~~~~-~~~------------------------------------------------~~~~~~~~~~~~~~~~~l~~ 250 (279)
T cd05057 220 IPDLLEKG-ERL------------------------------------------------PQPPICTIDVYMVLVKCWMI 250 (279)
T ss_pred HHHHHhCC-CCC------------------------------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 33322210 000 00112345788999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
||++|||+.++++
T Consensus 251 ~p~~Rp~~~~l~~ 263 (279)
T cd05057 251 DAESRPTFKELIN 263 (279)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=277.37 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=181.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhh----hHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
-|..++.||-|+||.|.+++...|...||+|.+++.+-. ......|-.||.....+-++...
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 488899999999999999999999999999999765432 22344577788776554432211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC--CCCCccc
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS--KDGSYFK 219 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~--~~~~~~~ 219 (405)
.+.|+|+.++.++.++..|+++.|.+|+|||||||+||||+.+|++||+||||+.-+. .+.+.+.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 3568999999999999999999999999999999999999999999999999985332 1121111
Q ss_pred CC---------------CCCCCceeccCCCCccccC-CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 220 NL---------------PKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 220 ~~---------------~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
+- +....+|+..+-..+.... ..-.++||+.|+|||++...+|+.-+|+||.|||||||+.|++
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 10 0011112111110000000 0123689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||......+....+.. |.. .+......++++++.
T Consensus 870 pf~~~tp~~tq~kv~n----------------------------w~~------------------~l~~~~~~~ls~e~~ 903 (1034)
T KOG0608|consen 870 PFLADTPGETQYKVIN----------------------------WRN------------------FLHIPYQGNLSKEAL 903 (1034)
T ss_pred CccCCCCCcceeeeee----------------------------hhh------------------ccccccccccCHHHH
Confidence 9987665443322211 100 011122346688999
Q ss_pred HHHHHccccCCCCCC---CHHHHHcCCCCCCCC
Q 015532 364 DLLQGLLRYDPAERL---KAREALRHPFFTRDV 393 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rp---ta~elL~hp~f~~~~ 393 (405)
+||.+ |..++++|. .++|+.+||||+.-.
T Consensus 904 ~li~k-Lc~sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 904 DLIQK-LCCSADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHHHH-HhcChhhhhcccchhhhhcCccccccc
Confidence 99988 456899998 488899999999754
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=257.89 Aligned_cols=217 Identities=23% Similarity=0.293 Sum_probs=159.1
Q ss_pred eeeecccceeEEEEEecC------------CCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 98 SKMGEGTFGQVVECFDNE------------KKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~------------~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
+.||+|+||.||+|+... ....||+|++.... .....+..|+.++..+.|+++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 22358999876433 2334667789999999999874321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++..+
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~--------------- 145 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG--------------- 145 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC---------------
Confidence 13478889999999999999999999999999999999997654211
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHh-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELC-SGEALFQTHENLEHL 294 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~ 294 (405)
.....++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+..
T Consensus 146 -----~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 146 -----ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred -----CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 11234789999987654322 2346788999999987 456889999999999999998 588888764432211
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..... . .......+.++.+||.+||+.||
T Consensus 220 ~~~~~-----------------------~----------------------------~~~~~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 220 RFYEG-----------------------Q----------------------------CMLVTPSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHhc-----------------------C----------------------------ccCCCCChHHHHHHHHHHcCCCh
Confidence 10000 0 00011224578899999999999
Q ss_pred CCCCCHHHHHcC
Q 015532 375 AERLKAREALRH 386 (405)
Q Consensus 375 ~~Rpta~elL~h 386 (405)
++||++.+|+++
T Consensus 249 ~~Rp~~~~il~~ 260 (262)
T cd05077 249 NQRPFFRAIMRD 260 (262)
T ss_pred hhCcCHHHHHHh
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=257.35 Aligned_cols=202 Identities=25% Similarity=0.360 Sum_probs=150.4
Q ss_pred ccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------------------c
Q 015532 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------------------Y 155 (405)
Q Consensus 103 G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------------------~ 155 (405)
|.||.||+|++..+++.||+|+++.... ...|...+....|+++.... .
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999976432 22344444444566652211 1
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCC
Q 015532 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235 (405)
Q Consensus 156 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 235 (405)
..+++..+..++.|++.||+|||++||+||||||+||+++.++. ++++|||.+
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---------------------------~~l~df~~~ 132 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH---------------------------IQLTYFSRW 132 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---------------------------EEEecccch
Confidence 24788899999999999999999999999999999999977654 555666654
Q ss_pred ccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHh
Q 015532 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR 315 (405)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~ 315 (405)
...........++..|+|||.+.+..++.++|+||+||++|+|++|..||........ .
T Consensus 133 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~---------------- 191 (237)
T cd05576 133 SEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----T---------------- 191 (237)
T ss_pred hccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----c----------------
Confidence 4333332334567789999999888899999999999999999999988753211000 0
Q ss_pred hHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH-----HHHHcCCCC
Q 015532 316 AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-----REALRHPFF 389 (405)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta-----~elL~hp~f 389 (405)
... ...+...++.+.+||.+||+.||++|+|+ +++++||||
T Consensus 192 -------~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 -------HTT--------------------------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -------ccc--------------------------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 000 01112346688999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=258.64 Aligned_cols=220 Identities=19% Similarity=0.291 Sum_probs=166.1
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.+|++.+.||+|+||.||+|+.+. +.+.||+|.+..... ..+.+.+|+++++++.|+++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 569999999999999999999753 346799998864332 356788999999999998763211
Q ss_pred -----------------cc---------cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccc
Q 015532 155 -----------------YR---------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 155 -----------------~~---------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~-- 162 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS-- 162 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc--
Confidence 11 47889999999999999999999999999999999999877655555554
Q ss_pred ccCCCCCCcccCCCCCCCceeccCCCCccccC----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCC
Q 015532 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 283 (405)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~ 283 (405)
++..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 163 -------------------------~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 163 -------------------------LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred -------------------------cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 4332111 1112345677999999988888999999999999999998 889
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||........+..+... ...| ......+..+.
T Consensus 218 p~~~~~~~~~~~~~~~~------------------------~~~~------------------------~~~~~~~~~l~ 249 (275)
T cd05046 218 PFYGLSDEEVLNRLQAG------------------------KLEL------------------------PVPEGCPSRLY 249 (275)
T ss_pred CccccchHHHHHHHHcC------------------------CcCC------------------------CCCCCCCHHHH
Confidence 99765544433322110 0011 11123466899
Q ss_pred HHHHHccccCCCCCCCHHHHHcC
Q 015532 364 DLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~h 386 (405)
+++.+||+.||++|||+.|+++.
T Consensus 250 ~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 250 KLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHcCCCcccCCCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=255.06 Aligned_cols=211 Identities=21% Similarity=0.308 Sum_probs=159.4
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
++||+|+||.||+|.+.. ++.||+|+++... ...+.+..|+++++.+.|+++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999977 8999999986532 2456788899999999998863210
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCc
Q 015532 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227 (405)
Q Consensus 155 -------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~ 227 (405)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~--------------------------- 132 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVL--------------------------- 132 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcE---------------------------
Confidence 1246778889999999999999999999999999999999876655
Q ss_pred eeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 015532 228 KLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 228 kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 301 (405)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred EEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 555555443322111 01123557999999988889999999999999999999 899997765543332221100
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
. . ......+..+.+++.+||+.+|++|||++
T Consensus 213 ~-----------------------~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 243 (251)
T cd05041 213 R-----------------------M--------------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFS 243 (251)
T ss_pred C-----------------------C--------------------------CCCccCCHHHHHHHHHHhccChhhCcCHH
Confidence 0 0 01123456899999999999999999999
Q ss_pred HHHc
Q 015532 382 EALR 385 (405)
Q Consensus 382 elL~ 385 (405)
|+++
T Consensus 244 ell~ 247 (251)
T cd05041 244 EIYN 247 (251)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=258.54 Aligned_cols=215 Identities=27% Similarity=0.416 Sum_probs=162.2
Q ss_pred EEEeeeecccceeEEEEEec----CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 95 RILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~----~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++.+.||.|.||.||+|... ..+..|+||+++.. ....+.+.+|++++++++|+++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999987 34678999999542 23367889999999999999873211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||+++|+|+||+++||+++.++.+|++||
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f-------------- 147 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDF-------------- 147 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEEST--------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 135788999999999999999999999999999999999987765555554
Q ss_pred CCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 293 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 293 (405)
|++...... .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..+.
T Consensus 148 -------------~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 148 -------------GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp -------------TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred -------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 444333111 111346678999999998889999999999999999999 7899988776665
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+.+.. + ......++..+.++|.+||..|
T Consensus 215 ~~~~~~~~-----------------------~--------------------------~~~~~~~~~~~~~li~~C~~~~ 245 (259)
T PF07714_consen 215 IEKLKQGQ-----------------------R--------------------------LPIPDNCPKDIYSLIQQCWSHD 245 (259)
T ss_dssp HHHHHTTE-----------------------E--------------------------TTSBTTSBHHHHHHHHHHT-SS
T ss_pred cccccccc-----------------------c--------------------------ceeccchhHHHHHHHHHHcCCC
Confidence 55442210 0 0112345678999999999999
Q ss_pred CCCCCCHHHHHc
Q 015532 374 PAERLKAREALR 385 (405)
Q Consensus 374 P~~Rpta~elL~ 385 (405)
|++|||+.++++
T Consensus 246 p~~RPs~~~i~~ 257 (259)
T PF07714_consen 246 PEKRPSFQEILQ 257 (259)
T ss_dssp GGGS--HHHHHH
T ss_pred hhhCcCHHHHHh
Confidence 999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=280.18 Aligned_cols=229 Identities=26% Similarity=0.441 Sum_probs=189.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCC------------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG------------------ 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~------------------ 152 (405)
++.|++.+.||.|.+|.||+++.+.+++.+|+|++.-.....++...|.+||+.+.+|....
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 46799999999999999999999999999999999877777788888999999998876522
Q ss_pred -----------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 153 -----------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 153 -----------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
.+...+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~----------------- 160 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA----------------- 160 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-----------------
Confidence 1245678999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCC-----CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
.|||+|||.+..... ...+.+||+.|||||++... .|+..+|+||||++..||.-|.+|+..
T Consensus 161 ----------~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 161 ----------EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred ----------cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 567777777654332 34557999999999999753 478899999999999999999999977
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
......+.. ..+.|.+....++..+.++.+||.
T Consensus 231 mHPmraLF~-----------------------------------------------IpRNPPPkLkrp~kWs~~FndFIs 263 (953)
T KOG0587|consen 231 MHPMRALFL-----------------------------------------------IPRNPPPKLKRPKKWSKKFNDFIS 263 (953)
T ss_pred cchhhhhcc-----------------------------------------------CCCCCCccccchhhHHHHHHHHHH
Confidence 655433322 223333344445667889999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.||..|-++||+..++|+|||++...
T Consensus 264 ~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 264 TCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred HHHhhccccCcchhhhccCCcccccc
Confidence 99999999999999999999999554
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=258.66 Aligned_cols=234 Identities=21% Similarity=0.283 Sum_probs=161.6
Q ss_pred CCeEEEeeeecccceeEEEEEe----cCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~----~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+|++.+.||+|+||.||+|.. ..+++.||||.+.... ...+.+.+|+++++.+.|+++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4699999999999999999974 4578899999986543 2345678899999999998863210
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg---------- 153 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG---------- 153 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCc----------
Confidence 1236778889999999999999999999999999999999876655555554
Q ss_pred cccCCCCCCCceeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
++........ ...++..|+|||++.+..++.++|||||||++|||++|..++.....
T Consensus 154 -----------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 154 -----------------LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred -----------------ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 4433221111 01234469999999988899999999999999999998877643221
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
..... .+..... .. ....+....... .........+.++.+|+.+||
T Consensus 217 -~~~~~----~~~~~~~-----------------------~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl 263 (284)
T cd05081 217 -EFMRM----MGNDKQG-----------------------QM-IVYHLIELLKNN----GRLPAPPGCPAEIYAIMKECW 263 (284)
T ss_pred -hhhhh----ccccccc-----------------------cc-chHHHHHHHhcC----CcCCCCCCCCHHHHHHHHHHc
Confidence 11111 1110000 00 000000000000 000112345678999999999
Q ss_pred ccCCCCCCCHHHHHc
Q 015532 371 RYDPAERLKAREALR 385 (405)
Q Consensus 371 ~~dP~~Rpta~elL~ 385 (405)
..+|++|||+.|+++
T Consensus 264 ~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 264 NNDPSQRPSFSELAL 278 (284)
T ss_pred cCChhhCCCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=256.70 Aligned_cols=217 Identities=20% Similarity=0.316 Sum_probs=162.4
Q ss_pred eeeecccceeEEEEEecCCC------cEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 98 SKMGEGTFGQVVECFDNEKK------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~------~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.||+|+||.||+|++.... +.||||.+.... .....+.+|+++++.+.|+++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986543 789999886432 3456678899999999999873211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||+++++|+||||+||+++.++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~---------------- 144 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY---------------- 144 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC----------------
Confidence 012566788889999999999999999999999999999986540
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
+....++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 145 ------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 145 ------DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred ------CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 112346777777665332211 11245678999999998889999999999999999998 999998766
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+.... . .......+..+.+||.+|
T Consensus 219 ~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~~~~~li~~~ 249 (269)
T cd05044 219 NQEVLQHVTAGG-----------------------R--------------------------LQKPENCPDKIYQLMTNC 249 (269)
T ss_pred HHHHHHHHhcCC-----------------------c--------------------------cCCcccchHHHHHHHHHH
Confidence 655443321100 0 001123466889999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|+.+|++||+++++++
T Consensus 250 l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 250 WAQDPSERPTFDRIQE 265 (269)
T ss_pred cCCCcccCCCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=255.22 Aligned_cols=212 Identities=20% Similarity=0.270 Sum_probs=154.2
Q ss_pred eeeecccceeEEEEEecC---CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~---~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|.+.. .+..||||.+... ....+.+..|+.+++.+.|+++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 3467999988542 23345677899999999999873211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|++
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~-------------------- 140 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVA-------------------- 140 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEEC--------------------
Confidence 1123566778889999999999999999999999999999876655444
Q ss_pred CCCceeccCCCCccccCC-------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 295 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 295 (405)
|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+...
T Consensus 141 -------dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~ 213 (262)
T cd05058 141 -------DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV 213 (262)
T ss_pred -------CccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 55444322111 112245678999999988889999999999999999999 567776655433322
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.. +.... .....++.+.+++.+||..+|+
T Consensus 214 ~~~~-----------------------~~~~~--------------------------~~~~~~~~~~~li~~cl~~~p~ 244 (262)
T cd05058 214 YLLQ-----------------------GRRLL--------------------------QPEYCPDPLYEVMLSCWHPKPE 244 (262)
T ss_pred HHhc-----------------------CCCCC--------------------------CCCcCCHHHHHHHHHHcCCChh
Confidence 2111 00000 0122356789999999999999
Q ss_pred CCCCHHHHHc
Q 015532 376 ERLKAREALR 385 (405)
Q Consensus 376 ~Rpta~elL~ 385 (405)
+||++.++++
T Consensus 245 ~Rp~~~~il~ 254 (262)
T cd05058 245 MRPTFSELVS 254 (262)
T ss_pred hCCCHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=252.00 Aligned_cols=211 Identities=22% Similarity=0.312 Sum_probs=159.0
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------------- 154 (405)
+.||+|+||.||+|... ++..||+|+++.. ......+.+|+++++.+.|+++....
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46999999999999864 6778999998643 23345678899999999999873211
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCc
Q 015532 155 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227 (405)
Q Consensus 155 -------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~ 227 (405)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~--------------------------- 132 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL--------------------------- 132 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeE---------------------------
Confidence 1246788999999999999999999999999999999999876654
Q ss_pred eeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 015532 228 KLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 228 kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g 302 (405)
+|+|||++....... ....++..|+|||++.+..++.++|||||||++|++++ |..||.+.........+....
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~- 211 (250)
T cd05085 133 KISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY- 211 (250)
T ss_pred EECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 555555443222111 11234567999999988889999999999999999998 999998765544333221100
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
. .......+..+.+|+.+||..+|++|||+.+
T Consensus 212 ----------------------~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 243 (250)
T cd05085 212 ----------------------R--------------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSE 243 (250)
T ss_pred ----------------------C--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 0 0011234668999999999999999999999
Q ss_pred HHc
Q 015532 383 ALR 385 (405)
Q Consensus 383 lL~ 385 (405)
+++
T Consensus 244 l~~ 246 (250)
T cd05085 244 LQK 246 (250)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=264.88 Aligned_cols=295 Identities=27% Similarity=0.411 Sum_probs=193.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecC---CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCC------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT------------ 153 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~------------ 153 (405)
.+.+.|.++++||+|+|++||++.+.. .++.||+|.+..... ......|+++|..+...+.+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 345679999999999999999999877 788999999865433 4558889999999877654221
Q ss_pred -------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc-cccccCCccccccCCCCC---C
Q 015532 154 -------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLSRSSKDG---S 216 (405)
Q Consensus 154 -------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~-~~~k~~df~~~~~~~~~~---~ 216 (405)
.+..++..+++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|.|||++....... .
T Consensus 112 ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred EEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 14567888999999999999999999999999999999999854 666799999987311100 0
Q ss_pred cc-----cCCC-------CCCCceecc-CCCCc--cc--cCCccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHH
Q 015532 217 YF-----KNLP-------KSSAIKLID-FGSTT--FE--HQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 278 (405)
Q Consensus 217 ~~-----~~~~-------~~~~~kl~D-fg~a~--~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l 278 (405)
.. .... ....+.... -|..+ .. ........||++|+|||++...+ .+.++||||.|+|++.+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 00 0000 000000000 00000 00 01112258999999999998764 78999999999999999
Q ss_pred HhCCCCCC-CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCC-CCCCchhhHHHHHHhc--------cch
Q 015532 279 CSGEALFQ-THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP-DGATSRDSMRAVWKLL--------RLP 348 (405)
Q Consensus 279 ltg~~pf~-~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--------~~~ 348 (405)
+++..||- ..++.+.+..+..+.|...-.-..... |...-|. +...........+... +.+
T Consensus 272 ls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~---------g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 272 LSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALP---------GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred hccccccccCccccchHHHHHHHhChHHHHHHhhcC---------CceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999974 455667778888777753321111110 0000111 1100111111111111 001
Q ss_pred hhhhh-cccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 349 NLIMQ-HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 349 ~~~~~-~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+.... ..+..+..+.||+.+||+.||.+|.||+++|+||||....
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 11122 2233455889999999999999999999999999999654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=255.73 Aligned_cols=212 Identities=21% Similarity=0.269 Sum_probs=156.4
Q ss_pred eeeecccceeEEEEEecCCCc--EEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------------------ 154 (405)
+.||+|+||.||+|++..++. .+|+|.++.. ....+.+..|++++.++ .|+++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 4688888642 23445678899999999 677663210
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~--------- 151 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--------- 151 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeE---------
Confidence 0136788899999999999999999999999999999999876654
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ 286 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~ 286 (405)
+|+|||++....... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 152 ------------------kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 152 ------------------KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred ------------------EECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 555555443211110 11123567999999988889999999999999999997 999997
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.+..+....+.... . .......+.++.+|+
T Consensus 214 ~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~~~~~li 244 (270)
T cd05047 214 GMTCAELYEKLPQGY-----------------------R--------------------------LEKPLNCDDEVYDLM 244 (270)
T ss_pred ccCHHHHHHHHhCCC-----------------------C--------------------------CCCCCcCCHHHHHHH
Confidence 765544333221100 0 001122356789999
Q ss_pred HHccccCCCCCCCHHHHHc
Q 015532 367 QGLLRYDPAERLKAREALR 385 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~ 385 (405)
.+||..||.+|||+.++++
T Consensus 245 ~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 245 RQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHcccChhhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.48 Aligned_cols=238 Identities=23% Similarity=0.388 Sum_probs=155.3
Q ss_pred CCCeEEEeeeecccceeEEEEEec----------------CCCcEEEEEEecchhh---------------hhHHHHHHH
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN----------------EKKELVAIKIVRSINK---------------YREAAMIEI 139 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~----------------~~~~~vAiK~~~~~~~---------------~~~~~~~E~ 139 (405)
.++|++.++||+|+||+||+|.+. ..++.||||.++.... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 2356799999854221 122334567
Q ss_pred HHHHHHhhcCCCCC----------------------c------------------------------------------c
Q 015532 140 DVLQRLARHDIGGT----------------------R------------------------------------------Y 155 (405)
Q Consensus 140 ~il~~l~~~~~~~~----------------------~------------------------------------------~ 155 (405)
.++.++.|+++... . .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766543000 0 0
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCC
Q 015532 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235 (405)
Q Consensus 156 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 235 (405)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++. ++|+|||++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~---------------------------~kL~DFGla 356 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---------------------------VKIIDFGAA 356 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc---------------------------EEEEeCcCc
Confidence 11245678889999999999999999999999999999976554 556666655
Q ss_pred ccccCCc----cceecCCCcchhHHHhCCC--------------------CC--CchhHHHHHHHHHHHHhCCC-CCCCC
Q 015532 236 TFEHQDH----SYVVSTRHYRAPEVILGLG--------------------WN--YPCDLWSVGCILVELCSGEA-LFQTH 288 (405)
Q Consensus 236 ~~~~~~~----~~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwSlG~il~~lltg~~-pf~~~ 288 (405)
....... ....+|+.|+|||++.... |+ .+.||||+||++|+|++|.. ||...
T Consensus 357 ~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 357 VDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred cccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 4322111 1123478999999986422 12 34799999999999999875 67543
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
...... +.. ... . ...|.............+..++..+||+.+
T Consensus 437 ~~f~~~--~~~-~~~------------~----------------------~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~ 479 (507)
T PLN03224 437 RLFNTE--LRQ-YDN------------D----------------------LNRWRMYKGQKYDFSLLDRNKEAGWDLACK 479 (507)
T ss_pred hhhhhH--Hhh-ccc------------h----------------------HHHHHhhcccCCCcccccccChHHHHHHHH
Confidence 211110 000 000 0 000100000111112234567889999999
Q ss_pred ccccCC---CCCCCHHHHHcCCCCCCC
Q 015532 369 LLRYDP---AERLKAREALRHPFFTRD 392 (405)
Q Consensus 369 ~L~~dP---~~Rpta~elL~hp~f~~~ 392 (405)
||..+| .+|+|++|+|+||||...
T Consensus 480 LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 480 LITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred HhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 999876 689999999999999764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=266.71 Aligned_cols=183 Identities=25% Similarity=0.329 Sum_probs=150.0
Q ss_pred CCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhh-hHHHHHHHHHHHHHhhcCCCCCc--
Q 015532 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTR-- 154 (405)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~E~~il~~l~~~~~~~~~-- 154 (405)
....|++......+++|.-...||+|+||.||+|....+ ..||||.+...... ..++..|+.++.+++|+|++...
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 334566666777889999999999999999999998544 88999988765443 45599999999999999983211
Q ss_pred ---------------------------cc-cCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEEecccccccC
Q 015532 155 ---------------------------YR-SFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 ---------------------------~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIli~~~~~~k~~ 203 (405)
.. .++|....+|+.+++.||+|||.. .|||||||++|||++.
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~------- 212 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE------- 212 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-------
Confidence 11 678999999999999999999974 3999999999999864
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccC-Cccc--e-ecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHH
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSY--V-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll 279 (405)
+...||+|||+|..... .... . .||.+|+|||++.....+.|+||||||+++.||+
T Consensus 213 --------------------~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 213 --------------------DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred --------------------CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 45678888888865544 2222 2 7999999999999888999999999999999999
Q ss_pred hCCCCCCCC
Q 015532 280 SGEALFQTH 288 (405)
Q Consensus 280 tg~~pf~~~ 288 (405)
||+.+.+..
T Consensus 273 tgr~~~d~~ 281 (361)
T KOG1187|consen 273 TGRKAVDQS 281 (361)
T ss_pred hCCcccCCC
Confidence 999888653
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=267.83 Aligned_cols=220 Identities=20% Similarity=0.319 Sum_probs=162.4
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHh-hcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~-~~~~~~~~--------- 154 (405)
++|.+.++||+|+||.||+|++. .+++.||||+++... ...+.+..|+.+|.++. |++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888999999999999999864 345689999997532 22346788999999998 88762110
Q ss_pred --------------------------------------------------------------------------------
Q 015532 155 -------------------------------------------------------------------------------- 154 (405)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (405)
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 ------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 ------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 01245566788999999999999999999999999999998765
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
.+ +|+|||++..... ......++..|+|||.+.+..++.++|||||||
T Consensus 277 ~~---------------------------kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv 329 (401)
T cd05107 277 LV---------------------------KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329 (401)
T ss_pred EE---------------------------EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHH
Confidence 54 5555555433211 111235678899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhh
Q 015532 274 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352 (405)
Q Consensus 274 il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (405)
++|||++ |..||......+........ +.+.
T Consensus 330 il~e~l~~g~~P~~~~~~~~~~~~~~~~----------------------~~~~-------------------------- 361 (401)
T cd05107 330 LLWEIFTLGGTPYPELPMNEQFYNAIKR----------------------GYRM-------------------------- 361 (401)
T ss_pred HHHHHHHcCCCCCCCCCchHHHHHHHHc----------------------CCCC--------------------------
Confidence 9999998 89999765443332211110 0000
Q ss_pred hcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 353 ~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
..+...+.++.+|+.+||..||++||++.+|++.
T Consensus 362 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 362 AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=255.88 Aligned_cols=216 Identities=22% Similarity=0.333 Sum_probs=158.4
Q ss_pred eeecccceeEEEEEecCC------------------------CcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCC
Q 015532 99 KMGEGTFGQVVECFDNEK------------------------KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGT 153 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~------------------------~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~ 153 (405)
.||+|+||.||+|....+ ...||+|++.... .....+..|+.+++.+.|+++...
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975321 2358999886433 234567788999999999987321
Q ss_pred c----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 154 R----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 154 ~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
. ...+++..+..++.||+.||+|||++||+||||||+|||++..+...
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~---- 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE---- 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc----
Confidence 1 23468889999999999999999999999999999999997644210
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHH-hCCC
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC-SGEA 283 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~ll-tg~~ 283 (405)
.....++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..
T Consensus 158 ----------------~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 158 ----------------GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred ----------------CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 12234789999987543222 22357888999999876 46889999999999999985 6999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||......+........ . ......+..+.
T Consensus 221 p~~~~~~~~~~~~~~~~-~--------------------------------------------------~~~~~~~~~~~ 249 (274)
T cd05076 221 PLKERTPSEKERFYEKK-H--------------------------------------------------RLPEPSCKELA 249 (274)
T ss_pred CccccChHHHHHHHHhc-c--------------------------------------------------CCCCCCChHHH
Confidence 99765443322111100 0 00112245788
Q ss_pred HHHHHccccCCCCCCCHHHHHcC
Q 015532 364 DLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~h 386 (405)
++|.+||+.+|++|||+.++|++
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHh
Confidence 99999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=281.13 Aligned_cols=217 Identities=20% Similarity=0.306 Sum_probs=177.5
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..-+..++||+|+||+||+|+... ....||||.++... ..+.+|.+|+++|..|+|+||+..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 446778999999999999998643 34689999997543 3678899999999999999984321
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
-..++..+...|+.||+.|++||-++.+|||||-..|+||+..
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~------ 639 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN------ 639 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc------
Confidence 1237888999999999999999999999999999999999754
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccce-----ecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
..|||+|||+++.......+. .-...||+||.|...+|+.++||||+||+|||+
T Consensus 640 ---------------------l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 640 ---------------------LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred ---------------------eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 456777777766544333222 236789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
++ |..||.+.++.+.++.|.+- .- ...++.
T Consensus 699 FsyG~QPy~glSn~EVIe~i~~g-----------------------~l--------------------------L~~Pe~ 729 (774)
T KOG1026|consen 699 FSYGKQPYYGLSNQEVIECIRAG-----------------------QL--------------------------LSCPEN 729 (774)
T ss_pred hccccCcccccchHHHHHHHHcC-----------------------Cc--------------------------ccCCCC
Confidence 98 99999999999988876541 11 233467
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHH
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREAL 384 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL 384 (405)
++.++.+||..||+.+|++||++.||=
T Consensus 730 CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 730 CPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 788999999999999999999999874
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=252.55 Aligned_cols=216 Identities=23% Similarity=0.318 Sum_probs=161.5
Q ss_pred eeeecccceeEEEEEecCCC----------cEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 98 SKMGEGTFGQVVECFDNEKK----------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~----------~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.||+|+||.||+|.+..++ ..|++|++.........+.+|+.+++.+.|+++....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 47999999999999998766 3588888765444367788899999999999874321
Q ss_pred -------------cc-cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -------------YR-SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -------------~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.. .+++..+..++.||+.||.|||++||+||||||+|||++.++..
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~-------------------- 140 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN-------------------- 140 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc--------------------
Confidence 11 46788899999999999999999999999999999999865411
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
......++|+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+.....
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~ 219 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY 219 (259)
T ss_pred cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH
Confidence 01122578889988876443 2234577889999999876 68899999999999999999 57888654322211100
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
. . .... .......+.++|.+||..||++|
T Consensus 220 ~-~----------------------~~~~----------------------------~~~~~~~~~~li~~~l~~~p~~R 248 (259)
T cd05037 220 Q-D----------------------QHRL----------------------------PMPDCAELANLINQCWTYDPTKR 248 (259)
T ss_pred h-c----------------------CCCC----------------------------CCCCchHHHHHHHHHhccChhhC
Confidence 0 0 0000 00112578899999999999999
Q ss_pred CCHHHHHc
Q 015532 378 LKAREALR 385 (405)
Q Consensus 378 pta~elL~ 385 (405)
||+.++++
T Consensus 249 pt~~~il~ 256 (259)
T cd05037 249 PSFRAILR 256 (259)
T ss_pred CCHHHHHH
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=251.28 Aligned_cols=216 Identities=19% Similarity=0.265 Sum_probs=152.4
Q ss_pred eeeecccceeEEEEEecC--CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~--~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
++||+|+||+||+|.... ....+|+|.+... ......+.+|+.+++.+.|+++....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996533 3457889987533 22345677899999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---------------------- 138 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS---------------------- 138 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc----------------------
Confidence 012346677899999999999999999999999999999977664
Q ss_pred CCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 015532 222 PKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-GEALFQTH 288 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~llt-g~~pf~~~ 288 (405)
+||+|||++...... .....++..|+|||++.. ..++.++|||||||++|+|++ |..||...
T Consensus 139 -----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 139 -----VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred -----EEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 455555554322111 112245678999999753 346789999999999999999 88999877
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
.+.+.+..+..... ..++. .......+..+.+++..
T Consensus 214 ~~~~~~~~~~~~~~-----------------------~~~~~---------------------~~~~~~~~~~~~~~~~~ 249 (269)
T cd05042 214 SDEQVLKQVVREQD-----------------------IKLPK---------------------PQLDLKYSDRWYEVMQF 249 (269)
T ss_pred CHHHHHHHHhhccC-----------------------ccCCC---------------------CcccccCCHHHHHHHHH
Confidence 66554443322110 00100 00112345677889988
Q ss_pred ccccCCCCCCCHHHHHc
Q 015532 369 LLRYDPAERLKAREALR 385 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~ 385 (405)
|+ .||++|||++++++
T Consensus 250 ~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 250 CW-LDPETRPTAEEVHE 265 (269)
T ss_pred Hh-cCcccccCHHHHHH
Confidence 88 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=252.59 Aligned_cols=219 Identities=22% Similarity=0.398 Sum_probs=163.2
Q ss_pred CeEEEeeeecccceeEEEEEecC-CCcEEEEEEecch-----------hhhhHHHHHHHHHHHH-HhhcCCCCCc-----
Q 015532 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI-----------NKYREAAMIEIDVLQR-LARHDIGGTR----- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~-~~~~vAiK~~~~~-----------~~~~~~~~~E~~il~~-l~~~~~~~~~----- 154 (405)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+... ......+..|+.++.+ +.|+++....
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999987 6789999988531 1223446678887765 6777762211
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~-------- 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK-------- 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--------
Confidence 1246788899999999999999996 78999999999999976654
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 153 -------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~ 213 (269)
T cd08528 153 -------------------VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213 (269)
T ss_pred -------------------EEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcc
Confidence 555566655433222 12346888999999999888999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
...........+....... ......+..+.+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~l 245 (269)
T cd08528 214 YSTNMLSLATKIVEAVYEP------------------------------------------------LPEGMYSEDVTDV 245 (269)
T ss_pred cccCHHHHHHHHhhccCCc------------------------------------------------CCcccCCHHHHHH
Confidence 7655443333222110000 0011345689999
Q ss_pred HHHccccCCCCCCCHHHHHcC
Q 015532 366 LQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~h 386 (405)
|.+||+.||++||++.|+.++
T Consensus 246 i~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 246 ITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=249.23 Aligned_cols=216 Identities=19% Similarity=0.246 Sum_probs=151.7
Q ss_pred eeeecccceeEEEEEec--CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------------------
Q 015532 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------------- 154 (405)
+.||+|+||.||+|... .++..+|+|.++... .....+.+|+.+++.+.|+++....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999864 345679999886543 2334677899999999999873211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
....++..+..++.|++.||.|||++|++||||||+||+++..+.+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~--------------------- 139 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTV--------------------- 139 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcE---------------------
Confidence 0123455677899999999999999999999999999999776554
Q ss_pred CCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 015532 222 PKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVELCS-GEALFQTH 288 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~~llt-g~~pf~~~ 288 (405)
+|+|||.+...... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 140 ------kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 140 ------KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ------EECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 55555544322111 1123567889999998642 35789999999999999996 99999776
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
...+......... ....+. .......+..+.+++.+
T Consensus 214 ~~~~~~~~~~~~~-----------------------~~~~~~---------------------~~~~~~~~~~~~~l~~~ 249 (269)
T cd05087 214 SDEQVLTYTVREQ-----------------------QLKLPK---------------------PRLKLPLSDRWYEVMQF 249 (269)
T ss_pred ChHHHHHHHhhcc-----------------------cCCCCC---------------------CccCCCCChHHHHHHHH
Confidence 5544332211100 000000 00011235578899999
Q ss_pred ccccCCCCCCCHHHHHc
Q 015532 369 LLRYDPAERLKAREALR 385 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~ 385 (405)
|+ .+|++|||++||+.
T Consensus 250 c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 250 CW-LQPEQRPSAEEVHL 265 (269)
T ss_pred Hh-cCcccCCCHHHHHH
Confidence 98 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=253.07 Aligned_cols=233 Identities=22% Similarity=0.316 Sum_probs=163.6
Q ss_pred CCeEEEeeeecccceeEEEEEec----CCCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~----~~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|++.+.||+|+||.||+|+.. .+++.||||+++.... ..+.+..|+++++.+.|+++....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45888899999999999999864 3478999999975444 356788999999999998873211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~---------------- 147 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---------------- 147 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC----------------
Confidence 113677888999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCceeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 148 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 148 -----------VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred -----------EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 45555555544331111 1234556999999988889999999999999999999999986532
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
... ....+..+... ............ .........+.++.+|+.+|
T Consensus 217 ~~~-----~~~~~~~~~~~-------------------------~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~c 262 (284)
T cd05038 217 AEF-----LRMIGIAQGQM-------------------------IVTRLLELLKEG----ERLPRPPSCPDEVYDLMKLC 262 (284)
T ss_pred chh-----ccccccccccc-------------------------cHHHHHHHHHcC----CcCCCCccCCHHHHHHHHHH
Confidence 211 00011000000 000000000000 00011123456899999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|+.||++|||+.|+++
T Consensus 263 l~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 263 WEAEPQDRPSFADLIL 278 (284)
T ss_pred hccChhhCCCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=276.55 Aligned_cols=218 Identities=22% Similarity=0.345 Sum_probs=175.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC-----cEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.+-++.+.||+|+||.||.|....-. ..||||.+++. ....+.|++|..+|..++|+|++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45678899999999999999876432 34999999765 44567899999999999999984321
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...++......++.||++|++||+++++|||||-..|+|++..
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~------------- 838 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER------------- 838 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-------------
Confidence 2346778899999999999999999999999999999998764
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCccce-----ecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 284 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~p 284 (405)
..+||+|||+|+.......+. .-...|||||.+....++.|+|||||||++||++| |..|
T Consensus 839 --------------r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 839 --------------RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred --------------CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 357777777777433332221 22457999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
|...++.+.+.... .+++++.|. .+++.+.+
T Consensus 905 Y~~~~n~~v~~~~~-----------------------~ggRL~~P~--------------------------~CP~~ly~ 935 (1025)
T KOG1095|consen 905 YPSRSNFEVLLDVL-----------------------EGGRLDPPS--------------------------YCPEKLYQ 935 (1025)
T ss_pred CCCcchHHHHHHHH-----------------------hCCccCCCC--------------------------CCChHHHH
Confidence 99998887765332 233554443 44667889
Q ss_pred HHHHccccCCCCCCCHHHHHc
Q 015532 365 LLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~ 385 (405)
+|.+||+.+|++||++..|++
T Consensus 936 lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 936 LMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHccCChhhCccHHHHHh
Confidence 999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=245.06 Aligned_cols=215 Identities=20% Similarity=0.243 Sum_probs=150.9
Q ss_pred eeecccceeEEEEEecCC--CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc--------------------
Q 015532 99 KMGEGTFGQVVECFDNEK--KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR-------------------- 154 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~--~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~-------------------- 154 (405)
.||+|+||.||+|....+ ...+++|.++... ...+.+.+|+.+++.++|+++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975433 3456777765432 3456788999999999999884321
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~------------------------ 137 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT------------------------ 137 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc------------------------
Confidence 112345567789999999999999999999999999999976664
Q ss_pred CCCceeccCCCCccccC-----CccceecCCCcchhHHHhC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015532 224 SSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-GEALFQTHEN 290 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 290 (405)
++|+|||++..... ......++..|+|||++.. ..++.++|||||||++|+|++ |..||...+.
T Consensus 138 ---~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 138 ---VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred ---EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 45555555432111 1122467889999999853 235789999999999999997 6788877666
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+.+..+..... ...+. .......++.+.+++..|+
T Consensus 215 ~~~~~~~~~~~~-----------------------~~~~~---------------------~~~~~~~~~~~~~l~~~c~ 250 (268)
T cd05086 215 REVLNHVIKDQQ-----------------------VKLFK---------------------PQLELPYSERWYEVLQFCW 250 (268)
T ss_pred HHHHHHHHhhcc-----------------------cccCC---------------------CccCCCCcHHHHHHHHHHh
Confidence 554443321100 00000 0011234567889999999
Q ss_pred ccCCCCCCCHHHHHc
Q 015532 371 RYDPAERLKAREALR 385 (405)
Q Consensus 371 ~~dP~~Rpta~elL~ 385 (405)
.+|++|||++++++
T Consensus 251 -~~P~~Rp~~~~i~~ 264 (268)
T cd05086 251 -LSPEKRATAEEVHR 264 (268)
T ss_pred -hCcccCCCHHHHHH
Confidence 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=258.00 Aligned_cols=243 Identities=25% Similarity=0.423 Sum_probs=181.3
Q ss_pred EeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--------hhhhHHHHHHHHHHHHHhhcCCCCCc-
Q 015532 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTR- 154 (405)
Q Consensus 84 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--------~~~~~~~~~E~~il~~l~~~~~~~~~- 154 (405)
+.....+.+||-++..||+|+|+.||+|.|...+++||+|+-... ..+.....+|..|.+.|.|+.|+...
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 334456788999999999999999999999999999999986432 23445677899999999999885432
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCCCcEEEecccccccCCc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIli~~~~~~k~~df 205 (405)
...+++.+++.|+.||+.||.||.+. -|||-||||.|||+.+..
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt------- 607 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT------- 607 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc-------
Confidence 24568999999999999999999965 699999999999997532
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCc----------cceecCCCcchhHHHhCC----CCCCchhHHHH
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGL----GWNYPCDLWSV 271 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~DiwSl 271 (405)
..+.+||.|||+++....+. +...||.+|++||.+.-. ..+.|+||||+
T Consensus 608 -----------------acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 608 -----------------ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred -----------------ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 22345555555554433221 225799999999988643 37889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 272 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 272 G~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|||+|..+.|+.||......+.+.+-..++ +.....+|
T Consensus 671 GVIFyQClYGrKPFGhnqsQQdILqeNTIl--------------------kAtEVqFP---------------------- 708 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHNQSQQDILQENTIL--------------------KATEVQFP---------------------- 708 (775)
T ss_pred ehhhhhhhccCCCCCCchhHHHHHhhhchh--------------------cceeccCC----------------------
Confidence 999999999999997654332221111111 00011111
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
..+-++.++++||++||++.-++|....++..||||.-...
T Consensus 709 --~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 709 --PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred --CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 12345778999999999999999999999999999986443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=260.09 Aligned_cols=216 Identities=22% Similarity=0.307 Sum_probs=167.2
Q ss_pred EEEeeeecccceeEEEEEecCCCc---E-EEEEEecc----hhhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 95 RILSKMGEGTFGQVVECFDNEKKE---L-VAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~~---~-vAiK~~~~----~~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+.++||+|+||.||+|+.+..+. . ||||..+. .......+++|.++|+.++|+|++...
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 446899999999999999875422 3 89999874 244567889999999999999983221
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v------------------ 301 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV------------------ 301 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE------------------
Confidence 1248889999999999999999999999999999999999876644
Q ss_pred cCCCCCCCceeccCCCCccccCCc--c-ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH--S-YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 294 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 294 (405)
||+|||+++....-. . ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....+..
T Consensus 302 ---------KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~ 372 (474)
T KOG0194|consen 302 ---------KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK 372 (474)
T ss_pred ---------EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH
Confidence 555555544332100 0 1123568999999999899999999999999999998 89999999988777
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.....+.+ .+...+..+..++.+|+..||
T Consensus 373 ~kI~~~~~r~~------------------------------------------------~~~~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 373 AKIVKNGYRMP------------------------------------------------IPSKTPKELAKVMKQCWKKDP 404 (474)
T ss_pred HHHHhcCccCC------------------------------------------------CCCCCHHHHHHHHHHhccCCh
Confidence 66633211111 112335678899999999999
Q ss_pred CCCCCHHHHHc
Q 015532 375 AERLKAREALR 385 (405)
Q Consensus 375 ~~Rpta~elL~ 385 (405)
++|+|+.++.+
T Consensus 405 ~~R~tm~~i~~ 415 (474)
T KOG0194|consen 405 EDRPTMSTIKK 415 (474)
T ss_pred hhccCHHHHHH
Confidence 99999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=225.73 Aligned_cols=181 Identities=20% Similarity=0.412 Sum_probs=141.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc--hhhhhHHHHHHHHHHHHHhhcCCCC-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGG----------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~--~~~~~~~~~~E~~il~~l~~~~~~~----------------- 152 (405)
+....+..||+|+||.|-+.++..+|...|+|.++. .++.....++|+++..+...-....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 335567889999999999999999999999999964 3344566777887766543322210
Q ss_pred --------------CccccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 153 --------------TRYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 153 --------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
.....++|..+-+++..++.||.|||++ .|||||+||+||||+..|
T Consensus 126 ~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G------------------- 186 (282)
T KOG0984|consen 126 LMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG------------------- 186 (282)
T ss_pred HhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-------------------
Confidence 1135678999999999999999999975 899999999999998766
Q ss_pred ccCCCCCCCceeccCCCCccccCCccc--eecCCCcchhHHHhC----CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSGEALFQT-HEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~ 290 (405)
++|+||||++....+.... -.|...|||||.+.. ..|+.++||||||+++.||.+++.||.. .++
T Consensus 187 --------qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 187 --------QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred --------cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 5777888877665544322 468889999999864 3699999999999999999999999975 456
Q ss_pred HHHHHHHHH
Q 015532 291 LEHLAMMER 299 (405)
Q Consensus 291 ~~~~~~i~~ 299 (405)
.+++.++.+
T Consensus 259 F~qLkqvVe 267 (282)
T KOG0984|consen 259 FQQLKQVVE 267 (282)
T ss_pred HHHHHHHhc
Confidence 666665544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=243.64 Aligned_cols=225 Identities=23% Similarity=0.293 Sum_probs=175.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCcc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRY------------- 155 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~~------------- 155 (405)
.++..+.++||+|.||.|.+|.-. .+..||||+++... ..+..+..||++|.+|.|||++....
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 467889999999999999999864 46889999997543 34678999999999999999843220
Q ss_pred ----------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 156 ----------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 156 ----------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
..........++.||+.|+.||.+.++|||||.+.|+|++.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~----------------------- 672 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDG----------------------- 672 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecC-----------------------
Confidence 11223345669999999999999999999999999999864
Q ss_pred CCCCCCCceeccCCCCccccCCccc-----eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS--GEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~ 292 (405)
+.++||+|||+++.......+ .+-...|||+|.+.-++++.++|+|+||+++||+++ .+.||....+.+
T Consensus 673 ----e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 673 ----EFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred ----cccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 456788888887754433332 345789999999999999999999999999999865 889998888877
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
........+...+... ....+.-++..+.++|.+|+.+
T Consensus 749 vven~~~~~~~~~~~~------------------------------------------~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQV------------------------------------------VLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred HHHhhhhhcCCCCcce------------------------------------------eccCCCcCcHHHHHHHHHHhch
Confidence 7766555443222110 1112234566888999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
|-++|||.+++-.
T Consensus 787 es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 787 ESEQRPSFEQLHL 799 (807)
T ss_pred hhhcCCCHHHHHH
Confidence 9999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=233.56 Aligned_cols=212 Identities=36% Similarity=0.547 Sum_probs=161.5
Q ss_pred cceeEEEEEecCCCcEEEEEEecchhhh--hHHHHHHHHHHHHHhhcCCCCCc---------------------------
Q 015532 104 TFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTR--------------------------- 154 (405)
Q Consensus 104 ~fg~V~~a~~~~~~~~vAiK~~~~~~~~--~~~~~~E~~il~~l~~~~~~~~~--------------------------- 154 (405)
+||.||+|.+..+++.||+|++...... .+.+..|++.++++.|+++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999988999999998654322 46788999999999888762110
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCC
Q 015532 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234 (405)
Q Consensus 155 ~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 234 (405)
...+++..+..++.+++.+|.|||+.||+|+||+|+||+++.++ .++|+|||.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---------------------------~~~l~d~~~ 133 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---------------------------HVKLADFGL 133 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---------------------------cEEEccccc
Confidence 11267888999999999999999999999999999999997655 456666666
Q ss_pred CccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHHHH
Q 015532 235 TTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIR 311 (405)
Q Consensus 235 a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~g~~p~~~~~~ 311 (405)
+...... .....++..|++||.+.+..++.++||||||+++|+|++|..||......+ ....+.......
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------- 206 (244)
T smart00220 134 ARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF------- 206 (244)
T ss_pred eeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------
Confidence 5544332 233467889999999988888999999999999999999999997733322 222111100000
Q ss_pred hhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCC
Q 015532 312 ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f 389 (405)
......++..+.+++.+||..||++||++.++++||||
T Consensus 207 ----------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ----------------------------------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----------------------------------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00000145688999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=264.14 Aligned_cols=225 Identities=24% Similarity=0.302 Sum_probs=161.2
Q ss_pred eEEEeeeeccccee-EEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc-CCCCCc---------c-------
Q 015532 94 YRILSKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTR---------Y------- 155 (405)
Q Consensus 94 y~~~~~LG~G~fg~-V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~-~~~~~~---------~------- 155 (405)
|.-.+.+|.|+-|+ ||+|... ++.||||.+- ......+.+||..|+.-+.| |++... |
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL--EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHh--hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44457899998875 6999874 7899999873 23445678999999987654 442211 0
Q ss_pred --------c---cC---CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 156 --------R---SF---PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 156 --------~---~l---~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
. .+ .....+.++.|++.||++||+.+||||||||.||||+... .
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~----------------------~ 644 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS----------------------A 644 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC----------------------C
Confidence 0 00 1123467889999999999999999999999999998632 1
Q ss_pred CCCCCceeccCCCCccccCCcc------ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLEHL 294 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~ 294 (405)
+....++|+|||+++......+ ...||-+|+|||++....-+.++||+||||++|+.++| .+||......+
T Consensus 645 ~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-- 722 (903)
T KOG1027|consen 645 DGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-- 722 (903)
T ss_pred CcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--
Confidence 2345678888888876554432 35799999999999998888899999999999999885 99997543221
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..|..-. ..+ .........++.|||.+||.+||
T Consensus 723 ~NIl~~~----------------------------------------------~~L-~~L~~~~d~eA~dLI~~ml~~dP 755 (903)
T KOG1027|consen 723 ANILTGN----------------------------------------------YTL-VHLEPLPDCEAKDLISRMLNPDP 755 (903)
T ss_pred hhhhcCc----------------------------------------------cce-eeeccCchHHHHHHHHHhcCCCc
Confidence 1111100 000 00001111278899999999999
Q ss_pred CCCCCHHHHHcCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDV 393 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~ 393 (405)
..||+|.++|.||||=...
T Consensus 756 ~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 756 QLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred ccCCCHHHHhCCCccCChH
Confidence 9999999999999995543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=252.35 Aligned_cols=221 Identities=19% Similarity=0.312 Sum_probs=174.6
Q ss_pred CeEEEeeeecccceeEEEEEecCC---CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
...+.++||+|.||+||+|.+... ...||||+++... .....|++|+.+|.+|.|++++..+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~E 190 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFE 190 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhh
Confidence 345678999999999999998643 2469999997543 2467899999999999999974322
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...|.......|+.||+.|+.||.++++|||||-..|||+-...
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--------------------- 249 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--------------------- 249 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc---------------------
Confidence 23456677788999999999999999999999999999986544
Q ss_pred CCCCCCCceeccCCCCccccCCcccee------cCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVV------STRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~------gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
.|||+|||+.+........++ -...|+|||.+....++.++|+|++||++|||++ |+.||.+....+
T Consensus 250 ------tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 250 ------TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ 323 (1039)
T ss_pred ------eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence 467777777665544433221 2457999999999999999999999999999998 899999999988
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
++..|..- .++ ..+..+++++.+++.+||..
T Consensus 324 IL~~iD~~-----------------------erL--------------------------pRPk~csedIY~imk~cWah 354 (1039)
T KOG0199|consen 324 ILKNIDAG-----------------------ERL--------------------------PRPKYCSEDIYQIMKNCWAH 354 (1039)
T ss_pred HHHhcccc-----------------------ccC--------------------------CCCCCChHHHHHHHHHhccC
Confidence 88776421 011 12245678899999999999
Q ss_pred CCCCCCCHHHHHcCCCC
Q 015532 373 DPAERLKAREALRHPFF 389 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f 389 (405)
+|++|||+..|.+.-+.
T Consensus 355 ~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 355 NPADRPTFSAIREDLVL 371 (1039)
T ss_pred CccccccHHHHHHhHHH
Confidence 99999999988654443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=250.35 Aligned_cols=213 Identities=25% Similarity=0.404 Sum_probs=171.6
Q ss_pred EEeeeecccceeEEEEEecCC----CcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 96 ILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~----~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.+.||.|.||.||+|....- .--||||..+.. ....+.++.|..+|+.++|++|+...
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~ 472 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELA 472 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecc
Confidence 356799999999999987533 335999998763 34578899999999999999985422
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...++......++.||+.||.|||+..+|||||-..|||+.+..
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~------------------------ 528 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ------------------------ 528 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc------------------------
Confidence 24567778888999999999999999999999999999997643
Q ss_pred CCCCceeccCCCCccccCCccc----eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDHSY----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
.|||+|||++++.+....+ ..-...|||||.+.-..++.++|||-|||.+||++. |..||.+-.+.+.+..+
T Consensus 529 ---CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i 605 (974)
T KOG4257|consen 529 ---CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI 605 (974)
T ss_pred ---eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe
Confidence 5788888888877665433 123567999999988899999999999999999987 99999998777665544
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
++ |.+++.| +.+++.+..|+.+||.+||.+|
T Consensus 606 En-----------------------GeRlP~P--------------------------~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 606 EN-----------------------GERLPCP--------------------------PNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred cC-----------------------CCCCCCC--------------------------CCCChHHHHHHHHHhccCcccC
Confidence 32 2233333 4567789999999999999999
Q ss_pred CCHHHHH
Q 015532 378 LKAREAL 384 (405)
Q Consensus 378 pta~elL 384 (405)
|+..|+.
T Consensus 637 Prftei~ 643 (974)
T KOG4257|consen 637 PRFTEIK 643 (974)
T ss_pred CcHHHHH
Confidence 9887765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=259.44 Aligned_cols=217 Identities=22% Similarity=0.311 Sum_probs=179.2
Q ss_pred CeEEEeeeecccceeEEEEEecCCC---cEEEEEEecc--hhhhhHHHHHHHHHHHHHhhcCCCC---------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGG--------------- 152 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~---~~vAiK~~~~--~~~~~~~~~~E~~il~~l~~~~~~~--------------- 152 (405)
.-.|.++||.|.||.|++|+.+..+ ..||||.++. .++.+.+|+.|..||-+++||||+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4578899999999999999988655 4799999975 4567788999999999999999832
Q ss_pred -------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 153 -------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 153 -------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+.|+..+...+++.|+.|++||-++|+|||||-..|||++++-
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--------------------- 768 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--------------------- 768 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce---------------------
Confidence 1235677888899999999999999999999999999999997654
Q ss_pred CCCCCCCceeccCCCCccccCCccc----eec--CCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSY----VVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~----~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
..|++|||+++..+++... .-| ...|.|||.+.-.+++.++||||+||+|||.++ |+.||...++.+
T Consensus 769 ------vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 769 ------VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred ------EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 4566666666655443311 112 458999999999999999999999999999776 999999999999
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..|++...-+|+ -+++..+.+|+..||++
T Consensus 843 VIkaIe~gyRLPpP-------------------------------------------------mDCP~aL~qLMldCWqk 873 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPP-------------------------------------------------MDCPAALYQLMLDCWQK 873 (996)
T ss_pred HHHHHHhccCCCCC-------------------------------------------------CCCcHHHHHHHHHHHHH
Confidence 99888776543332 24567899999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
|-.+||+..||++
T Consensus 874 dR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 874 DRNRRPKFAQIVS 886 (996)
T ss_pred HhhcCCCHHHHHH
Confidence 9999999999987
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=246.23 Aligned_cols=215 Identities=20% Similarity=0.350 Sum_probs=173.7
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------c-
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-----------------Y- 155 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-----------------~- 155 (405)
.....+||-|.||.||.|.++.-.-.||||.++......++|+.|..+|+.+.|+|++..+ +
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 3456899999999999999999888999999998888889999999999999999974422 1
Q ss_pred -----------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 156 -----------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 156 -----------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
..++.-...+++.||..|++||..+++|||||-..|+|++.+.
T Consensus 349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-------------------------- 402 (1157)
T KOG4278|consen 349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------------------------- 402 (1157)
T ss_pred cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc--------------------------
Confidence 1234445677889999999999999999999999999997544
Q ss_pred CCceeccCCCCccccCCccc-eec---CCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 015532 225 SAIKLIDFGSTTFEHQDHSY-VVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (405)
.||++|||++++...+..+ ..| .+.|.|||.+.-+.++.|+|||+|||+|||+.| |..||.+.+-.+....+.+
T Consensus 403 -iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 403 -IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK 481 (1157)
T ss_pred -eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc
Confidence 5677777777766554432 223 567999999998899999999999999999998 9999999776555443332
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
+-++ +.++.+++.+.+|++.||+|+|.+||+
T Consensus 482 -----------------------gyRM--------------------------~~PeGCPpkVYeLMraCW~WsPsDRPs 512 (1157)
T KOG4278|consen 482 -----------------------GYRM--------------------------DGPEGCPPKVYELMRACWNWSPSDRPS 512 (1157)
T ss_pred -----------------------cccc--------------------------cCCCCCCHHHHHHHHHHhcCCcccCcc
Confidence 2122 233466778999999999999999999
Q ss_pred HHHHH
Q 015532 380 AREAL 384 (405)
Q Consensus 380 a~elL 384 (405)
..|+-
T Consensus 513 FaeiH 517 (1157)
T KOG4278|consen 513 FAEIH 517 (1157)
T ss_pred HHHHH
Confidence 88764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=273.25 Aligned_cols=178 Identities=20% Similarity=0.214 Sum_probs=137.0
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCC
Q 015532 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235 (405)
Q Consensus 156 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 235 (405)
..+++.+++.++.||+.||.|||++||+||||||+||||+..|.+|++|||++..... +....+|++|||++
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~--------~~~~~~ki~DfG~a 146 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS--------DEDATTKSREIGSS 146 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc--------cccCcccccccccc
Confidence 4588999999999999999999999999999999999999999999999998754322 23457899999998
Q ss_pred ccccCC-------------------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 236 TFEHQD-------------------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 236 ~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+..... ....+||+.|||||++.+..|+.++|||||||++|||++|.+|+.... ..+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~ 224 (793)
T PLN00181 147 RREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSS 224 (793)
T ss_pred cccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHH
Confidence 643210 011468999999999999999999999999999999999988875321 11111
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+... ..|... ........+++.+||+.||.+
T Consensus 225 ~~~~--~~~~~~-----------------------------------------------~~~~~~~~~~~~~~L~~~P~~ 255 (793)
T PLN00181 225 LRHR--VLPPQI-----------------------------------------------LLNWPKEASFCLWLLHPEPSC 255 (793)
T ss_pred HHHh--hcChhh-----------------------------------------------hhcCHHHHHHHHHhCCCChhh
Confidence 1110 001000 001234568899999999999
Q ss_pred CCCHHHHHcCCCCCCC
Q 015532 377 RLKAREALRHPFFTRD 392 (405)
Q Consensus 377 Rpta~elL~hp~f~~~ 392 (405)
|||+.|+|+||||...
T Consensus 256 Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 256 RPSMSELLQSEFINEP 271 (793)
T ss_pred CcChHHHhhchhhhhh
Confidence 9999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=243.36 Aligned_cols=167 Identities=27% Similarity=0.450 Sum_probs=143.7
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHH---------HHHHHHHHHh---hcCCCCCc------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM---------IEIDVLQRLA---RHDIGGTR------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~---------~E~~il~~l~---~~~~~~~~------ 154 (405)
.|..++.||+|+||.|++|.++.....|+||.|.+.+...+.++ .||+||..|+ |+||.+.+
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 49999999999999999999999999999999977554444443 4999999999 88874322
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...++|.+++.|++||+.|+++||++||||||||-+|++++.+|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-------------- 707 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-------------- 707 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC--------------
Confidence 35678999999999999999999999999999999999998766
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCc-cceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCC
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.+||+|||.|....... ..++||..|.|||++.|.+|- ..-|||+||++||.++..+.||.
T Consensus 708 -------------~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 -------------FVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred -------------eEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 47888889887665443 457999999999999999875 66899999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=249.84 Aligned_cols=231 Identities=25% Similarity=0.393 Sum_probs=183.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.+.|+++.++|+|+||.||+|+++.+++..|+|+++.... .-.....|+-+++..+|+||+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4679999999999999999999999999999999975332 234456799999999999983221
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
-+.+++.++..++++.+.||+|||++|-+|||||-.|||+++.|.
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD----------------------- 150 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD----------------------- 150 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc-----------------------
Confidence 246789999999999999999999999999999999999987765
Q ss_pred CCCCceeccCCCCccccC---CccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+|++|||.+..+.. ....+.||++|||||+.. ...|+..+|||++|++..|+..-++|.-.......+..
T Consensus 151 ----vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L 226 (829)
T KOG0576|consen 151 ----VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL 226 (829)
T ss_pred ----eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH
Confidence 45555555433322 233468999999999874 45799999999999999999988888766666666665
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
|.+-...+|. .+.....++.|.+|++.+|..+|.+
T Consensus 227 mTkS~~qpp~---------------------------------------------lkDk~kws~~fh~fvK~altknpKk 261 (829)
T KOG0576|consen 227 MTKSGFQPPT---------------------------------------------LKDKTKWSEFFHNFVKGALTKNPKK 261 (829)
T ss_pred hhccCCCCCc---------------------------------------------ccCCccchHHHHHHHHHHhcCCCcc
Confidence 5443322221 1112345778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDV 393 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~ 393 (405)
|||++.+|.|||+++..
T Consensus 262 RptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 262 RPTAEKLLQHPFVSQTL 278 (829)
T ss_pred CCChhhheeceeeccch
Confidence 99999999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=227.00 Aligned_cols=176 Identities=24% Similarity=0.326 Sum_probs=133.9
Q ss_pred CceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHH--HhhcCCCCCc----
Q 015532 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTR---- 154 (405)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~--l~~~~~~~~~---- 154 (405)
..++-....+..+-.+.+.||+|.||.||+|.++ |+.||||++...++ ..+.+|.+|.+. |+|+||.+..
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 3444455677788999999999999999999987 88899999976443 445666666654 7899884422
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEEeccccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NIli~~~~~~ 200 (405)
...++.+...+++..++.||.+||-. .|.|||||..|||+..+|.+
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 13467788999999999999999942 49999999999999999988
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCC----CC--CchhHHHHHHH
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WN--YPCDLWSVGCI 274 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DiwSlG~i 274 (405)
.|+|+||+.+...+. ..+|. .....+||..|||||++...- +. ..+||||||.+
T Consensus 356 ~IADLGLAv~h~~~t------------~~idi--------~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDT------------DTIDI--------PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred EEeeceeeEEecccC------------CcccC--------CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 888888775543321 11221 223358999999999997531 21 45899999999
Q ss_pred HHHHHh
Q 015532 275 LVELCS 280 (405)
Q Consensus 275 l~~llt 280 (405)
+||++.
T Consensus 416 lWEiar 421 (513)
T KOG2052|consen 416 LWEIAR 421 (513)
T ss_pred HHHHHH
Confidence 999975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=266.84 Aligned_cols=164 Identities=17% Similarity=0.250 Sum_probs=129.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
..|...+.||+|+||.||+|++..+++.||||.++..... ...|++++++++|++++...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 3466778999999999999999889999999998653322 23468899999999984321
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 -------YRSFPIDLVRELGRQLLESVAFMH---ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 -------~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~---------------------- 824 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL---------------------- 824 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE----------------------
Confidence 123678899999999999999999 669999999999999976543222
Q ss_pred CCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
. ||.+...... ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 825 -----~-~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 825 -----R-LSLPGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -----E-eccccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1 3322221111 123678999999999988999999999999999999999999953
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=230.40 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=157.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHH--HHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ--RLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~--~l~~~~~~~~~--------------- 154 (405)
...++.+.||+|.||.||+|... ++.||||++...+ .+.+..|-+|.. .+.|+||....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44677899999999999999975 6899999996543 344666665554 46677763211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHH---------CCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHE---------LRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~---------~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++....+++..|+.||+|||+ ..|+|||||..|||+.+++++.|+||||+.+
T Consensus 286 Vt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred EeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 2356889999999999999999996 2699999999999999888776666665533
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCC-CC-----CchhHHHHHHHHHHHHhCCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WN-----YPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~~lltg~~p 284 (405)
.... .. ..+...-+||..|||||++.|.- +. .+.||||+|.++|||++.-.-
T Consensus 366 ~~p~-------------------~~---~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~ 423 (534)
T KOG3653|consen 366 LEPG-------------------KP---QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTD 423 (534)
T ss_pred ecCC-------------------CC---CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccc
Confidence 2211 00 01111258999999999998742 22 468999999999999987655
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
+......+...-....+|.-|..- +.-.....+..+..|++ .|. .+ .....+.+
T Consensus 424 ~~~~~vp~Yqlpfe~evG~hPt~e-----~mq~~VV~kK~RP~~p~----------~W~---------~h--~~~~~l~e 477 (534)
T KOG3653|consen 424 ADPGPVPEYQLPFEAEVGNHPTLE-----EMQELVVRKKQRPKIPD----------AWR---------KH--AGMAVLCE 477 (534)
T ss_pred ccCCCCCcccCchhHHhcCCCCHH-----HHHHHHHhhccCCCChh----------hhh---------cC--ccHHHHHH
Confidence 432111111111222233333110 00011111122222222 111 11 22447899
Q ss_pred HHHHccccCCCCCCCHHH------HHcCCCC
Q 015532 365 LLQGLLRYDPAERLKARE------ALRHPFF 389 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~e------lL~hp~f 389 (405)
.+..||..||+.|.||.= .|.|.|=
T Consensus 478 t~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 478 TIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 999999999999999853 3456663
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=232.54 Aligned_cols=216 Identities=22% Similarity=0.250 Sum_probs=164.3
Q ss_pred eEEEeeeecccceeEEEEEecCCC----cEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~----~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+..++||+|+||+||+|.+...| -+||||++.... +...+++.|+-+|.+|.|+++.+.+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 445689999999999999986555 368999986543 3467789999999999999985432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+-....+.+..||++|+.|||++++|||||-..|||+....++|+
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvki------------------ 839 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKI------------------ 839 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEE------------------
Confidence 133445667789999999999999999999999999999987665555
Q ss_pred CCCCCCceeccCCCCccccCCccc-----eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 294 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 294 (405)
.|||+++........ -.-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....++-
T Consensus 840 ---------tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~ 910 (1177)
T KOG1025|consen 840 ---------TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP 910 (1177)
T ss_pred ---------EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh
Confidence 455554433322211 123567999999999999999999999999999998 99999887654432
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
++++.+-++.-| +..+-++.-++.+||..|+
T Consensus 911 -----------------------dlle~geRLsqP--------------------------piCtiDVy~~mvkCwmid~ 941 (1177)
T KOG1025|consen 911 -----------------------DLLEKGERLSQP--------------------------PICTIDVYMVMVKCWMIDA 941 (1177)
T ss_pred -----------------------HHHhccccCCCC--------------------------CCccHHHHHHHHHHhccCc
Confidence 233334333333 2345577889999999999
Q ss_pred CCCCCHHHHHc
Q 015532 375 AERLKAREALR 385 (405)
Q Consensus 375 ~~Rpta~elL~ 385 (405)
..||+++++.+
T Consensus 942 ~~rp~fkel~~ 952 (1177)
T KOG1025|consen 942 DSRPTFKELAE 952 (1177)
T ss_pred ccCccHHHHHH
Confidence 99999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=210.80 Aligned_cols=234 Identities=24% Similarity=0.309 Sum_probs=168.7
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC-CCCc-------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTR------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~-~~~~------------- 154 (405)
.+.+.|.|.+.||+|.||.+-+|+++.++..+++|.+........++.+|...--.|.+|.. +...
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 35678999999999999999999999999999999997766666778888766555555433 1110
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+-|...+.++.|+++|++|+|++++||||||.+||||-..
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~----------------------- 157 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA----------------------- 157 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-----------------------
Confidence 1235677889999999999999999999999999999999542
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQTHENLE-HL 294 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~ 294 (405)
+...+||||||..+..........-+..|.+||++... ..++.+|+|.||+++|.++||.+||......+ -.
T Consensus 158 --df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y 235 (378)
T KOG1345|consen 158 --DFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY 235 (378)
T ss_pred --CccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH
Confidence 23379999999987765544444456679999987642 24678999999999999999999997432211 11
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
....+..+ ...+ .........++.+..+.++-|..++
T Consensus 236 ~~~~~w~~------------------------------------------rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~ 272 (378)
T KOG1345|consen 236 WEWEQWLK------------------------------------------RKNP-ALPKKFNPFSEKALRLFKKSLTPRF 272 (378)
T ss_pred HHHHHHhc------------------------------------------ccCc-cCchhhcccCHHHHHHHHHhcCCcc
Confidence 11111110 0011 0111223456788889999999999
Q ss_pred CCC---CCHHHHHcCCCCC
Q 015532 375 AER---LKAREALRHPFFT 390 (405)
Q Consensus 375 ~~R---pta~elL~hp~f~ 390 (405)
++| .++......-|..
T Consensus 273 ~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 273 KDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccchhHHHHHHHHHHHHH
Confidence 999 5666655555653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=204.15 Aligned_cols=156 Identities=23% Similarity=0.263 Sum_probs=113.8
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCC
Q 015532 156 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235 (405)
Q Consensus 156 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 235 (405)
..+++.+++.++.||+.||.|||+++ ||+|||++.++.+ ++ ||++
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~---------------------------~~--fG~~ 56 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLL---------------------------KL--DGSV 56 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccce---------------------------ee--ccce
Confidence 35899999999999999999999998 9999999766544 44 5555
Q ss_pred ccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHHHHhhH
Q 015532 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADR 314 (405)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~ 314 (405)
....... ..||+.|+|||++.+..++.++|||||||++|||++|..||....... .+..+.......
T Consensus 57 ~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 124 (176)
T smart00750 57 AFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---------- 124 (176)
T ss_pred Eeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC----------
Confidence 4433221 258899999999999999999999999999999999999996543321 122111111000
Q ss_pred hhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch--HHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 315 RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA--GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
.... . ......+ ..+.++|.+||..||++|||+.|+++|+|+..
T Consensus 125 ------------~~~~-~--------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 125 ------------DPRD-R--------------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ------------Cccc-c--------------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0000 0 0000112 26899999999999999999999999999764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=231.85 Aligned_cols=217 Identities=24% Similarity=0.449 Sum_probs=163.5
Q ss_pred CeEEEeeeecccceeEEEEEecC-------CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhc-CCCCCc--------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARH-DIGGTR-------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~-~~~~~~-------- 154 (405)
+..+.+.||+|.||.||+|.... ....||||.++.. ....+.+..|+++|+.+.+| |+....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34566799999999999997541 1457999998643 24567788999999999854 431100
Q ss_pred --------------------c---------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccc
Q 015532 155 --------------------Y---------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199 (405)
Q Consensus 155 --------------------~---------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~ 199 (405)
. ..++......++.||+.|++||++..+|||||-..|||+..+.
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~- 455 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK- 455 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC-
Confidence 1 1278888999999999999999999999999999999997543
Q ss_pred cccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccce----ec--CCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV----VS--TRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 200 ~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~g--t~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
.+||+|||+|+.......+. .| ...|||||.+....|+.++||||+||
T Consensus 456 --------------------------~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI 509 (609)
T KOG0200|consen 456 --------------------------VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGI 509 (609)
T ss_pred --------------------------EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHH
Confidence 56777777776544333221 12 33599999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCC-hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 274 ILVELCS-GEALFQTHE-NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 274 il~~llt-g~~pf~~~~-~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
+|||+++ |..||.+.. ..+.+. +...|.++.-|
T Consensus 510 ~L~EifsLG~~PYp~~~~~~~l~~-----------------------~l~~G~r~~~P---------------------- 544 (609)
T KOG0200|consen 510 LLWEIFTLGGTPYPGIPPTEELLE-----------------------FLKEGNRMEQP---------------------- 544 (609)
T ss_pred HHHHHhhCCCCCCCCCCcHHHHHH-----------------------HHhcCCCCCCC----------------------
Confidence 9999998 999998744 323222 22233333333
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
..++.++.++++.|++.+|++||+..++.+
T Consensus 545 ----~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 545 ----EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ----CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 345678889999999999999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=206.92 Aligned_cols=219 Identities=18% Similarity=0.221 Sum_probs=164.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
..|++....+-+|.||.||.|.+++. .+.|-+|.++.. ......++.|--.|..+.|+|+....
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46788999999999999999976532 345667766532 23345567788888888898873211
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
-+.++..+...++.|++.|++|||++||||.||-..|++|++.-
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--------- 433 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--------- 433 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe---------
Confidence 12345567778899999999999999999999999999997644
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccCCccce-----ecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-C
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-G 281 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g 281 (405)
++||+|-.+++..-...... .....||+||.+.+..|+.++|+||||+++|||+| |
T Consensus 434 ------------------qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 434 ------------------QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred ------------------eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 45666655554332222111 23557999999999999999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
+.|+...++.+....+.. |-++.- +-+++++
T Consensus 496 ~~PyaeIDPfEm~~ylkd-----------------------GyRlaQ--------------------------P~NCPDe 526 (563)
T KOG1024|consen 496 KLPYAEIDPFEMEHYLKD-----------------------GYRLAQ--------------------------PFNCPDE 526 (563)
T ss_pred CCCccccCHHHHHHHHhc-----------------------cceecC--------------------------CCCCcHH
Confidence 999988887776544422 222222 2356789
Q ss_pred HHHHHHHccccCCCCCCCHHHHHc
Q 015532 362 LIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
+..++.-||..+|++||+.+|+..
T Consensus 527 Lf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 527 LFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHhcCcccCCCHHHHHH
Confidence 999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=194.75 Aligned_cols=180 Identities=38% Similarity=0.591 Sum_probs=148.1
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc-----------------------
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR----------------------- 154 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~----------------------- 154 (405)
||+|++|.||++.+..+++.+++|++..... ..+.+.+|+++++.+.|+++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999988899999999976443 246788999999999987652211
Q ss_pred ---c--ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-ccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 155 ---Y--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 155 ---~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~-~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
. ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. .+ .++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~---------------------------~~~ 133 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG---------------------------KVK 133 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC---------------------------cEE
Confidence 0 24778889999999999999999999999999999999976 44 466
Q ss_pred eccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 015532 229 LIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304 (405)
Q Consensus 229 l~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~ 304 (405)
|+|||.+...... .....+...|++||.+... .++.+.|+|++|+++++| .
T Consensus 134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------~------------ 188 (215)
T cd00180 134 LADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------P------------ 188 (215)
T ss_pred EecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------H------------
Confidence 6777666544433 2334678889999999887 788999999999999998 0
Q ss_pred ChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHH
Q 015532 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 384 (405)
Q Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL 384 (405)
.+.+++.+||..||++||++.+++
T Consensus 189 --------------------------------------------------------~~~~~l~~~l~~~p~~R~~~~~l~ 212 (215)
T cd00180 189 --------------------------------------------------------ELKDLIRKMLQKDPEKRPSAKEIL 212 (215)
T ss_pred --------------------------------------------------------HHHHHHHHHhhCCcccCcCHHHHh
Confidence 456899999999999999999999
Q ss_pred cCC
Q 015532 385 RHP 387 (405)
Q Consensus 385 ~hp 387 (405)
+|+
T Consensus 213 ~~~ 215 (215)
T cd00180 213 EHL 215 (215)
T ss_pred hCC
Confidence 875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=193.47 Aligned_cols=171 Identities=39% Similarity=0.581 Sum_probs=138.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
|.+.+.||.|++|.||++.+..+++.+|+|.+..... ..+.+.+|++.++.+.|+++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678999999999999999998899999999975432 456788899999999888763211
Q ss_pred ----------ccc-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 ----------YRS-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 ----------~~~-l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
... +++..+..++.+++.+|.+||+++++|+||+|.||+++..+
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~------------------------- 135 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG------------------------- 135 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------------------
Confidence 122 77888999999999999999999999999999999997654
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHH-hCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSGEALFQT-HENL 291 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~ 291 (405)
.++|+|||.+....... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++.
T Consensus 136 --~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 136 --LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred --CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 46667777665444332 345778899999998 566788899999999999999999999976 3443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=227.76 Aligned_cols=232 Identities=26% Similarity=0.412 Sum_probs=170.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------cccCCHHHHHH
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------YRSFPIDLVRE 165 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------~~~l~~~~~~~ 165 (405)
..|..++.|..|+||.||+++|+.+.+.+|+|+ ++.+.. ++- |+.....+..++.. .+.++.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn--ilt~a~npfvvgDc~tllk~~g~lPv----- 150 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN--ILTFAGNPFVVGDCATLLKNIGPLPV----- 150 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc--cccccCCcceechhhhhcccCCCCcc-----
Confidence 468999999999999999999999999999964 332211 111 44444444443221 122222
Q ss_pred HHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC-Cccc
Q 015532 166 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSY 244 (405)
Q Consensus 166 ~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~ 244 (405)
+++.+++|||+.||+|||+||+|.+|..-|++|++|||+.+........ .++ .=++.....+ ....
T Consensus 151 ---dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at--------nl~--eg~I~k~t~Ef~dKq 217 (1205)
T KOG0606|consen 151 ---DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT--------NLK--EGHIEKDTHEFQDKQ 217 (1205)
T ss_pred ---hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc--------hhh--hcchHHHHHHhhhcc
Confidence 3378999999999999999999999999999999999987654332211 000 0001111111 1123
Q ss_pred eecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCC
Q 015532 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGA 324 (405)
Q Consensus 245 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~ 324 (405)
++||+.|+|||++...+|+..+|+|++|+|+|+.+.|..||.+++.++.+.++......
T Consensus 218 vcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~--------------------- 276 (1205)
T KOG0606|consen 218 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--------------------- 276 (1205)
T ss_pred ccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc---------------------
Confidence 68999999999999999999999999999999999999999999999888777654332
Q ss_pred cccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC---CHHHHHcCCCCCCCCCC
Q 015532 325 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL---KAREALRHPFFTRDVRR 395 (405)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp---ta~elL~hp~f~~~~~~ 395 (405)
|++. .+...++++++|.++|+.+|..|. .+-++.+|+||+.-.+.
T Consensus 277 ---wpE~-----------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 277 ---WPEE-----------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ---cccc-----------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 3321 134467899999999999999997 57888999999976554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=183.06 Aligned_cols=176 Identities=24% Similarity=0.328 Sum_probs=143.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCC------------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG------------------ 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~------------------ 152 (405)
.-.|++.++||+|+||+++.|...-+++.||||.-.. ....-++..|....+.|.+..-+.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3469999999999999999999999999999996532 223344566888777776532110
Q ss_pred ----------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 153 ----------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 153 ----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+.|+..++..++.|++.-++|+|++.+|.|||||+|+||+..+. .
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~----------------------k 163 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT----------------------K 163 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC----------------------C
Confidence 11467899999999999999999999999999999999999987552 2
Q ss_pred CCCCceeccCCCCccccCCc----------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
....+.++|||+|+...+.. ....||..||+--...|...+.+.|+-|||-+++..|-|..||.+..
T Consensus 164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 34468899999998665433 23679999999999999999999999999999999999999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=219.49 Aligned_cols=232 Identities=22% Similarity=0.326 Sum_probs=159.4
Q ss_pred CCe-EEEeeeecccceeEEEEEecCCCcEEEEEEec----chhh---hhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 92 PRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINK---YREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~----~~~~---~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
..| .....+|.|++|.|+.+......+.++.|..+ .... .......|+-+-..|.|+++....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 45678999999988888887766666666543 2111 111133455555566666642211
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+...++..++.|++.||+|||++||.|||||++|+++...|.+
T Consensus 397 ~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~l----------------- 459 (601)
T KOG0590|consen 397 LQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGIL----------------- 459 (601)
T ss_pred hhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCce-----------------
Confidence 1146667888899999999999999999999999999999887755
Q ss_pred ccCCCCCCCceeccCCCCccccC-------CccceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
||+|||.+..... .....+|+..|+|||++.+..|+ ...||||.|++++.|.+|+.||....
T Consensus 460 ----------ki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 460 ----------KIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred ----------EEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 5555554432211 11235899999999999999998 56899999999999999999996543
Q ss_pred hHHHHH-HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 290 NLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 290 ~~~~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
..+... .+ ........... .......++...+.+|.+
T Consensus 530 ~~~~~~~~~-----------------------------~~~~~~~~~~~-------------~~~~~~~lp~~~~~~~~~ 567 (601)
T KOG0590|consen 530 KSDNSFKTN-----------------------------NYSDQRNIFEG-------------PNRLLSLLPRETRIIIYR 567 (601)
T ss_pred ccccchhhh-----------------------------ccccccccccC-------------hHHHHHhchhhHHHHHHH
Confidence 322110 00 00000000001 111122345678899999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
||++||.+|.|+++|++.+||+..
T Consensus 568 ~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 568 MLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HccCChhheecHHHHhhChHhhhc
Confidence 999999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=178.92 Aligned_cols=177 Identities=25% Similarity=0.344 Sum_probs=141.8
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCC-----------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG----------------- 152 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~----------------- 152 (405)
+.++|.++++||+|+||.+|+|....+|+.||||+-++.. .......|..+...|.+..-..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3478999999999999999999999999999999865432 3445677888887776532100
Q ss_pred -----------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 153 -----------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 153 -----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+.|+..++.-++-|++.-++|+|.+++|||||||+|+|++-.-
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr----------------------- 148 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR----------------------- 148 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-----------------------
Confidence 0135678889999999999999999999999999999999987543
Q ss_pred CCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
....+.|+|||+|+...+. .....||..|.+--...+...+.+.|+-|+|.++..+.-|..||.+....
T Consensus 149 -h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 149 -HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred -ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 2235788999988654332 22368999999988888878889999999999999999999999986544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=207.96 Aligned_cols=225 Identities=22% Similarity=0.329 Sum_probs=154.8
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHhhcCCCCC--------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGT-------------- 153 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~~~~~~~~-------------- 153 (405)
.|...+.||++.|=+|.+|++.+ |. |+||++-+.. ..-.+.+.|++ ...++++|....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 58888999999999999999864 43 8899984322 11233444555 555566665321
Q ss_pred ------ccc------cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 154 ------RYR------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 154 ------~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
+|. -+..-+.+.|+.||+.||.-||..||+|+|||.+||||++-+.+.++||.-.+....+.+
T Consensus 101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD----- 175 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED----- 175 (1431)
T ss_pred HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC-----
Confidence 122 234567888999999999999999999999999999999999999999976554333221
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC----------C-CCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL----------G-WNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
--+||++-....... ..|+|||.+... . .+++.||||+||+++||++ |++||.-
T Consensus 176 ------NPadf~fFFDTSrRR------tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-- 241 (1431)
T KOG1240|consen 176 ------NPADFTFFFDTSRRR------TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-- 241 (1431)
T ss_pred ------CcccceEEEecCCce------eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--
Confidence 235676543322222 259999998642 2 5678999999999999988 7999942
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
.++....+... ..++...+..+ +..+++||..|
T Consensus 242 --SQL~aYr~~~~-------------------------------------------~~~e~~Le~Ie--d~~~Rnlil~M 274 (1431)
T KOG1240|consen 242 --SQLLAYRSGNA-------------------------------------------DDPEQLLEKIE--DVSLRNLILSM 274 (1431)
T ss_pred --HHHHhHhccCc-------------------------------------------cCHHHHHHhCc--CccHHHHHHHH
Confidence 11111110000 00111111111 23689999999
Q ss_pred cccCCCCCCCHHHHHcC
Q 015532 370 LRYDPAERLKAREALRH 386 (405)
Q Consensus 370 L~~dP~~Rpta~elL~h 386 (405)
++.||++|.+|++.|+-
T Consensus 275 i~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 275 IQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HccCchhccCHHHHHHh
Confidence 99999999999999974
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-22 Score=188.64 Aligned_cols=177 Identities=28% Similarity=0.358 Sum_probs=138.3
Q ss_pred CeEEEeeeecccceeEEEEEecCCC-cEEEEEEecchhhh-hHHHHHHHHHHHHHhh----cCC------CC--------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKY-REAAMIEIDVLQRLAR----HDI------GG-------- 152 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~~~-~~~~~~E~~il~~l~~----~~~------~~-------- 152 (405)
+|.+.++||+|+||.||+|.+..++ ..+|+|+....... ...+..|+.++..+.. ..+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998774 67899987653222 2257789999999984 111 10
Q ss_pred ---------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 153 ---------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 153 ---------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+.|+..++..++.|++.+|++||+.|++||||||+|++++..+.
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~------------------ 160 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSR------------------ 160 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCC------------------
Confidence 00256889999999999999999999999999999999999975420
Q ss_pred ccCCCCCCCceeccCCCCc--cc---------cC-C-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCC
Q 015532 218 FKNLPKSSAIKLIDFGSTT--FE---------HQ-D-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~--~~---------~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~p 284 (405)
.....+.|.|||+++ .. .. . ...+.||..|.++.+..+...+.+.|+||++.++.+++.|..|
T Consensus 161 ----~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LP 236 (322)
T KOG1164|consen 161 ----SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLP 236 (322)
T ss_pred ----cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCC
Confidence 012357777777776 21 01 1 1235699999999999999999999999999999999999999
Q ss_pred CCCCChH
Q 015532 285 FQTHENL 291 (405)
Q Consensus 285 f~~~~~~ 291 (405)
|.+....
T Consensus 237 W~~~~~~ 243 (322)
T KOG1164|consen 237 WEALEMT 243 (322)
T ss_pred Ccccccc
Confidence 9776543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=181.31 Aligned_cols=169 Identities=24% Similarity=0.270 Sum_probs=105.8
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhh----------cCC--------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLAR----------HDI-------- 150 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~----------~~~-------- 150 (405)
.+...+.||.|+|+.||.+++..|++.+|||++.... ..-+.+.+|.-....+.+ -.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3567889999999999999999999999999984321 122333333322221111 000
Q ss_pred -CCC-----------cc------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 015532 151 -GGT-----------RY------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 188 (405)
Q Consensus 151 -~~~-----------~~------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlk 188 (405)
.+. .+ ..+.......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 000 00 001112224455899999999999999999999
Q ss_pred CCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC--------
Q 015532 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-------- 260 (405)
Q Consensus 189 p~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-------- 260 (405)
|+|++++.+|.+.++||+.+ ............+..|.+||.....
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~---------------------------~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~ 225 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSL---------------------------VRAGTRYRCSEFPVAFTPPELESCAGQFGQNNA 225 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGE---------------------------EETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred eeeEEEcCCCCEEEcChHHH---------------------------eecCceeeccCCCcccCChhhhhhhcccCcccc
Confidence 99999988886666665532 2211111111335679999987542
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 261 GWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 261 ~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.++.+.|.|+||+++|.|++|..||...
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 4788999999999999999999999754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=190.05 Aligned_cols=164 Identities=18% Similarity=0.196 Sum_probs=110.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecC-CCcEEEEEEecch------hhhhHHHHHHHHHHHHHhhcCCCCCcc-------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRY------- 155 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vAiK~~~~~------~~~~~~~~~E~~il~~l~~~~~~~~~~------- 155 (405)
+.++|.+.+.||+|+||+||+|++.. +++.||||++... ....+.+.+|+++|+.+.|+++....+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L 95 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL 95 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence 45789999999999999999999876 6788899986422 223566889999999999998753110
Q ss_pred -------ccCCH---HHHHHHHHHHHHHHHHHHHCCcEecCC-CCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 156 -------RSFPI---DLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 156 -------~~l~~---~~~~~~~~qi~~aL~~LH~~givHrDl-kp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
..+.. .....++.|++.||.|||++||+|||| ||+|||++.++.++|+|||++......+.
T Consensus 96 VmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~-------- 167 (365)
T PRK09188 96 VRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA-------- 167 (365)
T ss_pred EEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc--------
Confidence 11111 012568899999999999999999999 99999997666555555544332211100
Q ss_pred CCceeccCCCCccccCCccceecCCCcchhHHHhCCC------CCCchhHH
Q 015532 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLW 269 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Diw 269 (405)
.+.. ..........+++.|+|||.+.... .+...|-|
T Consensus 168 -------~~~~-~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 168 -------LYRI-AAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred -------hhhh-hhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 0000 0001113457888899999886421 23446666
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-23 Score=198.30 Aligned_cols=211 Identities=23% Similarity=0.344 Sum_probs=156.8
Q ss_pred eeecccceeEEEEEec---CCCcEEEEEEecchh---hhhHHHHHHHHHHHHHh-hcCCCC-------------------
Q 015532 99 KMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGG------------------- 152 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~-~~~~~~------------------- 152 (405)
.+|+|.||.|++++.. ..+..+|+|+.++.. ..+.....|-.++..++ ++.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 4799999999887543 457789999886422 11223445777777776 333211
Q ss_pred --------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 153 --------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 153 --------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
.....+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++++.|||+
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfgl----------------- 143 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGL----------------- 143 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchh-----------------
Confidence 1134466778888999999999999999999999999999998888665555554
Q ss_pred CCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 015532 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~ 304 (405)
++..-..... +||..|||||++. ++...+|+||+|+++|+|++|..||.+ +...+|.+..-.+
T Consensus 144 ----------ske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~ 206 (612)
T KOG0603|consen 144 ----------SKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM 206 (612)
T ss_pred ----------hhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC
Confidence 4332222222 8999999999998 577889999999999999999999987 5555555443344
Q ss_pred ChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC-----
Q 015532 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK----- 379 (405)
Q Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt----- 379 (405)
|.. .+..+.+++..|+..+|.+|.-
T Consensus 207 p~~--------------------------------------------------l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 207 PRE--------------------------------------------------LSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred chh--------------------------------------------------hhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 433 3557889999999999999984
Q ss_pred HHHHHcCCCCCCCC
Q 015532 380 AREALRHPFFTRDV 393 (405)
Q Consensus 380 a~elL~hp~f~~~~ 393 (405)
+.|+++|+||+.-.
T Consensus 237 ~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 237 VDEIKQHEFFQSID 250 (612)
T ss_pred hHHHhccchheeee
Confidence 58999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=176.77 Aligned_cols=229 Identities=33% Similarity=0.461 Sum_probs=168.4
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcC-CCCCc--------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHD-IGGTR-------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~-~~~~~-------------- 154 (405)
|.+.+.||.|+||.||++.+. ..+|+|.+..... ....+.+|+.++..+.++. +....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 7789999865332 3567888999999999884 52110
Q ss_pred -------------c---ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 -------------Y---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 -------------~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
. ..+....+..++.|++.++.|+|+.|++|||+||+||+++..+.
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~------------------- 139 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR------------------- 139 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-------------------
Confidence 1 15788899999999999999999999999999999999976541
Q ss_pred cCCCCCCCceeccCCCCccccC---------CccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQ---------DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.++++|||.+..... ......||..|++||.+.+ ..+....|+||+|++++++++|..||.
T Consensus 140 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 140 -------VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred -------eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 356666665543222 1244689999999999988 578899999999999999999999987
Q ss_pred CCCh----HHHHHHHHHHhCC-CChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 287 THEN----LEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 287 ~~~~----~~~~~~i~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
.... ......+.....+ ... .... .........
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~----------------------~~~~~~~~~ 250 (384)
T COG0515 213 GEKNSSATSQTLKIILELPTPSLAS--------------------PLSP----------------------SNPELISKA 250 (384)
T ss_pred CCCccccHHHHHHHHHhcCCccccc--------------------ccCc----------------------cccchhhHH
Confidence 7653 2222222221111 000 0000 000112346
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+.+++.+++..+|..|.+..+...++|.....
T Consensus 251 ~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 251 ASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred HHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 78999999999999999999999887776543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-20 Score=168.66 Aligned_cols=150 Identities=24% Similarity=0.329 Sum_probs=107.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccc
Q 015532 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238 (405)
Q Consensus 159 ~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 238 (405)
+.....-++.|+++|+.|||++||.|||+|.+|||+.-+. |.-..+.++|||++-..
T Consensus 339 s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd 395 (598)
T KOG4158|consen 339 SYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------DEIPQLVVADFGCCLAD 395 (598)
T ss_pred chHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecC-----------------------CCCcEEEEcccceeeec
Confidence 4456677899999999999999999999999999996542 23445788888876332
Q ss_pred cC---------CccceecCCCcchhHHHhCCC-----CC-CchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHh
Q 015532 239 HQ---------DHSYVVSTRHYRAPEVILGLG-----WN-YPCDLWSVGCILVELCSGEALFQTHENLEH--LAMMERVL 301 (405)
Q Consensus 239 ~~---------~~~~~~gt~~y~aPE~~~~~~-----~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~--~~~i~~~~ 301 (405)
+. .....-|.-..||||+....+ .+ .++|.|+.|.+.||+++...||.+...... -..-+..+
T Consensus 396 ~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL 475 (598)
T KOG4158|consen 396 DNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL 475 (598)
T ss_pred cccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC
Confidence 21 112235788899999987532 12 579999999999999999999987332110 00001111
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
. ..++.+++.+++|+..+|+.||.+|+++.
T Consensus 476 P--------------------------------------------------alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 476 P--------------------------------------------------ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred C--------------------------------------------------CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1 12345677899999999999999999853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=177.31 Aligned_cols=157 Identities=30% Similarity=0.472 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCcccc
Q 015532 160 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239 (405)
Q Consensus 160 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 239 (405)
....+.++.|+..|++| +|.+|||+||.||++..+..+||.|||++....... ......
T Consensus 358 ~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~------------------~~~~~~ 416 (516)
T KOG1033|consen 358 LSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDE------------------TVAPAA 416 (516)
T ss_pred hhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCC------------------cccchh
Confidence 34566788999999999 999999999999998777666666666543322111 000001
Q ss_pred CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH-HhCCCChHHHHHhhHhhH
Q 015532 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLEHLAMMER-VLGPLPHHMVIRADRRAE 317 (405)
Q Consensus 240 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~-~~g~~p~~~~~~~~~~~~ 317 (405)
...+.-+||..||+||.+.+..|+.++||||||++++||+.- ...| +....+.. .-|.+|+.++
T Consensus 417 a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~r~g~ip~~~~-------- 482 (516)
T KOG1033|consen 417 ASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDIRDGIIPPEFL-------- 482 (516)
T ss_pred hhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhhhcCCCChHHh--------
Confidence 122335899999999999999999999999999999999862 2222 11111111 0122222111
Q ss_pred HhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCC
Q 015532 318 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
.+ .+.-.+|+.+||...|.+||++.+.--|+|.+
T Consensus 483 --------------------------------------~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 483 --------------------------------------QD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred --------------------------------------hc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 11 12445899999999999999888888888753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=158.06 Aligned_cols=153 Identities=10% Similarity=0.114 Sum_probs=107.1
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhh----------HHHHHHHHHHHHHhhcCCCCCcc--
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----------EAAMIEIDVLQRLARHDIGGTRY-- 155 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~----------~~~~~E~~il~~l~~~~~~~~~~-- 155 (405)
+-+.++|++++.||.|+||.||++.+ ++..+|||+++...... +.+.+|++.+.++.|+++.....
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34678999999999999999999765 36679999996432211 12578999999999988632110
Q ss_pred ---------------------ccCCHHHH----HHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 156 ---------------------RSFPIDLV----RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 156 ---------------------~~l~~~~~----~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+.... .....+++.+|..||+.|++|||+||+||+++.+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g------------ 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG------------ 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC------------
Confidence 00111111 23567999999999999999999999999997543
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHH
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll 279 (405)
++|+|||.......... .-.++....|+.++|+||||+++..+.
T Consensus 173 ----------------i~liDfg~~~~~~e~~a---------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 ----------------LRIIDLSGKRCTAQRKA---------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ----------------EEEEECCCcccccchhh---------HHHHHHHhHhcccccccceeEeehHHH
Confidence 67777776654322111 111344556778999999999877653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=151.63 Aligned_cols=98 Identities=26% Similarity=0.258 Sum_probs=77.1
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhh---h------------------------hHHHHHHHHHHHHHhhcC
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---Y------------------------REAAMIEIDVLQRLARHD 149 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~------------------------~~~~~~E~~il~~l~~~~ 149 (405)
.+.||+|+||.||+|.+. +|+.||||+++.... . ......|++++.++.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 899999999964311 0 112235999999998754
Q ss_pred CCC------------------C-------ccccCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCCCCcEEEe
Q 015532 150 IGG------------------T-------RYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILLV 195 (405)
Q Consensus 150 ~~~------------------~-------~~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrDlkp~NIli~ 195 (405)
+.. . ....+++..+..++.|++.+|.|+ |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~ 152 (190)
T cd05147 81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence 311 0 023467788999999999999999 699999999999999996
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=146.80 Aligned_cols=165 Identities=15% Similarity=0.060 Sum_probs=113.9
Q ss_pred EEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhH-----HHHHHHHHHHHHhhcCCCCC----------------
Q 015532 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE-----AAMIEIDVLQRLARHDIGGT---------------- 153 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~-----~~~~E~~il~~l~~~~~~~~---------------- 153 (405)
.+...|++|+||+||++.. .+..++.+.+........ .+.+|+++|++|.|+.....
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence 3567899999999998775 567788777765443222 57789999999976432111
Q ss_pred --ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCC-CCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceec
Q 015532 154 --RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 230 (405)
Q Consensus 154 --~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl-kp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~ 230 (405)
+....+. ....++.|++.+|.++|++||+|||| ||+|||++.+|. ++|+
T Consensus 83 ~~L~~~~~~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~---------------------------i~LI 134 (218)
T PRK12274 83 AAMYQRPPR-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS---------------------------PAVI 134 (218)
T ss_pred ccHHhhhhh-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC---------------------------EEEE
Confidence 1111111 22457889999999999999999999 799999976664 4555
Q ss_pred cCCCCccccCCcc----------------ceecCCCcchhHHHhCC-CCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 231 DFGSTTFEHQDHS----------------YVVSTRHYRAPEVILGL-GWN-YPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 231 Dfg~a~~~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
|||++........ ....++.|++|+...-. ..+ ...++++.|+-+|.++|+..++.++.
T Consensus 135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 5555543222110 02357889999865433 233 55678899999999999998876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=148.73 Aligned_cols=100 Identities=22% Similarity=0.184 Sum_probs=78.6
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhh---------------------------hhHHHHHHHHHHHHHhhcC
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQRLARHD 149 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------------------------~~~~~~~E~~il~~l~~~~ 149 (405)
.+.||+|+||.||+|++. +|+.||||+++.... .......|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999864311 0122357889999998876
Q ss_pred CCCC-------------------------ccccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEeccc
Q 015532 150 IGGT-------------------------RYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 150 ~~~~-------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~ 198 (405)
+... ....++...+..++.|++.+|.++|+ +||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 5210 01235667888999999999999999 9999999999999996 44
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=175.93 Aligned_cols=170 Identities=26% Similarity=0.439 Sum_probs=125.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh--------h-------cC--C-C-
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA--------R-------HD--I-G- 151 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~--------~-------~~--~-~- 151 (405)
...|.|.+.||+|+||+||+|.+.. |+.||||+-+....+. +..=.+++.+|. | ++ + +
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 4579999999999999999999976 9999999865432211 111111222221 1 00 0 0
Q ss_pred -----C------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 152 -----G------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 152 -----~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
+ .....+++..++.++.|++.-+++||.++|||+||||+|+||...- ..|
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~---~~~---------------- 834 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREI---CAD---------------- 834 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeeccc---CCC----------------
Confidence 0 1235678899999999999999999999999999999999996431 111
Q ss_pred CCCCCCceeccCCCCccc---cCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 221 LPKSSAIKLIDFGSTTFE---HQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~---~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
+.+.-++|+|||.+... .+.. ...++|-.+-++|+..|.++++.+|.|.|+.+++.||.|+.
T Consensus 835 -~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 835 -SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 12456899999988432 2221 23578899999999999999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=142.94 Aligned_cols=102 Identities=25% Similarity=0.181 Sum_probs=79.3
Q ss_pred eEEEeeeecccceeEEEEE-ecCCCcEEEEEEecchhh-------------------------hhHHHHHHHHHHHHHhh
Q 015532 94 YRILSKMGEGTFGQVVECF-DNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLAR 147 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~-~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~E~~il~~l~~ 147 (405)
|.+.+.||+|+||.||+|. +..+|+.||||+++.... ....+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8899999999999999999 667899999999864311 11234579999999986
Q ss_pred cCCC------------------CC-------ccccCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCCCcEEEe
Q 015532 148 HDIG------------------GT-------RYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENILLV 195 (405)
Q Consensus 148 ~~~~------------------~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIli~ 195 (405)
..+. +. ....+....+..++.||+.+|.+||++| |+||||||+||+++
T Consensus 110 ~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 4321 00 0112344456789999999999999999 99999999999996
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=132.64 Aligned_cols=96 Identities=25% Similarity=0.325 Sum_probs=70.7
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHh-----hcCCCCCc------------c---
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLA-----RHDIGGTR------------Y--- 155 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~-----~~~~~~~~------------~--- 155 (405)
.+.||+|+||.||. +..++.. +||++... ....+...+|+.+++.+. |++|.... +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999995 6666665 69988643 224566889999999995 47663211 0
Q ss_pred -----------------ccCCHHHHHHHHHHHHHHH-HHHHHCCcEecCCCCCcEEEecc
Q 015532 156 -----------------RSFPIDLVRELGRQLLESV-AFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 156 -----------------~~l~~~~~~~~~~qi~~aL-~~LH~~givHrDlkp~NIli~~~ 197 (405)
..+++. ..++.|++.++ +|||+++|+||||||+|||++..
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~ 141 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRI 141 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEecc
Confidence 012222 34578888888 99999999999999999999753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.7e-16 Score=136.97 Aligned_cols=212 Identities=17% Similarity=0.187 Sum_probs=147.6
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
..++-+|.+...|..|+|++. |..+++|+++..+ .....|..|.-.|+-+.|||+...+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 456778999999999999986 3446678875322 2334577788888888998873221
Q ss_pred -----c--------ccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 -----Y--------RSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 -----~--------~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
| -.....++.+++.+|+.|+.|||+.. |..--|....++|+.+-+.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta------------------- 330 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA------------------- 330 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh-------------------
Confidence 1 12345688999999999999999853 4444678888998765332
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+.++|--++.... ...-.+.||+||.++..+-+ .++|+|||++++|||.|.+.||...++.+.-.+
T Consensus 331 ------rismad~kfsfqe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk 400 (448)
T KOG0195|consen 331 ------RISMADTKFSFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK 400 (448)
T ss_pred ------heecccceeeeecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence 23333422221111 11346789999999887543 679999999999999999999998877665443
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
|.- .|.+. ..+..++.....|+.-|+.-||.+
T Consensus 401 ial----------------------eglrv--------------------------~ippgis~hm~klm~icmnedpgk 432 (448)
T KOG0195|consen 401 IAL----------------------EGLRV--------------------------HIPPGISRHMNKLMNICMNEDPGK 432 (448)
T ss_pred hhh----------------------ccccc--------------------------cCCCCccHHHHHHHHHHhcCCCCc
Confidence 311 11111 123455778889999999999999
Q ss_pred CCCHHHHH
Q 015532 377 RLKAREAL 384 (405)
Q Consensus 377 Rpta~elL 384 (405)
||..+.++
T Consensus 433 rpkfdmiv 440 (448)
T KOG0195|consen 433 RPKFDMIV 440 (448)
T ss_pred CCCcceeh
Confidence 99887654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=132.34 Aligned_cols=104 Identities=24% Similarity=0.216 Sum_probs=78.0
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-----------------------hhhHHHHHHHHHHHHHhhcCC
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------------------~~~~~~~~E~~il~~l~~~~~ 150 (405)
|.+.+.||+|+||.||+|... +|+.||||+++... ........|+.++..+.+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999874 78999999875321 011235678999999977643
Q ss_pred CC------------------CccccCCH-HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 151 GG------------------TRYRSFPI-DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 151 ~~------------------~~~~~l~~-~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
.. .....+.. .....++.+++.++.++|+.||+||||||+||+++.++
T Consensus 96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 10 00011122 45667899999999999999999999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-14 Score=126.16 Aligned_cols=100 Identities=29% Similarity=0.300 Sum_probs=71.6
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhh---hH----------------------HHHHHHHHHHHHhhcCCC
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---RE----------------------AAMIEIDVLQRLARHDIG 151 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~----------------------~~~~E~~il~~l~~~~~~ 151 (405)
.+.||+|+||+||+|.+. +++.||||+++..... .. ....|...+..+.+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 7889999998642210 11 113566677776655321
Q ss_pred C-----------------------CccccCCH-HHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEeccc
Q 015532 152 G-----------------------TRYRSFPI-DLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 152 ~-----------------------~~~~~l~~-~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~ 198 (405)
. ........ ..+..++.+++.++.++|. +||+||||||+||+++ ++
T Consensus 81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 0 00011111 5678899999999999999 9999999999999997 44
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.5e-16 Score=157.51 Aligned_cols=229 Identities=21% Similarity=0.318 Sum_probs=160.1
Q ss_pred CCeEEEeeeecccceeEEEEEecC-CCcEEEEEEecchh---hhhHHHHHHHHHHHHHh-hcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~-~~~~~~~~------------ 154 (405)
..|.+.+.||+|+|+.|-.+.... ....+|+|.+.... ...+....|..+-+.+. |.++....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 347888889999999998887643 34567777764332 22233334666666666 66552211
Q ss_pred ----------------c-ccCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ----------------Y-RSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ----------------~-~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
. ...+...+..++.|+..+|.|+| ..++.||||||+|.+++..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~----------------- 162 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS----------------- 162 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-----------------
Confidence 1 13456678899999999999999 999999999999999877650
Q ss_pred cccCCCCCCCceeccCCCCccccC-Cc-----cceec-CCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQ-DH-----SYVVS-TRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~-~~-----~~~~g-t~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.++++|||+|..... .. ...+| ++.|+|||...+.. .....|+||+|+++..+++|..|+...
T Consensus 163 ---------~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 163 ---------ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred ---------cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 355666665544333 11 12468 99999999998854 457899999999999999999998654
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
...+.. ...|.... .......+...+....+++.+
T Consensus 234 ~~~~~~------------------------------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~k 268 (601)
T KOG0590|consen 234 SRKDGR------------------------------YSSWKSNK---------------GRFTQLPWNSISDQAHDLLHK 268 (601)
T ss_pred cccccc------------------------------ceeecccc---------------cccccCccccCChhhhhcccc
Confidence 332200 00011000 000112234556788899999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
+|..+|+.|.+.+++..++|+..
T Consensus 269 ~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 269 ILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCCchhccccccccccccccc
Confidence 99999999999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=140.00 Aligned_cols=232 Identities=22% Similarity=0.289 Sum_probs=160.8
Q ss_pred cCCCeEEEeeeec--ccceeEEEEEe--cCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCC-C----------
Q 015532 90 LTPRYRILSKMGE--GTFGQVVECFD--NEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDI-G---------- 151 (405)
Q Consensus 90 ~~~~y~~~~~LG~--G~fg~V~~a~~--~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~-~---------- 151 (405)
+..++.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.- ......-.+|+.-.+++..+.. .
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4567888999999 99999999998 888999999973211 1111222334433333322211 0
Q ss_pred -----------------CCccccCCHHHHHHHHHHHHH----HHHHHHHCCcEecCCCCCcEEEecc-cccccCCccccc
Q 015532 152 -----------------GTRYRSFPIDLVRELGRQLLE----SVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLS 209 (405)
Q Consensus 152 -----------------~~~~~~l~~~~~~~~~~qi~~----aL~~LH~~givHrDlkp~NIli~~~-~~~k~~df~~~~ 209 (405)
......++...++..+.+... ||.++|+.+|+|-|+||+||++..+ ..++++||+++.
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 011234678888999999999 9999999999999999999999988 888888888753
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH- 288 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~- 288 (405)
+|.|.+++...... ....|...|++||++.+ -++...||+|+|.++.+..++..++...
T Consensus 272 ------------------~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 272 ------------------KISDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred ------------------EccCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 33444333322211 11246667999999876 6789999999999999999988776543
Q ss_pred -ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 289 -ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 289 -~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
+....+.++. +| .+..+..+.++...+.
T Consensus 332 ~~~W~~~r~~~-----ip----------------------------------------------~e~~~~~s~~l~~~~~ 360 (524)
T KOG0601|consen 332 NSSWSQLRQGY-----IP----------------------------------------------LEFCEGGSSSLRSVTS 360 (524)
T ss_pred CCCcccccccc-----Cc----------------------------------------------hhhhcCcchhhhhHHH
Confidence 2222111100 11 1122233456667999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
.|++.+|-.|++++.+++|+++...
T Consensus 361 ~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 361 QMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred HhcCcchhhhhHHHHHhccccccch
Confidence 9999999999999999999999753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-13 Score=122.64 Aligned_cols=96 Identities=19% Similarity=0.123 Sum_probs=72.0
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.||+|++|.||+|.+ .+..|+||+..... .....+.+|+.++..+.++++....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 56679999864311 1224567899999999887652211
Q ss_pred ---cccCCH------HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 155 ---YRSFPI------DLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 155 ---~~~l~~------~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
...+.. .....++.+++.+|.++|+.|++|+|++|+|||++
T Consensus 80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS 129 (211)
T ss_pred EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence 001110 14568899999999999999999999999999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.3e-13 Score=119.97 Aligned_cols=95 Identities=19% Similarity=0.135 Sum_probs=69.6
Q ss_pred eeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.||+|+||.||+|.. ++..|++|+..... ...+.+.+|++++..+.++++....
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 46779999864211 1124566899999999887642110
Q ss_pred --cccCCHHHHH---HHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 155 --YRSFPIDLVR---ELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 155 --~~~l~~~~~~---~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
...+...... .++.|++.+|.+||+.|++|+|++|+||+++
T Consensus 79 ~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 79 IEGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124 (199)
T ss_pred ECCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence 1111111111 7899999999999999999999999999996
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.2e-13 Score=136.87 Aligned_cols=110 Identities=19% Similarity=0.132 Sum_probs=77.7
Q ss_pred EeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEe-cch--------hhhhHHHHHHHHHHHHHhhcCCCCCc
Q 015532 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-RSI--------NKYREAAMIEIDVLQRLARHDIGGTR 154 (405)
Q Consensus 84 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~-~~~--------~~~~~~~~~E~~il~~l~~~~~~~~~ 154 (405)
....+.....|...+.||+|+||+||++.+.... +++|+. .+. ....+.+.+|+++++.+.++++....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3334444566778899999999999999875443 444432 110 01235577899999999998764311
Q ss_pred -----------------cccCCHH--HHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 155 -----------------YRSFPID--LVRELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 155 -----------------~~~l~~~--~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
...+... ....++.|++.+|.+||++||+||||||+|||++
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~ 462 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE
Confidence 1112221 2567889999999999999999999999999993
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-13 Score=140.63 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=169.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHH----HHHHHHHHHHHhhcCCCC---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHDIGG--------------- 152 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~----~~~E~~il~~l~~~~~~~--------------- 152 (405)
+.+.+.+-+-+|.++.++.+.-..++...++|+.....+.... ...+-+++-...++....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 4577888999999999999988888877777766543332211 111222222111111110
Q ss_pred C------c------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC-CCCccc
Q 015532 153 T------R------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK-DGSYFK 219 (405)
Q Consensus 153 ~------~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~-~~~~~~ 219 (405)
. + .+..+.+-++.++..+..+++|||...+.|||++|.|+++...|+.+++||+....... +.....
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 0 0 01234556667788899999999999999999999999999999999999985443221 111000
Q ss_pred CCCCCCCceeccCCCCccc---cC----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFE---HQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~---~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
. .....+..-+++..... .. .....+||+.|.+||.+.+......+|+|++|+++++.++|.+||......+
T Consensus 964 s-g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 964 S-GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred c-cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 00001111122211110 00 1122579999999999999999999999999999999999999998877766
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..|... ...|+.. ....+..+++++...|..
T Consensus 1043 ~f~ni~~~------------------------~~~~p~g-----------------------~~~~s~~aq~~~~~ll~~ 1075 (1205)
T KOG0606|consen 1043 IFENILNR------------------------DIPWPEG-----------------------PEEGSYEAQDLINRLLTE 1075 (1205)
T ss_pred hhhccccC------------------------CCCCCCC-----------------------ccccChhhhhhhhhhhcc
Confidence 55443221 2334331 234466889999999999
Q ss_pred CCCCCCCHH---HHHcCCCCCCCCCC
Q 015532 373 DPAERLKAR---EALRHPFFTRDVRR 395 (405)
Q Consensus 373 dP~~Rpta~---elL~hp~f~~~~~~ 395 (405)
+|.+|..+. ++-.|+||+...+.
T Consensus 1076 ~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1076 EPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CchhccCcccccccccCCccCCCCcc
Confidence 999999887 88899999987543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-12 Score=127.30 Aligned_cols=159 Identities=21% Similarity=0.307 Sum_probs=106.4
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCc-EecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCC
Q 015532 157 SFPIDLVRELGRQLLESVAFMHELRL-IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235 (405)
Q Consensus 157 ~l~~~~~~~~~~qi~~aL~~LH~~gi-vHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 235 (405)
.+++.....++++|+.||.|||...| .|+.++..|++++.. +.+||.|||+.
T Consensus 44 ~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~---------------------------w~lklt~~Gl~ 96 (484)
T KOG1023|consen 44 KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSR---------------------------WVLKLTDFGLN 96 (484)
T ss_pred CccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeee---------------------------EEEEechhhhc
Confidence 45566677889999999999997655 999999999999764 45666666665
Q ss_pred ccccC-----CccceecCCCcchhHHHhCCC-------CCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 015532 236 TFEHQ-----DHSYVVSTRHYRAPEVILGLG-------WNYPCDLWSVGCILVELCSGEALFQTHEN----LEHLAMMER 299 (405)
Q Consensus 236 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~ 299 (405)
..... ......-..-|.|||.+.+.. .+.+.||||+|++++|+++...||..... .+.+..+..
T Consensus 97 ~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 97 SLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred ccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence 44421 111112334689999998742 35679999999999999999999975322 222222222
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.+..+. .|.... .....+++..++.+|+..+|++||+
T Consensus 177 -~~~~~~----------------------------------------rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 177 -GGSNPF----------------------------------------RPSIEL--LNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred -cCCCCc----------------------------------------Ccchhh--hhhcchHHHHHHHHhcccChhhCcc
Confidence 010000 000000 0122347889999999999999999
Q ss_pred HHHHHc
Q 015532 380 AREALR 385 (405)
Q Consensus 380 a~elL~ 385 (405)
++++-.
T Consensus 214 ~~~i~~ 219 (484)
T KOG1023|consen 214 IEQIRS 219 (484)
T ss_pred HHHHHh
Confidence 988753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=112.27 Aligned_cols=112 Identities=21% Similarity=0.175 Sum_probs=77.9
Q ss_pred eeee-cccceeEEEEEecCCCcEEEEEEecchh--------------hhhHHHHHHHHHHHHHhhcCCCC----------
Q 015532 98 SKMG-EGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRLARHDIGG---------- 152 (405)
Q Consensus 98 ~~LG-~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------------~~~~~~~~E~~il~~l~~~~~~~---------- 152 (405)
..|| .|+.|+||.+... +..++||.++... .....+.+|++++..|.+.++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888889888764 6678999874311 12345678999999999876410
Q ss_pred --Ccc----------ccCCHHH-------HHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 153 --TRY----------RSFPIDL-------VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 153 --~~~----------~~l~~~~-------~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
..+ +.-+... ....+.||+.+|.+||++||+||||||+|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--------------- 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDG--------------- 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---------------
Confidence 000 0001111 123467899999999999999999999999996533
Q ss_pred CCCcccCCCCCCCceeccCCCCccc
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFE 238 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~ 238 (405)
.++|+|||.+...
T Consensus 180 ------------~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 ------------KFWLIDFDRGELR 192 (239)
T ss_pred ------------CEEEEECCCcccC
Confidence 5788888877653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.6e-11 Score=102.45 Aligned_cols=100 Identities=27% Similarity=0.300 Sum_probs=76.4
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc--CCCCC---------c----------
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--DIGGT---------R---------- 154 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~--~~~~~---------~---------- 154 (405)
+++.||+|.++.||++.... ..++||+...... ...+..|+.+++.+.+. .+... .
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 6799999865433 45688899999999885 22110 0
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEEeccc
Q 015532 155 -YRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 -~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIli~~~~ 198 (405)
...++......++.+++.+|.++|.. +++|+|++|+||+++..+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~ 126 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence 01113366778899999999999984 799999999999997544
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-11 Score=121.63 Aligned_cols=236 Identities=19% Similarity=0.224 Sum_probs=145.2
Q ss_pred CCccCCCeEEEeeeecccc---eeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCccccCCHHHH
Q 015532 87 GENLTPRYRILSKMGEGTF---GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRYRSFPIDLV 163 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~f---g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~~~~l~~~~~ 163 (405)
+....++|++.+.+|..+- +.+|.++....+.....|-. .....+ ....-++++.|-.- -...-+..
T Consensus 32 ~~~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~-~~~~ld----~~~~~~~~lr~~~~-----vs~aTe~~ 101 (700)
T KOG2137|consen 32 GPKESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSA-VVWMLD----KRASSLQQLRGLDG-----VSKATEDG 101 (700)
T ss_pred CcccccccccccceeecCCCchhhhhhhhccCccCcccccee-eeeecC----hhhhHHHHHhcccc-----hhhcccHh
Confidence 3344567888887776554 45666665555443311111 000001 11223344444111 01111222
Q ss_pred HHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc
Q 015532 164 RELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242 (405)
Q Consensus 164 ~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~ 242 (405)
..=+.+++.||.|+|. .++||+.|.|++|.++..|.+|++.|+++.....+. +.....-|+++....
T Consensus 102 f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~--------~~p~~~yd~~lp~~~---- 169 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPT--------EYPFSEYDPPLPLLL---- 169 (700)
T ss_pred hhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCC--------ccccccCCCCCChhh----
Confidence 2233456699999994 699999999999999999999999998765443221 122333444433222
Q ss_pred cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhh
Q 015532 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 321 (405)
Q Consensus 243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~ 321 (405)
.-...|.|||++.+...+.++|++|+||++|.+. .|+..+.......... .....+.
T Consensus 170 ---~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~------------------ 227 (700)
T KOG2137|consen 170 ---QPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLN------------------ 227 (700)
T ss_pred ---ccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccc------------------
Confidence 2345799999999988889999999999999998 5666665443221111 1000000
Q ss_pred cCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 322 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.........++.++++=|.++|..|+..||++.+++..|||++..
T Consensus 228 ---------------------------~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 228 ---------------------------AGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred ---------------------------cccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 000111245677899999999999999999999999999999864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.5e-10 Score=95.56 Aligned_cols=97 Identities=18% Similarity=0.070 Sum_probs=70.4
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------cccCC-
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------YRSFP- 159 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------~~~l~- 159 (405)
++.|+.|.++.||+++.. ++.|++|+.............|+.+++.+.+..+.... ...+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 467899999999999864 67799998755432233467899999998775542111 01111
Q ss_pred -HHHHHHHHHHHHHHHHHHHHCCc-----EecCCCCCcEEEe
Q 015532 160 -IDLVRELGRQLLESVAFMHELRL-----IHTDLKPENILLV 195 (405)
Q Consensus 160 -~~~~~~~~~qi~~aL~~LH~~gi-----vHrDlkp~NIli~ 195 (405)
......++.+++.+|..||+.++ +|+|++|.||+++
T Consensus 81 ~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~ 122 (170)
T cd05151 81 EDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD 122 (170)
T ss_pred ccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence 11234567899999999999885 9999999999996
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-10 Score=111.98 Aligned_cols=223 Identities=22% Similarity=0.201 Sum_probs=144.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEec-CCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhh-cCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~-~~~~~~~---------- 154 (405)
...+|..+..||.|.|+.|+.+... .++..|++|.+.+.- ......+.|+.+...+.. .+..+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567899999999999999998765 677889999775321 122223345555544433 2222210
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+.+...+.+..|++.++.++|+..++|+|+||+||++..+|
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~------------------- 403 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG------------------- 403 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-------------------
Confidence 11245567788899999999999999999999999999997752
Q ss_pred ccCCCCCCCceeccCCCCccccCCcccee-cCCCc-chhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVV-STRHY-RAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
...++.|||......-...... ++..| .+++......+..+.|++|||..+.+.+++...-........
T Consensus 404 -------~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-- 474 (524)
T KOG0601|consen 404 -------FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-- 474 (524)
T ss_pred -------hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee--
Confidence 1235555555542111111122 23334 355555556788999999999999999998765432221110
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
+.+ |. .........++..+...|+..|+.
T Consensus 475 -i~~--~~------------------------------------------------~p~~~~~~~~~q~~~kv~~~~~~~ 503 (524)
T KOG0601|consen 475 -IRS--GD------------------------------------------------TPNLPGLKLQLQVLLKVMINPDRK 503 (524)
T ss_pred -eec--cc------------------------------------------------ccCCCchHHhhhhhhhhhcCCccc
Confidence 000 00 000112235778899999999999
Q ss_pred CCCCHHHHHcCCCCCC
Q 015532 376 ERLKAREALRHPFFTR 391 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~ 391 (405)
.|+.+.++..|.=|-.
T Consensus 504 ~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 504 RRPSAVELSLHSEFYR 519 (524)
T ss_pred cchhhhhhcccchhhh
Confidence 9999999998876654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.6e-09 Score=94.20 Aligned_cols=98 Identities=21% Similarity=0.261 Sum_probs=70.8
Q ss_pred eeeecccceeEEEEEecC------CCcEEEEEEecch-----------------------hhhhHH----HHHHHHHHHH
Q 015532 98 SKMGEGTFGQVVECFDNE------KKELVAIKIVRSI-----------------------NKYREA----AMIEIDVLQR 144 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~------~~~~vAiK~~~~~-----------------------~~~~~~----~~~E~~il~~ 144 (405)
..||.|-=+.||.|.... .+..+|||+.+.. ...+.. ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998653 3578999987420 011222 2379999999
Q ss_pred HhhcCCC-----------------CC------c--cccCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCCCCcEEEe
Q 015532 145 LARHDIG-----------------GT------R--YRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILLV 195 (405)
Q Consensus 145 l~~~~~~-----------------~~------~--~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrDlkp~NIli~ 195 (405)
+....+. +. . ...+++.....+..|++.+|..| |+.||||+||++.|||+.
T Consensus 83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~ 159 (197)
T cd05146 83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH 159 (197)
T ss_pred HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE
Confidence 8876431 10 0 01234456677889999999998 899999999999999995
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.2e-09 Score=105.67 Aligned_cols=37 Identities=22% Similarity=0.378 Sum_probs=28.9
Q ss_pred HHHHHHHHH-HHHHHHHCCcEecCCCCCcEEEeccccc
Q 015532 164 RELGRQLLE-SVAFMHELRLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 164 ~~~~~qi~~-aL~~LH~~givHrDlkp~NIli~~~~~~ 200 (405)
..++.+++. .+..+|..|++|+|+||.||++..+|.+
T Consensus 259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i 296 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKI 296 (437)
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcE
Confidence 345666665 4788999999999999999999765543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.93 E-value=2e-09 Score=107.49 Aligned_cols=34 Identities=18% Similarity=0.287 Sum_probs=30.0
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecc
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~ 127 (405)
.|.. +.||+|++|.||+|+.+.+|+.||||+++.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP 154 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRP 154 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCc
Confidence 4665 789999999999999988899999999863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1e-08 Score=101.42 Aligned_cols=160 Identities=18% Similarity=0.278 Sum_probs=108.8
Q ss_pred eEEEeeeecccceeEE-EEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCcc----------------
Q 015532 94 YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRY---------------- 155 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~-~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~~---------------- 155 (405)
|.+ ....-++.+ +| .|..+.++.+|.|...+.... ..+...+-++-|+.|+||+|...+.
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR 92 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence 444 334444444 34 466677888899998865443 3345667889999999999955431
Q ss_pred ------ccCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 156 ------RSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 156 ------~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
..+....+..-+.||+.||.||| +++++|++|.-+.|+++..|.+||.+|.++....
T Consensus 93 Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~---------------- 156 (690)
T KOG1243|consen 93 PLETVLKELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS---------------- 156 (690)
T ss_pred cHHHHHHHhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc----------------
Confidence 12334556667899999999998 6799999999999999999999888887643221
Q ss_pred eccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 229 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
+|+- ......--..|..|+.+.... ...|.|-|||++++++.|
T Consensus 157 --~~~~------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 --GFNA------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cCCc------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1111 000111122356676554333 457999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-09 Score=95.56 Aligned_cols=164 Identities=18% Similarity=0.206 Sum_probs=103.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCC
Q 015532 158 FPIDLVRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235 (405)
Q Consensus 158 l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 235 (405)
+.....++++.||+.||.|||+. -|+|+++..+-|++..+|.+|+.--.... -...++.++
T Consensus 173 ~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-------------~h~s~~~~~---- 235 (458)
T KOG1266|consen 173 LFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-------------THPSVNSTR---- 235 (458)
T ss_pred hhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc-------------cchhhhhhh----
Confidence 45566778999999999999987 59999999999999887765542110000 000000000
Q ss_pred ccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChHHHHHhhH
Q 015532 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL-FQTHENLEHLAMMERVLGPLPHHMVIRADR 314 (405)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~ 314 (405)
......-.+-++|.|||.-.....+.++|||++|....+|..+..- -.+.+....-..+....-.+
T Consensus 236 ---~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---------- 302 (458)
T KOG1266|consen 236 ---EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---------- 302 (458)
T ss_pred ---HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec----------
Confidence 0011112466789999876555677899999999999999877643 21211111111111110000
Q ss_pred hhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 315 RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
...--++++.+||+-.|..||+|.++|.||-+-.-+.
T Consensus 303 -------------------------------------------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 303 -------------------------------------------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred -------------------------------------------cCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 0011247899999999999999999999998766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-07 Score=88.31 Aligned_cols=109 Identities=18% Similarity=0.302 Sum_probs=83.9
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCC
Q 015532 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234 (405)
Q Consensus 155 ~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 234 (405)
+..+.|....+.++.|+.+..-||.+|.+-+|+.++|+|+++++.+.+.|-. ...|++-|.
T Consensus 111 ~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD-------------------sfqi~~ng~ 171 (637)
T COG4248 111 YPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD-------------------SFQINANGT 171 (637)
T ss_pred CCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc-------------------ceeeccCCc
Confidence 4567789999999999999999999999999999999999988776665521 122222221
Q ss_pred CccccCCccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCC
Q 015532 235 TTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG-EALFQTH 288 (405)
Q Consensus 235 a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg-~~pf~~~ 288 (405)
- ....+|...|.+||.-. +..-+...|.|.||+++|+++.| ++||.+.
T Consensus 172 ~------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 172 L------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred e------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 1 11237888999999764 33456789999999999999986 9999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4e-07 Score=76.71 Aligned_cols=117 Identities=25% Similarity=0.222 Sum_probs=83.2
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEec-c--------hhhhhHHHHHHHHHHHHHhhcCCCCC-----------c-
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR-S--------INKYREAAMIEIDVLQRLARHDIGGT-----------R- 154 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~-~--------~~~~~~~~~~E~~il~~l~~~~~~~~-----------~- 154 (405)
.+..|-+|+-+.|+++.+. |+.+.||.-- + ..-.+....+|+.+|.++..-.|..- .
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999874 7777788421 1 11234556789999998876544110 0
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...........++++|-..+.-||.++|||+||..+||++.++|
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~------------------ 150 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG------------------ 150 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC------------------
Confidence 01111222367888999999999999999999999999998765
Q ss_pred cccCCCCCCCceeccCCCCccc
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFE 238 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~ 238 (405)
....+.++|||++...
T Consensus 151 ------~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 151 ------NQITPILIDFGLSSVS 166 (229)
T ss_pred ------CcCceEEEeecchhcc
Confidence 3445689999987543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.3e-07 Score=76.78 Aligned_cols=112 Identities=21% Similarity=0.194 Sum_probs=74.9
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEe-cc--------hhhhhHHHHHHHHHHHHHhhcCCCCCc------------cc
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIV-RS--------INKYREAAMIEIDVLQRLARHDIGGTR------------YR 156 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~-~~--------~~~~~~~~~~E~~il~~l~~~~~~~~~------------~~ 156 (405)
..+++|+=+.+|.+... |..+.+|.= .+ ..-..+...+|..++.++..-.+..-. ..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999998653 444666642 11 112345667899999998775442110 00
Q ss_pred cCCHHH--------HHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 157 SFPIDL--------VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 157 ~l~~~~--------~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
.+.-.. ...++..+-.-+.-||..||||+||.++||++... .+.
T Consensus 80 ~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----------------------------~i~ 131 (204)
T COG3642 80 YIEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----------------------------RIY 131 (204)
T ss_pred EeCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----------------------------cEE
Confidence 111111 23467777788889999999999999999998653 378
Q ss_pred eccCCCCcccc
Q 015532 229 LIDFGSTTFEH 239 (405)
Q Consensus 229 l~Dfg~a~~~~ 239 (405)
++|||++....
T Consensus 132 ~IDfGLg~~s~ 142 (204)
T COG3642 132 FIDFGLGEFSD 142 (204)
T ss_pred EEECCcccccc
Confidence 89999886543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=8e-07 Score=76.98 Aligned_cols=90 Identities=30% Similarity=0.360 Sum_probs=59.0
Q ss_pred eEEEEEecCCCcEEEEEEecch---------------------------hhhhHHHHHHHHHHHHHhhcCCC--------
Q 015532 107 QVVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLARHDIG-------- 151 (405)
Q Consensus 107 ~V~~a~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~E~~il~~l~~~~~~-------- 151 (405)
.||.|.. ..++.+|||+.+.. ........+|.+.|.++....+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899987 45778999987421 01234456799999998776431
Q ss_pred ------------CCcccc-----CCHHHHHHHHHHHHHHHHH-HHHCCcEecCCCCCcEEEecc
Q 015532 152 ------------GTRYRS-----FPIDLVRELGRQLLESVAF-MHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 152 ------------~~~~~~-----l~~~~~~~~~~qi~~aL~~-LH~~givHrDlkp~NIli~~~ 197 (405)
+..... ++......++.+++..+.. +|..||+|+||.+.|||++.+
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG 143 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT
T ss_pred CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc
Confidence 111111 1134567788888886655 579999999999999999753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.1e-06 Score=76.58 Aligned_cols=81 Identities=16% Similarity=0.132 Sum_probs=56.9
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCC--C-------C-----Cc-------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDI--G-------G-----TR------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~--~-------~-----~~------- 154 (405)
+.|+.|.++.||++.... |+.+++|+...... .......|+++++.+.+..+ . . ..
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998743 57899999765332 34567889999999876432 0 0 00
Q ss_pred -----c-----ccCCHHHHHHHHHHHHHHHHHHHH
Q 015532 155 -----Y-----RSFPIDLVRELGRQLLESVAFMHE 179 (405)
Q Consensus 155 -----~-----~~l~~~~~~~~~~qi~~aL~~LH~ 179 (405)
. ..+++.....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHS 117 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 0 124556677788888888888883
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.6e-06 Score=72.81 Aligned_cols=108 Identities=29% Similarity=0.288 Sum_probs=77.5
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecc----------h-------------hhhhHHHHHHHHHHHHHhhcCC
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----------I-------------NKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~----------~-------------~~~~~~~~~E~~il~~l~~~~~ 150 (405)
+.+...||-|-=|.||.|.+. .|..+|||.=+. . .-.+..+.+|.++|++|.....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567789999999999999985 677899996421 0 1124556789999999976521
Q ss_pred --C----------------CCccccC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 151 --G----------------GTRYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 151 --~----------------~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
. +.....+ ..+....++..|+.-+.-+-..||||+|+.+=||+++.+|.+.+
T Consensus 172 ~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 0 1111122 35666777778887777777999999999999999987664333
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.7e-05 Score=73.85 Aligned_cols=138 Identities=16% Similarity=0.190 Sum_probs=95.8
Q ss_pred ceeEEEEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCc-----------------------------
Q 015532 105 FGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTR----------------------------- 154 (405)
Q Consensus 105 fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~----------------------------- 154 (405)
-.+.|+|....+|..|++|++.-.+. .......-++.++++.|.|++...
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35779999999999999999832111 111122346788888888863211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
....+|..+|.++.||..||.++|+.|..-+-|.+.+||++.+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~------------------ 430 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM------------------ 430 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc------------------
Confidence 13457899999999999999999999999999999999986432
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
+++|+..|.......+.. |.+.+ -.+-|.=.||.+++.|.||..
T Consensus 431 ---------RIriS~C~i~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 431 ---------RIRISGCGIMDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ---------eEEEecccceeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 456655555443332220 11111 135688899999999999853
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.2e-05 Score=72.14 Aligned_cols=56 Identities=21% Similarity=0.134 Sum_probs=43.2
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCc
Q 015532 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236 (405)
Q Consensus 161 ~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~ 236 (405)
.....++.+++..+.-||..||+|+|+++.|||++.+... -.....+.++||+.+.
T Consensus 138 ~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~--------------------~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 138 RLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPG--------------------REEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccC--------------------CCCCceEEEEECCccc
Confidence 4566788999999999999999999999999999741000 0123468899998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.5e-05 Score=66.74 Aligned_cols=96 Identities=13% Similarity=0.080 Sum_probs=69.4
Q ss_pred ecccceeEEEEEecCCCcEEEEEEecc----h---hhhhHHHHHHHHHHHHHhhcCCCCC--------------------
Q 015532 101 GEGTFGQVVECFDNEKKELVAIKIVRS----I---NKYREAAMIEIDVLQRLARHDIGGT-------------------- 153 (405)
Q Consensus 101 G~G~fg~V~~a~~~~~~~~vAiK~~~~----~---~~~~~~~~~E~~il~~l~~~~~~~~-------------------- 153 (405)
|+||.+-|+..... |+.+-+|.-.. . ......+.+|+..|+.|....+...
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888888887654 33577886531 0 2245778999999999988665110
Q ss_pred --c--------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 154 --R--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 154 --~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
. ....+......++.+++..+.-||+.|+.|+|+-+.||+++..|
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC
Confidence 0 01123445568999999999999999999999999999997543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.7e-06 Score=84.21 Aligned_cols=218 Identities=16% Similarity=0.053 Sum_probs=146.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC-CCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~-~~~~---------------- 154 (405)
..|....-+++|+++++++.+...+...+ .+++... .....++++|.+++|++. ....
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 34666788999999999999987776655 7776543 334568999999999983 1111
Q ss_pred --c-----------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 --Y-----------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 --~-----------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
. -.+.+.+...+.+.-.++|+++|+..=+|+| ||+..+
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~------------------------- 367 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE------------------------- 367 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-------------------------
Confidence 0 0122234445666777889999988778998 887543
Q ss_pred CCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
...+..||+........ ..+..+|+.++|||+..+..+....|.|++|.-..++.-|.+|-..-
T Consensus 368 ---~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P----------- 433 (829)
T KOG0576|consen 368 ---EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP----------- 433 (829)
T ss_pred ---cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC-----------
Confidence 34677888877665554 45578999999999999999999999999998777887787776430
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH-HHHHHHccccCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL-IDLLQGLLRYDPAERL 378 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~ll~~~L~~dP~~Rp 378 (405)
|.. ......+..+.....+ ...+..+ .++...|+..-|..|+
T Consensus 434 -----~~~-----------------~~~~g~~p~s~~L~~~---------------~aw~~~~~~~~~~~~~~g~P~~pk 476 (829)
T KOG0576|consen 434 -----PAV-----------------LPMIGNGPNSPMLTDK---------------SAWSPVFHRDFPAPCLNGLPPTPK 476 (829)
T ss_pred -----ccc-----------------cCCCCCCCCccccchh---------------hhcCcccccCCcccccCCCCCCCc
Confidence 000 0000000000000000 0001111 2577899999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ta~elL~hp~f~~~~~ 394 (405)
++..++.|.+|.+..-
T Consensus 477 v~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 477 VHMGACFSKVFNGCPL 492 (829)
T ss_pred chhhHHHHHHhccCcc
Confidence 9999999999988753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0002 Score=63.72 Aligned_cols=97 Identities=22% Similarity=0.211 Sum_probs=66.6
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhh-------------------------hhHHHHHHHHHHHHHhhcCCC-
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLARHDIG- 151 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~E~~il~~l~~~~~~- 151 (405)
..|.+|--+.||+|.. .++..||||+++.... ...-...|...|+++....+-
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566677778999986 5678999999853110 011223578888887664330
Q ss_pred ----------------CC---ccc-----cCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEe
Q 015532 152 ----------------GT---RYR-----SFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 195 (405)
Q Consensus 152 ----------------~~---~~~-----~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~ 195 (405)
+. ... .+..+++..+..+++..+.-|-. .|+||+||..=|||+.
T Consensus 133 P~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 133 PEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 10 111 22334688888999999988876 9999999999999997
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0003 Score=61.91 Aligned_cols=107 Identities=16% Similarity=0.164 Sum_probs=67.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhH----------HHHHHHHHHHHHhhcCCCCCc-----
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----------AAMIEIDVLQRLARHDIGGTR----- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~----------~~~~E~~il~~l~~~~~~~~~----- 154 (405)
+.+.|.+.+.+-......|.+..- .|+.+.+|..+......+ ...+++..+.++....+....
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 467899999999998888877764 467789998764332222 223344545555443221100
Q ss_pred --------------------cccCCHH-HH-HHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 --------------------YRSFPID-LV-RELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 --------------------~~~l~~~-~~-~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
...+.+- .+ -.+...|..++.-||+.|+.|+|.+|.|+++..++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence 0111110 01 13456778889999999999999999999987543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=4.6e-05 Score=75.96 Aligned_cols=28 Identities=25% Similarity=0.316 Sum_probs=24.9
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEec
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVR 126 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~ 126 (405)
..|+.++-|.||+|+.+ +|+.||||+.+
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqr 158 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQR 158 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecC
Confidence 57999999999999986 48999999975
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00039 Score=60.47 Aligned_cols=100 Identities=22% Similarity=0.305 Sum_probs=69.5
Q ss_pred CCeEEEeeeecccc-eeEEEEEecCCCcEEEEEEecc------------hh----------hhhHHHHHHHHHHHHHhhc
Q 015532 92 PRYRILSKMGEGTF-GQVVECFDNEKKELVAIKIVRS------------IN----------KYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 92 ~~y~~~~~LG~G~f-g~V~~a~~~~~~~~vAiK~~~~------------~~----------~~~~~~~~E~~il~~l~~~ 148 (405)
..++.++.||.|.- |.||+++.. |+.||||+++. .. ...+.+..|.....+|.+.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56899999999999 999999874 77999999421 00 1223456677777777665
Q ss_pred CCCCC----c--cccCC-HHH------------------------------HHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 015532 149 DIGGT----R--YRSFP-IDL------------------------------VRELGRQLLESVAFMHELRLIHTDLKPEN 191 (405)
Q Consensus 149 ~~~~~----~--~~~l~-~~~------------------------------~~~~~~qi~~aL~~LH~~givHrDlkp~N 191 (405)
+-.+. . +-.++ +.+ ...-+.+|++-|..+|..||+-+|+|+.|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~n 194 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRN 194 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCcccc
Confidence 44221 1 11112 111 22346788999999999999999999999
Q ss_pred EE
Q 015532 192 IL 193 (405)
Q Consensus 192 Il 193 (405)
..
T Consensus 195 y~ 196 (207)
T PF13095_consen 195 YR 196 (207)
T ss_pred cc
Confidence 97
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00021 Score=60.26 Aligned_cols=98 Identities=23% Similarity=0.222 Sum_probs=67.5
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCcc--------------ccCC
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRY--------------RSFP 159 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~~--------------~~l~ 159 (405)
-++.+.|++|++|.||+|.+. |..+|+|+-+ .+..+..+..|.++|..+....+....+ ..|.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~ 100 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchh
Confidence 355788999999999999975 5689999754 4556777889999999998877644332 1222
Q ss_pred HHHH---HHHHHHHHHHHHHHHHCCcEecCCCC-C-cEEE
Q 015532 160 IDLV---RELGRQLLESVAFMHELRLIHTDLKP-E-NILL 194 (405)
Q Consensus 160 ~~~~---~~~~~qi~~aL~~LH~~givHrDlkp-~-NIli 194 (405)
.-.. ++-+..++++---|-..||-|+.|.- . ||++
T Consensus 101 ~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv 140 (201)
T COG2112 101 KLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV 140 (201)
T ss_pred hhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEe
Confidence 2222 34445566665556678999999863 3 5554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.69 E-value=4.8e-05 Score=67.30 Aligned_cols=40 Identities=35% Similarity=0.471 Sum_probs=35.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 159 ~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
+......++.+++..+.-||.+||+|+|+++.|||++.++
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~ 155 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD 155 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC
Confidence 3456678999999999999999999999999999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00095 Score=70.95 Aligned_cols=180 Identities=27% Similarity=0.420 Sum_probs=112.0
Q ss_pred HHHHHHHHHHHhhcCCCCCc-------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 015532 135 AMIEIDVLQRLARHDIGGTR-------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLI 183 (405)
Q Consensus 135 ~~~E~~il~~l~~~~~~~~~-------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~giv 183 (405)
...|+..+.++.|.+.++.. ....+.+.++.+..+++.||.|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l- 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL- 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc-
Confidence 34567788888888875533 1345677888899999999999999843
Q ss_pred ecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce--eccCCCCccccCCccc--eecCCCcchhHHHhC
Q 015532 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK--LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILG 259 (405)
Q Consensus 184 HrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k--l~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~ 259 (405)
.|+.+....... ...+....+. +.||+........... ...+..+.++|....
T Consensus 308 ------~~v~L~~s~~~~-----------------~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~ 364 (1351)
T KOG1035|consen 308 ------EHVVLSASSSKE-----------------STVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE 364 (1351)
T ss_pred ------ceeEEecccccc-----------------cccCccceeecchhhhcccccCCCcccchhhcCcccccccccccc
Confidence 444443221000 0011222233 3377766554433322 234556778888776
Q ss_pred CCCCC--chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhh
Q 015532 260 LGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 337 (405)
Q Consensus 260 ~~~~~--~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (405)
..+.. ..|+|.+|.....+..|..+-.... .+..+++
T Consensus 365 ~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------~~~~~l~----------------------------------- 403 (1351)
T KOG1035|consen 365 NTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------VPVSLLD----------------------------------- 403 (1351)
T ss_pred ccchhhhhhHHHHHHHHHhhhhhcCccccccc------chhhhhc-----------------------------------
Confidence 65554 4799999999999887765432110 0000000
Q ss_pred HHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCCc
Q 015532 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397 (405)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 397 (405)
........+++.+|+.-++++|+++.+++.|+|.+.+...+.
T Consensus 404 ------------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 404 ------------------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred ------------------cccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 000114568899999999999999999999999987765444
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0039 Score=55.67 Aligned_cols=51 Identities=24% Similarity=0.282 Sum_probs=40.3
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
++.|+.|..+.||++.... ..+++|+.... ........|..+++.+....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~ 52 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGI 52 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCC
Confidence 4689999999999999764 47899998665 445667789999998877644
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0089 Score=53.62 Aligned_cols=47 Identities=17% Similarity=0.142 Sum_probs=33.5
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcC
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~ 149 (405)
..||+|..+.||+.. +..+++|+..... ......+|.++++.+....
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~g 53 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSLG 53 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcC
Confidence 578999999999842 3357789875422 3345678999998887543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.012 Score=52.83 Aligned_cols=52 Identities=13% Similarity=0.282 Sum_probs=32.3
Q ss_pred EeeeecccceeEEEEEecC-CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 97 LSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
++.|..|-...+|++.... .++.|++|+........-...+|+.+++.+...
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~ 55 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKH 55 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhC
Confidence 4567788888999887543 345688887653222112233577777777553
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0063 Score=60.85 Aligned_cols=28 Identities=21% Similarity=0.233 Sum_probs=24.8
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEec
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVR 126 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~ 126 (405)
+.||.-+.|.||+|+.+. |+.||||+-+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~ 194 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQH 194 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecC
Confidence 579999999999999876 9999999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.017 Score=51.99 Aligned_cols=44 Identities=16% Similarity=0.165 Sum_probs=27.5
Q ss_pred eeeecccce-eEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhh
Q 015532 98 SKMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 98 ~~LG~G~fg-~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~ 147 (405)
+.|+.|+.. .||+.. ..+++|+.+. ........+|.+++..|..
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~ 47 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAP 47 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhc
Confidence 467766666 488752 2366787544 2234467778888887764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.016 Score=54.81 Aligned_cols=48 Identities=15% Similarity=0.107 Sum_probs=29.8
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
++.|+.|....+|+.... +| .+++|++.. ...+....|+.++..|...
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~ 74 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAAR 74 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHC
Confidence 356777777888988753 33 578898752 2233444566777776543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.065 Score=50.83 Aligned_cols=100 Identities=26% Similarity=0.270 Sum_probs=70.5
Q ss_pred EEEeeeecccceeEEEEEecCCCcEEEEEEecch---------------------------hhhhHHHHHHHHHHHHHhh
Q 015532 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~E~~il~~l~~ 147 (405)
.+-..|..|--+.||.|.. .+|..+|||+++.. ....--+..|+..|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3455677888889999986 56777999987521 1112234468889999877
Q ss_pred cCCCC-----------------C--------ccccCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEe
Q 015532 148 HDIGG-----------------T--------RYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLV 195 (405)
Q Consensus 148 ~~~~~-----------------~--------~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIli~ 195 (405)
..|.. . ....++...+..+-.|++.-+.-|- .+++||.||.-=|+|+-
T Consensus 226 aGIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 226 AGIPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred cCCCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 55411 0 0234566778888888888777665 67999999999999984
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.011 Score=54.83 Aligned_cols=114 Identities=18% Similarity=0.220 Sum_probs=77.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecc----------hh-------------hhhHHHHHHHHHHHHHhhcC
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----------IN-------------KYREAAMIEIDVLQRLARHD 149 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~----------~~-------------~~~~~~~~E~~il~~l~~~~ 149 (405)
-|.+.+.||-|--+-||.+-+. .|+..++|+-+. .. -.+-...+|...|+.|..+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999884 566788995321 00 01234567899999987754
Q ss_pred CCC-------------CccccCC------HHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 150 IGG-------------TRYRSFP------IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 150 ~~~-------------~~~~~l~------~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
... .+...+| ...+..+...++.-+.-|-.+|+||+|..-=||++..++.++++||.-
T Consensus 172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 172 FPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred CCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 311 0111122 223334555666666778899999999999999999887777777753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.053 Score=50.85 Aligned_cols=51 Identities=18% Similarity=0.156 Sum_probs=29.9
Q ss_pred eeeecccceeEEEEEecC------CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 98 SKMGEGTFGQVVECFDNE------KKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
+.|..|-...||++.... .++.|++|+............+|..++..+...
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~ 60 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSER 60 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhC
Confidence 456666666788776533 246788888654322223345566666666543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.019 Score=53.62 Aligned_cols=49 Identities=10% Similarity=0.083 Sum_probs=34.0
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcC
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~ 149 (405)
++.|..|....+|+.... +..+++|+... ...+....|+.++..|.+..
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g 67 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERG 67 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCC
Confidence 567888888899988643 33588898764 23445667888888886644
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.083 Score=46.23 Aligned_cols=98 Identities=16% Similarity=0.235 Sum_probs=59.4
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchh-----------------hhhHHHHHHHHHHHHHh-hcCCCCCc-----
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------KYREAAMIEIDVLQRLA-RHDIGGTR----- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------------~~~~~~~~E~~il~~l~-~~~~~~~~----- 154 (405)
..||+|+.-.||.-- ......||+++... .......+|+.....+. ........
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 479999999998633 23346789986544 22355677888777777 43321100
Q ss_pred -------------------cccC--CHHHHH-------HHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 -------------------YRSF--PIDLVR-------ELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 -------------------~~~l--~~~~~~-------~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
.+.+ +..... .+...+-.-.+||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 1111 111111 2233333445588899999999999999997643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.039 Score=50.38 Aligned_cols=48 Identities=13% Similarity=0.002 Sum_probs=28.5
Q ss_pred eecccceeEEEEEecCCCcEEEEEEecchhhhh-HHHHHHHHHHHHHhhcC
Q 015532 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHD 149 (405)
Q Consensus 100 LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~E~~il~~l~~~~ 149 (405)
+..|-.+.+|+.. .+++.+++|+........ -...+|..+++.+....
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g 52 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALG 52 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcC
Confidence 4556677888776 345567788754322111 12456888888876543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.04 Score=49.89 Aligned_cols=46 Identities=22% Similarity=0.112 Sum_probs=28.8
Q ss_pred eeecccc-eeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 99 KMGEGTF-GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 99 ~LG~G~f-g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
.|-.|.. +.||++... +..+.||+..... .....+|+.+++.+...
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~ 51 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK 51 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc
Confidence 4455555 778888653 3567788765432 23456788888877653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.013 Score=64.59 Aligned_cols=96 Identities=16% Similarity=0.099 Sum_probs=69.6
Q ss_pred HHHHHHHHHHHHHHHHHC-----CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCcc
Q 015532 163 VRELGRQLLESVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237 (405)
Q Consensus 163 ~~~~~~qi~~aL~~LH~~-----givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 237 (405)
+.....+.+.+..-+|+. -.+|++||+-|.+|..+- .+++.++|+.+.
T Consensus 1337 v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny---------------------------~v~~gk~gLdKI 1389 (2724)
T KOG1826|consen 1337 VHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY---------------------------NVKLGKGGLDKI 1389 (2724)
T ss_pred HHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC---------------------------cccccccccccc
Confidence 333334446666777743 268999999999987644 456666666663
Q ss_pred ccCCcc---ceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 238 EHQDHS---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 238 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
...... ..++++.|+++++.....++.++|+|+.|+.+|+...|..+|
T Consensus 1390 knp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1390 KNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 322222 246788999999998888998899999999999998887766
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.16 Score=54.67 Aligned_cols=50 Identities=16% Similarity=0.108 Sum_probs=35.1
Q ss_pred EeeeecccceeEEEEEecCCC--cEEEEEEecchh--hhhHHHHHHHHHHHHHh
Q 015532 97 LSKMGEGTFGQVVECFDNEKK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLA 146 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~--~~vAiK~~~~~~--~~~~~~~~E~~il~~l~ 146 (405)
++.|+.|.++.+|+......+ ..+++|+..... .....+.+|+.+|+.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~ 96 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALG 96 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHh
Confidence 577899999999998765432 357777754322 12345778999999986
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.14 Score=48.08 Aligned_cols=50 Identities=12% Similarity=0.016 Sum_probs=31.7
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
.++.++.|....+|++.. .++ .+++|+..... ..+....|++++..|...
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~ 75 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAAR 75 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHC
Confidence 356778887788998864 344 46788875421 123445677777777543
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.11 Score=49.64 Aligned_cols=54 Identities=13% Similarity=0.010 Sum_probs=31.8
Q ss_pred EeeeecccceeEEEEEecC----CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 97 LSKMGEGTFGQVVECFDNE----KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~----~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
+..|-.|-...+|++.... .++.|++|+........-....|..+++.+....+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl 98 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQ 98 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCC
Confidence 4456557778888886432 24678888775432211122457777777766544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.12 Score=49.11 Aligned_cols=53 Identities=11% Similarity=0.205 Sum_probs=28.1
Q ss_pred eeeecccceeEEEEEecCC---CcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
+.|..|-...+|++..... +..|++|+........-...+|..+++.+....+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl 75 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGF 75 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCC
Confidence 4454566667787764322 2367788764322211122356667766665443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.02 Score=56.40 Aligned_cols=96 Identities=22% Similarity=0.216 Sum_probs=66.6
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHH
Q 015532 264 YPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 343 (405)
Q Consensus 264 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (405)
+|+||||+|.++.++.-|...+......+.+..+.+.. ..+.....-.++.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~---------------------------- 160 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEH---------------------------- 160 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHH----------------------------
Confidence 59999999999999999998887766666666555432 2222211111100
Q ss_pred hccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCCc
Q 015532 344 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397 (405)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 397 (405)
...-..+..+.+++.+|+-..|..||...++.+++-|......++
T Consensus 161 ---------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t 205 (725)
T KOG1093|consen 161 ---------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLT 205 (725)
T ss_pred ---------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhh
Confidence 000123456789999999999999999999999998877655444
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.18 Score=49.01 Aligned_cols=51 Identities=24% Similarity=0.268 Sum_probs=36.4
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecc------h--hhhhHHHHHHHHHHHHHhh
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS------I--NKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~------~--~~~~~~~~~E~~il~~l~~ 147 (405)
.+.||.|.+..||++.+..+++.|.||.-.. . ....+....|.+.|+.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~ 89 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAK 89 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHh
Confidence 4689999999999999865446799997421 0 1234566778888887643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.3 Score=45.20 Aligned_cols=47 Identities=26% Similarity=0.111 Sum_probs=30.1
Q ss_pred eeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhh
Q 015532 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~ 147 (405)
..++|-...|+.+.+ ..|+.+++|+-+. ........+|..+|..|..
T Consensus 18 ~~~~g~~~~v~~i~~-~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~ 64 (276)
T cd05152 18 LNESGLDFQVVFAKD-TDGVPWVLRIPRR-PDVSERAAAEKRVLALVRK 64 (276)
T ss_pred ecCCcceeEEEEEEc-CCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHh
Confidence 345555556666643 3466788887653 2234557889999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.093 Score=49.01 Aligned_cols=66 Identities=21% Similarity=0.336 Sum_probs=40.5
Q ss_pred HHHHHHHHHHHHHHHHHHH----CCcEecCCCCCcEEEecccc---cccCCccccccCCCCCCcccCCCCCCCceeccCC
Q 015532 161 DLVRELGRQLLESVAFMHE----LRLIHTDLKPENILLVSAEY---VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233 (405)
Q Consensus 161 ~~~~~~~~qi~~aL~~LH~----~givHrDlkp~NIli~~~~~---~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 233 (405)
+-++.++.||+.-.-.+-+ .+.+|-||||+|||+-+... +++.|-.++ ..+....+|-||.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~v------------F~Epi~~~LnDFD 346 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYV------------FNEPIKACLNDFD 346 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEE------------eccchhhhhcccC
Confidence 3456678888765544432 46899999999999865432 222222111 2234456788888
Q ss_pred CCccc
Q 015532 234 STTFE 238 (405)
Q Consensus 234 ~a~~~ 238 (405)
++...
T Consensus 347 fSqv~ 351 (444)
T PHA03111 347 FSQVA 351 (444)
T ss_pred HHHHc
Confidence 77543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.16 Score=48.96 Aligned_cols=41 Identities=24% Similarity=0.390 Sum_probs=28.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEeccc
Q 015532 158 FPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 158 l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIli~~~~ 198 (405)
.++...++++.-...||.-+- -.+.+|.|+.|.||++.-+.
T Consensus 341 ~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 341 QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 345566666665566654433 56899999999999997544
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.83 E-value=1 Score=42.79 Aligned_cols=43 Identities=21% Similarity=0.069 Sum_probs=28.5
Q ss_pred ceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 105 FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 105 fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
-..||+... .++..+++|+.+...........|+.++..|...
T Consensus 38 eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~ 80 (325)
T PRK11768 38 ENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA 80 (325)
T ss_pred cceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC
Confidence 356888765 3455688998764433455666788888877654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.55 Score=45.52 Aligned_cols=51 Identities=27% Similarity=0.341 Sum_probs=34.7
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEe----cch---hhhhHHHHHHHHHHHHHhh
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSI---NKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~----~~~---~~~~~~~~~E~~il~~l~~ 147 (405)
.+.||-|.-..||++.+...++.|+||.- +.. ....++...|.++|+.+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~ 91 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEE 91 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHh
Confidence 57899999999999998544567999964 211 2234555667777776543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.093 Score=45.54 Aligned_cols=52 Identities=19% Similarity=0.195 Sum_probs=44.5
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCCCcEEEecccccccCCcccc
Q 015532 157 SFPIDLVRELGRQLLESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 157 ~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
.-+|..+.+++.+++..+++|+. ..+.-.|++++|+-++.+|.+|+.|...+
T Consensus 55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 46889999999999999999997 45778999999999998888877776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.53 Score=45.03 Aligned_cols=48 Identities=23% Similarity=0.302 Sum_probs=32.3
Q ss_pred eeecccceeEEEEEecCCCcEEEEEEec----c----hhhhhHHHHHHHHHHHHHh
Q 015532 99 KMGEGTFGQVVECFDNEKKELVAIKIVR----S----INKYREAAMIEIDVLQRLA 146 (405)
Q Consensus 99 ~LG~G~fg~V~~a~~~~~~~~vAiK~~~----~----~~~~~~~~~~E~~il~~l~ 146 (405)
.||-|....||++.+..+++.|+||.-. . .....++...|...|+...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~ 57 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQG 57 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhh
Confidence 5899999999999986444679999642 1 1223344556777776643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.079 Score=42.26 Aligned_cols=79 Identities=27% Similarity=0.378 Sum_probs=46.7
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCccccCCH-HHHHHHHHHHHHHHHH
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRYRSFPI-DLVRELGRQLLESVAF 176 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~~~~l~~-~~~~~~~~qi~~aL~~ 176 (405)
+.||.|+.|.||+|+.+. |+.||||+.+. ...+.+...+.+|+.+..---.-.....++. ..+..+..++..=|+|
T Consensus 17 ~PlasASiaQVh~a~l~~-g~~VaVKV~rP--~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ElDf 93 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKD-GEEVAVKVQRP--GIEEQIEADLRILRRLARLLERLPPFRRLDLEEIVDEFRDSLLEELDF 93 (119)
T ss_pred chhhheehhhheeeeecc-cchhhhhhcch--HHHHHHHHHHHHHHHHHHHHHHcccccccCHHHHHHHHHHHHHHHhCH
Confidence 579999999999999854 88999999764 2334444555555544321100000002333 3444555666666777
Q ss_pred HHH
Q 015532 177 MHE 179 (405)
Q Consensus 177 LH~ 179 (405)
.++
T Consensus 94 ~~E 96 (119)
T PF03109_consen 94 RRE 96 (119)
T ss_pred HHH
Confidence 664
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.47 E-value=1.5 Score=42.55 Aligned_cols=55 Identities=20% Similarity=0.228 Sum_probs=28.3
Q ss_pred EEeeeecccceeEEEEEecCC-Cc-----EEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 96 ILSKMGEGTFGQVVECFDNEK-KE-----LVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~-~~-----~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
.++.|..|-...+|++..... +. .|.+++........-...+|+++++.+....+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~gl 114 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNF 114 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCC
Confidence 345666687888888865332 11 24444321111111122457777777766554
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.62 E-value=0.27 Score=46.20 Aligned_cols=17 Identities=35% Similarity=0.391 Sum_probs=15.3
Q ss_pred CCcEecCCCCCcEEEec
Q 015532 180 LRLIHTDLKPENILLVS 196 (405)
Q Consensus 180 ~givHrDlkp~NIli~~ 196 (405)
.+++|+|+.+.||+++.
T Consensus 187 ~~liHgD~~~~Nil~~~ 203 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD 203 (313)
T ss_pred CceEcCCCCcccEEEeC
Confidence 58999999999999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.55 E-value=0.17 Score=47.51 Aligned_cols=68 Identities=19% Similarity=0.157 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHHH----HCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCcc
Q 015532 162 LVRELGRQLLESVAFMH----ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237 (405)
Q Consensus 162 ~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 237 (405)
-++.++.||+.-.--+- ..+.+|-||||+|||+-+....-...++-.. -...+....+|-||.++..
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~---------~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN---------YVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE---------EEecccceeeecccCHHHh
Confidence 34556677654332122 3468999999999998654322111111000 0022344568888887754
Q ss_pred c
Q 015532 238 E 238 (405)
Q Consensus 238 ~ 238 (405)
.
T Consensus 347 ~ 347 (434)
T PF05445_consen 347 A 347 (434)
T ss_pred c
Confidence 4
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.15 E-value=1.3 Score=42.07 Aligned_cols=49 Identities=20% Similarity=0.182 Sum_probs=33.2
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
..|.+ .-..||+.... .|+ +++|+.+.. ....+...|+..|..|....+
T Consensus 32 ~~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i 80 (331)
T COG2334 32 RGLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGI 80 (331)
T ss_pred ccccc-ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCC
Confidence 34455 45578888764 344 389998776 556667778888888876544
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.00 E-value=0.26 Score=42.53 Aligned_cols=17 Identities=18% Similarity=0.382 Sum_probs=14.6
Q ss_pred cEecCCCCCcEEEeccc
Q 015532 182 LIHTDLKPENILLVSAE 198 (405)
Q Consensus 182 ivHrDlkp~NIli~~~~ 198 (405)
.+|+|+.|.||+++.+|
T Consensus 79 p~H~D~~~~N~~~~~~~ 95 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG 95 (188)
T ss_pred eecCCCCCccEEEECCC
Confidence 59999999999987654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.45 E-value=0.23 Score=43.84 Aligned_cols=36 Identities=25% Similarity=0.411 Sum_probs=29.0
Q ss_pred HHHHHHHHH--CCcEecCCCCCcEEEecccccccCCcc
Q 015532 171 LESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 171 ~~aL~~LH~--~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
+.+|.-.|+ .+.+|+|..|+|||.+..|.+|+.|=+
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 566788883 579999999999999888877666644
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.17 E-value=2.6 Score=41.82 Aligned_cols=55 Identities=16% Similarity=0.146 Sum_probs=31.6
Q ss_pred EEeeeecccceeEEEEEecC--------CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 96 ILSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~--------~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
-++.|..|-...+|++.... .++.|.+++.-......-....|..+++.+....+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi 171 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRI 171 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCC
Confidence 45667777777888886532 14578888764322211223446666666665444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=86.46 E-value=0.7 Score=43.46 Aligned_cols=25 Identities=16% Similarity=0.167 Sum_probs=18.8
Q ss_pred CcEecCCCCCcEEEecccccccCCc
Q 015532 181 RLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 181 givHrDlkp~NIli~~~~~~k~~df 205 (405)
++||+|+.+.|||++.++.+.+.||
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDf 221 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINF 221 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEh
Confidence 7999999999999976554333333
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=85.91 E-value=0.72 Score=42.47 Aligned_cols=35 Identities=23% Similarity=0.248 Sum_probs=23.1
Q ss_pred HHHHHHHHHHHHHHC--CcEecCCCCCcEEEeccccc
Q 015532 166 LGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 166 ~~~qi~~aL~~LH~~--givHrDlkp~NIli~~~~~~ 200 (405)
.+..+-.++.-.+.. -++|+|+.|+|+|.+..|.+
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l 173 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGL 173 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcE
Confidence 344444445544433 58999999999998764433
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=85.04 E-value=1.5 Score=41.82 Aligned_cols=48 Identities=17% Similarity=0.219 Sum_probs=34.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccc
Q 015532 159 PIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 159 ~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
..+++..++.+.+.-+.-+..+ ..-|||+.-.||||+ +|.+.++||.+
T Consensus 319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 3567777877777666666643 688999999999998 66554444443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.00 E-value=0.38 Score=42.40 Aligned_cols=18 Identities=39% Similarity=0.613 Sum_probs=11.9
Q ss_pred CcEecCCCCCcEEE-eccc
Q 015532 181 RLIHTDLKPENILL-VSAE 198 (405)
Q Consensus 181 givHrDlkp~NIli-~~~~ 198 (405)
.++|+|+.+.|||+ ..++
T Consensus 144 v~cHnDl~~~Nil~~~~~~ 162 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDG 162 (211)
T ss_dssp EEE-S--SGGGEEETSSSS
T ss_pred eEeeccCccccEEeccCCC
Confidence 58999999999999 4444
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 405 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-73 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-70 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-70 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-70 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-65 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-64 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-52 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-40 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-40 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-39 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-37 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-37 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-36 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-34 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-34 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-32 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-25 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-21 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-20 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-20 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-20 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-20 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-20 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-20 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-20 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-20 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-19 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-19 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-19 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-16 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-13 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 405 | |||
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-159 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-150 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-148 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-127 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-123 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-115 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-93 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-49 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-48 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-47 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-45 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-44 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-44 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-44 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-42 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-42 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-42 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-41 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-41 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-41 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-40 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-40 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-39 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-39 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-37 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-37 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-37 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-37 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-36 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-36 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-36 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-36 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-35 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-35 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-35 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-35 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-35 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-34 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-34 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-34 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-34 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-34 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-34 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-34 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-34 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-34 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-34 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-34 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-34 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-33 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-33 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-33 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-33 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-33 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-33 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-33 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-33 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-33 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-33 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-33 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-33 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-32 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-32 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-32 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-32 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-32 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-32 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-32 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-32 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-31 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-31 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-31 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-30 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-29 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-28 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-28 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-28 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-27 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-26 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-26 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-26 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-26 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-26 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-04 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-24 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-22 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-21 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-21 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-21 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-21 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-21 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-20 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-20 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 8e-20 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-19 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-19 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-19 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-19 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-18 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-18 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-18 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-17 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-17 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-17 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-17 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-16 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 7e-16 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-16 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-15 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-15 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-14 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-14 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-13 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-13 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-12 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-11 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-11 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-11 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-11 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-11 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 7e-10 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-09 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-09 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-09 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-09 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-08 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-08 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-08 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-07 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-07 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-07 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-07 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 8e-07 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-06 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-06 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-06 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-05 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-05 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 8e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-04 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 9e-05 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-04 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-04 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-04 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-04 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-04 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-04 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-04 |
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 450 bits (1160), Expect = e-159
Identities = 120/359 (33%), Positives = 187/359 (52%), Gaps = 43/359 (11%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ ++ DD+ H+ + G L + ++ KMG+GTFG+V+ C + K+ A+K+V
Sbjct: 9 SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68
Query: 126 RSINKYREAAMIEIDVLQRLARHDIGG--------------------------------- 152
R+I KY +A IE D+L+++ DI
Sbjct: 69 RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128
Query: 153 TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212
Y F I+ ++ ++L+++ ++ ++ L HTDLKPENILL + K
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272
K ++ KS+ IKLIDFG TF+ H +++TR YRAPEVIL LGW+ D+WS G
Sbjct: 189 KKIQIYR--TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 273 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGA-RLDWPD 330
C+L EL +G LF+THE++EHLAMME ++ P+P +M+ A + KY + +L WP+
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306
Query: 331 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
A+S +S++ V K L L +I + D L +L+ DP R E L+H F
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHEL------FCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 427 bits (1101), Expect = e-150
Identities = 139/347 (40%), Positives = 200/347 (57%), Gaps = 49/347 (14%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIE 138
H + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EAA E
Sbjct: 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 139 IDVLQRLARHD----------------------------------IGGTRYRSFPIDLVR 164
I VL+ L D I + F +D +R
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 165 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224
++ Q+ +SV F+H +L HTDLKPENIL V ++Y + + K + +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLIN 173
Query: 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
F TH++ EHLAMMER+LGPLP HM+ + +R KYF RLDW + +++ + K
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHD-RLDWDEHSSAGRYVSRACKP 290
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
L+ ++ Q V+H L DL+Q +L YDPA+R+ REAL+HPFF
Sbjct: 291 LK-EFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-148
Identities = 141/351 (40%), Positives = 208/351 (59%), Gaps = 49/351 (13%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 135 AMIEIDVLQRLARHD----------------------------------IGGTRYRSFPI 160
A +EI+VL+++ D + ++ +P+
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + + S +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH--------KSCEEK 174
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G LFQTHEN EHL MME++LGP+P HM+ R ++ KYF +G L W + ++ ++
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFYKG-GLVWDENSSDGRYVKE 291
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
K L+ ++ ++H L DL++ +L +DPA+R+ EAL HPFF
Sbjct: 292 NCKPLK-SYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-127
Identities = 108/365 (29%), Positives = 170/365 (46%), Gaps = 70/365 (19%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD G YV +++ RY +L +G+G+FGQVV+ +D++ + VA+K+VR+ ++ A
Sbjct: 81 DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHD----------------------------------IGGTRYRSFPID 161
EI +L+ L + D I +++ F +
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 162 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221
LVR+ +L+ + +H+ R+IH DLKPENILL
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ------------------------- 235
Query: 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
S IK+IDFGS+ +EHQ + +R YRAPEVILG + P D+WS+GCIL EL +G
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW------PDGATSR 335
L + + LA M +LG + + A +RA+ + + DG+
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQKL-LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVL 354
Query: 336 DSMRAVWKLLRLPNLIMQHVDHSAG----DLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ R+ LR P + + G +D L+ L +DPA R+ +ALRHP+ R
Sbjct: 355 NGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
Query: 392 DVRRP 396
+ +P
Sbjct: 415 RLPKP 419
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-123
Identities = 106/369 (28%), Positives = 167/369 (45%), Gaps = 77/369 (20%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD + Y+ GE RY I S +G+G+FGQVV+ +D ++E VAIKI+++ + A
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 136 MIEIDVLQRLARHD----------------------------------IGGTRYRSFPID 161
IE+ +L+ + +HD + T +R ++
Sbjct: 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157
Query: 162 LVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219
L R+ +Q+ ++ F+ EL +IH DLKPENILL +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN----------------------- 194
Query: 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279
PK SAIK++DFGS+ Q + +R YR+PEV+LG+ ++ D+WS+GCILVE+
Sbjct: 195 --PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
+GE LF ++ + + VLG P H+ + +A K+F + W T
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHI-LDQAPKARKFFEKLPDGTWNLKKTKDGKRE 311
Query: 340 AVWKLLR-LPNLIMQHVDHSAG--------------DLIDLLQGLLRYDPAERLKAREAL 384
R L N++ G DL+ +L YDP R++ AL
Sbjct: 312 YKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYAL 371
Query: 385 RHPFFTRDV 393
+H FF +
Sbjct: 372 QHSFFKKTA 380
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-115
Identities = 91/367 (24%), Positives = 147/367 (40%), Gaps = 80/367 (21%)
Query: 76 DDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
G++ GE RY ++ K+G G F V D VA+KIVR Y EA
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61
Query: 135 AMIEIDVLQRLARHD-------------------------------------------IG 151
A EI +LQR+ D I
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 152 GTRYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210
+R P+ V+++ +QLL + +MH +IHTD+KPEN+L+ + +
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE--------- 172
Query: 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 270
IK+ D G+ + + ++ + TR YR+PEV+LG W D+WS
Sbjct: 173 ------------NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS 220
Query: 271 VGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGA 324
C++ EL +G+ LF+ E + +H+A + +LG LP ++ +R + +F
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL-LRNGKYTRTFFNS-- 277
Query: 325 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 384
G S W L + + A ++ D L +L+ DP +R A +
Sbjct: 278 -----RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332
Query: 385 RHPFFTR 391
HP+
Sbjct: 333 NHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 2e-93
Identities = 95/390 (24%), Positives = 167/390 (42%), Gaps = 83/390 (21%)
Query: 72 PWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
K G+++ IG+ RY ++ K+G G F V +D + K+ VA+K+V+S Y
Sbjct: 17 DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76
Query: 132 REAAMIEIDVLQRLARHDI--------------------GGT------------------ 153
E A+ EI +L+ + D GT
Sbjct: 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136
Query: 154 --RYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEY------VKVPD 204
Y+ P+ V+++ +Q+L+ + ++H + R+IHTD+KPENILL E + +
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 205 YKFLSRSSKDGSYFKNLP----------------KSSAIKLIDFGSTTFEHQDHSYVVST 248
++ GS P + +K+ D G+ + H+ + + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE------HLAMMERVLG 302
R YR+ EV++G G+N P D+WS C+ EL +G+ LF+ H E H+A++ +LG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD- 361
+P +++ E + ++G K L ++++ + S +
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKL-----------KPWGLFEVLVEKYEWSQEEA 365
Query: 362 --LIDLLQGLLRYDPAERLKAREALRHPFF 389
D L +L P +R A E LRHP+
Sbjct: 366 AGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-49
Identities = 82/342 (23%), Positives = 134/342 (39%), Gaps = 96/342 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L +GEG++G V++C + + +VAIK + + AM EI +L++L RH
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQL-RH 83
Query: 149 -------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMHEL 180
++ + R +V++ Q++ + F H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
+IH D+KPENIL+ S+ G +KL DFG + T
Sbjct: 144 NIIHRDIKPENILV-----------------SQSGV----------VKLCDFGFARTLAA 176
Query: 240 QDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLA 295
Y V+TR YRAPE+++G Y D+W++GC++ E+ GE LF +++ L
Sbjct: 177 PGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-----NL 350
+ LG L + + +RLP
Sbjct: 236 HIMMCLGNLIPR-------------------HQELFNKNPV-----FAGVRLPEIKEREP 271
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
+ + + +IDL + L DP +R E L H FF D
Sbjct: 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-48
Identities = 84/348 (24%), Positives = 146/348 (41%), Gaps = 99/348 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEG++G V +C + + ++VAIK ++ A+ EI +L++L +H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61
Query: 149 -------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMHEL 180
++ + R P LV+ + Q L++V F H+
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
IH D+KPENIL+ +K IKL DFG +
Sbjct: 122 NCIHRDVKPENILI-----------------TKHSV----------IKLCDFGFARLLTG 154
Query: 240 QDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLA 295
Y V+TR YR+PE+++G Y P D+W++GC+ EL SG L+ +++ L
Sbjct: 155 PSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213
Query: 296 MMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-----N 349
++ + LG +P H +T++ + +++P
Sbjct: 214 LIRKTLGDLIPRH--------------------QQVFSTNQY-----FSGVKIPDPEDME 248
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+ + + + LL+G L DP ERL + L HP+F ++R
Sbjct: 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF-ENIREIE 295
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-47
Identities = 77/344 (22%), Positives = 136/344 (39%), Gaps = 83/344 (24%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90
Query: 149 -------DIGGTR--------------------YRSFPIDLVRELGRQLLESVAFMHELR 181
DI Y++ +R ++L+++ + H +
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
++H D+KP N+++ + ++LID+G F H
Sbjct: 151 IMHRDVKPHNVMID--------------------------HEHRKLRLIDWGLAEFYHPG 184
Query: 242 HSYV--VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG-EALFQTHENLEHLAMM 297
Y V++R+++ PE+++ ++Y D+WS+GC+L + E F H+N + L +
Sbjct: 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244
Query: 298 ERVLGP-----LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
+VLG I D R R +R W + +
Sbjct: 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER---------------FVHSENQ 289
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
V A +D L LLRYD RL AREA+ HP+F V +
Sbjct: 290 HLVSPEA---LDFLDKLLRYDHQSRLTAREAMEHPYF-YTVVKD 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 92/377 (24%), Positives = 134/377 (35%), Gaps = 109/377 (28%)
Query: 66 PRTGSPPWRPDDKDGHYVFAI--------GENLTPRYRILSKMGEGTFGQVVECFDNEKK 117
P DKDG V + Y +G G+FG V + +
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 118 ELVAIKIVRSINKY--REAAMIEI-------------DV--------------------- 141
ELVAIK V ++ RE ++I
Sbjct: 80 ELVAIKKVLQDKRFKNRE---LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136
Query: 142 --LQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199
+ R+ARH + + P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 137 ETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL----- 189
Query: 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-TFEHQDH--SYVVSTRHYRAPEV 256
+ P ++ +KL DFGS + SY+ +R+YRAPE+
Sbjct: 190 --------------------D-PDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYRAPEL 227
Query: 257 ILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRA-- 312
I G +Y D+WS GC+L EL G+ +F ++ L + +VLG P IR
Sbjct: 228 IFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTREQIREMN 285
Query: 313 DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372
E F + K + A I L LL Y
Sbjct: 286 PNYTEFKFPQ-------------------IKAHPWTKVFRPRTPPEA---IALCSRLLEY 323
Query: 373 DPAERLKAREALRHPFF 389
P RL EA H FF
Sbjct: 324 TPTARLTPLEACAHSFF 340
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 78/355 (21%), Positives = 127/355 (35%), Gaps = 108/355 (30%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA-------AMIEIDVLQRL 145
RY ++++G G +G V + D VA+K VR + + E+ +L+RL
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRL 68
Query: 146 AR--------------------------------HDIGG----TRYRSFPIDLVRELGRQ 169
D+ P + +++L RQ
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
L + F+H ++H DLKPENIL+ + G +KL
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILV-----------------TSGG----------TVKL 161
Query: 230 IDFG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
DFG VV T YRAPEV+L + P D+WSVGCI E+ +
Sbjct: 162 ADFGLARIYSYQMALTPV----VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
Query: 283 ALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
LF + + L + ++G P DWP +
Sbjct: 217 PLFCGNSEADQLGKIFDLIGLPPED--------------------DWPRDVSLPRGAFPP 256
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ +++ ++ S LL +L ++P +R+ A AL+H + +D P
Sbjct: 257 RGPRPVQSVV-PEMEESG---AQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 95/360 (26%), Positives = 144/360 (40%), Gaps = 97/360 (26%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMI------- 137
GE Y +G G+FG V + E E VAIK V ++ RE ++
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPN 93
Query: 138 ----------------EIDV----------LQRLARHDIGGTRYRSFPIDLVRELGRQLL 171
E+ + + R +RH ++ P+ L++ QLL
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH--YAKLKQTMPMLLIKLYMYQLL 151
Query: 172 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 231
S+A++H + + H D+KP+N+LL + P S +KLID
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLL-------------------------D-PPSGVLKLID 185
Query: 232 FGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQ 286
FGS + + SY+ +R+YRAPE+I G NY D+WS GC++ EL G+ LF
Sbjct: 186 FGSAKILIAGEPNVSYIC-SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQPLFP 243
Query: 287 THENLEHLAMMERVLGPLPHHMVIRAD--RRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
++ L + +VLG P I+ E F + +
Sbjct: 244 GESGIDQLVEIIKVLGT-PSREQIKTMNPNYMEHKFPQ-------------------IRP 283
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLLVATGE 404
+ A IDL+ LL Y P+ RL A EAL HPFF ++R + G
Sbjct: 284 HPFSKVFRPRTPPDA---IDLISRLLEYTPSARLTAIEALCHPFF-DELRTGEARMPNGR 339
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 82/337 (24%), Positives = 135/337 (40%), Gaps = 87/337 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
RYR ++K+GEGT+G+V + D E VAIK +R + E A+ E+ +L+ L +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QH 92
Query: 149 -------DIGGT--------------------RYRSFPIDLVRELGRQLLESVAFMHELR 181
+ + + +++ QL+ V F H R
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFE 238
+H DLKP+N+LL S +S+ +K+ DFG +
Sbjct: 153 CLHRDLKPQNLLLSV------------SDASETP----------VLKIGDFGLARAFGIP 190
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ ++ + T YR PE++LG +Y D+WS+ CI E+ LF ++ L
Sbjct: 191 IRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
Query: 297 MERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAVWKLLRLPNLIMQ 353
+ VLG P WP D ++ L ++
Sbjct: 250 IFEVLGLPDDT--------------------TWPGVTALPDWKQSFPKFRGKTLKRVLGA 289
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+D +DLL +L DP +R+ A+ AL HP+F+
Sbjct: 290 LLDDEG---LDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 86/352 (24%), Positives = 141/352 (40%), Gaps = 100/352 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+++ L K+G GT+ V + + VA+K V+ ++ E A+ EI +++ L +H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KH 62
Query: 149 -------DI--------------------------GGTRYRSFPIDLVRELGRQLLESVA 175
D+ G R ++LV+ QLL+ +A
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 234
F HE +++H DLKP+N+L+ +K G +KL DFG +
Sbjct: 123 FCHENKILHRDLKPQNLLI-----------------NKRGQ----------LKLGDFGLA 155
Query: 235 TTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 289
F +++ VV T YRAP+V++G Y D+WS GCIL E+ +G+ LF
Sbjct: 156 RAFGIPVNTFSSEVV-TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213
Query: 290 NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAVWKLLR 346
+ E L ++ ++G P WP
Sbjct: 214 DEEQLKLIFDIMGTPNES--------------------LWPSVTKLPKYNPNIQQRPPRD 253
Query: 347 LPNLIMQHVDHSAGDL-IDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
L ++ H +D L GLL+ +P RL A++AL HP+F +
Sbjct: 254 LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF-AEYYHHA 304
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 86/355 (24%), Positives = 132/355 (37%), Gaps = 98/355 (27%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEI- 139
R+++ G+GTFG V + VAIK V ++ RE +++
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL 73
Query: 140 ------------------------DV------------LQRLARHDIGGTRYRSFPIDLV 163
D+ L R R+ R + P L+
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILI 131
Query: 164 RELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221
+ QL+ S+ +H + + H D+KP N+L+ N
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-------------------------N- 165
Query: 222 PKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPC--DLWSVGCILV 276
+KL DFGS + + +Y+ +R+YRAPE+I G +Y D+WSVGCI
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQ-HYTTAVDIWSVGCIFA 223
Query: 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADR--RAEKYFRRGARLDWPDGATS 334
E+ GE +F+ + L + RVLG P V+R + + W
Sbjct: 224 EMMLGEPIFRGDNSAGQLHEIVRVLGC-PSREVLRKLNPSHTDVDLYNSKGIPWS----- 277
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ H A + DLL LL+Y P ER+K EAL HP+F
Sbjct: 278 --------NVFS------DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-42
Identities = 89/341 (26%), Positives = 140/341 (41%), Gaps = 100/341 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y+ L K+GEGT+G V + D+ + +VA+K +R ++ E A+ EI +L+ L H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HH 78
Query: 149 -------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMHEL 180
D+ + ++ QLL VA H+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
R++H DLKP+N+L+ + DG+ +KL DFG + F
Sbjct: 139 RILHRDLKPQNLLI-----------------NSDGA----------LKLADFGLARAFGI 171
Query: 240 QDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHL 294
SY VV T YRAP+V++G Y D+WS+GCI E+ +G+ LF + + L
Sbjct: 172 PVRSYTHEVV-TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229
Query: 295 AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP----N 349
+ +LG P P +WP WK
Sbjct: 230 PKIFSILGTPNPR--------------------EWPQVQELPL-----WKQRTFQVFEKK 264
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+ + IDLL +L +DP +R+ AR+A+ HP+F
Sbjct: 265 PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 86/339 (25%), Positives = 137/339 (40%), Gaps = 97/339 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + +N E A+K +R + K E + EI +L+ L +H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 149 -------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMHEL 180
D+ T+ R + QLL +A+ H+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
R++H DLKP+N+L+ +++G +K+ DFG + F
Sbjct: 120 RVLHRDLKPQNLLI-----------------NREG----------ELKIADFGLARAFGI 152
Query: 240 QDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHL 294
Y +V T YRAP+V++G Y D+WSVGCI E+ +G LF + L
Sbjct: 153 PVRKYTHEIV-TLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 295 AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAVWKLLRLPNLI 351
+ R+LG P +WP+ V++ P
Sbjct: 211 MRIFRILGTPNSK--------------------NWPNVTELPKYDPNFTVYE----PLPW 246
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+ IDLL +L+ DP +R+ A++AL H +F
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 88/340 (25%), Positives = 141/340 (41%), Gaps = 97/340 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L +H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60
Query: 149 -------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMHEL 180
D+ + + ++V+ QLL+ + F H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
++H DLKP+N+L+ +++G +KL +FG + F
Sbjct: 121 NVLHRDLKPQNLLI-----------------NRNGE----------LKLANFGLARAFGI 153
Query: 240 QDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS-GEALFQTHENLEHL 294
Y V T YR P+V+ G Y D+WS GCI EL + G LF ++ + L
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 295 AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL---PNL 350
+ R+LG P WP D +K +
Sbjct: 213 KRIFRLLGTPTEE--------------------QWPSMTKLPD-----YKPYPMYPATTS 247
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
++ V DLLQ LL+ +P +R+ A EAL+HP+F+
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 8e-42
Identities = 84/353 (23%), Positives = 131/353 (37%), Gaps = 105/353 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLAR 147
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 70
Query: 148 --------------------------------HDIGG----TRYRSFPIDLVRELGRQLL 171
D+ P + ++++ QLL
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 172 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 231
+ F+H R++H DLKP+NIL+ + G IKL D
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILV-----------------TSSG----------QIKLAD 163
Query: 232 FG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
FG VV T YRAPEV+L + P DLWSVGCI E+ + L
Sbjct: 164 FGLARIYSFQMALTSV----VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
F+ +++ L + V+G P WP
Sbjct: 219 FRGSSDVDQLGKILDVIGL-PGEED------------------WPRDVALPRQAFHSKSA 259
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+ + +D DLL L ++PA+R+ A AL HP+F +D+ R
Sbjct: 260 QPIEKFV-TDIDELG---KDLLLKCLTFNPAKRISAYSALSHPYF-QDLERCK 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 85/348 (24%), Positives = 135/348 (38%), Gaps = 101/348 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y L K+GEGT+ V + LVA+K +R ++ E A+ E+ +L+ L +H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KH 59
Query: 149 -------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMHEL 180
DI T + V+ QLL +A+ H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
+++H DLKP+N+L+ ++ G +KL DFG +
Sbjct: 120 KVLHRDLKPQNLLI-----------------NERG----------ELKLADFGLARAKSI 152
Query: 240 QDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHL 294
+Y VV T YR P+++LG +Y D+W VGCI E+ +G LF E L
Sbjct: 153 PTKTYDNEVV-TLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210
Query: 295 AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP----N 349
+ R+LG P WP ++ + +K P
Sbjct: 211 HFIFRILGTPTEE--------------------TWPGILSNEE-----FKTYNYPKYRAE 245
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
++ H D DLL LL+++ R+ A +A++HPFF +
Sbjct: 246 ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LSLGERI 292
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 73/347 (21%), Positives = 123/347 (35%), Gaps = 123/347 (35%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +H
Sbjct: 29 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 150 I----------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
+ +S + + +LE+V +H+
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
++H+DLKP N L+V DG +KLIDFG + +
Sbjct: 148 IVHSDLKPANFLIV------------------DGM----------LKLIDFGIANQMQPD 179
Query: 241 DHSYVVSTR----HYRAPEVILGLGW-----------NYPCDLWSVGCILVELCSGEALF 285
S V ++ +Y PE I + + D+WS+GCIL + G+ F
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
Q N ++ + ++ P +++PD
Sbjct: 240 QQIIN--QISKLHAIIDP-------------------NHEIEFPDIPEK----------- 267
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
DL D+L+ L+ DP +R+ E L HP+
Sbjct: 268 ---------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 73/352 (20%), Positives = 123/352 (34%), Gaps = 123/352 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +H
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 150 I----------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
+ +S + + +LE+V +H+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
++H+DLKP N L+V DG +KLIDFG + +
Sbjct: 129 IVHSDLKPANFLIV------------------DGM----------LKLIDFGIANQMQPD 160
Query: 241 DHSYVVSTR----HYRAPEVILGLG-----------WNYPCDLWSVGCILVELCSGEALF 285
S V ++ +Y PE I + + D+WS+GCIL + G+ F
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
Q N ++ + ++ P +++PD
Sbjct: 221 QQIIN--QISKLHAIIDP-------------------NHEIEFPDIPEK----------- 248
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
DL D+L+ L+ DP +R+ E L HP+
Sbjct: 249 ---------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 83/340 (24%), Positives = 133/340 (39%), Gaps = 96/340 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL- 69
Query: 147 RH-------DIGGTRYR---------------------SFPIDLVRELGRQLLESVAFMH 178
H D G + ++ L+ + ++H
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 237
+ ++H DLKP N+LL ++G +KL DFG + +F
Sbjct: 130 QHWILHRDLKPNNLLL-----------------DENG----------VLKLADFGLAKSF 162
Query: 238 EHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLE 292
+ +Y VV TR YRAPE++ G Y D+W+VGCIL EL +L+
Sbjct: 163 GSPNRAYTHQVV-TRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL--PNL 350
L + LG P E+ WPD + D + +
Sbjct: 221 QLTRIFETLGT-PT----------EEQ--------WPDMCSLPD-----YVTFKSFPGIP 256
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+ + DL+DL+QGL ++P R+ A +AL+ +F+
Sbjct: 257 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-40
Identities = 67/341 (19%), Positives = 114/341 (33%), Gaps = 100/341 (29%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
T Y + +G G++ C A+KI I+K + EI++L R +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74
Query: 148 H-------DI---------------GG------TRYRSFPIDLVRELGRQLLESVAFMHE 179
H D+ GG R + F + + ++V ++H
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 238
++H DLKP NIL V +I++ DFG +
Sbjct: 135 QGVVHRDLKPSNILYVDES-----------------------GNPESIRICDFGFAKQLR 171
Query: 239 HQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
++ T ++ APEV+ G++ CD+WS+G +L + +G F + +
Sbjct: 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ R+ + G W V
Sbjct: 232 LARIG---------------------SGKFSLSGGY---------WN----------SVS 251
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+A DL+ +L DP +RL A LRHP+ + P
Sbjct: 252 DTAKDLVS---KMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 84/356 (23%), Positives = 139/356 (39%), Gaps = 111/356 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRL--- 145
+Y L+K+G+GTFG+V + + + VA+K V + +E A+ EI +LQ L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHE 76
Query: 146 -----------------------------ARHDIGG---TRYRSFPIDLVRELGRQLLES 173
HD+ G F + ++ + + LL
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ ++H +++H D+K N+L+ ++DG +KL DFG
Sbjct: 137 LYYIHRNKILHRDMKAANVLI-----------------TRDGV----------LKLADFG 169
Query: 234 -----STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEA 283
S Q + Y VV T YR PE++LG +Y P DLW GCI+ E+ +
Sbjct: 170 LARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSP 227
Query: 284 LFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 342
+ Q + LA++ ++ G P WP+ +
Sbjct: 228 IMQGNTEQHQLALISQLCGSITPE--------------------VWPNVDNYEL-----Y 262
Query: 343 KLLRLP----NLIMQHVDHSAGDL--IDLLQGLLRYDPAERLKAREALRHPFFTRD 392
+ L L + + D +DL+ LL DPA+R+ + +AL H FF D
Sbjct: 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 73/349 (20%), Positives = 123/349 (35%), Gaps = 123/349 (35%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +H
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 150 I----------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
+ +S + + +LE+V +H+
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
++H+DLKP N L+V DG +KLIDFG + +
Sbjct: 176 IVHSDLKPANFLIV------------------DGM----------LKLIDFGIANQMQPD 207
Query: 241 DHSYVVSTR----HYRAPEVILGLGWN-----------YPCDLWSVGCILVELCSGEALF 285
S V ++ +Y PE I + + D+WS+GCIL + G+ F
Sbjct: 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
Query: 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
Q N ++ + ++ P +++PD
Sbjct: 268 QQIIN--QISKLHAIIDP-------------------NHEIEFPDIPEK----------- 295
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394
DL D+L+ L+ DP +R+ E L HP+
Sbjct: 296 ---------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 64/340 (18%), Positives = 117/340 (34%), Gaps = 104/340 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-I-- 150
+ ++ +G+G FGQVV+ + AIK +R + + E+ +L L H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVR 66
Query: 151 --------------------------------GGT-------RYRSFPIDLVRELGRQLL 171
GT + D L RQ+L
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 172 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 230
E+++++H +IH DLKP NI + + VK+ D F L+++ L +
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD--FGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 231 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHE 289
D ++ + T Y A EV+ G G N D++S+G I E+ F T
Sbjct: 185 DNLTS---------AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGM 232
Query: 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349
++ ++++ R +++P
Sbjct: 233 ERVNI--LKKL---------------------RSVSIEFPP------------------- 250
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
D+ +++ L+ +DP +R AR L +
Sbjct: 251 ---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 88/337 (26%), Positives = 146/337 (43%), Gaps = 46/337 (13%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ +Y ++ K+G+G +G V + D E+VA+K I + +A EI +L L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65
Query: 146 ARH-------DIGGTRYRSFP-IDLVRE-----LGR-----------------QLLESVA 175
+ H ++ R + + LV + L QL++ +
Sbjct: 66 SGHENIVNLLNV--LRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGS 234
++H L+H D+KP NILL + +VKV D F LSRS + N S + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVAD--FGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
YV TR YRAPE++LG + D+WS+GCIL E+ G+ +F +
Sbjct: 182 DDQPILTD-YVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 294 LAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
L + V+ P + A+ +++ + WK L L
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV-EIRQSNKRDIFTKWKNLLLKINPK 298
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ A +DLL LL+++P +R+ A +AL+HPF
Sbjct: 299 ADCNEEA---LDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 75/351 (21%), Positives = 130/351 (37%), Gaps = 103/351 (29%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G ++ + +L+ Y+ + K+G G +G+V+ C D AIKI+
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 135 AMIEIDVLQRLARHDI---------------------GG------TRYRSFPIDLVRELG 167
+ E+ VL+ L +I GG F +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
+Q+L V ++H+ ++H DLKPEN+LL S E K + I
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKE------------------------KDALI 178
Query: 228 KLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
K++DFG + + T +Y APEV+ ++ CD+WS+G IL L +G F
Sbjct: 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237
Query: 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
+ E ++ +V + + F +W
Sbjct: 238 GGQTDQE---ILRKVE-------------KGKYTFD---SPEWK---------------- 262
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+V A DL++ +L++D R+ A++AL HP+ +
Sbjct: 263 --------NVSEGA---KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 86/341 (25%), Positives = 141/341 (41%), Gaps = 79/341 (23%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLA 146
N++ +++ S +GEG +G V E+VAIK + +K A EI +L+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 147 RHD--------IGGTRYRSFP-IDLVRE-----LGR-----------------QLLESVA 175
+H+ + +F + +++E L R Q L +V
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGS 234
+H +IH DLKP N+L+ S +KV D F L+R + + + P +++
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCD--FGLARIIDESAADNSEPTGQQSGMVE--- 181
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
+V TR YRAPEV+L ++ D+WS GCIL EL +F +
Sbjct: 182 ---------FVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 294 LAMMERVLG-PLPHHMVIR-ADRRAEKYFR---RGARLDWPDGATSRDSMRAVWKLLRLP 348
L ++ ++G P + + RA +Y + P
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK---------------MFP 276
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
V+ IDLLQ +L +DPA+R+ A+EAL HP+
Sbjct: 277 R-----VNPKG---IDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 59/332 (17%), Positives = 97/332 (29%), Gaps = 112/332 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ LS++G G++G+V + E L A+K S K R + E+ +++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 150 ----------------I-----GGT-------RYRSFPIDLVRELGRQLLESVAFMHELR 181
+ G + S P V R L ++A +H
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
L+H D+KP NI L G KL DFG
Sbjct: 178 LVHLDVKPANIFL-----------------GPRGR----------CKLGDFGLLVELGTA 210
Query: 241 DHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
Y APE++ G + D++S+G ++E+ L E + L
Sbjct: 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQGY 268
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+ + S +
Sbjct: 269 LPPEFTAGL-------------------------SSE----------------------- 280
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
L +L +L DP R A L P +
Sbjct: 281 --LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 79/347 (22%), Positives = 132/347 (38%), Gaps = 103/347 (29%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAM 136
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 137 IEIDVLQRLARHDI---------------------GG------TRYRSFPIDLVRELGRQ 169
E+++L++L +I GG + + F + +Q
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+ + +MH+ ++H DLKPENILL S E K IK+
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKI 165
Query: 230 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287
IDFG +T Q+ + T +Y APEV+ G ++ CD+WS G IL L SG F
Sbjct: 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347
+ +++RV + F W
Sbjct: 225 KNEYD---ILKRVE-------------TGKYAFDLP---QWR------------------ 247
Query: 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394
+ A DLI + +L + P+ R+ A + L HP+ +
Sbjct: 248 ------TISDDAKDLI---RKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 54/349 (15%), Positives = 98/349 (28%), Gaps = 92/349 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARH-- 148
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 149 -----DI-----------------GG---------TRYRSFPIDLVRELGRQLLESVAFM 177
I G + P + R ++ + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 236
E ++H ++KP NI+ V E S KL DFG +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFGAARE 165
Query: 237 FEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVELCSGEALFQT 287
E + + T Y P++ DLWS+G +G F+
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 288 HENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
E +M +++ P + +DW S+ ++L
Sbjct: 226 FEGPRRNKEVMYKIITGKPS------GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL- 278
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
L +L +L D + +
Sbjct: 279 ---------------LTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 79/351 (22%), Positives = 134/351 (38%), Gaps = 104/351 (29%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI 137
G +V + RY+ +G+G+FG+V+ C D + A+K++ R + + + +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 138 --EIDVLQRLARHDI---------------------GG------TRYRSFPIDLVRELGR 168
E+ +L++L +I GG + F + R
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+L + +MH+ +++H DLKPEN+LL S K + I+
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKS------------------------KDANIR 169
Query: 229 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
+IDFG +T + T +Y APEV+ G ++ CD+WS G IL L SG F
Sbjct: 170 IIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN 228
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
+ ++++V + + F W
Sbjct: 229 GANEYD---ILKKVE-------------KGKYTFELP---QWK----------------- 252
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
V SA DLI + +L Y P+ R+ AR+AL H + +
Sbjct: 253 -------KVSESAKDLI---RKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 74/333 (22%), Positives = 120/333 (36%), Gaps = 106/333 (31%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARH-------DI-- 150
GEG+F +C + + A+KI I+K EA EI L+ H ++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 151 -------------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 191
GG + + F + R+L+ +V+ MH++ ++H DLKPEN
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136
Query: 192 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDHSY--VVST 248
+L + IK+IDFG + + T
Sbjct: 137 LLFTDEN------------------------DNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF----QTHENLEHLAMMERVLGPL 304
HY APE++ G++ CDLWS+G IL + SG+ F ++ + +M+++
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--- 229
Query: 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364
+ A WK +V A DLI
Sbjct: 230 ------------------KGDFSFEGEA---------WK----------NVSQEAKDLI- 251
Query: 365 LLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
QGLL DP +RLK + + + +
Sbjct: 252 --QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 65/362 (17%), Positives = 121/362 (33%), Gaps = 113/362 (31%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLA 146
++L +G G+ G VV + + VA+K + + + A++EI +L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR---MLIDFCDIALMEIKLLTESD 66
Query: 147 RH----------------------------------DIGGTRYRSFPIDLVRELGRQLLE 172
H ++ + L RQ+
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
VA +H L++IH DLKP+NIL+ + SS+ + + ++ I + DF
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVST--------------SSRFTADQQTGAENLRILISDF 172
Query: 233 G-STTFEHQDHSYVVSTRH------YRAPEVILGLGW-------NYPCDLWSVGCIL-VE 277
G + S+ + + +RAPE++ D++S+GC+
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 278 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 337
L G+ F + +
Sbjct: 233 LSKGKHPF------------------------------------------GDKYSRESNI 250
Query: 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+R ++ L + L + + A DLI ++ +DP +R A + LRHP F ++
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLI---SQMIDHDPLKRPTAMKVLRHPLFWPKSKKLE 307
Query: 398 LL 399
L
Sbjct: 308 FL 309
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 67/343 (19%), Positives = 114/343 (33%), Gaps = 101/343 (29%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-- 145
+ L +Y I +G G FG V C + K+ K V+ + EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 146 ----ARHDI---------------GG-------TRYRSFPIDLVRELGRQLLESVAFMHE 179
H+ G T + Q+ E++ F+H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
+ H D++PENI+ + +SS IK+I+FG
Sbjct: 121 HNIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFGQARQLK 155
Query: 240 QDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
++ + + Y APEV + D+WS+G ++ L SG F N + ++
Sbjct: 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II 212
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
E ++ AE F A + + +
Sbjct: 213 ENIM-------------NAEYTFDEEA---FKE------------------------ISI 232
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLLV 400
A D + LL + R+ A EAL+HP+ + + R + V
Sbjct: 233 EAMDFV---DRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 5e-35
Identities = 71/334 (21%), Positives = 116/334 (34%), Gaps = 99/334 (29%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
N+ + + +G G F +V +L A+K ++ +R++++ EI VL+++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 147 RHDI---------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHE 179
+I GG + + +Q+L +V ++HE
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 238
++H DLKPEN+L ++ E ++S I + DFG S +
Sbjct: 125 NGIVHRDLKPENLLYLTPE------------------------ENSKIMITDFGLSKMEQ 160
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ S T Y APEV+ ++ D WS+G I L G F E L E
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKL--FE 217
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
++ F W D + S
Sbjct: 218 KIK-------------EGYYEFESP---FWDD------------------------ISES 237
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
A D I LL DP ER +AL HP+ +
Sbjct: 238 AKDFIC---HLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 68/349 (19%), Positives = 116/349 (33%), Gaps = 114/349 (32%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+T Y++ ++ G G G+V+ECF + A+K+ + A E+D + +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD-SPKARQEVDHHWQAS 79
Query: 147 RH-----------DIGGTRYRSFPIDLVREL---G-----------------------RQ 169
++ + ++ E G R
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLL---IIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+ ++ F+H + H D+KPEN+L S E K + +KL
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVLKL 172
Query: 230 IDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT- 287
DFG + T +Y APEV+ ++ CD+WS+G I+ L G F +
Sbjct: 173 TDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232
Query: 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347
M R+ R + +P+ W
Sbjct: 233 TGQAISPGMKRRI---------------------RLGQYGFPNP---------EWS---- 258
Query: 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
V A LI + LL+ DP ERL + + HP+ + + P
Sbjct: 259 ------EVSEDAKQLI---RLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 80/350 (22%), Positives = 132/350 (37%), Gaps = 103/350 (29%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 135 AMIEIDVLQRLARHDI---------------------GG------TRYRSFPIDLVRELG 167
+ E+++L++L +I GG + + F +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
+Q+ + +MH+ ++H DLKPENILL S E K I
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDI 163
Query: 228 KLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
K+IDFG +T Q+ + T +Y APEV+ G ++ CD+WS G IL L SG F
Sbjct: 164 KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222
Query: 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
+N +++RV + F W
Sbjct: 223 -YGKNEY--DILKRVE-------------TGKYAFDLP---QWR---------------- 247
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
+ A DLI +L + P+ R+ A + L HP+ +
Sbjct: 248 --------TISDDAKDLIR---KMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 70/367 (19%), Positives = 118/367 (32%), Gaps = 109/367 (29%)
Query: 66 PRTGSPPW-RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
P S + + ++ + Y + ++G+G F V C A KI
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 125 VRSINK----YREAAMI--EIDVLQRLARHDI---------------------GG----- 152
IN R+ + E + ++L +I GG
Sbjct: 62 ---INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 153 -TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211
+ +Q+LES+A+ H ++H +LKPEN+LL S
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------- 165
Query: 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLW 269
K +A+KL DFG + ++ T Y +PEV+ ++ P D+W
Sbjct: 166 -----------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 270 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 329
+ G IL L G F E+ + ++ + +W
Sbjct: 215 ACGVILYILLVGYPPFW-DED--QHRLYAQIK-------------AGAYDYPSP---EWD 255
Query: 330 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
V A LID +L +P +R+ A +AL+ P+
Sbjct: 256 ------------------------TVTPEAKSLID---SMLTVNPKKRITADQALKVPWI 288
Query: 390 TRDVRRP 396
R
Sbjct: 289 CNRERVA 295
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 85/356 (23%), Positives = 136/356 (38%), Gaps = 77/356 (21%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
+ + Y +G++ + RY+ L +G G G V +D VAIK + R
Sbjct: 41 KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 100
Query: 130 KYREA--AMIEIDVLQRLARHD--IG-------GTRYRSFP-IDLVRELGR--------- 168
A A E+ +++ + H I F + LV EL
Sbjct: 101 NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 159
Query: 169 ------------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216
Q+L + +H +IH DLKP NI++ S
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------------- 199
Query: 217 YFKNLPKSSAIKLIDFG-STTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
+K++DFG + T YVV TR+YRAPEVILG+G+ D+WSVGC
Sbjct: 200 -------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 274 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 333
I+ E+ + LF + ++ + LG + + Y +
Sbjct: 252 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK-------Y 304
Query: 334 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + ++ P +H A DLL +L DPA+R+ +AL+HP+
Sbjct: 305 AGLTFPKLFPDSLFPADS-EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 82/372 (22%), Positives = 134/372 (36%), Gaps = 109/372 (29%)
Query: 93 RYRILS-KMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL---- 145
+ K+G GT+G V + D + + A+K + +A EI +L+ L
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPN 79
Query: 146 ----------------------ARHD-----------IGGTRYRSFPIDLVRELGRQLLE 172
A HD + P +V+ L Q+L+
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
+ ++H ++H DLKP NIL++ P+ +K+ D
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADM 176
Query: 233 G-STTFEHQDHSY-----VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEAL 284
G + F VV T YRAPE++LG +Y D+W++GCI EL + E +
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPI 235
Query: 285 FQ---------THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD----- 330
F + + L + V+G P +K DW D
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGF-PA----------DK--------DWEDIKKMP 276
Query: 331 --GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+D R + L + +H LLQ LL DP +R+ + +A++ P+
Sbjct: 277 EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336
Query: 389 FTRDVRRPTLLV 400
F + PT V
Sbjct: 337 F-LEDPLPTSDV 347
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 74/358 (20%), Positives = 114/358 (31%), Gaps = 106/358 (29%)
Query: 89 NLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLA 146
Y++ + GEG +V C + + A+KI+ + R E+++L +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 147 RH-------DIGGTRYRSFPIDLVREL---G---------------------RQLLESVA 175
H + R + LV E G + + ++
Sbjct: 69 GHRNVLELIEFFEEEDRFY---LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 234
F+H + H DLKPENIL + S +K+ DF
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPN------------------------QVSPVKICDFDLG 161
Query: 235 TTFEHQDHSYVVSTR---------HYRAPEVILGLGW---NY--PCDLWSVGCILVELCS 280
+ + +ST Y APEV+ Y CDLWS+G IL L S
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
G F P +M+ + + + F DW
Sbjct: 222 GYPPFV-GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK---DWA----------- 266
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
H+ +A DLI LL D +RL A + L+HP+ TL
Sbjct: 267 -------------HISCAAKDLI---SKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 98/413 (23%), Positives = 146/413 (35%), Gaps = 110/413 (26%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
+ G + + RY I +G G++G V E +D +K +VAI
Sbjct: 24 QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83
Query: 123 K-IVRSINKYREAAMI--EIDVLQRLARHD--------IGGTRYRSF------------- 158
K I+R + I EI +L RL HD + F
Sbjct: 84 KKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142
Query: 159 -------PIDLVRELGR----QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207
P+ L + LL V ++H ++H DLKP N L+ VKV D F
Sbjct: 143 FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD--F 200
Query: 208 -LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLG 261
L+R+ + S + T ++ +VV TR YRAPE+IL
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILLQE 259
Query: 262 WNY--PCDLWSVGCILVELCS-----------GEALF--------------------QTH 288
NY D+WS+GCI EL + LF T
Sbjct: 260 -NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318
Query: 289 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKY---FRRGARLDWPDGATSRDSMRAVWKL 344
N + L ++ +LG P + A++Y F + D +
Sbjct: 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE-------------- 364
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
R P A I LL+ +L ++P +R+ E L HPFF ++VR
Sbjct: 365 -RFPA-----SSADA---IHLLKRMLVFNPNKRITINECLAHPFF-KEVRIAE 407
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 72/353 (20%), Positives = 126/353 (35%), Gaps = 114/353 (32%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------------SINKYRE 133
+ Y + K+G G +G+V+ C + AIK+++ +I K+ E
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 134 AAMIEIDVLQRLARHDI---------------------GG------TRYRSFPIDLVREL 166
EI +L+ L +I GG F +
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 167 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226
+Q+L + ++H+ ++H D+KPENILL +
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKN------------------------SLLN 187
Query: 227 IKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
IK++DFG ++F +D+ + T +Y APEV+ +N CD+WS G I+ L G
Sbjct: 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
F + + ++++V + + YF DW
Sbjct: 247 FGGQNDQD---IIKKVE-------------KGKYYFDFN---DWK--------------- 272
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
++ A +LI + +L YD +R A EAL + +
Sbjct: 273 ---------NISDEAKELI---KLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 89/355 (25%), Positives = 139/355 (39%), Gaps = 95/355 (26%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYRE 133
K G Y + + Y + +G G +G V D E VAIK + R
Sbjct: 7 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66
Query: 134 A--AMIEIDVLQRLARHD---------IGGTRYRSFP-IDLVRE-----LGR-------- 168
A A E+ +L+ + +H+ + R+F LV L +
Sbjct: 67 AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE 125
Query: 169 --------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
Q+L+ + ++H ++H DLKP N+ +
Sbjct: 126 EKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE------------------------ 161
Query: 221 LPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVEL 278
+K++DFG + + + YVV TR YRAPEVIL N D+WSVGCI+ E+
Sbjct: 162 ---DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
Query: 279 CSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWPDGATS 334
+G+ LF+ + L+ L + +V G P + D+ A+ Y + + R D+
Sbjct: 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ---- 273
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
P A DLL+ +L D +RL A +AL HPFF
Sbjct: 274 -----------LFPR-----ASPQA---ADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 74/358 (20%), Positives = 120/358 (33%), Gaps = 113/358 (31%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVL 142
+L RY L +G G G V DN+ + VAIK + + RE I ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-----IKII 62
Query: 143 QRLARHD-----------------IGGTRYRSFP-IDLVRE-----LGR----------- 168
+RL HD + +V+E L
Sbjct: 63 RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121
Query: 169 ------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222
QLL + ++H ++H DLKP N+ + +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-------------------------- 155
Query: 223 KSSAIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCI 274
+ +K+ DFG H H +V T+ YR+P ++L + D+W+ GCI
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCI 214
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR---RGARLDWPDG 331
E+ +G+ LF LE + ++ + + Y R
Sbjct: 215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ- 273
Query: 332 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
LP + A +D L+ +L + P +RL A EAL HP+
Sbjct: 274 --------------LLPG-----ISREA---VDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 71/255 (27%), Positives = 111/255 (43%), Gaps = 60/255 (23%)
Query: 142 LQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201
L ++ + I RS P++L+ QL +V F+H L + H D+KP+N+L+
Sbjct: 124 LHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV------- 174
Query: 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVIL 258
N K + +KL DFGS + +Y+ +R YRAPE++L
Sbjct: 175 ------------------N-SKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELML 214
Query: 259 GLGWNYPC--DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRA--DR 314
G Y DLWS+GC+ EL G+ LF +++ L + +++G P +
Sbjct: 215 G-ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT-PTKEQMIRMNPH 272
Query: 315 RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374
E F DW K+L + + IDLL+ +LRY+P
Sbjct: 273 YTEVRFPTLKAKDWR-------------KILP---------EGTPSLAIDLLEQILRYEP 310
Query: 375 AERLKAREALRHPFF 389
R+ EA+ HPFF
Sbjct: 311 DLRINPYEAMAHPFF 325
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-34
Identities = 68/344 (19%), Positives = 114/344 (33%), Gaps = 111/344 (32%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQ 143
++ Y + + +G G++G+V + A K I KY + EI++++
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61
Query: 144 RLARHDI---------------------GG------TRYRSFPIDLVRELGRQLLESVAF 176
L +I GG R F + + +L +VA+
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
H+L + H DLKPEN L ++ S +KLIDFG
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKLIDFGLAA 157
Query: 237 FEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 292
V T +Y +P+V+ G + CD WS G ++ L G F T +
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV- 215
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
M ++ +P+ W
Sbjct: 216 ----MLKIR---------------------EGTFTFPE---------KDWL--------- 232
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+V A LI + LL P +R+ + +AL H +F + +
Sbjct: 233 -NVSPQAESLI---RRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 87/356 (24%), Positives = 139/356 (39%), Gaps = 77/356 (21%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
R + Y IG++ + RY+ L +G G G V +D + VAIK + R
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IG-------GTRYRSFP-IDLVRE-----LGR---- 168
A A E+ +++ + H IG F + +V E L +
Sbjct: 64 NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 122
Query: 169 ------------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216
Q+L + +H +IH DLKP NI++ S
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------------- 162
Query: 217 YFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273
+K++DFG + YVV TR+YRAPEVILG+G+ D+WSVGC
Sbjct: 163 -------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 274 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 333
I+ E+ G LF ++++ + LG + + Y +
Sbjct: 215 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK-------Y 267
Query: 334 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ S ++ + P +H A DLL +L D ++R+ EAL+HP+
Sbjct: 268 AGYSFEKLFPDVLFPADS-EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 88/354 (24%), Positives = 136/354 (38%), Gaps = 97/354 (27%)
Query: 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--E 138
V ++ PRY LS +GEG +G V +DN K VAIK + E
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75
Query: 139 IDVLQRLARHD--------IGGTRYRSFP-IDLVRE-----LGR---------------- 168
I +L R RH+ I + +V++ L +
Sbjct: 76 IKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 169 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
Q+L + ++H ++H DLKP N+LL + + +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 167
Query: 228 KLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 279
K+ DFG DH+ YV TR YRAPE++L G+ D+WSVGCIL E+
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 280 SGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWPDGATSR 335
S +F L+ L + +LG P + + +A Y ++ W
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR----- 281
Query: 336 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
PN D A +DLL +L ++P +R++ +AL HP+
Sbjct: 282 ----------LFPN-----ADSKA---LDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 78/334 (23%), Positives = 121/334 (36%), Gaps = 103/334 (30%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRL 145
+ L+ + + S++G G V C ++ A+K + K + ++ EI VL RL
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRL 105
Query: 146 ARHDI---------------------GG------TRYRSFPIDLVRELGRQLLESVAFMH 178
+ +I GG + + +Q+LE+VA++H
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 237
E ++H DLKPEN+L + + +K+ DFG S
Sbjct: 166 ENGIVHRDLKPENLLYATPA------------------------PDAPLKIADFGLSKIV 201
Query: 238 EHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
EHQ V T Y APE++ G + D+WSVG I L G F + M
Sbjct: 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM 259
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
R+L E YF W + V
Sbjct: 260 FRRIL-------------NCEYYFISP---WWDE------------------------VS 279
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+A DL+ L+ DP +RL +AL+HP+ T
Sbjct: 280 LNAKDLVR---KLIVLDPKKRLTTFQALQHPWVT 310
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 73/348 (20%), Positives = 111/348 (31%), Gaps = 113/348 (32%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-- 137
G + + K+G G FG V + IK INK R +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66
Query: 138 ---EIDVLQRLA-------------RHDI--------GG----------TRYRSFPIDLV 163
EI+VL+ L H++ GG R ++ V
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 164 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223
EL +Q++ ++A+ H ++H DLKPENIL
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS------------------------P 162
Query: 224 SSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
S IK+IDFG D T Y APEV + CD+WS G ++ L +G
Sbjct: 163 HSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTG 221
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
F +LE + ++ E + +
Sbjct: 222 CLPFT-GTSLE--EVQQKAT-------------YKEPNYAV----EC------------- 248
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + A DL+ + +L DP R A + L H +F
Sbjct: 249 -----------RPLTPQAVDLL---KQMLTKDPERRPSAAQVLHHEWF 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 63/347 (18%), Positives = 94/347 (27%), Gaps = 133/347 (38%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-I- 150
++ + +G G FGQV + + IK + E A E+ L +L H I
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKL-DHVNIV 67
Query: 151 ------------------------------------GGT--------RYRSFPIDLVREL 166
GT R L EL
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 167 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226
Q+ + V ++H +LI+ DLKP NI L
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFL-----------------VDTKQ---------- 160
Query: 227 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
+K+ DFG T+ ++ + T Y +PE I + DL+++G IL EL +
Sbjct: 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HV 217
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
T R G + +
Sbjct: 218 CDTAFETSKFFTDLR-DGIISDIF-------------------------DKK-------- 243
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
LLQ LL P +R E LR +
Sbjct: 244 -----------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 64/341 (18%), Positives = 118/341 (34%), Gaps = 117/341 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEG+FG+ + E IK + K RE + E+ VL + +H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83
Query: 150 -I---------------------GGT--------RYRSFPIDLVRELGRQLLESVAFMHE 179
I GG + F D + + Q+ ++ +H+
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 238
+++H D+K +NI L +KDG+ ++L DFG +
Sbjct: 144 RKILHRDIKSQNIFL-----------------TKDGT----------VQLGDFGIARVLN 176
Query: 239 HQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ T +Y +PE+ +N D+W++GC+L ELC+ + F+ ++++L +
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVL 235
Query: 297 --MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
+ P+ H S D
Sbjct: 236 KIISGSFPPVSLHY-------------------------SYD------------------ 252
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
L L+ L + +P +R L F + + +
Sbjct: 253 -------LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 88/360 (24%), Positives = 139/360 (38%), Gaps = 96/360 (26%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
P + G Y + + + YR L +G G +G V D VAIK + R
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD---------IGGTRYRSFP-IDLVRE-----LGR---- 168
A A E+ +L+ + RH+ F LV LG+
Sbjct: 64 SELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 169 -------------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215
Q+L+ + ++H +IH DLKP N+ +
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE------------------- 163
Query: 216 SYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGC 273
+K++DFG + + + YVV TR YRAPEVIL + D+WSVGC
Sbjct: 164 --------DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 274 ILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWP 329
I+ E+ +G+ LF+ ++L+ L + +V G P + A+ Y + + D+
Sbjct: 215 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 274
Query: 330 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
L N A ++LL+ +L D +R+ A EAL HP+F
Sbjct: 275 S---------------ILTN-----ASPLA---VNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 69/347 (19%), Positives = 114/347 (32%), Gaps = 108/347 (31%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEIDV 141
+ Y + ++G+G F V C A KI IN + + E +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARI 58
Query: 142 LQRLARHDI---------------------GG------TRYRSFPIDLVRELGRQLLESV 174
++L +I GG + +Q+LES+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 118
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
A+ H ++H +LKPEN+LL S K +A+KL DFG
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKA------------------------KGAAVKLADFGL 154
Query: 235 TTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
+ ++ T Y +PEV+ ++ P D+W+ G IL L G F E+
Sbjct: 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF-WDED-- 211
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
+ ++ D+P W
Sbjct: 212 QHRLYAQIK---------------------AGAYDYPS---------PEWD--------- 232
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLL 399
V A LID +L +P +R+ A +AL+ P+ R + +
Sbjct: 233 -TVTPEAKSLID---SMLTVNPKKRITADQALKVPWICNRERVASAI 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 53/339 (15%), Positives = 98/339 (28%), Gaps = 97/339 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ L K+G G FG V +C + AIK + + + + A+ E+ L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 150 ----------------I------GGT----------RYRSFPIDLVRELGRQLLESVAFM 177
I GG+ F +++L Q+ + ++
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H + L+H D+KP NI + + K+ D G T
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKIGDLGHVTR 183
Query: 238 EHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ A EV+ D++++ +V E L + + +
Sbjct: 184 ISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
G LP R+P
Sbjct: 243 -----GRLP----------------------------------------RIP-------Q 250
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
+ + +LL+ ++ DP R A ++H R+
Sbjct: 251 VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 68/341 (19%), Positives = 115/341 (33%), Gaps = 102/341 (29%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLA 146
++ Y IL ++G G FG V C + + K + + EI ++ +L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 147 RHDI---------------------GG-------TRYRSFPIDLVRELGRQLLESVAFMH 178
+ GG V RQ E + MH
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
E ++H D+KPENI+ + K+S++K+IDFG T
Sbjct: 167 EHSIVHLDIKPENIMCET-------------------------KKASSVKIIDFGLATKL 201
Query: 239 HQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ D +T + APE++ + D+W++G + L SG + F ++LE
Sbjct: 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---T 258
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
++ V ++ + A + V
Sbjct: 259 LQNVK---------------------RCDWEFDEDA---------FS----------SVS 278
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
A D I + LL+ +P +RL +AL HP+ D T
Sbjct: 279 PEAKDFI---KNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 69/351 (19%), Positives = 107/351 (30%), Gaps = 117/351 (33%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------EAAMIEI 139
Y + +G+G F V C + E + A+KI ++ + E E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77
Query: 140 DVLQRLARHDI---------------------GG----------TRYRSFPIDLVRELGR 168
+ L I G + + R
Sbjct: 78 SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+LE++ + H+ +IH D+KP +LL S E S+ +K
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------NSAPVK 173
Query: 229 LIDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285
L FG + V T H+ APEV+ + P D+W G IL L SG F
Sbjct: 174 LGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
+ E ++ + + W
Sbjct: 234 Y-GTKER---LFEGII-------------KGKYKMNPR---QWSH--------------- 258
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ SA DL+ + +L DPAER+ EAL HP+ R
Sbjct: 259 ---------ISESAKDLV---RRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 69/343 (20%), Positives = 117/343 (34%), Gaps = 103/343 (30%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-EIDVLQ 143
T Y++ ++G+G F V C + A I+ + ++ + E + +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 144 RLARHDI---------------------GG------TRYRSFPIDLVRELGRQLLESVAF 176
L +I GG + +Q+LE+V
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 235
H++ ++H +LKPEN+LL S K +A+KL DFG +
Sbjct: 126 CHQMGVVHRNLKPENLLLASKL------------------------KGAAVKLADFGLAI 161
Query: 236 TFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
E + ++ T Y +PEV+ + P DLW+ G IL L G F E+
Sbjct: 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW-DEDQHR 220
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
L +++ F +W
Sbjct: 221 L--YQQIK-------------AGAYDFPSP---EWDT----------------------- 239
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
V A DLI+ +L +P++R+ A EAL+HP+ +
Sbjct: 240 -VTPEAKDLIN---KMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 67/370 (18%), Positives = 116/370 (31%), Gaps = 113/370 (30%)
Query: 68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
PP +G N +RI K+G G F +V VA+K V+
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 128 IN----KYREAAMIEIDVLQRLARH--------------------------DIG------ 151
+ K R + EID+L++L H D+
Sbjct: 68 FDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF 126
Query: 152 GTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211
+ R P V + QL ++ MH R++H D+KP N+ +
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----------------- 169
Query: 212 SKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDL 268
+ G +KL D G F + +V T +Y +PE I G+N+ D+
Sbjct: 170 TATGV----------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 269 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW 328
WS+GC+L E+ + ++ F + + ++ +++ +
Sbjct: 220 WSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIE--------------------QCDYPPL 258
Query: 329 PDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
P S +L L+ + DP +R
Sbjct: 259 PSDHYSE-------------------------ELRQLVNMCINPDPEKRPDVTYVYDVAK 293
Query: 389 FTRDVRRPTL 398
+L
Sbjct: 294 RMHACTASSL 303
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 78/346 (22%), Positives = 123/346 (35%), Gaps = 111/346 (32%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMI--E 138
+ L Y + +G G G+V F+ + + VAI+I+ S + A + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 139 IDVLQRLARH-------------DI--------GG------TRYRSFPIDLVRELGRQLL 171
I++L++L H D GG + + Q+L
Sbjct: 191 IEILKKL-NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 172 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 231
+V ++HE +IH DLKPEN+LL S E + IK+ D
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITD 285
Query: 232 FGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQ 286
FG + + + T Y APEV++ + G+N D WS+G IL SG F
Sbjct: 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
H +++ +++ + ++ VW
Sbjct: 346 EHRT--QVSLKDQIT---------------------SGKYNFIP---------EVWA--- 370
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
V A DL+ LL DP R EALRHP+ +
Sbjct: 371 -------EVSEKALDLVK---KLLVVDPKARFTTEEALRHPWLQDE 406
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 66/344 (19%), Positives = 111/344 (32%), Gaps = 105/344 (30%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDV 141
+ Y + ++G G F V +C + A K ++ RE E+++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 142 LQRLA-------------RHDI--------GG------TRYRSFPIDLVRELGRQLLESV 174
L+ + + D+ GG S D + +Q+L+ V
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 233
++H R+ H DLKPENI+L+ + IKLIDFG
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKN-----------------------VPNPRIKLIDFGI 158
Query: 234 STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
+ E + + T + APE++ D+WS+G I L SG + F E
Sbjct: 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
+ + D+ + +
Sbjct: 219 ---TLTNIS---------------------AVNYDFDEEY---------FS--------- 236
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ A D I + LL DP R+ ++L H + RR
Sbjct: 237 -NTSELAKDFI---RRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 67/347 (19%), Positives = 114/347 (32%), Gaps = 105/347 (30%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLA-------------RHDI--------GG------TRYRSFPIDLVRELGRQLLES 173
+L+ + + D+ GG S + E +Q+L
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
V ++H L++ H DLKPENI+L+ IK+IDFG
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPRIKIIDFG 163
Query: 234 -STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
+ + + + T + APE++ D+WS+G I L SG + F
Sbjct: 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
E + V ++ D +
Sbjct: 224 E---TLANVS---------------------AVNYEFEDEY---------FS-------- 242
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+ A D I + LL DP +R+ +++L+HP+ + L
Sbjct: 243 --NTSALAKDFI---RRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 75/408 (18%), Positives = 130/408 (31%), Gaps = 126/408 (30%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P P P P F ++G + D + V +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT--SQ 68
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
L G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 69 VL----------GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 114
Query: 149 -----------DIGGTRYRSFPIDLVREL--G------------------------RQLL 171
++ R +V E G + +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLL---IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 172 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 231
E++ ++H + + H D+KPEN+L S ++ +KL D
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILKLTD 207
Query: 232 FGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ-TH 288
FG +S T +Y APEV+ ++ CD+WS+G I+ L G F H
Sbjct: 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
M R+ R + F +W
Sbjct: 268 GLAISPGMKTRI-------------RMGQYEFPNP---EWS------------------- 292
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
V LI + LL+ +P +R+ E + HP+ + + P
Sbjct: 293 -----EVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 78/369 (21%), Positives = 124/369 (33%), Gaps = 110/369 (29%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
K + + + Y + + G++G V D+E VAIK V +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRT 63
Query: 135 AMI------------EIDVLQRLARHD--------IGGTRYRSFP-IDLVREL------- 166
I EI +L H + + LV EL
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 167 ----GR-------------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209
R +L + +HE ++H DL P NILL
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD------------- 169
Query: 210 RSSKDGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYP 265
++ I + DF T + YV R YRAPE+++ G+
Sbjct: 170 --------------NNDITICDFNLAREDTADANKTHYVT-HRWYRAPELVMQFKGFTKL 214
Query: 266 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRG- 323
D+WS GC++ E+ + +ALF+ L + V+G P +V+ + A Y R
Sbjct: 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274
Query: 324 ---ARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380
W +P D A +DL+ +L ++P R+
Sbjct: 275 SNVPARAWTA---------------VVPT-----ADPVA---LDLIAKMLEFNPQRRIST 311
Query: 381 REALRHPFF 389
+ALRHP+F
Sbjct: 312 EQALRHPYF 320
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 68/348 (19%), Positives = 115/348 (33%), Gaps = 105/348 (30%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 141 VLQRLARHDI---------------------GG------TRYRSFPIDLVRELGRQLLES 173
+L+++ H++ GG + S + +Q+L+
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
V ++H ++ H DLKPENI+L+ IKLIDFG
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPHIKLIDFG 164
Query: 234 -STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
+ E + T + APE++ D+WS+G I L SG + F
Sbjct: 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
E + + D+ + +
Sbjct: 225 E---TLANIT---------------------SVSYDFDEEF---------FS-------- 243
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLL 399
H A D I + LL + +RL +EALRHP+ T + ++
Sbjct: 244 --HTSELAKDFI---RKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 85/427 (19%), Positives = 129/427 (30%), Gaps = 131/427 (30%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
+++ R++ R P + N P + F P
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLA--EAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---- 125
P W + +Y +G G V C A+KI+
Sbjct: 83 LPDWAA-----------AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 126 -----RSINKYREAAMIEIDVLQRLARH-------DI---------------GG------ 152
+ + REA E +L+++A H D G
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191
Query: 153 TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212
T + R + R LLE+V+F+H ++H DLKPENILL
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD---------------- 235
Query: 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL------GWNY 264
+ I+L DFG + + T Y APE++ G+
Sbjct: 236 -----------NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 265 PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGA 324
DLW+ G IL L +G F H + M+ ++
Sbjct: 285 EVDLWACGVILFTLLAGSPPF-WHRR--QILMLRMIM---------------------EG 320
Query: 325 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 384
+ + W + DLI LL+ DP RL A +AL
Sbjct: 321 QYQFSSP---------EWD----------DRSSTVKDLIS---RLLQVDPEARLTAEQAL 358
Query: 385 RHPFFTR 391
+HPFF R
Sbjct: 359 QHPFFER 365
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 67/368 (18%), Positives = 108/368 (29%), Gaps = 112/368 (30%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN 129
SP DD D I + + +G G G +V VA+K + +
Sbjct: 4 SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58
Query: 130 KYREAAMIEIDVLQRLARHD---------------------IGGT-------RYRSFPID 161
+ A E+ +L+ H T + +
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL 118
Query: 162 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221
L +Q +A +H L ++H DLKP NIL+ N
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM----------------------PNA 156
Query: 222 PKSSAIKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGL---GWNYPCDLWSVG 272
+ DFG HS+ V T + APE++ Y D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 273 CILVE-LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 331
C+ + G F ++L+ A + L L
Sbjct: 217 CVFYYVISEGSHPF--GKSLQRQANILLGACSLDC-------------------LHPEK- 254
Query: 332 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
H D A +LI + ++ DP +R A+ L+HPFF
Sbjct: 255 ----------------------HEDVIARELI---EKMIAMDPQKRPSAKHVLKHPFFWS 289
Query: 392 DVRRPTLL 399
++
Sbjct: 290 LEKQLQFF 297
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 82/353 (23%), Positives = 123/353 (34%), Gaps = 111/353 (31%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMI-----E 138
+ L Y + +G G G+V F+ + + VAIKI+ +I REA E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 139 IDVLQRLARH-------------DI--------GG------TRYRSFPIDLVRELGRQLL 171
I++L++L H D GG + + Q+L
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 172 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 231
+V ++HE +IH DLKPEN+LL S E + IK+ D
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITD 160
Query: 232 FGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQ 286
FG + + + T Y APEV++ + G+N D WS+G IL SG F
Sbjct: 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
H L +++ + ++ VW
Sbjct: 221 EHRTQVSL--KDQIT---------------------SGKYNFIP---------EVWA--- 245
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLL 399
V A DL+ LL DP R EALRHP+ + +
Sbjct: 246 -------EVSEKALDLVK---KLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 79/347 (22%), Positives = 137/347 (39%), Gaps = 103/347 (29%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEID 140
+ RY+ LS +G G +G V FD + VA+K + + YRE +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LR 80
Query: 141 VLQRLARHD--IG-------GTRYRSFP-IDLVREL----------------------GR 168
+L+ + +H+ IG F + LV L
Sbjct: 81 LLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
Q+L + ++H +IH DLKP N+ + +K
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNE---------------------------DCELK 172
Query: 229 LIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 286
++DFG + + YV TR YRAPE++L +N D+WSVGCI+ EL +G LF
Sbjct: 173 ILDFGLARHTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 287 THENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWPDGATSRDSMRAVW 342
++++ L ++ R++G P + + A Y + + ++++ +
Sbjct: 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN------------ 279
Query: 343 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ A +DLL+ +L D +R+ A +AL H +F
Sbjct: 280 ---VFIG-----ANPLA---VDLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 54/340 (15%), Positives = 99/340 (29%), Gaps = 92/340 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARH-- 148
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 149 -----DI-----------------GG---------TRYRSFPIDLVRELGRQLLESVAFM 177
I G + P + R ++ + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 236
E ++H ++KP NI+ V E S KL DFG +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFGAARE 165
Query: 237 FEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVELCSGEALFQT 287
E + + T Y P++ DLWS+G +G F+
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 288 HENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
E +M +++ P + + +DW S+ ++L
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAI------SGVQKAENGPIDWSGDMPVSCSLSRGLQVL- 278
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386
L +L +L D + +
Sbjct: 279 ---------------LTPVLANILEADQEKCWGFDQFFAE 303
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 66/348 (18%), Positives = 113/348 (32%), Gaps = 105/348 (30%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 141 VLQRLARHDI---------------------GG------TRYRSFPIDLVRELGRQLLES 173
+L+++ +I GG + S + +Q+L+
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
V ++H ++ H DLKPENI+L+ IKLIDFG
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPHIKLIDFG 164
Query: 234 -STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
+ E + T + APE++ D+WS+G I L SG + F +
Sbjct: 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-GDT- 222
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
+ + D+ + +
Sbjct: 223 -KQETLANIT---------------------AVSYDFDEEF---------FS-------- 243
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLL 399
A D I + LL + +RL +EALRHP+ T + ++
Sbjct: 244 --QTSELAKDFI---RKLLVKETRKRLTIQEALRHPWITPVDTQQAMV 286
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 74/336 (22%), Positives = 107/336 (31%), Gaps = 102/336 (30%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLA 146
+++ Y I ++G G FG V + A K V + ++ +E EI + L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 147 R------HDI---------------GG-------TRYRSFPIDLVRELGRQLLESVAFMH 178
HD GG + D E RQ+ + + MH
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
E +H DLKPENI+ + +S+ +KLIDFG T
Sbjct: 273 ENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAHL 307
Query: 239 HQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
S T + APEV G Y D+WSVG + L SG + F + E
Sbjct: 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---T 364
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ V + D A + +
Sbjct: 365 LRNVK---------------------SCDWNMDDSA---------FS----------GIS 384
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
D I LL DP R+ +AL HP+ T
Sbjct: 385 EDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPG 417
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 75/356 (21%), Positives = 111/356 (31%), Gaps = 119/356 (33%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINKYREAAMI 137
Y +G G V C + A+KI+ + + REA +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 138 EIDVLQRLARH-------DI---------------GG------TRYRSFPIDLVRELGRQ 169
E+D+L++++ H D G T + R++ R
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
LLE + +H+L ++H DLKPENILL IKL
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDD---------------------------DMNIKL 165
Query: 230 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELCSG 281
DFG + V T Y APE+I G+ D+WS G I+ L +G
Sbjct: 166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 341
F H + M+ ++ F +W
Sbjct: 226 SPPF-WHRK--QMLMLRMIM-------------SGNYQFGSP---EWD------------ 254
Query: 342 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+ DL+ L P +R A EAL HPFF + V
Sbjct: 255 ------------DYSDTVKDLVS---RFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 84/370 (22%), Positives = 134/370 (36%), Gaps = 96/370 (25%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ Y I +G G++G V +D ++ VAIK + R + I EI +L RL
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 146 ARHD--------IGGTRYRSFP-IDLVRELGR-----------------------QLLES 173
+ D I F + +V E+ LL
Sbjct: 83 -KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDF 232
F+HE +IH DLKP N LL VKV D F L+R+ + +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCD--FGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 233 GSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG---------- 281
+ + Q S+VV TR YRAPE+IL + D+WS GCI EL +
Sbjct: 200 HNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 282 -EALFQ-----------------THENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR- 321
LF N + L ++ ++G P + KY +
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 322 --RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379
++ + P+ + I+LL+ +L+++P +R+
Sbjct: 319 FPHRKPINLKQ---------------KYPS-----ISDDG---INLLESMLKFNPNKRIT 355
Query: 380 AREALRHPFF 389
+AL HP+
Sbjct: 356 IDQALDHPYL 365
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 66/341 (19%), Positives = 104/341 (30%), Gaps = 106/341 (31%)
Query: 87 GENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVL 142
EN Y + SK +G G F V +C + A K + R R + EI VL
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 143 QRLARH------------------------------DIGGTRYRSFPIDLVRELGRQLLE 172
+ + V L +Q+LE
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
V ++H+ ++H DLKP+NILL S IK++DF
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIY------------------------PLGDIKIVDF 178
Query: 233 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290
G + ++ T Y APE++ D+W++G I L + + F +N
Sbjct: 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238
Query: 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 350
E + +D+ + +
Sbjct: 239 QE---TYLNIS---------------------QVNVDYSEET---------FS------- 258
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
V A D I Q LL +P +R A L H + +
Sbjct: 259 ---SVSQLATDFI---QSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 67/339 (19%), Positives = 107/339 (31%), Gaps = 92/339 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH-- 148
+ + ++G G FG V+ + E VAIK R K RE +EI ++++L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73
Query: 149 -----DI---------------------GG---------TRYRSFPIDLVRELGRQLLES 173
++ GG +R L + +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ ++HE R+IH DLKPENI+L + K+ID G
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKIIDLG 169
Query: 234 -STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291
+ + + + V T Y APE++ + D WS G + E +G F +
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ- 228
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
P+ H +R EK D GA S+ L
Sbjct: 229 -----------PVQWHGKVR-----EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
LQ +L + +R + F
Sbjct: 273 KLE---------RWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 57/350 (16%), Positives = 105/350 (30%), Gaps = 126/350 (36%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
Y +L +G G++G+ + +++ K + + ++ + E+++L+ L +H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 150 -I-----------------------GGT----------RYRSFPIDLVRELGRQLLESVA 175
I GG + + V + QL ++
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 176 FMHELRL-----IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 230
H +H DLKP N+ L + +KL
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFL-----------------DGKQN----------VKLG 158
Query: 231 DFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287
DFG + H V T +Y +PE + + +N D+WS+GC+L ELC+ F
Sbjct: 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218
Query: 288 HENLEHLAM--MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 345
+ + LA E +P+ S
Sbjct: 219 -FSQKELAGKIREGKFRRIPYRY-------------------------SD---------- 242
Query: 346 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
+L +++ +L R E L +P
Sbjct: 243 ---------------ELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 43/243 (17%), Positives = 80/243 (32%), Gaps = 59/243 (24%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +GEG F QV E D + K+ +K+ + N + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 147 RHDI---------------------GGT-----------RYRSFPIDLVRELGRQLLESV 174
+H GT + P LV ++L +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 233
+H+ +IH D+KP+N +L + S+ + LID G
Sbjct: 186 EQVHDCEIIHGDIKPDNFIL----------------GNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 234 STTFEHQDHSYVVS----TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289
S + + + T ++ E++ WNY D + V + + G + +E
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
Query: 290 NLE 292
E
Sbjct: 290 GGE 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 75/362 (20%), Positives = 118/362 (32%), Gaps = 104/362 (28%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSK--MGEGTFGQVVECFDNEKKELVAIKIVR- 126
P P D V A + Y + +G G FGQV +C + +A KI++
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 127 SINKYREAAMIEIDVLQRLARHDI---------------------GG-------TRYRSF 158
K +E EI V+ +L ++ GG +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL 184
Query: 159 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
+Q+ E + MH++ ++H DLKPENIL V+
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN---------------------- 222
Query: 219 KNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276
+ IK+IDFG T + APEV+ ++P D+WSVG I
Sbjct: 223 ---RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279
Query: 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD 336
L SG + F + E + +L ++ D
Sbjct: 280 MLLSGLSPFLGDNDAE---TLNNIL-------------ACRWDLEDE---EFQD------ 314
Query: 337 SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ A + I LL + + R+ A EAL+HP+ +
Sbjct: 315 ------------------ISEEAKEFI---SKLLIKEKSWRISASEALKHPWLSDHKLHS 353
Query: 397 TL 398
L
Sbjct: 354 RL 355
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 62/332 (18%), Positives = 94/332 (28%), Gaps = 114/332 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
++G G+FG+V D + A+K VR + E+ L
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSPRIV 113
Query: 150 -------------I------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
I GG + P D Q LE + ++H R++H
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--------STT 236
D+K +N+LL S DGS L DFG
Sbjct: 174 GDVKADNVLL-----------------SSDGS---------RAALCDFGHALCLQPDGLG 207
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
Y+ T + APEV++G + D+WS C+++ + +G
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC-------------- 253
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
P W K+ P I +
Sbjct: 254 ------H-P----------------------WTQ----YFRGPLCLKIASEPPPIREIPP 280
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
A +Q LR +P R A E R
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 61/348 (17%), Positives = 113/348 (32%), Gaps = 132/348 (37%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+ Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68
Query: 147 RH-----------DIGGTRYRSFPIDLVREL---G-----------------------RQ 169
+ ++ R +V E G +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLL---IVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+ E++ ++H + + H D+KPEN+L S ++ +KL
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILKL 161
Query: 230 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ-TH 288
DFG A E G ++ CD+WS+G I+ L G F H
Sbjct: 162 TDFG------------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
M R+ + F +W
Sbjct: 203 GLAISPGMKTRIR-------------MGQYEFPNP---EWS------------------- 227
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
V LI + LL+ +P +R+ E + HP+ + + P
Sbjct: 228 -----EVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 66/339 (19%), Positives = 117/339 (34%), Gaps = 111/339 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + E+++ L RH
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 149 --------------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHEL 180
+ G + F +L ++++ H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
R+IH D+KPEN+LL G +K+ DFG S
Sbjct: 129 RVIHRDIKPENLLL-----------------GSAGE----------LKIADFGWSVHAPS 161
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
+ + T Y PE+I G + DLWS+G + E G+ F+ + + +R
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKR 218
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+ R + + GAR
Sbjct: 219 IS---------RVEFTFPDFVTEGAR---------------------------------- 235
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
DL+ LL+++P++R RE L HP+ T + +P+
Sbjct: 236 ----DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 62/352 (17%), Positives = 95/352 (26%), Gaps = 129/352 (36%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHD-I 150
Y + K+GEG F V A+K + + RE A E D+ + H I
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 151 -------------------------GGT----------RYRSFPIDLVRELGRQLLESVA 175
GT + D + L + +
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235
+H H DLKP NILL +G L+D GS
Sbjct: 149 AIHAKGYAHRDLKPTNILL-----------------GDEGQP----------VLMDLGSM 181
Query: 236 TFEH------------QDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCS 280
QD + T YRAPE+ + D+WS+GC+L +
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 281 GEALFQ-THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
GE + + + +A + ++ P
Sbjct: 242 GEGPYDMVFQKGDSVA------------LAVQNQLS------------IPQSPR------ 271
Query: 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
HS+ L LL ++ DP +R L +
Sbjct: 272 -----------------HSS-ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 51/238 (21%), Positives = 81/238 (34%), Gaps = 80/238 (33%)
Query: 164 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223
+ RQ+ ++ ++H + H D+KPEN L + K
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFST-------------------------NK 205
Query: 224 SSAIKLIDFG-STTFEHQDHSY------VVSTRHYRAPEVILGLGWNY--PCDLWSVGCI 274
S IKL+DFG S F ++ T ++ APEV+ +Y CD WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
L L G F N + +VL +L + +
Sbjct: 266 LHLLLMGAVPFP-GVN--DADTISQVL---------------------NKKLCFEN---- 297
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
+ + A DL+ LL + ER A AL+HP+ ++
Sbjct: 298 -----PNYN----------VLSPLARDLL---SNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-28
Identities = 61/336 (18%), Positives = 115/336 (34%), Gaps = 114/336 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+++ + +G+G+F V VAIK++ +++ K + E+ + +L +H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 149 --------------DI--------GGT-------RYRSFPIDLVRELGRQLLESVAFMHE 179
+ G R + F + R Q++ + ++H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 238
++H DL N+LL +++ + IK+ DFG +T +
Sbjct: 131 HGILHRDLTLSNLLL-----------------TRNMN----------IKIADFGLATQLK 163
Query: 239 HQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ T +Y +PE+ D+WS+GC+ L G F T + +++
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNT-- 220
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ D +P+ +
Sbjct: 221 -----------------------LNKVVLAD-----------------YEMPS----FLS 236
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
A DLI LLR +PA+RL L HPF +R+
Sbjct: 237 IEAKDLI---HQLLRRNPADRLSLSSVLDHPFMSRN 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 74/341 (21%), Positives = 116/341 (34%), Gaps = 113/341 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
RY +G+G F + E D + KE+ A KIV + K + + EI + + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 149 --------------DI--------GGT------RYRSFPIDLVRELGRQLLESVAFMHEL 180
+ + R ++ R RQ++ ++H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
R+IH DLK N+ L ++D +K+ DFG +T E+
Sbjct: 135 RVIHRDLKLGNLFL-----------------NEDLE----------VKIGDFGLATKVEY 167
Query: 240 QDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
V T +Y APEV+ G ++ D+WS+GCI+ L G+ F+T L+
Sbjct: 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLK--ETY 224
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
R+ + P H++
Sbjct: 225 LRI---------------------KKNEYSIPK-----------------------HINP 240
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
A LI Q +L+ DP R E L FFT L
Sbjct: 241 VAASLI---QKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 62/347 (17%), Positives = 96/347 (27%), Gaps = 115/347 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + +G G FG V E + AIK +R + RE M E+ L +L H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64
Query: 150 ---------------------------I------GGT---------RYRSFPIDLVRELG 167
I + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 168 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 226
Q+ E+V F+H L+H DLKP NI + VKV D F L + + +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVTAMDQDEEEQTVLTPMP 182
Query: 227 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
+ H+ V T+ Y +PE I G +++ D++S+G IL EL F
Sbjct: 183 -----------AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP---FS 228
Query: 287 THENLEHLAM--MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
T PL
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQ-------------------------KYPC-------- 255
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
++ +L P ER +A + + F
Sbjct: 256 --EYVMVQD---------------MLSPSPMERPEAINIIENAVFED 285
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 60/268 (22%), Positives = 88/268 (32%), Gaps = 89/268 (33%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDV 141
+GE R R+ + EG F V E D A+K + S + A + E+
Sbjct: 22 TVELGEL---RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 142 LQRLARH---------------DIGGTRY-----------------------RSFPIDLV 163
+++L+ H + + D V
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 164 RELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221
++ Q +V MH + +IH DLK EN+LL S G+
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-----------------SNQGTI---- 177
Query: 222 PKSSAIKLIDFGSTTFEHQDHSYVVS-----------TRH----YRAPEVI---LGLGWN 263
KL DFGS T Y S TR+ YR PE+I
Sbjct: 178 ------KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 264 YPCDLWSVGCILVELCSGEALFQTHENL 291
D+W++GCIL LC + F+ L
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 32/254 (12%), Positives = 59/254 (23%), Gaps = 70/254 (27%)
Query: 140 DVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199
D+ + D I + L QL+ A + L+H P+N+ +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI----- 227
Query: 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG 259
DG + L D + Y E +
Sbjct: 228 ------------MPDGR----------LMLGDVSALWKVGTRGPASSVPVTYAPREFLNA 265
Query: 260 LGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 317
+ + W +G + + F + + +R
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTP-----------------GIKGSWKRPS 308
Query: 318 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377
L + D ++ L+ L +D R
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK------------------------TLIGRFLNFDRRRR 344
Query: 378 LKAREALRHPFFTR 391
L EA+ P F +
Sbjct: 345 LLPLEAMETPEFLQ 358
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 85/405 (20%), Positives = 129/405 (31%), Gaps = 137/405 (33%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P K G+P A A P P D +
Sbjct: 2 PAPADPGK-------------AGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR------- 41
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQR 144
RY +G+G F + E D + KE+ A KIV + K + + EI + +
Sbjct: 42 ----RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 145 LARH--------------DI--------GGT------RYRSFPIDLVRELGRQLLESVAF 176
L H + + R ++ R RQ++ +
Sbjct: 98 L-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 235
+H R+IH DLK N+ L ++D +K+ DFG +T
Sbjct: 157 LHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKIGDFGLAT 189
Query: 236 TFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
E+ V T +Y APEV+ G ++ D+WS+GCI+ L G+ F+T L+
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLK- 247
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
R+ + P
Sbjct: 248 -ETYLRI---------------------KKNEYSIPK----------------------- 262
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
H++ A LI Q +L+ DP R E L FFT L
Sbjct: 263 HINPVAASLI---QKMLQTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 60/335 (17%), Positives = 115/335 (34%), Gaps = 111/335 (33%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHD---------- 149
G+GT+G V D + +AIK + + Y + EI + + L +H
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFS 89
Query: 150 ------I------GGT-------RYRSFPID--LVRELGRQLLESVAFMHELRLIHTDLK 188
I GG+ ++ + + +Q+LE + ++H+ +++H D+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS---TTFEHQDHSYV 245
+N+L+ ++ G +K+ DFG+ +
Sbjct: 150 GDNVLI----------------NTYSGV----------LKISDFGTSKRLAGINPCTETF 183
Query: 246 VSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303
T Y APE+I G+ D+WS+GC ++E+ +G+ F +E E A M
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEPQAAM------ 235
Query: 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363
F+ G P+ +P + + +
Sbjct: 236 ----------------FKVGMFKVHPE----------------IP-------ESMSAEAK 256
Query: 364 DLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+ DP +R A + L F ++
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 63/358 (17%), Positives = 124/358 (34%), Gaps = 114/358 (31%)
Query: 74 RPDDKDGHYVFAIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--- 129
+ DD + A+G + R+ + ++G G+F V + D E VA ++
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66
Query: 130 KYREAAMIEIDVLQRLARHD-I-------------------------GGT------RYRS 157
R+ E ++L+ L +H I GT R++
Sbjct: 67 SERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 125
Query: 158 FPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215
I ++R RQ+L+ + F+H +IH DLK +NI + + G
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----------------TGPTG 169
Query: 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
S +K+ D G T + + V+ T + APE+ ++ D+++ G
Sbjct: 170 S----------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMC 218
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
++E+ + E + +N + RV +
Sbjct: 219 MLEMATSEYPYSECQNAA--QIYRRVTSGVK----------------------------- 247
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
P + ++ ++++G +R + ER ++ L H FF +
Sbjct: 248 -------------PASFDKVAIP---EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-26
Identities = 64/336 (19%), Positives = 109/336 (32%), Gaps = 111/336 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + EI++ L RH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 149 --------------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHEL 180
I G ++ F +L +++ + HE
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 239
++IH D+KPEN+L+ +K+ DFG S
Sbjct: 134 KVIHRDIKPENLLMGYKGE---------------------------LKIADFGWSVHAPS 166
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
+ T Y PE+I G + DLW G + E G F + H R
Sbjct: 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---SHTETHRR 223
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
++ D + + G++
Sbjct: 224 IV---------NVDLKFPPFLSDGSK---------------------------------- 240
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
DL+ LLRY P +RL + + HP+ + RR
Sbjct: 241 ----DLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 48/240 (20%), Positives = 79/240 (32%), Gaps = 65/240 (27%)
Query: 152 GTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 210
+ + Q+ E+V F+H L+H DLKP NI + VKV D F L
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVT 212
Query: 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 270
+ + + + + H+ V T+ Y +PE I G +++ D++S
Sbjct: 213 AMDQDEEEQTVL-----------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 271 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 330
+G IL EL F T MERV
Sbjct: 262 LGLILFELLYS---FSTQ--------MERVR----------------------------- 281
Query: 331 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+ +R + ++Q +L P ER +A + + + F
Sbjct: 282 ----------IITDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 18/54 (33%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRL 145
+ + MG G FG V E + AIK +R N+ RE M E+ L +L
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 62/332 (18%), Positives = 114/332 (34%), Gaps = 70/332 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQR------- 144
+ +S++G G G V + ++A K++ K I E+ VL
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 145 ------LARHDI--------GGT------RYRSFPIDLVRELGRQLLESVAFMH-ELRLI 183
+ +I GG+ + P ++ ++ +++ + ++ + +++
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH 242
H D+KP NIL+ + G IKL DFG S
Sbjct: 155 HRDVKPSNILV-----------------NSRGE----------IKLCDFGVSGQLIDSMA 187
Query: 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302
+ V TR Y +PE + G ++ D+WS+G LVE+ G + E M +
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247
Query: 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL-RLPNLIMQHVDHSA-- 359
R A+++LL + N +
Sbjct: 248 GDAAETPPRPRTPGRP---------LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ D + L +PAER ++ + H F R
Sbjct: 299 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 56/362 (15%), Positives = 111/362 (30%), Gaps = 118/362 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI------------- 137
YRI+ + +G F +++ C + + A+K + K R+
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 138 ---EIDVLQRLARH--------------DI--------GG--------------TRYRSF 158
E+ ++ + ++ ++
Sbjct: 90 FKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 159 PIDLVRELGRQLLESVAFMHELRLI-HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
PI +++ + + +L S +++H + I H D+KP NIL+ K+G
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM-----------------DKNGR- 190
Query: 218 FKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW--NYPCDLWSVGCI 274
+KL DFG S + T + PE D+WS+G
Sbjct: 191 ---------VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
L + F +L + + + +++P
Sbjct: 242 LYVMFYNVVPFSLKISL--VELFNNIR---------------------TKNIEYPLDRNH 278
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394
K + + + ID L+ LR +PAER+ + +AL+H +
Sbjct: 279 FLYPLTNKKSTCSN-------NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331
Query: 395 RP 396
Sbjct: 332 ED 333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 58/342 (16%), Positives = 115/342 (33%), Gaps = 117/342 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H--------------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHE 179
H GG P + QL+ V ++H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 238
+ + H D+KPEN+LL D N +K+ DFG +T F
Sbjct: 124 IGITHRDIKPENLLL-------------------DER--DN------LKISDFGLATVFR 156
Query: 239 HQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ + +++ Y APE++ ++ P D+WS G +L + +GE + +
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
+ + Y W +
Sbjct: 217 E---------------YSDWKEKKTYL-----NPW------------------------K 232
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
+D + + LL +L +P+ R+ + + ++ + +++
Sbjct: 233 KIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 36/251 (14%), Positives = 70/251 (27%), Gaps = 93/251 (37%)
Query: 152 GTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211
+ ++S +L Q++ +A +H L+HT L+P +I+L
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL----------------- 239
Query: 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW--------- 262
+ G + L F + +R + PE+
Sbjct: 240 DQRGG----------VFLTGFEHLVRDGARVV-SSVSRGFEPPELEARRATISYHRDRRT 288
Query: 263 --NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF 320
+ D W++G ++ + + T + +E F
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPI-TKDAALGG---------------------SEWIF 326
Query: 321 RRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380
R + P LL+G LRY +RL
Sbjct: 327 RS--CKNIPQPV------------------------------RALLEGFLRYPKEDRLLP 354
Query: 381 REALRHPFFTR 391
+A+ P + +
Sbjct: 355 LQAMETPEYEQ 365
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 72/352 (20%), Positives = 109/352 (30%), Gaps = 133/352 (37%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMIEIDVLQRLAR--- 147
+Y +S +G G FG V D EK + V +K I K + E IE L ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF---IKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 148 -----------------------------HDIGG------TRYRSFPIDLVRELGRQLLE 172
H G R+ L + RQL+
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
+V ++ +IH D+K ENI++ F IKLIDF
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVI---------AEDF------------------TIKLIDF 174
Query: 233 GSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 289
GS + + T Y APEV++G + P ++WS+G L L E F E
Sbjct: 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
Query: 290 NLEHLAMMERVLGPL--PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347
E V + P+ + S++ M
Sbjct: 235 --------ETVEAAIHPPYLV-------------------------SKELMS-------- 253
Query: 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLL 399
L+ GLL+ P R + + P+ T+ V
Sbjct: 254 -----------------LVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 58/345 (16%), Positives = 115/345 (33%), Gaps = 117/345 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H--------------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHE 179
H GG P + QL+ V ++H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 238
+ + H D+KPEN+LL D N +K+ DFG +T F
Sbjct: 124 IGITHRDIKPENLLL-------------------DER--DN------LKISDFGLATVFR 156
Query: 239 HQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ + +++ Y APE++ ++ P D+WS G +L + +GE + +
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
+ + Y W +
Sbjct: 217 E---------------YSDWKEKKTY-----LNPW------------------------K 232
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+D + + LL +L +P+ R+ + + ++ + +++
Sbjct: 233 KIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 69/341 (20%), Positives = 121/341 (35%), Gaps = 110/341 (32%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
+ +L K+GEG++G V + E ++VAIK V + + + EI ++Q+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHV 86
Query: 151 GGTRYR-SF-----------------PIDLVRELG------------RQLLESVAFMHEL 180
+Y S+ D++R + L+ + ++H +
Sbjct: 87 --VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST---TF 237
R IH D+K NILL + +G KL DFG T
Sbjct: 145 RKIHRDIKAGNILL-----------------NTEGH----------AKLADFGVAGQLTD 177
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+ V+ T + APEVI +G+N D+WS+G +E+ G+
Sbjct: 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK--------------- 222
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
P P+ + MRA++ + P + +
Sbjct: 223 -----P-PYADI--------------------------HPMRAIFMIPTNPPPTFRKPEL 250
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+ + D ++ L P +R A + L+HPF L
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 73/337 (21%), Positives = 108/337 (32%), Gaps = 105/337 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
RY + +G G FG D KELVA+K + E EI R RH
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSLRHPNIV 79
Query: 149 ----------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
+ GG F D R +QLL V++ H +++ H
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-- 242
DLK EN LL DGS +K+ DFG +
Sbjct: 140 RDLKLENTLL-------------------DGSPAPR------LKICDFGYSKSSVLHSQP 174
Query: 243 SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEHL--AMMER 299
V T Y APEV+L ++ D+WS G L + G F+ ++R
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRDYRKTIQR 233
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+L + KY +P+ I +
Sbjct: 234 IL--------------SVKY--------------------------SIPDDI-----RIS 248
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ L+ + DPA R+ E H +F +++
Sbjct: 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPAD 285
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 71/336 (21%), Positives = 122/336 (36%), Gaps = 108/336 (32%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 147 RHDIGGTRYR-SFPI-----------------DLVRELG----------RQLLESVAFMH 178
+I Y S+ + D+V E R+ L+++ F+H
Sbjct: 76 NPNI--VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--- 235
++IH D+K +NILL DGS +KL DFG
Sbjct: 134 SNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFCAQI 166
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
T E S +V T ++ APEV+ + D+WS+G + +E+ GE
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------------- 213
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
P P+ + + +RA++ + +Q+
Sbjct: 214 -------P-PYL--------------------------NENPLRALYLIATNGTPELQNP 239
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ + D L L D +R A+E L+H F
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 65/336 (19%), Positives = 122/336 (36%), Gaps = 108/336 (32%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ K+GEG+ G V + VA+K++ + R + E+ +++
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 147 RHDIGGTRYR-SFPI-----------------DLVRELG----------RQLLESVAFMH 178
++ S+ + D+V ++ +L+++A++H
Sbjct: 101 HFNV--VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---ST 235
+IH D+K ++ILL + DG +KL DFG
Sbjct: 159 AQGVIHRDIKSDSILL-----------------TLDGR----------VKLSDFGFCAQI 191
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
+ + +V T ++ APEVI + D+WS+G +++E+ GE
Sbjct: 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE------------- 238
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
P P+ S ++A+ +L P +++
Sbjct: 239 -------P-PYF--------------------------SDSPVQAMKRLRDSPPPKLKNS 264
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ L D L+ +L DP ER A+E L HPF +
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 74/343 (21%), Positives = 108/343 (31%), Gaps = 117/343 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70
Query: 149 --------------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHEL 180
D GG ++ R L +Q+L +V + H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
++H DLKPEN+LL D N K+ DFG +
Sbjct: 131 MVVHRDLKPENVLL---------DAH------------MN------AKIADFGLSNMMSD 163
Query: 241 DHSYVVSTR----HYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEHLA 295
+ T +Y APEVI G + P D+WS G IL L G F E++ L
Sbjct: 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTL- 219
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
+ +Y R
Sbjct: 220 ----------FKKIRGGVFYIPEYLNRSVA------------------------------ 239
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
LL +L+ DP +R ++ H +F +D+
Sbjct: 240 --------TLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 62/352 (17%), Positives = 114/352 (32%), Gaps = 123/352 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAM---IEIDVLQRLAR 147
+Y + +GEG++G+V E D+E A+KI+ + + + EI +L+RL R
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 148 H----------------DI--------GGTR-------YRSFPIDLVRELGRQLLESVAF 176
H + G + + FP+ QL++ + +
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 235
+H ++H D+KP N+LL + G+ +K+ G +
Sbjct: 125 LHSQGIVHKDIKPGNLLL-----------------TTGGT----------LKISALGVAE 157
Query: 236 TFEHQDHSYVVSTR----HYRAPEVILGLGWNY---PCDLWSVGCILVELCSGEALFQTH 288
T ++ PE+ GL + D+WS G L + +G F+
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYPFE-G 215
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
+N+ L + +
Sbjct: 216 DNIYKL-----------FENIGKGSYAIPGDCGPPLS----------------------- 241
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLLV 400
DLL+G+L Y+PA+R R+ +H +F + V
Sbjct: 242 ---------------DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 65/327 (19%), Positives = 106/327 (32%), Gaps = 111/327 (33%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH-------- 148
GEG+F VV + AIKI+ I K + E DV+ RL H
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYF 97
Query: 149 --------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 188
G + SF R +++ ++ ++H +IH DLK
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 248
PENILL ++++ D+ S + + + +F V T
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQAR--------------ANSF--------VGT 195
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM 308
Y +PE++ DLW++GCI+ +L +G F N + ++++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGN--EYLIFQKII------- 245
Query: 309 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368
D+P+ DL++
Sbjct: 246 --------------KLEYDFPEKFFP--------------------------KARDLVEK 265
Query: 369 LLRYDPAERL------KAREALRHPFF 389
LL D +RL HPFF
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 70/338 (20%), Positives = 117/338 (34%), Gaps = 112/338 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y I +GEG+FG+V + ++ VA+K + + + K + EI L +L RH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68
Query: 149 --------------DI-------GG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
DI GG + D R +Q++ ++ + H +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
++H DLKPEN+LL D N +K+ DFG +
Sbjct: 129 IVHRDLKPENLLL---------DDN------------LN------VKIADFGLSNIMTDG 161
Query: 242 HSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ S + +Y APEVI G + P D+WS G +L + G F E + +L
Sbjct: 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFIPNL---- 216
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
V + GA+
Sbjct: 217 -------FKKVNSCVYVMPDFLSPGAQ--------------------------------- 236
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
L++ ++ DP +R+ +E R P+F ++
Sbjct: 237 -----SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDY 269
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 55/238 (23%), Positives = 81/238 (34%), Gaps = 73/238 (30%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-----EID 140
E L +Y++ +G G FG V VAIK V I+ + E E+
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 141 VLQRLARH---------DIGGTRYRSFPI----------------------DLVRELGRQ 169
+L+++ D I +L R Q
Sbjct: 99 LLKKV-SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 170 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+LE+V H ++H D+K ENIL+ D +KL
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILI---------DLNRGE-----------------LKL 191
Query: 230 IDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY---PCDLWSVGCILVELCSGE 282
IDFGS +D Y TR Y PE I Y +WS+G +L ++ G+
Sbjct: 192 IDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGD 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 52/257 (20%), Positives = 82/257 (31%), Gaps = 73/257 (28%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
PP P E YR+ +G+G FG V + VAIK++
Sbjct: 9 GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR 68
Query: 128 INKYREAAMI-----EIDVLQRLAR----------HDIGGTRYRSFPI------------ 160
+ + + E+ +L ++ D T+ +
Sbjct: 69 VLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFD 128
Query: 161 ----------DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210
R Q++ ++ H ++H D+K ENIL+
Sbjct: 129 YITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI---------------- 172
Query: 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY---P 265
+ G KLIDFGS D Y TR Y PE I Y P
Sbjct: 173 DLRRGC----------AKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YHALP 219
Query: 266 CDLWSVGCILVELCSGE 282
+WS+G +L ++ G+
Sbjct: 220 ATVWSLGILLYDMVCGD 236
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 59/343 (17%), Positives = 118/343 (34%), Gaps = 119/343 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 150 --IGGTRYRSFPI------------------DLVRELG-------------RQLLESVAF 176
G ++ P DL++ R++L ++
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 233
+H+ ++IH D+K +N+LL +++ +KL+DFG
Sbjct: 145 LHQHKVIHRDIKGQNVLL-----------------TENAE----------VKLVDFGVSA 177
Query: 234 STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH 288
+ + T ++ APEVI +++ DLWS+G +E+ G
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP----- 232
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
P + MRA++ + R P
Sbjct: 233 ----------------PLCDM--------------------------HPMRALFLIPRNP 250
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
++ S ++ L + ++R + ++HPF
Sbjct: 251 APRLKSKKWSK-KFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 69/345 (20%), Positives = 123/345 (35%), Gaps = 115/345 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+ I+ ++G+G FG+V + + E L A K++ + ++ I EI++L I
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI- 78
Query: 152 GTRYR-SFPI-----------------DLVRELG------------RQLLESVAFMHELR 181
+ ++ ++ EL RQ+LE++ F+H R
Sbjct: 79 -VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST---TFE 238
+IH DLK N+L+ + +G I+L DFG +
Sbjct: 138 IIHRDLKAGNVLM-----------------TLEGD----------IRLADFGVSAKNLKT 170
Query: 239 HQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
Q + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE----------- 219
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
P PHH + + MR + K+ + +
Sbjct: 220 ---------P-PHHEL--------------------------NPMRVLLKIAKSDPPTLL 243
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+ + D L+ L +P R A + L HPF + L
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 63/230 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
+ L K+G+G+FG+V + DN +++VAIKI+ E EI VL + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 151 GGTRYR-SF-----------------PIDLVRELG----------RQLLESVAFMHELRL 182
T+Y S+ +DL+ R++L+ + ++H +
Sbjct: 83 --TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STTFEH 239
IH D+K N+LL S+ G +KL DFG T
Sbjct: 141 IHRDIKAANVLL-----------------SEHGE----------VKLADFGVAGQLTDTQ 173
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA-LFQTH 288
+ V T + APEVI ++ D+WS+G +EL GE + H
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 34/273 (12%), Positives = 74/273 (27%), Gaps = 90/273 (32%)
Query: 128 INKYREAAMIEIDVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
++++ ++ ++ + ++S +L Q++ +A +H L+HT L
Sbjct: 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----S 243
+P +I+L + G + L F +
Sbjct: 238 RPVDIVL-----------------DQRGG----------VFLTGFEHLVRDGASAVSPIG 270
Query: 244 YVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ A ++ + D W++G + +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI-------------------- 310
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
LP A L I + +
Sbjct: 311 -WCADLP--------------NTDDA-------------------ALGGSEWIFRSCKNI 336
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ LL+G LRY +RL +A+ P + +
Sbjct: 337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 64/360 (17%), Positives = 116/360 (32%), Gaps = 136/360 (37%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINK-------------------- 130
+Y + ++G+G++G V ++ A+K++ + + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 131 ----------YREAA---MIE-------IDVLQRLARHDI--------GG-----TRYRS 157
Y+E A ++ ++VL + G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 158 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217
D R + L++ + ++H ++IH D+KP N+L+ +DG
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-----------------GEDGH- 175
Query: 218 FKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNY---PCDLWSV 271
IK+ DFG S F+ D S V T + APE + + D+W++
Sbjct: 176 ---------IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226
Query: 272 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 331
G L G+ F E + L H +
Sbjct: 227 GVTLYCFVFGQCPFM-DERIMCL-----------HSKIKSQA------------------ 256
Query: 332 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
L P+ D + DL DL+ +L +P R+ E HP+ TR
Sbjct: 257 -------------LEFPD----QPDIAE-DLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 56/350 (16%), Positives = 107/350 (30%), Gaps = 77/350 (22%)
Query: 94 YRILSKMGEG--TFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRL--- 145
Y +L+ +G+G V E V ++ + N+ E+ V +
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 146 --------------------------ARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHE 179
A+ I + + + +L+++ ++H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS----- 234
+ +H +K +IL+ S DG + L S
Sbjct: 147 MGYVHRSVKASHILI-----------------SVDGK----------VYLSGLRSNLSMI 179
Query: 235 -----TTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVELCSGEALFQT 287
H Y V + +PEV+ G++ D++SVG EL +G F+
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK- 238
Query: 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347
++ M+ L ++ + AE+ +R G + +
Sbjct: 239 --DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
Query: 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
H S ++ L+ +P R A L H FF + RR +
Sbjct: 297 SPSHPYHRTFSP-HFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRAS 345
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 64/335 (19%), Positives = 111/335 (33%), Gaps = 113/335 (33%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SI--NKYREAAMIEIDVLQRLARHDI 150
+ +G G FG+V C + ++ A+K + I + A+ E +L ++ D
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 151 ------------------------GG------TRYRSFPIDLVRELGRQLLESVAFMHEL 180
GG +++ F +R +++ + MH
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
+++ DLKP NILL +V++ D A
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGL------------------ACDFSKKKPHAS--- 350
Query: 241 DHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
V T Y APEV+ G+ ++ D +S+GC+L +L G + F+ H+ + +
Sbjct: 351 -----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
L ++ PD +
Sbjct: 406 TL---------------------TMAVELPDSFSP------------------------- 419
Query: 360 GDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
+L LL+GLL+ D RL A+E PFF
Sbjct: 420 -ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 73/339 (21%), Positives = 108/339 (31%), Gaps = 113/339 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75
Query: 149 --------------DI--------GG------TRYRSFPIDLVRELGRQLLESVAFMHEL 180
DI GG + R L +Q+L V + H
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
++H DLKPEN+LL D N K+ DFG +
Sbjct: 136 MVVHRDLKPENVLL---------DAH------------MN------AKIADFGLSNMMSD 168
Query: 241 DHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
S + +Y APEVI G + P D+WS G IL L G F +++ L
Sbjct: 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTL--- 224
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
+ +Y
Sbjct: 225 --------FKKICDGIFYTPQYLNPSVI-------------------------------- 244
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
LL+ +L+ DP +R ++ H +F +D+ +
Sbjct: 245 ------SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKY 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 68/354 (19%), Positives = 117/354 (33%), Gaps = 128/354 (36%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQ 143
++ + L ++G G+FG V D E+VAIK + K E+ LQ
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 144 RLARHDIGGTRYR-SF----------------PIDLVRELG------------RQLLESV 174
+L + +YR + DL+ L+ +
Sbjct: 110 KLRHPNT--IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
A++H +IH D+K NILL S+ G +KL DFGS
Sbjct: 168 AYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLGDFGS 200
Query: 235 -------TTFEHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEAL 284
+F V T ++ APEVIL + ++ D+WS+G +EL +
Sbjct: 201 ASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-- 250
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
P P + ++M A++ +
Sbjct: 251 ------------------P-PLFNM--------------------------NAMSALYHI 265
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+ + +Q S + + L+ P +R + L+H F R+ +
Sbjct: 266 AQNESPALQSGHWSE-YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 71/349 (20%), Positives = 113/349 (32%), Gaps = 118/349 (33%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEID 140
+ YR+L +G+G F +V VAIKI I+K + + E+
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFREVR 66
Query: 141 VLQRLARH-------DIGGTRYRSFPI----------DLVRELGR-----------QLLE 172
+++ L H ++ T + I D + GR Q++
Sbjct: 67 IMKIL-NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
+V + H+ R++H DLK EN+LL D + IK+ DF
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLL-----------------DADMN----------IKIADF 158
Query: 233 G-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 289
G S F Y APE+ G ++ P D+WS+G IL L SG F +
Sbjct: 159 GFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQ 217
Query: 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349
NL+ L V+R R Y
Sbjct: 218 NLKEL-----------RERVLRGKYRIPFYMSTDCE------------------------ 242
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
+LL+ L +P +R + ++ + L
Sbjct: 243 --------------NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 60/355 (16%), Positives = 107/355 (30%), Gaps = 129/355 (36%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH--- 148
L +MG GT GQV + + ++A+K +R + + ++++DV+ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMH-ELRL 182
+ P ++ ++ +++++ ++ + +
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--------- 233
IH D+KP NILL + G IKL DFG
Sbjct: 147 IHRDVKPSNILL-----------------DERGQ----------IKLCDFGISGRLVDDK 179
Query: 234 -STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGEA-LFQ 286
Y APE I ++ D+WS+G LVEL +G+
Sbjct: 180 AKDRS--------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
+ E L + + P
Sbjct: 232 CKTDFEVLTKV--LQEEPP----------------------------------------L 249
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLLVA 401
LP H+ S D ++ L D +R K + L H F R + +
Sbjct: 250 LPG----HMGFSG-DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVAS 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 60/337 (17%), Positives = 106/337 (31%), Gaps = 115/337 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR----- 144
+R+L G G FG+V C +L A K + K + AM+E +L +
Sbjct: 190 FRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 145 -------------------------LARH-DIGGTRYRSFPIDLVRELGRQLLESVAFMH 178
+ H F Q++ + +H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+ +I+ DLKPEN+LL V++ D + + + K +
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGL----AVELKAGQTKTK------------GY- 349
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENLEHLAMM 297
T + APE++LG +++ D +++G L E+ + F+ E +E+ +
Sbjct: 350 -------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
+RVL + +PD +
Sbjct: 403 QRVL---------------------EQAVTYPDKFSP----------------------- 418
Query: 358 SAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
D + LL+ DP +RL HP F
Sbjct: 419 ---ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 64/346 (18%), Positives = 114/346 (32%), Gaps = 114/346 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH--- 148
+ L ++G G +G V + +++A+K +RS +E + ++DV+ R +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 149 -----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMH- 178
+ P +++ ++ ++++ +
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 237
L++IH D+KP NILL + G+ IKL DFG S
Sbjct: 144 NLKIIHRDIKPSNILL-----------------DRSGN----------IKLCDFGISGQL 176
Query: 238 EH-QDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEA-LFQTHENL 291
+ R Y APE I G++ D+WS+G L EL +G + +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351
+ L + V G P +L + S
Sbjct: 237 DQLTQV--VKGDPP-------------------QL--SNSEEREFSP------------- 260
Query: 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
I+ + L D ++R K +E L+HPF R
Sbjct: 261 ---------SFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 58/333 (17%), Positives = 113/333 (33%), Gaps = 113/333 (33%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH-- 148
IL +G+G+FG+V N+ K++ A+K + + E E+ ++Q L H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 149 ------------------D--IGG------TRYRSFPIDLVRELGRQLLESVAFMHELRL 182
D +GG + F + V+ +L+ ++ ++ R+
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQD 241
IH D+KP+NILL D + G + + DF + +
Sbjct: 137 IHRDMKPDNILL---------D--------EHGH----------VHITDFNIAAMLPRET 169
Query: 242 HSYVVS-TRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
++ T+ Y APE+ G G+++ D WS+G EL G + + ++
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
+ +P +
Sbjct: 230 HTFE---------------------TTVVTYPSAWSQ----------------------- 245
Query: 358 SAGDLIDLLQGLLRYDPAERL-KAREALRHPFF 389
+++ LL+ LL +P +R + + P+
Sbjct: 246 ---EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 64/333 (19%), Positives = 114/333 (34%), Gaps = 115/333 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G G+FG+V+ E A+KI+ + K ++ + E +LQ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101
Query: 150 ----------------------IGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG R F R Q++ + ++H L
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
LI+ DLKPEN+L+ Y++V D+ F K + + T
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGF-------------------AKRVKGRTWTL---- 198
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
T APE+IL G+N D W++G ++ E+ +G F + + + E+++
Sbjct: 199 ----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQIYEKIV 251
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
++ +P +S D
Sbjct: 252 ---------------------SGKVRFPSHFSS--------------------------D 264
Query: 362 LIDLLQGLLRYDPAERL-----KAREALRHPFF 389
L DLL+ LL+ D +R + H +F
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 71/335 (21%), Positives = 108/335 (32%), Gaps = 114/335 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR----- 144
YR+L G+G FG+V C ++ A K + K A+ E +L++
Sbjct: 189 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 145 -------------------------LARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHE 179
L H I FP ++ + +H
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFH-IYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
R+++ DLKPENILL ++++ D L+ +G
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLG-LAVHVPEGQ----------------TIKGR-- 345
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
V T Y APEV+ + + D W++GC+L E+ +G++ FQ + +ER
Sbjct: 346 ------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+V + F AR
Sbjct: 400 --------LVKEVPEEYSERFSPQAR---------------------------------- 417
Query: 360 GDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
L LL DPAERL ARE HP F
Sbjct: 418 ----SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 57/353 (16%), Positives = 114/353 (32%), Gaps = 132/353 (37%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH--- 148
+ ++G G +G V + +++A+K +R+ +E + ++D+ R
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 149 -----------DI-------GG----------TRYRSFPIDLVRELGRQLLESVAFMH-E 179
D+ + ++ P D++ ++ +++++ +H +
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ 233
L +IH D+KP N+L+ + G +K+ DFG
Sbjct: 129 LSVIHRDVKPSNVLI-----------------NALGQ----------VKMCDFGISGYLV 161
Query: 234 ----STTFEHQDHSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSGEALF 285
+ Y APE I G++ D+WS+G ++EL +
Sbjct: 162 DDVAKDID--------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 286 QTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
+ + L + V P P +L P S
Sbjct: 214 DSWGTPFQQLKQV--VEEPSP-------------------QL--PADKFSA--------- 241
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
+ +D L+ + ER E ++HPFFT + T
Sbjct: 242 ----------------EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 62/334 (18%), Positives = 118/334 (35%), Gaps = 103/334 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ +L +G G++ +V+ + + A+K+V+ +N + E V ++ + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG R R P + R ++ ++ ++HE
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N+LL S ++K+ DY K+G + G TT
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDTT----- 167
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
S T +Y APE++ G + + D W++G ++ E+ +G + F + ++
Sbjct: 168 -STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP------- 219
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
+ + +L I + + A
Sbjct: 220 ---------DQNTEDYLF----------------------QVILEKQIRIPRSLSVKA-- 246
Query: 362 LIDLLQGLLRYDPAERL------KAREALRHPFF 389
+L+ L DP ERL + HPFF
Sbjct: 247 -ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 61/334 (18%), Positives = 118/334 (35%), Gaps = 103/334 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ +L +G G++ +V+ + + A+++V+ +N + E V ++ + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG R R P + R ++ ++ ++HE
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N+LL S ++K+ DY K+G + G TT
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDTT----- 210
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
S T +Y APE++ G + + D W++G ++ E+ +G + F + ++
Sbjct: 211 -STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP------- 262
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
+ + +L I + + A
Sbjct: 263 ---------DQNTEDYLF----------------------QVILEKQIRIPRSLSVKA-- 289
Query: 362 LIDLLQGLLRYDPAERL------KAREALRHPFF 389
+L+ L DP ERL + HPFF
Sbjct: 290 -ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 61/336 (18%), Positives = 110/336 (32%), Gaps = 117/336 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + E M+E VL +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 150 ----------------------IGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG + F ++ + F+
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N++L S ++K+ D+ K+ I G TT
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVTT----- 499
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
T Y APE+I + D W+ G +L E+ +G+A F+ + E + + ++
Sbjct: 500 -KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM 555
Query: 302 G---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
P M S+++
Sbjct: 556 EHNVAYPKSM-------------------------SKEA--------------------- 569
Query: 359 AGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
+ + +GL+ P +RL R+ H FF
Sbjct: 570 ----VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 72/354 (20%), Positives = 118/354 (33%), Gaps = 131/354 (37%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
Y + +G G V + KKE VAIK + + + EI + + +I
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 151 GGTRYR-SF-----------------PIDLVRELG-------------------RQLLES 173
Y SF +D+++ + R++LE
Sbjct: 76 --VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ ++H+ IH D+K NILL +DGS +++ DFG
Sbjct: 134 LEYLHKNGQIHRDVKAGNILL-----------------GEDGS----------VQIADFG 166
Query: 234 -----STTFEHQDHSY---VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEAL 284
+T + + V T + APEV+ G+++ D+WS G +EL +G A
Sbjct: 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA- 225
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
P+H KY M+ +
Sbjct: 226 --------------------PYH----------KY----------------PPMKVLMLT 239
Query: 345 LRL--PNLIMQHVDHSAG-----DLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
L+ P+L D ++ L+ DP +R A E LRH FF +
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 59/332 (17%), Positives = 110/332 (33%), Gaps = 113/332 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ + +G+G+FG+V + + AIK ++ + + M+E VL H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG F + +++ + F+H
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+++ DLK +NILL ++K+ D+ K+ + + T
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGM----CKEN--------------MLGDAKT----- 175
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+++ T Y APE++LG +N+ D WS G +L E+ G++ F + E + +
Sbjct: 176 NTF-CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR 231
Query: 302 G---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
P + +++
Sbjct: 232 MDNPFYPRWL-------------------------EKEA--------------------- 245
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALR-HPFF 389
DLL L +P +RL R +R HP F
Sbjct: 246 ----KDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 73/325 (22%), Positives = 119/325 (36%), Gaps = 110/325 (33%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH-------- 148
G+G+FG+V+ ++ A+K+++ +I K +E M E +VL + +H
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF 106
Query: 149 --------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 188
GG R R F R ++ ++ ++H L +++ DLK
Sbjct: 107 SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166
Query: 189 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 248
PENILL S ++ + D+ K+ I+ STT S T
Sbjct: 167 PENILLDSQGHIVLTDFGL----CKEN--------------IEHNSTT------STFCGT 202
Query: 249 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM 308
Y APEV+ ++ D W +G +L E+ G F + E M + +L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN------ 253
Query: 309 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368
K L+L ++ +SA LL+G
Sbjct: 254 ----------------------------------KPLQLK----PNITNSA---RHLLEG 272
Query: 369 LLRYDPAERL----KAREALRHPFF 389
LL+ D +RL E H FF
Sbjct: 273 LLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 61/336 (18%), Positives = 105/336 (31%), Gaps = 111/336 (33%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G F +V + ++ A+KI+ + K E + E DVL R I
Sbjct: 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 152 GTRY----------------------------RSFPIDLVRELGRQLLESVAFMHELRLI 183
+ P ++ R +++ ++ +H L +
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H D+KP+NILL ++++ D+ + DG S
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADG---------------TVRSLVA------ 223
Query: 244 YVVSTRHYRAPEVILGLGWNY-------PCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
V T Y +PE++ +G CD W++G E+ G+ F ++
Sbjct: 224 --VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTA--ET 278
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+++ H+ L P
Sbjct: 279 YGKIV----HYKE---------------HLSLPLVDEGVPE------------------- 300
Query: 357 HSAGDLIDLLQGLLRYDPAERL---KAREALRHPFF 389
+ D +Q LL P RL A + HPFF
Sbjct: 301 ----EARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 75/335 (22%), Positives = 120/335 (35%), Gaps = 116/335 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ L +G+GTFG+V+ + A+KI+R I E A + E VLQ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG +R R F + R G +++ ++ ++H
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+++ D+K EN++L ++K+ D+ K+G I G+T
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGL----CKEG--------------ISDGATM----- 162
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMER 299
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 163 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+ P + S ++
Sbjct: 222 I--RFPRTL-------------------------SPEA---------------------- 232
Query: 360 GDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
LL GLL+ DP +RL A+E + H FF
Sbjct: 233 ---KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 60/336 (17%), Positives = 111/336 (33%), Gaps = 117/336 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ L +G+G+FG+V+ EL A+KI++ + + + M+E VL +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG + F ++ + F+
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N++L S ++K+ D+ K+ I G TT
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVTT----- 178
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
T Y APE+I + D W+ G +L E+ +G+A F E+ + + + ++
Sbjct: 179 -KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDE--LFQSIM 234
Query: 302 G---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
P M S+++
Sbjct: 235 EHNVAYPKSM-------------------------SKEA--------------------- 248
Query: 359 AGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
+ + +GL+ P +RL R+ H FF
Sbjct: 249 ----VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 63/340 (18%), Positives = 112/340 (32%), Gaps = 120/340 (35%)
Query: 92 PRYRI-----LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVL 142
P+Y + L +G G+FG+V A+K+++ + + ++ E +L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 143 QRLARHD----------------------IGG------TRYRSFPIDLVRELGRQLLESV 174
+ H GG + + FP + + ++ ++
Sbjct: 61 SIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
++H +I+ DLKPENILL ++K+ D+ F K + +
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-------------------AKYVPDVT 160
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
T T Y APEV+ +N D WS G ++ E+ +G F N +
Sbjct: 161 YTL--------CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSN--TM 209
Query: 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
E++L A L +P
Sbjct: 210 KTYEKIL---------------------NAELRFP-----------------------PF 225
Query: 355 VDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
+ DLL L+ D ++RL + HP+F
Sbjct: 226 FNEDV---KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 63/331 (19%), Positives = 112/331 (33%), Gaps = 107/331 (32%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDI- 150
++ +G G FG+V +++ A+K++ + K ++A E D++ +
Sbjct: 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 151 --------------------GG-----TRYRSFPIDLVRELGRQLLESVAFMHELRLIHT 185
GG P R +++ ++ +H + IH
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 245
D+KP+N+LL + ++K+ D+ + +K+G T
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEG---------------MVRCDTA-------- 229
Query: 246 VSTRHYRAPEVILGLGWNYP----CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
V T Y +PEV+ G + CD WSVG L E+ G+ F ++L +++
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLV--GTYSKIM 286
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
+H L +PD D S +
Sbjct: 287 ----NHKN---------------SLTFPD-----------------------DNDISK-E 303
Query: 362 LIDLLQGLLRYDPAERLK---AREALRHPFF 389
+L+ L D RL E RH FF
Sbjct: 304 AKNLICAFLT-DREVRLGRNGVEEIKRHLFF 333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 63/337 (18%), Positives = 114/337 (33%), Gaps = 118/337 (35%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ + +G+G+FG+V+ E +L A+K+++ I + + M E +L H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG + R F R +++ ++ F+H+
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+I+ DLK +N+LL + K+ D+ + K+G I G TT
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADF-GM---CKEG--------------ICNGVTT----- 181
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ T Y APE++ + + D W++G +L E+ G A F+ + + E +L
Sbjct: 182 -ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAIL 237
Query: 302 G---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
P + D+
Sbjct: 238 NDEVVYPTWL-------------------------HEDA--------------------- 251
Query: 359 AGDLIDLLQGLLRYDPAERL------KAREALRHPFF 389
+L+ + +P RL LRHPFF
Sbjct: 252 ----TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 55/314 (17%), Positives = 96/314 (30%), Gaps = 80/314 (25%)
Query: 18 PRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDD 77
P P P +P K C + G S G P GSP
Sbjct: 16 PDIDPLEALMTNPVVPESKRFCW-NCGRPVGRSDSETKGASE---GWCPYCGSPYSFLPQ 71
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSIN--KYREA 134
G+ + +Y + + G G + D N V +K + + +
Sbjct: 72 ------LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM 125
Query: 135 AMIEIDVLQRL------ARHDIG--------GTRY----------------RSFPIDLVR 164
AM E L + + Y + P+
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI 185
Query: 165 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224
++L +++++H + L++ DLKPENI+L +++
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIML-----------------TEEQ--------- 219
Query: 225 SAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
+KLID G Y+ T ++APE++ G D+++VG L L
Sbjct: 220 --LKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLD 272
Query: 282 EALFQTHENLEHLA 295
++ L
Sbjct: 273 LPTR-NGRYVDGLP 285
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 111/335 (33%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD-- 149
IL +G G FG+V ++ A+KI+ + K E A E DVL
Sbjct: 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWI 136
Query: 150 --------------------IGG------TRYRS-FPIDLVRELGRQLLESVAFMHELRL 182
+GG +++ P ++ R +++ ++ +H+L
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H D+KP+NIL+ ++++ D+ + +DG S+
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---------------TVQSSVA----- 236
Query: 243 SYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
V T Y +PE++ + + CD WS+G + E+ GE F E+L
Sbjct: 237 ---VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV--ETY 290
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
+++ R +P V
Sbjct: 291 GKIM-------------------NHKERFQFP-----------------------TQVTD 308
Query: 358 SAGDLIDLLQGLLRYDPAERL---KAREALRHPFF 389
+ + DL++ L+ RL + +HPFF
Sbjct: 309 VSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFF 342
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 65/333 (19%), Positives = 115/333 (34%), Gaps = 114/333 (34%)
Query: 101 GEGTFGQVV---ECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARH---- 148
G G +G+V + ++ +L A+K+++ K E E VL+ + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 149 ----------------D--IGG------TRYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
D GG ++ F V+ +++ ++ +H+L +I+
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 182
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K ENILL S +V + D+ SK+ + D + +
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGL----SKEF-------------VADETERA-----YDF 220
Query: 245 VVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQT-HENLEHLAMMERVL 301
T Y AP+++ G G + D WS+G ++ EL +G + F E + R+L
Sbjct: 221 -CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
+ +P ++
Sbjct: 280 ---------------------KSEPPYPQEMSA--------------------------L 292
Query: 362 LIDLLQGLLRYDPAERL-----KAREALRHPFF 389
DL+Q LL DP +RL A E H FF
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 75/336 (22%), Positives = 122/336 (36%), Gaps = 117/336 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARH- 148
+ L +G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208
Query: 149 ---------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
GG +R R F D R G +++ ++ ++H +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 182 -LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240
+++ DLK EN++L ++K+ D+ K+G I G+T
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------IKDGATM---- 306
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME 298
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 307 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
+ P + ++
Sbjct: 365 EI--RFPRTL-------------------------GPEA--------------------- 376
Query: 359 AGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
LL GLL+ DP +RL A+E ++H FF
Sbjct: 377 ----KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 54/234 (23%), Positives = 85/234 (36%), Gaps = 62/234 (26%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD------ 149
+ +G G FG V C + + VAIK + S R+A ++E+ L R+ H
Sbjct: 12 VEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-NHPNIVKLY 67
Query: 150 --------------IGGTRYR---------SFPIDLVRELGRQLLESVAFMHELR---LI 183
GG+ Y + Q + VA++H ++ LI
Sbjct: 68 GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DLKP N+LLV+ V +K+ DFG+ +
Sbjct: 128 HRDLKPPNLLLVAGGTV--------------------------LKICDFGTACDIQTHMT 161
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+ + APEV G ++ CD++S G IL E+ + F M
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 6e-15
Identities = 67/339 (19%), Positives = 125/339 (36%), Gaps = 122/339 (35%)
Query: 95 RILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAA--MIEIDVLQRLA 146
+L +G+G +G+V + ++ A+K+++ + ++ A E ++L+
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-V 78
Query: 147 RH----------------------DIGG------TRYRSFPIDLVRELGRQLLESVAFMH 178
+H GG R F D ++ ++ +H
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+ +I+ DLKPENI+L +VK+ D+ K+ I G+ T
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGL----CKES--------------IHDGTVT-- 178
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
H++ T Y APE+++ G N D WS+G ++ ++ +G F T EN + ++
Sbjct: 179 ---HTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRK--KTID 231
Query: 299 RVLG---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
++L LP ++ ++++
Sbjct: 232 KILKCKLNLPPYL-------------------------TQEA------------------ 248
Query: 356 DHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
DLL+ LL+ + A RL A E HPFF
Sbjct: 249 -------RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 74/344 (21%), Positives = 117/344 (34%), Gaps = 136/344 (39%)
Query: 96 ILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARH- 148
+L +G+G+FG+V + ++ ++L A+K+++ + R +E D+L H
Sbjct: 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-VNHP 86
Query: 149 -------------------D--IGG------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
D GG ++ F + V+ +L ++ +H L
Sbjct: 87 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-------- 233
+I+ DLKPENILL ++G IKL DFG
Sbjct: 147 IIYRDLKPENILL-----------------DEEGH----------IKLTDFGLSKESIDH 179
Query: 234 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290
+ +F T Y APEV+ G D WS G ++ E+ +G FQ +
Sbjct: 180 EKKAYSF--------CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 350
E M +L L +P
Sbjct: 232 KE---TMTMILK----------------------------------------AKLGMP-- 246
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 389
Q + A LL+ L + +PA RL E RH FF
Sbjct: 247 --QFLSPEA---QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 51/243 (20%), Positives = 83/243 (34%), Gaps = 61/243 (25%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLARHD 149
+ +G G FG+V F + VA+K R + I E + L +H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 150 ----------------------IGGT-----RYRSFPIDLVRELGRQLLESVAFMHE--- 179
GG + P D++ Q+ + ++H+
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
+ +IH DLK NIL+ + +K+ DFG H
Sbjct: 127 VPIIHRDLKSSNILI-------------------LQKVENGDLSNKILKITDFGLAREWH 167
Query: 240 QDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ + APEVI ++ D+WS G +L EL +GE F ++ LA+
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---RGIDGLAVAY 224
Query: 299 RVL 301
V
Sbjct: 225 GVA 227
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 43/240 (17%), Positives = 75/240 (31%), Gaps = 65/240 (27%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--------EIDVLQRLAR 147
++G+G FG V + + K +VAIK + + E MI E+ ++ L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81
Query: 148 HD--------------------IGGT-------RYRSFPIDLVRELGRQLLESVAFMHEL 180
H G + + L + + +M
Sbjct: 82 HPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 181 R--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
++H DL+ NI L S + K+ DFG +
Sbjct: 142 NPPIVHRDLRSPNIFLQS----------------------LDENAPVCAKVADFGLSQQS 179
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
S ++ + APE I +Y D +S IL + +GE F + + +
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---DEYSYGKI 236
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 58/269 (21%), Positives = 88/269 (32%), Gaps = 90/269 (33%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
G +PR + ++G F YR+ +G G G V E D ++ +VA+
Sbjct: 13 GLVPRGSHMDGTAESREG-TQFG-------PYRLRRLVGRGGMGDVYEAEDTVRERIVAL 64
Query: 123 KIVRS--------INKY-REAAMIEIDVLQRLAR---------HDIG---GTRY------ 155
K++ + REA + R HD G G Y
Sbjct: 65 KLMSETLSSDPVFRTRMQREA--------RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116
Query: 156 ----------RSFPIDLVR--ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203
R P+ R + RQ+ ++ H H D+KPENIL+
Sbjct: 117 NGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV--------- 167
Query: 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVI 257
S D L+DFG V T +Y APE
Sbjct: 168 --------SADD----------FAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPERF 207
Query: 258 LGLGWNYPCDLWSVGCILVELCSGEALFQ 286
Y D++++ C+L E +G +Q
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 49/242 (20%), Positives = 86/242 (35%), Gaps = 82/242 (33%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
IG+ + RY+I+ K+G G V D VAIK + + ++ RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREV-- 62
Query: 137 IEIDVLQRLAR---------HDIG---GTRY------------------RSFPIDLVREL 166
++ D+ Y +D
Sbjct: 63 ------HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF 116
Query: 167 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226
Q+L+ + H++R++H D+KP+NIL+ + +
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILI-----------------DSNKT---------- 149
Query: 227 IKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
+K+ DFG T+ +H V+ T Y +PE G + D++S+G +L E+
Sbjct: 150 LKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 281 GE 282
GE
Sbjct: 208 GE 209
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 45/218 (20%), Positives = 83/218 (38%), Gaps = 43/218 (19%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD----- 149
+G+G FGQ ++ E E++ +K + ++ + + E+ V++ L H
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKF 72
Query: 150 IG-GTRYRSFPI-----------DLVRELGRQLLESV------------AFMHELRLIHT 185
IG + + +++ + Q S A++H + +IH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 186 DLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL N L+ + V V D F L+R D +S T
Sbjct: 133 DLNSHNCLVRENKNVVVAD--FGLARLMVDEKTQPEGLRSLKKPDRKKRYT--------- 181
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 282
VV ++ APE+I G ++ D++S G +L E+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 51/246 (20%), Positives = 88/246 (35%), Gaps = 84/246 (34%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
+L+ RY + +G G +V D VA+K++R+ ++ REA
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA-- 63
Query: 137 IEIDVLQRLAR---------HDIGGTRYRSFPI--------------DLVRELGR----- 168
Q A +D G + P+ D+V G
Sbjct: 64 ------QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 169 ------QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222
+++ F H+ +IH D+KP NI++ S
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMI-----------------SATN------- 153
Query: 223 KSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276
A+K++DFG + + V+ T Y +PE G + D++S+GC+L
Sbjct: 154 ---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 277 ELCSGE 282
E+ +GE
Sbjct: 211 EVLTGE 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 45/228 (19%), Positives = 79/228 (34%), Gaps = 61/228 (26%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--- 148
P +R+ K+G G FG++ + E VAIK+ ++ +E ++L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQLGSGDGI 67
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
D+ R+F + V + QL+ + ++H LI
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-------STT 236
+ D+KPEN L+ G I +IDF T
Sbjct: 128 YRDVKPENFLI--------------------GR--PGNKTQQVIHIIDFALAKEYIDPET 165
Query: 237 FEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
+H ++H + T Y + LG + DL ++G + + G
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 29/131 (22%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--- 148
RYR+ K+G G+FG + D E VAIK+ K+ + + E + + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQGGVGI 67
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
D+ R F + V L Q++ + ++H I
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127
Query: 184 HTDLKPENILL 194
H D+KP+N L+
Sbjct: 128 HRDVKPDNFLM 138
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 33/187 (17%), Positives = 57/187 (30%), Gaps = 70/187 (37%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA----- 146
++ + K+G G FG + F K E A +V+ + E+ QR+A
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 147 ---------------------RHDIGGTRYR-------------------SFPIDLVREL 166
+ G YR +F V +L
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 167 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226
G ++L+ + ++HE +H D+K N+LL
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLL-------------------------GYKNPDQ 191
Query: 227 IKLIDFG 233
+ L D+G
Sbjct: 192 VYLADYG 198
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 28/131 (21%), Positives = 51/131 (38%), Gaps = 29/131 (22%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--- 148
++R+ K+G G+FG++ + + E VAIK+ K+ + E + + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRILQGGTGI 65
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
D+ R + V L Q++ V F+H +
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
Query: 184 HTDLKPENILL 194
H D+KP+N L+
Sbjct: 126 HRDIKPDNFLM 136
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 44/228 (19%), Positives = 79/228 (34%), Gaps = 61/228 (26%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--- 148
Y++ ++GEG+FG + E + + VAIK + + E + LA
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLLAGCTGI 68
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
D+ R F + V +Q+L V +HE L+
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-------STT 236
+ D+KP+N L+ N ++ I ++DFG T
Sbjct: 129 YRDIKPDNFLI----------------------GRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 237 FEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281
+H ++ + T Y + LG + DL ++G + + G
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 64/234 (27%)
Query: 95 RILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
+ ++G G+FG V + + + VA+K++ + +A E+ VL++ RH
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVN 81
Query: 150 --------------------IGGTRYR-------SFPIDLVRELGRQLLESVAFMHELRL 182
G + Y F + + ++ RQ + ++H +
Sbjct: 82 ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 183 IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
IH DLK NI L VK+ D F L+ S
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGD--FGLAT---------------------EKSRWSGSHQ 178
Query: 242 HSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLE 292
+ + + APEVI N + D+++ G +L EL +G+ + N +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 48/244 (19%), Positives = 83/244 (34%), Gaps = 72/244 (29%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD--- 149
I K+G G+FG V + VA+KI+ + + + E+ +++RL RH
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIV 97
Query: 150 -------------------IGGTRYR---------SFPIDLVRELGRQLLESVAFMHELR 181
G+ YR + + + + ++H
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 182 --LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
++H +LK N+L+ VKV DFG + +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKV---------------------------CDFGLSRLKA 190
Query: 240 QDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
S T + APEV+ N D++S G IL EL + + + NL +
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW---GNLNPAQV 247
Query: 297 MERV 300
+ V
Sbjct: 248 VAAV 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 24/190 (12%), Positives = 58/190 (30%), Gaps = 73/190 (38%)
Query: 92 PRYRILSKMGEGTFGQV--------VECFDNEKKELVAIKI-------VRSINKY-REAA 135
++++ S G + + C +K+ ++K+ N + R A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 136 MIEIDVLQRLARHDIGG-----------TRYR---------------------SFPIDLV 163
++++ ++L + +YR V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 164 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223
++ +LL+++ F+HE +H ++ ENI + +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFV-------------------------DPED 196
Query: 224 SSAIKLIDFG 233
S + L +G
Sbjct: 197 QSQVTLAGYG 206
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 37/205 (18%), Positives = 62/205 (30%), Gaps = 83/205 (40%)
Query: 84 FAIGENLT----PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSINKYREA 134
FA+GE +T +++ +G+G FG + N +K+ S N
Sbjct: 23 FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF- 81
Query: 135 AMIEIDVLQRLA--------------------------RHDIGGTRY------------- 155
E+ QR A HD G Y
Sbjct: 82 --TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ 139
Query: 156 -------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208
+ F V +L ++L+ + ++HE +H D+K N+LL
Sbjct: 140 KIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-------------- 185
Query: 209 SRSSKDGSYFKNLPKSSAIKLIDFG 233
N + L+D+G
Sbjct: 186 -----------NYKNPDQVYLVDYG 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 53/301 (17%), Positives = 97/301 (32%), Gaps = 85/301 (28%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+L +G+G +G+V + + E VA+KI S ++ E+ L RH+ I
Sbjct: 12 LLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFI 68
Query: 151 G---------------------GT-----RYRSFPIDLVRELGRQLLESVAFMHELRL-- 182
G+ + + + + +A +H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 183 ------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 235
H DLK +NIL+ + D L+ S + +D G+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIAD--LGLAVM-----------HSQSTNQLDVGNN 175
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCSGEALFQTHE 289
V T+ Y APEV+ D+W+ G +L E+ E
Sbjct: 176 P--------RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRDSMRAVWKLL 345
+ + P + V+ D E R + P+ S ++ ++ KL+
Sbjct: 228 DYK-----------PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
Query: 346 R 346
+
Sbjct: 277 K 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 44/247 (17%), Positives = 83/247 (33%), Gaps = 69/247 (27%)
Query: 96 ILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD-- 149
I +G+G FGQV + E VAI+++ +A E+ ++ RH+
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENV 91
Query: 150 --------------------IGGTRYR-------SFPIDLVRELGRQLLESVAFMHELRL 182
G T Y ++ R++ +++++ + ++H +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 183 IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+H DLK +N+ V + D F L S +
Sbjct: 152 LHKDLKSKNV-FYDNGKVVITD--FGLFSISGVLQAGRR------------------EDK 190
Query: 242 HSYVVSTRHYRAPEVILGLGWNYP---------CDLWSVGCILVELCSGEALFQTHENLE 292
+ APE+I L + D++++G I EL + E F+T
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250
Query: 293 HLAMMER 299
+ M
Sbjct: 251 IIWQMGT 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 56/301 (18%), Positives = 104/301 (34%), Gaps = 85/301 (28%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G+G FG+V + E VA+KI S + EI L RH+ I
Sbjct: 46 LQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 102
Query: 151 GG--------------TRY------------RSFPIDLVRELGRQLLESVAFMHELRL-- 182
+ Y + ++ + +L +A +H +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 183 ------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 235
H DLK +NIL+ + D L+ SA ID
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVR-----------HDSATDTIDIAPN 209
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCSGEALFQTHE 289
V T+ Y APEV+ D++++G + E+ ++ HE
Sbjct: 210 H--------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRDSMRAVWKLL 345
+ + LP++ ++ +D E+ + R + P+ S +++R + K++
Sbjct: 262 DYQ-----------LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310
Query: 346 R 346
R
Sbjct: 311 R 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 46/237 (19%), Positives = 86/237 (36%), Gaps = 57/237 (24%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----I 150
+ K+G G +G+V E + VA+K ++ E + E V++ + +H +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 281
Query: 151 GGTRYRSFPIDLVREL-------------GRQLLESV-------------AFMHELRLIH 184
G R P ++ E RQ + +V ++ + IH
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 185 TDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
+L N L+ VKV D F LSR +Y + IK
Sbjct: 342 RNLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTAHAGAKFPIKWT------------- 386
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
APE + ++ D+W+ G +L E+ + G + + + + ++E+
Sbjct: 387 ---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 54/302 (17%), Positives = 98/302 (32%), Gaps = 87/302 (28%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++ ++G+G +G+V + EK VA+K+ + + EI + RH+
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK---VAVKVFFTTEEASWFRETEIYQTVLM-RHENILGF 96
Query: 150 IG---------------------GTRYR-----SFPIDLVRELGRQLLESVAFMHELRL- 182
I G+ Y + + +L + + +H
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 183 -------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGS 234
H DLK +NIL+ + D L+ S +D
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVK-----------FISDTNEVDIPP 203
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCSGEALFQTH 288
T V T+ Y PEV+ D++S G IL E+
Sbjct: 204 NT--------RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRDSMRAVWKL 344
E + LP+H ++ +D E + R +P+ +S + +R + KL
Sbjct: 256 EEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 345 LR 346
+
Sbjct: 305 MT 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 57/293 (19%), Positives = 96/293 (32%), Gaps = 79/293 (26%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 150 -----IG-GTRYRSFPIDLVREL-------------------------GRQLLESVAFMH 178
G + L+ E Q+ + + ++
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
R IH DL NIL+ + VK+ DFG T
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIG---------------------------DFGLTKVL 164
Query: 239 HQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
QD + APE + ++ D+WS G +L EL + ++
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 343
+ G + +I + + RL PDG M W
Sbjct: 225 MRMIGNDKQGQMIVFHLI-------ELLKNNGRLPRPDGCPDEIYMIMTECWN 270
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 58/293 (19%), Positives = 96/293 (32%), Gaps = 79/293 (26%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 150 -----IG-GTRYRSFPIDLVREL-------------------------GRQLLESVAFMH 178
G + L+ E Q+ + + ++
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
R IH DL NIL+ + VK+ DFG T
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIG---------------------------DFGLTKVL 195
Query: 239 HQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
QD Y APE + ++ D+WS G +L EL + ++
Sbjct: 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 343
+ G + +I + + RL PDG M W
Sbjct: 256 MRMIGNDKQGQMIVFHLI-------ELLKNNGRLPRPDGCPDEIYMIMTECWN 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 57/307 (18%), Positives = 100/307 (32%), Gaps = 87/307 (28%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD- 149
+ ++L G FG V + E VA+KI +K E+ L + +H+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79
Query: 150 ----IG-GTRYRSFPID--LVRE----------LGRQLL---------ESVA----FMHE 179
IG R S +D L+ L ++ E++A ++HE
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 180 ----------LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 229
+ H D+K +N+LL + + +
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLL-----------------KNNLT----------ACI 172
Query: 230 IDFGSTTFEHQDHSYVVS-----TRHYRAPEVILG-LGWNYP----CDLWSVGCILVELC 279
DFG S + TR Y APEV+ G + + D++++G +L EL
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
S E++ E +G P ++ E + R D M
Sbjct: 233 SRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQ-----EVVVHKKKRPVLRDYWQKHAGMA 286
Query: 340 AVWKLLR 346
+ + +
Sbjct: 287 MLCETIE 293
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 32/247 (12%), Positives = 75/247 (30%), Gaps = 79/247 (31%)
Query: 96 ILSKMGEGTFGQVVE--CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
L+K+ E G++ + N+ + +K+++ + + E L+ H
Sbjct: 14 FLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPN 68
Query: 150 -----------------------IGGTRYR------SFPIDLVRELG--RQLLESVAFMH 178
G+ Y +F +D + + + +AF+H
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 179 ELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
L + L ++++ +D + ++
Sbjct: 129 TLEPLIPRHALNSRSVMI-----------------DEDMT----------ARISMADVKF 161
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYP---CDLWSVGCILVELCSGEALFQTHENLEH 293
+ + APE + + D+WS +L EL + E F +L +
Sbjct: 162 SFQSPG--RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSN 216
Query: 294 LAMMERV 300
+ + +V
Sbjct: 217 MEIGMKV 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQL 244
Query: 150 ----------------IGG-------TRYRSF--PIDLVRELGRQLLESVAFMHELRLIH 184
G + LV ++ Q+ +A++ + +H
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVH 303
Query: 185 TDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
DL+ NIL+ KV D F L+R +D Y IK
Sbjct: 304 RDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT------------- 348
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 349 ---------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 38/280 (13%), Positives = 56/280 (20%), Gaps = 108/280 (38%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ +PP G + RYR+L G Q + D VA+ V
Sbjct: 11 RESSAPPDDVQLVPGARI------ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV 64
Query: 126 RSINK---------YREAAMIEIDVLQRLAR---------HDIGGTRYRSFPIDLVREL- 166
RL+R D+ TR +V E
Sbjct: 65 DPQGVLPDDVLQETLSRT--------LRLSRIDKPGVARVLDVVHTRAGGL---VVAEWI 113
Query: 167 ---------------------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205
+ L + H + + P + +
Sbjct: 114 RGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV----------- 162
Query: 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 265
S DG + L N
Sbjct: 163 ------SIDG----------DVVLAYPA-----------------TMPDA-------NPQ 182
Query: 266 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 305
D+ +G L L LA ER P
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 59/276 (21%), Positives = 102/276 (36%), Gaps = 73/276 (26%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V ++ E+VA+K +++ ++R EID+L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 149 D-----IG-GTRYRSFPIDLVREL-----------------------GRQLLESVAFMHE 179
+ G + + LV E +Q+ E +A++H
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGS--YFKNLPKSSAIKLIDFGSTT 236
IH DL N+LL + VK+ D F L+++ +G Y S +
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGD--FGLAKAVPEGHEYYRVREDGDSPVF-------- 202
Query: 237 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 295
+ APE + + Y D+WS G L EL + ++ L
Sbjct: 203 --------------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 331
+ + G + + + RG RL PD
Sbjct: 249 GIAQ--GQMTVLRLT-------ELLERGERLPRPDK 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 55/295 (18%), Positives = 92/295 (31%), Gaps = 83/295 (28%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V C + E VA+K ++ S + EI++L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 149 D-----IG-GTRYRSFPIDLVREL-------------------------GRQLLESVAFM 177
+ G T I L+ E Q+ + + ++
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
+ +H DL N+L+ S VK+ DFG T
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIG---------------------------DFGLTKA 175
Query: 238 EHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 290
D Y APE ++ + D+WS G L EL + ++
Sbjct: 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235
Query: 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 343
+ G + ++ + G RL P MR W+
Sbjct: 236 FLKMIGPTH--GQMTVTRLV-------NTLKEGKRLPCPPNCPDEVYQLMRKCWE 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQL 327
Query: 150 ----------------IGG-------TRYRSF--PIDLVRELGRQLLESVAFMHELRLIH 184
G + LV ++ Q+ +A++ + +H
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVH 386
Query: 185 TDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
DL+ NIL+ KV D F L+R +D Y IK
Sbjct: 387 RDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT------------- 431
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 432 ---------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 43/251 (17%), Positives = 74/251 (29%), Gaps = 71/251 (28%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L +G G +G V + D VA+K+ N+ I + + HD
Sbjct: 17 LLELIGRGRYGAVYKGSLDERP---VAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARF 72
Query: 150 IGGTRYRSFPID--------------LVRELGRQLLES-------------VAFMHE--- 179
I G + L + L + +A++H
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 180 ------LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDF 232
+ H DL N+L+ + + D F LS + + +A
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISD--FGLSMRLTGNRLVRPGEEDNA------ 184
Query: 233 GSTTFEHQDHSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVELCSGEALF 285
V T Y APEV+ G D++++G I E+
Sbjct: 185 ---------AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 286 QTHENLEHLAM 296
E++ M
Sbjct: 236 FPGESVPEYQM 246
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 57/294 (19%), Positives = 94/294 (31%), Gaps = 82/294 (27%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD 149
+ +S++G+G FG V C + LVA+K ++ ++ EI +L+ L D
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 150 -----IG-GTRYRSFPIDLVREL-------------------------GRQLLESVAFMH 178
G + LV E Q+ + + ++
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
R +H DL NIL+ S +VK+ DFG
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIA---------------------------DFGLAKLL 177
Query: 239 HQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291
D Y V + APE + ++ D+WS G +L EL + +
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA-- 235
Query: 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 343
E L MM ++ + G RL P + + M+ W
Sbjct: 236 EFLRMMGCERDVPALSRLL-------ELLEEGQRLPAPPACPAEVHELMKLCWA 282
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 6e-06
Identities = 60/493 (12%), Positives = 128/493 (25%), Gaps = 159/493 (32%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPP------PKVLP---ALYCVQE------FGNGG--- 51
P +R RL ++ L AL ++ G G
Sbjct: 105 PSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163
Query: 52 --MPNYACSS-----MFYGAIPRTGSPPW-------RPDDKDGHYVFAIGENL----TPR 93
+ C S I W P+ V + + L P
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIF------WLNLKNCNSPET-----VLEMLQKLLYQIDPN 212
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH----D 149
+ S + E + L+ K Y ++ ++V + A+ +
Sbjct: 213 WTSRSDHSSNIK-LRIHSIQAELRRLLKSK------PYENCLLVLLNV--QNAKAWNAFN 263
Query: 150 IG-----GTRYRSFPIDLVRELGRQLLESV----AFMHE---------LRLIHTDLKPE- 190
+ TR++ D + + + L DL E
Sbjct: 264 LSCKILLTTRFKQV-TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322
Query: 191 ---NILLVS--AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 245
N +S AE ++ L+ +K++ +I+ ++ + +
Sbjct: 323 LTTNPRRLSIIAESIR----DGLATWD----NWKHVNCDKLTTIIE---SSLNVLEPAEY 371
Query: 246 VSTRHYRA----------PEVILGLGWNYPCDLWSVGCILVELCSGEAL----------- 284
+ + P ++L L W V ++ +L +
Sbjct: 372 --RKMFDRLSVFPPSAHIPTILLSLIWFDV-IKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 285 ----FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG--------- 331
+ LE+ + H ++ + + + D
Sbjct: 429 PSIYLELKVKLENEYAL--------HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH 480
Query: 332 --ATSRDSMRAVWKLLRLPNL--IMQHVDHS------AGDLIDLLQGLLRYDPAERLKAR 381
+++++ L + + Q + H +G +++ LQ L Y K
Sbjct: 481 LKNIEHPERMTLFRMVFL-DFRFLEQKIRHDSTAWNASGSILNTLQQLKFY------KPY 533
Query: 382 EALRHPFFTRDVR 394
P + R V
Sbjct: 534 ICDNDPKYERLVN 546
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 51/241 (21%), Positives = 86/241 (35%), Gaps = 62/241 (25%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451
Query: 150 -----IG------------------------GTRYRSFPIDLVRELGRQLLESVAFMHEL 180
IG ++ L+ QL ++A++
Sbjct: 452 HIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-LYAYQLSTALAYLESK 510
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
R +H D+ N+L+ S + VK+ D F LSR +D +Y+K IK +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIKWM--------- 559
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298
APE I + D+W G + E+ G FQ +N + + +E
Sbjct: 560 -------------APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
Query: 299 R 299
Sbjct: 607 N 607
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 36/156 (23%), Positives = 59/156 (37%), Gaps = 34/156 (21%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----I 150
+ K+G G +G+V E + VA+K ++ E + E V++ + +H +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 74
Query: 151 GGTRYRSFPIDLV-------------RELGRQLLESV-------------AFMHELRLIH 184
G R P ++ RE RQ + +V ++ + IH
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 185 TDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 219
DL N L+ VKV D F LSR +Y
Sbjct: 135 RDLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTA 168
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 41/187 (21%), Positives = 65/187 (34%), Gaps = 41/187 (21%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
++G R KD + E+L + ++G G FG+V LVA+
Sbjct: 91 PLTKKSGVVLHRAVPKDKWVLNH--EDLV----LGEQIGRGNFGEVFSGRLRADNTLVAV 144
Query: 123 KIVR--SINKYREAAMIEIDVLQRLARHD----IGGTRYRSFPIDLVREL---------- 166
K R + + E +L++ H + G + PI +V EL
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 167 ---GRQLLESV------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 210
G +L ++ IH DL N L+ +K+ D F +SR
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISD--FGMSR 261
Query: 211 SSKDGSY 217
DG Y
Sbjct: 262 EEADGVY 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 8e-05
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 160 IDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218
+ + + QL S+A LR H DL N+LL K+ Y +SS S
Sbjct: 160 LATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKL-HYTLNGKSSTIPSC- 217
Query: 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 270
+ +ID+ + E ++ G G +Y D++
Sbjct: 218 -----GLQVSIIDYTLSRLERDGIVVFCDV--SMDEDLFTGDG-DYQFDIYR 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 5e-04
Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 11/67 (16%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---------SINKYREAAMIEIDV 141
T + + K+GEG FG+V + VAIKI+ S K E + EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 142 LQRLARH 148
+ L+
Sbjct: 77 SKELSLL 83
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 34/153 (22%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++ K+G G FG+V N+ + VA+K ++ + EA + E +V++ L +HD
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKL 248
Query: 150 IG------------------------GTRYRSFPIDLVRELGRQLLESVAFMHELRLIHT 185
P+ + + Q+ E +AF+ + IH
Sbjct: 249 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 186 DLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 217
DL+ NIL+ ++ K+ D F L+R +D Y
Sbjct: 309 DLRAANILVSASLVCKIAD--FGLARVIEDNEY 339
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 53/246 (21%), Positives = 87/246 (35%), Gaps = 72/246 (29%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76
Query: 150 -----IG------------------------GTRYRSFPIDLVRELGRQLLESVAFMHEL 180
IG +Y L+ QL ++A++
Sbjct: 77 HIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK 135
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
R +H D+ N+L+ S + VK+ D F LSR +D +Y+K IK +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIKWM--------- 184
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNY-----PCDLWSVGCILVELCS-GEALFQTHENLEH 293
APE I N+ D+W G + E+ G FQ +N +
Sbjct: 185 -------------APESI-----NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
Query: 294 LAMMER 299
+ +E
Sbjct: 227 IGRIEN 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 43/247 (17%), Positives = 73/247 (29%), Gaps = 45/247 (18%)
Query: 14 MDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPW 73
M R V + P+ P L + Y + +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 74 RPDDKDGHYVFAIGENLTPRYR----ILSKMGEGTFGQVVECF---DNEKKELVAIKIVR 126
+ V A+ + +G G FG V ++ KK A+K +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 127 SINKYREAA--MIEIDVLQRLARH-----------DIGGTRY-----------RSF---- 158
I E + + E +++ H G+ R+F
Sbjct: 127 RITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 159 -----PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSS 212
DL+ G Q+ + + F+ + +H DL N +L VKV D F L+R
Sbjct: 186 THNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD--FGLARDM 242
Query: 213 KDGSYFK 219
D +
Sbjct: 243 YDKEFDS 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 64/335 (19%), Positives = 107/335 (31%), Gaps = 84/335 (25%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPA-LYCVQEFGNGGMPNYACSSMFYGAIPRT 68
P + P L + Y + M
Sbjct: 259 ASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESP 318
Query: 69 GSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR 126
S P DK +F +NL ++G G FG V + + KK++ VAIK+++
Sbjct: 319 FSDPEELKDKK---LFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK 372
Query: 127 --SINKYREAAMIEIDVLQRLARHD---------------------IGG-------TRYR 156
+ E M E ++ +L + GG +
Sbjct: 373 QGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE 431
Query: 157 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216
P+ V EL Q+ + ++ E +H +L N+LLV+ Y K+
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKIS------------- 478
Query: 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----P 265
DFG + D SY + + APE I N+
Sbjct: 479 --------------DFGLSKALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSR 519
Query: 266 CDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299
D+WS G + E S G+ ++ + E +A +E+
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 33/153 (21%), Positives = 65/153 (42%), Gaps = 34/153 (22%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRL 73
Query: 150 IG------------------------GTRYRSFPIDLVRELGRQLLESVAFMHELRLIHT 185
I+ + ++ Q+ E +AF+ E IH
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 186 DLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 217
DL+ NIL+ K+ D F L+R +D Y
Sbjct: 134 DLRAANILVSDTLSCKIAD--FGLARLIEDNEY 164
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 48/241 (19%), Positives = 87/241 (36%), Gaps = 67/241 (27%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----I 150
+L ++G G FG V + + VA+K+++ + + E + +L H
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKF 68
Query: 151 GGTRYRSFPIDLVREL-------------------------GRQLLESVAFMHELRLIHT 185
G + +PI +V E + E +AF+ + IH
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 186 DLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL N L+ VKV D F ++R D Y ++ +K
Sbjct: 129 DLAARNCLVDRDLCVKVSD--FGMTRYVLDDQYVSSVGTKFPVK---------------- 170
Query: 245 VVSTRHYRAPEVILGLGWNY-----PCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298
+ APEV +Y D+W+ G ++ E+ S G+ + + N E + +
Sbjct: 171 ------WSAPEVF-----HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
Query: 299 R 299
+
Sbjct: 220 Q 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 5e-04
Identities = 38/153 (24%), Positives = 59/153 (38%), Gaps = 34/153 (22%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----I 150
+ ++G G FG V + K + VAIK +R E + E +V+ +L H +
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQL 68
Query: 151 GGTRYRSFPIDLVREL-------------------------GRQLLESVAFMHELRLIHT 185
G PI LV E + E +A++ E +IH
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 186 DLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 217
DL N L+ + +KV D F ++R D Y
Sbjct: 129 DLAARNCLVGENQVIKVSD--FGMTRFVLDDQY 159
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 38/160 (23%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 251
Query: 150 IGGTRYRSFPIDLVREL-------------GRQLLESV-------------AFMHELRLI 183
+G + +V E GR +L ++ +
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 184 HTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 222
H DL N+L+ KV D F L++ + LP
Sbjct: 312 HRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 349
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 405 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.71 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.66 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.52 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.45 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.37 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.79 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 93.4 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.38 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.01 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 86.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.11 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=422.95 Aligned_cols=229 Identities=26% Similarity=0.426 Sum_probs=191.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
..|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++|+.++|+||+...
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999996433 3456678999999999999985432
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
...+++.+++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------------------------- 207 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-------------------------- 207 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--------------------------
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC--------------------------
Confidence 24689999999999999999999999999999999999997655
Q ss_pred CCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 015532 225 SAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (405)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 208 -~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 286 (346)
T 4fih_A 208 -RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 286 (346)
T ss_dssp -CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred -CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 4667777776544322 234789999999999999999999999999999999999999999988877776654421
Q ss_pred CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHH
Q 015532 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 381 (405)
Q Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~ 381 (405)
.+. ...+..+++++++||.+||++||++|||++
T Consensus 287 ~~~-----------------------------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 319 (346)
T 4fih_A 287 PPR-----------------------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAA 319 (346)
T ss_dssp CCC-----------------------------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCC-----------------------------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 110 011234578999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 015532 382 EALRHPFFTRDVR 394 (405)
Q Consensus 382 elL~hp~f~~~~~ 394 (405)
|+|+||||++...
T Consensus 320 e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 320 ELLKHPFLAKAGP 332 (346)
T ss_dssp HHTTCGGGGGCCC
T ss_pred HHhcCHhhcCCCC
Confidence 9999999997643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=411.29 Aligned_cols=225 Identities=25% Similarity=0.400 Sum_probs=177.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+++|+.++|+|++...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999643 23356788999999999999985432
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~----------------------- 149 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL----------------------- 149 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-----------------------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-----------------------
Confidence 25689999999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.+||+|||+|+..... ..+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus 150 ----~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~ 225 (275)
T 3hyh_A 150 ----NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS 225 (275)
T ss_dssp ----CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ----CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 4677777777654332 234689999999999998886 589999999999999999999999877766665554
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
.....+ +..+++++++||.+||+.||++||
T Consensus 226 ~~~~~~--------------------------------------------------p~~~s~~~~~li~~~L~~dP~~R~ 255 (275)
T 3hyh_A 226 NGVYTL--------------------------------------------------PKFLSPGAAGLIKRMLIVNPLNRI 255 (275)
T ss_dssp HTCCCC--------------------------------------------------CTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred cCCCCC--------------------------------------------------CCCCCHHHHHHHHHHccCChhHCc
Confidence 322111 123577899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
|++|+|+||||+.+.
T Consensus 256 s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 256 SIHEIMQDDWFKVDL 270 (275)
T ss_dssp CHHHHHHCHHHHTTC
T ss_pred CHHHHHcCcccccCC
Confidence 999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=413.25 Aligned_cols=225 Identities=27% Similarity=0.387 Sum_probs=189.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+++|+.|+|+||+...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45999999999999999999999999999999997532 3346788999999999999985432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g---------------------- 169 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---------------------- 169 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----------------------
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC----------------------
Confidence 24689999999999999999999999999999999999997665
Q ss_pred CCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||+|+.... ...+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 170 -----~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 244 (311)
T 4aw0_A 170 -----HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA 244 (311)
T ss_dssp -----CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -----CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 456666666654321 1234689999999999999999999999999999999999999999988877776
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.|.+....+ ++.+++++++||.+||++||+
T Consensus 245 ~i~~~~~~~--------------------------------------------------p~~~s~~~~dli~~lL~~dp~ 274 (311)
T 4aw0_A 245 KIIKLEYDF--------------------------------------------------PEKFFPKARDLVEKLLVLDAT 274 (311)
T ss_dssp HHHHTCCCC--------------------------------------------------CTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHcCCCCC--------------------------------------------------CcccCHHHHHHHHHHccCCHh
Confidence 665432111 124577899999999999999
Q ss_pred CCCCHHH------HHcCCCCCCCC
Q 015532 376 ERLKARE------ALRHPFFTRDV 393 (405)
Q Consensus 376 ~Rpta~e------lL~hp~f~~~~ 393 (405)
+|+|++| +++||||++-.
T Consensus 275 ~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 275 KRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp GSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HCcChHHHcCCHHHHCCCCcCCCC
Confidence 9999988 68999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=422.59 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=200.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+++|+++|+.|+|+||+...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4578999999999999999999999999999999996532 3345678999999999999985421
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 132 ~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--------------- 196 (398)
T 4b99_A 132 KSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--------------- 196 (398)
T ss_dssp CCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---------------
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC---------------
Confidence 245899999999999999999999999999999999999987664
Q ss_pred CCcccCCCCCCCceeccCCCCcccc-------CCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEH-------QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
+||+|||+|+... ......+||+.|||||++.+. .|+.++||||+||++|||++|++||.
T Consensus 197 ------------~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 197 ------------LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp ------------EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ------------EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 4555555554321 122346899999999999886 46899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhh-HHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
+.+..+++..|....|.++........... ..+.... +. ..+..........+++++||
T Consensus 265 g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~-----~~---------------~~~~~~~~~~~~~s~~~~dL 324 (398)
T 4b99_A 265 GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSL-----PP---------------RQPVPWETVYPGADRQALSL 324 (398)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSS-----CC---------------CCCCCHHHHSTTCCHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcC-----CC---------------cCCCCHHHhCCCCCHHHHHH
Confidence 999999999999999988765432211100 0110000 00 00111112234567899999
Q ss_pred HHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 366 LQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
|.+||++||++|+||+|+|+||||++..
T Consensus 325 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 325 LGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 9999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-56 Score=420.24 Aligned_cols=227 Identities=25% Similarity=0.412 Sum_probs=184.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+++|++|+|+||+...
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999999999999999999643 23456788999999999999985422
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--------------------- 162 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--------------------- 162 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC---------------------
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC---------------------
Confidence 12468899999999999999999999999999999999997655
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+
T Consensus 163 ------~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 236 (350)
T 4b9d_A 163 ------TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236 (350)
T ss_dssp ------CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ------CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 4677777777654432 1346899999999999999999999999999999999999999999888777766
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+.. .| .....+++++.+||.+||+.||++
T Consensus 237 i~~~~--~~-----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~ 267 (350)
T 4b9d_A 237 IISGS--FP-----------------------------------------------PVSLHYSYDLRSLVSQLFKRNPRD 267 (350)
T ss_dssp HHHTC--CC-----------------------------------------------CCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHcCC--CC-----------------------------------------------CCCccCCHHHHHHHHHHccCChhH
Confidence 64421 11 011345778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~ 394 (405)
|||++|+|+||||++...
T Consensus 268 R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 268 RPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp SCCHHHHHTSHHHHTTGG
T ss_pred CcCHHHHhcCHHhhcCCC
Confidence 999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=424.24 Aligned_cols=230 Identities=26% Similarity=0.424 Sum_probs=192.4
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
...|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.++|+||+...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999999999999999996533 3456688999999999999986532
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++.+++.++.||+.||+|||++|||||||||+||||+.+|
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g------------------------- 284 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG------------------------- 284 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-------------------------
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-------------------------
Confidence 24689999999999999999999999999999999999997665
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 285 --~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 285 --RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp --CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred --CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 4666777766544322 24578999999999999999999999999999999999999999998887777665442
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
..+. ...+..+++++++||.+||+.||++|+||
T Consensus 363 ~~~~-----------------------------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta 395 (423)
T 4fie_A 363 LPPR-----------------------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATA 395 (423)
T ss_dssp CCCC-----------------------------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCC-----------------------------------------------CcccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 1110 11223567899999999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015532 381 REALRHPFFTRDVR 394 (405)
Q Consensus 381 ~elL~hp~f~~~~~ 394 (405)
+|+|+||||++...
T Consensus 396 ~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 396 AELLKHPFLAKAGP 409 (423)
T ss_dssp HHHTTCGGGGGCCC
T ss_pred HHHhcCHHhcCCCC
Confidence 99999999997643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=399.39 Aligned_cols=230 Identities=23% Similarity=0.409 Sum_probs=181.7
Q ss_pred ccCCCe-EEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 89 NLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
...++| ++.++||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|++|+|+||+...
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 344566 7788999999999999999999999999999643 23456788999999999999986421
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||+|||++| ||||||||+|||++.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--------------- 166 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--------------- 166 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS---------------
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC---------------
Confidence 245789999999999999999999998 999999999999963
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.++.+||+|||+|+..... ....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+..+
T Consensus 167 -----------~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 167 -----------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp -----------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred -----------CCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 1235677777777654333 234689999999999875 699999999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
...+...... +..|. ......++++.+||.+||
T Consensus 235 ~~~~~~~i~~-~~~~~----------------------------------------------~~~~~~~~~~~~li~~~L 267 (290)
T 3fpq_A 235 AAQIYRRVTS-GVKPA----------------------------------------------SFDKVAIPEVKEIIEGCI 267 (290)
T ss_dssp HHHHHHHHTT-TCCCG----------------------------------------------GGGGCCCHHHHHHHHHHS
T ss_pred HHHHHHHHHc-CCCCC----------------------------------------------CCCccCCHHHHHHHHHHc
Confidence 4443222110 11111 111234678999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+.||++|||++|+|+||||++.
T Consensus 268 ~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 268 RQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CSSGGGSCCHHHHHTSGGGC--
T ss_pred cCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=404.83 Aligned_cols=224 Identities=29% Similarity=0.429 Sum_probs=179.1
Q ss_pred CCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
++|++++.||+|+||+||+|++. .+++.||||++++.. .....+.+|+++|++++|+||+...
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999984 467899999996432 2334577899999999999984321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.+++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~------------------- 164 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH------------------- 164 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC-------------------
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC-------------------
Confidence 246899999999999999999999999999999999999987665
Q ss_pred cCCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+||+|||+|+... ....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+.
T Consensus 165 --------vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 236 (304)
T 3ubd_A 165 --------IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236 (304)
T ss_dssp --------EEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --------EEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence 5555555554322 12234689999999999999999999999999999999999999999988877777
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.+....+ +..+++++++||.+||+.||+
T Consensus 237 ~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~~L~~dP~ 266 (304)
T 3ubd_A 237 MILKAKLGM--------------------------------------------------PQFLSPEAQSLLRMLFKRNPA 266 (304)
T ss_dssp HHHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHcCCCCC--------------------------------------------------CCcCCHHHHHHHHHHcccCHH
Confidence 665432211 123577899999999999999
Q ss_pred CCCC-----HHHHHcCCCCCCC
Q 015532 376 ERLK-----AREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpt-----a~elL~hp~f~~~ 392 (405)
+||| ++|+++||||++-
T Consensus 267 ~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 267 NRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp GSTTCSTTTHHHHHTSGGGTTC
T ss_pred HCCCCCcCCHHHHHcCccccCC
Confidence 9998 5899999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=399.81 Aligned_cols=285 Identities=24% Similarity=0.367 Sum_probs=197.9
Q ss_pred ccCCCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~---------- 154 (405)
.+.++|++.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ .|++++...
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45678999999999999999999875 467899999986543 345678899999998 577775432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc-cccccCCccccccCCCCCCccc
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~-~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||++......
T Consensus 97 lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~----- 171 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT----- 171 (361)
T ss_dssp EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC-----
T ss_pred EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc-----
Confidence 2468999999999999999999999999999999999999876 78888888887644322
Q ss_pred CCCCCCCceeccCCCCccc---------------cCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCC
Q 015532 220 NLPKSSAIKLIDFGSTTFE---------------HQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~ 283 (405)
...+.+|+.+... .......+||+.|||||++.+. .|+.++||||+||++|||++|+.
T Consensus 172 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 172 ------KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp ------SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ------cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 2233343322111 1112335899999999999886 48999999999999999999999
Q ss_pred CCC-CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHH----------Hhccchhhhh
Q 015532 284 LFQ-THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW----------KLLRLPNLIM 352 (405)
Q Consensus 284 pf~-~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~ 352 (405)
||. +.++.+++..|.+++|+.+.......... .... ....+... .......+. ..........
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~---~~~~--~~~~p~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGK---SILC--SKEVPAQD-LRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTE---EEEE--SSCCCCCC-HHHHHHHHC--------------------
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccc---cccc--cccCcchh-hhHHHHhhccccccccccccccccccccc
Confidence 984 56677889999998886443222111000 0000 00011000 000000000 0000011112
Q ss_pred hcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 353 ~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
..+...+++++|||.+||++||++|+||+|+|+||||++
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 334567889999999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=397.27 Aligned_cols=224 Identities=25% Similarity=0.307 Sum_probs=181.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|+||+...
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 569999999999999999999999999999999975432 24699999999999985432
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 155 ----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 155 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~------------------------- 188 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS------------------------- 188 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-------------------------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-------------------------
Confidence 246899999999999999999999999999999999999976541
Q ss_pred CCceeccCCCCccccCC--------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 225 SAIKLIDFGSTTFEHQD--------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+||+|||+|+..... ...++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..
T Consensus 189 -~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 267 (336)
T 4g3f_A 189 -RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267 (336)
T ss_dssp -CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH
T ss_pred -EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 3677777776543321 1235799999999999999999999999999999999999999988765554444
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+... +. .....+..+++.+.+||.+||+.||++
T Consensus 268 i~~~--~~---------------------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~ 300 (336)
T 4g3f_A 268 IASE--PP---------------------------------------------PIREIPPSCAPLTAQAIQEGLRKEPVH 300 (336)
T ss_dssp HHHS--CC---------------------------------------------GGGGSCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHcC--CC---------------------------------------------CchhcCccCCHHHHHHHHHHccCCHhH
Confidence 4321 10 011223456789999999999999999
Q ss_pred CCCHHHH-------------HcCCCCCCC
Q 015532 377 RLKAREA-------------LRHPFFTRD 392 (405)
Q Consensus 377 Rpta~el-------------L~hp~f~~~ 392 (405)
|||+.|+ |+|||+.+.
T Consensus 301 R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 301 RASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999998 579999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=376.77 Aligned_cols=238 Identities=26% Similarity=0.337 Sum_probs=167.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|++|+|+||+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3599999999999999999999999999999999643 33456788999999999999985421
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
....++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 01234456889999999999999999999999999999998877666666665
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
++....+..... .... ..........+||+.|||||++.+..|+.++|||||||++|||++ ||.+
T Consensus 165 a~~~~~~~~~~~--------~~~~----~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 165 VTAMDQDEEEQT--------VLTP----MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp C--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ceecCCCccccc--------cccc----cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 543322110000 0000 000011233589999999999999999999999999999999996 7754
Q ss_pred CChHHHHHHHHHH-hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 288 HENLEHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 288 ~~~~~~~~~i~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
. .+....+... .+..|+.+ ...++.+.+||
T Consensus 230 ~--~~~~~~~~~~~~~~~p~~~-----------------------------------------------~~~~~~~~~li 260 (299)
T 4g31_A 230 Q--MERVRTLTDVRNLKFPPLF-----------------------------------------------TQKYPCEYVMV 260 (299)
T ss_dssp H--HHHHHHHHHHHTTCCCHHH-----------------------------------------------HHHCHHHHHHH
T ss_pred c--cHHHHHHHHHhcCCCCCCC-----------------------------------------------cccCHHHHHHH
Confidence 2 2222222221 12222211 11244678999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.+||+.||++|||+.|+|+||||++-.
T Consensus 261 ~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 261 QDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=408.83 Aligned_cols=234 Identities=29% Similarity=0.409 Sum_probs=197.2
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++|+.|+|+|++...
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 44578999999999999999999999999999999996533 3456788999999999999984321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~---------------------- 291 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK---------------------- 291 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS----------------------
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC----------------------
Confidence 2457899999999999999999999999999999999999643
Q ss_pred CCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
....+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+
T Consensus 292 ---~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i 368 (573)
T 3uto_A 292 ---RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368 (573)
T ss_dssp ---SCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred ---CCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 23468889999887665433 3468999999999999999999999999999999999999999998888877766
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
......++. ..+..+++++++||.+||++||++|
T Consensus 369 ~~~~~~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~~dp~~R 402 (573)
T 3uto_A 369 KSCDWNMDD----------------------------------------------SAFSGISEDGKDFIRKLLLADPNTR 402 (573)
T ss_dssp HTTCCCCCS----------------------------------------------GGGTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HhCCCCCCc----------------------------------------------ccccCCCHHHHHHHHHHccCChhHC
Confidence 554332221 1123467899999999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDV 393 (405)
Q Consensus 378 pta~elL~hp~f~~~~ 393 (405)
||++|+|+||||+...
T Consensus 403 ~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 403 MTIHQALEHPWLTPGN 418 (573)
T ss_dssp CCHHHHHHSTTTSCCC
T ss_pred cCHHHHhcCcCcCCCC
Confidence 9999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=364.16 Aligned_cols=225 Identities=23% Similarity=0.318 Sum_probs=172.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.+++.++||+|+||+||+|++.. .||||+++.. ....+.+.+|+.+|++++|+|++...
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEc
Confidence 568899999999999999998743 5999998643 33456788999999999999985321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.++..++.||+.||+|||+++||||||||+|||++.++.
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~---------------------- 170 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT---------------------- 170 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE----------------------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc----------------------
Confidence 245899999999999999999999999999999999999987664
Q ss_pred CCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
+||+|||+|+.... .....+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+....
T Consensus 171 -----~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~ 245 (307)
T 3omv_A 171 -----VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245 (307)
T ss_dssp -----EEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred -----EEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH
Confidence 55566666543321 12335899999999999753 589999999999999999999999988776655
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+.......|. .......+++.+.+||.+||+.|
T Consensus 246 ~~~~~~~~~~~p~--------------------------------------------~~~~~~~~~~~l~~li~~cl~~d 281 (307)
T 3omv_A 246 IIFMVGRGYASPD--------------------------------------------LSKLYKNCPKAMKRLVADCVKKV 281 (307)
T ss_dssp HHHHHHTTCCCCC--------------------------------------------STTSCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHhcCCCCCC--------------------------------------------cccccccchHHHHHHHHHHcCCC
Confidence 4433221111110 01122356778999999999999
Q ss_pred CCCCCCHHHH------HcCCCCC
Q 015532 374 PAERLKAREA------LRHPFFT 390 (405)
Q Consensus 374 P~~Rpta~el------L~hp~f~ 390 (405)
|++|||+.|+ |+|++-+
T Consensus 282 P~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 282 KEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp STTSCCHHHHHHHHHHHHTTCCC
T ss_pred HhHCcCHHHHHHHHHHHhccCCC
Confidence 9999999976 4677643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=396.05 Aligned_cols=228 Identities=25% Similarity=0.380 Sum_probs=175.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHH---HHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIE---IDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E---~~il~~l~~~~~~~~~---------- 154 (405)
++|+++++||+|+||+||+|+++.+|+.||||++++.. ........| +.+++.+.|++|+...
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999999999999999996532 222334444 4555566788885421
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
.+.|++..++.|+.||+.||+|||++|||||||||+||||+.+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~------------------ 330 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH------------------ 330 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC------------------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC------------------
Confidence 246899999999999999999999999999999999999987664
Q ss_pred ccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+||+|||+|...... ..+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...
T Consensus 331 ---------vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 331 ---------VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp ---------EEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred ---------EEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 566666666543322 334689999999999974 579999999999999999999999997643221111
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
....... .....+..+++++++||.+||+.||+
T Consensus 402 i~~~i~~-----------------------------------------------~~~~~p~~~S~~a~dLI~~lL~~dP~ 434 (689)
T 3v5w_A 402 IDRMTLT-----------------------------------------------MAVELPDSFSPELRSLLEGLLQRDVN 434 (689)
T ss_dssp HHHHHHH-----------------------------------------------CCCCCCTTSCHHHHHHHHHHTCSCGG
T ss_pred HHHhhcC-----------------------------------------------CCCCCCccCCHHHHHHHHHHccCCHh
Confidence 1111100 00112235678999999999999999
Q ss_pred CCCC-----HHHHHcCCCCCCCC
Q 015532 376 ERLK-----AREALRHPFFTRDV 393 (405)
Q Consensus 376 ~Rpt-----a~elL~hp~f~~~~ 393 (405)
+|++ |+||++||||++-.
T Consensus 435 ~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 435 RRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp GCTTCSSSTHHHHTTSGGGTTCC
T ss_pred HCCCCCCCCHHHHhcCccccCCC
Confidence 9998 89999999998743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=379.68 Aligned_cols=280 Identities=27% Similarity=0.431 Sum_probs=210.0
Q ss_pred CCCCceEeeCC---ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCC
Q 015532 78 KDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIG 151 (405)
Q Consensus 78 ~~~~~~~~~~~---~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~ 151 (405)
..+++.+..++ .+.++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.+.|++++
T Consensus 45 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 124 (464)
T 3ttj_A 45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124 (464)
T ss_dssp -CCEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCC
Confidence 34567777776 4568999999999999999999999999999999999653 23456678999999999999985
Q ss_pred CCc------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 152 GTR------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 152 ~~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 125 ~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--- 201 (464)
T 3ttj_A 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--- 201 (464)
T ss_dssp CCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---
T ss_pred cEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC---
Confidence 432 12378899999999999999999999999999999999997655
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHH
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll 279 (405)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 202 ------------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 257 (464)
T 3ttj_A 202 ------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257 (464)
T ss_dssp ------------------------CEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ------------------------CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence 4677777776554332 23468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 280 tg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
+|++||.+.+..+++..+.+.+|.++..+..........+........-. .....+.....+ .........+
T Consensus 258 ~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~s 329 (464)
T 3ttj_A 258 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL-------TFPKLFPDSLFP-ADSEHNKLKA 329 (464)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCC-------CHHHHSCGGGSC-CSSHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCC-------ChHHhCcccccc-cccccccccC
Confidence 99999999999999999999999998887766655555554432211100 000000000000 0000011126
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+++++||.+||++||++|||++|+|+||||+..
T Consensus 330 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 330 SQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 689999999999999999999999999999853
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=368.05 Aligned_cols=308 Identities=37% Similarity=0.653 Sum_probs=230.7
Q ss_pred CCCCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-----hcC
Q 015532 75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-----RHD 149 (405)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~-----~~~ 149 (405)
.++....+.+..|+.+.++|++.++||+|+||+||+|++..+++.||||+++...........|+.+++.+. |++
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 344455677888999999999999999999999999999999999999999876666677888999999997 777
Q ss_pred CCCCc----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 150 IGGTR----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 150 ~~~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
+.... ...+++..++.++.||+.||.|||++||+||||||+|||++.....+
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred eecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 64321 12488999999999999999999999999999999999997532110
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
.. .. ...................+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 178 ~~-~~-~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 178 SL-IT-VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EE-EE-EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cc-cc-hhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 00 00 00000000000000135578999999998776666667899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHh--hhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKY--FRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
..||.+.+..+.+..+....+++|..+........... ........|+................. . .....+
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~----~~~~~~ 329 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP--L----YKIIKH 329 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC--H----HHHCCC
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc--c----cccchH
Confidence 99999999999999999999999988765543222211 122234456655544443332221111 1 111235
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
+.+.+||.+||++||++|||++|+|+||||+
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 6889999999999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=374.38 Aligned_cols=293 Identities=33% Similarity=0.580 Sum_probs=218.0
Q ss_pred CCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc------CCC
Q 015532 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH------DIG 151 (405)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~------~~~ 151 (405)
..+.+....++.+..+|++.+.||+|+||+||+|++..+++.||||+++........+..|+.+++.+.+. ++.
T Consensus 83 ~~~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv 162 (429)
T 3kvw_A 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162 (429)
T ss_dssp TTSCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred cCCCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEE
Confidence 34445555677788999999999999999999999999999999999987666677788999999999765 332
Q ss_pred CCc----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 152 GTR----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 152 ~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 163 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~----- 237 (429)
T 3kvw_A 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG----- 237 (429)
T ss_dssp CEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-----
T ss_pred EEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-----
Confidence 210 13478999999999999999999999999999999999997644
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
...+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 238 --------------------~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 238 --------------------RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp --------------------SCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------CcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 123789999988776666666789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhh----------HHHHHHhccchhhhhh
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS----------MRAVWKLLRLPNLIMQ 353 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~ 353 (405)
||.+.+..+.+..+.+.++.++..+........ .++.......+......... ................
T Consensus 298 pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (429)
T 3kvw_A 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAK-NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376 (429)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH-HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh-hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhh
Confidence 999999999999999999999988776554333 22222111111000000000 0000000000001111
Q ss_pred cccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 354 ~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
.....++.+.+||.+||++||++|||++|+|+||||++....+
T Consensus 377 l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp TTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred ccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence 1223467899999999999999999999999999999876544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=362.88 Aligned_cols=221 Identities=19% Similarity=0.305 Sum_probs=176.1
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
++|.+.++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+++|++|+|+|++...
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57999999999999999999875 35788999999753 34457789999999999999984421
Q ss_pred -----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 155 -----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 155 -----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
...+++.++..++.||+.||.|||+++||||||||+|||++.++
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~------- 165 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL------- 165 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-------
Confidence 12578999999999999999999999999999999999997665
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
.+||+|||+|+...... ....||+.|||||++.+..|+.++|||||||++|||+|
T Consensus 166 --------------------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt 225 (299)
T 4asz_A 166 --------------------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225 (299)
T ss_dssp --------------------CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --------------------cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence 45666666665432221 22579999999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 281 -GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 281 -g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
|+.||.+.+..+.+..+.+.. ... .+..++
T Consensus 226 ~G~~Pf~~~~~~~~~~~i~~~~-----------------------~~~--------------------------~p~~~~ 256 (299)
T 4asz_A 226 YGKQPWYQLSNNEVIECITQGR-----------------------VLQ--------------------------RPRTCP 256 (299)
T ss_dssp TTCCTTTTSCHHHHHHHHHHTC-----------------------CCC--------------------------CCTTCC
T ss_pred CCCCCCCCCCHHHHHHHHHcCC-----------------------CCC--------------------------CCccch
Confidence 999999988877666554311 111 123456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
+++.+||.+||+.||++|||++|+++ |++
T Consensus 257 ~~~~~li~~cl~~dP~~RPs~~~i~~--~L~ 285 (299)
T 4asz_A 257 QEVYELMLGCWQREPHMRKNIKGIHT--LLQ 285 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH--HHH
Confidence 78999999999999999999999953 554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=364.41 Aligned_cols=219 Identities=20% Similarity=0.316 Sum_probs=173.1
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|.+.++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+++|++|+|+||+...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56899999999999999999865 36889999999753 34457789999999999999984321
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++.++..++.||+.||.|||+++||||||||+|||++.++.
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~---- 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---- 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE----
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc----
Confidence 124789999999999999999999999999999999999987654
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
+||+|||+++..... ....+||+.|||||++.+..|+.++|||||||++|||
T Consensus 197 -----------------------~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~El 253 (329)
T 4aoj_A 197 -----------------------VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253 (329)
T ss_dssp -----------------------EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------------------EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHH
Confidence 566666665533221 1235799999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
+| |+.||.+.+..+.+..+.+.. +.. .+..
T Consensus 254 lt~G~~Pf~~~~~~~~~~~i~~g~-----------------------~~~--------------------------~p~~ 284 (329)
T 4aoj_A 254 FTYGKQPWYQLSNTEAIDCITQGR-----------------------ELE--------------------------RPRA 284 (329)
T ss_dssp HTTSCCTTCSSCHHHHHHHHHHTC-----------------------CCC--------------------------CCTT
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCC-----------------------CCC--------------------------Cccc
Confidence 99 999999988777666554311 111 1234
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
+++++.+||.+||+.||++|||++||+++
T Consensus 285 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 285 CPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 56789999999999999999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=360.41 Aligned_cols=219 Identities=21% Similarity=0.259 Sum_probs=175.1
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..+++.++||+|+||+||+|+.. .+++.||||+++.. ....+.+.+|+.++++++|+|++...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 56899999999999999999864 46789999999643 23457799999999999999984321
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 155 ---------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 155 ---------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
...+++..+..++.||+.||+|||+++||||||||+|||++.++.
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-- 183 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-- 183 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence 124788999999999999999999999999999999999987664
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
+||+|||+++..... ....+||+.|||||++.+..|+.++|||||||++|
T Consensus 184 -------------------------~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 184 -------------------------VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp -------------------------EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred -------------------------EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 566666665533211 22357999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 277 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 277 ~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
||+| |..||.+.+..+.+..+... . ... .+
T Consensus 239 El~t~g~~Pf~~~~~~~~~~~i~~~--~---------------------~~~--------------------------~p 269 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQDVVEMIRNR--Q---------------------VLP--------------------------CP 269 (308)
T ss_dssp HHHTTTCCTTTTCCHHHHHHHHHTT--C---------------------CCC--------------------------CC
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC--C---------------------CCC--------------------------Cc
Confidence 9998 89999998877766554321 1 111 12
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
+.+++.+.+|+.+||+.||++|||+.||+++
T Consensus 270 ~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 270 DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3456789999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.80 Aligned_cols=310 Identities=28% Similarity=0.521 Sum_probs=223.5
Q ss_pred CCCCCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc-----
Q 015532 74 RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH----- 148 (405)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~----- 148 (405)
......+++++..|+.+.++|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+.|.
T Consensus 19 ~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 19 NDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp ---CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred ccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 344556788899999999999999999999999999999999999999999987666678889999999999853
Q ss_pred ---CCCCCc--------------------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcE
Q 015532 149 ---DIGGTR--------------------------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENI 192 (405)
Q Consensus 149 ---~~~~~~--------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NI 192 (405)
++.... ...+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI 178 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence 342210 13588999999999999999999998 999999999999
Q ss_pred EEecccccccCCccccccCCCCC-----------------C-----cccCCCCCCCceeccCCCCccccCCccceecCCC
Q 015532 193 LLVSAEYVKVPDYKFLSRSSKDG-----------------S-----YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRH 250 (405)
Q Consensus 193 li~~~~~~k~~df~~~~~~~~~~-----------------~-----~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~ 250 (405)
|++.++.....+++........+ . ..........+||+|||++..........+||+.
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~ 258 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ 258 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGG
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCc
Confidence 99877632221111110000000 0 0000012347999999999877666666789999
Q ss_pred cchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCC
Q 015532 251 YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGA 324 (405)
Q Consensus 251 y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~ 324 (405)
|+|||++.+..++.++|||||||++|+|++|..||.+.+ ..+.+..+.+..|.+|..+......... ++....
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~ 337 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE-FFTKKG 337 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGG-TBCTTS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccc-ccCCcc
Confidence 999999999999999999999999999999999997654 5677888899999999887654433222 222221
Q ss_pred cccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 325 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
.................... .......+..+.+||.+||++||++|||++|+|+||||++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEK-------YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHT-------SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccCCcchhHhhhhh-------cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 11111111111111111111 1112234678999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=357.17 Aligned_cols=261 Identities=31% Similarity=0.542 Sum_probs=192.7
Q ss_pred eCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHh---hcCCCCCc--
Q 015532 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLA---RHDIGGTR-- 154 (405)
Q Consensus 86 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~---~~~~~~~~-- 154 (405)
+|+.+.++|++.++||+|+||+||+|++..+++.||||+++... .......+|+.+++.+. |+++....
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 45667889999999999999999999999999999999986322 22345677888888876 88874311
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~----- 157 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG----- 157 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-----
T ss_pred eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-----
Confidence 12289999999999999999999999999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 158 ----------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 215 (308)
T 3g33_A 158 ----------------------TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215 (308)
T ss_dssp ----------------------CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred ----------------------CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence 4666777766543322 2335789999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
.+||.+.+..+.+..+.+..+.++... |+........ .+ ....+..........++.
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------------~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~ 272 (308)
T 3g33_A 216 KPLFCGNSEADQLGKIFDLIGLPPEDD-------------------WPRDVSLPRG---AF-PPRGPRPVQSVVPEMEES 272 (308)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTT-------------------SCSSCSSCGG---GS-CCCCCCCHHHHSCSCCHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhh-------------------ccchhhcccc---cc-CCCCCCcHHHhCccccHH
Confidence 999999999999998888887766432 1111100000 00 000111122233566789
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
+.+||.+||++||++|||+.|+|+||||++....|
T Consensus 273 ~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~~ 307 (308)
T 3g33_A 273 GAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307 (308)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSTTC-------
T ss_pred HHHHHHHHhcCCCccCCCHHHHhcCccccCCCCCC
Confidence 99999999999999999999999999999876544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=357.08 Aligned_cols=304 Identities=44% Similarity=0.812 Sum_probs=230.2
Q ss_pred CCCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCC-cEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc
Q 015532 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154 (405)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~ 154 (405)
++..+++....|+.+.++|++.+.||+|+||+||+|++..++ +.||||+++......+.+.+|+.+++.+.|++.....
T Consensus 3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence 456778889999999999999999999999999999998776 7899999987666677888999999999987631100
Q ss_pred ----------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccc
Q 015532 155 ----------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 155 ----------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~ 200 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+...+..
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 1358899999999999999999999999999999999999665433
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
.+.+.... .....+....+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 163 TLYNEHKS--------CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp EEECCC-C--------CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccc--------ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 32221110 0000124567999999999877666666789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+....+.+..+.+..+++|..+........ ++. .....|+............ ..............+.
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 308 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQK--YFY-KGGLVWDENSSDGRYVKEN---CKPLKSYMLQDSLEHV 308 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGG--GEE-TTEECCCTTSHHHHHHHHH---CCCGGGGCSCCSHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchh--hhc-ccccccccccchhcccccc---CCcccccccccchhHH
Confidence 999999999999999999999999988765542211 111 1122333322111111111 1100001111123366
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
++.+||.+||+.||++|||+.|+|+||||++-.
T Consensus 309 ~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 899999999999999999999999999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.83 Aligned_cols=286 Identities=29% Similarity=0.458 Sum_probs=192.3
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.+.|++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3568899999999999999999999999999999998642 23446688999999999999985421
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred ceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 134789999999999999999999999999999999999999999999999988765432
Q ss_pred CCcccCC---CCCCCceeccCCCCccccCCccceecCCCcchhHHHh-CCCCCCchhHHHHHHHHHHHHh----------
Q 015532 215 GSYFKNL---PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS---------- 280 (405)
Q Consensus 215 ~~~~~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~llt---------- 280 (405)
....... .......+.+|+............+||+.|+|||++. +..|+.++|||||||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 2111000 0112234455554444334445578999999999875 5569999999999999999998
Q ss_pred -CCCCCCCCC--------------------hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHH
Q 015532 281 -GEALFQTHE--------------------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339 (405)
Q Consensus 281 -g~~pf~~~~--------------------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (405)
|.++|.+.+ ..+++..|...+|.++...+..........+... ++.
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~----~~~--------- 356 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI----FPK--------- 356 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTT----SCC---------
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHh----cCC---------
Confidence 778887654 3577888889999988876544322211111100 000
Q ss_pred HHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.............++++.+||.+||++||++|||++|+|+||||++..
T Consensus 357 ------~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 357 ------REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp ------CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred ------CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 001111223345678999999999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=360.31 Aligned_cols=257 Identities=29% Similarity=0.508 Sum_probs=200.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|++.+.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+|+.+.|+++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 457899999999999999999999999999999998542 23456678999999999999884321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----------------- 165 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC----------------- 165 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----------------
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-----------------
Confidence 13478889999999999999999999999999999999997654
Q ss_pred CcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++
T Consensus 166 ----------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 235 (367)
T 1cm8_A 166 ----------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235 (367)
T ss_dssp ----------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------CEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4677777777665555555689999999999987 67999999999999999999999999999999999
Q ss_pred HHHHHHhCCCChHHHHHhhHhh-HHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 295 AMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
..+.+..|.+|..+........ ..+....... ............++.+.+||.+||++|
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~ll~~mL~~d 295 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL--------------------EKKDFASILTNASPLAVNLLEKMLVLD 295 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCC--------------------CCCCGGGTCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCC--------------------CCCCHHHHCCCCCHHHHHHHHHHccCC
Confidence 9999999999987765432111 1111111000 000111223456789999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|++|||++|+|+||||+.-.
T Consensus 296 P~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 296 AEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TTTSCCHHHHHHSGGGTTTC
T ss_pred hhHCCCHHHHhcChHHHhhc
Confidence 99999999999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=361.49 Aligned_cols=290 Identities=35% Similarity=0.622 Sum_probs=217.0
Q ss_pred CCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcC------CC
Q 015532 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD------IG 151 (405)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~------~~ 151 (405)
....+.+..|+.+.++|++.+.||+|+||+||+|++..+++.||||+++........+..|+.+++.+.+++ +.
T Consensus 40 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp TTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred CCCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 334467788899999999999999999999999999999999999999876666677888999999998665 21
Q ss_pred CC----------------------------ccccCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCCCcEEEecccccc
Q 015532 152 GT----------------------------RYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 152 ~~----------------------------~~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIli~~~~~~k 201 (405)
.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.+
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~---- 195 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP---- 195 (382)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST----
T ss_pred EeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC----
Confidence 10 0134789999999999999999999 5799999999999999542
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
.+..+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 196 ---------------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 254 (382)
T 2vx3_A 196 ---------------------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254 (382)
T ss_dssp ---------------------TSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------CCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 23468899999887766655667899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCC----------CCCchhhHHHHHHhcc-chhh
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD----------GATSRDSMRAVWKLLR-LPNL 350 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~-~~~~ 350 (405)
.+||.+.+..+.+..+.+..+.+|..+..... ....++.......|.. .......+........ .+..
T Consensus 255 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 333 (382)
T 2vx3_A 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAP-KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333 (382)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT-THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGG
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH-HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCc
Confidence 99999999999999999999998887654432 2233333221111100 0000011111111000 0000
Q ss_pred h----hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 351 I----MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 351 ~----~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
. .......++++++||.+||++||++|||++|+|+||||++..
T Consensus 334 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred cccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 0 000011235789999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=359.48 Aligned_cols=221 Identities=24% Similarity=0.346 Sum_probs=171.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhc-CCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARH-DIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~-~~~~~~-------- 154 (405)
.++|++.++||+|+||+||+|++..+ ++.||||+++... ...+.+.+|+++|.++.|+ ||+...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 36899999999999999999997654 3689999996532 3456788999999999885 553211
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 ------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 ------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
...+++..+..++.||+.||+|||+++||||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 12368889999999999999999999999999999999998776
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
.+ ||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||
T Consensus 223 ~v---------------------------Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv 275 (353)
T 4ase_A 223 VV---------------------------KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 275 (353)
T ss_dssp CE---------------------------EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CE---------------------------EECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHH
Confidence 55 55555555433221 12357999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhh
Q 015532 274 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352 (405)
Q Consensus 274 il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (405)
++|||+| |..||.+.+..+.+..+... +.+...
T Consensus 276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~~----------------------g~~~~~------------------------ 309 (353)
T 4ase_A 276 LLWEIFSLGASPYPGVKIDEEFCRRLKE----------------------GTRMRA------------------------ 309 (353)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHHH----------------------TCCCCC------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHHc----------------------CCCCCC------------------------
Confidence 9999998 99999886543333222111 111111
Q ss_pred hcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 353 ~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
++.+++++.+||.+||+.||++|||+.||++|
T Consensus 310 --p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 310 --PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 23456789999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.13 Aligned_cols=298 Identities=46% Similarity=0.819 Sum_probs=223.9
Q ss_pred CceEeeCCccCCCeEEEeeeecccceeEEEEEe-cCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCC------
Q 015532 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT------ 153 (405)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~-~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~------ 153 (405)
++.+..|+.+.++|++.+.||+|+||+||+|.+ ..+++.||||+++......+.+.+|+.+++.+.|++....
T Consensus 3 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 3 HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp GGTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ceeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 445667888999999999999999999999998 5678999999998766667788899999999999763110
Q ss_pred c----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 154 R----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 154 ~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.....+.
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 83 LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred ecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 0 124788999999999999999999999999999999999976543222111
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
+... ......+..+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 163 ~~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKR--------DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---C--------EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccc--------ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 1000 00001145689999999987766666678999999999999989999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
...+..+.+..+.+..+++|..+....... .++ ......|........... ................++.+.+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYF-HHDRLDWDEHSSAGRYVS---RACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCG--GGE-ETTEECCCTTSHHHHHHH---HHCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccch--hHH-hhccccccccccccchhh---hcCcchhhhcccchhhHHHHHHH
Confidence 999999999999999999998876654321 111 112334443222111111 11111111111223446789999
Q ss_pred HHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 366 LQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
|.+||+.||++|||+.|+|+||||+.-
T Consensus 309 i~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 999999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=352.09 Aligned_cols=261 Identities=30% Similarity=0.453 Sum_probs=196.2
Q ss_pred eeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 85 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
..++.+.++|+++++||+|+||+||+|++. +++.||||+++... ...+.+.+|+++++.+.|+++....
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 345678899999999999999999999985 58899999996432 2346678999999999999985321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~---------------- 156 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG---------------- 156 (311)
T ss_dssp CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----------------
T ss_pred EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC----------------
Confidence 23488999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 157 -----------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 157 -----------ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp -----------CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred -----------CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 4566666666543321 223478999999999987 4689999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+.+..+...++.++...+...... ..+.... .... ............++++.+||.+||
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~L 285 (311)
T 3niz_A 226 DDQLPKIFSILGTPNPREWPQVQEL-PLWKQRT--FQVF-----------------EKKPWSSIIPGFCQEGIDLLSNML 285 (311)
T ss_dssp TTHHHHHHHHHCCCCTTTSGGGTTS-HHHHSCC--CCCC-----------------CCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHHHHCCCChHHhhhhhcc-chhhhcc--cccc-----------------cCCcHHHhCcccCHHHHHHHHHHc
Confidence 8888888888876554322111000 0000000 0000 000011123456778999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
++||++|||++|+|+||||++-.
T Consensus 286 ~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 286 CFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CSCTTTSCCHHHHHTSGGGTTSC
T ss_pred CCChhHCCCHHHHhcCcccccCC
Confidence 99999999999999999999743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=353.03 Aligned_cols=226 Identities=26% Similarity=0.351 Sum_probs=186.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467999999999999999999999999999999996532 3345678899999999999984321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~---------------------- 151 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM---------------------- 151 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----------------------
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC----------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.+||+|||++...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+
T Consensus 152 -----~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 226 (328)
T 3fe3_A 152 -----NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226 (328)
T ss_dssp -----CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -----CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4667777766543322 2345799999999999988875 7899999999999999999999988776665555
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.......| ...++++.+||.+||+.||++|
T Consensus 227 ~~~~~~~p--------------------------------------------------~~~s~~~~~li~~~L~~dP~~R 256 (328)
T 3fe3_A 227 LRGKYRIP--------------------------------------------------FYMSTDCENLLKRFLVLNPIKR 256 (328)
T ss_dssp HHCCCCCC--------------------------------------------------TTSCHHHHHHHHHHCCSSTTTS
T ss_pred HhCCCCCC--------------------------------------------------CCCCHHHHHHHHHHCCCChhHC
Confidence 43211111 2346789999999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDV 393 (405)
Q Consensus 378 pta~elL~hp~f~~~~ 393 (405)
||++|+|+||||+...
T Consensus 257 ~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 257 GTLEQIMKDRWINAGH 272 (328)
T ss_dssp CCHHHHTTCTTTTTTC
T ss_pred cCHHHHhcCHhhcCCC
Confidence 9999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=357.63 Aligned_cols=236 Identities=27% Similarity=0.413 Sum_probs=194.6
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-------hhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
..+.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.+|+.+.|+++....
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 4567889999999999999999999999999999999965322 346788999999999999984321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~-------------- 153 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI-------------- 153 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS--------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC--------------
Confidence 245789999999999999999999999999999999999975431
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
....+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 154 ---------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~ 224 (361)
T 2yab_A 154 ---------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (361)
T ss_dssp ---------SSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------CccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1225788888888654433 23467999999999999989999999999999999999999999998877
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+.+..+......++.. .+...++.+++||.+||.
T Consensus 225 ~~~~~i~~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~ 258 (361)
T 2yab_A 225 ETLANITAVSYDFDEE----------------------------------------------FFSQTSELAKDFIRKLLV 258 (361)
T ss_dssp HHHHHHHTTCCCCCHH----------------------------------------------HHTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHhcCCCCCch----------------------------------------------hccCCCHHHHHHHHHHCC
Confidence 7766665433322221 123457789999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~ 392 (405)
.||++|||++|+|+||||+..
T Consensus 259 ~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 259 KETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp SSTTTSCCHHHHHTSTTTSCS
T ss_pred CChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=355.09 Aligned_cols=289 Identities=30% Similarity=0.493 Sum_probs=214.4
Q ss_pred CCCceEeeCCccC-CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-----------
Q 015532 79 DGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA----------- 146 (405)
Q Consensus 79 ~~~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~----------- 146 (405)
+++++...++.+. ++|++.+.||+|+||+||+|++..+++.||||+++......+.+.+|+.+++++.
T Consensus 5 ~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 5 GGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp --CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccc
Confidence 3455666666664 6899999999999999999999999999999999876666777889999999988
Q ss_pred hcCCCCCc--------------------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEE
Q 015532 147 RHDIGGTR--------------------------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENIL 193 (405)
Q Consensus 147 ~~~~~~~~--------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIl 193 (405)
|+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 45553221 12478899999999999999999998 9999999999999
Q ss_pred EecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 194 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 194 i~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
++..+. .+....+||+|||++...........||+.|+|||++.+..++.++|||||||
T Consensus 165 l~~~~~---------------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 223 (373)
T 1q8y_A 165 MEIVDS---------------------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 223 (373)
T ss_dssp EEEEET---------------------TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred EeccCC---------------------CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHH
Confidence 975431 01234689999999877666556678999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc
Q 015532 274 ILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347 (405)
Q Consensus 274 il~~lltg~~pf~~~~------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (405)
++|+|++|..||.+.. ..+.+..+...+|.+|..+......... ++................ ......
T Consensus 224 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~---- 297 (373)
T 1q8y_A 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT-FFNSRGLLRNISKLKFWP-LEDVLT---- 297 (373)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHH-HBCC--CBSSCCCCCBCC-HHHHHH----
T ss_pred HHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhh-hcCCcchhcccccccccc-hhhhhh----
Confidence 9999999999998654 5667888889999999887655433222 222211111111110000 011100
Q ss_pred hhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 348 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
.........+.++.+||.+||+.||++|||++|+|+||||++.....
T Consensus 298 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 298 --EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp --HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred --hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 00112234567899999999999999999999999999999865443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=360.79 Aligned_cols=292 Identities=24% Similarity=0.384 Sum_probs=195.5
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHh-hcCCCCCc--------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTR-------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~-~~~~~~~~-------- 154 (405)
+..+.++|++.+.||+|+||+||+|.+..+++.||||++... ........+|+.+++.+. |+++....
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 345668999999999999999999999999999999998542 334566778999999998 88874321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred CEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 1347888999999999999999999999999999999999988887777777765432211
Q ss_pred CcccCCCCCCCceeccCCCC-ccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGST-TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
..... ....+.+.... ..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 164 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 164 RVTNN----IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp CCCCC----GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccc----ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 10000 00000000000 000111233589999999999987 5789999999999999999999999999999999
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhH-Hhhhc----C--CcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAE-KYFRR----G--ARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~----~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+..+...++.++............ .+... . ....+.. ........ ..........++++.+||
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRD---IFTKWKNL-------LLKINPKADCNEEALDLL 309 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCC---CHHHHHHH-------HHHHCTTCCCCHHHHHHH
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHH---hCcchhhh-------cccccccccCCHHHHHHH
Confidence 999999998887765432211100 00000 0 0000000 00000000 000111235678999999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
.+||++||++|||++|+|+||||+.-
T Consensus 310 ~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHhhccCcccCCCHHHHhCCHHHHHh
Confidence 99999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=357.40 Aligned_cols=257 Identities=28% Similarity=0.508 Sum_probs=191.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 458899999999999999999999999999999998642 23456678999999999999884321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~----------------- 169 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----------------- 169 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----------------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-----------------
Confidence 13478899999999999999999999999999999999997654
Q ss_pred CcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 170 ----------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 239 (367)
T 2fst_X 170 ----------ELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239 (367)
T ss_dssp ----------CEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------CEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4677777777665554555689999999999987 57899999999999999999999999999999999
Q ss_pred HHHHHHhCCCChHHHHHhhHh-hHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 295 AMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
..+.+.+|.++.......... ...+....... + ...........++.+.+||.+||++|
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~--~------------------~~~~~~~~~~~~~~~~dLl~~mL~~d 299 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQSLTQM--P------------------KMNFANVFIGANPLAVDLLEKMLVLD 299 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC--C------------------CCCHHHHTTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCC--C------------------CCCHHHHCCCCCHHHHHHHHHhCCCC
Confidence 999999999887665432211 11111110000 0 00011122345778999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|++|||++|+|+||||++..
T Consensus 300 P~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 300 SDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp GGGSCCHHHHHTSGGGTTTC
T ss_pred cccCcCHHHHhcChhhhhcc
Confidence 99999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=353.50 Aligned_cols=272 Identities=29% Similarity=0.496 Sum_probs=211.0
Q ss_pred CCCCCCCCceEeeCCc---cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhh
Q 015532 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 74 ~~~~~~~~~~~~~~~~---~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~ 147 (405)
......+++....+.. +.++|.+.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+.|
T Consensus 21 ~~~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h 100 (371)
T 4exu_A 21 SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 100 (371)
T ss_dssp CCSSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC
T ss_pred eeeccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCC
Confidence 3445666777666653 678999999999999999999999999999999999653 2345677899999999999
Q ss_pred cCCCCCc------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 148 HDIGGTR------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 148 ~~~~~~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 101 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~ 180 (371)
T 4exu_A 101 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED 180 (371)
T ss_dssp TTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCchhhhhheeccCCcccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC
Confidence 9885321 1247899999999999999999999999999999999999755
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILV 276 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ 276 (405)
+ .+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 181 ~---------------------------~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (371)
T 4exu_A 181 C---------------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233 (371)
T ss_dssp C---------------------------CEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred C---------------------------CEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence 4 5677777777666555555689999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc-hhhhhhcc
Q 015532 277 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL-PNLIMQHV 355 (405)
Q Consensus 277 ~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 355 (405)
+|++|..||.+.+..+.+..+.+..+.++..+...........+... .... ........
T Consensus 234 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~ 293 (371)
T 4exu_A 234 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS--------------------LPQTPRKDFTQLF 293 (371)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHH--------------------SCCCCCCCHHHHS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhc--------------------cCCCcchhHHHhc
Confidence 99999999999999999999999999888776543322111111000 0000 00111223
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
...++.+.+||.+||++||++|||++|+|+||||+..
T Consensus 294 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 294 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred cccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 4567899999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=350.93 Aligned_cols=234 Identities=24% Similarity=0.380 Sum_probs=195.9
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+.++|++.+.||+|+||+||+|.+..+++.||+|+++......+.+.+|+.+++.+.|+++....
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 456899999999999999999999999999999999976666667788999999999999984321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~----------------------- 138 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR----------------------- 138 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-----------------------
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-----------------------
Confidence 1358899999999999999999999999999999999999652
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.+..+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 139 --~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 139 --RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp --SCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred --CCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 13467888888887654332 33679999999999998889999999999999999999999999988877766665
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
.....++.. .+..++.++.+||.+||..||++||
T Consensus 217 ~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~~dp~~Rp 250 (321)
T 1tki_A 217 NAEYTFDEE----------------------------------------------AFKEISIEAMDFVDRLLVKERKSRM 250 (321)
T ss_dssp HTCCCCCHH----------------------------------------------HHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCCCCChh----------------------------------------------hhccCCHHHHHHHHHHcCCChhHCc
Confidence 433322221 1234577899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
|+.|+|+||||++..
T Consensus 251 t~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 251 TASEALQHPWLKQKI 265 (321)
T ss_dssp CHHHHHHSHHHHSCG
T ss_pred CHHHHhcChhhccCc
Confidence 999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=359.38 Aligned_cols=277 Identities=27% Similarity=0.407 Sum_probs=197.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+|+.+.|+++....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3568899999999999999999999999999999999653 23446788999999999999874321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred CeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 134789999999999999999999999999999999999988777777766665433221
Q ss_pred CCcccCCCCCCCceeccCCCC-------ccccCCccceecCCCcchhHHHh-CCCCCCchhHHHHHHHHHHHHh------
Q 015532 215 GSYFKNLPKSSAIKLIDFGST-------TFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS------ 280 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a-------~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~llt------ 280 (405)
.... ...++... ..........+||+.|+|||++. +..|+.++|||||||++|||++
T Consensus 183 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTN---------IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccc---------ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 1000 00000000 00001123468999999999974 5569999999999999999998
Q ss_pred -----CCCCCCCCC-----------------hHHHHHHHHHHhCCCChHHHHHhhHhh-HHhhhcCCcccCCCCCCchhh
Q 015532 281 -----GEALFQTHE-----------------NLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDS 337 (405)
Q Consensus 281 -----g~~pf~~~~-----------------~~~~~~~i~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 337 (405)
|.++|.+.+ ..+++..+...+|.++...+....... ..+.....
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~------------- 320 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP------------- 320 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC-------------
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCC-------------
Confidence 555665543 367888899999998877654322111 11111100
Q ss_pred HHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
...+..........++++.+||.+||++||++|||++|+|+||||++...
T Consensus 321 -------~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 321 -------HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp -------CCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred -------CCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 00011111223456889999999999999999999999999999997543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=355.75 Aligned_cols=224 Identities=25% Similarity=0.396 Sum_probs=181.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+....|+.++..+ .|+++....
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 6799999999999999999999999999999999753 23345677899999998 577774321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~-------------------- 162 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-------------------- 162 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--------------------
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--------------------
Confidence 245889999999999999999999999999999999999976664
Q ss_pred CCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....
T Consensus 163 -------ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 235 (353)
T 3txo_A 163 -------CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235 (353)
T ss_dssp -------EEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -------EEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5666666655322 122346899999999999998899999999999999999999999999888777666
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.......| ...+..+.+||.+||+.||++
T Consensus 236 i~~~~~~~p--------------------------------------------------~~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 236 ILNDEVVYP--------------------------------------------------TWLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHcCCCCCC--------------------------------------------------CCCCHHHHHHHHHHhhhCHHH
Confidence 644221111 234678999999999999999
Q ss_pred CCCH------HHHHcCCCCCCC
Q 015532 377 RLKA------REALRHPFFTRD 392 (405)
Q Consensus 377 Rpta------~elL~hp~f~~~ 392 (405)
|+++ +|+++||||++-
T Consensus 266 R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTTC
T ss_pred ccCCcccCCHHHHhhCCcccCC
Confidence 9998 999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.03 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=193.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999996432 3346778999999999999985421
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~----------------------- 138 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----------------------- 138 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-----------------------
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----------------------
Confidence 24688999999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEAL-FQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~ 296 (405)
.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..
T Consensus 139 ----~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~ 214 (292)
T 3o0g_A 139 ----ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp ----CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred ----CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 4566666666543221 22357899999999998765 89999999999999999987666 677777788888
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+..+.++...+....... . ...++. ..............+..+.+||.+||++||++
T Consensus 215 i~~~~~~~~~~~~~~~~~~~----~---~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 273 (292)
T 3o0g_A 215 IFRLLGTPTEEQWPSMTKLP----D---YKPYPM--------------YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGST----T---CCCCCC--------------CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCChhhhhhhcccc----c---cccccc--------------ccCCcchhhcccccChHHHHHHHHHhccChhh
Confidence 88888776543221110000 0 000000 00001111223456789999999999999999
Q ss_pred CCCHHHHHcCCCCCCC
Q 015532 377 RLKAREALRHPFFTRD 392 (405)
Q Consensus 377 Rpta~elL~hp~f~~~ 392 (405)
|||++|+|+||||++.
T Consensus 274 R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 274 RISAEEALQHPYFSDF 289 (292)
T ss_dssp SCCHHHHHTSGGGTTC
T ss_pred CCCHHHHhcCcccccC
Confidence 9999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=354.95 Aligned_cols=240 Identities=25% Similarity=0.401 Sum_probs=193.2
Q ss_pred ceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----
Q 015532 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---- 154 (405)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---- 154 (405)
+....+..+.++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 444555667789999999999999999999999999999999996532 3345678899999999999984321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~------------- 165 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------- 165 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-------------
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-------------
Confidence 23478999999999999999999999999999999999997543
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
....+||+|||++....... ....||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 166 -----------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 166 -----------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp -----------TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 23458888888886654332 23589999999999999899999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+.......|. ..+..+++++.+||.+|
T Consensus 235 ~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 235 QHRLYAQIKAGAYDYPS----------------------------------------------PEWDTVTPEAKSLIDSM 268 (362)
T ss_dssp HHHHHHHHHHTCCCCCT----------------------------------------------TGGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCc----------------------------------------------ccccCCCHHHHHHHHHH
Confidence 76666555442221111 11134567899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~ 391 (405)
|+.||++|||+.|+|+||||+.
T Consensus 269 L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 269 LTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SCSSGGGSCCHHHHTTSHHHHT
T ss_pred cCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.72 Aligned_cols=263 Identities=30% Similarity=0.526 Sum_probs=202.5
Q ss_pred EeeCCcc--CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----
Q 015532 84 FAIGENL--TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----- 154 (405)
Q Consensus 84 ~~~~~~~--~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----- 154 (405)
+..|+.+ .++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+++++.+.|+++....
T Consensus 17 ~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 17 MVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp BCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred EEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 3445544 47999999999999999999999999999999999643 23346788999999999999985421
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---------- 166 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---------- 166 (364)
T ss_dssp SSTTTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----------
T ss_pred CCccccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC----------
Confidence 134788999999999999999999999999999999999976554
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~ 282 (405)
+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 167 -----------------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 167 -----------------LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp -----------------EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred -----------------EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 566666666443221 1235799999999987654 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhh-HHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
+||.+.+..+.+..+...++.++........... ..+.... +.. ............+++
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~---------------~~~~~~~~~~~~~~~ 289 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL-----PHK---------------NKVPWNRLFPNADSK 289 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS-----CCC---------------CCCCHHHHCTTSCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhc-----CCc---------------cCCCHHHhCCCCCHH
Confidence 9999999999999999999988876554321111 1111100 000 000011222456778
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+.+||.+||++||++|||++|+|+||||++..
T Consensus 290 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 99999999999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=345.97 Aligned_cols=237 Identities=26% Similarity=0.416 Sum_probs=194.2
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-------hhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
+.+.++|++.+.||+|+||.||+|++..+++.||||+++.... ..+.+.+|+.+|+.+.|+++....
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456789999999999999999999999999999999964321 356788999999999999984321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~-------------- 152 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV-------------- 152 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS--------------
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC--------------
Confidence 235789999999999999999999999999999999999976541
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 153 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 223 (326)
T 2y0a_A 153 ---------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223 (326)
T ss_dssp ---------SSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------CCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 2235788888888654322 23457999999999999889999999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+.+..+.......+.. .....+..+.+||.+||+
T Consensus 224 ~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~L~ 257 (326)
T 2y0a_A 224 ETLANVSAVNYEFEDE----------------------------------------------YFSNTSALAKDFIRRLLV 257 (326)
T ss_dssp HHHHHHHHTCCCCCHH----------------------------------------------HHTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHhcCCCcCcc----------------------------------------------ccccCCHHHHHHHHHHcc
Confidence 7666655433332221 113446789999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.||++|||++|+|+||||+...
T Consensus 258 ~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 258 KDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SSGGGSCCHHHHHHSTTTSCCS
T ss_pred CChhhCCCHHHHhcCCCccCCc
Confidence 9999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=360.04 Aligned_cols=234 Identities=26% Similarity=0.410 Sum_probs=191.6
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 456678999999999999999999999999999999996532 3446678999999999999985421
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+.
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~------------------- 147 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL------------------- 147 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-------------------
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-------------------
Confidence 24578999999999999999999999999999999999997532
Q ss_pred ccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+..+||+|||++....... ....||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+..
T Consensus 148 -----~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~ 222 (444)
T 3soa_A 148 -----KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222 (444)
T ss_dssp -----TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 23468888888886554332 2357999999999999989999999999999999999999999988877776
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.......|. ..+..+++++.+||.+||+.||
T Consensus 223 ~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP 256 (444)
T 3soa_A 223 QQIKAGAYDFPS----------------------------------------------PEWDTVTPEAKDLINKMLTINP 256 (444)
T ss_dssp HHHHHTCCCCCT----------------------------------------------TTTTTSCHHHHHHHHHHSCSST
T ss_pred HHHHhCCCCCCc----------------------------------------------cccccCCHHHHHHHHHHcCCCh
Confidence 666543222211 1123457789999999999999
Q ss_pred CCCCCHHHHHcCCCCCC
Q 015532 375 AERLKAREALRHPFFTR 391 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~ 391 (405)
++|||+.|+|+||||+.
T Consensus 257 ~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 257 SKRITAAEALKHPWISH 273 (444)
T ss_dssp TTSCCHHHHHHSCTTHH
T ss_pred hHCCCHHHHhcCccccC
Confidence 99999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.08 Aligned_cols=279 Identities=28% Similarity=0.449 Sum_probs=202.7
Q ss_pred CCCceEeeCC---ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCC
Q 015532 79 DGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 79 ~~~~~~~~~~---~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~ 152 (405)
.+++++..|+ .+.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++..
T Consensus 9 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 88 (371)
T 2xrw_A 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88 (371)
T ss_dssp GGEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccc
Confidence 3456677776 3568999999999999999999999999999999999642 234466788999999999998843
Q ss_pred Cc------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 153 TR------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 153 ~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~---- 164 (371)
T 2xrw_A 89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---- 164 (371)
T ss_dssp EEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----
T ss_pred eEEeeccccccccccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC----
Confidence 21 12468889999999999999999999999999999999997655
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 165 -----------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 221 (371)
T 2xrw_A 165 -----------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221 (371)
T ss_dssp -----------------------CEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------CEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 4666677766544322 233579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+.+..+.+..+.+.++.++..+..........+.......... ...........+. ........+.
T Consensus 222 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~ 293 (371)
T 2xrw_A 222 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY-------SFEKLFPDVLFPA-DSEHNKLKAS 293 (371)
T ss_dssp SSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCC-------CHHHHSCGGGSCC-SSHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcccccc-------chhhhcccccCcc-cccccccccH
Confidence 9999999999998888888888877766655444444433322111100 0000000000000 0000112256
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
++++||.+||++||++|||++|+|+||||+..
T Consensus 294 ~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 294 QARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 89999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=346.33 Aligned_cols=224 Identities=25% Similarity=0.371 Sum_probs=187.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||||++++.. ...+.+.+|+.+++.+.|+++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999997532 2346677899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---------------------- 143 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---------------------- 143 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS----------------------
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC----------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 144 -----~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 218 (318)
T 1fot_A 144 -----HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218 (318)
T ss_dssp -----CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred -----CEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 467777777765555555578999999999999999999999999999999999999999987776665555432
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC--
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-- 378 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-- 378 (405)
.... +...++++.+||.+||+.||++|+
T Consensus 219 ~~~~--------------------------------------------------p~~~~~~~~~li~~lL~~dp~~R~~~ 248 (318)
T 1fot_A 219 ELRF--------------------------------------------------PPFFNEDVKDLLSRLITRDLSQRLGN 248 (318)
T ss_dssp CCCC--------------------------------------------------CTTSCHHHHHHHHHHTCSCTTTCTTS
T ss_pred CCCC--------------------------------------------------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1111 123467899999999999999999
Q ss_pred ---CHHHHHcCCCCCCC
Q 015532 379 ---KAREALRHPFFTRD 392 (405)
Q Consensus 379 ---ta~elL~hp~f~~~ 392 (405)
+++|+++||||++-
T Consensus 249 ~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 249 LQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp STTTTHHHHTSGGGSSC
T ss_pred cCCCHHHHhcCccccCC
Confidence 99999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=348.64 Aligned_cols=224 Identities=25% Similarity=0.398 Sum_probs=183.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+.+.+|+.+|+.+.|+++....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999753 23345678899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--------------------- 143 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--------------------- 143 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---------------------
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC---------------------
Confidence 235789999999999999999999999999999999999987664
Q ss_pred CCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 144 ------vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 217 (337)
T 1o6l_A 144 ------IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp ------EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ------EEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 5555555554321 1223468999999999999989999999999999999999999999887766655544
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...... .+..+++++.+||.+||+.||++|
T Consensus 218 ~~~~~~--------------------------------------------------~p~~~s~~~~~li~~lL~~dP~~R 247 (337)
T 1o6l_A 218 LMEEIR--------------------------------------------------FPRTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp HHCCCC--------------------------------------------------CCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HcCCCC--------------------------------------------------CCCCCCHHHHHHHHHHhhcCHHHh
Confidence 331111 112356789999999999999999
Q ss_pred C-----CHHHHHcCCCCCCC
Q 015532 378 L-----KAREALRHPFFTRD 392 (405)
Q Consensus 378 p-----ta~elL~hp~f~~~ 392 (405)
| +++|+++||||+.-
T Consensus 248 ~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 248 LGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTTC
T ss_pred cCCCCCCHHHHHcCCCcCCC
Confidence 9 99999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=341.08 Aligned_cols=231 Identities=26% Similarity=0.387 Sum_probs=187.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
..++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3568999999999999999999999999999999986433 3456678999999999999985422
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~------------------------ 153 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------------------------ 153 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------------------------
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC------------------------
Confidence 13478899999999999999999999999999999999997655
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 154 ---~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 230 (297)
T 3fxz_A 154 ---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (297)
T ss_dssp ---CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ---CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 4566666665443322 2335799999999999999999999999999999999999999988777665554432
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
...+. ......++..+.+||.+||+.||++|||
T Consensus 231 ~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps 263 (297)
T 3fxz_A 231 NGTPE-----------------------------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGS 263 (297)
T ss_dssp HCSCC-----------------------------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCC-----------------------------------------------CCCccccCHHHHHHHHHHccCChhHCcC
Confidence 21100 0112345678999999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015532 380 AREALRHPFFTRDVR 394 (405)
Q Consensus 380 a~elL~hp~f~~~~~ 394 (405)
++|+|+||||+....
T Consensus 264 ~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 264 AKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHTTCGGGGGCCC
T ss_pred HHHHhhChhhcccCc
Confidence 999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=339.81 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=188.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++++.||+|+||+||+|++ .+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 678899999996432 2346778999999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---------------------- 138 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---------------------- 138 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----------------------
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC----------------------
Confidence 245788999999999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 139 -----~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 139 -----LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp -----EEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred -----EEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55556665543221 11234789999999999864 5899999999999999999999999999888888888
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+..+..+...+...... ..+ ...+.. ..+..........++++.+||.+||+.||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 272 (288)
T 1ob3_A 214 FRILGTPNSKNWPNVTEL-PKY-----DPNFTV---------------YEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272 (288)
T ss_dssp HHHHCCCCTTTSTTGGGS-TTC-----CTTCCC---------------CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHCCCChhhchhhhcc-ccc-----cccccc---------------ccCccHHHHhhhcCHHHHHHHHHHcCCCcccC
Confidence 887776543211100000 000 000000 00000112234567899999999999999999
Q ss_pred CCHHHHHcCCCCCCC
Q 015532 378 LKAREALRHPFFTRD 392 (405)
Q Consensus 378 pta~elL~hp~f~~~ 392 (405)
||++|+|+||||++.
T Consensus 273 pt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 273 ITAKQALEHAYFKEN 287 (288)
T ss_dssp CCHHHHHTSGGGGC-
T ss_pred CCHHHHhcCcchhhc
Confidence 999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=350.72 Aligned_cols=265 Identities=29% Similarity=0.485 Sum_probs=193.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..++|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3568999999999999999999999999999999996432 2235567899999999999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 112 ~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--------------------- 170 (329)
T 3gbz_A 112 FEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA--------------------- 170 (329)
T ss_dssp EECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC------------------------
T ss_pred EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC---------------------
Confidence 235789999999999999999999999999999999999965431
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+....+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..
T Consensus 171 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 249 (329)
T 3gbz_A 171 -SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249 (329)
T ss_dssp ---CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence 13445788888887654322 2335789999999999875 489999999999999999999999999999998888
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+.++......... ...|...... ..............++++.+||.+||++||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 309 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTA----------LPDWKQSFPK----------FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309 (329)
T ss_dssp HHHHHCCCCTTTSTTGGG----------STTCCTTCCC----------CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCchhhhhhhhh----------hhhhhhhhhh----------hccccHhhhcccccCHHHHHHHHHHccCChhh
Confidence 888877665432111000 0001000000 00000011111235678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~~~ 396 (405)
|||++|+|+||||++....|
T Consensus 310 R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 310 RISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp SCCHHHHHTSGGGSSSCSCC
T ss_pred CCCHHHHhCCcccCCCCCCC
Confidence 99999999999999876554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=357.93 Aligned_cols=250 Identities=29% Similarity=0.492 Sum_probs=195.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
.+|++.+.||+|+||+||+|++..+++.||||++..... ...+|+++|+.+.|++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 469999999999999999999999999999999865332 234699999999999985421
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~----------------- 193 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT----------------- 193 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-----------------
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-----------------
Confidence 13467888999999999999999999999999999999997532
Q ss_pred CcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
..+||+|||+++.... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+
T Consensus 194 ---------~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~ 264 (420)
T 1j1b_A 194 ---------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264 (420)
T ss_dssp ---------TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2467777777764332 22345789999999999875 69999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.+.+|.++...+...... .....++.... ...........++++.+||.+||++
T Consensus 265 ~l~~i~~~lg~p~~~~~~~~~~~-------~~~~~~p~~~~--------------~~~~~~~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 265 QLVEIIKVLGTPTREQIREMNPN-------YTEFKFPQIKA--------------HPWTKVFRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp HHHHHHHHHCSCCHHHHHHHCSC-------CCCCCCCCCCC--------------CCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCCHHHHHhhChh-------hhhhccCccCC--------------CCHHHhcCCCCCHHHHHHHHHhccC
Confidence 99999999998876654332110 01111111000 0000111234577899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTR 391 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~ 391 (405)
||++|||+.|+|+||||+.
T Consensus 324 dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 324 TPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp SGGGSCCHHHHHTSGGGGG
T ss_pred ChhHCCCHHHHhCCHhhcc
Confidence 9999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=347.69 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=190.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhh--hHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|+++++||+|+||+||+|++..+++.||||+++..... ...+.+|+.+++.+.|+++....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999999999999999999653321 12345799999999999885421
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~----------------------- 138 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE----------------------- 138 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC-----------------------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC-----------------------
Confidence 134788999999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 139 ----~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 214 (324)
T 3mtl_A 139 ----LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214 (324)
T ss_dssp ----EEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ----EEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 555666655433221 123478999999999987 468999999999999999999999999999999999999
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.++.++...+........ +. ...++. ............+++++.+||.+||++||++||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~-~~----~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 274 (324)
T 3mtl_A 215 RILGTPTEETWPGILSNEE-FK----TYNYPK---------------YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274 (324)
T ss_dssp HHHCCCCTTTSTTGGGCHH-HH----HTCCCC---------------CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHhCCCChHhchhhhcchh-hc----cccccc---------------ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence 9888776543221110000 00 000000 001111222345678999999999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ta~elL~hp~f~~~~~ 394 (405)
|++|+|+||||++...
T Consensus 275 t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 275 SAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHTTSGGGGGGCS
T ss_pred CHHHHhcChhhhhccc
Confidence 9999999999987544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=348.96 Aligned_cols=224 Identities=26% Similarity=0.395 Sum_probs=188.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++++.||+|+||.||+|++..+++.||||++++.. ...+.+.+|+.+|+.+.|+++....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999999999999999996532 2346678899999999999874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---------------------- 178 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---------------------- 178 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----------------------
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC----------------------
Confidence 14578999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 179 -----~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 179 -----YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp -----CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred -----CEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 467777777766555555678999999999999999999999999999999999999999988776666555432
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC-
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK- 379 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt- 379 (405)
...+ +..++..+.+||.+||+.||++||+
T Consensus 254 ~~~~--------------------------------------------------p~~~~~~~~~li~~lL~~dp~~R~~~ 283 (350)
T 1rdq_E 254 KVRF--------------------------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGN 283 (350)
T ss_dssp CCCC--------------------------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTS
T ss_pred CCCC--------------------------------------------------CCCCCHHHHHHHHHHhhcCHHhccCC
Confidence 1111 1234678999999999999999998
Q ss_pred ----HHHHHcCCCCCCC
Q 015532 380 ----AREALRHPFFTRD 392 (405)
Q Consensus 380 ----a~elL~hp~f~~~ 392 (405)
++|+++||||+..
T Consensus 284 ~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 284 LKNGVNDIKNHKWFATT 300 (350)
T ss_dssp STTTTHHHHTSGGGTTC
T ss_pred ccCCHHHHHhCcCcCCC
Confidence 9999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=350.22 Aligned_cols=232 Identities=28% Similarity=0.407 Sum_probs=186.0
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
+.++|++.+.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999999999999999996432 1356788999999999999984321
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-------------- 167 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-------------- 167 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS--------------
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC--------------
Confidence 11378899999999999999999999999999999999997643
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
....+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 168 ----------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 168 ----------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp ----------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred ----------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 23357888888886554332 23579999999999999899999999999999999999999998743
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
.+....+.......+. ..+..++.++.+||.+|
T Consensus 238 -~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~ 270 (351)
T 3c0i_A 238 -ERLFEGIIKGKYKMNP----------------------------------------------RQWSHISESAKDLVRRM 270 (351)
T ss_dssp -HHHHHHHHHTCCCCCH----------------------------------------------HHHTTSCHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCc----------------------------------------------cccccCCHHHHHHHHHH
Confidence 3333333221111110 11134577899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
|+.||++|||+.|+|+||||+..
T Consensus 271 L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 271 LMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCCChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=347.50 Aligned_cols=225 Identities=25% Similarity=0.371 Sum_probs=183.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc-----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR----------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~----------- 154 (405)
.++|++.+.||+|+||.||+|+++.+++.||||++++.. ...+....|..++..+ .|+++....
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 367999999999999999999999999999999997532 3345677899999987 788774321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~------------------- 156 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH------------------- 156 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-------------------
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC-------------------
Confidence 145789999999999999999999999999999999999977664
Q ss_pred cCCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 157 --------vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 228 (345)
T 1xjd_A 157 --------IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228 (345)
T ss_dssp --------EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --------EEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 5555666554321 12234689999999999999999999999999999999999999999887766665
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+....... +...++++.+||.+||+.||+
T Consensus 229 ~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~lL~~dp~ 258 (345)
T 1xjd_A 229 SIRMDNPFY--------------------------------------------------PRWLEKEAKDLLVKLFVREPE 258 (345)
T ss_dssp HHHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCC--------------------------------------------------CcccCHHHHHHHHHHhcCCHh
Confidence 553321111 123467899999999999999
Q ss_pred CCCCHH-HHHcCCCCCCC
Q 015532 376 ERLKAR-EALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpta~-elL~hp~f~~~ 392 (405)
+||++. ++++||||+.-
T Consensus 259 ~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 259 KRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp GSBTTBSCGGGSGGGTTC
T ss_pred HcCCChHHHHcCccccCC
Confidence 999998 99999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=335.57 Aligned_cols=257 Identities=31% Similarity=0.571 Sum_probs=194.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999999999999999985432 2346677899999999999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------------------- 139 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS---------------------- 139 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----------------------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC----------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..
T Consensus 140 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (311)
T 4agu_A 140 -----VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214 (311)
T ss_dssp -----CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -----CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4677777776544322 123578999999999987 5689999999999999999999999999999999999
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+..+..+.......... .++. +.....+.... ........++..+.+||.+||++||++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (311)
T 4agu_A 215 IRKTLGDLIPRHQQVFSTN--QYFS-GVKIPDPEDME----------------PLELKFPNISYPALGLLKGCLHMDPTE 275 (311)
T ss_dssp HHHHHCSCCHHHHHHHHTC--GGGT-TCCCCCCSSCC----------------CHHHHCTTCCHHHHHHHHHHCCSSTTT
T ss_pred HHHHhcccccccccccccc--cccc-cCcCCCccccc----------------hhhhhcccccHHHHHHHHHHccCChhh
Confidence 9888888776543322111 1110 11111110000 001112356778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDV 393 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~ 393 (405)
|||++|+|+||||++-.
T Consensus 276 Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 276 RLTCEQLLHHPYFENIR 292 (311)
T ss_dssp SCCHHHHHTSGGGTTCC
T ss_pred cCCHHHHhcChHHHhcc
Confidence 99999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=348.47 Aligned_cols=235 Identities=26% Similarity=0.435 Sum_probs=192.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+|+.+.|+++....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4578999999999999999999999999999999996532 3345678899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~----------------------- 185 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK----------------------- 185 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-----------------------
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-----------------------
Confidence 1357899999999999999999999999999999999999642
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 186 --~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~ 263 (387)
T 1kob_A 186 --KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263 (387)
T ss_dssp --TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred --CCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 23457888888887654332 33579999999999999899999999999999999999999999887766665554
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
......+ ......+++++.+||.+||+.||++||
T Consensus 264 ~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rp 297 (387)
T 1kob_A 264 RCDWEFD----------------------------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRL 297 (387)
T ss_dssp HCCCCCC----------------------------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred hCCCCCC----------------------------------------------ccccccCCHHHHHHHHHHcCCChhHCc
Confidence 3211111 011234577899999999999999999
Q ss_pred CHHHHHcCCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVRR 395 (405)
Q Consensus 379 ta~elL~hp~f~~~~~~ 395 (405)
|+.|+|+||||++....
T Consensus 298 t~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 298 TVHDALEHPWLKGDHSN 314 (387)
T ss_dssp CHHHHHTSTTTSSCCTT
T ss_pred CHHHHhhCccccCCccc
Confidence 99999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=342.94 Aligned_cols=261 Identities=31% Similarity=0.535 Sum_probs=183.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++++.||+|+||+||+|.+..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357999999999999999999999999999999996432 2346788999999999999984321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~----------------- 146 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ----------------- 146 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-----------------
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC-----------------
Confidence 124788999999999999999999999999999999999976654
Q ss_pred cccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 147 ----------~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 216 (317)
T 2pmi_A 147 ----------LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216 (317)
T ss_dssp ----------EEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ----------EEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 566666665443221 2234789999999999874 68999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+....+.++...+...... ..+ ...... ......... .........+.++.+||.+||+.
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~L~~ 280 (317)
T 2pmi_A 217 QLKLIFDIMGTPNESLWPSVTKL-PKY-----NPNIQQ--RPPRDLRQV--------LQPHTKEPLDGNLMDFLHGLLQL 280 (317)
T ss_dssp HHHHHHHHHCSCCTTTCGGGGGC-TTC-----CTTCCC--CCCCCSHHH--------HGGGCSSCCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCChhHhhhhhhh-hhc-----cccccc--ccchhHHHh--------hcccccccCCHHHHHHHHHHCCC
Confidence 99999888887665432221100 000 000000 000000000 01112235678999999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~~ 394 (405)
||++|||++|+|+||||++...
T Consensus 281 dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 281 NPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp SGGGSCCHHHHTTSGGGGGGCC
T ss_pred CcccCCCHHHHhCChhhhcccc
Confidence 9999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.61 Aligned_cols=253 Identities=32% Similarity=0.560 Sum_probs=196.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
...++|++.+.||+|+||+||+|++..+++.||||++...... ..+|+++++.+.|+++....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3457899999999999999999999999999999998654332 33699999999999874310
Q ss_pred ------------------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHC
Q 015532 155 ------------------------------------------------------YRSFPIDLVRELGRQLLESVAFMHEL 180 (405)
Q Consensus 155 ------------------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~ 180 (405)
...+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 13477889999999999999999999
Q ss_pred CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHh
Q 015532 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVIL 258 (405)
Q Consensus 181 givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~ 258 (405)
||+||||||+|||++. .+..+||+|||++..... ......||+.|+|||++.
T Consensus 161 gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML 214 (383)
T ss_dssp TEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT
T ss_pred cCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc
Confidence 9999999999999973 123567777777764432 223457899999999998
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhh
Q 015532 259 GLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 337 (405)
Q Consensus 259 ~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (405)
+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+.+|.++...+........ ...++....
T Consensus 215 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~-------~~~~~~~~~---- 283 (383)
T 3eb0_A 215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT-------EVRFPTLKA---- 283 (383)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC---------CCCCCCCC----
T ss_pred CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc-------cccCCccCc----
Confidence 754 89999999999999999999999999999999999999999988765544321111 111111100
Q ss_pred HHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
...........++++.+||.+||++||++|||+.|+|+||||++
T Consensus 284 ----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 284 ----------KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp ----------CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred ----------ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 01111223456788999999999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=341.24 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=199.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+.++|.+.+.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 457899999999999999999999999999999999643 23346678899999999999884321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~------------------ 163 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC------------------ 163 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC------------------
T ss_pred eeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC------------------
Confidence 12478999999999999999999999999999999999997654
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 164 ---------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 234 (353)
T 3coi_A 164 ---------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234 (353)
T ss_dssp ---------CEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred ---------cEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4677777777665544455688999999999987 578999999999999999999999999999999999
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.+..|.++..+...........+.... +. .............++.+.+||.+||+.||+
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 295 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSL----PQ---------------TPRKDFTQLFPRASPQAADLLEKMLELDVD 295 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTS----CB---------------CSSCCTTTTCTTSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhC----cC---------------CCCccHHHhcCCcCHHHHHHHHHHcCCCcc
Confidence 99999998887665433222111110000 00 000001112235678999999999999999
Q ss_pred CCCCHHHHHcCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~ 392 (405)
+|||++|+|+||||+..
T Consensus 296 ~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 296 KRLTAAQALTHPFFEPF 312 (353)
T ss_dssp TSCCHHHHHTSGGGTTT
T ss_pred cCCCHHHHhcCcchhhc
Confidence 99999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=348.52 Aligned_cols=224 Identities=23% Similarity=0.402 Sum_probs=176.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+..|..++.++ .|++++...
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57999999999999999999999999999999997542 2234567899999888 788774321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-------------------- 191 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-------------------- 191 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--------------------
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--------------------
Confidence 245899999999999999999999999999999999999977664
Q ss_pred CCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----
Q 015532 220 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE---- 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---- 292 (405)
+||+|||+++... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+
T Consensus 192 -------ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~ 264 (396)
T 4dc2_A 192 -------IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264 (396)
T ss_dssp -------EEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------
T ss_pred -------EEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch
Confidence 5666666654311 22334689999999999999999999999999999999999999996532211
Q ss_pred -----HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 293 -----HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 293 -----~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
....+... . ...+..++.++.+||.
T Consensus 265 ~~~~~~~~~i~~~------------------------~--------------------------~~~p~~~s~~~~~li~ 294 (396)
T 4dc2_A 265 NTEDYLFQVILEK------------------------Q--------------------------IRIPRSLSVKAASVLK 294 (396)
T ss_dssp CCHHHHHHHHHHC------------------------C--------------------------CCCCTTSCHHHHHHHH
T ss_pred hhHHHHHHHHhcc------------------------c--------------------------cCCCCcCCHHHHHHHH
Confidence 11111110 0 1122345778999999
Q ss_pred HccccCCCCCCCH------HHHHcCCCCCCC
Q 015532 368 GLLRYDPAERLKA------REALRHPFFTRD 392 (405)
Q Consensus 368 ~~L~~dP~~Rpta------~elL~hp~f~~~ 392 (405)
+||+.||++|+++ +|+++||||++-
T Consensus 295 ~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 295 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999985 899999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=343.66 Aligned_cols=168 Identities=23% Similarity=0.245 Sum_probs=131.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
..+|.+.++||+|+||+||+|++ +|+.||||+++...........|+..+..++|+|++...
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35699999999999999999987 488999999976544333444566677789999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..+..++.|++.||.|||++ +||||||||+|||++.++
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-------------- 145 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-------------- 145 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS--------------
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC--------------
Confidence 13568889999999999999999987 999999999999997665
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCc-------cceecCCCcchhHHHhCC------CCCCchhHHHHHHHHHHHH
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~~ll 279 (405)
.+||+|||+|+...... ...+||+.|||||++.+. .|+.++|||||||++|||+
T Consensus 146 -------------~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 146 -------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp -------------CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred -------------CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 45666666665432221 235799999999999864 3677999999999999999
Q ss_pred hCCCCCCC
Q 015532 280 SGEALFQT 287 (405)
Q Consensus 280 tg~~pf~~ 287 (405)
||.+||..
T Consensus 213 tg~~~~~~ 220 (303)
T 3hmm_A 213 RRCSIGGI 220 (303)
T ss_dssp HTBCBTTB
T ss_pred HCCCCCCc
Confidence 99888754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.77 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=196.3
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++....+|++.+.||+|+||+||+|++..+++ ||+|++...... ..+|+++++.+.|+++....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 34455689999999999999999999987776 888877543322 23699999999999985421
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cccccccCCccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPDYKFLS 209 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~-~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----------- 179 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG----------- 179 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-----------
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC-----------
Confidence 23578889999999999999999999999999999999997 444
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.+||+|||++..... ......||+.|+|||++.+. .|+.++|||||||++|+|++|++||.
T Consensus 180 ----------------~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 180 ----------------VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp ----------------EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 467777777754322 22345789999999999875 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+.+..+.+..+.+.+|.++...+........ ...++... ............++++.+||
T Consensus 244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~-------~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li 302 (394)
T 4e7w_A 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYM-------EHKFPQIR--------------PHPFSKVFRPRTPPDAIDLI 302 (394)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS-------SSCCCCCC--------------CCCHHHHSCTTCCHHHHHHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhh-------hhcccccc--------------CCcHHHhccccCCHHHHHHH
Confidence 9999999999999999988765543321110 01111100 00011112234678999999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
.+||++||++|||+.|+|+||||++-
T Consensus 303 ~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 303 SRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHhCCChhhCCCHHHHhcChhhhhh
Confidence 99999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.93 Aligned_cols=233 Identities=28% Similarity=0.412 Sum_probs=176.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.+.|+++....
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 4689999999999999999999999999999999987666667788999999999999985421
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~------------------------- 153 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP------------------------- 153 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-------------------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-------------------------
Confidence 24578999999999999999999999999999999999997543
Q ss_pred CCCceeccCCCCcccc--CCccceecCCCcchhHHHhCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHH
Q 015532 224 SSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEHLAM-MER 299 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~lltg~~pf~~~~~~~~~~~-i~~ 299 (405)
...+||+|||++.... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......... +..
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 233 (361)
T 3uc3_A 154 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233 (361)
T ss_dssp SCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH
T ss_pred CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 2347888888876332 22234579999999999998888755 8999999999999999999986543221111 111
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.... ...++ ....+++.+.+||.+||+.||++|||
T Consensus 234 ~~~~---------------------~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps 268 (361)
T 3uc3_A 234 ILSV---------------------KYSIP------------------------DDIRISPECCHLISRIFVADPATRIS 268 (361)
T ss_dssp HHTT---------------------CCCCC------------------------TTSCCCHHHHHHHHHHSCSCTTTSCC
T ss_pred HhcC---------------------CCCCC------------------------CcCCCCHHHHHHHHHHccCChhHCcC
Confidence 1100 00000 01235678999999999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 015532 380 AREALRHPFFTRDV 393 (405)
Q Consensus 380 a~elL~hp~f~~~~ 393 (405)
+.|+++||||.+..
T Consensus 269 ~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 269 IPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHTSHHHHTTC
T ss_pred HHHHHhCcchhcCC
Confidence 99999999997654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=331.49 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=194.3
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 356789999999999999999999999999999999996533 2345677899999999999884321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------------- 142 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------------- 142 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-------------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-------------------
Confidence 13478899999999999999999999999999999999997543
Q ss_pred ccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 143 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 217 (284)
T 3kk8_A 143 -----KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217 (284)
T ss_dssp -----TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -----CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH
Confidence 23457888888886554332 23579999999999999899999999999999999999999999887776665
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.......|. ......++.+.+||.+||+.||+
T Consensus 218 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~dp~ 251 (284)
T 3kk8_A 218 QIKAGAYDYPS----------------------------------------------PEWDTVTPEAKSLIDSMLTVNPK 251 (284)
T ss_dssp HHHHTCCCCCT----------------------------------------------TTTTTSCHHHHHHHHHHSCSSTT
T ss_pred HHHhccccCCc----------------------------------------------hhhcccCHHHHHHHHHHcccChh
Confidence 55443222111 11134567899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~~~ 396 (405)
+|||++|+|+||||++..+..
T Consensus 252 ~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 252 KRITADQALKVPWICNRERVA 272 (284)
T ss_dssp TSCCHHHHTTSHHHHSCCCGG
T ss_pred hCCCHHHHhcCccccCChhHH
Confidence 999999999999998865443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=344.96 Aligned_cols=225 Identities=24% Similarity=0.342 Sum_probs=182.0
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc-----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR----------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~----------- 154 (405)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ...+....|..++..+ .|+++....
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 367999999999999999999999999999999997532 3346677899999887 555553211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~------------------- 159 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH------------------- 159 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-------------------
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc-------------------
Confidence 246789999999999999999999999999999999999987664
Q ss_pred cCCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 160 --------vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 231 (353)
T 2i0e_A 160 --------IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231 (353)
T ss_dssp --------EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --------EEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 5555555554321 12234689999999999999999999999999999999999999999887776665
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+....... +...+.++.+||.+||+.||+
T Consensus 232 ~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~lL~~dP~ 261 (353)
T 2i0e_A 232 SIMEHNVAY--------------------------------------------------PKSMSKEAVAICKGLMTKHPG 261 (353)
T ss_dssp HHHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHTCSCTT
T ss_pred HHHhCCCCC--------------------------------------------------CCCCCHHHHHHHHHHhhcCHH
Confidence 554321111 123567899999999999999
Q ss_pred CCC-----CHHHHHcCCCCCCC
Q 015532 376 ERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rp-----ta~elL~hp~f~~~ 392 (405)
+|+ +++++++||||+.-
T Consensus 262 ~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 262 KRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp SCTTCSTTHHHHHHTSGGGTTC
T ss_pred HcCCCCCCCHHHHhcCccccCC
Confidence 999 47999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=339.82 Aligned_cols=231 Identities=22% Similarity=0.370 Sum_probs=179.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5678999999999999999999999999999999986432 2346678999999999999984321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~---------------------- 142 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---------------------- 142 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----------------------
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC----------------------
Confidence 23578999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........
T Consensus 143 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 143 -----NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp -----CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred -----CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 4666677766533211 223579999999999988775 67899999999999999999999765543211
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
........ ........+++.+.+||.+||+.||
T Consensus 218 ~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP 250 (323)
T 3tki_A 218 YSDWKEKK-----------------------------------------------TYLNPWKKIDSAPLALLHKILVENP 250 (323)
T ss_dssp HHHHHTTC-----------------------------------------------TTSTTGGGSCHHHHHHHHHHSCSST
T ss_pred HHHHhccc-----------------------------------------------ccCCccccCCHHHHHHHHHHccCCh
Confidence 11100000 0001113456788999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~ 394 (405)
++|||++|+++||||++...
T Consensus 251 ~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 251 SARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp TTSCCHHHHTTCTTTTCCCC
T ss_pred hhCcCHHHHhhChhhccccc
Confidence 99999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=343.14 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=176.3
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+.+.++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|+.+++++.|+++....
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3456788999999999999999999999999999999997543 345677899999999999984321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~---------------------- 184 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP---------------------- 184 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS----------------------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC----------------------
Confidence 2347899999999999999999999999999999999999642
Q ss_pred CCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-HLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~ 296 (405)
+.+..+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+ .+..
T Consensus 185 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 262 (349)
T 2w4o_A 185 --APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262 (349)
T ss_dssp --STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH
T ss_pred --CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH
Confidence 12446788888887654432 234579999999999999899999999999999999999999997765544 2222
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.......+ ......++.++.+||.+||+.||++
T Consensus 263 i~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~ 296 (349)
T 2w4o_A 263 ILNCEYYFI----------------------------------------------SPWWDEVSLNAKDLVRKLIVLDPKK 296 (349)
T ss_dssp HHTTCCCCC----------------------------------------------TTTTTTSCHHHHHHHHTTSCSSGGG
T ss_pred HHhCCCccC----------------------------------------------CchhhhCCHHHHHHHHHHccCChhh
Confidence 221110000 0112345778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~~ 395 (405)
|||+.|+|+||||++....
T Consensus 297 Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 297 RLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp SCCHHHHHHSTTTTSTTCC
T ss_pred CcCHHHHhcCcccCCCccc
Confidence 9999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=337.27 Aligned_cols=237 Identities=24% Similarity=0.324 Sum_probs=180.5
Q ss_pred CCCCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHH-hhcCCCC
Q 015532 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGG 152 (405)
Q Consensus 77 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l-~~~~~~~ 152 (405)
...++++...++.+.++|++.++||+|+||+||+|++..+++.||||++... .........|+..+..+ .|+++..
T Consensus 42 ~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~ 121 (311)
T 3p1a_A 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121 (311)
T ss_dssp CCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 3445556666777888999999999999999999999999999999998542 23334555677666666 7777643
Q ss_pred Cc---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCc
Q 015532 153 TR---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 153 ~~---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df 205 (405)
.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 122 l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~------ 195 (311)
T 3p1a_A 122 LEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR------ 195 (311)
T ss_dssp EEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC------
T ss_pred EEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC------
Confidence 21 135899999999999999999999999999999999999977654
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 196 ---------------------~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~ 253 (311)
T 3p1a_A 196 ---------------------CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253 (311)
T ss_dssp ---------------------EEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCC
T ss_pred ---------------------EEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 566666665443322 123468999999999886 79999999999999999999977
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||.+...... +.. +..+. .....+++.+.
T Consensus 254 ~~~~~~~~~~---~~~--~~~~~----------------------------------------------~~~~~~~~~l~ 282 (311)
T 3p1a_A 254 LPHGGEGWQQ---LRQ--GYLPP----------------------------------------------EFTAGLSSELR 282 (311)
T ss_dssp CCSSHHHHHH---HTT--TCCCH----------------------------------------------HHHTTSCHHHH
T ss_pred CCCCccHHHH---Hhc--cCCCc----------------------------------------------ccccCCCHHHH
Confidence 7754322111 100 11111 11234577899
Q ss_pred HHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 364 DLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+||.+||+.||++|||++|+|+||||++.
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence 99999999999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=337.23 Aligned_cols=226 Identities=24% Similarity=0.401 Sum_probs=176.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---------------------------hhHHHHHHHHHHH
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQ 143 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------------------------~~~~~~~E~~il~ 143 (405)
.++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3689999999999999999999999999999999864321 1245788999999
Q ss_pred HHhhcCCCCCc----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 015532 144 RLARHDIGGTR----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 195 (405)
Q Consensus 144 ~l~~~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~ 195 (405)
.+.|+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 99999874311 23578999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCC---CCCchhHH
Q 015532 196 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG---WNYPCDLW 269 (405)
Q Consensus 196 ~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Diw 269 (405)
.++ .+||+|||++....... ....||+.|+|||++.+.. ++.++|||
T Consensus 172 ~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~ 224 (298)
T 2zv2_A 172 EDG---------------------------HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224 (298)
T ss_dssp TTS---------------------------CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHH
T ss_pred CCC---------------------------CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhH
Confidence 655 45666666665433221 2357999999999998765 37889999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh
Q 015532 270 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349 (405)
Q Consensus 270 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (405)
||||++|+|++|..||.+.........+...... ++
T Consensus 225 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------------~~-------------------- 260 (298)
T 2zv2_A 225 AMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE------------------------FP-------------------- 260 (298)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------------CC--------------------
T ss_pred hHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCC------------------------CC--------------------
Confidence 9999999999999999877655443333221111 00
Q ss_pred hhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 350 ~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
....+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 261 ----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 261 ----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp ----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 11245678999999999999999999999999999963
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=342.08 Aligned_cols=259 Identities=28% Similarity=0.498 Sum_probs=194.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.++||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 68999999999999999999999999999999985432 2345678899999999999874311
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~-------------- 162 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-------------- 162 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--------------
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--------------
Confidence 135789999999999999999999999999999999999987665
Q ss_pred CCCcccCCCCCCCceeccCCCCcccc-------CCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEH-------QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
+||+|||++.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 163 -------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 163 -------------LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp -------------EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -------------EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 4555555553322 111235789999999999874 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
.+....+.+..+.+..+.++........... .+. .......... ....... . ...++.+.+|
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~--~~~~~~~---------~--~~~~~~~~~l 291 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYE--LYE---KLELVKGQKR--KVKDRLK---------A--YVRDPYALDL 291 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG--GGT---SSCCCSSCCC--CHHHHHH---------H--HHCCHHHHHH
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccch--hhc---cccccccccc--CHHHHhh---------h--ccCChHHHHH
Confidence 9999999999999998887765432221100 000 0000000000 0000000 0 0125678999
Q ss_pred HHHccccCCCCCCCHHHHHcCCCCCCCCCC
Q 015532 366 LQGLLRYDPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
|.+||++||++|||++|+|+||||+.....
T Consensus 292 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 292 IDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred HHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.89 Aligned_cols=258 Identities=30% Similarity=0.475 Sum_probs=191.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||+||+|++..+++.||||++............|++.+..+.|+++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 3689999999999999999999999999999999876655556677888999999999885421
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCCCcEEEec-ccccccCCcccccc
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVS-AEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIli~~-~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||.||| ++||+||||||+|||++. ++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~------------ 169 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG------------ 169 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT------------
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC------------
Confidence 124577888999999999999999 999999999999999975 44
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
.+||+|||++....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 170 ---------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 170 ---------------TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp ---------------EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 46777777765443322 2357899999999997654 89999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.+..+.+..+.+..+.++..+..........+ .+..... ..+...........++++.+||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~ 296 (360)
T 3e3p_A 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV-------DLYNSKG-----------IPWSNVFSDHSLKDAKEAYDLLS 296 (360)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG-------GGGCCCC-----------CCHHHHTTTCCCTTHHHHHHHHH
T ss_pred CChHHHHHHHHHHcCCCCHHHHHhcccchhhc-------ccccccc-----------CCcccccchhhccccHHHHHHHH
Confidence 99999999999999998887665442211110 0000000 00111112223346789999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+||++||++|||+.|+|+||||++..
T Consensus 297 ~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 297 ALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHhccCccccCCHHHHhcCccccccC
Confidence 99999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.07 Aligned_cols=228 Identities=25% Similarity=0.376 Sum_probs=181.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
...++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999996432 2345688999999999999985421
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 86 lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-------------------- 145 (336)
T 3h4j_B 86 MVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-------------------- 145 (336)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--------------------
T ss_pred EEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred cCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+...
T Consensus 146 -------~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~ 218 (336)
T 3h4j_B 146 -------NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK 218 (336)
T ss_dssp -------CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC
T ss_pred -------CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 4666777766543322 234579999999999988776 689999999999999999999997643211100
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+ .......+...++.+.+||.+||+.||+
T Consensus 219 ~i--------------------------------------------------~~~~~~~p~~~s~~~~~li~~~L~~dP~ 248 (336)
T 3h4j_B 219 KV--------------------------------------------------NSCVYVMPDFLSPGAQSLIRRMIVADPM 248 (336)
T ss_dssp CC--------------------------------------------------CSSCCCCCTTSCHHHHHHHHTTSCSSGG
T ss_pred HH--------------------------------------------------HcCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 00 0000112234577899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDV 393 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~ 393 (405)
+|||++|+++||||+...
T Consensus 249 ~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 249 QRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp GSCCHHHHTTCHHHHTTC
T ss_pred HCcCHHHHHhChhhccCC
Confidence 999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=341.18 Aligned_cols=224 Identities=22% Similarity=0.384 Sum_probs=175.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|+++.+++.||||++++.. ...+.+.+|+.++..+ .|+++....
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999997532 2345577899999988 788774321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG------------- 155 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG------------- 155 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGG-------------
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecc-------------
Confidence 1458899999999999999999999999999999999999877655555555
Q ss_pred CCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 015532 220 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL----- 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----- 291 (405)
++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 --------------~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 221 (345)
T 3a8x_A 156 --------------MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221 (345)
T ss_dssp --------------GCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred --------------ccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence 443211 1223458999999999999999999999999999999999999999653211
Q ss_pred ----HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 292 ----EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 292 ----~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.....+... . ...+...+.++.+||.
T Consensus 222 ~~~~~~~~~i~~~------------------------~--------------------------~~~p~~~s~~~~~li~ 251 (345)
T 3a8x_A 222 NTEDYLFQVILEK------------------------Q--------------------------IRIPRSLSVKAASVLK 251 (345)
T ss_dssp -CHHHHHHHHHHC------------------------C--------------------------CCCCTTSCHHHHHHHH
T ss_pred ccHHHHHHHHHcC------------------------C--------------------------CCCCCCCCHHHHHHHH
Confidence 111111110 0 0112345778999999
Q ss_pred HccccCCCCCCCH------HHHHcCCCCCCC
Q 015532 368 GLLRYDPAERLKA------REALRHPFFTRD 392 (405)
Q Consensus 368 ~~L~~dP~~Rpta------~elL~hp~f~~~ 392 (405)
+||+.||++||++ +|+++||||++-
T Consensus 252 ~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999999999995 899999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=358.46 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=197.4
Q ss_pred CCCceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--------------hhhHHHHHHHHHHHH
Q 015532 79 DGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQR 144 (405)
Q Consensus 79 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------------~~~~~~~~E~~il~~ 144 (405)
.+.+....+..+.++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.
T Consensus 23 ~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 102 (504)
T 3q5i_A 23 PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102 (504)
T ss_dssp GGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHT
T ss_pred hhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHh
Confidence 344555666778899999999999999999999999999999999996532 335678899999999
Q ss_pred HhhcCCCCCc---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 145 LARHDIGGTR---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 145 l~~~~~~~~~---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
+.|+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 9999984321 2457899999999999999999999999999999999999764
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 275 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 275 (405)
+ ....+||+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++
T Consensus 183 ~------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 237 (504)
T 3q5i_A 183 N------------------------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIM 237 (504)
T ss_dssp T------------------------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHH
T ss_pred C------------------------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHH
Confidence 3 2235889999988765433 234579999999999875 699999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcc
Q 015532 276 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355 (405)
Q Consensus 276 ~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (405)
|+|++|.+||.+.+..+.+..+.......+. ..+
T Consensus 238 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~ 271 (504)
T 3q5i_A 238 YILLCGYPPFGGQNDQDIIKKVEKGKYYFDF----------------------------------------------NDW 271 (504)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH----------------------------------------------HHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----------------------------------------------ccc
Confidence 9999999999998887777666543222211 112
Q ss_pred cCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 356 ~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
..+++++++||.+||++||++|||++|+|+||||++...
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 345778999999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=336.09 Aligned_cols=237 Identities=27% Similarity=0.419 Sum_probs=192.4
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-------hhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
..+.++|++.+.||+|+||.||+|++..+++.||||+++.... ..+.+.+|+.+++.+.|+++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4466789999999999999999999999999999999965321 356788999999999999984321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~-------------- 153 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI-------------- 153 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS--------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC--------------
Confidence 234688999999999999999999999999999999999976541
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
....++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 154 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 224 (321)
T 2a2a_A 154 ---------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (321)
T ss_dssp ---------SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH
Confidence 12257888888876544322 3357999999999999989999999999999999999999999988777
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+.+..+.......+.. .....+..+.+||.+||+
T Consensus 225 ~~~~~i~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~ 258 (321)
T 2a2a_A 225 ETLANITSVSYDFDEE----------------------------------------------FFSHTSELAKDFIRKLLV 258 (321)
T ss_dssp HHHHHHHTTCCCCCHH----------------------------------------------HHTTCCHHHHHHHHTTSC
T ss_pred HHHHHHHhcccccChh----------------------------------------------hhcccCHHHHHHHHHHcC
Confidence 7666554432222221 112446789999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.||++|||++|+|+||||+...
T Consensus 259 ~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 259 KETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp SSTTTSCCHHHHHHSTTTSCSS
T ss_pred CChhhCcCHHHHhcCccccCCC
Confidence 9999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.18 Aligned_cols=231 Identities=24% Similarity=0.431 Sum_probs=172.7
Q ss_pred CCCeEEE-eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc--------------
Q 015532 91 TPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~-------------- 154 (405)
.++|.+. +.||+|+||+||+|++..+++.||||+++.. ....+|+.++.++ .|+++....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3567776 7899999999999999999999999999643 3456788887555 667763311
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----------------- 198 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----------------- 198 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-----------------
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-----------------
Confidence 12478999999999999999999999999999999999997521
Q ss_pred CcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE- 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~- 292 (405)
.+..+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....
T Consensus 199 -------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 199 -------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp -------TTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred -------CCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 2346788888888654432 234689999999999998899999999999999999999999997654321
Q ss_pred ---HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 293 ---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 293 ---~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
....+... ...++ ...+..++.++.+||.+|
T Consensus 272 ~~~~~~~i~~~------------------------~~~~~----------------------~~~~~~~s~~~~~li~~~ 305 (400)
T 1nxk_A 272 SPGMKTRIRMG------------------------QYEFP----------------------NPEWSEVSEEVKMLIRNL 305 (400)
T ss_dssp CCSHHHHHHHT------------------------CCCCC----------------------TTTTTTSCHHHHHHHHTT
T ss_pred cHHHHHHHHcC------------------------cccCC----------------------CcccccCCHHHHHHHHHH
Confidence 11111110 00000 011234677899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
|+.||++|||++|+|+||||.+....
T Consensus 306 L~~dP~~Rpt~~eil~hp~~~~~~~~ 331 (400)
T 1nxk_A 306 LKTEPTQRMTITEFMNHPWIMQSTKV 331 (400)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred CCCChhHCcCHHHHhcCccccCCCCC
Confidence 99999999999999999999876543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=349.97 Aligned_cols=269 Identities=26% Similarity=0.456 Sum_probs=184.9
Q ss_pred CccCCCeEEE-eeeecccceeEEEEEec--CCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCcc---------
Q 015532 88 ENLTPRYRIL-SKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRY--------- 155 (405)
Q Consensus 88 ~~~~~~y~~~-~~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~~--------- 155 (405)
+.+.+.|++. ++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.+.|++++....
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 3455678884 58999999999999965 568899999997533 3456789999999999999854320
Q ss_pred ----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 156 ----------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 156 ----------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
..+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~--------- 165 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------- 165 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS---------
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC---------
Confidence 1388899999999999999999999999999999999995321
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHh
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~llt 280 (405)
+.+..+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 166 --------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 231 (405)
T 3rgf_A 166 --------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231 (405)
T ss_dssp --------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH
T ss_pred --------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh
Confidence 23456888888888654422 2335799999999999875 48999999999999999999
Q ss_pred CCCCCCCCCh---------HHHHHHHHHHhCCCChHHHHHhhHhhH--HhhhcCCcccCCCCCCchhhHHHHHHhccchh
Q 015532 281 GEALFQTHEN---------LEHLAMMERVLGPLPHHMVIRADRRAE--KYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349 (405)
Q Consensus 281 g~~pf~~~~~---------~~~~~~i~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (405)
|.+||.+... .+.+..+...+|.++...+........ ..........+. ......
T Consensus 232 g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~ 297 (405)
T 3rgf_A 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT--------------NCSLIK 297 (405)
T ss_dssp SSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT--------------TCCHHH
T ss_pred CCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC--------------cchhhh
Confidence 9999976554 477788888888766533211110000 000000000000 000001
Q ss_pred hhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 350 ~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.........++.+.+||.+||++||++|||++|+|+||||++...
T Consensus 298 ~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 111112233668999999999999999999999999999988643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=347.83 Aligned_cols=230 Identities=23% Similarity=0.390 Sum_probs=185.4
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+++.+.|++++...
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999996532 2234577899999999999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 148 ~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--------------------- 206 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--------------------- 206 (410)
T ss_dssp ECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---------------------
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC---------------------
Confidence 135789999999999999999999999999999999999976654
Q ss_pred CCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+||+|||++...... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+
T Consensus 207 ------ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 207 ------LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp ------EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ------EEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 566666666543322 12468999999999998765 7899999999999999999999999888777
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+..... ...+| ....++.++++||.+||+.
T Consensus 281 ~~~~i~~~~~----------------------~~~~p------------------------~~~~~s~~~~~li~~lL~~ 314 (410)
T 3v8s_A 281 TYSKIMNHKN----------------------SLTFP------------------------DDNDISKEAKNLICAFLTD 314 (410)
T ss_dssp HHHHHHTHHH----------------------HCCCC------------------------TTCCCCHHHHHHHHHHSSC
T ss_pred HHHHHHhccc----------------------cccCC------------------------CcccccHHHHHHHHHHccC
Confidence 6665543210 00011 1124577999999999999
Q ss_pred CCCC--CCCHHHHHcCCCCCCCC
Q 015532 373 DPAE--RLKAREALRHPFFTRDV 393 (405)
Q Consensus 373 dP~~--Rpta~elL~hp~f~~~~ 393 (405)
+|++ |++++|+++||||++..
T Consensus 315 ~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 315 REVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp GGGCTTSSCHHHHHTSGGGCCSS
T ss_pred hhhhCCCCCHHHHhcCccccCCC
Confidence 9998 99999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=337.57 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=194.8
Q ss_pred CCCCCceEeeCCccCCCeEEE-eeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhh-cCCC
Q 015532 77 DKDGHYVFAIGENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIG 151 (405)
Q Consensus 77 ~~~~~~~~~~~~~~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~-~~~~ 151 (405)
+..+...+..++.+.++|.+. +.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.+.+ +++.
T Consensus 13 ~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv 92 (327)
T 3lm5_A 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92 (327)
T ss_dssp ---CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBC
T ss_pred ccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEE
Confidence 344456677778889999998 89999999999999999999999999996532 335678899999999966 5552
Q ss_pred CC-----------------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 152 GT-----------------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 152 ~~-----------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
.. ....+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~---- 168 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY---- 168 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT----
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC----
Confidence 21 124578999999999999999999999999999999999997521
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 169 --------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 228 (327)
T 3lm5_A 169 --------------------PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228 (327)
T ss_dssp --------------------TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred --------------------CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh
Confidence 13457777777776543322 23579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+.+..+....+.......+. .....+++
T Consensus 229 g~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~ 262 (327)
T 3lm5_A 229 HTSPFVGEDNQETYLNISQVNVDYSE----------------------------------------------ETFSSVSQ 262 (327)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCT----------------------------------------------TTTTTSCH
T ss_pred CCCCCCCCCchHHHHHHHhcccccCc----------------------------------------------hhhcccCH
Confidence 99999988877766665544322221 11234567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.+.+||.+||+.||++|||++|+|+||||++...
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 8999999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=336.53 Aligned_cols=273 Identities=28% Similarity=0.424 Sum_probs=195.9
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
+..+.++|++.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+.|+++....
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 455778999999999999999999999999999999999643 23445677899999999999885321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred cceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 134788999999999999999999999999999999999987765555555543322111
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
..... ............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 166 ~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 166 AADNS--------------EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231 (353)
T ss_dssp ----------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccc--------------CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 00000 00000001122478999999999875 5789999999999999999999999999998888
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhc-cch-hhhhhcccCchHHHHHHHHHccc
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL-RLP-NLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+..+....+.++...... .............. ..+ .........+++++.+||.+||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 291 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLR--------------------CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291 (353)
T ss_dssp HHHHHHHHCCCCSTTTTT--------------------TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHhCCCchhcccc--------------------ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcC
Confidence 888888777654211000 00000011111100 000 11112234567899999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.||++|||++|+|+||||+...
T Consensus 292 ~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 292 FDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp SSGGGSCCHHHHHTSGGGTTTC
T ss_pred cCcccCCCHHHHhcCccccccC
Confidence 9999999999999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=337.54 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=194.3
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh------------hhhHHHHHHHHHHHHHhhcCCCCCc
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------------KYREAAMIEIDVLQRLARHDIGGTR 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~~~~E~~il~~l~~~~~~~~~ 154 (405)
...+.++|++.+.||+|+||.||+|.+.. ++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34567899999999999999999999865 8899999985321 1236788999999999999985421
Q ss_pred --------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 155 --------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 155 --------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~---- 171 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN---- 171 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----
T ss_pred eeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC----
Confidence 12478999999999999999999999999999999999997655
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHH
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~ll 279 (405)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 172 -----------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 172 -----------------------DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp -----------------------CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred -----------------------CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 4677777776533222 233578999999999987 57899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHh-hHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc
Q 015532 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358 (405)
Q Consensus 280 tg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (405)
+|..||.+....+.+..+....+.++.......... ...+.... ....+. ..........
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~ 289 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS-LSNVPA------------------RAWTAVVPTA 289 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTC-CCCCCC------------------CCHHHHSTTS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhh-cccCCh------------------hhHHhhCCCC
Confidence 999999999999999999998888776543322111 11111111 011110 0111223455
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 359 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 359 ~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
++.+.+||.+||++||++|||+.|+|+||||++-.
T Consensus 290 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 290 DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 77899999999999999999999999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=358.08 Aligned_cols=236 Identities=31% Similarity=0.546 Sum_probs=192.3
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.+.++|++.++||+|+||+||+|++..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3467899999999999999999999999999999999643 23456788999999999999985421
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-------------------- 158 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-------------------- 158 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS--------------------
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC--------------------
Confidence 24578999999999999999999999999999999999996532
Q ss_pred cCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
....+||+|||++....... ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 159 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 233 (486)
T 3mwu_A 159 ----KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233 (486)
T ss_dssp ----TTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ----CCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 34468899999887544332 33579999999999986 599999999999999999999999999888777666
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.......+ ...+..+++++++||.+||+.||++
T Consensus 234 i~~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~ 267 (486)
T 3mwu_A 234 VETGKYAFD----------------------------------------------LPQWRTISDDAKDLIRKMLTFHPSL 267 (486)
T ss_dssp HHHTCCCSC----------------------------------------------SGGGGGSCHHHHHHHHHHTCSSTTT
T ss_pred HHhCCCCCC----------------------------------------------CcccCCCCHHHHHHHHHHcCCChhh
Confidence 544221111 0112345778999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~~ 395 (405)
|||+.|+|+||||++....
T Consensus 268 R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 268 RITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp SCCHHHHHHCHHHHHTCCC
T ss_pred CcCHHHHhcCHhhccCccc
Confidence 9999999999999875443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.30 Aligned_cols=231 Identities=28% Similarity=0.405 Sum_probs=182.3
Q ss_pred CCCeEE--EeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~--~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+.|.+ .+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+++++.|+++....
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 344555 678999999999999999999999999997543 3456788999999999999984321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||+..+
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------------------- 223 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR---------------------- 223 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET----------------------
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC----------------------
Confidence 1347889999999999999999999999999999999998532
Q ss_pred CCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
....+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 224 ---~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 300 (373)
T 2x4f_A 224 ---DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300 (373)
T ss_dssp ---TTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ---CCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23357888888876544322 2357999999999999888999999999999999999999999998877776665
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
......++. .....+++++.+||.+||+.||++|
T Consensus 301 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~L~~dp~~R 334 (373)
T 2x4f_A 301 LACRWDLED----------------------------------------------EEFQDISEEAKEFISKLLIKEKSWR 334 (373)
T ss_dssp HHTCCCSCS----------------------------------------------GGGTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HhccCCCCh----------------------------------------------hhhccCCHHHHHHHHHHcCCChhhC
Confidence 543222111 1123457789999999999999999
Q ss_pred CCHHHHHcCCCCCCC
Q 015532 378 LKAREALRHPFFTRD 392 (405)
Q Consensus 378 pta~elL~hp~f~~~ 392 (405)
||++|+|+||||++.
T Consensus 335 ps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 335 ISASEALKHPWLSDH 349 (373)
T ss_dssp CCHHHHHHSHHHHCH
T ss_pred CCHHHHhcCcCcCCC
Confidence 999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.20 Aligned_cols=225 Identities=25% Similarity=0.385 Sum_probs=176.4
Q ss_pred CCCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||.||+|++. .+++.||||+++... .....+.+|+.+|+.+.|+++....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 367999999999999999999985 688999999997532 2344567899999999999985421
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~---------------- 159 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---------------- 159 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC----------------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc----------------
Confidence 134788899999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 160 -----------~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 228 (327)
T 3a62_A 160 -----------VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228 (327)
T ss_dssp -----------EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH
Confidence 56666666543221 1223579999999999999899999999999999999999999999887766
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.+....+| ...+..+.+||.+||+.
T Consensus 229 ~~~~i~~~~~~~p--------------------------------------------------~~~~~~~~~li~~~L~~ 258 (327)
T 3a62_A 229 TIDKILKCKLNLP--------------------------------------------------PYLTQEARDLLKKLLKR 258 (327)
T ss_dssp HHHHHHHTCCCCC--------------------------------------------------TTSCHHHHHHHHHHSCS
T ss_pred HHHHHHhCCCCCC--------------------------------------------------CCCCHHHHHHHHHHHhc
Confidence 6655543221111 23467899999999999
Q ss_pred CCCCCC-----CHHHHHcCCCCCCC
Q 015532 373 DPAERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 373 dP~~Rp-----ta~elL~hp~f~~~ 392 (405)
||++|| +++|+++||||+.-
T Consensus 259 dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 259 NAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp CGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999 89999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=359.98 Aligned_cols=239 Identities=30% Similarity=0.494 Sum_probs=193.5
Q ss_pred eEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc----
Q 015532 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR---- 154 (405)
Q Consensus 83 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~---- 154 (405)
....+..+.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp --CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3334456778999999999999999999999999999999998643 23457788999999999999984321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------------- 163 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS------------- 163 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-------------
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-------------
Confidence 24578999999999999999999999999999999999995421
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
.+..+||+|||++....... ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+
T Consensus 164 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 164 -----------KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp -----------TTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------CCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 34467888888876544332 33579999999999987 69999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+.+..+.......+ ...+..+++.+.+||.+|
T Consensus 232 ~~~~~~~i~~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~ 265 (484)
T 3nyv_A 232 EYDILKKVEKGKYTFE----------------------------------------------LPQWKKVSESAKDLIRKM 265 (484)
T ss_dssp HHHHHHHHHHCCCCCC----------------------------------------------SGGGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC----------------------------------------------CcccccCCHHHHHHHHHH
Confidence 8777766644221111 011234577899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
|++||++|||+.|+|+||||+..
T Consensus 266 L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 266 LTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp TCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CCCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=329.10 Aligned_cols=231 Identities=28% Similarity=0.404 Sum_probs=182.3
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+.++|++.++||+|+||.||+|++..+++.||+|++.... ...+.+.+|+++++.+.|+++....
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 45678999999999999999999999999999999996543 2346788999999999999984321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~----------------- 161 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS----------------- 161 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-----------------
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-----------------
Confidence 14578899999999999999999999999999999999995421
Q ss_pred CcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
....++|+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.
T Consensus 162 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~ 233 (285)
T 3is5_A 162 -------PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233 (285)
T ss_dssp -------TTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------CCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3446888999988654332 23457999999999986 4789999999999999999999999988776554
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+.......+ ......++.+.+||.+||+.|
T Consensus 234 ~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~L~~d 266 (285)
T 3is5_A 234 QQKATYKEPNYA-----------------------------------------------VECRPLTPQAVDLLKQMLTKD 266 (285)
T ss_dssp HHHHHHCCCCCC-----------------------------------------------C--CCCCHHHHHHHHHHTCSC
T ss_pred HhhhccCCcccc-----------------------------------------------cccCcCCHHHHHHHHHHccCC
Confidence 433322111000 001224678999999999999
Q ss_pred CCCCCCHHHHHcCCCCCC
Q 015532 374 PAERLKAREALRHPFFTR 391 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~ 391 (405)
|++|||+.|+|+||||++
T Consensus 267 P~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 267 PERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp TTTSCCHHHHHTSGGGGC
T ss_pred hhhCcCHHHHhcCHHhhc
Confidence 999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=341.81 Aligned_cols=232 Identities=25% Similarity=0.414 Sum_probs=181.9
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc-------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~------------- 154 (405)
.+.++|++.+.||+|+||+||+|+++.+++.||||++++... ...+|++++.++ .|+++....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456789999999999999999999999999999999975432 235688999988 688874321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||+....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~---------------------- 153 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES---------------------- 153 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS----------------------
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC----------------------
Confidence 23578999999999999999999999999999999999985421
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH---ENLEHL 294 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~---~~~~~~ 294 (405)
.....+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+. ...+.+
T Consensus 154 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 232 (342)
T 2qr7_A 154 -GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232 (342)
T ss_dssp -CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH
T ss_pred -CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH
Confidence 12235788888888654332 23457899999999999888999999999999999999999999763 223333
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+......+ ....+..+++++.+||.+||+.||
T Consensus 233 ~~i~~~~~~~----------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP 266 (342)
T 2qr7_A 233 ARIGSGKFSL----------------------------------------------SGGYWNSVSDTAKDLVSKMLHVDP 266 (342)
T ss_dssp HHHHHCCCCC----------------------------------------------CSTTTTTSCHHHHHHHHHHTCSST
T ss_pred HHHccCCccc----------------------------------------------CccccccCCHHHHHHHHHHCCCCh
Confidence 3332211000 011123467899999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRD 392 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~ 392 (405)
++|||+.|+|+||||.+.
T Consensus 267 ~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 267 HQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCCHHHHTTSHHHHTG
T ss_pred hHCcCHHHHhcCCeecCc
Confidence 999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.58 Aligned_cols=225 Identities=23% Similarity=0.423 Sum_probs=180.2
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+|+.+.|++++...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 378999999999999999999999999999999996532 2346678899999999999985421
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--------------------- 152 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--------------------- 152 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC---------------------
Confidence 23588999999999999999999999999999999999997665
Q ss_pred CCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENL--- 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--- 291 (405)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||......
T Consensus 153 ------~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~ 226 (384)
T 4fr4_A 153 ------HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226 (384)
T ss_dssp ------CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH
T ss_pred ------CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH
Confidence 456666666654332 2234689999999999974 45899999999999999999999999754332
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+..... ..+..++..+.+||.+||+
T Consensus 227 ~~~~~~~~~~~--------------------------------------------------~~p~~~s~~~~~li~~lL~ 256 (384)
T 4fr4_A 227 EIVHTFETTVV--------------------------------------------------TYPSAWSQEMVSLLKKLLE 256 (384)
T ss_dssp HHHHHHHHCCC--------------------------------------------------CCCTTSCHHHHHHHHHHSC
T ss_pred HHHHHHhhccc--------------------------------------------------CCCCcCCHHHHHHHHHHhc
Confidence 22222211111 1123456789999999999
Q ss_pred cCCCCCCC-HHHHHcCCCCCCC
Q 015532 372 YDPAERLK-AREALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~Rpt-a~elL~hp~f~~~ 392 (405)
.||++||+ ++++++||||+.-
T Consensus 257 ~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 257 PNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp SSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCHhHhcccHHHHHcChhhhcC
Confidence 99999998 9999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.53 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=186.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh------hhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ....+.+|+.+++.+.|+++....
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 4789999999999999999999999999999999864221 224577899999999999884321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 89 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~----------------- 151 (346)
T 1ua2_A 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL----------------- 151 (346)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE-----------------
T ss_pred EEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCE-----------------
Confidence 1347888999999999999999999999999999999999876655
Q ss_pred ccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 152 ----------kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~ 221 (346)
T 1ua2_A 152 ----------KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 221 (346)
T ss_dssp ----------EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ----------EEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 5555554443221 12235789999999999765 588999999999999999999999999999888
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccch-hhhhhcccCchHHHHHHHHHcccc
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
+..+....+.++... |+......... .....+ ..........+.++.+||.+||+.
T Consensus 222 ~~~i~~~~~~~~~~~-------------------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 278 (346)
T 1ua2_A 222 LTRIFETLGTPTEEQ-------------------WPDMCSLPDYV----TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 278 (346)
T ss_dssp HHHHHHHHCCCCTTT-------------------SSSTTSSTTCC----CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHcCCCChhh-------------------hhhhccCcccc----cccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence 888887776654322 11110000000 000000 001112345678999999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~ 393 (405)
||++|||++|+|+||||++..
T Consensus 279 dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 279 NPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTTSCCHHHHHTSGGGTSSS
T ss_pred ChhhCCCHHHHhcChhhhcCC
Confidence 999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.39 Aligned_cols=232 Identities=25% Similarity=0.386 Sum_probs=184.8
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..++|++.++||+|+||+||+|+++.+++.||||++++... ....+..|+.++..+.|+++....
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 34789999999999999999999999999999999975322 223477899999999999874311
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~------------------ 213 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH------------------ 213 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC------------------
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC------------------
Confidence 246899999999999999999999999999999999999976654
Q ss_pred ccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
+||+|||++....... ...+||+.|+|||++. +..|+.++|||||||++|||++|..||.+.
T Consensus 214 ---------vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 214 ---------IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp ---------EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 5666666654332221 2358999999999997 456899999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
+..+....+..... ...+|. ....+++++++||.+
T Consensus 285 ~~~~~~~~i~~~~~----------------------~~~~p~-----------------------~~~~~s~~~~dLi~~ 319 (437)
T 4aw2_A 285 SLVETYGKIMNHKE----------------------RFQFPT-----------------------QVTDVSENAKDLIRR 319 (437)
T ss_dssp SHHHHHHHHHTHHH----------------------HCCCCS-----------------------SCCCSCHHHHHHHHT
T ss_pred ChhHHHHhhhhccc----------------------cccCCc-----------------------ccccCCHHHHHHHHH
Confidence 87776665543110 001110 113457899999999
Q ss_pred ccccCCCC--CCCHHHHHcCCCCCCCC
Q 015532 369 LLRYDPAE--RLKAREALRHPFFTRDV 393 (405)
Q Consensus 369 ~L~~dP~~--Rpta~elL~hp~f~~~~ 393 (405)
||..+|++ |++++|+++||||++-.
T Consensus 320 lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 320 LICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp TSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred HhcccccccCCCCHHHHhCCCccCCCC
Confidence 99999988 99999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.06 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=196.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999999999999999985432 3345677899999999999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~---------------------- 161 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG---------------------- 161 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC----------------------
Confidence 24578899999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.++|+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..
T Consensus 162 -----~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 236 (331)
T 4aaa_A 162 -----VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236 (331)
T ss_dssp -----CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -----cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 4666777766543321 2235789999999999876 689999999999999999999999999999999988
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+..++........... + . ....+.... ..........+++.+.+||.+||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~--~-~--~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 297 (331)
T 4aaa_A 237 IMMCLGNLIPRHQELFNKNPV--F-A--GVRLPEIKE--------------REPLERRYPKLSEVVIDLAKKCLHIDPDK 297 (331)
T ss_dssp HHHHHCSCCHHHHHHHHHCGG--G-T--TCCCCCCSS--------------CCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCChhhhhHhhhccc--c-c--cccCccccc--------------cchhhhcccchhHHHHHHHHHHhccCccc
Confidence 888888877654332211100 0 0 011111000 01111222356789999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDV 393 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~ 393 (405)
|||++|+|+||||+...
T Consensus 298 Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 298 RPFCAELLHHDFFQMDG 314 (331)
T ss_dssp SCCGGGGGGSHHHHGGG
T ss_pred CCCHHHHhcCchhccCC
Confidence 99999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.22 Aligned_cols=280 Identities=19% Similarity=0.217 Sum_probs=183.8
Q ss_pred CCeEEEeeeecc--cceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G--~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.++||+| +||+||+|++..+++.||||+++... ...+.+.+|+.+++.+.|++++...
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 579999999999 99999999999999999999996532 3446677899999999999985421
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~-------- 176 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL-------- 176 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE--------
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce--------
Confidence 1457899999999999999999999999999999999999988877777777542
Q ss_pred ccCCCCCCCceeccCCCCccc-cCCccceecCCCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+.+.|..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 177 ----------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 177 ----------SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp ----------ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred ----------eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 22222221111 111223478999999999987 57999999999999999999999999886655544
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHH-hccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK-LLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
..+.. +..+....... .....+........... ........... ..............+++.+.+||.+||++|
T Consensus 247 ~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 247 LEKLN--GTVPCLLDTST-IPAEELTMSPSRSVANS--GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp HHC-------------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHHhc--CCCCccccccc-ccccccccccccccccc--ccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 33221 11111000000 00000000000000000 00000000000 000001111233456789999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~ 394 (405)
|++|||++|+|+||||++...
T Consensus 322 P~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 322 PDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp TTTSCCHHHHTTSGGGGGC--
T ss_pred cccCCCHHHHhcCHHHHHHhh
Confidence 999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=331.72 Aligned_cols=259 Identities=25% Similarity=0.519 Sum_probs=189.0
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-hcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~-~~~~~~~~--------------- 154 (405)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++.+. |+++....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36799999999999999999999999999999999743 3466889999999998 77763211
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~------------------------- 167 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH------------------------- 167 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-------------------------
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC-------------------------
Confidence 23578899999999999999999999999999999999997543
Q ss_pred CCCceeccCCCCccccCC--ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ-THENLEHLAMMER 299 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~ 299 (405)
..++|+|||++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+.+
T Consensus 168 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 168 -RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp -TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred -CEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 24677777777543322 233578999999999987 568999999999999999999999984 4556666776666
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhcc---chh-hhhhcccCchHHHHHHHHHccccCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR---LPN-LIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.++..+.. .+.... .... ............ +.. ........+++++.+||.+||++||+
T Consensus 247 ~~~~~~~~----------~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 309 (330)
T 3nsz_A 247 VLGTEDLY----------DYIDKY-NIEL------DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309 (330)
T ss_dssp HHCHHHHH----------HHHHHT-TCCC------CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred hcCCchhh----------hHHHHh-cccc------ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence 65532110 000000 0000 000000000000 000 00111223578999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~ 394 (405)
+|||++|+|+||||++-.+
T Consensus 310 ~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 310 SRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp GSCCHHHHHTSGGGTTCC-
T ss_pred cCCCHHHHhcCccHhhhcc
Confidence 9999999999999997543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=351.89 Aligned_cols=225 Identities=25% Similarity=0.405 Sum_probs=177.2
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999999999999999997532 2334567899999999999884321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-------------------- 286 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-------------------- 286 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--------------------
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--------------------
Confidence 2357899999999999999999998 9999999999999997655
Q ss_pred cCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+...
T Consensus 287 -------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 359 (446)
T 4ejn_A 287 -------HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359 (446)
T ss_dssp -------CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -------CEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 456666666654221 1234689999999999999999999999999999999999999999887766665
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+......+ +..+++++.+||.+||+.||+
T Consensus 360 ~i~~~~~~~--------------------------------------------------p~~~~~~~~~li~~~L~~dP~ 389 (446)
T 4ejn_A 360 LILMEEIRF--------------------------------------------------PRTLGPEAKSLLSGLLKKDPK 389 (446)
T ss_dssp HHHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHTCSSTT
T ss_pred HHHhCCCCC--------------------------------------------------CccCCHHHHHHHHHHcccCHH
Confidence 543321111 123467899999999999999
Q ss_pred CCC-----CHHHHHcCCCCCCC
Q 015532 376 ERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rp-----ta~elL~hp~f~~~ 392 (405)
+|| |++|+++||||++-
T Consensus 390 ~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 390 QRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhCCCCCCCHHHHHhCccccCC
Confidence 999 99999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=329.25 Aligned_cols=229 Identities=28% Similarity=0.445 Sum_probs=184.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367999999999999999999999999999999986432 2345678899999999999884321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~-------------------- 147 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-------------------- 147 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--------------------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--------------------
Confidence 135788999999999999999999999999999999999976654
Q ss_pred CCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.
T Consensus 148 -------~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 148 -------LKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp -------EEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -------EEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 566666655433222 233578999999999999899999999999999999999999999887766665554
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
......| ...++.+.+||.+||+.||++||
T Consensus 221 ~~~~~~~--------------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 221 RVEFTFP--------------------------------------------------DFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp HTCCCCC--------------------------------------------------TTSCHHHHHHHHHHCCSSGGGSC
T ss_pred hCCCCCC--------------------------------------------------CcCCHHHHHHHHHHhccChhhCC
Confidence 4322221 23466889999999999999999
Q ss_pred CHHHHHcCCCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVRRP 396 (405)
Q Consensus 379 ta~elL~hp~f~~~~~~~ 396 (405)
|++|+|+||||+.....+
T Consensus 251 s~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 251 MLREVLEHPWITANSSKP 268 (279)
T ss_dssp CHHHHHHCHHHHHHCSSC
T ss_pred CHHHHhhCccccCCccCc
Confidence 999999999998765544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=355.72 Aligned_cols=234 Identities=30% Similarity=0.489 Sum_probs=188.4
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
...+.++|+++++||+|+||+||+|+++.+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3446678999999999999999999999999999999996532 3356788999999999999985421
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------------------ 173 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE------------------ 173 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS------------------
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC------------------
Confidence 13578899999999999999999999999999999999997533
Q ss_pred cccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
....+||+|||++....... ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+
T Consensus 174 ------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 246 (494)
T 3lij_A 174 ------KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246 (494)
T ss_dssp ------TTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------CCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 23458899999886554332 34579999999999864 6999999999999999999999999998887776
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.......+. ..+..+++.+.+||.+||++||
T Consensus 247 ~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dp 280 (494)
T 3lij_A 247 RKVEKGKYTFDS----------------------------------------------PEWKNVSEGAKDLIKQMLQFDS 280 (494)
T ss_dssp HHHHHTCCCCCS----------------------------------------------GGGTTSCHHHHHHHHHHTCSST
T ss_pred HHHHhCCCCCCc----------------------------------------------hhcccCCHHHHHHHHHHCCCCh
Confidence 666543222111 1123457789999999999999
Q ss_pred CCCCCHHHHHcCCCCCC
Q 015532 375 AERLKAREALRHPFFTR 391 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~ 391 (405)
++|||+.|+|+||||++
T Consensus 281 ~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 281 QRRISAQQALEHPWIKE 297 (494)
T ss_dssp TTSCCHHHHHTCHHHHH
T ss_pred hhCccHHHHhcCccccc
Confidence 99999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.63 Aligned_cols=229 Identities=26% Similarity=0.344 Sum_probs=185.9
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
....++|.+.+.||+|+||.||+|++..+|+.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 334578999999999999999999999999999999996532 2345678999999999999984321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~------------------ 153 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM------------------ 153 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC------------------
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....
T Consensus 154 ---------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 224 (476)
T 2y94_A 154 ---------NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224 (476)
T ss_dssp ---------CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH
T ss_pred ---------CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 4566666666543322 234579999999999998775 6899999999999999999999988776655
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+....... +...++++.+||.+||+.|
T Consensus 225 ~~~i~~~~~~~--------------------------------------------------p~~~s~~~~~Li~~~L~~d 254 (476)
T 2y94_A 225 FKKICDGIFYT--------------------------------------------------PQYLNPSVISLLKHMLQVD 254 (476)
T ss_dssp HHHHHTTCCCC--------------------------------------------------CTTCCHHHHHHHHHHTCSS
T ss_pred HHHHhcCCcCC--------------------------------------------------CccCCHHHHHHHHHHcCCC
Confidence 54443211111 1234678999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|++|||++|+++||||++..
T Consensus 255 P~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 255 PMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp TTTSCCHHHHHTCHHHHTTC
T ss_pred chhCcCHHHHHhCHHhhhcC
Confidence 99999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.32 Aligned_cols=235 Identities=25% Similarity=0.396 Sum_probs=190.4
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+++++.+.|+++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3567899999999999999999999999999999998653 23456788999999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+..+
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~----------------------- 142 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD----------------------- 142 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-----------------------
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC-----------------------
Confidence 2347889999999999999999999999999999999999332
Q ss_pred CCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
+.+..++|+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.
T Consensus 143 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 220 (277)
T 3f3z_A 143 -SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR 220 (277)
T ss_dssp -STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -CCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 13446788888877654332 233579999999999876 48999999999999999999999999888777666665
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
......|... ...+++.+.+||.+||+.||++||
T Consensus 221 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~li~~~l~~dp~~R~ 254 (277)
T 3f3z_A 221 EGTFTFPEKD----------------------------------------------WLNVSPQAESLIRRLLTKSPKQRI 254 (277)
T ss_dssp HCCCCCCHHH----------------------------------------------HTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred hCCCCCCchh----------------------------------------------hhcCCHHHHHHHHHHccCChhhCc
Confidence 5433333211 123467899999999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ta~elL~hp~f~~~~~ 394 (405)
|+.|+|+||||++...
T Consensus 255 s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 255 TSLQALEHEWFEKQLS 270 (277)
T ss_dssp CHHHHTTSHHHHHHHC
T ss_pred CHHHHhcCHHHhcccc
Confidence 9999999999987433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.44 Aligned_cols=232 Identities=28% Similarity=0.475 Sum_probs=164.0
Q ss_pred CCCeEEE---eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-hcCCCCCc------------
Q 015532 91 TPRYRIL---SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~---~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~-~~~~~~~~------------ 154 (405)
.++|++. +.||+|+||+||+|++..+++.||||++... ......+|+.+++.+. |+++....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 3567775 7899999999999999999999999999653 3456778999999998 88874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--------------------- 143 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN--------------------- 143 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----------------------
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC---------------------
Confidence 23578999999999999999999999999999999999997643
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL----- 291 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----- 291 (405)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 144 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 220 (325)
T 3kn6_A 144 ---DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220 (325)
T ss_dssp -----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC
T ss_pred ---CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc
Confidence 2335788888888654332 23357899999999999999999999999999999999999999764431
Q ss_pred --HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 292 --EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 292 --~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
+.+..+....... ....+..+++++.+||.+|
T Consensus 221 ~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~~s~~~~~li~~~ 254 (325)
T 3kn6_A 221 AVEIMKKIKKGDFSF----------------------------------------------EGEAWKNVSQEAKDLIQGL 254 (325)
T ss_dssp HHHHHHHHTTTCCCC----------------------------------------------CSHHHHTSCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCC----------------------------------------------CcccccCCCHHHHHHHHHH
Confidence 1111111100000 0111234577899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
|+.||++|||++|+++||||++...
T Consensus 255 L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 255 LTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCCChhHCCCHHHHhcChhhccCcc
Confidence 9999999999999999999998644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=331.15 Aligned_cols=237 Identities=25% Similarity=0.364 Sum_probs=176.4
Q ss_pred CccCCCeEEE-eeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHH-hhcCCCCCc----------
Q 015532 88 ENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRL-ARHDIGGTR---------- 154 (405)
Q Consensus 88 ~~~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l-~~~~~~~~~---------- 154 (405)
..+.++|++. +.||+|+||+||+|++..+++.||||+++... ...+.+.+|++++.++ .|+++....
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3467789996 78999999999999999999999999996543 3456788999999995 688874321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~------------------ 149 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ------------------ 149 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS------------------
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC------------------
Confidence 135788999999999999999999999999999999999976542
Q ss_pred ccCCCCCCCceeccCCCCccccC----------CccceecCCCcchhHHHhC-----CCCCCchhHHHHHHHHHHHHhCC
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~lltg~ 282 (405)
...+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 150 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 150 ------VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp ------SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred ------cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence 22367777777654321 1122469999999999975 45889999999999999999999
Q ss_pred CCCCCCChHH---------------HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc
Q 015532 283 ALFQTHENLE---------------HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347 (405)
Q Consensus 283 ~pf~~~~~~~---------------~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (405)
.||.+....+ ....+.......|
T Consensus 224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------------------------------------------ 261 (316)
T 2ac3_A 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP------------------------------------------ 261 (316)
T ss_dssp CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC------------------------------------------
T ss_pred CCCcccccccccccccccchhHHHHHHHHHhccCcccC------------------------------------------
Confidence 9997654211 1111111000000
Q ss_pred hhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 348 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
......++..+.+||.+||+.||++|||++|+|+||||++...
T Consensus 262 ----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 262 ----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp ----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred ----chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 1111345778999999999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=329.52 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=192.3
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
|..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4567789999999999999999999999999999999986433 3456788999999999999885421
Q ss_pred ----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcc
Q 015532 155 ----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 155 ----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~--------- 156 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE--------- 156 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---------
T ss_pred cccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---------
Confidence 1346888999999999999999999999999999999999742
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccC------CccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHH
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~ll 279 (405)
+..+||+|||++..... ......+|..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 157 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 157 -----------------DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp -----------------TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred -----------------CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 22456667776654322 1123467999999999876 57899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 280 tg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
+|..||.+....+.+..+....+................+.... . .............++
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~--~~~~~~~~~~~~~~~ 279 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRND------------------M--TEPHKPLTQLLPGIS 279 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHH------------------T--TSCCCCHHHHSTTCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccccccc------------------c--cCCCCChhHhcchhh
Confidence 99999999988888877777665555433222211111111000 0 000011112234567
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.++.+||.+||+.||++|||++|+|+||||+...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 280 REAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 8999999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=330.72 Aligned_cols=228 Identities=25% Similarity=0.404 Sum_probs=183.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
.|...++||+|+||.||+|++..+|+.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 4888899999999999999999999999999996533 3456688999999999999985321
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 155 ---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 155 ---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 126 ~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--------------------------- 178 (321)
T 2c30_A 126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--------------------------- 178 (321)
T ss_dssp SCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---------------------------
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---------------------------
Confidence 13578999999999999999999999999999999999997655
Q ss_pred CceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 226 AIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 258 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP 258 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence 4566666665443322 2335799999999999998999999999999999999999999988776665544432110
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
+. .......++.+.+||.+||+.||++|||++|
T Consensus 259 ~~-----------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 259 PK-----------------------------------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp CC-----------------------------------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CC-----------------------------------------------cCccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 00 0011234678999999999999999999999
Q ss_pred HHcCCCCCCCCC
Q 015532 383 ALRHPFFTRDVR 394 (405)
Q Consensus 383 lL~hp~f~~~~~ 394 (405)
+|+||||.+...
T Consensus 292 ll~hp~~~~~~~ 303 (321)
T 2c30_A 292 LLDHPFLLQTGL 303 (321)
T ss_dssp HHTSGGGGGCCC
T ss_pred HhcChhhccCCC
Confidence 999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.99 Aligned_cols=234 Identities=30% Similarity=0.460 Sum_probs=178.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
+.++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|+++.|+++....
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4578999999999999999999999999999999996532 1122467899999999999985422
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~---------------- 276 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE---------------- 276 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS----------------
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC----------------
Confidence 24578999999999999999999999999999999999996543
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
....+||+|||++....... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||....
T Consensus 277 --------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 277 --------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp --------SSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred --------CcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 23458899999887654332 34689999999999864 468889999999999999999999997654
Q ss_pred hHHHH-HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 290 NLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 290 ~~~~~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
....+ ..+....... ....+..+++.+.+||.+
T Consensus 349 ~~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~ 382 (419)
T 3i6u_A 349 TQVSLKDQITSGKYNF----------------------------------------------IPEVWAEVSEKALDLVKK 382 (419)
T ss_dssp SSCCHHHHHHTTCCCC----------------------------------------------CHHHHTTSCHHHHHHHHH
T ss_pred chHHHHHHHhcCCCCC----------------------------------------------CchhhcccCHHHHHHHHH
Confidence 32211 1111110000 011123457789999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
||++||++|||++|+|+||||++..
T Consensus 383 ~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 383 LLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred HccCChhHCcCHHHHhCCcccCChh
Confidence 9999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=341.49 Aligned_cols=228 Identities=26% Similarity=0.367 Sum_probs=181.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.+.||+|+||+||+|+++.+++.||||++++.. ...+.+..|+.++..+.|+++....
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 478999999999999999999999999999999997532 2234577899999999998874321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~------------------- 200 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH------------------- 200 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-------------------
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC-------------------
Confidence 136889999999999999999999999999999999999977664
Q ss_pred cCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHh-------CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL-------GLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
+||+|||++....... ...+||+.|+|||++. +..|+.++|||||||++|||++|..||.+
T Consensus 201 --------vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 201 --------IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp --------EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --------EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 5556666554432221 2358999999999997 34689999999999999999999999998
Q ss_pred CChHHHHHHHHHHh--CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 288 HENLEHLAMMERVL--GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 288 ~~~~~~~~~i~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
.+..+....+.... ...| .....+++++++|
T Consensus 273 ~~~~~~~~~i~~~~~~~~~p-----------------------------------------------~~~~~~s~~~~dl 305 (412)
T 2vd5_A 273 DSTAETYGKIVHYKEHLSLP-----------------------------------------------LVDEGVPEEARDF 305 (412)
T ss_dssp SSHHHHHHHHHTHHHHCCCC---------------------------------------------------CCCHHHHHH
T ss_pred CCHHHHHHHHHhcccCcCCC-----------------------------------------------ccccCCCHHHHHH
Confidence 88777665554311 0111 0012457799999
Q ss_pred HHHccccCCCCC---CCHHHHHcCCCCCCCC
Q 015532 366 LQGLLRYDPAER---LKAREALRHPFFTRDV 393 (405)
Q Consensus 366 l~~~L~~dP~~R---pta~elL~hp~f~~~~ 393 (405)
|.+||. +|++| ++++|+++||||+.-.
T Consensus 306 i~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 306 IQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp HHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999 99998 5999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.65 Aligned_cols=224 Identities=28% Similarity=0.393 Sum_probs=174.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh----hhHHHHHHHHH-HHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDV-LQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~i-l~~l~~~~~~~~~------------ 154 (405)
++|++++.||+|+||.||+|+++.+++.||||++++... .......|..+ ++.+.|+++....
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 569999999999999999999999999999999975432 23345566666 4668888874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-------------------- 177 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-------------------- 177 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--------------------
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--------------------
Confidence 135788999999999999999999999999999999999987665
Q ss_pred CCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....
T Consensus 178 -------ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 250 (373)
T 2r5t_A 178 -------IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250 (373)
T ss_dssp -------EEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH
T ss_pred -------EEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 4555555554321 122346899999999999999999999999999999999999999998777666555
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....- .....++..+.+||.+||+.||++
T Consensus 251 i~~~~~--------------------------------------------------~~~~~~~~~~~~li~~lL~~dp~~ 280 (373)
T 2r5t_A 251 ILNKPL--------------------------------------------------QLKPNITNSARHLLEGLLQKDRTK 280 (373)
T ss_dssp HHHSCC--------------------------------------------------CCCSSSCHHHHHHHHHHTCSSGGG
T ss_pred HHhccc--------------------------------------------------CCCCCCCHHHHHHHHHHcccCHHh
Confidence 433111 111345678999999999999999
Q ss_pred CCCH----HHHHcCCCCCCC
Q 015532 377 RLKA----REALRHPFFTRD 392 (405)
Q Consensus 377 Rpta----~elL~hp~f~~~ 392 (405)
|+++ +++++||||+.-
T Consensus 281 R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 281 RLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp STTTTTTHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHhCCccccCC
Confidence 9986 699999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=331.96 Aligned_cols=230 Identities=29% Similarity=0.399 Sum_probs=186.7
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
....++|.+.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.+.|+++....
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 44567899999999999999999999999999999998653 23456788899999999999984421
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~----------------- 179 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE----------------- 179 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-----------------
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC-----------------
Confidence 135788999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+.
T Consensus 180 ----------~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 180 ----------VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp ----------EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ----------EEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 56666666644321 12335789999999999998999999999999999999999999988776555
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+...... ....+++.+.+||.+||+.|
T Consensus 250 ~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 250 YLRIKKNEYS--------------------------------------------------IPKHINPVAASLIQKMLQTD 279 (335)
T ss_dssp HHHHHHTCCC--------------------------------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHhcCCCC--------------------------------------------------CCccCCHHHHHHHHHHccCC
Confidence 4443321111 11234668899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~ 394 (405)
|++|||++|+|+||||+....
T Consensus 280 p~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 280 PTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp GGGSCCGGGGGGSHHHHTSCC
T ss_pred hhHCcCHHHHhcCccccCCCc
Confidence 999999999999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=334.11 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=184.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 446799999999999999999999999999999998642 22345678999999999999985421
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~------------------- 192 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL------------------- 192 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE-------------------
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-------------------
Confidence 235788999999999999999999999999999999999987654
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+||+|||++...... ....||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 193 --------~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 263 (348)
T 1u5q_A 193 --------VKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 263 (348)
T ss_dssp --------EEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred --------EEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 566666666544322 2357999999999996 4568999999999999999999999998877666554
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.....+. .....+++.+.+||.+||+.||+
T Consensus 264 ~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~dP~ 295 (348)
T 1u5q_A 264 HIAQNESPA------------------------------------------------LQSGHWSEYFRNFVDSCLQKIPQ 295 (348)
T ss_dssp HHHHSCCCC------------------------------------------------CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHhcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcccChh
Confidence 443211000 00123466899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~ 394 (405)
+|||++++|+||||.....
T Consensus 296 ~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 296 DRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp GSCCHHHHTTCHHHHSCCC
T ss_pred hCcCHHHHhhChhhhccCC
Confidence 9999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=361.27 Aligned_cols=225 Identities=24% Similarity=0.351 Sum_probs=183.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++++.||+|+||+||+|+++.+++.||||++++. ....+....|..+|..+.+++++..+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999753 23446677899999988554432111
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~------------------- 480 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH------------------- 480 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC-------------------
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc-------------------
Confidence 145889999999999999999999999999999999999977664
Q ss_pred cCCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
+||+|||+++... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+.
T Consensus 481 --------ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 481 --------IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp --------EEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --------EEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 5666666654321 12234689999999999999999999999999999999999999999988777666
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.|......+ +..+++++.+||.+||+.||+
T Consensus 553 ~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~lL~~dP~ 582 (674)
T 3pfq_A 553 SIMEHNVAY--------------------------------------------------PKSMSKEAVAICKGLMTKHPG 582 (674)
T ss_dssp HHHSSCCCC--------------------------------------------------CTTSCHHHHHHHHHHSCSSST
T ss_pred HHHhCCCCC--------------------------------------------------CccCCHHHHHHHHHHccCCHH
Confidence 554321111 124577899999999999999
Q ss_pred CCCCH-----HHHHcCCCCCCC
Q 015532 376 ERLKA-----REALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpta-----~elL~hp~f~~~ 392 (405)
+|+++ +||++||||+.-
T Consensus 583 ~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 583 KRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp TCTTCSTTHHHHHHSSGGGSSC
T ss_pred HCCCCCCCcHHHHhcCccccCC
Confidence 99997 999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=330.77 Aligned_cols=238 Identities=26% Similarity=0.330 Sum_probs=170.4
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCcc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRY------------ 155 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~~------------ 155 (405)
+.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.+|+++.|+++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 446799999999999999999999999999999999642 334577889999999999999864210
Q ss_pred ---------------------------------------------------------------------------ccCCH
Q 015532 156 ---------------------------------------------------------------------------RSFPI 160 (405)
Q Consensus 156 ---------------------------------------------------------------------------~~l~~ 160 (405)
...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 11244
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC
Q 015532 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 240 (405)
Q Consensus 161 ~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~ 240 (405)
..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............ ... .....
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~--------~~~----~~~~~ 231 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV--------LTP----MPAYA 231 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc--------ccc----ccccc
Confidence 468899999999999999999999999999999987776555555544332211100000 000 00001
Q ss_pred CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCChHHHHHhhHhhHHh
Q 015532 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV-LGPLPHHMVIRADRRAEKY 319 (405)
Q Consensus 241 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~-~g~~p~~~~~~~~~~~~~~ 319 (405)
......||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ....+... .+..|...
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~----------- 295 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLF----------- 295 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHH-----------
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCccc-----------
Confidence 11234799999999999999999999999999999999998766421 11111111 11111110
Q ss_pred hhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 320 FRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
...++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 296 ------------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 ------------------------------------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ------------------------------------HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ------------------------------------ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 112457789999999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=334.53 Aligned_cols=234 Identities=26% Similarity=0.401 Sum_probs=184.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch------hhhhHHHHHHHHHHHHHhhcCCCCCcc-------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRY------- 155 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~il~~l~~~~~~~~~~------- 155 (405)
.+.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++.....
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4567899999999999999999999999999999998643 234467889999999999999843210
Q ss_pred ------------------------------------------------------------ccCCHHHHHHHHHHHHHHHH
Q 015532 156 ------------------------------------------------------------RSFPIDLVRELGRQLLESVA 175 (405)
Q Consensus 156 ------------------------------------------------------------~~l~~~~~~~~~~qi~~aL~ 175 (405)
..+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 01246778899999999999
Q ss_pred HHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC-------CccceecC
Q 015532 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVST 248 (405)
Q Consensus 176 ~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt 248 (405)
|||++||+||||||+|||++.++ ...+||+|||++..... ......||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 237 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSS-------------------------SCCEEECCCTTCEEGGGTTCC--------CCC
T ss_pred HHHHCCccccCCChhhEEEecCC-------------------------CceEEEeeccccccccccCccccccccccCCC
Confidence 99999999999999999997543 23578888887764322 12335799
Q ss_pred CCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcc
Q 015532 249 RHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 326 (405)
Q Consensus 249 ~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 326 (405)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......+.
T Consensus 238 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------- 297 (345)
T 3hko_A 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------- 297 (345)
T ss_dssp GGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS--------------------
T ss_pred ccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC--------------------
Confidence 99999999976 57899999999999999999999999988877666554432111110
Q ss_pred cCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 327 DWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.....+++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 298 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 298 --------------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp --------------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred --------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 11123467899999999999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=330.47 Aligned_cols=230 Identities=31% Similarity=0.476 Sum_probs=182.4
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHH-hhcCCCCCc----
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRL-ARHDIGGTR---- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l-~~~~~~~~~---- 154 (405)
.+.++|++.+.||+|+||.||+|++..+|+.||||+++... ...+.+.+|+.+++.+ .|+++....
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 45578999999999999999999999899999999986432 2245677899999999 688874321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~------------- 237 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM------------- 237 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------------
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------------
Confidence 13578899999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCC------CCCCchhHHHHHHHHHHHHhCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~~lltg~~ 283 (405)
.++|+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 238 --------------~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 238 --------------QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp --------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 4566666665443322 2335799999999999743 58899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||........+..+.......+. ..+...+..+.
T Consensus 304 pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~~~~ 337 (365)
T 2y7j_A 304 PFWHRRQILMLRMIMEGQYQFSS----------------------------------------------PEWDDRSSTVK 337 (365)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCH----------------------------------------------HHHSSSCHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCCC----------------------------------------------cccccCCHHHH
Confidence 99887766655544332111111 11134567899
Q ss_pred HHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 364 DLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
+||.+||+.||++|||++|+|+||||++
T Consensus 338 ~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 338 DLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=325.38 Aligned_cols=235 Identities=26% Similarity=0.402 Sum_probs=188.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-------hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
+.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3467999999999999999999999999999999986432 1356788999999999999884321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------------- 145 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN----------------- 145 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-----------------
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC-----------------
Confidence 13578999999999999999999999999999999999997654
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.
T Consensus 146 ------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 219 (283)
T 3bhy_A 146 ------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219 (283)
T ss_dssp ------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH
Confidence 123367888888886543322 235789999999999988999999999999999999999999998877665
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+.......+. ......+..+.+||.+||..|
T Consensus 220 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~d 253 (283)
T 3bhy_A 220 LTNISAVNYDFDE----------------------------------------------EYFSNTSELAKDFIRRLLVKD 253 (283)
T ss_dssp HHHHHTTCCCCCH----------------------------------------------HHHTTCCHHHHHHHHTTSCSS
T ss_pred HHHhHhcccCCcc----------------------------------------------hhcccCCHHHHHHHHHHccCC
Confidence 5544332222111 111344678999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~ 393 (405)
|++|||+.|+|+||||+.-.
T Consensus 254 p~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 254 PKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp GGGSCCHHHHHHCHHHHHHH
T ss_pred HhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=350.50 Aligned_cols=225 Identities=28% Similarity=0.415 Sum_probs=180.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.+.||+|+||.||+|+++.+++.||||++++.. .....+.+|+++|+.+.|++++...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999996532 2345678899999999999884321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~------------------ 324 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH------------------ 324 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC------------------
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC------------------
Confidence 123889999999999999999999999999999999999976654
Q ss_pred ccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----H
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN----L 291 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~ 291 (405)
+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+... .
T Consensus 325 ---------vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~ 395 (576)
T 2acx_A 325 ---------IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395 (576)
T ss_dssp ---------EEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH
T ss_pred ---------eEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH
Confidence 566666666544322 2335899999999999998999999999999999999999999987532 1
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.....+.... ......+++++.+||.+||+
T Consensus 396 ~i~~~i~~~~--------------------------------------------------~~~p~~~s~~~~dLI~~lL~ 425 (576)
T 2acx_A 396 EVERLVKEVP--------------------------------------------------EEYSERFSPQARSLCSQLLC 425 (576)
T ss_dssp HHHHHHHHCC--------------------------------------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHhhccc--------------------------------------------------ccCCccCCHHHHHHHHHhcc
Confidence 1111111100 01123457799999999999
Q ss_pred cCCCCCC-----CHHHHHcCCCCCCC
Q 015532 372 YDPAERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~Rp-----ta~elL~hp~f~~~ 392 (405)
.||++|+ +++|+++||||+.-
T Consensus 426 ~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 426 KDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp SSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred CCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999 89999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=326.77 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=188.0
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-hhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+.++|++.+.||+|+||.||+|++..+++.||||+++.... ..+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 456789999999999999999999999999999999975432 345678899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+||++...
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~----------------------- 142 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP----------------------- 142 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS-----------------------
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC-----------------------
Confidence 1346889999999999999999999999999999999998421
Q ss_pred CCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
+.+..++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.+
T Consensus 143 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 143 -EENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp -STTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred -CCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 13446788888877654432 2335799999999999998999999999999999999999999988777666555443
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.....+. .....+++.+.+||.+||+.||++|||
T Consensus 222 ~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps 255 (304)
T 2jam_A 222 GYYEFES----------------------------------------------PFWDDISESAKDFICHLLEKDPNERYT 255 (304)
T ss_dssp CCCCCCT----------------------------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred CCCCCCc----------------------------------------------cccccCCHHHHHHHHHHcCCChhHCcC
Confidence 2211110 112345678999999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015532 380 AREALRHPFFTRDVR 394 (405)
Q Consensus 380 a~elL~hp~f~~~~~ 394 (405)
++|+|+||||+....
T Consensus 256 ~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 256 CEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHTSHHHHSSCS
T ss_pred HHHHhcCccccCCCc
Confidence 999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=335.38 Aligned_cols=222 Identities=28% Similarity=0.447 Sum_probs=179.1
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---------hhHHHHHHHHHHHHHhhcCCCCCc-----
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMIEIDVLQRLARHDIGGTR----- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~~~~E~~il~~l~~~~~~~~~----- 154 (405)
.+.++|++.+.||+|+||+||+|++..+++.||||+++.... ..+.+.+|+.+++.+.|+++....
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 356789999999999999999999999999999999975421 233566799999999999884321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------------- 167 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF------------- 167 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------------
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-------------
Confidence 23578999999999999999999999999999999999997654
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.+||+|||++....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 168 --------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 168 --------------TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp --------------CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred --------------cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 46777777775543322 34579999999999998876 78999999999999999999999652
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
... . .........+++++.+||.+
T Consensus 234 ~~~---------~-----------------------------------------------~~~~~~~~~~~~~l~~li~~ 257 (335)
T 3dls_A 234 EET---------V-----------------------------------------------EAAIHPPYLVSKELMSLVSG 257 (335)
T ss_dssp GGG---------T-----------------------------------------------TTCCCCSSCCCHHHHHHHHH
T ss_pred HHH---------H-----------------------------------------------hhccCCCcccCHHHHHHHHH
Confidence 110 0 00001112356789999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
||+.||++|||++|+++||||++..
T Consensus 258 ~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 258 LLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=325.46 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=192.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEec-CCCcEEEEEEecchh---hhhHHHHHHHHHHHHH---hhcCCCCCc--------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTR-------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l---~~~~~~~~~-------- 154 (405)
..++|++.+.||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++.+ .|+++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 678999999986432 2234566788888877 688874321
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~----------- 157 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----------- 157 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----------
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-----------
Confidence 12378999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 158 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 158 ----------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp ----------------CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----------------CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 4566666666543322 2235789999999999998999999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
....+.+..+....+.++... |+........ ... .............++..+.+||.
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~-------------------~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~li~ 278 (326)
T 1blx_A 222 SSDVDQLGKILDVIGLPGEED-------------------WPRDVALPRQ---AFH-SKSAQPIEKFVTDIDELGKDLLL 278 (326)
T ss_dssp SSHHHHHHHHHHHHCCCCGGG-------------------SCTTCSSCGG---GSC-CCCCCCGGGTCCSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHcCCCCccc-------------------Cccccccchh---hhc-ccCcchhhhccccCCHHHHHHHH
Confidence 998888888877776554321 1111000000 000 00001112233456789999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+||+.||++|||+.|+|+||||++-.
T Consensus 279 ~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 279 KCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHcCCCcccCCCHHHHhcCccccccc
Confidence 99999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=347.22 Aligned_cols=224 Identities=23% Similarity=0.334 Sum_probs=179.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|+++.+++.||||++++.. ...+.+.+|+.+|+.+.|+++....
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999999999999999996532 2345678899999999999874311
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~----------------- 327 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN----------------- 327 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-----------------
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC-----------------
Confidence 125889999999999999999999999999999999999977664
Q ss_pred cccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--- 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--- 290 (405)
+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+...
T Consensus 328 ----------vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~ 397 (543)
T 3c4z_A 328 ----------VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397 (543)
T ss_dssp ----------EEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC
T ss_pred ----------EEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh
Confidence 566666665443322 1235899999999999999999999999999999999999999987532
Q ss_pred -HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 -LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 -~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
.+....+..... ..+..+++.+.+||.+|
T Consensus 398 ~~~~~~~i~~~~~--------------------------------------------------~~p~~~s~~~~~li~~l 427 (543)
T 3c4z_A 398 NKELKQRVLEQAV--------------------------------------------------TYPDKFSPASKDFCEAL 427 (543)
T ss_dssp HHHHHHHHHHCCC--------------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhhccc--------------------------------------------------CCCcccCHHHHHHHHHh
Confidence 222222211100 11234577899999999
Q ss_pred cccCCCCCCC-----HHHHHcCCCCCCC
Q 015532 370 LRYDPAERLK-----AREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rpt-----a~elL~hp~f~~~ 392 (405)
|+.||++||+ ++++++||||+.-
T Consensus 428 L~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp SCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999995 5899999999973
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.78 Aligned_cols=226 Identities=25% Similarity=0.393 Sum_probs=183.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999999999999999996432 2345678899999999999884321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------------------- 151 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG---------------------- 151 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC----------------------
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC----------------------
Confidence 13578899999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..
T Consensus 152 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 226 (284)
T 2vgo_A 152 -----ELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226 (284)
T ss_dssp -----CEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred -----CEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc
Confidence 4566666665433322 2335789999999999998999999999999999999999999988776555443322
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.... .....+..+.+||.+||+.||++|||
T Consensus 227 ~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 256 (284)
T 2vgo_A 227 VDLK--------------------------------------------------FPPFLSDGSKDLISKLLRYHPPQRLP 256 (284)
T ss_dssp TCCC--------------------------------------------------CCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred cccC--------------------------------------------------CCCcCCHHHHHHHHHHhhcCHhhCCC
Confidence 1111 11234678999999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015532 380 AREALRHPFFTRDVR 394 (405)
Q Consensus 380 a~elL~hp~f~~~~~ 394 (405)
++|+++||||+....
T Consensus 257 ~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 257 LKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHTCHHHHHHCC
T ss_pred HHHHhhCHHHHhhcc
Confidence 999999999987544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.38 Aligned_cols=234 Identities=30% Similarity=0.442 Sum_probs=181.8
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHHhhcCCCCCc-----
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTR----- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l~~~~~~~~~----- 154 (405)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45578999999999999999999999999999999986432 1224577899999999999884321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--------------- 151 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE--------------- 151 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS---------------
T ss_pred CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC---------------
Confidence 23578899999999999999999999999999999999997543
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
....+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|+|++|..||...
T Consensus 152 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 152 ---------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp ---------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ---------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 23458899999887654432 2357999999999985 456889999999999999999999999765
Q ss_pred ChHH-HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 289 ENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 289 ~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.... ....+........ ......++..+.+||.
T Consensus 223 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~ 256 (322)
T 2ycf_A 223 RTQVSLKDQITSGKYNFI----------------------------------------------PEVWAEVSEKALDLVK 256 (322)
T ss_dssp TCSSCHHHHHHHTCCCCC----------------------------------------------HHHHTTSCHHHHHHHH
T ss_pred chHHHHHHHHHhCccccC----------------------------------------------chhhhhcCHHHHHHHH
Confidence 4321 1111211100000 0112345678999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+||+.||++|||++|+|+||||+..
T Consensus 257 ~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 257 KLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHcccCHhhCCCHHHHhhCcCcCCH
Confidence 9999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=328.62 Aligned_cols=227 Identities=30% Similarity=0.460 Sum_probs=171.2
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhh--cCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR--HDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~--~~~~~~~---------- 154 (405)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|+.+|+.+.| +++....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 356799999999999999999998 468899999986432 334667889999999987 5553211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 86 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-------------------- 144 (343)
T 3dbq_A 86 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-------------------- 144 (343)
T ss_dssp EEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT--------------------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC--------------------
Confidence 23578899999999999999999999999999999999995 23
Q ss_pred cCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhC-----------CCCCCchhHHHHHHHHHHHHhCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~~lltg~ 282 (405)
.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 145 -------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 145 -------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp -------EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred -------cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 36777777776543222 23579999999999975 56889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||....... ..+.....+ ..... .....+..+
T Consensus 218 ~pf~~~~~~~--~~~~~~~~~-------------------~~~~~--------------------------~~~~~~~~l 250 (343)
T 3dbq_A 218 TPFQQIINQI--SKLHAIIDP-------------------NHEIE--------------------------FPDIPEKDL 250 (343)
T ss_dssp CTTTTCCSHH--HHHHHHHCT-------------------TSCCC--------------------------CCCCSCHHH
T ss_pred CcchhhhhHH--HHHHHHhcC-------------------CcccC--------------------------CcccCCHHH
Confidence 9997644321 111111100 00111 112335688
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
.+||.+||+.||++|||+.|+|+||||+..
T Consensus 251 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=322.60 Aligned_cols=226 Identities=25% Similarity=0.395 Sum_probs=157.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56999999999999999999999999999999996532 2236688899999999999884321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--------------------- 149 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--------------------- 149 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC---------------------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---------------------
Confidence 14578999999999999999999999999999999999997655
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.+..
T Consensus 150 ------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 223 (278)
T 3cok_A 150 ------NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223 (278)
T ss_dssp ------CEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred ------CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Confidence 4566666666543321 1235789999999999988899999999999999999999999976543222211
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.. . .......++.++.+||.+||+.||++
T Consensus 224 ~~~--------------------------~------------------------~~~~~~~~~~~~~~li~~~l~~dp~~ 253 (278)
T 3cok_A 224 VVL--------------------------A------------------------DYEMPSFLSIEAKDLIHQLLRRNPAD 253 (278)
T ss_dssp CCS--------------------------S------------------------CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred Hhh--------------------------c------------------------ccCCccccCHHHHHHHHHHcccCHhh
Confidence 100 0 00112235678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~ 394 (405)
|||++++|+||||++...
T Consensus 254 Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 254 RLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp SCCHHHHTTSTTTC----
T ss_pred CCCHHHHhcCccccCCCC
Confidence 999999999999997653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.05 Aligned_cols=233 Identities=30% Similarity=0.459 Sum_probs=183.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----------hhhHHHHHHHHHHHHHh-hcCCCCCc---
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTR--- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~il~~l~-~~~~~~~~--- 154 (405)
.+.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+++++. |+++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999999999999999996432 23466788999999996 88874321
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----------- 162 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN----------- 162 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-----------
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc-----------
Confidence 135788999999999999999999999999999999999976554
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHh------CCCCCCchhHHHHHHHHHHHHhCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~~lltg~ 282 (405)
++|+|||++...... .....||+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 163 ----------------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 163 ----------------IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp ----------------EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ----------------EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 566666665443222 22357899999999986 346889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||...+.......+.......+. .....++..+
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~l 260 (298)
T 1phk_A 227 PPFWHRKQMLMLRMIMSGNYQFGS----------------------------------------------PEWDDYSDTV 260 (298)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCT----------------------------------------------TTGGGSCHHH
T ss_pred CCCcCccHHHHHHHHhcCCcccCc----------------------------------------------ccccccCHHH
Confidence 999887766655544332111110 1112356789
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.+||.+||+.||++|||+.|+|+||||++...
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 99999999999999999999999999997643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=319.72 Aligned_cols=245 Identities=19% Similarity=0.256 Sum_probs=179.4
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
..+.++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.++..+ .|+++....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 34567899999999999999999999999999999999742 23456678899999999 888874321
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~- 165 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD- 165 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc-
Confidence 134789999999999999999999999999999999999987765544433211100
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
.......++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++......
T Consensus 166 -------~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 -------WASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred -------ccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 01245578999999987665433 34699999999999876 5668999999999999999999887543221
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
. .+.+ +.. ......+++.+.+||.+||+
T Consensus 238 ~---~~~~--~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~ 265 (289)
T 1x8b_A 238 H---EIRQ--GRL-----------------------------------------------PRIPQVLSQEFTELLKVMIH 265 (289)
T ss_dssp H---HHHT--TCC-----------------------------------------------CCCSSCCCHHHHHHHHHHTC
T ss_pred H---HHHc--CCC-----------------------------------------------CCCCcccCHHHHHHHHHHhC
Confidence 1 1110 000 01123457789999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.||++|||+.|+|+||||++..
T Consensus 266 ~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 266 PDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp SSGGGSCCHHHHHTCTTC----
T ss_pred CCcccCCCHHHHhhChHhhhhc
Confidence 9999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=336.32 Aligned_cols=233 Identities=16% Similarity=0.128 Sum_probs=166.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHh--hcCCCCCc------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA--RHDIGGTR------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~--~~~~~~~~------------ 154 (405)
.|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.|. |+++....
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 499999999999999999999999999999999763 334556677877677765 88753310
Q ss_pred ---------------------c------------------ccCCHHHH------HHHHHHHHHHHHHHHHCCcEecCCCC
Q 015532 155 ---------------------Y------------------RSFPIDLV------RELGRQLLESVAFMHELRLIHTDLKP 189 (405)
Q Consensus 155 ---------------------~------------------~~l~~~~~------~~~~~qi~~aL~~LH~~givHrDlkp 189 (405)
+ ..+++..+ ..++.||+.||.|||++||+||||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 0 01223334 56779999999999999999999999
Q ss_pred CcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC--CCCCCchh
Q 015532 190 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCD 267 (405)
Q Consensus 190 ~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 267 (405)
+|||++.+| .+||+|||++...........+|+.|+|||++.+ ..++.++|
T Consensus 223 ~NIll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~D 275 (371)
T 3q60_A 223 DNLFIMPDG---------------------------RLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALN 275 (371)
T ss_dssp GGEEECTTS---------------------------CEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHH
T ss_pred HHEEECCCC---------------------------CEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCcccc
Confidence 999997665 4566666666554443334567799999999987 67999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc
Q 015532 268 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347 (405)
Q Consensus 268 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (405)
||||||++|+|++|..||.+....... .+. ...... ...
T Consensus 276 iwSlG~il~elltg~~Pf~~~~~~~~~------------------------~~~---~~~~~~--------------~~~ 314 (371)
T 3q60_A 276 AWQLGLSIYRVWCLFLPFGLVTPGIKG------------------------SWK---RPSLRV--------------PGT 314 (371)
T ss_dssp HHHHHHHHHHHHHSSCSTTBCCTTCTT------------------------CCC---BCCTTS--------------CCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcCccccc------------------------chh---hhhhhh--------------ccc
Confidence 999999999999999999765321000 000 000000 000
Q ss_pred hhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 348 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
..........+++.+.+||.+||+.||++|||+.|+|+||||++-.
T Consensus 315 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 315 DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 0111112235678999999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=321.38 Aligned_cols=230 Identities=29% Similarity=0.399 Sum_probs=185.6
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
....++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.+.|+++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 34567899999999999999999999999999999998643 23456778899999999999984421
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----------------- 153 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE----------------- 153 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-----------------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC-----------------
Confidence 135789999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+.
T Consensus 154 ----------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 154 ----------VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp ----------EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ----------EEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56666666544321 12235789999999999998899999999999999999999999988766554
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+...... .....++.+.+||.+||+.|
T Consensus 224 ~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 224 YLRIKKNEYS--------------------------------------------------IPKHINPVAASLIQKMLQTD 253 (294)
T ss_dssp HHHHHTTCCC--------------------------------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHhhccCC--------------------------------------------------CccccCHHHHHHHHHHcccC
Confidence 4333221101 11234668899999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~ 394 (405)
|++|||++|+++||||+....
T Consensus 254 p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 254 PTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp GGGSCCGGGGGGSHHHHTSCC
T ss_pred hhhCcCHHHHhhChheecCCc
Confidence 999999999999999987643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.65 Aligned_cols=228 Identities=25% Similarity=0.447 Sum_probs=181.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
+.++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999999999999999996532 3346788999999999999874311
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--------------- 147 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--------------- 147 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---------------
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc---------------
Confidence 134788899999999999999999999999999999999976654
Q ss_pred CCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCC--CCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
++|+|||.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 148 ------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 148 ------------LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp ------------EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55555555543321 112346899999999998754 37899999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.+..+....+..... .....+++.+.+||.
T Consensus 216 ~~~~~~~~~i~~~~~--------------------------------------------------~~~~~~~~~l~~li~ 245 (305)
T 2wtk_C 216 DNIYKLFENIGKGSY--------------------------------------------------AIPGDCGPPLSDLLK 245 (305)
T ss_dssp SSHHHHHHHHHHCCC--------------------------------------------------CCCSSSCHHHHHHHH
T ss_pred chHHHHHHHHhcCCC--------------------------------------------------CCCCccCHHHHHHHH
Confidence 776555544432111 011244678999999
Q ss_pred HccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
+||+.||++|||++|+++||||++...
T Consensus 246 ~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHccCChhhCCCHHHHhcCcccccCCC
Confidence 999999999999999999999987644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=333.01 Aligned_cols=225 Identities=30% Similarity=0.474 Sum_probs=171.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhh--cCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLAR--HDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~--~~~~~~~------------ 154 (405)
.+|++.+.||+|+||+||+|.+.. ++.||||++... ....+.+.+|+.+|+.+.| +++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 469999999999999999999865 889999999643 2345678899999999986 5553321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~---------------------- 191 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG---------------------- 191 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS----------------------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC----------------------
Confidence 13567889999999999999999999999999999999994 23
Q ss_pred CCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhC-----------CCCCCchhHHHHHHHHHHHHhCCCC
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~~lltg~~p 284 (405)
.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 192 -----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~P 266 (390)
T 2zmd_A 192 -----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266 (390)
T ss_dssp -----CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred -----eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCc
Confidence 46777777776543221 23579999999999976 3688999999999999999999999
Q ss_pred CCCCChH-HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 285 FQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 285 f~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
|...... ..+..+ ... .....+ ....+..+.
T Consensus 267 f~~~~~~~~~~~~~---~~~-------------------~~~~~~--------------------------~~~~~~~~~ 298 (390)
T 2zmd_A 267 FQQIINQISKLHAI---IDP-------------------NHEIEF--------------------------PDIPEKDLQ 298 (390)
T ss_dssp TTTCCCHHHHHHHH---HCT-------------------TSCCCC--------------------------CCCSCHHHH
T ss_pred chhhhHHHHHHHHH---hCc-------------------cccCCC--------------------------CccchHHHH
Confidence 9765432 222211 110 001111 122356889
Q ss_pred HHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 364 DLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
+||.+||+.||++|||+.|+|+||||+...
T Consensus 299 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 999999999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.07 Aligned_cols=232 Identities=22% Similarity=0.303 Sum_probs=181.7
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
...+.++|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+.|+++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3456789999999999999999999999999999999996532 2345678899999999999985421
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~------------ 154 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA------------ 154 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC------------
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC------------
Confidence 134788999999999999999999999999999999999987664
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 155 ---------------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf 219 (311)
T 3ork_A 155 ---------------VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219 (311)
T ss_dssp ---------------EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 566666665433221 12256899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
.+....+....+..... .+. ......++.++.+|
T Consensus 220 ~~~~~~~~~~~~~~~~~-~~~---------------------------------------------~~~~~~~~~~l~~l 253 (311)
T 3ork_A 220 TGDSPVSVAYQHVREDP-IPP---------------------------------------------SARHEGLSADLDAV 253 (311)
T ss_dssp CCSSHHHHHHHHHHCCC-CCH---------------------------------------------HHHSTTCCHHHHHH
T ss_pred CCCChHHHHHHHhcCCC-CCc---------------------------------------------ccccCCCCHHHHHH
Confidence 98877665544332211 111 01123457789999
Q ss_pred HHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 366 LQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
|.+||+.||++||++.++|.|+|++.
T Consensus 254 i~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 254 VLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 99999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=334.53 Aligned_cols=273 Identities=22% Similarity=0.311 Sum_probs=187.5
Q ss_pred eCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 86 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
.++...++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3455568899999999999999999999999999999999653 34456788999999999999884321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----------------- 169 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----------------- 169 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-----------------
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-----------------
Confidence 13578889999999999999999985 999999999999997654
Q ss_pred CcccCCCCCCCceeccCCCCccccC-CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 170 ----------~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 170 ----------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp ----------CEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred ----------CEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 467777777653321 223357999999999999999999999999999999999999999887765544
Q ss_pred HHHHHHh-CCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 295 AMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 295 ~~i~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
..+.... +..+... ....... ..+... ................+.... . .......++.++.+||.+||++|
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 240 LMFGCQVEGDAAETP-PRPRTPG-RPLNKF-GMDSRPPMAIFELLDYIVNEP-P---PKLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp HHHC---------------------------------CCCHHHHHHHHHHSC-C---CCCCTTTSCHHHHHHHHHHHCSS
T ss_pred HHhcccccccCCCCC-CCcccCC-Cccccc-ccCCCCcccchhhhhHHhccC-C---CCCCcccccHHHHHHHHHHhhcC
Confidence 3332111 1111100 0000000 000000 000000000011111111100 0 01112345778999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRD 392 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~ 392 (405)
|++|||++|+|+||||++.
T Consensus 313 P~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 313 PAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp TTTSCCHHHHHTSHHHHHH
T ss_pred hhhCCCHHHHhhChHhhcc
Confidence 9999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.35 Aligned_cols=233 Identities=22% Similarity=0.416 Sum_probs=180.7
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc-----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR----------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~----------- 154 (405)
.....++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++++ .|+++....
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34467899999999999999999999999999999999976656667888999999999 677763210
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------------ 166 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA------------ 166 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC------------
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC------------
Confidence 13478889999999999999999999999999999999997655
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~ 282 (405)
.++|+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 167 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 167 ---------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp ---------------CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSS
T ss_pred ---------------CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 4566666666543321 22357899999999997 456889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||.+......+..+.... .|. .....++..+
T Consensus 232 ~p~~~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~l 263 (326)
T 2x7f_A 232 PPLCDMHPMRALFLIPRNP--APR----------------------------------------------LKSKKWSKKF 263 (326)
T ss_dssp CTTTTSCHHHHHHHHHHSC--CCC----------------------------------------------CSCSCSCHHH
T ss_pred CCCCCCcHHHHHHHhhcCc--ccc----------------------------------------------CCccccCHHH
Confidence 9998877655444332210 000 0012346789
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.+||.+||..||++|||++|+++||||++...
T Consensus 264 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 264 QSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 99999999999999999999999999987644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.09 Aligned_cols=231 Identities=26% Similarity=0.345 Sum_probs=176.7
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
|....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 3445578999999999999999999999999999999996432 2345678899999999999884321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---------------- 149 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN---------------- 149 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC----------------
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC----------------
Confidence 135788999999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
++|+|||++....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 150 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 150 -----------AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp -----------EEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -----------EEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 5566666554433221 23468999999999988765 589999999999999999999998876655
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+....... ....+..+.+||.+||+.
T Consensus 219 ~~~~~~~~~~~~--------------------------------------------------~~~~~~~l~~li~~~l~~ 248 (276)
T 2h6d_A 219 LFKKIRGGVFYI--------------------------------------------------PEYLNRSVATLLMHMLQV 248 (276)
T ss_dssp HHHHHHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHTCS
T ss_pred HHHHhhcCcccC--------------------------------------------------chhcCHHHHHHHHHHccC
Confidence 444433211111 123456889999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~~ 394 (405)
||++|||++|+++||||++...
T Consensus 249 ~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 249 DPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp SGGGSCCHHHHHHSHHHHTTCC
T ss_pred ChhhCCCHHHHHhChhhccCch
Confidence 9999999999999999988643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.33 Aligned_cols=230 Identities=22% Similarity=0.379 Sum_probs=179.4
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999999999999999986433 3456788999999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---------------------- 143 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---------------------- 143 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----------------------
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC----------------------
Confidence 135789999999999999999999999999999999999976554
Q ss_pred CCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHH-H
Q 015532 222 PKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEH-L 294 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~ 294 (405)
++|+|||.+..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .
T Consensus 144 -----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 144 -----LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp -----EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred -----EEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 56666666543221 1223578999999999988765 6789999999999999999999987543211 1
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+..... ........++.+.+||.+||+.||
T Consensus 219 ~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p 250 (276)
T 2yex_A 219 SDWKEKKT------------------------------------------------YLNPWKKIDSAPLALLHKILVENP 250 (276)
T ss_dssp HHHHTTCT------------------------------------------------TSTTGGGSCHHHHHHHHHHSCSST
T ss_pred HHhhhccc------------------------------------------------ccCchhhcCHHHHHHHHHHCCCCc
Confidence 11110000 000112356789999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~ 395 (405)
++|||++|+++||||++....
T Consensus 251 ~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 251 SARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp TTSCCHHHHTTCTTTTCCCC-
T ss_pred hhCCCHHHHhcCccccChhhc
Confidence 999999999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.17 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=181.4
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..+.++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 345678999999999999999999999999999999997533 3346678999999999999874321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--------------- 149 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE--------------- 149 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT---------------
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC---------------
Confidence 01288999999999999999999999999999999999983221
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHh--------CCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL--------GLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
+....+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 150 --------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 221 (319)
T 4euu_A 150 --------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (319)
T ss_dssp --------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 123457888888886544332 3357999999999987 4678999999999999999999999
Q ss_pred CCCCCChH-HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 284 LFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 284 pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
||...... .....+.++....|...+..... .......|.... ..........+..+
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~------~~~~~~~~~~~~----------------~~~~~~~~~~~~~l 279 (319)
T 4euu_A 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQK------AENGPIDWSGDM----------------PVSCSLSRGLQVLL 279 (319)
T ss_dssp SEECTTCGGGCHHHHHHHHHHCCTTCCEEEEC------STTCCEEEESSC----------------CTTCSSCHHHHHHH
T ss_pred CCCCCCccchhHHHHHHHhcCCCcccchhhhc------ccCCccccCccC----------------CcccccchhHHHHh
Confidence 99754321 11222222222222110000000 000001110000 00001122346688
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHP 387 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp 387 (405)
.+||.+||++||++|||++|+|+||
T Consensus 280 ~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 280 TPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHHHhccCChhhhccHHHhhhcc
Confidence 9999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.61 Aligned_cols=227 Identities=22% Similarity=0.401 Sum_probs=177.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
..|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.+.|+++....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4589999999999999999999999999999998643 23456678899999999999885321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~------------------- 166 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG------------------- 166 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-------------------
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-------------------
Confidence 135788899999999999999999999 999999999999962
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc-cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+..++|+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........
T Consensus 167 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 167 -------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp -------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred -------CCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence 22356777777775443332 23579999999998875 5899999999999999999999999876554433
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
...... +..+ .......++.+.+||.+||+.||
T Consensus 239 ~~~~~~-~~~~----------------------------------------------~~~~~~~~~~l~~li~~~l~~dp 271 (290)
T 1t4h_A 239 YRRVTS-GVKP----------------------------------------------ASFDKVAIPEVKEIIEGCIRQNK 271 (290)
T ss_dssp HHHHTT-TCCC----------------------------------------------GGGGGCCCHHHHHHHHHHSCSSG
T ss_pred HHHHhc-cCCc----------------------------------------------cccCCCCCHHHHHHHHHHccCCh
Confidence 221110 0000 01112345689999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRD 392 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~ 392 (405)
++|||++|+|+||||+++
T Consensus 272 ~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 272 DERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GGSCCHHHHHTSGGGC--
T ss_pred hhCCCHHHHhhCcccccC
Confidence 999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.92 Aligned_cols=238 Identities=26% Similarity=0.424 Sum_probs=183.6
Q ss_pred EeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 84 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
+..+....++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 11 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp CBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred cccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 3344556789999999999999999999999999999999986533 3456788999999999999884321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--------------- 155 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--------------- 155 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC---------------
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC---------------
Confidence 245789999999999999999999999999999999999976654
Q ss_pred CCcccCCCCCCCceeccCCCCcccc---CCccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
++|+|||++.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 156 ------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 156 ------------IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp ------------EEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ------------EEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 5555555543211 1122347899999999984 5678999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
..+.......+.....+. ......++..+.+||
T Consensus 224 ~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~l~~li 256 (302)
T 2j7t_A 224 ELNPMRVLLKIAKSDPPT-----------------------------------------------LLTPSKWSVEFRDFL 256 (302)
T ss_dssp TSCHHHHHHHHHHSCCCC-----------------------------------------------CSSGGGSCHHHHHHH
T ss_pred cCCHHHHHHHHhccCCcc-----------------------------------------------cCCccccCHHHHHHH
Confidence 877665544433211000 001123466899999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
.+||+.||++|||+.|+++||||+.....
T Consensus 257 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 257 KIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred HHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 99999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.61 Aligned_cols=231 Identities=24% Similarity=0.364 Sum_probs=177.7
Q ss_pred eCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc----hhhhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 86 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
.|+.+.++|++.+.||+|+||.||+|++..+++.||||++.. .....+.+.+|+.+++.+.|+++....
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 567788999999999999999999999999999999999843 223446778999999999999984321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~---------------- 148 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK---------------- 148 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------------
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----------------
Confidence 13578999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 149 -----------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 149 -----------TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp -----------CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred -----------CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4666666666543322 1235799999999999999999999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+...... ....| .........+++.+.++|.+||
T Consensus 218 ~~~~~~~~--~~~~~-------------------------------------------~~~~~~~~~~~~~l~~li~~~l 252 (294)
T 4eqm_A 218 VSIAIKHI--QDSVP-------------------------------------------NVTTDVRKDIPQSLSNVILRAT 252 (294)
T ss_dssp HHHHHHHH--SSCCC-------------------------------------------CHHHHSCTTSCHHHHHHHHHHS
T ss_pred HHHHHHHh--hccCC-------------------------------------------CcchhcccCCCHHHHHHHHHHh
Confidence 55432221 11111 1111223456778999999999
Q ss_pred ccCCCCCCCHHHHHcCCC
Q 015532 371 RYDPAERLKAREALRHPF 388 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~ 388 (405)
+.||++||+..+.+.+.|
T Consensus 253 ~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 253 EKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CSSGGGSCSSHHHHHHHH
T ss_pred cCCHhHccccHHHHHHHH
Confidence 999999995555554444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=340.18 Aligned_cols=219 Identities=19% Similarity=0.265 Sum_probs=167.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHH---HHHHHhhcCCCCC----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEID---VLQRLARHDIGGT---------- 153 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~---il~~l~~~~~~~~---------- 153 (405)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+. +|+.+.|++++..
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999998632 234567788994 4555567765210
Q ss_pred -----------------------cc-----------------ccCC-------HHHHHHHHHHHHHHHHHHHHCCcEecC
Q 015532 154 -----------------------RY-----------------RSFP-------IDLVRELGRQLLESVAFMHELRLIHTD 186 (405)
Q Consensus 154 -----------------------~~-----------------~~l~-------~~~~~~~~~qi~~aL~~LH~~givHrD 186 (405)
.+ ..++ +..+..++.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 00 1123 367778999999999999999999999
Q ss_pred CCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC------
Q 015532 187 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL------ 260 (405)
Q Consensus 187 lkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~------ 260 (405)
|||+|||++.++ .+||+|||++..........+| +.|+|||++.+.
T Consensus 232 ikp~NIll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~ 283 (377)
T 3byv_A 232 LRPVDIVLDQRG---------------------------GVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYH 283 (377)
T ss_dssp CCGGGEEECTTC---------------------------CEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHH
T ss_pred CCHHHEEEcCCC---------------------------CEEEEechhheecCCcccCCCC-cCccChhhhccccccccc
Confidence 999999997655 4666666666654444445678 999999999987
Q ss_pred -----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCch
Q 015532 261 -----GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 335 (405)
Q Consensus 261 -----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (405)
.++.++|||||||++|+|++|..||.+........
T Consensus 284 ~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------------------------------- 323 (377)
T 3byv_A 284 RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------------------------------------- 323 (377)
T ss_dssp HCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG----------------------------------------
T ss_pred ccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh----------------------------------------
Confidence 79999999999999999999999996543211110
Q ss_pred hhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 336 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
........+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 324 --------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 324 --------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp --------------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred --------------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 001112345778999999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=318.47 Aligned_cols=235 Identities=31% Similarity=0.543 Sum_probs=188.1
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+++++++.|+++....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999999999999999986432 3456788999999999999874321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~------------------- 158 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------------- 158 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-------------------
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-------------------
Confidence 13578899999999999999999999999999999999997543
Q ss_pred ccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
....+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+...
T Consensus 159 -----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (287)
T 2wei_A 159 -----KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232 (287)
T ss_dssp -----TTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -----CcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 23457888888776543322 23468999999999876 58999999999999999999999999877766555
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.......+ ......+++.+.+||.+||+.||+
T Consensus 233 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~ 266 (287)
T 2wei_A 233 RVETGKYAFD----------------------------------------------LPQWRTISDDAKDLIRKMLTFHPS 266 (287)
T ss_dssp HHHHCCCCCC----------------------------------------------SGGGTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHcCCCCCC----------------------------------------------chhhhhcCHHHHHHHHHHcccChh
Confidence 4433111100 011134567899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDV 393 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~ 393 (405)
+|||+.|+|+||||++..
T Consensus 267 ~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 267 LRITATQCLEHPWIQKYS 284 (287)
T ss_dssp GSCCHHHHHHSHHHHHHC
T ss_pred hCcCHHHHhcCHHHhccc
Confidence 999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=317.91 Aligned_cols=229 Identities=21% Similarity=0.361 Sum_probs=166.2
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---hhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..++|++.+.||+|+||+||+|++..+++.||||+++.... ..+....+...++.+.|+++....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 34789999999999999999999999999999999965322 222333444557778888874321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~----------------- 147 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG----------------- 147 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-----------------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-----------------
Confidence 13588999999999999999999998 999999999999997655
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHH----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
.+||+|||++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 148 ----------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 148 ----------QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp ----------CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred ----------CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 46666676665433222 224789999999997 45568899999999999999999999998633
Q ss_pred -hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 290 -NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 290 -~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
....+..+..... + . ......++++.+||.+
T Consensus 218 ~~~~~~~~~~~~~~--~---------------------~-------------------------~~~~~~~~~~~~li~~ 249 (290)
T 3fme_A 218 TPFQQLKQVVEEPS--P---------------------Q-------------------------LPADKFSAEFVDFTSQ 249 (290)
T ss_dssp CHHHHHHHHHHSCC--C---------------------C-------------------------CCTTTSCHHHHHHHHH
T ss_pred chHHHHHHHhccCC--C---------------------C-------------------------cccccCCHHHHHHHHH
Confidence 3333322211100 0 0 0012356789999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
||+.||++|||+.|+++||||+...
T Consensus 250 ~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 250 CLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HhhcChhhCcCHHHHHhCcccccCc
Confidence 9999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=317.16 Aligned_cols=232 Identities=26% Similarity=0.409 Sum_probs=186.2
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
..++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 346799999999999999999999999999999999643 23456788999999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 100 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------------------- 156 (303)
T 3a7i_A 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG----------------------- 156 (303)
T ss_dssp ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-----------------------
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-----------------------
Confidence 13578999999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 157 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 232 (303)
T 3a7i_A 157 ----EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 232 (303)
T ss_dssp ----CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ----CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence 4566666666443322 233578999999999999899999999999999999999999998876655444332
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
... . ......++..+.+||.+||+.||++||
T Consensus 233 ~~~--~-----------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 233 KNN--P-----------------------------------------------PTLEGNYSKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp HSC--C-----------------------------------------------CCCCSSCCHHHHHHHHHHCCSSGGGSC
T ss_pred cCC--C-----------------------------------------------CCCccccCHHHHHHHHHHcCCChhhCc
Confidence 210 0 011134567899999999999999999
Q ss_pred CHHHHHcCCCCCCCCCCCc
Q 015532 379 KAREALRHPFFTRDVRRPT 397 (405)
Q Consensus 379 ta~elL~hp~f~~~~~~~~ 397 (405)
|+.|+++||||........
T Consensus 264 s~~~ll~~~~~~~~~~~~~ 282 (303)
T 3a7i_A 264 TAKELLKHKFILRNAKKTS 282 (303)
T ss_dssp CHHHHTTCHHHHHHCCCGG
T ss_pred CHHHHhhChhhhcCCCccH
Confidence 9999999999987654433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.41 Aligned_cols=232 Identities=25% Similarity=0.441 Sum_probs=179.0
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.+.|+++....
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345678999999999999999999999999999999997543 346688999999999999884321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-------------------- 163 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH-------------------- 163 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--------------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--------------------
Confidence 235788999999999999999999999999999999999976554
Q ss_pred CCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 164 -------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 236 (314)
T 3com_A 164 -------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236 (314)
T ss_dssp -------EEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred -------EEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 566666666443222 2235789999999999998999999999999999999999999988766554433
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.....+ .......++..+.+||.+||..||++
T Consensus 237 ~~~~~~~-----------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~ 269 (314)
T 3com_A 237 IPTNPPP-----------------------------------------------TFRKPELWSDNFTDFVKQCLVKSPEQ 269 (314)
T ss_dssp HHHSCCC-----------------------------------------------CCSSGGGSCHHHHHHHHHHTCSCTTT
T ss_pred HhcCCCc-----------------------------------------------ccCCcccCCHHHHHHHHHHccCChhh
Confidence 2221000 00011234678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~ 394 (405)
|||+.++|+||||+....
T Consensus 270 Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 270 RATATQLLQHPFVRSAKG 287 (314)
T ss_dssp SCCHHHHTTSHHHHTCCC
T ss_pred CcCHHHHHhCHHHhcCCc
Confidence 999999999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=323.99 Aligned_cols=230 Identities=25% Similarity=0.365 Sum_probs=177.0
Q ss_pred CceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-------hhHHHHHHHHHHHHHhh--cCCC
Q 015532 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLAR--HDIG 151 (405)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~il~~l~~--~~~~ 151 (405)
..+...++.+.++|++.+.||+|+||.||+|++..+++.||||+++.... ..+.+.+|+.+++++.+ +++.
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 34456677888999999999999999999999999999999999965431 22456679999999975 6653
Q ss_pred CCc----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-ccccccc
Q 015532 152 GTR----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKV 202 (405)
Q Consensus 152 ~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~-~~~~~k~ 202 (405)
... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---- 187 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG---- 187 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT----
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC----
Confidence 211 13578899999999999999999999999999999999997 334
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHh
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCS 280 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~llt 280 (405)
.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 188 -----------------------~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 244 (320)
T 3a99_A 188 -----------------------ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244 (320)
T ss_dssp -----------------------EEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------CEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence 4677777766544332 223578999999999987765 688999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||..... +.. +. . .....+++
T Consensus 245 g~~pf~~~~~------~~~--~~----------------------~--------------------------~~~~~~~~ 268 (320)
T 3a99_A 245 GDIPFEHDEE------IIR--GQ----------------------V--------------------------FFRQRVSS 268 (320)
T ss_dssp SSCSCCSHHH------HHH--CC----------------------C--------------------------CCSSCCCH
T ss_pred CCCCCCChhh------hhc--cc----------------------c--------------------------cccccCCH
Confidence 9999965311 000 00 0 01124567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
++.+||.+||+.||++|||++|+++||||++..
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 899999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.77 Aligned_cols=227 Identities=27% Similarity=0.382 Sum_probs=171.5
Q ss_pred CCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHh-hcCCCCCc--------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTR-------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~-~~~~~~~~-------- 154 (405)
++|++.+.||+|+||.||+|++. .+++.||||+++... ...+.+.+|+++++.+. |+++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999984 478999999986432 23455678999999995 66663211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---------------- 197 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---------------- 197 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----------------
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc----------------
Confidence 135788999999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCceeccCCCCccccC----CccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 198 -----------~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 198 -----------VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp -----------EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred -----------EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 55566665543221 11235799999999999863 47899999999999999999999997543
Q ss_pred hHHHHHHHHH-HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 290 NLEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 290 ~~~~~~~i~~-~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
.......+.+ .... .......++..+.+||.+
T Consensus 267 ~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~li~~ 299 (355)
T 1vzo_A 267 EKNSQAEISRRILKS-----------------------------------------------EPPYPQEMSALAKDLIQR 299 (355)
T ss_dssp SCCCHHHHHHHHHHC-----------------------------------------------CCCCCTTSCHHHHHHHHH
T ss_pred ccchHHHHHHHHhcc-----------------------------------------------CCCCCcccCHHHHHHHHH
Confidence 2111111111 0000 001123456788999999
Q ss_pred ccccCCCCCC-----CHHHHHcCCCCCCC
Q 015532 369 LLRYDPAERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 369 ~L~~dP~~Rp-----ta~elL~hp~f~~~ 392 (405)
||+.||++|| |++|+++||||+..
T Consensus 300 ~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 300 LLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999 99999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=317.64 Aligned_cols=235 Identities=17% Similarity=0.258 Sum_probs=163.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCc---EEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCcc--------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRY-------- 155 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~~-------- 155 (405)
..++|++.+.||+|+||+||+|++..+++ .||||+++.. ....+.+.+|+.+++.+.|+++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45789999999999999999999887765 7999998653 234567889999999999998743210
Q ss_pred -------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCC
Q 015532 156 -------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 204 (405)
Q Consensus 156 -------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~d 204 (405)
..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~------ 174 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM------ 174 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC------
Confidence 1478889999999999999999999999999999999997655
Q ss_pred ccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHH
Q 015532 205 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 205 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll 279 (405)
.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 175 ---------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 233 (323)
T 3qup_A 175 ---------------------TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233 (323)
T ss_dssp ---------------------CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ---------------------CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHH
Confidence 45666666665432221 1235678899999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc
Q 015532 280 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358 (405)
Q Consensus 280 t-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (405)
+ |..||.+....+....+.... .. .....+
T Consensus 234 ~~g~~p~~~~~~~~~~~~~~~~~-----------------------~~--------------------------~~~~~~ 264 (323)
T 3qup_A 234 TRGQTPYAGIENAEIYNYLIGGN-----------------------RL--------------------------KQPPEC 264 (323)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTC-----------------------CC--------------------------CCCTTC
T ss_pred hCCCCCccccChHHHHHHHhcCC-----------------------CC--------------------------CCCCcc
Confidence 9 999998877655444332210 00 111245
Q ss_pred hHHHHHHHHHccccCCCCCCC-------HHHHHcCCCCCCCCCCCcchh
Q 015532 359 AGDLIDLLQGLLRYDPAERLK-------AREALRHPFFTRDVRRPTLLV 400 (405)
Q Consensus 359 ~~~l~~ll~~~L~~dP~~Rpt-------a~elL~hp~f~~~~~~~~~~~ 400 (405)
++.+.+||.+||+.||++||| ++++++|+|+......|....
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~ 313 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------------
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Confidence 678999999999999999999 788889999999877765543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.73 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=157.7
Q ss_pred ccCCCeEEEe-eeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 89 NLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~-~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.+.++|++.+ .||+|+||+||+|++..+++.||||++......... ....++.+.|+++....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4668899965 599999999999999999999999999764332222 22345666777763211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~---------------- 165 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE---------------- 165 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC----------------
Confidence 12588999999999999999999999999999999999997533
Q ss_pred CCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 166 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 166 --------KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp --------TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred --------CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 2345889999988654432 2345789999999999888899999999999999999999999976544332
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+..... ..... ........+++.+.+||.+||+.|
T Consensus 238 ~~~~~~~~~--------------------~~~~~----------------------~~~~~~~~~~~~~~~li~~~L~~d 275 (336)
T 3fhr_A 238 SPGMKRRIR--------------------LGQYG----------------------FPNPEWSEVSEDAKQLIRLLLKTD 275 (336)
T ss_dssp ---------------------------------C----------------------CCTTTSTTCCHHHHHHHHHHSCSS
T ss_pred hhhHHHhhh--------------------ccccc----------------------cCchhhccCCHHHHHHHHHHCCCC
Confidence 111110000 00000 001112345778999999999999
Q ss_pred CCCCCCHHHHHcCCCCCCCCCC
Q 015532 374 PAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~~~~~ 395 (405)
|++|||++|+|+||||++....
T Consensus 276 P~~Rpt~~ell~hp~~~~~~~~ 297 (336)
T 3fhr_A 276 PTERLTITQFMNHPWINQSMVV 297 (336)
T ss_dssp GGGSCCHHHHHHSHHHHTGGGS
T ss_pred hhHCcCHHHHhcCccccccccC
Confidence 9999999999999999875443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=314.21 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=172.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.++|++.+.||+|+||.||+|++..+++.||||+++......+.+.+|+.+++.+.|+++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 34679999999999999999999999999999999977666667788999999999999874321
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 123567888999999999999999999999999999999987776666666654
Q ss_pred ccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
......... .. .+...............||+.|+|||++.+. .++.++|||||||++|+|++ ||..
T Consensus 164 ~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 164 KNVHRSLDI---------LK-LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp SCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred hhcccccch---------hc-cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 322211000 00 0000000001112235789999999999875 68999999999999999998 5543
Q ss_pred CCh-HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 288 HEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 288 ~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
... .+....+...... ++ .......+..+.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~------------------------~~----------------------~~~~~~~~~~~~~li 264 (303)
T 1zy4_A 231 GMERVNILKKLRSVSIE------------------------FP----------------------PDFDDNKMKVEKKII 264 (303)
T ss_dssp HHHHHHHHHHHHSTTCC------------------------CC----------------------TTCCTTTSHHHHHHH
T ss_pred chhHHHHHHhccccccc------------------------cC----------------------ccccccchHHHHHHH
Confidence 221 1222211111111 11 011233456789999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.+||+.||++|||++|+++||||+....
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 265 RLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 9999999999999999999999987644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=309.23 Aligned_cols=227 Identities=22% Similarity=0.361 Sum_probs=181.0
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.+.|+++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35799999999999999999999999999999999643 23456788999999999999884421
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEEecccccccCCccccc
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~----------- 153 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----------- 153 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-----------
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-----------
Confidence 012788999999999999999999999 99999999999997655
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 154 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 154 ----------------NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp ----------------CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------CEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 45666666654433222 22478999999999999899999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
..+..+....+..... + .....++.++.+||
T Consensus 218 ~~~~~~~~~~i~~~~~--~-----------------------------------------------~~~~~~~~~l~~li 248 (279)
T 2w5a_A 218 AFSQKELAGKIREGKF--R-----------------------------------------------RIPYRYSDELNEII 248 (279)
T ss_dssp CSSHHHHHHHHHHTCC--C-----------------------------------------------CCCTTSCHHHHHHH
T ss_pred ccCHHHHHHHHhhccc--c-----------------------------------------------cCCcccCHHHHHHH
Confidence 8776555444332110 0 01123467899999
Q ss_pred HHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 367 QGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
.+||+.||++|||++|+|+|+|+.++.
T Consensus 249 ~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 249 TRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999999999999999998864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=316.28 Aligned_cols=225 Identities=24% Similarity=0.388 Sum_probs=170.6
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-------hhHHHHHHHHHHHHH----hhcCCCCCc-
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRL----ARHDIGGTR- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~il~~l----~~~~~~~~~- 154 (405)
++.+.++|++.+.||+|+||.||+|++..+++.||||+++.... ....+.+|+.++.++ .|+++....
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 45567889999999999999999999999999999999965332 223345799999999 788874321
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cccccccCCcc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPDYK 206 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~-~~~~~k~~df~ 206 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-------- 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-------- 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--------
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--------
Confidence 13478899999999999999999999999999999999997 444
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCC-CchhHHHHHHHHHHHHhCCCC
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~lltg~~p 284 (405)
.++|+|||++...... .....||..|+|||++.+..+. .++|||||||++|+|++|..|
T Consensus 178 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 238 (312)
T 2iwi_A 178 -------------------CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238 (312)
T ss_dssp -------------------EEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------------eEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCC
Confidence 4666777766544332 2335789999999999877664 589999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 285 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
|..... +... .. .....++..+.+
T Consensus 239 f~~~~~------~~~~------------------------~~--------------------------~~~~~~~~~~~~ 262 (312)
T 2iwi_A 239 FERDQE------ILEA------------------------EL--------------------------HFPAHVSPDCCA 262 (312)
T ss_dssp CCSHHH------HHHT------------------------CC--------------------------CCCTTSCHHHHH
T ss_pred CCChHH------Hhhh------------------------cc--------------------------CCcccCCHHHHH
Confidence 965211 1000 00 111245678999
Q ss_pred HHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 365 LLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
||.+||+.||++|||++|+++||||+....
T Consensus 263 li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 999999999999999999999999998643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.25 Aligned_cols=218 Identities=18% Similarity=0.213 Sum_probs=167.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCC-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDI----------------- 150 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~----------------- 150 (405)
..|.+.+.||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+.+++.+.|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588999999999999999999999999999998732 2234667889988888876210
Q ss_pred ------------CC-C------------------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 015532 151 ------------GG-T------------------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187 (405)
Q Consensus 151 ------------~~-~------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl 187 (405)
.. . ....+++..+..++.||+.||.|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 00 0 0122456678888999999999999999999999
Q ss_pred CCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHH----------
Q 015532 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---------- 257 (405)
Q Consensus 188 kp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---------- 257 (405)
||+|||++.++. +||+|||++..........+| +.|+|||++
T Consensus 238 Kp~NILl~~~~~---------------------------~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 238 RPVDIVLDQRGG---------------------------VFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp CGGGEEECTTCC---------------------------EEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred ccceEEEecCCe---------------------------EEEEeccceeecCCccccCCC-CceeCchhhhccccccccc
Confidence 999999977654 566666666554444445678 999999999
Q ss_pred hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhh
Q 015532 258 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 337 (405)
Q Consensus 258 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (405)
.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~------------------------------------------ 327 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE------------------------------------------ 327 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG------------------------------------------
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH------------------------------------------
Confidence 44458889999999999999999999997654211100
Q ss_pred HHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCC
Q 015532 338 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~ 391 (405)
........+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus 328 ------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 328 ------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp ------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 001111245678999999999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.70 Aligned_cols=224 Identities=21% Similarity=0.251 Sum_probs=169.1
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45678999999999999999999999999999999875433 234578899999999998864321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecccccccCCccccccCCCCCCc
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli---~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~------------------- 145 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN------------------- 145 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-------------------
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-------------------
Confidence 2357899999999999999999999999999999999999 4444
Q ss_pred ccCCCCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 146 --------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 146 --------LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp --------CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred --------eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 4566666666443221 1235799999999999999999999999999999999999999976
Q ss_pred CChHH---HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHH
Q 015532 288 HENLE---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364 (405)
Q Consensus 288 ~~~~~---~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 364 (405)
..... .+..+...... .........+++.+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~l~~ 252 (296)
T 4hgt_A 218 LKAATKRQKYERISEKKMS---------------------------------------------TPIEVLCKGYPSEFAT 252 (296)
T ss_dssp CCCSSSSSHHHHHHHHHHH---------------------------------------------SCHHHHTTTSCHHHHH
T ss_pred cchhhhhhhhhhhhccccc---------------------------------------------chhhhhhccCCHHHHH
Confidence 43321 11111111000 0011112345678999
Q ss_pred HHHHccccCCCCCCCHHHHHc
Q 015532 365 LLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 365 ll~~~L~~dP~~Rpta~elL~ 385 (405)
||.+||+.||++|||++++++
T Consensus 253 li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 253 YLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHhcCCCCCCCHHHHHH
Confidence 999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.34 Aligned_cols=227 Identities=21% Similarity=0.263 Sum_probs=174.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~-------------- 154 (405)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+ .|+++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4578999999999999999999999999999999986533 234578899999999 888773321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~---------------------- 143 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN---------------------- 143 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG----------------------
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC----------------------
Confidence 246889999999999999999999999999999999999987653
Q ss_pred CCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
.....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 144 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 144 KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 01223667777766543221 13468999999999999999999999999999999999999999875432
Q ss_pred H---HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 292 E---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 292 ~---~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
+ .+..+.......|. .......+ ++.+||..
T Consensus 224 ~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~~p-~~~~li~~ 257 (330)
T 2izr_A 224 TLKERYQKIGDTKRATPI---------------------------------------------EVLCENFP-EMATYLRY 257 (330)
T ss_dssp SHHHHHHHHHHHHHHSCH---------------------------------------------HHHTTTCH-HHHHHHHH
T ss_pred cHHHHHHHHHhhhccCCH---------------------------------------------HHHhccCh-HHHHHHHH
Confidence 2 22222211111110 00112234 89999999
Q ss_pred ccccCCCCCCCHHHHHc
Q 015532 369 LLRYDPAERLKAREALR 385 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~ 385 (405)
||+.||++||+++++++
T Consensus 258 ~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 258 VRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHCCTTCCCCHHHHHH
T ss_pred HHhCCCCCCCCHHHHHH
Confidence 99999999999998876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=307.21 Aligned_cols=231 Identities=19% Similarity=0.237 Sum_probs=177.5
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc-----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR----------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~----------- 154 (405)
++.+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+ .|+++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 4556789999999999999999999999999999999986433 345578899999999 455442211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 v~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~------------------- 144 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS------------------- 144 (298)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------------------
T ss_pred EEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-------------------
Confidence 135899999999999999999999999999999999999976552
Q ss_pred cCCCCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
.....++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 145 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 145 ---KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp ---TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ---CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 12334777777777544322 23357999999999999999999999999999999999999999874
Q ss_pred C---hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 289 E---NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 289 ~---~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
. ..+.+..+.......+ .......+++.+.+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~l 256 (298)
T 1csn_A 222 KAATNKQKYERIGEKKQSTP---------------------------------------------LRELCAGFPEEFYKY 256 (298)
T ss_dssp CSCCHHHHHHHHHHHHHHSC---------------------------------------------HHHHTTTSCHHHHHH
T ss_pred hccccHHHHHHHHhhccCcc---------------------------------------------HHHHHhhCcHHHHHH
Confidence 3 2233322222110000 011123457789999
Q ss_pred HHHccccCCCCCCCHHHHHc
Q 015532 366 LQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~ 385 (405)
|.+||+.||++|||++++++
T Consensus 257 i~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 257 MHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcccCCCHHHHHH
Confidence 99999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=322.73 Aligned_cols=228 Identities=18% Similarity=0.269 Sum_probs=179.5
Q ss_pred cCCCeEEEeeeecccceeEEEEE-----ecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
..++|++.+.||+|+||+||+|+ +..+++.||||+++.. ......+.+|+.+++.+.|+++....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34789999999999999999999 4457789999998642 33445678899999999999984321
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~ 208 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---------- 218 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---------- 218 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----------
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC----------
Confidence 12478889999999999999999999999999999999997554
Q ss_pred ccCCCCCCcccCCCCCCCceeccCCCCcccc-----CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CC
Q 015532 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 282 (405)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~ 282 (405)
....+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 219 --------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 219 --------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp --------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred --------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 23347777887775321 12223568999999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
.||.+....+....+...... .....++..+
T Consensus 285 ~pf~~~~~~~~~~~i~~~~~~-------------------------------------------------~~~~~~~~~l 315 (367)
T 3l9p_A 285 MPYPSKSNQEVLEFVTSGGRM-------------------------------------------------DPPKNCPGPV 315 (367)
T ss_dssp CSSTTCCHHHHHHHHHTTCCC-------------------------------------------------CCCTTCCHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCC-------------------------------------------------CCCccCCHHH
Confidence 999988776655544321100 0112346689
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCCCCC
Q 015532 363 IDLLQGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
.+||.+||+.||++|||+.++++|.|+-
T Consensus 316 ~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 316 YRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=320.04 Aligned_cols=248 Identities=20% Similarity=0.323 Sum_probs=183.8
Q ss_pred eCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhh------------------hHHHHHHHHHHHHHhh
Q 015532 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY------------------REAAMIEIDVLQRLAR 147 (405)
Q Consensus 86 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------------------~~~~~~E~~il~~l~~ 147 (405)
.++...++|++.+.||+|+||.||+|++ +++.||||++...... .+.+.+|+.+++.+.|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3445568999999999999999999998 8999999999653221 1778899999999999
Q ss_pred cCCCCCc-----------------------------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCc
Q 015532 148 HDIGGTR-----------------------------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPEN 191 (405)
Q Consensus 148 ~~~~~~~-----------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~N 191 (405)
+++.... ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9873211 2457889999999999999999999 999999999999
Q ss_pred EEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCC-CCCC-chhH
Q 015532 192 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGL-GWNY-PCDL 268 (405)
Q Consensus 192 Ili~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~-~~Di 268 (405)
|+++.++ .++|+|||.+...... .....||..|+|||++.+. .++. ++||
T Consensus 183 il~~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 183 ILMDKNG---------------------------RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp EEECTTS---------------------------CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred EEEcCCC---------------------------cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 9997655 4667777766543322 2335789999999999887 5665 9999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc
Q 015532 269 WSVGCILVELCSGEALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347 (405)
Q Consensus 269 wSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (405)
|||||++|+|++|..||..... .+....+.......|... ..+.... .
T Consensus 236 ~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~--------------~ 284 (348)
T 2pml_X 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR-----------------NHFLYPL--------------T 284 (348)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS-----------------SSSTTTT--------------C
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch-----------------hhhhccc--------------c
Confidence 9999999999999999987765 444443322111111100 0000000 0
Q ss_pred hhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCC
Q 015532 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 348 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
..........++..+.+||.+||+.||++|||++|+|+||||++..
T Consensus 285 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 285 NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 0000111235678999999999999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=306.12 Aligned_cols=227 Identities=22% Similarity=0.272 Sum_probs=174.1
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 456889999999999999999999999999999999865433 34578899999999998863221
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++...
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~---------------------- 142 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK---------------------- 142 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG----------------------
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC----------------------
Confidence 23578999999999999999999999999999999999995211
Q ss_pred CCCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.+..+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 143 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 143 --KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp --GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred --CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 2234666666666543322 1335799999999999999999999999999999999999999976432
Q ss_pred H---HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 291 L---EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 291 ~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
. +.+..+.......| .......+++.+.+||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~ 255 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTP---------------------------------------------IEVLCKGYPSEFATYLN 255 (296)
T ss_dssp SSSSSHHHHHHHHHHHSC---------------------------------------------HHHHTTTSCHHHHHHHH
T ss_pred hhhhhhhhhhcccccCCc---------------------------------------------hHHHHhhCCHHHHHHHH
Confidence 1 12222211100000 01112345678999999
Q ss_pred HccccCCCCCCCHHHHHc
Q 015532 368 GLLRYDPAERLKAREALR 385 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~ 385 (405)
+||+.||++|||++++++
T Consensus 256 ~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 256 FCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTSCTTCCCCHHHHHH
T ss_pred HHHhcCcCcCCCHHHHHH
Confidence 999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=310.93 Aligned_cols=237 Identities=29% Similarity=0.427 Sum_probs=173.6
Q ss_pred ceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhh--cCCCCCc--
Q 015532 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLAR--HDIGGTR-- 154 (405)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~--~~~~~~~-- 154 (405)
+.+.......++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+++.+.| +++....
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 334444455678999999999999999999985 5888999999542 2345678899999999986 5553211
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 97 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~------------ 163 (313)
T 3cek_A 97 EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G------------ 163 (313)
T ss_dssp EECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T------------
T ss_pred eecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C------------
Confidence 235788899999999999999999999999999999999953 3
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhC-----------CCCCCchhHHHHHHH
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCI 274 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~i 274 (405)
.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 164 ---------------~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i 228 (313)
T 3cek_A 164 ---------------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228 (313)
T ss_dssp ---------------EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred ---------------eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence 36677777665433221 23478999999999976 468889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhc
Q 015532 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354 (405)
Q Consensus 275 l~~lltg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (405)
+|+|++|..||........ .+..... ...... .
T Consensus 229 l~el~~g~~pf~~~~~~~~--~~~~~~~-------------------~~~~~~--------------------------~ 261 (313)
T 3cek_A 229 LYYMTYGKTPFQQIINQIS--KLHAIID-------------------PNHEIE--------------------------F 261 (313)
T ss_dssp HHHHHHSSCTTTTCCSHHH--HHHHHHC-------------------TTSCCC--------------------------C
T ss_pred HHHHHhCCCchhhHHHHHH--HHHHHHh-------------------cccccC--------------------------C
Confidence 9999999999976543211 1111110 000111 1
Q ss_pred ccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCC
Q 015532 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 355 ~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
....+..+.+||.+||+.||++|||+.|+|+||||+....
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 1233568899999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=309.89 Aligned_cols=226 Identities=20% Similarity=0.274 Sum_probs=171.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||+||+|++ +++.||||++.... ...+.+.+|+.+++++.|+++....
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 46899999999999999999987 47889999986532 3345678999999999999884321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.||+.||.|||++| |+||||||+|||++.++
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~----------------- 176 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY----------------- 176 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-----------------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-----------------
Confidence 012788999999999999999999999 99999999999997655
Q ss_pred CcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 177 ----------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~ 246 (309)
T 3p86_A 177 ----------TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246 (309)
T ss_dssp ----------CEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred ----------cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4666667666543322 223579999999999999999999999999999999999999998877766
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+...... . .....+++.+.+||.+||+.
T Consensus 247 ~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~l~~li~~~l~~ 278 (309)
T 3p86_A 247 VVAAVGFKCKR----------------------L--------------------------EIPRNLNPQVAAIIEGCWTN 278 (309)
T ss_dssp HHHHHHHSCCC----------------------C--------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCC----------------------C--------------------------CCCccCCHHHHHHHHHHccC
Confidence 55443221110 0 11234567899999999999
Q ss_pred CCCCCCCHHHHHc--CCCCCCCC
Q 015532 373 DPAERLKAREALR--HPFFTRDV 393 (405)
Q Consensus 373 dP~~Rpta~elL~--hp~f~~~~ 393 (405)
||++|||++|+++ +++++...
T Consensus 279 dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 279 EPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp SGGGSCCHHHHHHHHHHHHC---
T ss_pred ChhhCcCHHHHHHHHHHHHHhCC
Confidence 9999999999997 56666543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=305.29 Aligned_cols=218 Identities=23% Similarity=0.331 Sum_probs=175.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||.||+|++. +++.||||+++......+.+.+|+.+++++.|+++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57999999999999999999986 467799999987666667889999999999999874321
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~------------------------ 144 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV------------------------ 144 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC------------------------
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC------------------------
Confidence 134788999999999999999999999999999999999976654
Q ss_pred CCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 145 ---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~ 221 (269)
T 4hcu_A 145 ---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 221 (269)
T ss_dssp ---EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ---EEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence 566666665443221 112356778999999999899999999999999999999 999999887766555443
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
..... ......++.+.+||.+||+.||++||
T Consensus 222 ~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 222 TGFRL-------------------------------------------------YKPRLASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp TTCCC-------------------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCccC-------------------------------------------------CCCCcCCHHHHHHHHHHccCCcccCc
Confidence 21110 01123467899999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|+.|+++|
T Consensus 253 s~~~ll~~ 260 (269)
T 4hcu_A 253 AFSRLLRQ 260 (269)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.28 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=160.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46899999999999999999999989999999998643 23345677899999999999874311
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+|++|||++.....
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 12378999999999999999999999999999999999998777666666665432211
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
... ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 174 ~~~-------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 174 GGD-------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp ---------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred CCC-------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 100 000011123478999999999976 468999999999999999999999998766544
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....... +..+. ... ..........++..+.+||.+||+.
T Consensus 235 ~~~~~~~--~~~~~---------------------~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~ 274 (303)
T 2vwi_A 235 VLMLTLQ--NDPPS---------------------LET-----------------GVQDKEMLKKYGKSFRKMISLCLQK 274 (303)
T ss_dssp HHHHHHT--SSCCC---------------------TTC----------------------CCCCCCCHHHHHHHHHHCCS
T ss_pred HHHHHhc--cCCCc---------------------ccc-----------------ccccchhhhhhhHHHHHHHHHHccC
Confidence 3322211 00000 000 0000112245577899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
||++|||+.|+++||||++....
T Consensus 275 dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 275 DPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp SGGGSCCHHHHHTSTTC------
T ss_pred ChhhCcCHHHHhhChhhhcCCCC
Confidence 99999999999999999976443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.55 Aligned_cols=220 Identities=21% Similarity=0.265 Sum_probs=173.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCc---EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..++|++.+.||+|+||.||+|++..+++ .||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 35789999999999999999999986554 5999999753 34456788999999999999884321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----------------- 189 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV----------------- 189 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-----------------
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC-----------------
Confidence 236789999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 190 ----------~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 190 ----------CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ----------EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ----------EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 5666666655433221 11245778999999998899999999999999999999 999998887
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+..... . .....+++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~l~~li~~~ 290 (325)
T 3kul_A 260 NRDVISSVEEGYR-----------------------L--------------------------PAPMGCPHALHQLMLDC 290 (325)
T ss_dssp HHHHHHHHHTTCC-----------------------C--------------------------CCCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC-----------------------C--------------------------CCCCCcCHHHHHHHHHH
Confidence 7666554432110 0 01124567899999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|..||++|||+.|+++
T Consensus 291 l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 291 WHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=306.30 Aligned_cols=226 Identities=20% Similarity=0.231 Sum_probs=178.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh--------hhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
..++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.+++.+.|+++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 35789999999999999999999999999999999854221 115678999999999999874321
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..+..++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~-------------- 162 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE-------------- 162 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT--------------
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC--------------
Confidence 235788999999999999999999999 999999999999976441
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
+....+||+|||++...........||+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 163 --------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 163 --------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp --------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred --------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 1233488999999887666656678999999999984 445789999999999999999999999765433
Q ss_pred HH--HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 292 EH--LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 292 ~~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
.. ...+.. .+. . ......+++.+.+||.+|
T Consensus 235 ~~~~~~~~~~-~~~---------------------~--------------------------~~~~~~~~~~l~~li~~~ 266 (287)
T 4f0f_A 235 KIKFINMIRE-EGL---------------------R--------------------------PTIPEDCPPRLRNVIELC 266 (287)
T ss_dssp HHHHHHHHHH-SCC---------------------C--------------------------CCCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhc-cCC---------------------C--------------------------CCCCcccCHHHHHHHHHH
Confidence 22 111111 000 0 011234567899999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|+.||++|||++|+++
T Consensus 267 l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 267 WSGDPKKRPHFSYIVK 282 (287)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.58 Aligned_cols=219 Identities=19% Similarity=0.270 Sum_probs=175.4
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||.||+|.+. ++..||||+++......+.+.+|+++++.+.|+++....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468999999999999999999875 567799999987666667789999999999999874321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~----------------------- 142 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC----------------------- 142 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC-----------------------
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC-----------------------
Confidence 124789999999999999999999999999999999999976554
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 143 ----~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 218 (268)
T 3sxs_A 143 ----VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218 (268)
T ss_dssp ----EEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ----EEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence 5666666654333221 11345678999999999889999999999999999999 99999887776655443
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
...... ......++.+.+||.+||+.||++|
T Consensus 219 ~~~~~~-------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~R 249 (268)
T 3sxs_A 219 SQGHRL-------------------------------------------------YRPHLASDTIYQIMYSCWHELPEKR 249 (268)
T ss_dssp HTTCCC-------------------------------------------------CCCTTSCHHHHHHHHHTTCSSGGGS
T ss_pred HcCCCC-------------------------------------------------CCCCcChHHHHHHHHHHcCCChhhC
Confidence 321100 0012346689999999999999999
Q ss_pred CCHHHHHcC
Q 015532 378 LKAREALRH 386 (405)
Q Consensus 378 pta~elL~h 386 (405)
||+.|+++|
T Consensus 250 ps~~~ll~~ 258 (268)
T 3sxs_A 250 PTFQQLLSS 258 (268)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=313.56 Aligned_cols=219 Identities=22% Similarity=0.286 Sum_probs=165.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcE----EEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~----vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
++|++.+.||+|+||+||+|++..+++. ||+|.++.. ....+.+.+|+.+++.+.|+++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 6799999999999999999999877765 477777532 23456788999999999999985321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~D-------------- 160 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD-------------- 160 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECC--------------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEcc--------------
Confidence 23578899999999999999999999999999999999998877555555
Q ss_pred cCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
||++...... .....||..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 -------------fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 161 -------------FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp -------------TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred -------------CcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 4444332211 112356889999999999999999999999999999999 999998876554
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.... .. ......+..+.+|+.+||+.
T Consensus 228 ~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~ 258 (327)
T 3poz_A 228 ISSILEKGE-----------------------RL--------------------------PQPPICTIDVYMIMVKCWMI 258 (327)
T ss_dssp HHHHHHTTC-----------------------CC--------------------------CCCTTBCHHHHHHHHHHTCS
T ss_pred HHHHHHcCC-----------------------CC--------------------------CCCccCCHHHHHHHHHHcCC
Confidence 433322110 00 01123466899999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++|||+.|++++
T Consensus 259 ~p~~Rps~~ell~~ 272 (327)
T 3poz_A 259 DADSRPKFRELIIE 272 (327)
T ss_dssp CGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999965
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=314.00 Aligned_cols=221 Identities=22% Similarity=0.315 Sum_probs=170.2
Q ss_pred CCCeEEEeeeecccceeEEEEE-----ecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... ...+.+.+|+.++.++ .|+++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 4789999999999999999999 55677899999997532 3345688999999999 566763211
Q ss_pred --------------------c-----------------------------------------------------------
Q 015532 155 --------------------Y----------------------------------------------------------- 155 (405)
Q Consensus 155 --------------------~----------------------------------------------------------- 155 (405)
.
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 0
Q ss_pred -------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCce
Q 015532 156 -------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228 (405)
Q Consensus 156 -------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~k 228 (405)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg---------------------- 238 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG---------------------- 238 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCG----------------------
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEecc----------------------
Confidence 018889999999999999999999999999999999999877655555555
Q ss_pred eccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 015532 229 LIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 229 l~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g 302 (405)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+........
T Consensus 239 -----~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 313 (359)
T 3vhe_A 239 -----LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313 (359)
T ss_dssp -----GGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred -----ceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC
Confidence 44322111 122468899999999999999999999999999999998 9999987654433322221110
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
.. ......++++.+||.+||+.||++|||+.|
T Consensus 314 ----------------------~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 314 ----------------------RM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp ----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----------------------CC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 00 111234678999999999999999999999
Q ss_pred HHcC
Q 015532 383 ALRH 386 (405)
Q Consensus 383 lL~h 386 (405)
+++|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=305.22 Aligned_cols=227 Identities=21% Similarity=0.326 Sum_probs=171.2
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
|.....||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 333458999999999999999999999999986543 3456788999999999999985421
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-ccccccCCccccccCCCCCCcccCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~-~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----------------------- 160 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG----------------------- 160 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC-----------------------
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC-----------------------
Confidence 113467888999999999999999999999999999999975 34
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.++|+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........
T Consensus 161 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 236 (295)
T 2clq_A 161 ----VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF 236 (295)
T ss_dssp ----CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH
T ss_pred ----CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH
Confidence 4677777766543321 22357899999999997653 88999999999999999999999975443322111
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
........ ......++..+.+||.+||+.||++
T Consensus 237 ~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 237 KVGMFKVH-----------------------------------------------PEIPESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHHHCCC-----------------------------------------------CCCCTTSCHHHHHHHHHTTCSSTTT
T ss_pred hhcccccc-----------------------------------------------ccccccCCHHHHHHHHHHccCChhh
Confidence 10000000 0112345678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~ 394 (405)
|||++|+|+||||+....
T Consensus 270 Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 270 RACANDLLVDEFLKVSSK 287 (295)
T ss_dssp SCCHHHHHTSGGGCC---
T ss_pred CCCHHHHhcChhhhhccc
Confidence 999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=304.81 Aligned_cols=219 Identities=19% Similarity=0.300 Sum_probs=173.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||+||+|.+. ++..||||+++......+.+.+|+.+++.+.|+++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 357999999999999999999886 677899999987666667789999999999999874311
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~------------------------ 157 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------------------------ 157 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS------------------------
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC------------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
.++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 158 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 234 (283)
T 3gen_A 158 ---VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234 (283)
T ss_dssp ---CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ---CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH
Confidence 45666666665432211 12346778999999998899999999999999999998 99999988776655544
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+..... .....++.+.+||.+||+.||++|
T Consensus 235 ~~~~~~~-------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~R 265 (283)
T 3gen_A 235 AQGLRLY-------------------------------------------------RPHLASEKVYTIMYSCWHEKADER 265 (283)
T ss_dssp HTTCCCC-------------------------------------------------CCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred hcccCCC-------------------------------------------------CCCcCCHHHHHHHHHHccCChhHC
Confidence 3321110 112345689999999999999999
Q ss_pred CCHHHHHcC
Q 015532 378 LKAREALRH 386 (405)
Q Consensus 378 pta~elL~h 386 (405)
||+.|+++|
T Consensus 266 ps~~~ll~~ 274 (283)
T 3gen_A 266 PTFKILLSN 274 (283)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=306.30 Aligned_cols=226 Identities=23% Similarity=0.336 Sum_probs=178.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCC-------cEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~-------~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
..++|++.+.||+|+||+||+|++..++ ..||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3468999999999999999999998777 469999986533 4557788999999999999984321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++..++.+++
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~------- 158 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP------- 158 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC-------
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc-------
Confidence 1237889999999999999999999999999999999999998876666654
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSG-EALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~ 291 (405)
.++|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||......
T Consensus 159 ------------~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 159 ------------FIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp ------------EEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ------------eeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 3799999998655432 33568999999999987 6789999999999999999995 5555554443
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
...... ..... .....+..+.+||.+||+
T Consensus 226 ~~~~~~-~~~~~--------------------------------------------------~~~~~~~~l~~li~~~l~ 254 (289)
T 4fvq_A 226 RKLQFY-EDRHQ--------------------------------------------------LPAPKAAELANLINNCMD 254 (289)
T ss_dssp HHHHHH-HTTCC--------------------------------------------------CCCCSSCTTHHHHHHHSC
T ss_pred HHHHHh-hccCC--------------------------------------------------CCCCCCHHHHHHHHHHcC
Confidence 322211 11100 112234578899999999
Q ss_pred cCCCCCCCHHHHHcC
Q 015532 372 YDPAERLKAREALRH 386 (405)
Q Consensus 372 ~dP~~Rpta~elL~h 386 (405)
.||++|||+.|+++|
T Consensus 255 ~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 255 YEPDHRPSFRAIIRD 269 (289)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhHCcCHHHHHHH
Confidence 999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=304.53 Aligned_cols=221 Identities=18% Similarity=0.302 Sum_probs=178.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
...++|++.+.||+|+||.||+|.+..+++.||||++.......+.+.+|+.+++.+.|+++....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 345789999999999999999999999999999999987666677889999999999999874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-------------------- 149 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-------------------- 149 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--------------------
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--------------------
Confidence 134788999999999999999999999999999999999977664
Q ss_pred CCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 294 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 294 (405)
++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 150 -------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 150 -------VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp -------EEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred -------EEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 5566666554433222 12457889999999999899999999999999999999 99999877655444
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+..... ......+++.+.+||.+||..||
T Consensus 223 ~~~~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~~l~~dp 253 (288)
T 3kfa_A 223 ELLEKDYR-------------------------------------------------MERPEGCPEKVYELMRACWQWNP 253 (288)
T ss_dssp HHHHTTCC-------------------------------------------------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHhccCC-------------------------------------------------CCCCCCCCHHHHHHHHHHhCCCh
Confidence 33322100 01123456789999999999999
Q ss_pred CCCCCHHHHHc
Q 015532 375 AERLKAREALR 385 (405)
Q Consensus 375 ~~Rpta~elL~ 385 (405)
++|||++|+++
T Consensus 254 ~~Rps~~~~~~ 264 (288)
T 3kfa_A 254 SDRPSFAEIHQ 264 (288)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.86 Aligned_cols=227 Identities=19% Similarity=0.266 Sum_probs=174.0
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+.++|++.++||+|+||.||+|++..+++.||||+++.... ...+..|+++++.|.|+++....
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 456889999999999999999999999999999998865332 34578899999999987653221
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++|||||||||+||||+..
T Consensus 83 e~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----------------------- 139 (483)
T 3sv0_A 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------------------- 139 (483)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-----------------------
T ss_pred ECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC-----------------------
Confidence 2458899999999999999999999999999999999999421
Q ss_pred CCCCCCceeccCCCCccccCCc----------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 140 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 140 -RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp -GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred -CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 123346666666665433221 245799999999999999999999999999999999999999987543
Q ss_pred H---HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 291 L---EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 291 ~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
. +.+..+.... ...........++.++.+||.
T Consensus 219 ~~~~~~~~~i~~~~---------------------------------------------~~~~~~~l~~~~p~~l~~li~ 253 (483)
T 3sv0_A 219 GTKKQKYEKISEKK---------------------------------------------VATSIEALCRGYPTEFASYFH 253 (483)
T ss_dssp SSHHHHHHHHHHHH---------------------------------------------HHSCHHHHHTTSCHHHHHHHH
T ss_pred hhHHHHHHHHhhcc---------------------------------------------ccccHHHHhcCCcHHHHHHHH
Confidence 2 2222221110 000011112345678999999
Q ss_pred HccccCCCCCCCHHHHHc
Q 015532 368 GLLRYDPAERLKAREALR 385 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~ 385 (405)
+||+.||++||++++|++
T Consensus 254 ~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 254 YCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTCCTTCCCCHHHHHH
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=310.02 Aligned_cols=219 Identities=21% Similarity=0.290 Sum_probs=168.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEE----EEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~v----AiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.++|++.+.||+|+||+||+|++..+++.| |+|.++.. ....+.+.+|+.+++.+.|+++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 478999999999999999999998887765 66665432 23456788999999999999985432
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~------------------ 155 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH------------------ 155 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE------------------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC------------------
Confidence 235788999999999999999999999999999999999987664
Q ss_pred ccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 291 (405)
+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 156 ---------~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 156 ---------VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp ---------EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ---------EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 4555555554332211 12356788999999999999999999999999999999 99999887665
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.... .. ......+.++.+||.+||+
T Consensus 227 ~~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~~l~ 257 (327)
T 3lzb_A 227 EISSILEKGE-----------------------RL--------------------------PQPPICTIDVYMIMRKCWM 257 (327)
T ss_dssp GHHHHHHTTC-----------------------CC--------------------------CCCTTBCHHHHHHHHHHTC
T ss_pred HHHHHHHcCC-----------------------CC--------------------------CCCccCCHHHHHHHHHHcC
Confidence 5443332211 00 0112346689999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.||++|||+.|+++
T Consensus 258 ~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 258 IDADSRPKFRELII 271 (327)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=308.16 Aligned_cols=237 Identities=17% Similarity=0.221 Sum_probs=171.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecc-hhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
++|++.+.||+|+||+||+|++..+++.||+|++.. .....+.+.+|+++++.+.|+++....
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 679999999999999999999999999999998854 334567788999999999999984321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-- 167 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG-- 167 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc--
Confidence 245788999999999999999999999999999999999987776666666554332211100000
Q ss_pred CCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 015532 223 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~g 302 (405)
. ...............||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 168 ------~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------- 232 (310)
T 3s95_A 168 ------L--RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------- 232 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------
T ss_pred ------c--ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------
Confidence 0 0000000011123579999999999999999999999999999999999999986532210000
Q ss_pred CCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHH
Q 015532 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 382 (405)
Q Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~e 382 (405)
....... ........+++.+.+||.+||+.||++|||+.+
T Consensus 233 --------------------------------~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 272 (310)
T 3s95_A 233 --------------------------------GLNVRGF--------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK 272 (310)
T ss_dssp --------------------------------SBCHHHH--------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHH
T ss_pred --------------------------------hhhhhcc--------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000000 000112345678999999999999999999999
Q ss_pred HHc
Q 015532 383 ALR 385 (405)
Q Consensus 383 lL~ 385 (405)
+++
T Consensus 273 l~~ 275 (310)
T 3s95_A 273 LEH 275 (310)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.10 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=172.3
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCcc----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRY---------- 155 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~~---------- 155 (405)
.+.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|+.+ .|++++....
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 34566788889999999999998754 467899999998653 245578899999987 7888754210
Q ss_pred ------c----------c-------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 156 ------R----------S-------FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 156 ------~----------~-------l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
+ . .++..+..++.||+.||.|||++||+||||||+|||++..+.......
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~------- 159 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ------- 159 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT-------
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc-------
Confidence 0 0 122234679999999999999999999999999999987543211110
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCc-------cceecCCCcchhHHHhC-------CCCCCchhHHHHHHHHHHH
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~l 278 (405)
..+.+..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 160 -------~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~el 232 (434)
T 2rio_A 160 -------TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232 (434)
T ss_dssp -------TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHH
T ss_pred -------cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHH
Confidence 01234578999999887654322 23579999999999976 5689999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
++ |..||......+. .+...... .+. ........
T Consensus 233 lt~g~~Pf~~~~~~~~--~i~~~~~~------------------------~~~-------------------~~~~~~~~ 267 (434)
T 2rio_A 233 LSKGKHPFGDKYSRES--NIIRGIFS------------------------LDE-------------------MKCLHDRS 267 (434)
T ss_dssp HTTSCCTTCSTTTHHH--HHHHTCCC------------------------CCC-------------------CTTCCCHH
T ss_pred HhCCCCCCCCchhhHH--HHhcCCCC------------------------ccc-------------------cccccccc
Confidence 99 9999976543321 11111000 000 00000112
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
.+.++.+||.+||+.||++|||+.|+++||||...
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 268 LIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 35689999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.92 Aligned_cols=226 Identities=27% Similarity=0.349 Sum_probs=160.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh---hhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+..+..+++.+.|+++....
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 679999999999999999999999999999999965322 222333444567778888874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 105 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~---------------------- 162 (318)
T 2dyl_A 105 LMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---------------------- 162 (318)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS----------------------
T ss_pred ccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC----------------------
Confidence 24578899999999999999999995 999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHE-NLE 292 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~ 292 (405)
.+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.... ..+
T Consensus 163 -----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (318)
T 2dyl_A 163 -----QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237 (318)
T ss_dssp -----CEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred -----CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH
Confidence 4566666666443222 22347899999999995 4568899999999999999999999998743 333
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.....+ .. .....++..+.+||.+||+.
T Consensus 238 ~~~~~~~~~~~-----------------------~~------------------------~~~~~~~~~l~~li~~~l~~ 270 (318)
T 2dyl_A 238 VLTKVLQEEPP-----------------------LL------------------------PGHMGFSGDFQSFVKDCLTK 270 (318)
T ss_dssp HHHHHHHSCCC-----------------------CC------------------------CSSSCCCHHHHHHHHHHTCS
T ss_pred HHHHHhccCCC-----------------------CC------------------------CccCCCCHHHHHHHHHHccC
Confidence 33332221000 00 01123567899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTR 391 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~ 391 (405)
||++|||++|+++||||++
T Consensus 271 dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 271 DHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CTTTSCCHHHHTTSHHHHH
T ss_pred ChhHCcCHHHHhhCHHHHh
Confidence 9999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.88 Aligned_cols=220 Identities=18% Similarity=0.303 Sum_probs=170.8
Q ss_pred CCCeEEEeeeecccceeEEEEEec-------CCCcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------ 154 (405)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ....+.+.+|+.+++.+ .|+++....
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 368999999999999999999874 34567999999753 23456788999999999 788874311
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 -------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 0136788899999999999999999999999999999999776
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+. +||+|||++...... .....+|+.|+|||++.+..++.++||||||
T Consensus 240 ~~---------------------------~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 292 (370)
T 2psq_A 240 NV---------------------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292 (370)
T ss_dssp CC---------------------------EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHH
T ss_pred CC---------------------------EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHH
Confidence 64 455555555432221 1223567899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|||++ |..||.+....+....+.... ..
T Consensus 293 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------------~~------------------------- 324 (370)
T 2psq_A 293 VLMWEIFTLGGSPYPGIPVEELFKLLKEGH-----------------------RM------------------------- 324 (370)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------------CC-------------------------
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-----------------------CC-------------------------
Confidence 99999999 999998876554443322110 00
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.....++..+.+||.+||+.||++|||+.|++++
T Consensus 325 -~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 325 -DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122456789999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=307.55 Aligned_cols=232 Identities=16% Similarity=0.227 Sum_probs=168.3
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecC---CCcEEEEEEecchhh------------hhHHHHHHHHHHHHHhhcCCCC
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~------------~~~~~~~E~~il~~l~~~~~~~ 152 (405)
+...++|++.+.||+|+||.||+|++.. ++..||||++..... ....+.+|+.++..+.|+++..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3445789999999999999999999987 788999999864321 1234566788888889998843
Q ss_pred Cc------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccccccc
Q 015532 153 TR------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 153 ~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~ 202 (405)
.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---- 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN---- 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS----
T ss_pred eecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC----
Confidence 21 12578999999999999999999999999999999999998654
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
...+||+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus 189 ---------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 247 (345)
T 2v62_A 189 ---------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILG 247 (345)
T ss_dssp ---------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred ---------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHH
Confidence 124566666666433211 1335799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhh
Q 015532 273 CILVELCSGEALFQTH--ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 350 (405)
Q Consensus 273 ~il~~lltg~~pf~~~--~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (405)
|++|+|++|..||.+. ...............+|..+...
T Consensus 248 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 288 (345)
T 2v62_A 248 YCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW--------------------------------------- 288 (345)
T ss_dssp HHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH---------------------------------------
T ss_pred HHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh---------------------------------------
Confidence 9999999999999652 22222222223222333221100
Q ss_pred hhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 351 ~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.....++.++.+||.+||+.||++|||++++++
T Consensus 289 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 289 --APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp --SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 001245778999999999999999999999886
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=300.66 Aligned_cols=227 Identities=22% Similarity=0.290 Sum_probs=167.9
Q ss_pred eeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 85 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
..++...++|++.++||+|+||+||+|++.. .||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCc
Confidence 3456677899999999999999999998743 5999998643 23446688999999999999884321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--------------- 158 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--------------- 158 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE---------------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC---------------
Confidence 235788999999999999999999999999999999999987664
Q ss_pred CCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHh---CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
++|+|||++..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 159 ------------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 159 ------------VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp ------------EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ------------EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 45555555543221 112357899999999997 5568899999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+....+.+..+.......+ ........+++.+.+||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~l~~li 262 (289)
T 3og7_A 227 NINNRDQIIEMVGRGSLSP--------------------------------------------DLSKVRSNCPKRMKRLM 262 (289)
T ss_dssp SCCCHHHHHHHHHHTSCCC--------------------------------------------CTTSSCTTSCHHHHHHH
T ss_pred ccchHHHHHHHhcccccCc--------------------------------------------chhhccccCCHHHHHHH
Confidence 8766554443322111000 00111234567899999
Q ss_pred HHccccCCCCCCCHHHHHc
Q 015532 367 QGLLRYDPAERLKAREALR 385 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~ 385 (405)
.+||+.||++|||+.++++
T Consensus 263 ~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 263 AECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=310.33 Aligned_cols=220 Identities=21% Similarity=0.254 Sum_probs=168.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcE----EEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~----vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.++|++.+.||+|+||+||+|++..+++. ||+|++.... .....+.+|+.+++.+.|+++....
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL 91 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence 36899999999999999999999888775 7777764322 2234567899999999999984321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~------------------ 153 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ------------------ 153 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC------------------
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe------------------
Confidence 235788899999999999999999999999999999999976664
Q ss_pred ccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 291 (405)
+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 154 ---------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 224 (325)
T 3kex_A 154 ---------VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224 (325)
T ss_dssp ---------EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred ---------EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence 455555555433221 123467889999999999899999999999999999999 99999887655
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.... ... .....+..+.+||.+||+
T Consensus 225 ~~~~~~~~~~-----------------------~~~--------------------------~~~~~~~~~~~li~~~l~ 255 (325)
T 3kex_A 225 EVPDLLEKGE-----------------------RLA--------------------------QPQICTIDVYMVMVKCWM 255 (325)
T ss_dssp HHHHHHHTTC-----------------------BCC--------------------------CCTTBCTTTTHHHHHHTC
T ss_pred HHHHHHHcCC-----------------------CCC--------------------------CCCcCcHHHHHHHHHHcC
Confidence 5443332210 000 112235577899999999
Q ss_pred cCCCCCCCHHHHHcC
Q 015532 372 YDPAERLKAREALRH 386 (405)
Q Consensus 372 ~dP~~Rpta~elL~h 386 (405)
.||++|||+.|+++|
T Consensus 256 ~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 256 IDENIRPTFKELANE 270 (325)
T ss_dssp SCTTTSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.23 Aligned_cols=221 Identities=24% Similarity=0.314 Sum_probs=167.7
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..++|++.+.||+|+||.||+|++..+ +..||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 457899999999999999999998654 457999998653 33456788999999999999884321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~----------------- 155 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV----------------- 155 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE-----------------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCE-----------------
Confidence 1247889999999999999999999999999999999999876654
Q ss_pred ccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 156 ----------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~ 225 (281)
T 1mp8_A 156 ----------KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225 (281)
T ss_dssp ----------EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ----------EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence 555555554332211 12356788999999998899999999999999999996 999998876655
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.... .. .....+++.+.+||.+||+.
T Consensus 226 ~~~~i~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~~l~~ 256 (281)
T 1mp8_A 226 VIGRIENGE-----------------------RL--------------------------PMPPNCPPTLYSLMTKCWAY 256 (281)
T ss_dssp HHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHcCC-----------------------CC--------------------------CCCCCCCHHHHHHHHHHccC
Confidence 444332210 00 01134567899999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++|||+.|++++
T Consensus 257 ~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 257 DPSRRPRFTELKAQ 270 (281)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=296.80 Aligned_cols=227 Identities=23% Similarity=0.300 Sum_probs=170.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-----hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ...+.+.+|+++++.+.|+++....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999975 7889999986432 2346678899999999999884321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..++.++.||+.||.|||++| |+||||||+|||++..+..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~---------------- 147 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN---------------- 147 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS----------------
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc----------------
Confidence 246789999999999999999999999 9999999999999753210
Q ss_pred cccCCCCCCCceeccCCCCccccCCc-cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
....+..++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 148 ---~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (271)
T 3dtc_A 148 ---GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224 (271)
T ss_dssp ---SCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred ---ccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00124568999999887544332 23579999999999999899999999999999999999999998877655443
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+..... .......+++.+.+||.+||+.||+
T Consensus 225 ~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~ 256 (271)
T 3dtc_A 225 GVAMNKL------------------------------------------------ALPIPSTCPEPFAKLMEDCWNPDPH 256 (271)
T ss_dssp HHHTSCC------------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred hhhcCCC------------------------------------------------CCCCCcccCHHHHHHHHHHhcCCcc
Confidence 3221100 0011234567899999999999999
Q ss_pred CCCCHHHHHcC
Q 015532 376 ERLKAREALRH 386 (405)
Q Consensus 376 ~Rpta~elL~h 386 (405)
+|||+.|+++|
T Consensus 257 ~Rps~~e~l~~ 267 (271)
T 3dtc_A 257 SRPSFTNILDQ 267 (271)
T ss_dssp GSCCHHHHHHH
T ss_pred cCcCHHHHHHH
Confidence 99999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.04 Aligned_cols=228 Identities=24% Similarity=0.278 Sum_probs=165.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~---------------- 154 (405)
.+|.+.+.||+|+||+||. ....+++.||||++.... .....+|+.+|+.+ .|++++...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4699999999999999764 344678899999986532 22356799999999 788885432
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+.+..+..++.||+.||.|||++||+||||||+|||++.++. +.
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~----------------------~~ 158 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA----------------------HG 158 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT----------------------TT
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC----------------------CC
Confidence 112344567789999999999999999999999999999964321 12
Q ss_pred CCCceeccCCCCccccCC------ccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 293 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 293 (405)
...++|+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus 159 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~ 238 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238 (432)
T ss_dssp BCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH
T ss_pred ceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH
Confidence 345678888887654422 223579999999999974 467889999999999999999 9999965543322
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
.. ..+... .... ......+..+.+||.+||+.|
T Consensus 239 ~~----~~~~~~--------------------~~~~-----------------------~~~~~~~~~~~~li~~~L~~d 271 (432)
T 3p23_A 239 NI----LLGACS--------------------LDCL-----------------------HPEKHEDVIARELIEKMIAMD 271 (432)
T ss_dssp HH----HTTCCC--------------------CTTS-----------------------CTTCHHHHHHHHHHHHHSCSS
T ss_pred HH----HhccCC--------------------cccc-----------------------CccccccHHHHHHHHHHHhCC
Confidence 11 111000 0000 000122456889999999999
Q ss_pred CCCCCCHHHHHcCCCCCC
Q 015532 374 PAERLKAREALRHPFFTR 391 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~ 391 (405)
|++|||++|+++||||..
T Consensus 272 P~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 272 PQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp GGGSCCHHHHHTSTTTCC
T ss_pred HhhCCCHHHHHhCccccC
Confidence 999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=310.09 Aligned_cols=220 Identities=20% Similarity=0.303 Sum_probs=173.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-------CcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-------~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------ 154 (405)
.++|++.++||+|+||.||+|++..+ +..||||+++.. ......+.+|+++++.+ .|+++....
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 47899999999999999999997543 357999999653 23346688999999999 888874311
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 -------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 0238899999999999999999999999999999999999766
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+. +||+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus 228 ~~---------------------------~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG 280 (382)
T 3tt0_A 228 NV---------------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280 (382)
T ss_dssp CC---------------------------EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHH
T ss_pred Cc---------------------------EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHH
Confidence 54 555666655433221 1224578899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++ |..||.+....+....+.... ..
T Consensus 281 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------------~~------------------------- 312 (382)
T 3tt0_A 281 VLLWEIFTLGGSPYPGVPVEELFKLLKEGH-----------------------RM------------------------- 312 (382)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----------------------CC-------------------------
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------------CC-------------------------
Confidence 99999999 999998877665554432211 00
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.....+++++.+||.+||+.||++|||+.|++++
T Consensus 313 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 313 -DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123456789999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=300.65 Aligned_cols=236 Identities=22% Similarity=0.307 Sum_probs=170.2
Q ss_pred cCCCeEEEeeeecccceeEEEEE----ecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..++|++.+.||+|+||+||+|+ +..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 35789999999999999999998 56789999999997533 3446788999999999999884321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~-------------- 153 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV-------------- 153 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE--------------
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeE--------------
Confidence 1237888999999999999999999999999999999999876654
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 -------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 154 -------------KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred -------------EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 555555554332211 1234677899999999999999999999999999999999998643
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
... .....+..+...... .........+.+ ......+++++.+||.+
T Consensus 221 ~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~ 267 (295)
T 3ugc_A 221 PAE-----FMRMIGNDKQGQMIV--FHLIELLKNNGR--------------------------LPRPDGCPDEIYMIMTE 267 (295)
T ss_dssp HHH-----HHHHHCTTCCTHHHH--HHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHH
T ss_pred hHH-----HHhhhcCccccchhH--HHHHHHHhccCc--------------------------CCCCcCcCHHHHHHHHH
Confidence 211 111111111100000 000000011111 11223567789999999
Q ss_pred ccccCCCCCCCHHHHHc
Q 015532 369 LLRYDPAERLKAREALR 385 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~ 385 (405)
||+.||++|||+.|+++
T Consensus 268 ~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 268 CWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HSCSSGGGSCCHHHHHH
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.35 Aligned_cols=253 Identities=20% Similarity=0.312 Sum_probs=177.1
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..+.++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|+++++.+.|+++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 445678999999999999999999999999999999997533 3346678999999999999874321
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+....
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------------- 149 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE--------------- 149 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT---------------
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC---------------
Confidence 01288999999999999999999999999999999999983211
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhC--------CCCCCchhHHHHHHHHHHHHhCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG--------LGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
+.+..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 150 --------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~ 221 (396)
T 4eut_A 150 --------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (396)
T ss_dssp --------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred --------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCC
Confidence 123356777777776543322 23579999999999875 457789999999999999999999
Q ss_pred CCCCCCh-HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHH
Q 015532 284 LFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362 (405)
Q Consensus 284 pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 362 (405)
||..... ......+.+.....|...+..... .......|..... .........+..+
T Consensus 222 Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~------~~~~~~~~~~~~~----------------~~~~l~~~~~~~l 279 (396)
T 4eut_A 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQK------AENGPIDWSGDMP----------------VSCSLSRGLQVLL 279 (396)
T ss_dssp SEECTTCTTTCHHHHHHHHHSCCTTCCEEEEC------STTCCEEEESSCC----------------TTCSSCHHHHHHH
T ss_pred CCCCCCcccchHHHHHHHhcCCCcccchhhee------ccCCCcccCccCC----------------cccccchHHHhhc
Confidence 9965322 111222222222222211000000 0000111111000 0001112346688
Q ss_pred HHHHHHccccCCCCCCCHHHHHc
Q 015532 363 IDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 363 ~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+||.+||++||++|||++|+++
T Consensus 280 ~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 280 TPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hHHHHHhhccChhhhccHHHHHH
Confidence 99999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=309.54 Aligned_cols=232 Identities=25% Similarity=0.410 Sum_probs=155.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHH-HHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEID-VLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~-il~~l~~~~~~~~~------------- 154 (405)
.++|++.+.||+|+||.||+|.+..+++.||||+++... .....+..|+. +++.+.|+++....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999999999999999996532 23344555665 66777888874321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~---------------- 164 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---------------- 164 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE----------------
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC----------------
Confidence 24578889999999999999999998 9999999999999987664
Q ss_pred CcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHH----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
+||+|||++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+..
T Consensus 165 -----------~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 165 -----------IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -----------EEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred -----------EEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 5666666654433221 224689999999998 45568999999999999999999999997643
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
... ..+..... +.. +.........+++.+.+||.+|
T Consensus 234 ~~~--~~~~~~~~--------------------~~~----------------------~~~~~~~~~~~~~~l~~li~~~ 269 (327)
T 3aln_A 234 SVF--DQLTQVVK--------------------GDP----------------------PQLSNSEEREFSPSFINFVNLC 269 (327)
T ss_dssp --------CCCCC--------------------SCC----------------------CCCCCCSSCCCCHHHHHHHHHH
T ss_pred hHH--HHHHHHhc--------------------CCC----------------------CCCCCcccccCCHHHHHHHHHH
Confidence 211 00000000 000 0000111234577899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
|+.||++|||+.|+++||||....
T Consensus 270 l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 270 LTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred hhCChhhCcCHHHHHhChHHHHhH
Confidence 999999999999999999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=295.78 Aligned_cols=219 Identities=22% Similarity=0.351 Sum_probs=175.0
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..++|++.+.||+|+||.||+|.+. +++.||||+++......+.+.+|+++++.+.|+++....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence 3468999999999999999999975 567899999977665677889999999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~----------------------- 146 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL----------------------- 146 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-----------------------
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-----------------------
Confidence 01578899999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....
T Consensus 147 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 222 (279)
T 1qpc_A 147 ----SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222 (279)
T ss_dssp ----CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred ----CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 45666666665433221 12356788999999998889999999999999999999 9999988776655444
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+... . .....++..+.+||.+||..||++
T Consensus 223 ~~~~~~-----------------------~--------------------------~~~~~~~~~l~~li~~~l~~~p~~ 253 (279)
T 1qpc_A 223 LERGYR-----------------------M--------------------------VRPDNCPEELYQLMRLCWKERPED 253 (279)
T ss_dssp HHTTCC-----------------------C--------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HhcccC-----------------------C--------------------------CCcccccHHHHHHHHHHhccChhh
Confidence 322100 0 011244678999999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
|||++++++
T Consensus 254 Rps~~~l~~ 262 (279)
T 1qpc_A 254 RPTFDYLRS 262 (279)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.10 Aligned_cols=218 Identities=19% Similarity=0.296 Sum_probs=171.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+++|+.+.|+++....
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 6799999999999999999999989999999998653 22345677899999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG--------------- 258 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG--------------- 258 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG---------------
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC---------------
Confidence 1247889999999999999999999999999999999999876655555554
Q ss_pred CCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 295 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 295 (405)
++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus 259 ------------~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~ 326 (377)
T 3cbl_A 259 ------------MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326 (377)
T ss_dssp ------------GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred ------------CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 443322111 11235778999999998889999999999999999998 999998877655444
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+... .+... +..+++.+.+||.+||+.||+
T Consensus 327 ~~~~~-----------------------~~~~~--------------------------~~~~~~~l~~li~~cl~~dP~ 357 (377)
T 3cbl_A 327 FVEKG-----------------------GRLPC--------------------------PELCPDAVFRLMEQCWAYEPG 357 (377)
T ss_dssp HHHTT-----------------------CCCCC--------------------------CTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHcC-----------------------CCCCC--------------------------CCCCCHHHHHHHHHHcCCCch
Confidence 33221 11111 123466899999999999999
Q ss_pred CCCCHHHHHc
Q 015532 376 ERLKAREALR 385 (405)
Q Consensus 376 ~Rpta~elL~ 385 (405)
+|||++++++
T Consensus 358 ~Rps~~~i~~ 367 (377)
T 3cbl_A 358 QRPSFSTIYQ 367 (377)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=294.91 Aligned_cols=218 Identities=23% Similarity=0.331 Sum_probs=174.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||.||+|.+. +++.||||+++......+.+.+|+.+++.+.|+++....
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57999999999999999999986 567899999987665667889999999999999874311
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~------------------------ 142 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV------------------------ 142 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC------------------------
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC------------------------
Confidence 134788999999999999999999999999999999999977664
Q ss_pred CCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
++|+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 143 ---~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~ 219 (267)
T 3t9t_A 143 ---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219 (267)
T ss_dssp ---EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ---EEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 555555555433221 112356788999999998899999999999999999999 999998877665554432
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
..... ......+..+.+||.+||+.||++||
T Consensus 220 ~~~~~-------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 220 TGFRL-------------------------------------------------YKPRLASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp TTCCC-------------------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCcC-------------------------------------------------CCCccCcHHHHHHHHHHccCChhhCc
Confidence 21100 01123466899999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|+.+++++
T Consensus 251 s~~~ll~~ 258 (267)
T 3t9t_A 251 AFSRLLRQ 258 (267)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.68 Aligned_cols=229 Identities=18% Similarity=0.272 Sum_probs=175.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEE-----ecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
...++|++.+.||+|+||.||+|+ +..+++.||||++... ......+.+|+.+++.+.|+++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 345789999999999999999999 5567889999999542 33456688899999999999874321
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~--------- 177 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--------- 177 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---------
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC---------
Confidence 02378889999999999999999999999999999999997543
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-C
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-G 281 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g 281 (405)
....++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 178 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 242 (327)
T 2yfx_A 178 ---------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 242 (327)
T ss_dssp ---------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ---------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCC
Confidence 233577777776653221 1123467889999999999899999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
..||......+....+..... . .....++..
T Consensus 243 ~~p~~~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~ 273 (327)
T 2yfx_A 243 YMPYPSKSNQEVLEFVTSGGR-----------------------M--------------------------DPPKNCPGP 273 (327)
T ss_dssp CCSSTTCCHHHHHHHHHTTCC-----------------------C--------------------------CCCTTCCHH
T ss_pred CCCCCCcCHHHHHHHHhcCCC-----------------------C--------------------------CCCCCCCHH
Confidence 999988776655443322100 0 011234678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~ 390 (405)
+.+||.+||+.||++|||+.++++|.|+-
T Consensus 274 l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 274 VYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999988764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=307.04 Aligned_cols=229 Identities=15% Similarity=0.208 Sum_probs=163.4
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCC-----CcEEEEEEecchhhh------------hHHHHHHHHHHHHHhhcCC
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSINKY------------REAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~~~------------~~~~~~E~~il~~l~~~~~ 150 (405)
+...++|++.+.||+|+||.||+|.+..+ ++.||||++...... ......|+..+..+.|+++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 34456899999999999999999998764 578999998653211 1122234444555567776
Q ss_pred CCCc-------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe--cc
Q 015532 151 GGTR-------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV--SA 197 (405)
Q Consensus 151 ~~~~-------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~--~~ 197 (405)
.... ...+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 4321 14589999999999999999999999999999999999998 44
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchh
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCD 267 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (405)
+ .+||+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 191 ~---------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 243 (364)
T 3op5_A 191 D---------------------------QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGD 243 (364)
T ss_dssp T---------------------------CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHH
T ss_pred C---------------------------eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhh
Confidence 4 4566666665432211 12346999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhcc
Q 015532 268 LWSVGCILVELCSGEALFQTHENLEH-LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346 (405)
Q Consensus 268 iwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (405)
||||||++|+|++|..||.+...... ...........
T Consensus 244 i~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------------------------------ 281 (364)
T 3op5_A 244 LEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN------------------------------------------ 281 (364)
T ss_dssp HHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC------------------------------------------
T ss_pred HHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh------------------------------------------
Confidence 99999999999999999986432222 21111110000
Q ss_pred chhhhhhc--ccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 347 LPNLIMQH--VDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 347 ~~~~~~~~--~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
........ ....+.++.+||..||..||++||++.++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 282 IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 00000000 1345678999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=310.80 Aligned_cols=237 Identities=22% Similarity=0.209 Sum_probs=168.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||+||+|++. ++.||||+++...........|+.++..+.|+++....
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 57999999999999999999875 78999999977666666677799999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHC----------CcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHEL----------RLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~----------givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~------------- 168 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL------------- 168 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-------------
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-------------
Confidence 13478899999999999999999999 999999999999997655
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCC-----CCCCchhHHHHHHHHHHHHhC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~~lltg 281 (405)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 169 --------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 169 --------------TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp --------------CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred --------------eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 4566666666433221 1225799999999999873 455788999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhh-cccCchH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ-HVDHSAG 360 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 360 (405)
..||.+....................... ........+ +..... .....+.
T Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~----------------------~~~~~~~~~~~~~~ 286 (322)
T 3soc_A 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQ------EVVVHKKKR----------------------PVLRDYWQKHAGMA 286 (322)
T ss_dssp BTTSSSCCCCCCCTTHHHHCSSCCHHHHH------HHHTTSCCC----------------------CCCCGGGGSSHHHH
T ss_pred CCCCCCCcchhccchhhhhccCCchhhhh------hhhhcccCC----------------------CCccccccccchHH
Confidence 99997654321111111111110000000 000000000 000000 0112345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHc
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+.+||.+||+.||++|||+.|+++
T Consensus 287 ~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 287 MLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 6999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.31 Aligned_cols=218 Identities=25% Similarity=0.334 Sum_probs=164.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||+||+|++. ++.||||++... ...+.+.+|+++++++.|+++....
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 57999999999999999999975 788999999653 3456788999999999999884321
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--------------------- 143 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--------------------- 143 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT---------------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC---------------------
Confidence 1235788899999999999999999 89999999999999976542
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 144 -----~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 218 (307)
T 2eva_A 144 -----VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH 218 (307)
T ss_dssp -----EEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH
T ss_pred -----EEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh
Confidence 257788887765544444557999999999999989999999999999999999999999754322111000000
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.+.. ......++..+.+||.+||+.||++|||+
T Consensus 219 ~~~~-----------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 251 (307)
T 2eva_A 219 NGTR-----------------------------------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSM 251 (307)
T ss_dssp TTCC-----------------------------------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCC-----------------------------------------------CCcccccCHHHHHHHHHHhcCChhhCcCH
Confidence 0000 01123456789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
+++++
T Consensus 252 ~ell~ 256 (307)
T 2eva_A 252 EEIVK 256 (307)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=296.49 Aligned_cols=220 Identities=24% Similarity=0.318 Sum_probs=170.2
Q ss_pred CCCeEEEeeeecccceeEEEEEecC---CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.++|++.+.||+|+||+||+|++.. ++..||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 3679999999999999999998653 3456999998753 23456788999999999999884321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+|++
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~--------------- 155 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG--------------- 155 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEEC---------------
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeC---------------
Confidence 1347888999999999999999999999999999999999877655554
Q ss_pred cCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 293 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 293 (405)
|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus 156 ------------Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 156 ------------DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp ------------CCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred ------------ccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence 55544332221 122356788999999998899999999999999999998 9999987665554
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
...+..... . .....+++.+.+||.+||..|
T Consensus 224 ~~~~~~~~~-----------------------~--------------------------~~~~~~~~~l~~li~~~l~~~ 254 (281)
T 3cc6_A 224 IGVLEKGDR-----------------------L--------------------------PKPDLCPPVLYTLMTRCWDYD 254 (281)
T ss_dssp HHHHHHTCC-----------------------C--------------------------CCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHhcCCC-----------------------C--------------------------CCCCCCCHHHHHHHHHHccCC
Confidence 433322110 0 011234678999999999999
Q ss_pred CCCCCCHHHHHcC
Q 015532 374 PAERLKAREALRH 386 (405)
Q Consensus 374 P~~Rpta~elL~h 386 (405)
|++|||+.|++++
T Consensus 255 p~~Rps~~ell~~ 267 (281)
T 3cc6_A 255 PSDRPRFTELVCS 267 (281)
T ss_dssp GGGSCCHHHHHHH
T ss_pred chhCcCHHHHHHH
Confidence 9999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=318.07 Aligned_cols=225 Identities=24% Similarity=0.365 Sum_probs=178.8
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
..++|++.+.||+|+||.||+|.+. ++..||||+++......+.+.+|+.+|+.+.|+++....
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 3468999999999999999999985 467799999987666678899999999999999884321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----------------------- 321 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----------------------- 321 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-----------------------
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-----------------------
Confidence 12467888999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
.+||+|||++...... .....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....
T Consensus 322 ----~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~ 397 (454)
T 1qcf_A 322 ----VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397 (454)
T ss_dssp ----CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred ----cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 4566666666543221 112346778999999998899999999999999999999 9999998877766655
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+... . ..+..+++.+.+||.+||..||++
T Consensus 398 i~~~~~-----------------------~--------------------------~~~~~~~~~l~~li~~cl~~dp~~ 428 (454)
T 1qcf_A 398 LERGYR-----------------------M--------------------------PRPENCPEELYNIMMRCWKNRPEE 428 (454)
T ss_dssp HHHTCC-----------------------C--------------------------CCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHcCCC-----------------------C--------------------------CCCCCCCHHHHHHHHHHccCChhH
Confidence 433210 0 011245678999999999999999
Q ss_pred CCCHHHHHc--CCCCCC
Q 015532 377 RLKAREALR--HPFFTR 391 (405)
Q Consensus 377 Rpta~elL~--hp~f~~ 391 (405)
|||++++++ ..++..
T Consensus 429 RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 429 RPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp SCCHHHHHHHHHTSSSS
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 999999975 344443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=304.76 Aligned_cols=231 Identities=25% Similarity=0.339 Sum_probs=153.1
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHh-hcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLA-RHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~-~~~~~~~~-------------- 154 (405)
..+|++.++||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++. |+++....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999999999999999885433 34566788999999996 88875321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccc
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 124788999999999999999999999 9999999999999877766555555443
Q ss_pred cCCCCCCcccCCCCCCCceeccCCC-CccccCCccceecCCCcchhHHH---hCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGS-TTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~-a~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
......... +.. ............||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 187 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 187 TISHYPDYS-------------WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp CCSSCC--------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred eccccCccc-------------ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 222111000 000 00000111234689999999998 4567889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHH
Q 015532 286 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 365 (405)
Q Consensus 286 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 365 (405)
........... . ... ......+..+.+|
T Consensus 254 ~~~~~~~~~~~---~-------------------------~~~------------------------~~~~~~~~~~~~l 281 (337)
T 3ll6_A 254 EDGAKLRIVNG---K-------------------------YSI------------------------PPHDTQYTVFHSL 281 (337)
T ss_dssp ----------------------------------------CCC------------------------CTTCCSSGGGHHH
T ss_pred cchhHHHhhcC---c-------------------------ccC------------------------CcccccchHHHHH
Confidence 75433221110 0 000 0012334568899
Q ss_pred HHHccccCCCCCCCHHHHHcC
Q 015532 366 LQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 366 l~~~L~~dP~~Rpta~elL~h 386 (405)
|.+||+.||++|||+.|+++|
T Consensus 282 i~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 282 IRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp HHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=300.78 Aligned_cols=226 Identities=23% Similarity=0.302 Sum_probs=164.9
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHH--HhhcCCCCCc----------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTR---------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~--l~~~~~~~~~---------- 154 (405)
++.+.++|++.+.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. +.|+++....
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 345678999999999999999999987 58899999996543 3445667777777 7898874321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCCCCcEEEecccccccCCcc
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH--------~~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
...+++..+..++.||+.||.||| ++||+||||||+|||++.++
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-------- 150 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-------- 150 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--------
T ss_pred ceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--------
Confidence 135788999999999999999999 99999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-------cceecCCCcchhHHHhCC------CCCCchhHHHHHH
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL------GWNYPCDLWSVGC 273 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~ 273 (405)
.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||
T Consensus 151 -------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 151 -------------------QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp -------------------CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred -------------------CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 45666666664332221 224799999999999876 3457899999999
Q ss_pred HHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHH
Q 015532 274 ILVELCSG----------EALFQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339 (405)
Q Consensus 274 il~~lltg----------~~pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (405)
++|+|++| ..||..... ......+....+. ....+.
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~--------- 261 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ---------------------RPNIPN--------- 261 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC---------------------CCCCCG---------
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCC---------------------CCCCCh---------
Confidence 99999999 788854321 1111111110000 000000
Q ss_pred HHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.......+..+.+||.+||+.||++|||+.|+++
T Consensus 262 ------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 262 ------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp ------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 0011234568999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.01 Aligned_cols=219 Identities=17% Similarity=0.315 Sum_probs=175.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
...|++.++||+|+||.||+|++..++..||||+++......+.+.+|+.+|+++.|++++...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4679999999999999999999998899999999987666678899999999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---------------------- 356 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL---------------------- 356 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC----------------------
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc----------------------
Confidence 134788899999999999999999999999999999999987665
Q ss_pred CCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....
T Consensus 357 -----~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~ 431 (495)
T 1opk_A 357 -----VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431 (495)
T ss_dssp -----EEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred -----EEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 4555555554332211 12346778999999998899999999999999999999 9999988765544433
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.... +. ..+..+++.+.+||.+||+.||++
T Consensus 432 ~~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~ 462 (495)
T 1opk_A 432 LEKDY-----------------------RM--------------------------ERPEGCPEKVYELMRACWQWNPSD 462 (495)
T ss_dssp HHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHcCC-----------------------CC--------------------------CCCCCCCHHHHHHHHHHcCcChhH
Confidence 32110 00 112345678999999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
|||+.++++
T Consensus 463 RPs~~el~~ 471 (495)
T 1opk_A 463 RPSFAEIHQ 471 (495)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=302.49 Aligned_cols=220 Identities=20% Similarity=0.323 Sum_probs=171.8
Q ss_pred CCCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.. ....+.+.+|+++++.+.|+++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467999999999999999999983 45689999999653 23446678899999999999884321
Q ss_pred ------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 015532 155 ------------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 192 (405)
Q Consensus 155 ------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 192 (405)
...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 01278889999999999999999999999999999999
Q ss_pred EEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchh
Q 015532 193 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCD 267 (405)
Q Consensus 193 li~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D 267 (405)
|++.++. ++|+|||++....... ....+|+.|+|||++.+..++.++|
T Consensus 182 li~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 234 (314)
T 2ivs_A 182 LVAEGRK---------------------------MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234 (314)
T ss_dssp EEETTTE---------------------------EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHH
T ss_pred EEcCCCC---------------------------EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhh
Confidence 9987664 4555555554332211 1235678899999999988999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhcc
Q 015532 268 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346 (405)
Q Consensus 268 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (405)
||||||++|+|++ |..||.+.........+.... .
T Consensus 235 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------~--------------------- 270 (314)
T 2ivs_A 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-----------------------R--------------------- 270 (314)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------------C---------------------
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-----------------------c---------------------
Confidence 9999999999999 999998776544433322110 0
Q ss_pred chhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 347 ~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
......+++.+.+||.+||+.||++|||+.|++++
T Consensus 271 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 271 -----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123456789999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=315.51 Aligned_cols=215 Identities=20% Similarity=0.299 Sum_probs=171.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+++.|+++....
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 67999999999999999999985 7789999997644 457789999999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----------------------- 326 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----------------------- 326 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-----------------------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-----------------------
Confidence 01268889999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++...........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.+.
T Consensus 327 ----~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 402 (450)
T 1k9a_A 327 ----VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402 (450)
T ss_dssp ----CEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT
T ss_pred ----CEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 4677777776644433333467889999999999999999999999999999998 99999876655544333221
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
.+. ..+..+++.+.+||.+||+.||++|||+
T Consensus 403 -----------------------~~~--------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~ 433 (450)
T 1k9a_A 403 -----------------------YKM--------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTF 433 (450)
T ss_dssp -----------------------CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----------------------CCC--------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 011 1123456789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
.++++
T Consensus 434 ~~l~~ 438 (450)
T 1k9a_A 434 LQLRE 438 (450)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.07 Aligned_cols=224 Identities=28% Similarity=0.425 Sum_probs=164.2
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
+....++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 444557899999999999999999999999999999999642 33456788999999999999884321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~------------ 174 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV------------ 174 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC------------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC------------
Confidence 123788899999999999999999999999999999999976554
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 175 ---------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 175 ---------------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ---------------EEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ---------------EEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 566666665443222 12346899999999999989999999999999999999999999764
Q ss_pred Ch--HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 289 EN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 289 ~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
.. ......+... . ++ . .....++..+.+||
T Consensus 240 ~~~~~~~~~~~~~~--~------------------------~~-------------------~---~~~~~~~~~l~~li 271 (310)
T 2wqm_A 240 KMNLYSLCKKIEQC--D------------------------YP-------------------P---LPSDHYSEELRQLV 271 (310)
T ss_dssp -CCHHHHHHHHHTT--C------------------------SC-------------------C---CCTTTSCHHHHHHH
T ss_pred chhHHHHHHHhhcc--c------------------------CC-------------------C---CcccccCHHHHHHH
Confidence 32 1111111110 0 00 0 00123567899999
Q ss_pred HHccccCCCCCCCHHHHHc
Q 015532 367 QGLLRYDPAERLKAREALR 385 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~ 385 (405)
.+||..||++|||+.++++
T Consensus 272 ~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 272 NMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCCCHHHHHH
Confidence 9999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.06 Aligned_cols=221 Identities=18% Similarity=0.254 Sum_probs=169.0
Q ss_pred CCCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||.||+|++. .+++.||||+++.. ....+.+.+|+.+++++ .|+++....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 368999999999999999999973 45678999999643 23456788999999999 888874311
Q ss_pred --------------------c----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 015532 155 --------------------Y----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 192 (405)
Q Consensus 155 --------------------~----------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 192 (405)
. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 0 1268889999999999999999999999999999999
Q ss_pred EEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchh
Q 015532 193 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 267 (405)
Q Consensus 193 li~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (405)
|++.++.+||+||| ++...... .....||+.|+|||++.+..++.++|
T Consensus 204 ll~~~~~~kL~Dfg---------------------------~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 256 (344)
T 1rjb_A 204 LVTHGKVVKICDFG---------------------------LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 256 (344)
T ss_dssp EEETTTEEEECCCG---------------------------GGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred EEcCCCcEEeCCCc---------------------------cCcccccCccceeccCccCccCccCHHHhccCCCChhHh
Confidence 99877655555555 44322211 12246788999999999989999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhcc
Q 015532 268 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346 (405)
Q Consensus 268 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (405)
||||||++|+|++ |..||.+......+..+.... ...
T Consensus 257 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------------~~~-------------------- 294 (344)
T 1rjb_A 257 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG----------------------FKM-------------------- 294 (344)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT----------------------CCC--------------------
T ss_pred HHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC----------------------CCC--------------------
Confidence 9999999999998 999998765443332221110 000
Q ss_pred chhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 347 ~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
......++.+.+||.+||+.||++|||+.|+++|
T Consensus 295 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 295 ------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 1112346789999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=305.52 Aligned_cols=221 Identities=19% Similarity=0.262 Sum_probs=173.6
Q ss_pred ccCCCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
...++|++.+.||+|+||.||+|++. .+++.||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999987 34589999999653 23456788999999999999874311
Q ss_pred --------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCC
Q 015532 155 --------------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 190 (405)
Q Consensus 155 --------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 190 (405)
...+++.+++.++.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 035788899999999999999999999999999999
Q ss_pred cEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCc
Q 015532 191 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYP 265 (405)
Q Consensus 191 NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~ 265 (405)
|||++.++. +||+|||++..... ......||+.|+|||++.+..++.+
T Consensus 204 NIl~~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 256 (343)
T 1luf_A 204 NCLVGENMV---------------------------VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 256 (343)
T ss_dssp GEEECGGGC---------------------------EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred eEEECCCCe---------------------------EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc
Confidence 999987664 55555555543211 1122467889999999999899999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHh
Q 015532 266 CDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344 (405)
Q Consensus 266 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (405)
+|||||||++|+|++ |..||.+....+....+.... . .
T Consensus 257 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~---------------------~------------------ 295 (343)
T 1luf_A 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--I---------------------L------------------ 295 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--C---------------------C------------------
T ss_pred cccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC--c---------------------C------------------
Confidence 999999999999999 999998877665554432210 0 0
Q ss_pred ccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 345 ~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 296 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 296 --------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011245678999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.24 Aligned_cols=219 Identities=25% Similarity=0.332 Sum_probs=172.3
Q ss_pred CCeEEEe-eeecccceeEEEEEec--CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~-~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|.+.+ .||+|+||.||+|.+. .+++.||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 5688887 9999999999999864 46788999999753 34456788999999999999874321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~------------------- 149 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA------------------- 149 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE-------------------
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCE-------------------
Confidence 2347899999999999999999999999999999999999877655
Q ss_pred CCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 150 --------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 150 --------KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp --------EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred --------EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 55555554433211 112356889999999998889999999999999999998 999998877655
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.... .. .....+++.+.+||.+||+.
T Consensus 222 ~~~~i~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~~l~~ 252 (287)
T 1u59_A 222 VMAFIEQGK-----------------------RM--------------------------ECPPECPPELYALMSDCWIY 252 (287)
T ss_dssp HHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHTTCS
T ss_pred HHHHHhcCC-----------------------cC--------------------------CCCCCcCHHHHHHHHHHcCC
Confidence 544332210 00 11134567899999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++|||+.++++|
T Consensus 253 ~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 253 KWEDRPDFLTVEQR 266 (287)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.03 Aligned_cols=221 Identities=24% Similarity=0.353 Sum_probs=171.5
Q ss_pred CCCeEEEeeeecccceeEEEEEe-----cCCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... ...+.+.+|+.+++++ .|+++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36899999999999999999985 4567899999997543 3456788999999999 888874311
Q ss_pred --------------------c-----------------ccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 --------------------Y-----------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 --------------------~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 0 137899999999999999999999999999999999999877
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+.+|++|||++ ....... ....||+.|+|||++.+..++.++||||||
T Consensus 182 ~~~kl~Dfg~~---------------------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 234 (313)
T 1t46_A 182 RITKICDFGLA---------------------------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234 (313)
T ss_dssp TEEEECCCGGG---------------------------SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred CCEEEcccccc---------------------------ccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHH
Confidence 76655555544 3222111 123578899999999998999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++ |..||.+.........+......
T Consensus 235 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------ 266 (313)
T 1t46_A 235 IFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR------------------------------------------------ 266 (313)
T ss_dssp HHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC------------------------------------------------
T ss_pred HHHHHHHhCCCCCCCcccchhHHHHHhccCCC------------------------------------------------
Confidence 99999999 99999876544333322211000
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.......+..+.+||.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 00112346789999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.60 Aligned_cols=223 Identities=22% Similarity=0.329 Sum_probs=175.3
Q ss_pred CccCCCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
+...++|++.+.||+|+||.||+|++. .+++.||||++.... .....+.+|+.+++.+.|+++....
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345578999999999999999999886 357889999996533 3345678999999999999874321
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~----- 175 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF----- 175 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-----
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-----
Confidence 02347788999999999999999999999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 176 ----------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 233 (322)
T 1p4o_A 176 ----------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233 (322)
T ss_dssp ----------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ----------------------eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 46666666665432221 223678899999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
++ |..||.+.+..+....+... .. . .....
T Consensus 234 ~~~g~~p~~~~~~~~~~~~~~~~--~~---------------------~--------------------------~~~~~ 264 (322)
T 1p4o_A 234 ATLAEQPYQGLSNEQVLRFVMEG--GL---------------------L--------------------------DKPDN 264 (322)
T ss_dssp HHTSCCTTTTSCHHHHHHHHHTT--CC---------------------C--------------------------CCCTT
T ss_pred HhcCCCccccCCHHHHHHHHHcC--Cc---------------------C--------------------------CCCCC
Confidence 99 89999887765554433221 00 0 01124
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
++..+.+||.+||+.||++|||+.|+++|
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 265 CPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 56789999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=298.49 Aligned_cols=221 Identities=22% Similarity=0.321 Sum_probs=168.7
Q ss_pred CCCeEEEeeeecccceeEEEEEe-----cCCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||+||+|++ ..+++.||||+++... ...+.+.+|+.++..+ .|+++....
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 3567899999997532 2345678999999999 566663211
Q ss_pred --------------------cc----------------cCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 --------------------YR----------------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 --------------------~~----------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
.. .+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 00 178889999999999999999999999999999999998776
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
.+|++||| ++...... .....||+.|+|||++.+..++.++|||||||
T Consensus 186 ~~kl~Dfg---------------------------~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 238 (316)
T 2xir_A 186 VVKICDFG---------------------------LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238 (316)
T ss_dssp CEEECCCG---------------------------GGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CEEECCCc---------------------------cccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHH
Confidence 55555554 44332211 12246788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhh
Q 015532 274 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352 (405)
Q Consensus 274 il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (405)
++|+|++ |..||.+....+.+........ ..
T Consensus 239 il~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------------~~-------------------------- 270 (316)
T 2xir_A 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGT----------------------RM-------------------------- 270 (316)
T ss_dssp HHHHHHTTSCCSSTTCCCSHHHHHHHHHTC----------------------CC--------------------------
T ss_pred HHHHHHhCCCCCCcccchhHHHHHHhccCc----------------------cC--------------------------
Confidence 9999998 9999987654333222111100 00
Q ss_pred hcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 353 ~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
......++.+.++|.+||+.||++|||+.|+++|
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112346789999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=314.40 Aligned_cols=225 Identities=25% Similarity=0.345 Sum_probs=176.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+.+|+++.|+++....
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 4679999999999999999999865 45699999986655667899999999999999884321
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~----------------------- 318 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV----------------------- 318 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-----------------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC-----------------------
Confidence 123788899999999999999999999999999999999976654
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+
T Consensus 319 ----~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 319 ----CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp ----EEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ----EEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 5666666665432211 12356788999999998899999999999999999999 99999988776665544
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+.. +.. .+..+++.+.+||.+||+.||++|
T Consensus 395 ~~~~-----------------------~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~R 425 (452)
T 1fmk_A 395 ERGY-----------------------RMP--------------------------CPPECPESLHDLMCQCWRKEPEER 425 (452)
T ss_dssp HTTC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HcCC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHccCChhhC
Confidence 3211 000 112456789999999999999999
Q ss_pred CCHHHHHc--CCCCCCC
Q 015532 378 LKAREALR--HPFFTRD 392 (405)
Q Consensus 378 pta~elL~--hp~f~~~ 392 (405)
||++++++ ..++...
T Consensus 426 pt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 426 PTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCHHHHHHHHHTTTSCS
T ss_pred cCHHHHHHHHHHHhccC
Confidence 99999987 4666553
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=303.74 Aligned_cols=242 Identities=21% Similarity=0.192 Sum_probs=174.3
Q ss_pred EeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------
Q 015532 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------- 154 (405)
Q Consensus 84 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------- 154 (405)
+...+...++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++.+.|+++....
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3334556789999999999999999999974 68899999986432 3456788999999999999873211
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~------------ 177 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV------------ 177 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC------------
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC------------
Confidence 124788999999999999999999999999999999999976554
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 286 (405)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 178 ---------------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 178 ---------------PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp ---------------EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred ---------------EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 55666665543221 1123468999999999998899999999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHH
Q 015532 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366 (405)
Q Consensus 287 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 366 (405)
+....+....+... ......+......+ +..........+..+.+|+
T Consensus 243 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~li 289 (321)
T 2qkw_B 243 QSLPREMVNLAEWA----------------VESHNNGQLEQIVD-----------------PNLADKIRPESLRKFGDTA 289 (321)
T ss_dssp CSSSSSCCCHHHHT----------------HHHHTTTCCCSSSS-----------------SSCTTCSCHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHh----------------hhccccccHHHhcC-----------------hhhccccCHHHHHHHHHHH
Confidence 64432111100000 00000000000000 0000111123466899999
Q ss_pred HHccccCCCCCCCHHHHHcC
Q 015532 367 QGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 367 ~~~L~~dP~~Rpta~elL~h 386 (405)
.+||+.||++|||+.|+++|
T Consensus 290 ~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 290 VKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.04 Aligned_cols=221 Identities=21% Similarity=0.288 Sum_probs=164.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367999999999999999999999999999999996532 2346678899999999999885421
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--------------------- 171 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--------------------- 171 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---------------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC---------------------
Confidence 13578899999999999999999999999999999999997655
Q ss_pred CCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 172 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (309)
T 2h34_A 172 ------FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA 245 (309)
T ss_dssp ------CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH
T ss_pred ------CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH
Confidence 4566666665443322 123478999999999998889999999999999999999999998765432221
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.. ..+ ........++..+.+||.+||+.||+
T Consensus 246 ~~~~---~~~--------------------------------------------~~~~~~~~~~~~l~~li~~~l~~dP~ 278 (309)
T 2h34_A 246 HINQ---AIP--------------------------------------------RPSTVRPGIPVAFDAVIARGMAKNPE 278 (309)
T ss_dssp HHHS---CCC--------------------------------------------CGGGTSTTCCTHHHHHHHHHTCSSGG
T ss_pred Hhcc---CCC--------------------------------------------CccccCCCCCHHHHHHHHHhccCCHH
Confidence 1111 000 00111234567899999999999999
Q ss_pred CCC-CHHHHHc
Q 015532 376 ERL-KAREALR 385 (405)
Q Consensus 376 ~Rp-ta~elL~ 385 (405)
+|| |++++++
T Consensus 279 ~Rp~s~~~l~~ 289 (309)
T 2h34_A 279 DRYVTCGDLSA 289 (309)
T ss_dssp GSCSSHHHHHH
T ss_pred HHHHhHHHHHH
Confidence 999 8888875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=293.72 Aligned_cols=218 Identities=24% Similarity=0.349 Sum_probs=169.8
Q ss_pred CCeEEEe-eeecccceeEEEEEe--cCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILS-KMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~-~LG~G~fg~V~~a~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
++|++.+ .||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|+++++.+.|+++....
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv 95 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV 95 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence 5799998 999999999999954 5677899999996532 2356788999999999999884321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~------------------- 156 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA------------------- 156 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE-------------------
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE-------------------
Confidence 1347899999999999999999999999999999999999876654
Q ss_pred CCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 157 --------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 157 --------KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp --------EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred --------EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 555555554332211 11346788999999998889999999999999999999 999999877655
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.... .. .....+++.+.+||.+||+.
T Consensus 229 ~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~~l~~ 259 (291)
T 1xbb_A 229 VTAMLEKGE-----------------------RM--------------------------GCPAGCPREMYDLMNLCWTY 259 (291)
T ss_dssp HHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHcCC-----------------------CC--------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 444332210 00 01124567899999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
||++|||+.++++
T Consensus 260 dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 260 DVENRPGFAAVEL 272 (291)
T ss_dssp STTTSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=297.55 Aligned_cols=220 Identities=17% Similarity=0.242 Sum_probs=166.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecC---CCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.++|.+.+.||+|+||.||+|.+.. +++.||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3689999999999999999998765 5568999998643 23346688999999999999874321
Q ss_pred ----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcc
Q 015532 155 ----------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 155 ----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~------- 185 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT------- 185 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC-------
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-------
Confidence 134788999999999999999999999999999999999976554
Q ss_pred ccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 207 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 186 --------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 245 (313)
T 3brb_A 186 --------------------VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245 (313)
T ss_dssp --------------------EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred --------------------EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence 566666655433221 122457889999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+....+....+.... .. .....+++
T Consensus 246 g~~p~~~~~~~~~~~~~~~~~-----------------------~~--------------------------~~~~~~~~ 276 (313)
T 3brb_A 246 GMTPYPGVQNHEMYDYLLHGH-----------------------RL--------------------------KQPEDCLD 276 (313)
T ss_dssp SCCSSTTCCGGGHHHHHHTTC-----------------------CC--------------------------CCBTTCCH
T ss_pred CCCCCccCCHHHHHHHHHcCC-----------------------CC--------------------------CCCccccH
Confidence 999998876654443322110 00 11234567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+.+||.+||..||++|||+.+++++
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.41 Aligned_cols=215 Identities=20% Similarity=0.299 Sum_probs=165.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+++.+.|+++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 67999999999999999999874 7899999997543 456788999999999999874321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----------------------- 154 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----------------------- 154 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-----------------------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-----------------------
Confidence 01267888999999999999999999999999999999997654
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
.++|+|||++...........+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+...
T Consensus 155 ----~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 155 ----VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230 (278)
T ss_dssp ----CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred ----cEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 4677777776655444444567889999999999899999999999999999998 99999876554433322110
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
. . ......+++.+.+||.+||+.||++|||+
T Consensus 231 ~-----------------------~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 261 (278)
T 1byg_A 231 Y-----------------------K--------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSF 261 (278)
T ss_dssp C-----------------------C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred C-----------------------C--------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCH
Confidence 0 0 01123456789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
.|+++
T Consensus 262 ~~l~~ 266 (278)
T 1byg_A 262 LQLRE 266 (278)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=308.78 Aligned_cols=218 Identities=22% Similarity=0.284 Sum_probs=164.2
Q ss_pred CCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|++. .++..||||+++.. ....+.+.+|+.+++++.|+++....
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999986 46778999999643 33456788999999999999884321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~------------------- 185 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV------------------- 185 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-------------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC-------------------
Confidence 125788999999999999999999999999999999999976654
Q ss_pred cCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 291 (405)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 186 --------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~ 257 (373)
T 2qol_A 186 --------CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257 (373)
T ss_dssp --------EEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred --------EEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 5556666554432211 11235778999999999999999999999999999998 99999887766
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+..... . .....++..+.+||.+||+
T Consensus 258 ~~~~~i~~~~~-----------------------~--------------------------~~~~~~~~~l~~li~~cl~ 288 (373)
T 2qol_A 258 DVIKAVDEGYR-----------------------L--------------------------PPPMDCPAALYQLMLDCWQ 288 (373)
T ss_dssp HHHHHHHTTEE-----------------------C--------------------------CCCTTCBHHHHHHHHHHTC
T ss_pred HHHHHHHcCCC-----------------------C--------------------------CCCccccHHHHHHHHHHhC
Confidence 55544322110 0 0112346789999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.||++|||+.|+++
T Consensus 289 ~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 289 KDRNNRPKFEQIVS 302 (373)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhhCcCHHHHHH
Confidence 99999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=297.48 Aligned_cols=225 Identities=20% Similarity=0.288 Sum_probs=170.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCc-----EEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc--------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR-------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~-------- 154 (405)
.++|++.+.||+|+||.||+|.+..+++ .||||+++... ...+.+.+|+.+++.+ .|+++....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4789999999999999999999976654 79999996532 3456788999999999 888874321
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 155 ---------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 155 ---------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence 11357888999999999999999999999999999999998877666
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
|+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 205 l~Dfg~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 205 IGDFGLARDIMNDSN----------------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp BCCCGGGCCGGGCTT----------------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ECccccccccccccc----------------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcC
Confidence 666655422111000 000112457889999999999899999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+.........+...... . ......+.
T Consensus 263 g~~p~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~ 294 (333)
T 2i1m_A 263 GLNPYPGILVNSKFYKLVKDGYQ----------------------M--------------------------AQPAFAPK 294 (333)
T ss_dssp SCCSSTTCCSSHHHHHHHHHTCC----------------------C--------------------------CCCTTCCH
T ss_pred CCCCCcccchhHHHHHHHhcCCC----------------------C--------------------------CCCCCCCH
Confidence 99999876544433322221100 0 01123466
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHc
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+.+||.+||+.||++|||+.|+++
T Consensus 295 ~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 295 NIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 8999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=298.42 Aligned_cols=220 Identities=18% Similarity=0.294 Sum_probs=170.6
Q ss_pred CCCeEEEeeeecccceeEEEEEec-------CCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~------ 154 (405)
.++|++.+.||+|+||.||+|++. .+++.||||+++... ...+.+.+|+.+++.+ .|+++....
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999975 356789999996532 3446688999999999 888873311
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecc
Q 015532 155 -------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 155 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~ 197 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 0137888999999999999999999999999999999999766
Q ss_pred cccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHH
Q 015532 198 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 272 (405)
Q Consensus 198 ~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 272 (405)
+. +||+|||++...... .....+|+.|+|||++.+..++.++||||||
T Consensus 194 ~~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 246 (334)
T 2pvf_A 194 NV---------------------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246 (334)
T ss_dssp CC---------------------------EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHH
T ss_pred CC---------------------------EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHH
Confidence 54 556666655433221 1223567889999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++ |..||.+....+....+..... .
T Consensus 247 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------------------~------------------------- 278 (334)
T 2pvf_A 247 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------------------M------------------------- 278 (334)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-----------------------C-------------------------
T ss_pred HHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC-----------------------C-------------------------
Confidence 99999999 9999988776655443332110 0
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.....++..+.+||.+||+.||++|||+.|++++
T Consensus 279 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 279 -DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112346789999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=302.38 Aligned_cols=233 Identities=16% Similarity=0.171 Sum_probs=168.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC--------CcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCC----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG---------- 152 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~--------~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~---------- 152 (405)
.++|++.+.||+|+||.||+|++..+ ++.||||++... +.+.+|+++++++.|+++..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 47899999999999999999999874 789999998754 34778999999998866421
Q ss_pred --------------Cc--------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 153 --------------TR--------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 153 --------------~~--------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 00 14588999999999999999999999999999999999998776
Q ss_pred --ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHH
Q 015532 199 --YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 276 (405)
Q Consensus 199 --~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 276 (405)
.+||+|||++......... ............||+.|+|||++.+..++.++|||||||++|
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKH-----------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCC-----------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CceEEEecCcceeeccCCCcc-----------------ccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 6666666654332211000 000001112347999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHH-HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhc
Q 015532 277 ELCSGEALFQTHE-NLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354 (405)
Q Consensus 277 ~lltg~~pf~~~~-~~~~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (405)
+|++|..||.... ....+. .........+. +. .....
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------~~--------------------~~~~~ 298 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP---------------------FV--------------------GPCGH 298 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC---------------------EE--------------------CTTSC
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhccCChhh---------------------hh--------------------hhccc
Confidence 9999999998753 222222 22111111000 00 00001
Q ss_pred ccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 355 ~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
...++..+.+||.+||+.||++|||++++++
T Consensus 299 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 299 WIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp EECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 1245678999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=292.13 Aligned_cols=217 Identities=21% Similarity=0.271 Sum_probs=165.9
Q ss_pred CeEEEeeeecccceeEEEEEecCCCc---EEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~---~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+|.+.++||+|+||+||+|++..+++ .||+|++.... ...+.+.+|+.+++.+.|+++....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 57788999999999999999765544 79999986533 3446788999999999999874321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~------------------- 162 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT------------------- 162 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-------------------
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-------------------
Confidence 134678899999999999999999999999999999999976654
Q ss_pred cCCCCCCCceeccCCCCccccC-------CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 290 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 290 (405)
++|+|||++..... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.
T Consensus 163 --------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 163 --------VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp --------EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred --------EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 55555555543221 1122467889999999999999999999999999999999 5555655554
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+....+..... . ......++.+.+||.+||
T Consensus 235 ~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~l~~li~~~l 265 (298)
T 3pls_A 235 FDLTHFLAQGRR-----------------------L--------------------------PQPEYCPDSLYQVMQQCW 265 (298)
T ss_dssp GGHHHHHHTTCC-----------------------C--------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHhhcCCC-----------------------C--------------------------CCCccchHHHHHHHHHHc
Confidence 443333222110 0 011234678999999999
Q ss_pred ccCCCCCCCHHHHHc
Q 015532 371 RYDPAERLKAREALR 385 (405)
Q Consensus 371 ~~dP~~Rpta~elL~ 385 (405)
+.||++|||+.++++
T Consensus 266 ~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 266 EADPAVRPTFRVLVG 280 (298)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999885
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=296.87 Aligned_cols=220 Identities=22% Similarity=0.293 Sum_probs=168.3
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCC----cEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..+|++.+.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++.+.|+++....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 468999999999999999999987553 45999999653 23455688999999999999984321
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~----------------- 185 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV----------------- 185 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-----------------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc-----------------
Confidence 135788999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 186 ----------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 186 ----------CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp ----------EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ----------EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 5666666654432211 11245778999999999899999999999999999999 999998877
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+.... +. .....++..+.+||.+|
T Consensus 256 ~~~~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~~ 286 (333)
T 1mqb_A 256 NHEVMKAINDGF-----------------------RL--------------------------PTPMDCPSAIYQLMMQC 286 (333)
T ss_dssp HHHHHHHHHTTC-----------------------CC--------------------------CCCTTCBHHHHHHHHHH
T ss_pred HHHHHHHHHCCC-----------------------cC--------------------------CCcccCCHHHHHHHHHH
Confidence 665544432210 00 01123467899999999
Q ss_pred cccCCCCCCCHHHHHcC
Q 015532 370 LRYDPAERLKAREALRH 386 (405)
Q Consensus 370 L~~dP~~Rpta~elL~h 386 (405)
|+.||++|||+.+++++
T Consensus 287 l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 287 WQQERARRPKFADIVSI 303 (333)
T ss_dssp TCSSTTTSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=333.13 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=178.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.++||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999999999999998643 34456788999999999999874210
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g-------------- 158 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-------------- 158 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS--------------
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC--------------
Confidence 01477889999999999999999999999999999999998654
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
....++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 159 ----------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 159 ----------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp ----------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred ----------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 23347888888887654332 335799999999999988999999999999999999999999987543
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
..... ........ .....+........+.. ...........+++.+.+||.+||
T Consensus 229 ~~~~~------~~i~~~~~----~~~~~~~~l~g~~~~~~----------------~lp~p~~l~~~ls~~L~dLI~~mL 282 (676)
T 3qa8_A 229 PVQWH------GKVREKSN----EHIVVYDDLTGAVKFSS----------------VLPTPNHLSGILAGKLERWLQCML 282 (676)
T ss_dssp HHHSS------TTCC----------CCSCCCCSSSCCCCS----------------SSCCSCCCCGGGHHHHHHHHHHHS
T ss_pred hhhhh------hhhhcccc----hhhhhhhhhcccccccc----------------ccCCchhhchhhhHHHHHHHHHHc
Confidence 32110 00000000 00000000000011110 000011122346788999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTR 391 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~ 391 (405)
.+||++|||+.|+++||||+.
T Consensus 283 ~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 283 MWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSCC---CCTTCCCCTTHHH
T ss_pred cCCHhhCcCHHHHhcCHHHHH
Confidence 999999999999999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=293.36 Aligned_cols=234 Identities=21% Similarity=0.365 Sum_probs=170.8
Q ss_pred CCCeEEEeeeecccceeEEEEE----ecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..+|++.+.||+|+||.||+|+ +..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4679999999999999999999 56789999999996432 2346788999999999999874321
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--------------- 164 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--------------- 164 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---------------
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---------------
Confidence 134788899999999999999999999999999999999987665
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
++|+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 165 ------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 165 ------------VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp ------------EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ------------EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 4555555554332221 1235788899999999988999999999999999999999987432
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
...+....++........ ........+.. ......+++.+.+||.+
T Consensus 233 -----~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~ 278 (302)
T 4e5w_A 233 -----MALFLKMIGPTHGQMTVT---RLVNTLKEGKR--------------------------LPCPPNCPDEVYQLMRK 278 (302)
T ss_dssp -----HHHHHHHHCSCCGGGHHH---HHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHH
T ss_pred -----hhHHhhccCCcccccCHH---HHHHHHhccCC--------------------------CCCCCCCCHHHHHHHHH
Confidence 111222222222111100 00000011101 11223567799999999
Q ss_pred ccccCCCCCCCHHHHHc
Q 015532 369 LLRYDPAERLKAREALR 385 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~ 385 (405)
||+.||++|||+.|+++
T Consensus 279 ~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 279 CWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCCHHHHHH
Confidence 99999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=297.11 Aligned_cols=222 Identities=28% Similarity=0.345 Sum_probs=174.2
Q ss_pred CCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 87 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
+..+.++|++.+.||+|+||.||+|++..+++.||||+++... +.+.+|+++++.+.|+++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4456678999999999999999999999999999999997543 3466899999999999875310
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 155 ---------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 155 ---------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-- 160 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-- 160 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--
Confidence 124678899999999999999999999999999999999987664
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHH
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll 279 (405)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 -------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 161 -------------------------VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp -------------------------EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred -------------------------EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence 455556655433221 22346899999999999989999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCch
Q 015532 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359 (405)
Q Consensus 280 tg~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (405)
+|..||.... .....+.. + .....++
T Consensus 216 ~~~~~~~~~~--~~~~~~~~--~--------------------------------------------------~~~~~~~ 241 (284)
T 2a19_B 216 HVCDTAFETS--KFFTDLRD--G--------------------------------------------------IISDIFD 241 (284)
T ss_dssp SCCSSHHHHH--HHHHHHHT--T--------------------------------------------------CCCTTSC
T ss_pred hcCCcchhHH--HHHHHhhc--c--------------------------------------------------cccccCC
Confidence 9998874210 10000000 0 0112346
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
..+.+||.+||+.||++|||+.|+++|.|.-..
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 688999999999999999999999999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.74 Aligned_cols=224 Identities=25% Similarity=0.348 Sum_probs=178.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+++|+.+.|++++...
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcC
Confidence 469999999999999999999865 45699999987655667899999999999999985321
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~------------------------- 400 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------------- 400 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------------
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-------------------------
Confidence 12378889999999999999999999999999999999997655
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.
T Consensus 401 --~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~ 478 (535)
T 2h8h_A 401 --VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478 (535)
T ss_dssp --CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH
T ss_pred --cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 45666666665433211 12346778999999998899999999999999999999 999999887766655443
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.. +.. ....++..+.+||.+||+.||++||
T Consensus 479 ~~~-----------------------~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 479 RGY-----------------------RMP--------------------------CPPECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp TTC-----------------------CCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCC-----------------------CCC--------------------------CCCCCCHHHHHHHHHHcCCChhHCc
Confidence 211 000 1124567899999999999999999
Q ss_pred CHHHHHcC--CCCCCC
Q 015532 379 KAREALRH--PFFTRD 392 (405)
Q Consensus 379 ta~elL~h--p~f~~~ 392 (405)
|+++|++. .+|...
T Consensus 510 t~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 510 TFEYLQAFLEDYFTST 525 (535)
T ss_dssp CHHHHHHHHHTSSCCC
T ss_pred CHHHHHHHHHHHhhcc
Confidence 99999873 666543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.90 Aligned_cols=253 Identities=19% Similarity=0.219 Sum_probs=162.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
.++|++.+.||+|+||.||+|++ +++.||||+++...........|+..+..+.|+++....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 36799999999999999999976 588999999975443333333344445568888874421
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~---------givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 90 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~---------- 159 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC---------- 159 (336)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE----------
T ss_pred EEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE----------
Confidence 12346778899999999999999999 99999999999999876655
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccC-----------CccceecCCCcchhHHHhC-------CCCCCchhHHHHH
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----------DHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVG 272 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----------~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG 272 (405)
||+|||++..... ......||+.|+|||++.+ ..++.++||||||
T Consensus 160 -----------------kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 222 (336)
T 3g2f_A 160 -----------------VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222 (336)
T ss_dssp -----------------EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred -----------------EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence 5555555433221 1123469999999999987 3466789999999
Q ss_pred HHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhh
Q 015532 273 CILVELCSGEALFQT-HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 351 (405)
Q Consensus 273 ~il~~lltg~~pf~~-~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (405)
|++|+|++|..||.. ....+....+....+..|...... ........+..++...
T Consensus 223 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~------------------- 278 (336)
T 3g2f_A 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ-----VLVSREKQRPKFPEAW------------------- 278 (336)
T ss_dssp HHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHH-----HHHTTSCCCCCCCTTC-------------------
T ss_pred HHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHH-----hhhcccccCCCCCccc-------------------
Confidence 999999999766533 221111111111122222110000 0000011111111100
Q ss_pred hhcccCchHHHHHHHHHccccCCCCCCCHHHH------HcCCCCCCCCCCCc
Q 015532 352 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREA------LRHPFFTRDVRRPT 397 (405)
Q Consensus 352 ~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~el------L~hp~f~~~~~~~~ 397 (405)
......++.+.+||.+||+.||++|||+.|+ +-++|-+++...++
T Consensus 279 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~~ 329 (336)
T 3g2f_A 279 -KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329 (336)
T ss_dssp -CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-------
T ss_pred -ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCCCc
Confidence 0011245679999999999999999999999 45899988766543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.22 Aligned_cols=243 Identities=19% Similarity=0.219 Sum_probs=172.1
Q ss_pred CccC-CCeEEEeeeecccceeEEEEE----ecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 88 ENLT-PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 88 ~~~~-~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
+.+. ++|++.+.||+|+||.||+|+ +..+++.||||++.... ...+.+.+|+++++.+.|+++....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 3444 689999999999999999999 56789999999996543 3446688999999999998874321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 134788999999999999999999999999999999999988776655555543221
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
..... .........||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 178 ~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~ 236 (327)
T 3lxl_A 178 PLDKD---------------------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236 (327)
T ss_dssp CTTCS---------------------EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred ccCCc---------------------cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch
Confidence 11000 000111235788899999999988999999999999999999999999753321
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
.... .......+.. .........+. .......+++.+.+||.+||+
T Consensus 237 ~~~~--~~~~~~~~~~------~~~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~ 282 (327)
T 3lxl_A 237 FLRM--MGCERDVPAL------SRLLELLEEGQ--------------------------RLPAPPACPAEVHELMKLCWA 282 (327)
T ss_dssp HHHH--CC----CCHH------HHHHHHHHTTC--------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred hhhh--cccccccccH------HHHHHHhhccc--------------------------CCCCCCcccHHHHHHHHHHcC
Confidence 1110 0000000000 00000000000 011224567889999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.||++|||+.|+++
T Consensus 283 ~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 283 PSPQDRPSFSALGP 296 (327)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=291.71 Aligned_cols=225 Identities=15% Similarity=0.186 Sum_probs=166.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
.+|++.+.||+|+||+||+|++..+ ...||+|+++... ...+.+.+|+.+++++.|+++....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4699999999999999999997543 3468999986532 3446688999999999999874322
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|++|||++.......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 182 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-- 182 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG--
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc--
Confidence 1346788999999999999999999999999999999999877655555555432211000
Q ss_pred ccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 296 (405)
...........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....
T Consensus 183 ------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3f66_A 183 ------------------YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244 (298)
T ss_dssp ------------------GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred ------------------hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 000011122467889999999999999999999999999999999 6777876655444333
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+.... ......++.+.+||.+||+.||++
T Consensus 245 ~~~~~~~-------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~ 275 (298)
T 3f66_A 245 LLQGRRL-------------------------------------------------LQPEYCPDPLYEVMLKCWHPKAEM 275 (298)
T ss_dssp HHTTCCC-------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HhcCCCC-------------------------------------------------CCCccCCHHHHHHHHHHcCCChhh
Confidence 3221100 011234668999999999999999
Q ss_pred CCCHHHHHc
Q 015532 377 RLKAREALR 385 (405)
Q Consensus 377 Rpta~elL~ 385 (405)
|||+.|+++
T Consensus 276 Rps~~ell~ 284 (298)
T 3f66_A 276 RPSFSELVS 284 (298)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=293.53 Aligned_cols=219 Identities=20% Similarity=0.299 Sum_probs=163.8
Q ss_pred CCeEEEeeeecccceeEEEEEecC-CC--cEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-~~--~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|++.+.||+|+||+||+|++.. ++ ..||||+++.. ....+.+.+|+++++.+.|+++....
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 579999999999999999998643 33 36999998643 23456788999999999999874321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~----------------- 160 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV----------------- 160 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE-----------------
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCE-----------------
Confidence 1347889999999999999999999999999999999999876654
Q ss_pred ccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 290 (405)
+|+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 161 ----------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 161 ----------KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp ----------EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ----------EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 555555554332211 12357788999999998889999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+.+..+....... .....++..+.++|.+||
T Consensus 231 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l 262 (291)
T 1u46_A 231 SQILHKIDKEGERL------------------------------------------------PRPEDCPQDIYNVMVQCW 262 (291)
T ss_dssp HHHHHHHHTSCCCC------------------------------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHccCCCC------------------------------------------------CCCcCcCHHHHHHHHHHc
Confidence 65554432211000 011245678999999999
Q ss_pred ccCCCCCCCHHHHHc
Q 015532 371 RYDPAERLKAREALR 385 (405)
Q Consensus 371 ~~dP~~Rpta~elL~ 385 (405)
..||++|||+.++++
T Consensus 263 ~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 263 AHKPEDRPTFVALRD 277 (291)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999997
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.69 Aligned_cols=219 Identities=25% Similarity=0.328 Sum_probs=169.6
Q ss_pred CCCeEEEe-eeecccceeEEEEEec--CCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 91 ~~~y~~~~-~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
.++|.+.+ +||+|+||.||+|.+. .++..||||+++.. ....+.+.+|+++|+.+.|++++...
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv 413 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 413 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEE
Confidence 35677766 8999999999999875 35677999999753 23467789999999999999984321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v------------------ 475 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA------------------ 475 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE------------------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcE------------------
Confidence 2347899999999999999999999999999999999999877654
Q ss_pred cCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 291 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 291 (405)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 476 ---------kL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 476 ---------KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp ---------EECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred ---------EEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 555555554332111 11245688999999998899999999999999999998 99999988776
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.+.. +.. .+..+++++.+||.+||+
T Consensus 547 ~~~~~i~~~~-----------------------~~~--------------------------~p~~~~~~l~~li~~cl~ 577 (613)
T 2ozo_A 547 EVMAFIEQGK-----------------------RME--------------------------CPPECPPELYALMSDCWI 577 (613)
T ss_dssp HHHHHHHTTC-----------------------CCC--------------------------CCTTCCHHHHHHHHHTTC
T ss_pred HHHHHHHcCC-----------------------CCC--------------------------CCCcCCHHHHHHHHHHcC
Confidence 6555443211 111 123456789999999999
Q ss_pred cCCCCCCCHHHHHc
Q 015532 372 YDPAERLKAREALR 385 (405)
Q Consensus 372 ~dP~~Rpta~elL~ 385 (405)
.||++|||+.++++
T Consensus 578 ~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 578 YKWEDRPDFLTVEQ 591 (613)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999853
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=299.21 Aligned_cols=219 Identities=21% Similarity=0.273 Sum_probs=168.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEE--EEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELV--AIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~v--AiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|++..++..+ |||+++.. ....+.+.+|+.+++++ .|+++....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999999888765 99988642 23345678899999999 788874311
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~---- 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---- 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC----
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe----
Confidence 125789999999999999999999999999999999999977654
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 280 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt- 280 (405)
+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 181 -----------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 181 -----------------------AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp -----------------------EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred -----------------------EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcC
Confidence 55566665543221 1122357889999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
|..||.+....+....+.... . ......+++
T Consensus 238 g~~pf~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~ 268 (327)
T 1fvr_A 238 GGTPYCGMTCAELYEKLPQGY-----------------------R--------------------------LEKPLNCDD 268 (327)
T ss_dssp SCCTTTTCCHHHHHHHGGGTC-----------------------C--------------------------CCCCTTBCH
T ss_pred CCCCCCCCcHHHHHHHhhcCC-----------------------C--------------------------CCCCCCCCH
Confidence 999998877655443321100 0 011124567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+.+||.+||+.||++|||++|++++
T Consensus 269 ~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 269 EVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999974
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=299.92 Aligned_cols=231 Identities=20% Similarity=0.278 Sum_probs=162.8
Q ss_pred eEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH--hhcCCCCCc------
Q 015532 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL--ARHDIGGTR------ 154 (405)
Q Consensus 83 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l--~~~~~~~~~------ 154 (405)
+...+..+.++|++.+.||+|+||.||+|++. ++.||||++..... .....|.+++..+ .|+++....
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34455667789999999999999999999985 88999999865433 3344555555544 788874321
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEEeccccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYVKV 202 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NIli~~~~~~k~ 202 (405)
...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--- 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--- 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC---
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC---
Confidence 13468889999999999999999998 9999999999999976654
Q ss_pred CCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-------cceecCCCcchhHHHhCCCCCCc------hhHH
Q 015532 203 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGLGWNYP------CDLW 269 (405)
Q Consensus 203 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~------~Diw 269 (405)
+||+|||++....... ....||+.|+|||++.+..++.+ +|||
T Consensus 181 ------------------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diw 236 (337)
T 3mdy_A 181 ------------------------CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236 (337)
T ss_dssp ------------------------EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHH
T ss_pred ------------------------EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchH
Confidence 5666666654332211 13479999999999988766655 9999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCch
Q 015532 270 SVGCILVELCSG----------EALFQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 335 (405)
Q Consensus 270 SlG~il~~lltg----------~~pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (405)
||||++|+|++| ..||..... .......... ...+..++.
T Consensus 237 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~----- 290 (337)
T 3mdy_A 237 SFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI---------------------KKLRPSFPN----- 290 (337)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT---------------------SCCCCCCCG-----
T ss_pred HHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhh---------------------hccCccccc-----
Confidence 999999999999 566643211 1111110000 000000000
Q ss_pred hhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 336 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
......+++++.+||.+||+.||++|||+.|+++|
T Consensus 291 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 291 ----------------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp ----------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00112346789999999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.67 Aligned_cols=222 Identities=23% Similarity=0.336 Sum_probs=167.7
Q ss_pred eEEE-eeeecccceeEEEEEe--cCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 94 YRIL-SKMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 94 y~~~-~~LG~G~fg~V~~a~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.+. ++||+|+||.||+|.+ ..+++.||||+++... ...+.+.+|+++|+.+.|++++...
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E 449 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVME 449 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4443 4899999999999954 4567899999997533 2357789999999999999985422
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~----- 524 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN----- 524 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-----
Confidence 23578899999999999999999999999999999999998877655555554432211000
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
.........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 525 ----------------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 588 (635)
T 4fl3_A 525 ----------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 588 (635)
T ss_dssp --------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ----------------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 0001112356788999999999999999999999999999998 99999988877665544331
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
. ... ....+++++.+||.+||+.||++|||+
T Consensus 589 ~-----------------------~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~ 619 (635)
T 4fl3_A 589 E-----------------------RMG--------------------------CPAGCPREMYDLMNLCWTYDVENRPGF 619 (635)
T ss_dssp C-----------------------CCC--------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C-----------------------CCC--------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCH
Confidence 1 111 112456789999999999999999999
Q ss_pred HHHHc
Q 015532 381 REALR 385 (405)
Q Consensus 381 ~elL~ 385 (405)
+++++
T Consensus 620 ~~l~~ 624 (635)
T 4fl3_A 620 AAVEL 624 (635)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=303.42 Aligned_cols=243 Identities=19% Similarity=0.217 Sum_probs=173.9
Q ss_pred ceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh--hhHHHHHHHHHHHHHhhcCCCCCc-----
Q 015532 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR----- 154 (405)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~il~~l~~~~~~~~~----- 154 (405)
+++.......++|++.+.||+|+||.||+|++ .+++.||||+++.... ....+.+|+.+++.+.|+++....
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 34444556678999999999999999999986 4688999999865332 223578899999999999984322
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEEecccccccCCc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKVPDY 205 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIli~~~~~~k~~df 205 (405)
...+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~------- 171 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF------- 171 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-------
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-------
Confidence 12378899999999999999999999 999999999999997655
Q ss_pred cccccCCCCCCcccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 206 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
.++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 172 --------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 172 --------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp --------------------CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred --------------------CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 45666666665433221 224589999999999988899999999999999999999
Q ss_pred CCCCCCCC-----hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhccc
Q 015532 282 EALFQTHE-----NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356 (405)
Q Consensus 282 ~~pf~~~~-----~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (405)
..||.... .......+... .......... ..........
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~-----------------~~~~~~~~~~ 275 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGL-------------------LKEKKLEALV-----------------DVDLQGNYKD 275 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTT-------------------TSSCCSTTSS-----------------CTTCTTSCCH
T ss_pred CCcccccccccccchhHHHHHHHH-------------------hhchhhhhhc-----------------ChhhccccCH
Confidence 99995210 00000000000 0000000000 0001111122
Q ss_pred CchHHHHHHHHHccccCCCCCCCHHHHHcCCC
Q 015532 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388 (405)
Q Consensus 357 ~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~ 388 (405)
..+..+.+|+.+||+.||++|||+.|+++|-.
T Consensus 276 ~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 276 EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 34578999999999999999999999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=293.00 Aligned_cols=218 Identities=23% Similarity=0.447 Sum_probs=160.3
Q ss_pred cCCCeEEE-eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHH-HHHhhcCCCCCc-------------
Q 015532 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL-QRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il-~~l~~~~~~~~~------------- 154 (405)
+.++|.+. +.||+|+||.||+|.+..+++.||||+++.. ....+|+.++ +.+.|+++....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 44567777 7899999999999999999999999999653 3466788888 555777763211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---------------- 154 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR---------------- 154 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS----------------
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC----------------
Confidence 12478999999999999999999999999999999999997521
Q ss_pred CCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+..++|+|||++.... +..++.++|||||||++|+|++|..||.+.......
T Consensus 155 --------~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 207 (299)
T 3m2w_A 155 --------PNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 207 (299)
T ss_dssp --------TTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred --------CCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence 24468899999875432 235778999999999999999999999765432211
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.. ...... ..........+++++.+||.+||+.||
T Consensus 208 ~~~~~-------------------------~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~dP 245 (299)
T 3m2w_A 208 PGMKT-------------------------RIRMGQ-----------------YEFPNPEWSEVSEEVKMLIRNLLKTEP 245 (299)
T ss_dssp CCSCC-------------------------SSCTTC-----------------CSSCHHHHTTSCHHHHHHHHHHTCSST
T ss_pred HHHHH-------------------------HHhhcc-----------------ccCCchhcccCCHHHHHHHHHHcccCh
Confidence 10000 000000 000001113457799999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~~ 396 (405)
++|||+.|+|+||||++....+
T Consensus 246 ~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 246 TQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp TTSCCHHHHHTSHHHHTGGGSC
T ss_pred hhCCCHHHHhcChhhcccccCC
Confidence 9999999999999998765443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=295.37 Aligned_cols=236 Identities=25% Similarity=0.367 Sum_probs=168.3
Q ss_pred ccCCCe-EEEeeeecccceeEEEEEe----cCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------
Q 015532 89 NLTPRY-RILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------- 154 (405)
Q Consensus 89 ~~~~~y-~~~~~LG~G~fg~V~~a~~----~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------- 154 (405)
.+.++| +++++||+|+||+||+|.. ..+++.||||+++... ...+.+.+|+++++.+.|+++....
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 355666 9999999999999988754 4578999999997542 3456788999999999999874311
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~------------- 173 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLV------------- 173 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE-------------
T ss_pred CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCE-------------
Confidence 1247889999999999999999999999999999999999776655
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
+|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 174 --------------kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 174 --------------KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp --------------EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred --------------EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 55555544433221 1224578889999999998899999999999999999999999965
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
..... ....+........ .........+.. ......++..+.+||.
T Consensus 240 ~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~ 285 (318)
T 3lxp_A 240 PPTKF-----LELIGIAQGQMTV---LRLTELLERGER--------------------------LPRPDKCPAEVYHLMK 285 (318)
T ss_dssp HHHHH-----HHHHCSCCHHHHH---HHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHH
T ss_pred cchhh-----hhhhcccccchhH---HHHHHHHhcccC--------------------------CCCCccccHHHHHHHH
Confidence 32211 0000100000000 000000111100 1122345778999999
Q ss_pred HccccCCCCCCCHHHHHc
Q 015532 368 GLLRYDPAERLKAREALR 385 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~ 385 (405)
+||+.||++|||+.|+++
T Consensus 286 ~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 286 NCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCcccCcCHHHHHH
Confidence 999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=286.97 Aligned_cols=215 Identities=15% Similarity=0.138 Sum_probs=167.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|++.+.||+|+||.||+|++. ++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 67999999999999999999985 8889999997532 3446688999999999999873210
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--------------- 152 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA--------------- 152 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCE---------------
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcce---------------
Confidence 113789999999999999999999999 9999999999999876644
Q ss_pred CcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCC---chhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY---PCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+|+|||++.... .....||+.|+|||++.+..++. ++|||||||++|+|++|..||.+....+
T Consensus 153 ------------~l~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 218 (271)
T 3kmu_A 153 ------------RISMADVKFSFQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218 (271)
T ss_dssp ------------EEEGGGSCCTTS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH
T ss_pred ------------eEEeccceeeec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH
Confidence 444333332211 12246899999999999865544 7999999999999999999998877666
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+..... .. .....+++.+.+||.+||+.
T Consensus 219 ~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~~li~~~l~~ 250 (271)
T 3kmu_A 219 IGMKVALEGL----------------------RP--------------------------TIPPGISPHVSKLMKICMNE 250 (271)
T ss_dssp HHHHHHHSCC----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCC----------------------CC--------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 5443322100 00 11234567899999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
||++|||++|+++
T Consensus 251 ~p~~Rps~~~il~ 263 (271)
T 3kmu_A 251 DPAKRPKFDMIVP 263 (271)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=295.10 Aligned_cols=221 Identities=24% Similarity=0.311 Sum_probs=166.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999999999999999988543 34456788999999999999985421
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~---------------- 171 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG---------------- 171 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS----------------
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC----------------
Confidence 13478899999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCceeccCCCCccccCC------------ccceecCCCcchhHHHhCCC---CCCchhHHHHHHHHHHHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELC 279 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~~ll 279 (405)
.++|+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 172 -----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 172 -----------QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp -----------CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred -----------CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 4566666655433211 01235799999999987654 689999999999999999
Q ss_pred hCCCCCCCCChHH-HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCc
Q 015532 280 SGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358 (405)
Q Consensus 280 tg~~pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (405)
+|..||....... ....... . ... .......
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~----------------------~--~~~------------------------~~~~~~~ 272 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALAVQ----------------------N--QLS------------------------IPQSPRH 272 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHHHH----------------------C--C--------------------------CCCCTTS
T ss_pred hCCCChhhhhcccchhhHHhh----------------------c--cCC------------------------CCccccC
Confidence 9999994310000 0000000 0 000 0111245
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 359 AGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 359 ~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
+..+.+||.+||+.||++|||+.+++++
T Consensus 273 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 6789999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=302.48 Aligned_cols=219 Identities=17% Similarity=0.206 Sum_probs=162.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..|++.+.||+|+||+||+|++..+ +..||||.++... ...+.+.+|+.+++++.|+++....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3589999999999999999997543 3468999986432 3456788999999999999884422
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~------------------ 230 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT------------------ 230 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC------------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC------------------
Confidence 123677889999999999999999999999999999999976654
Q ss_pred ccCCCCCCCceeccCCCCccccCC-------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 231 ---------~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 231 ---------VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp ---------EEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ---------EEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 455555555432211 122457788999999999999999999999999999999 788887765
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+.+.. .. ..+..++..+.+||.+|
T Consensus 302 ~~~~~~~~~~~~-----------------------~~--------------------------~~p~~~~~~l~~li~~c 332 (373)
T 3c1x_A 302 TFDITVYLLQGR-----------------------RL--------------------------LQPEYCPDPLYEVMLKC 332 (373)
T ss_dssp SSCHHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCC-----------------------CC--------------------------CCCCCCCHHHHHHHHHH
Confidence 444333221110 00 01123467899999999
Q ss_pred cccCCCCCCCHHHHHcC
Q 015532 370 LRYDPAERLKAREALRH 386 (405)
Q Consensus 370 L~~dP~~Rpta~elL~h 386 (405)
|+.||++|||+.|++++
T Consensus 333 l~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 333 WHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.09 Aligned_cols=233 Identities=22% Similarity=0.336 Sum_probs=169.0
Q ss_pred CCeEEEeeeecccceeEEEEE----ecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||.||+|+ +..+++.||||+++... ...+.+.+|+.+++.+.|+++....
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 569999999999999999998 46689999999996533 3456788999999999999874311
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~---------------- 184 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV---------------- 184 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE----------------
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcE----------------
Confidence 1247888999999999999999999999999999999999876654
Q ss_pred cccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 185 -----------kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~- 252 (326)
T 2w1i_A 185 -----------KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP- 252 (326)
T ss_dssp -----------EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-
T ss_pred -----------EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH-
Confidence 555555554332221 12356778999999998889999999999999999999999986421
Q ss_pred HHHHHHHHHHhCCCCh-HHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 LEHLAMMERVLGPLPH-HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
.. ..+..+..+. .... .........+.+. .....++.++.+||.+|
T Consensus 253 -~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~c 299 (326)
T 2w1i_A 253 -AE---FMRMIGNDKQGQMIV---FHLIELLKNNGRL--------------------------PRPDGCPDEIYMIMTEC 299 (326)
T ss_dssp -HH---HHHHHCTTCCTHHHH---HHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHH
T ss_pred -HH---HHHhhccccchhhhH---HHHHHHhhcCCCC--------------------------CCCCcccHHHHHHHHHH
Confidence 11 1111111110 0000 0000001111010 11234577899999999
Q ss_pred cccCCCCCCCHHHHHc
Q 015532 370 LRYDPAERLKAREALR 385 (405)
Q Consensus 370 L~~dP~~Rpta~elL~ 385 (405)
|+.||++|||+.|+++
T Consensus 300 l~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 300 WNNNVNQRPSFRDLAL 315 (326)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.85 Aligned_cols=180 Identities=22% Similarity=0.316 Sum_probs=139.0
Q ss_pred cCCCeEEEeeeecccceeEEEEE-----ecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh---hcCCCCC--------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA---RHDIGGT-------- 153 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~---~~~~~~~-------- 153 (405)
..++|++.+.||+|+||+||+|. +..+++.||||+++.. ....+..|+++++.+. |+++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 35789999999999999999994 6678899999999753 3455778888888887 5655221
Q ss_pred ------------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccc
Q 015532 154 ------------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 209 (405)
Q Consensus 154 ------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~ 209 (405)
....+++..++.++.||+.||+|||++||+||||||+|||++......-
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~------- 213 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD------- 213 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--------
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc-------
Confidence 1235889999999999999999999999999999999999976210000
Q ss_pred cCCCCCCcccCCCCCCCceeccCCCCcccc---C--CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCC
Q 015532 210 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEH---Q--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284 (405)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~p 284 (405)
........+||+|||++.... . .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.|
T Consensus 214 ---------~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 214 ---------DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp --------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ---------ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 000124568888898885432 1 12235799999999999999999999999999999999999999
Q ss_pred CCC
Q 015532 285 FQT 287 (405)
Q Consensus 285 f~~ 287 (405)
|..
T Consensus 285 f~~ 287 (365)
T 3e7e_A 285 KVK 287 (365)
T ss_dssp CEE
T ss_pred ccc
Confidence 954
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=296.92 Aligned_cols=239 Identities=20% Similarity=0.251 Sum_probs=167.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHHh---------hcCCC--
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLA---------RHDIG-- 151 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l~---------~~~~~-- 151 (405)
++|++.+.||+|+||+||+|++ +++.||||+++... ...+.+.+|+.+++.+. |++++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 6799999999999999999998 68999999996532 12367889999999997 33321
Q ss_pred ------------------------------------CC-c-----------------cccCCHHHHHHHHHHHHHHHHHH
Q 015532 152 ------------------------------------GT-R-----------------YRSFPIDLVRELGRQLLESVAFM 177 (405)
Q Consensus 152 ------------------------------------~~-~-----------------~~~l~~~~~~~~~~qi~~aL~~L 177 (405)
.. . ...+++..++.++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 00 0 13468999999999999999999
Q ss_pred H-HCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHH
Q 015532 178 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEV 256 (405)
Q Consensus 178 H-~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~ 256 (405)
| ++||+||||||+|||++.++... .++++... ..........+||+|||+++..... ..+||+.|+|||+
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~~------~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNGK------SSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSE-EEEEETTE------EEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGG
T ss_pred HHhCCEeECCCCHHHEEEeccCCcc-eeeeccCc------cccccCCCceEEEeeccccEecCCC--cEEEeecccChhh
Confidence 9 99999999999999998765211 11111000 0000012236899999999866543 4589999999999
Q ss_pred HhCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCc
Q 015532 257 ILGLGWNYPCDLWSVGCI-LVELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334 (405)
Q Consensus 257 ~~~~~~~~~~DiwSlG~i-l~~lltg~~pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (405)
+.+.. +.++|||||+++ .+++++|..||....... ....+.... .+...
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~~--- 299 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-------------------------TFKTK--- 299 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-------------------------CCSSC---
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-------------------------ccCcc---
Confidence 98766 899999998777 778888999984321101 111111000 00000
Q ss_pred hhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHH-cCCCCC
Q 015532 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL-RHPFFT 390 (405)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL-~hp~f~ 390 (405)
........+++++.+||.+||++| ||+|+| +||||+
T Consensus 300 ---------------~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 ---------------CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---------------CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---------------cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 000011234778999999999987 999999 999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.12 Aligned_cols=228 Identities=22% Similarity=0.316 Sum_probs=164.3
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecch-----hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
|...+.||+|+||.||+|.+ +++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999986 5788999998642 23456788999999999999874321
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~------------------- 171 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT------------------- 171 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-------------------
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc-------------------
Confidence 124788999999999999999999999999999999999976554
Q ss_pred cCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
++|+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.
T Consensus 172 --------~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 172 --------AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp --------EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred --------EEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 556666655433221 122478999999999876 588999999999999999999999987544332
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+.+........+ ..+.. ..........+..+.+++.+||+.|
T Consensus 243 ~~~~~~~~~~~~~~~--------~~~~~---------------------------~~~~~~~~~~~~~l~~li~~cl~~~ 287 (307)
T 2nru_A 243 LLDIKEEIEDEEKTI--------EDYID---------------------------KKMNDADSTSVEAMYSVASQCLHEK 287 (307)
T ss_dssp TTHHHHHHHTTSCCH--------HHHSC---------------------------SSCSCCCHHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHhhhhhhhh--------hhhcc---------------------------ccccccchHHHHHHHHHHHHHcCCC
Confidence 222211110000000 00000 0000011223567899999999999
Q ss_pred CCCCCCHHHHHcC
Q 015532 374 PAERLKAREALRH 386 (405)
Q Consensus 374 P~~Rpta~elL~h 386 (405)
|++|||+.+++++
T Consensus 288 p~~Rps~~~l~~~ 300 (307)
T 2nru_A 288 KNKRPDIKKVQQL 300 (307)
T ss_dssp TTTSCCHHHHHHH
T ss_pred cccCcCHHHHHHH
Confidence 9999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=292.25 Aligned_cols=233 Identities=19% Similarity=0.243 Sum_probs=169.1
Q ss_pred CceEeeCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHH--HhhcCCCCCc----
Q 015532 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTR---- 154 (405)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~--l~~~~~~~~~---- 154 (405)
..++..++.+.++|++.+.||+|+||.||+|++ +++.||||+++... ...+.+|++++.. +.|+++....
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344556667778999999999999999999998 48899999996533 4557789999988 7888874211
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCCCCcEEEeccccc
Q 015532 155 --------------------------YRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILLVSAEYV 200 (405)
Q Consensus 155 --------------------------~~~l~~~~~~~~~~qi~~aL~~LH--------~~givHrDlkp~NIli~~~~~~ 200 (405)
...+++..++.++.||+.||.||| ++||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-- 184 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-- 184 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--
Confidence 124688899999999999999999 89999999999999997655
Q ss_pred ccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-------cceecCCCcchhHHHhCCC------CCCchh
Q 015532 201 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGLG------WNYPCD 267 (405)
Q Consensus 201 k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~D 267 (405)
.+||+|||++....... ....||+.|+|||++.+.. ++.++|
T Consensus 185 -------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 239 (342)
T 1b6c_B 185 -------------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239 (342)
T ss_dssp -------------------------CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHH
T ss_pred -------------------------CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCccc
Confidence 45666666664433221 2347999999999998753 336899
Q ss_pred HHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCC
Q 015532 268 LWSVGCILVELCSG----------EALFQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 333 (405)
Q Consensus 268 iwSlG~il~~lltg----------~~pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (405)
||||||++|+|++| ..||..... .+.+..... ....+...+.
T Consensus 240 i~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~--- 295 (342)
T 1b6c_B 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC---------------------EQKLRPNIPN--- 295 (342)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT---------------------TSCCCCCCCG---
T ss_pred HHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHH---------------------HHHhCCCCcc---
Confidence 99999999999999 778865321 111111100 0000000000
Q ss_pred chhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 334 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.......+..+.+||.+||+.||++|||+.|+++|
T Consensus 296 ------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 296 ------------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp ------------------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ------------------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 00011235678999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.55 Aligned_cols=220 Identities=24% Similarity=0.311 Sum_probs=172.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCC---CcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
..++|++.+.||+|+||.||+|.+..+ +..||||+++.. ....+.+.+|+.+++.+.|+++....
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 347899999999999999999998643 467999998643 33457788999999999999984321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~------------------ 529 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC------------------ 529 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE------------------
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC------------------
Confidence 124788899999999999999999999999999999999987665
Q ss_pred ccCCCCCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 530 ---------vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 530 ---------VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp ---------EEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ---------EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 4555555554432221 12356789999999999899999999999999999997 999999887776
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.... ... ....+++.+.+||.+||..
T Consensus 601 ~~~~i~~~~-----------------------~~~--------------------------~~~~~~~~l~~li~~~l~~ 631 (656)
T 2j0j_A 601 VIGRIENGE-----------------------RLP--------------------------MPPNCPPTLYSLMTKCWAY 631 (656)
T ss_dssp HHHHHHHTC-----------------------CCC--------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHcCC-----------------------CCC--------------------------CCccccHHHHHHHHHHcCC
Confidence 655543311 000 1124467899999999999
Q ss_pred CCCCCCCHHHHHc
Q 015532 373 DPAERLKAREALR 385 (405)
Q Consensus 373 dP~~Rpta~elL~ 385 (405)
||++|||+.|+++
T Consensus 632 dP~~RPs~~el~~ 644 (656)
T 2j0j_A 632 DPSRRPRFTELKA 644 (656)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=316.08 Aligned_cols=221 Identities=23% Similarity=0.332 Sum_probs=175.6
Q ss_pred EeeCCccCCCeEEEeeeecccceeEEEEEecC-CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 84 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
+..|+.+.++|++.+.||+|+||+||+|++.. +++.||||++... ....+.+.+|+.+++.+.|+++....
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 34577788999999999999999999999976 7899999998543 23456678999999999999884311
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~------------- 218 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE------------- 218 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-------------
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-------------
Confidence 1357899999999999999999999999999999999999642
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+...
T Consensus 219 ---------------~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~ 281 (681)
T 2pzi_A 219 ---------------QLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV 281 (681)
T ss_dssp ---------------CEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC
T ss_pred ---------------cEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc
Confidence 4788888888765443 445799999999999874 48899999999999999999998864211
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
. ..+.. . + ....++.+.+||.+||
T Consensus 282 ~-----------~~~~~----------------------------~-----------~------~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 282 D-----------GLPED----------------------------D-----------P------VLKTYDSYGRLLRRAI 305 (681)
T ss_dssp S-----------SCCTT----------------------------C-----------H------HHHHCHHHHHHHHHHT
T ss_pred c-----------ccccc----------------------------c-----------c------ccccCHHHHHHHhhhc
Confidence 0 00000 0 0 0012357889999999
Q ss_pred ccCCCCCCCHHHHHcCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~ 390 (405)
+.||++||++.+.+.|+|+.
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHH
Confidence 99999999988888887763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.83 Aligned_cols=217 Identities=19% Similarity=0.237 Sum_probs=165.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..++|++.+.||+|+||.||+|++.. .||+|+++... ...+.+.+|+.+++.+.|+++....
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999999853 49999986432 2234566799999999999884322
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~------------------- 167 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK------------------- 167 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C-------------------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC-------------------
Confidence 12478899999999999999999999999999999999996 343
Q ss_pred cCCCCCCCceeccCCCCcccc--------CCccceecCCCcchhHHHhC---------CCCCCchhHHHHHHHHHHHHhC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEH--------QDHSYVVSTRHYRAPEVILG---------LGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~~lltg 281 (405)
++|+|||++.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 168 --------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 239 (319)
T 2y4i_B 168 --------VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239 (319)
T ss_dssp --------CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred --------EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 5666666544321 11223468999999999975 3478899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
..||...........+.....+. .....++..
T Consensus 240 ~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~ 271 (319)
T 2y4i_B 240 EWPFKTQPAEAIIWQMGTGMKPN------------------------------------------------LSQIGMGKE 271 (319)
T ss_dssp SCSSSSCCHHHHHHHHHTTCCCC------------------------------------------------CCCSSCCTT
T ss_pred CCCCCCCCHHHHHHHhccCCCCC------------------------------------------------CCcCCCCHH
Confidence 99998877665554432211000 001134567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHc
Q 015532 362 LIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
+.+||.+||..||++|||+.++++
T Consensus 272 l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 899999999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=282.37 Aligned_cols=207 Identities=15% Similarity=0.034 Sum_probs=156.0
Q ss_pred EeeCC-ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc----
Q 015532 84 FAIGE-NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR---- 154 (405)
Q Consensus 84 ~~~~~-~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~---- 154 (405)
+..|+ .+.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.++..+.|+++....
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 44566 56789999999999999999999999999999999997542 2346788999999999999985422
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
.......++..++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~-------------- 167 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD-------------- 167 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--------------
T ss_pred ECCcEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--------------
Confidence 112355678889999999999999999999999999999987654
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
++|+++ .|++ .++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 168 -------------~kl~~~-----------------~~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~ 210 (286)
T 3uqc_A 168 -------------VVLAYP-----------------ATMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210 (286)
T ss_dssp -------------EEECSC-----------------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC
T ss_pred -------------EEEEec-----------------cccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh
Confidence 455433 2443 378999999999999999999999987543211
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+....+ ... ............+++.+.+||.+||+.|
T Consensus 211 ~~~~~~----------------------------~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~d 247 (286)
T 3uqc_A 211 LAPAER----------------------------DTA---------------GQPIEPADIDRDIPFQISAVAARSVQGD 247 (286)
T ss_dssp SEECCB----------------------------CTT---------------SCBCCHHHHCTTSCHHHHHHHHHHHCTT
T ss_pred hHHHHH----------------------------Hhc---------------cCCCChhhcccCCCHHHHHHHHHHcccC
Confidence 100000 000 0000011222456778999999999999
Q ss_pred CCCCCCHHHHHc
Q 015532 374 PAERLKAREALR 385 (405)
Q Consensus 374 P~~Rpta~elL~ 385 (405)
|++| |+.|+++
T Consensus 248 P~~R-s~~el~~ 258 (286)
T 3uqc_A 248 GGIR-SASTLLN 258 (286)
T ss_dssp SSCC-CHHHHHH
T ss_pred CccC-CHHHHHH
Confidence 9999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-27 Score=239.70 Aligned_cols=156 Identities=17% Similarity=0.079 Sum_probs=96.1
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecch-----------hhhhHHHHHHHHHHHHHh-hcCCCCCc----------
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------NKYREAAMIEIDVLQRLA-RHDIGGTR---------- 154 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----------~~~~~~~~~E~~il~~l~-~~~~~~~~---------- 154 (405)
...++.|++|.+..++....|+.||+|++.+. ....+.+.+|+++|+++. |+++....
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34578888888888888888999999999532 234567889999999994 55553211
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
.+.+++ ..|+.||+.||+|||++|||||||||+|||++.+|
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg------------------- 376 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ------------------- 376 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-------------------
T ss_pred EEEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-------------------
Confidence 133444 35889999999999999999999999999997665
Q ss_pred ccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCC
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
.+||+|||+|+..... ..+.+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 377 --------~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 377 --------HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --------CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred --------CEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 4566666666543322 234689999999999987 46678999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=208.22 Aligned_cols=161 Identities=19% Similarity=0.171 Sum_probs=116.6
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---------hhhHHHHHHHHHHHHHhhcCCCCCcc---------
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRY--------- 155 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~il~~l~~~~~~~~~~--------- 155 (405)
+...+.||+|+||+||+|.. .++.+|+|+..... ...+.+.+|+++++++.|+++.....
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 34567999999999999954 47789999863211 12345789999999999999973210
Q ss_pred ---ccC---CHHH----HHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCC
Q 015532 156 ---RSF---PIDL----VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 225 (405)
Q Consensus 156 ---~~l---~~~~----~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~ 225 (405)
..+ +... +..++.||+.||+|||++||+||||||+|||++.
T Consensus 416 lVmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----------------------------- 466 (540)
T 3en9_A 416 IMMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----------------------------- 466 (540)
T ss_dssp EEEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----------------------------
T ss_pred EEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----------------------------
Confidence 000 1111 5689999999999999999999999999999853
Q ss_pred CceeccCCCCccccCCc----------cceecCCCcchhHHHhC--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 015532 226 AIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALF 285 (405)
Q Consensus 226 ~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf 285 (405)
.+||+|||+++...... ...+||+.|||||++.+ ..|+..+|+||..+-..+.+.++.+|
T Consensus 467 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 467 DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 57888888887665432 24689999999999987 56888899999998888887777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6e-22 Score=183.15 Aligned_cols=127 Identities=26% Similarity=0.292 Sum_probs=98.6
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-------------------hhhHHHHHHHHHHHHHhhcCCCC-
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGG- 152 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~E~~il~~l~~~~~~~- 152 (405)
.|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+.+++.+.|..+..
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~ 169 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 169 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeE
Confidence 466779999999999999999 889999999996422 13456789999999998422211
Q ss_pred ----------------CccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 153 ----------------TRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 153 ----------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
.+.. +.......++.||+.||.|||++||+||||||+|||++ ++
T Consensus 170 ~~~~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~------------------ 229 (282)
T 1zar_A 170 YAWEGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE------------------ 229 (282)
T ss_dssp EEEETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT------------------
T ss_pred EeccceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC------------------
Confidence 1112 34456778999999999999999999999999999997 55
Q ss_pred cccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG 259 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~ 259 (405)
.++|+|||++. .+..|+|||++.+
T Consensus 230 ---------~vkl~DFG~a~----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 230 ---------GIWIIDFPQSV----------EVGEEGWREILER 253 (282)
T ss_dssp ---------EEEECCCTTCE----------ETTSTTHHHHHHH
T ss_pred ---------cEEEEECCCCe----------ECCCCCHHHHHHH
Confidence 46788888774 3456899999854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=156.49 Aligned_cols=116 Identities=19% Similarity=0.139 Sum_probs=90.5
Q ss_pred eEEEeeeecccceeEEEEEecCCCcE--EEEEEecchhh-------------------------hhHHHHHHHHHHHHHh
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSINK-------------------------YREAAMIEIDVLQRLA 146 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~--vAiK~~~~~~~-------------------------~~~~~~~E~~il~~l~ 146 (405)
|++.+.||+|+||.||+|.+..+|+. ||||+++.... ....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778888 99998753211 1135778999999999
Q ss_pred hcCCCCC--------------cc------cc-------CCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEeccc
Q 015532 147 RHDIGGT--------------RY------RS-------FPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 147 ~~~~~~~--------------~~------~~-------l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIli~~~~ 198 (405)
|+++... .. .. .++..+..++.||+.||.||| ++||+||||||+|||++.
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-- 206 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-- 206 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--
Confidence 8754110 00 01 123367889999999999999 999999999999999842
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccc
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 238 (405)
.++|+|||+|...
T Consensus 207 ---------------------------~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 ---------------------------KVYFIDMGQAVTL 219 (258)
T ss_dssp ---------------------------SEEECCCTTCEET
T ss_pred ---------------------------cEEEEECcccccC
Confidence 5788999988654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.5e-16 Score=148.14 Aligned_cols=105 Identities=22% Similarity=0.213 Sum_probs=79.6
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-----------------------hhhHHHHHHHHHHHHHhhcCC
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------------------~~~~~~~~E~~il~~l~~~~~ 150 (405)
|++.+.||+|+||.||+|.+. +|+.||||+++... ..+-...+|...|.++.+..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999984 68899999975210 001123468888888876554
Q ss_pred CCC-------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccc
Q 015532 151 GGT-------------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199 (405)
Q Consensus 151 ~~~-------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~ 199 (405)
... ............++.||+.+|.+||++|||||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 211 0111233456788999999999999999999999999999998763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=4.2e-08 Score=88.78 Aligned_cols=86 Identities=13% Similarity=0.026 Sum_probs=59.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
+.|++...++.|+++.||++... ++.+++|+..... .....+.+|+.+++.+.....+-..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 45899999999999999999854 5789999986421 2234578899999999653211110
Q ss_pred --cccC-----CHHHHHHHHHHHHHHHHHHHH
Q 015532 155 --YRSF-----PIDLVRELGRQLLESVAFMHE 179 (405)
Q Consensus 155 --~~~l-----~~~~~~~~~~qi~~aL~~LH~ 179 (405)
...+ +......++.++..+|..||+
T Consensus 92 i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 92 ADGVLCSEEYEDEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp CSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHH
T ss_pred cCCeehhhccCCcccHHHHHHHHHHHHHHHhC
Confidence 0011 122345788999999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.66 E-value=5.1e-08 Score=87.79 Aligned_cols=87 Identities=13% Similarity=-0.028 Sum_probs=56.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC-CCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~-~~~~---------------- 154 (405)
..|.+....+.|..+.||++.. .+|+.+++|+.... ....+..|+.+++.+.+..+ +...
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 4566655555667799999965 45677999997643 23456789999999987644 1100
Q ss_pred --cccCC--HHHHHHHHHHHHHHHHHHHHCC
Q 015532 155 --YRSFP--IDLVRELGRQLLESVAFMHELR 181 (405)
Q Consensus 155 --~~~l~--~~~~~~~~~qi~~aL~~LH~~g 181 (405)
...+. ......++.++...|..||+..
T Consensus 97 i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 97 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSC
T ss_pred cCCcccCcCcCCHhHHHHHHHHHHHHHhCCC
Confidence 11121 1122367788888899998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2.4e-07 Score=85.86 Aligned_cols=76 Identities=14% Similarity=0.195 Sum_probs=52.0
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc-CCC----------C----Cc--------
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIG----------G----TR-------- 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~-~~~----------~----~~-------- 154 (405)
+.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+... .+. . ..
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468999999999863 34889986543 3456678899999998543 220 0 00
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHH
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHE 179 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~ 179 (405)
...++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence 0123455667888999999999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.45 E-value=6.5e-07 Score=84.89 Aligned_cols=82 Identities=13% Similarity=0.127 Sum_probs=55.8
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEec--chh--hhhHHHHHHHHHHHHHhhcCCC--------------CCc---
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SIN--KYREAAMIEIDVLQRLARHDIG--------------GTR--- 154 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~--~~~--~~~~~~~~E~~il~~l~~~~~~--------------~~~--- 154 (405)
.++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.|....+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4678999999999999864 3568889875 322 2235677899999999864330 000
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHH
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHE 179 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~ 179 (405)
...++......++.+++..|..||+
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 1234577788899999999999997
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00062 Score=62.76 Aligned_cols=46 Identities=17% Similarity=0.185 Sum_probs=34.6
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
++.++.|....||+. +..+++|+-.. ......+..|..+|+.|.++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~ 69 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGC 69 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTT
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhc
Confidence 356889999999988 45578898643 23456678999999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.002 Score=61.60 Aligned_cols=51 Identities=24% Similarity=0.324 Sum_probs=34.7
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchh--------hhhHHHHHHHHHHHHHhh
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------KYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------~~~~~~~~E~~il~~l~~ 147 (405)
.+.||.|.++.||++....+++.|+||...... ...+....|.++|+.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~ 93 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGE 93 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhh
Confidence 568999999999999876567789999864211 123445778899888754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.014 Score=53.94 Aligned_cols=46 Identities=15% Similarity=0.203 Sum_probs=27.1
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhh
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~ 147 (405)
++.|+.|..+.||++... ++ .+++|+..... +....|+.+++.|..
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~ 82 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE---KKALFSIFAQDYLAK 82 (346)
T ss_dssp EEECC----CEEEEEEET-TE-EEEEEEECSCH---HHHHHHHHHHHHHHH
T ss_pred eeeccccccCcEEEEEeC-CC-CEEEEecCCCH---HHHHHHHHHHHHHHH
Confidence 356777778999998763 33 48899986522 333456667776654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0054 Score=56.10 Aligned_cols=48 Identities=10% Similarity=-0.045 Sum_probs=31.9
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
++.|+.|....+|++ +.+++|+.............|+.+++.+....+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~ 70 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGV 70 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTS
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCC
Confidence 578999999999998 347889875432211223468888888876544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.012 Score=52.73 Aligned_cols=47 Identities=13% Similarity=0.118 Sum_probs=33.3
Q ss_pred eeecccce-eEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhh
Q 015532 99 KMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 99 ~LG~G~fg-~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~ 147 (405)
.+..|..+ .||+......+..+.+|+-... ....+..|..+|+.|..
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~ 78 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA 78 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc
Confidence 34455544 6999888777778899986543 34457789999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0077 Score=56.43 Aligned_cols=54 Identities=6% Similarity=0.071 Sum_probs=36.9
Q ss_pred EEEeee-ecccceeEEEEEec---C---CCcEEEEEEecchh---h-hhHHHHHHHHHHHHHhhc
Q 015532 95 RILSKM-GEGTFGQVVECFDN---E---KKELVAIKIVRSIN---K-YREAAMIEIDVLQRLARH 148 (405)
Q Consensus 95 ~~~~~L-G~G~fg~V~~a~~~---~---~~~~vAiK~~~~~~---~-~~~~~~~E~~il~~l~~~ 148 (405)
...+.| +.|..+.+|+.... . +++.+++|+..... . ....+..|+.+++.|...
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~ 87 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGEL 87 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHH
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhc
Confidence 345678 88889999988753 0 15678899865432 1 124567899999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.019 Score=51.95 Aligned_cols=55 Identities=11% Similarity=-0.032 Sum_probs=41.1
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhc
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~ 148 (405)
...-++.+|.|..+.||+.+. .+|+.|.+|+-.... .....+..|...|+.|...
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~ 71 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRS 71 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCS
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhh
Confidence 456678999999999999986 467889999864322 2234567899999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.86 E-value=0.061 Score=49.29 Aligned_cols=52 Identities=12% Similarity=0.103 Sum_probs=32.3
Q ss_pred EEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcC
Q 015532 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~ 149 (405)
.-++.|+.|....+|++... ++ .+++|+.... ...+.+..|+.+++.|....
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g 76 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKG 76 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTT
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCC
Confidence 34567888988999998764 34 5789988652 12334566888888887643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.063 Score=46.25 Aligned_cols=88 Identities=10% Similarity=-0.053 Sum_probs=51.5
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCCceeccCC
Q 015532 155 YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233 (405)
Q Consensus 155 ~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 233 (405)
...++|++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.+.+.+ +
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~----------------------------~ 94 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP----------------------------A 94 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC----------------------------C
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc----------------------------c
Confidence 4578999999999999999877621 1111233446788887776543221 0
Q ss_pred CCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh
Q 015532 234 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 234 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 280 (405)
.+. .....+.+||... ...+.+.=|||||+++|..+-
T Consensus 95 ~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 95 ADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 000 1122355777653 244577889999999998774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.56 E-value=0.067 Score=51.56 Aligned_cols=54 Identities=13% Similarity=0.190 Sum_probs=38.4
Q ss_pred EEeeeecccceeEEEEEecC-------CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 96 ILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
-++.|+.|....||++.... .++.|++|+.... ...+.+..|..+++.|....+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~ 137 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL 137 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCC
Confidence 35678889899999998643 2567899987431 111455679999998877654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.38 E-value=0.053 Score=51.32 Aligned_cols=53 Identities=13% Similarity=0.194 Sum_probs=32.1
Q ss_pred eeeecccceeEEEEEecC-------CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 98 SKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
+.|..|-...+|++.... .++.|.+|+............+|..+++.|....+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv 115 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL 115 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC
Confidence 567778888899988642 34678899864322234556689999998877654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.37 E-value=0.038 Score=51.95 Aligned_cols=54 Identities=17% Similarity=0.158 Sum_probs=31.7
Q ss_pred EeeeecccceeEEEEEecC--------CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 97 LSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~--------~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
.+.|+.|....+|++.... .++.+++|+.............|..+++.|....+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~ 99 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI 99 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC
Confidence 4578888888999988643 12578899875432211123568888888876544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.93 E-value=0.11 Score=47.72 Aligned_cols=49 Identities=14% Similarity=0.150 Sum_probs=33.4
Q ss_pred eeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
..|+ |....||++.. .+|+.+++|+.+......+....|..+++.|...
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~ 80 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND 80 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHc
Confidence 3466 77788998765 3455688999864323345566788888888654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.02 E-value=0.17 Score=49.06 Aligned_cols=55 Identities=13% Similarity=0.053 Sum_probs=34.6
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
-++.|+.|-...+|++.....+..|++|+........-....|..+++.|....+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl 166 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNI 166 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCC
Confidence 3567888989999999875445778899874321111112468888888876544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=93.40 E-value=0.72 Score=42.17 Aligned_cols=49 Identities=27% Similarity=0.258 Sum_probs=37.3
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhc
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~ 148 (405)
-.+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.|...
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~ 88 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKT 88 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHT
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhh
Confidence 357899999999999875 3567889987543 355677899999988754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.38 E-value=0.063 Score=51.49 Aligned_cols=20 Identities=25% Similarity=0.474 Sum_probs=16.7
Q ss_pred HHCCcEecCCCCCcEEEecc
Q 015532 178 HELRLIHTDLKPENILLVSA 197 (405)
Q Consensus 178 H~~givHrDlkp~NIli~~~ 197 (405)
+...++|+|+++.|||++.+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~ 249 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD 249 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS
T ss_pred CCCeEEecCCCCCcEEEeCC
Confidence 35689999999999999643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.01 E-value=0.49 Score=45.32 Aligned_cols=54 Identities=15% Similarity=0.129 Sum_probs=34.2
Q ss_pred EeeeecccceeEEEEEecCC-------CcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 97 LSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
++.|..|-...+|++..... ++.|++|+........-...+|..+++.|....+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi 135 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI 135 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC
Confidence 45677788888999886521 5678899864322211223468888888776544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.42 E-value=1.2 Score=42.25 Aligned_cols=15 Identities=40% Similarity=0.636 Sum_probs=13.3
Q ss_pred cEecCCCCCcEEEec
Q 015532 182 LIHTDLKPENILLVS 196 (405)
Q Consensus 182 ivHrDlkp~NIli~~ 196 (405)
++|+|+.+.|||+..
T Consensus 246 fcHnDl~~gNil~~~ 260 (401)
T 3g15_A 246 FCHNDCQEGNILLLE 260 (401)
T ss_dssp EECSCCCGGGEEEET
T ss_pred eEEecCCCCeEEEec
Confidence 679999999999954
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=86.56 E-value=0.23 Score=45.69 Aligned_cols=17 Identities=24% Similarity=0.649 Sum_probs=15.2
Q ss_pred CCcEecCCCCCcEEEec
Q 015532 180 LRLIHTDLKPENILLVS 196 (405)
Q Consensus 180 ~givHrDlkp~NIli~~ 196 (405)
..++|+|+.+.|||++.
T Consensus 183 ~~lvHgD~~~~Nil~~~ 199 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLP 199 (333)
T ss_dssp CEEECSCCSGGGEEECT
T ss_pred CeeEeCCcCcccEEecc
Confidence 47999999999999965
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.11 E-value=0.51 Score=43.62 Aligned_cols=27 Identities=26% Similarity=0.480 Sum_probs=20.7
Q ss_pred CCcEecCCCCCcEEEecccccccCCcc
Q 015532 180 LRLIHTDLKPENILLVSAEYVKVPDYK 206 (405)
Q Consensus 180 ~givHrDlkp~NIli~~~~~~k~~df~ 206 (405)
..++|+|+.+.||+++.++.+.+.||+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e 232 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWD 232 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCS
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECC
Confidence 468999999999999766555555553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 405 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-28 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-25 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-25 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-21 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-20 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-20 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-19 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-19 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-19 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-19 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-18 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-10 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-46
Identities = 61/330 (18%), Positives = 110/330 (33%), Gaps = 64/330 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ +S++G G G V + ++A K++ R + E+ VL I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 151 ---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHE-LRL 182
GG+ + P ++ ++ +++ + ++ E ++
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H D+KP NIL+ + G IKL DFG +
Sbjct: 127 MHRDVKPSNILV-----------------NSRGE----------IKLCDFGVSGQLIDSM 159
Query: 243 SY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ V TR Y +PE + G ++ D+WS+G LVE+ G + E M +
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
R G P +LP+ + +
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL------E 273
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFFTR 391
D + L +PAER ++ + H F R
Sbjct: 274 FQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 5e-42
Identities = 87/364 (23%), Positives = 142/364 (39%), Gaps = 80/364 (21%)
Query: 86 IGENLTP-RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR 144
GE RY ++ K+G G F V D VA+KIVR Y EAA EI +LQR
Sbjct: 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65
Query: 145 LARHDI-------------------------------------------GGTRYRSFPID 161
+ D +R P+
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 162 LVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
V+++ +QLL + +MH +IHTD+KPEN+L+ +
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-------------------- 165
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
IK+ D G+ + + ++ + TR YR+PEV+LG W D+WS C++ EL +
Sbjct: 166 -ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
Query: 281 GEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
G+ LF+ E + +H+A + +LG LP +++ + RG +
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK---- 280
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 394
W L + + A ++ D L +L+ DP +R A + HP+ +
Sbjct: 281 ----LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336
Query: 395 RPTL 398
+
Sbjct: 337 MEEI 340
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-42
Identities = 68/339 (20%), Positives = 130/339 (38%), Gaps = 77/339 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L+K+G+GTFG+V + + + VA+K V N + A+ EI +LQ L +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 150 I-----------------------------------GGTRYRSFPIDLVRELGRQLLESV 174
+ F + ++ + + LL +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
++H +++H D+K N+L+ +K+ D+ +
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGL-------------------ARAFSLAK 171
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ ++ + VV T YR PE++LG + P DLW GCI+ E+ + + Q +
Sbjct: 172 NSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
LA++ ++ G + + D + ++ + +
Sbjct: 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR----------------KVKDRLKA 274
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
+V +DL+ LL DPA+R+ + +AL H FF D
Sbjct: 275 YVRDP--YALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-42
Identities = 75/336 (22%), Positives = 128/336 (38%), Gaps = 73/336 (21%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA 146
++ PRY LS +GEG +G V +DN K VAIK + Y + + EI +L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 147 RHDI-------------------------GGT-----RYRSFPIDLVRELGRQLLESVAF 176
+I G + + D + Q+L + +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H ++H DLKP N+LL + +K+ D+ + D +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH------------------- 165
Query: 237 FEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
+ V+TR YRAPE++L G+ D+WSVGCIL E+ S +F L+ L
Sbjct: 166 --TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
+ +LG D + + + +
Sbjct: 224 HILGILGSPSQE-------------------DLNCIINLKARNYLLSLPHKNKVPWNRLF 264
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
++ +DLL +L ++P +R++ +AL HP+ +
Sbjct: 265 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-42
Identities = 79/343 (23%), Positives = 131/343 (38%), Gaps = 89/343 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLARH 148
+Y ++++GEG +G+V + D + VA+K VR + + E+ VL+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 149 D------------------------------------IGGTRYRSFPIDLVRELGRQLLE 172
+ + P + ++++ QLL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
+ F+H R++H DLKP+NIL+ S+ +K+ D
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------FGL 162
Query: 233 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292
+ VV T YRAPEV+L + P DLWSVGCI E+ + LF+ +++
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
L + V+G DWP ++ + I
Sbjct: 223 QLGKILDVIGLPGEE-------------------DWPRDV----ALPRQAFHSKSAQPIE 259
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
+ V DLL L ++PA+R+ A AL HP+F +D+ R
Sbjct: 260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLER 301
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 65/332 (19%), Positives = 108/332 (32%), Gaps = 109/332 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ E+++ L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 149 DI---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELR 181
+I GT + F +L ++++ H R
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQ 240
+IH D+KPEN+LL SA +K + DFG S
Sbjct: 127 VIHRDIKPENLLLGSAGELK---------------------------IADFGWSVHAPSS 159
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300
+ + T Y PE+I G + DLWS+G + E G+ F+ + E + RV
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360
P D
Sbjct: 220 EFTFP--------------------------------------------------DFVTE 229
Query: 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
DL+ LL+++P++R RE L HP+ T +
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-40
Identities = 63/341 (18%), Positives = 119/341 (34%), Gaps = 107/341 (31%)
Query: 93 RYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-- 149
Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHI 67
Query: 150 --------------------------------IGGTRYRSFPIDLVRELGRQLLESVAFM 177
I ++F E+ + + E++ ++
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H + + H D+KPEN+L S + +KL DFG
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAI------------------------LKLTDFGFAKE 163
Query: 238 --EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
H + T +Y APEV+ ++ CD+WS+G I+ L G F ++ L
Sbjct: 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
M+ R PN V
Sbjct: 224 GMKT---------------------------------------RIRMGQYEFPNPEWSEV 244
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
++ L++ LL+ +P +R+ E + HP+ + + P
Sbjct: 245 SE---EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 142 bits (359), Expect = 7e-40
Identities = 67/329 (20%), Positives = 136/329 (41%), Gaps = 72/329 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGPNII 93
Query: 150 ---------------------IGGT---RYRSFPIDLVRELGRQLLESVAFMHELRLIHT 185
Y++ +R ++L+++ + H + ++H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 186 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHS 243
D+KP N+++ + ++LID+G F H Q+++
Sbjct: 154 DVKPHNVMIDH--------------------------EHRKLRLIDWGLAEFYHPGQEYN 187
Query: 244 YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE-ALFQTHENLEHLAMMERVL 301
V++R+++ PE+++ ++Y D+WS+GC+L + + F H+N + L + +VL
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
G + I + + D + + + ++ + +
Sbjct: 248 GTEDLYDYID-------------KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFFT 390
+D L LLRYD RL AREA+ HP+F
Sbjct: 295 ALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 65/346 (18%), Positives = 119/346 (34%), Gaps = 113/346 (32%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLAR 147
N + I+ ++G+G FG+V + + E L A K++ + + + E M+EID+L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-D 67
Query: 148 H-----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMH 178
H + R ++ + +Q L+++ ++H
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+ ++IH DLK NIL + DG IKL DFG +
Sbjct: 128 DNKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGVSAKN 160
Query: 239 HQDHSY---VVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQTHEN 290
+ + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH---- 216
Query: 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 350
+ MR + K+ +
Sbjct: 217 -------------------------------------------ELNPMRVLLKIAKSEPP 233
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ + + D L+ L + R + L+HPF T D +P
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-39
Identities = 83/374 (22%), Positives = 133/374 (35%), Gaps = 106/374 (28%)
Query: 65 IPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
+ G P RP + Y +G G+FG V + + ELVAIK
Sbjct: 7 VATPGQGPDRPQEVS--------------YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 52
Query: 125 VRSINKYREAAMIEIDVLQRLARHDI---------------------------------- 150
V +++ E+ ++++L +I
Sbjct: 53 VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 151 --GGTRYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 208
++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------------- 156
Query: 209 SRSSKDGSYFKNLPKSSAIKLIDFGSTTF--EHQDHSYVVSTRHYRAPEVILG-LGWNYP 265
P ++ +KL DFGS + + + +R+YRAPE+I G +
Sbjct: 157 -------------PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 266 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGA 324
D+WS GC+L EL G+ +F ++ L + +VLG P + E F +
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263
Query: 325 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 384
W R + I L LL Y P RL EA
Sbjct: 264 AHPWTKVFRPRTPP----------------------EAIALCSRLLEYTPTARLTPLEAC 301
Query: 385 RHPFFTRDVRRPTL 398
H FF ++R P +
Sbjct: 302 AHSFF-DELRDPNV 314
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 141 bits (356), Expect = 4e-39
Identities = 70/332 (21%), Positives = 101/332 (30%), Gaps = 104/332 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARH--- 148
Y I ++G G FG V + A K V + + +E EI + L RH
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTL 85
Query: 149 --------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
+ + D E RQ+ + + MHE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF--EHQ 240
+H DLKPENI+ + +S+ +KLIDFG T Q
Sbjct: 146 VHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAHLDPKQ 180
Query: 241 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300
T + APEV G Y D+WSVG + L SG + F + E L ++
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360
+
Sbjct: 241 DWNMDDSAFSGISE---------------------------------------------- 254
Query: 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
D D ++ LL DP R+ +AL HP+ T
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-39
Identities = 75/334 (22%), Positives = 121/334 (36%), Gaps = 72/334 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
RY+ L +G G G V +D VAIK + + + A E+ +++ + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 150 I--------------------------GGTRYRSF----PIDLVRELGRQLLESVAFMHE 179
I + + + L Q+L + +H
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
+IH DLKP NI++ S +K+ D T
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILD-------------------------FGLARTAGTS 172
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
+ V TR+YRAPEVILG+G+ D+WSVGCI+ E+ + LF + ++ +
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 300 VLGPLPHHMVIRADRRAEKYFR---RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
LG + + Y + A L +P L +H
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK-----------LFPDSLFPADSEHNK 281
Query: 357 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
A DLL +L DPA+R+ +AL+HP+
Sbjct: 282 LKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-39
Identities = 83/337 (24%), Positives = 136/337 (40%), Gaps = 78/337 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ + K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 150 I----------------------------GGTRYRSFPIDLVRELGRQLLESVAFMHELR 181
I + P+ L++ QLL+ +AF H R
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
++H DLKP+N+L+ + +K+ D+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT------------------------ 158
Query: 242 HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300
+++ V T YRAPE++LG ++ D+WS+GCI E+ + ALF ++ L + R
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218
Query: 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360
LG + WP + D + K R + V
Sbjct: 219 LGTPD-------------------EVVWPGVTSMPDYKPSFPKWARQD--FSKVVPPLDE 257
Query: 361 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
D LL +L YDP +R+ A+ AL HPFF +DV +P
Sbjct: 258 DGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (352), Expect = 1e-38
Identities = 65/336 (19%), Positives = 108/336 (32%), Gaps = 102/336 (30%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDI- 150
Y IL ++G G FG V C + + K + + + EI ++ +L +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 151 --------------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRLI 183
GG V RQ E + MHE ++
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H D+KPENI+ K+S++K+IDFG T + D
Sbjct: 150 HLDIKPENIMC-------------------------ETKKASSVKIIDFGLATKLNPDEI 184
Query: 244 Y--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+T + APE++ + D+W++G + L SG + F ++LE L ++R
Sbjct: 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
+
Sbjct: 245 WEFDEDAFSSVSP----------------------------------------------E 258
Query: 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPT 397
D ++ LL+ +P +RL +AL HP+ D T
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-38
Identities = 56/339 (16%), Positives = 99/339 (29%), Gaps = 101/339 (29%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 148 HDI---------------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHE 179
+I G + Q+ E++ F+H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
+ H D++PENI+ + + K+I+FG
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFGQARQLK 155
Query: 240 QDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
++ + + Y APEV + D+WS+G ++ L SG F N + + +
Sbjct: 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
Sbjct: 216 MNAEYTFDEEAFKEISI------------------------------------------- 232
Query: 358 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
+ +D + LL + R+ A EAL+HP+ + + R
Sbjct: 233 ---EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-37
Identities = 63/334 (18%), Positives = 113/334 (33%), Gaps = 100/334 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHD-- 149
+Y K+G+G G V D + VAI+ + +E + EI V++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNI 79
Query: 150 --------------------IGGT-----RYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
GG+ + + R+ L+++ F+H ++IH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+K +NILL VK+ D+ F ++ + + S S
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK------------------------RST 175
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304
+V T ++ APEV+ + D+WS+G + +E+ GE + L L ++ P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP- 234
Query: 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364
L P+ ++ D
Sbjct: 235 --------------------ELQNPEKLSA--------------------------IFRD 248
Query: 365 LLQGLLRYDPAERLKAREALRHPFFTRDVRRPTL 398
L L D +R A+E L+H F +L
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSL 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-37
Identities = 77/335 (22%), Positives = 127/335 (37%), Gaps = 88/335 (26%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRL---- 145
L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 146 -----------------------ARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
I ++ L+ + ++H+ +
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF---EH 239
+H DLKP N+LL ++G +KL DFG +
Sbjct: 122 LHRDLKPNNLLL-----------------DENGV----------LKLADFGLAKSFGSPN 154
Query: 240 QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+ +++ V TR YRAPE++ G + D+W+VGCIL EL +L+ L +
Sbjct: 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
LG WPD S+ P + + H+ +
Sbjct: 215 ETLGTPTEE-------------------QWPDMC----SLPDYVTFKSFPGIPLHHIFSA 251
Query: 359 AG-DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
AG DL+DL+QGL ++P R+ A +AL+ +F+
Sbjct: 252 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-37
Identities = 78/351 (22%), Positives = 138/351 (39%), Gaps = 84/351 (23%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KY 131
+ G Y + + + YR L +G G +G V D VAIK + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 132 REAAMIEIDVLQRLARHDIGG-------------------------------TRYRSFPI 160
+ A E+ +L+ + ++ G ++
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
D ++ L Q+L+ + ++H +IH DLKP N+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA--------------------------- 153
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 279
+ + +K++DFG + + V TR YRAPEVIL + + D+WSVGCI+ E+
Sbjct: 154 VNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
+G+ LF+ ++L+ L + +V G P V R K + +G P+
Sbjct: 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG----LPE--------- 260
Query: 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 390
+ +++ ++LL+ +L D +R+ A EAL HP+F
Sbjct: 261 ------LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-36
Identities = 73/339 (21%), Positives = 135/339 (39%), Gaps = 83/339 (24%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL 145
+ RY+ LS +G G +G V FD + VA+K + + + E+ +L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 146 ARHDI-------------------------------GGTRYRSFPIDLVRELGRQLLESV 174
++ + + D V+ L Q+L +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
++H +IH DLKP N+ + + +K++DFG
Sbjct: 135 KYIHSADIIHRDLKPSNLAV---------------------------NEDCELKILDFGL 167
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ + V+TR YRAPE++L +N D+WSVGCI+ EL +G LF ++++
Sbjct: 168 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
L ++ R++G + +S + + L ++P +
Sbjct: 228 LKLILRLVGTPGAEL--------------------LKKISSESARNYIQSLTQMPKMNFA 267
Query: 354 HVDHSAG-DLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+V A +DLL+ +L D +R+ A +AL H +F +
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (332), Expect = 2e-36
Identities = 74/345 (21%), Positives = 110/345 (31%), Gaps = 119/345 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----------SINKYREAAMIEIDVL 142
Y +G G V C + A+KI+ + + REA + E+D+L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 143 QRLARHDI----------------------GGT------RYRSFPIDLVRELGRQLLESV 174
++++ H G + R++ R LLE +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
+H+L ++H DLKPENILL D + IKL DFG
Sbjct: 124 CALHKLNIVHRDLKPENILL-----------------DDDMN----------IKLTDFGF 156
Query: 235 TTFEHQDHSY--VVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELCSGEALFQ 286
+ V T Y APE+I G+ D+WS G I+ L +G F
Sbjct: 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
+ + L M+ F D+ D
Sbjct: 217 HRKQMLMLRMI----------------MSGNYQFGSPEWDDYSD---------------- 244
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 391
+ DL+ L P +R A EAL HPFF +
Sbjct: 245 --------------TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (334), Expect = 2e-36
Identities = 64/347 (18%), Positives = 114/347 (32%), Gaps = 112/347 (32%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQ 143
++ + L ++G G+FG V D E+VAIK + N+ + + E+ LQ
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 144 RLARH----------------------------DIGGTRYRSFPIDLVRELGRQLLESVA 175
+L RH D+ + + + L+ +A
Sbjct: 71 KL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 235
++H +IH D+K NILL S+ G +KL DFGS
Sbjct: 130 YLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLGDFGSA 162
Query: 236 TFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQTHENLE 292
+ +S+ V T ++ APEVIL + ++ D+WS+G +EL + +
Sbjct: 163 SIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352
L + + P W +
Sbjct: 222 ALYHIAQNESPALQSG------------------HWSE---------------------- 241
Query: 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRPTLL 399
+ + L+ P +R + L+H F R+ ++
Sbjct: 242 --------YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 54/333 (16%), Positives = 111/333 (33%), Gaps = 99/333 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++ +GEG +G+V + +E VA+KIV E EI + + L ++
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 151 ---------------------GGTRY------RSFPIDLVRELGRQLLESVAFMHELRLI 183
GG + P + QL+ V ++H + +
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H D+KPEN+LL + +K+ D+ + + + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNN----------------------RERLLN 163
Query: 244 YVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302
+ T Y APE++ ++ P D+WS G +L + +GE
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL------------------- 204
Query: 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362
D + + WK + + +D
Sbjct: 205 -------------------------PWDQPSDSCQEYSDWKEKKTYLNPWKKIDS---AP 236
Query: 363 IDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395
+ LL +L +P+ R+ + + ++ + +++
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-35
Identities = 77/330 (23%), Positives = 128/330 (38%), Gaps = 77/330 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + + E E+VA+K VR + +A+ EI +L+ L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 150 I---------------------------GGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
I + ++V+ QLL+ + F H +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
+H DLKP+N+L+ +K+ ++ + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------RCY 158
Query: 243 SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEA-LFQTHENLEHLAMMERV 300
S V T YR P+V+ G + D+WS GCI EL + LF ++ + L + R+
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360
LG WP D + + ++ V
Sbjct: 219 LGTPTEE-------------------QWPSMTKLPDYKP--YPMYPATTSLVNVVPKLNA 257
Query: 361 DLIDLLQGLLRYDPAERLKAREALRHPFFT 390
DLLQ LL+ +P +R+ A EAL+HP+F+
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 2e-35
Identities = 72/337 (21%), Positives = 116/337 (34%), Gaps = 101/337 (29%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQR 144
E++ Y +G G F +V+ D ++LVAIK + ++ + EI VL +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 145 LARHDI---------------------GGT------RYRSFPIDLVRELGRQLLESVAFM 177
+ +I GG + L Q+L++V ++
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
H+L ++H DLKPEN+L S L + S I + DFG +
Sbjct: 124 HDLGIVHRDLKPENLLYYS------------------------LDEDSKIMISDFGLSKM 159
Query: 238 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295
E T Y APEV+ ++ D WS+G I L G F + +
Sbjct: 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--- 216
Query: 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 355
+ E++L +AE F D D
Sbjct: 217 LFEQIL-------------KAEYEFDSPYWDDISD------------------------- 238
Query: 356 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392
D ++ L+ DP +R +AL+HP+ D
Sbjct: 239 -----SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-35
Identities = 63/339 (18%), Positives = 109/339 (32%), Gaps = 107/339 (31%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 141 VLQRLARH----------------------------DIGGTRYRSFPIDLVRELGRQLLE 172
+L+ + +H S + E +Q+L
Sbjct: 66 ILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 173 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
V ++H L++ H DLKPENI+L+ IK+IDF
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPRIKIIDF 161
Query: 233 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290
G + + + T + APE++ D+WS+G I L SG + F
Sbjct: 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 350
E LA + V
Sbjct: 222 QETLANVSAVNYEFED-------------------------------------------- 237
Query: 351 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
++ +++ D ++ LL DP +R+ +++L+HP+
Sbjct: 238 --EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-34
Identities = 59/343 (17%), Positives = 119/343 (34%), Gaps = 112/343 (32%)
Query: 85 AIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
A+G + R+ + ++G G+F V + D E VA ++ R+ E +
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60
Query: 141 VLQRLARHDI-------------------------GGT------RYRSFPIDLVRELGRQ 169
+L+ L +I GT R++ I ++R RQ
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120
Query: 170 LLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 227
+L+ + F+H +IH DLK +NI + + GS +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFI----------------TGPTGS----------V 154
Query: 228 KLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 286
K+ D G T + + V+ T + APE+ ++ D+++ G ++E+ + E +
Sbjct: 155 KIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213
Query: 287 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346
+N + R V ++
Sbjct: 214 ECQNAAQI-------------------------------------------YRRVTSGVK 230
Query: 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
+ + ++ ++++G +R + ER ++ L H FF
Sbjct: 231 PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (318), Expect = 2e-34
Identities = 75/331 (22%), Positives = 126/331 (38%), Gaps = 83/331 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + +N + A+K +R + EI +L+ L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 150 I---------------------------GGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
I + QLL +A+ H+ R+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD- 241
+H DLKP+N+L+ +++G +K+ DFG
Sbjct: 122 LHRDLKPQNLLI-----------------NREGE----------LKIADFGLARAFGIPV 154
Query: 242 --HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
+++ + T YRAP+V++G ++ D+WSVGCI E+ +G LF + L +
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
R+LG +WP+ LP +
Sbjct: 215 RILGTPNSK-------------------NWPNVTELPKYDPNFTVYEPLP--WESFLKGL 253
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALRHPFF 389
IDLL +L+ DP +R+ A++AL H +F
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-31
Identities = 56/339 (16%), Positives = 103/339 (30%), Gaps = 120/339 (35%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
Y +L +G G++G+ + +++ K + ++ + E+++L+ L +I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 151 -----------------------GGT----------RYRSFPIDLVRELGRQLLESVAFM 177
GG + + V + QL ++
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 178 HEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 232
H ++H DLKP N+ L + +KL DF
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFL-----------------DGKQN----------VKLGDF 158
Query: 233 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 289
G + D S+ V T +Y +PE + + +N D+WS+GC+L ELC+ F
Sbjct: 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218
Query: 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349
E + R G P +
Sbjct: 219 QKELAGKI-----------------------REGKFRRIPYRYSD--------------- 240
Query: 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
+L +++ +L R E L +P
Sbjct: 241 -----------ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 5e-31
Identities = 50/330 (15%), Positives = 93/330 (28%), Gaps = 88/330 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-- 150
RYR+ K+G G+FG + D E VAIK+ + IE + + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 151 -------------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
G + R F + V L Q++ + ++H IH
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
D+KP+N L+ + + D K + ++++
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYII-------DFGLAKKYRDAR-------THQHIPYRENKN 172
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304
+ T Y + LG+ + DL S+G +L+ G +Q + ER
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----- 227
Query: 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364
++ I +
Sbjct: 228 -------------------------------------ISEKKMSTPIEVLCKGYPSEFAT 250
Query: 365 LLQGLLRYDPAERLKA---REALRHPFFTR 391
L ++ R+ R+ F +
Sbjct: 251 YLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 7e-31
Identities = 62/333 (18%), Positives = 103/333 (30%), Gaps = 113/333 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G+G+FG+V + + AIK ++ ++ E M+E VL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 149 DI----------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHEL 180
GG F + +++ + F+H
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 181 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF--- 237
+++ DLK +NIL KDG K+ DFG
Sbjct: 123 GIVYRDLKLDNIL-----------------LDKDGHI----------KIADFGMCKENML 155
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297
+ T Y APE++LG +N+ D WS G +L E+ G++ F + E +
Sbjct: 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215
Query: 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357
R +P
Sbjct: 216 ------------------------RMDNPFYPRWLEK----------------------- 228
Query: 358 SAGDLIDLLQGLLRYDPAERLKAR-EALRHPFF 389
+ DLL L +P +RL R + +HP F
Sbjct: 229 ---EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-30
Identities = 61/334 (18%), Positives = 101/334 (30%), Gaps = 109/334 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ +GEG+F VV + AIKI+ E DV+ RL
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 149 DI---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELR 181
G + SF R +++ ++ ++H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+IH DLKPENILL ++++ D+ S + +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES----------------------KQAR 166
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ V T Y +PE++ DLW++GCI+ +L +G F+ + ++
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
P +P
Sbjct: 227 YDFPEKF-------------------FP-------------------------------K 236
Query: 362 LIDLLQGLLRYDPAERLKAREA------LRHPFF 389
DL++ LL D +RL E HPFF
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (290), Expect = 7e-30
Identities = 61/333 (18%), Positives = 103/333 (30%), Gaps = 113/333 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ + +G G+FG+V+ E A+KI+ K E + E +LQ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 149 DIGG---------------------------TRYRSFPIDLVRELGRQLLESVAFMHELR 181
+ R F R Q++ + ++H L
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
LI+ DLKPEN+L+ + G I++ DFG
Sbjct: 162 LIYRDLKPENLLI-----------------DQQGY----------IQVTDFGFAKRVKGR 194
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ T APE+IL G+N D W++G ++ E+ +G F + ++ +
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
P H D
Sbjct: 255 VRFPSHF-------------------SSD------------------------------- 264
Query: 362 LIDLLQGLLRYDPAERLK-----AREALRHPFF 389
L DLL+ LL+ D +R + H +F
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 62/343 (18%), Positives = 99/343 (28%), Gaps = 122/343 (35%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRL 145
+Y++ +G G FG V VAIK V +E+ +L+++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 146 ARHDIGGTRY------------------------------RSFPIDLVRELGRQLLESVA 175
+ G R + +L R Q+LE+V
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 176 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 234
H ++H D+K ENIL+ +KLIDFG
Sbjct: 125 HCHNCGVLHRDIKDENILIDL--------------------------NRGELKLIDFGSG 158
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ ++ TR Y PE I +WS+G +L ++ G+ F+ E
Sbjct: 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 215
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
++R Q
Sbjct: 216 --------------------------------------------------IIRGQVFFRQ 225
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRP 396
V LI + L P++R E HP+ +DV P
Sbjct: 226 RVSSECQHLI---RWCLALRPSDRPTFEEIQNHPWM-QDVLLP 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-29
Identities = 64/335 (19%), Positives = 108/335 (32%), Gaps = 116/335 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 150 I---------------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRL 182
+ GG R R F + R G +++ ++ ++H +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
++ D+K EN++L KDG IK+ DFG D
Sbjct: 127 VYRDIKLENLML-----------------DKDGH----------IKITDFGLCKEGISDG 159
Query: 243 S---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
+ T Y APEV+ + D W +G ++ E+ G F ++ ++
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+ +P +
Sbjct: 220 ------------------------EEIRFPRTLSP------------------------- 230
Query: 360 GDLIDLLQGLLRYDPAERLK-----AREALRHPFF 389
+ LL GLL+ DP +RL A+E + H FF
Sbjct: 231 -EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 3e-29
Identities = 63/332 (18%), Positives = 107/332 (32%), Gaps = 113/332 (34%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRL---- 145
++IL +G G+FG+V A+K+++ K E E +L +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 146 -----------------------ARHDIGGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
+ + FP + + ++ ++ ++H +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
I+ DLKPENILL K+G IK+ DFG +
Sbjct: 126 IYRDLKPENILL-----------------DKNGH----------IKITDFGFAKYVPDVT 158
Query: 243 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 302
+ T Y APEV+ +N D WS G ++ E+ +G F ++ E++L
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKIL- 214
Query: 303 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 362
A L +P D+
Sbjct: 215 --------------------NAELRFPPFFNE--------------------------DV 228
Query: 363 IDLLQGLLRYDPAERLK-----AREALRHPFF 389
DLL L+ D ++RL + HP+F
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (279), Expect = 1e-28
Identities = 44/247 (17%), Positives = 81/247 (32%), Gaps = 61/247 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
Y++ ++GEG+FG + E + + VAIK E + LA
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 149 ------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
D+ R F + V +Q+L V +HE L++
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG----------S 234
D+KP+N L+ ++ I ++DFG
Sbjct: 125 RDIKPDNFLIGRPNS----------------------KNANMIYVVDFGMVKFYRDPVTK 162
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
+++ + T Y + LG + DL ++G + + G +Q + +
Sbjct: 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222
Query: 295 AMMERVL 301
ER+
Sbjct: 223 QKYERIG 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 111 bits (278), Expect = 5e-28
Identities = 64/338 (18%), Positives = 114/338 (33%), Gaps = 115/338 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG+V C + ++ A+K + + + A+ E +L ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 149 DI------------------------GGT------RYRSFPIDLVRELGRQLLESVAFMH 178
D GG ++ F +R +++ + MH
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 237
+++ DLKP NILL +V ++ D G + F
Sbjct: 125 NRFVVYRDLKPANILLDEHGHV---------------------------RISDLGLACDF 157
Query: 238 EHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296
+ V T Y APEV+ G+ ++ D +S+GC+L +L G + F+ H+ + +
Sbjct: 158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
Query: 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
L ++ PD +
Sbjct: 218 DRMTLTM---------------------AVELPDSFSP---------------------- 234
Query: 357 HSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 389
+L LL+GLL+ D RL A+E PFF
Sbjct: 235 ----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-26
Identities = 48/325 (14%), Positives = 95/325 (29%), Gaps = 110/325 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
++L +G+G FG V+ + VA+K +++ + +A + E V+ +L RH
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQL-RHSNLV 63
Query: 150 ----------------------------IGGTRYRSFPIDLVRELGRQLLESVAFMHELR 181
+ D + + + E++ ++
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 182 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 241
+H DL N+L+ S+D K+ DFG T
Sbjct: 124 FVHRDLAARNVLV-----------------SEDNV----------AKVSDFGLTKEASST 156
Query: 242 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 301
+ APE + ++ D+WS G +L E+ S + L+ +
Sbjct: 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------ 210
Query: 302 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361
+G ++D PDG
Sbjct: 211 ----------------PRVEKGYKMDAPDGCPP--------------------------A 228
Query: 362 LIDLLQGLLRYDPAERLKAREALRH 386
+ ++++ D A R +
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 102 bits (254), Expect = 2e-25
Identities = 54/335 (16%), Positives = 93/335 (27%), Gaps = 102/335 (30%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR 144
+L+ RY + +G G +V D VA+K++R + E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 145 LARHDI-------------------------GGT------RYRSFPIDLVRELGRQLLES 173
L I G T E+ ++
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 174 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 233
+ F H+ +IH D+KP NI++ + VKV D+ + G+
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS---------------- 167
Query: 234 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293
+ V+ T Y +PE G + D++S+GC+L E+ +GE F +
Sbjct: 168 -----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS- 221
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353
V R +
Sbjct: 222 ---------------VAYQHVREDPIPPSARHEGLSA----------------------- 243
Query: 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 388
DL ++ L +P R + +R
Sbjct: 244 -------DLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 6e-25
Identities = 54/329 (16%), Positives = 103/329 (31%), Gaps = 104/329 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLV 71
Query: 150 --------------------------IGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
+ I+ + ++ Q+ E +AF+ E I
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DL+ NIL+ K+ D+ L+R +D Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTA----------------------RE 168
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303
+ APE I + D+WS G +L E+ + + +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------- 220
Query: 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363
+ RG R+ PD +L
Sbjct: 221 --------------QNLERGYRMVRPDNCPE--------------------------ELY 240
Query: 364 DLLQGLLRYDPAERLKAREALR--HPFFT 390
L++ + P +R FFT
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-24
Identities = 52/332 (15%), Positives = 105/332 (31%), Gaps = 112/332 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ + ++G G+FG V + + VA+K++ + +A E+ VL++ +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 150 I--------------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRL 182
I G + F + + ++ RQ + + ++H +
Sbjct: 66 ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 242
IH DLK NI L +D + +K+ DFG T + +
Sbjct: 126 IHRDLKSNNIFL-----------------HEDLT----------VKIGDFGLATVKSRWS 158
Query: 243 SY-----VVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHL 294
+ + + APEVI N + D+++ G +L EL +G+ +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--------- 209
Query: 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
+RD + + L + +
Sbjct: 210 -----------------------------------SNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386
+ + L+ L+ ER + L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 5e-24
Identities = 58/328 (17%), Positives = 100/328 (30%), Gaps = 102/328 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-- 150
R+ K+G+G FG+V N VAIK ++ EA + E V+++L +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 151 ------------------GGT--------RYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
G+ + + + ++ Q+ +A++ + +H
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 136
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL+ NIL+ KV D+ L+R +D Y
Sbjct: 137 RDLRAANILVGENLVCKVADFG-LARLIEDNEYTA----------------------RQG 173
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 304
+ APE L + D+WS G +L EL + + + +++V
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQV---- 227
Query: 305 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 364
RG R+ P L D
Sbjct: 228 ----------------ERGYRMPCPPECPE--------------------------SLHD 245
Query: 365 LLQGLLRYDPAERLKAREALR--HPFFT 390
L+ R +P ER +FT
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 1e-22
Identities = 59/326 (18%), Positives = 110/326 (33%), Gaps = 105/326 (32%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI--- 150
++G G FG V + + KK + VA+KI++ + ++ + E +V+Q+L I
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 151 -----------------GGT------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
G + R + EL Q+ + ++ E +H DL
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
N+LLV+ Y K+ D+ LS+ + ++ ++
Sbjct: 134 AARNVLLVTQHYAKISDF-GLSK--------------------ALRADENYYKAQTHGKW 172
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSGEALFQTHENLEHLAMMERVLGPLPH 306
+ APE I ++ D+WS G ++ E G+ ++ + E AM+E
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------- 224
Query: 307 HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366
+G R+ P G ++ DL+
Sbjct: 225 ---------------KGERMGCPAGCPR--------------------------EMYDLM 243
Query: 367 QGLLRYDPAERLKARE---ALRHPFF 389
YD R LR+ ++
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 7e-22
Identities = 50/323 (15%), Positives = 95/323 (29%), Gaps = 102/323 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
+ ++G G FG V + K+ VAIK +R E + E +V+ +L H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLV 63
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
D T+ F + + + + E +A++ E +I
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DL N L+ + +KV D+ D ++ +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----------------------QYTSST 160
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303
+ +PEV ++ D+WS G ++ E+ S + + + +
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------ 214
Query: 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363
G RL P A++ +
Sbjct: 215 ----------------ISTGFRLYKPRLAST--------------------------HVY 232
Query: 364 DLLQGLLRYDPAERLKAREALRH 386
++ + P +R LR
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 1e-21
Identities = 55/327 (16%), Positives = 90/327 (27%), Gaps = 105/327 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLAR 147
R + +GEG FG V + VAIK ++ + RE + E +++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66
Query: 148 H----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHE 179
H R S + + QL ++A++
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
R +H D+ N+L+ S + VK+ D+ LSR +D +Y+K
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDF-GLSRYMEDSTYYK-------------------- 165
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
S + APE I + D+W G + E+ +
Sbjct: 166 --ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-- 221
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
G RL P
Sbjct: 222 --------------------IENGERLPMPPNCPP------------------------- 236
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRH 386
L L+ YDP+ R + E
Sbjct: 237 -TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 60/340 (17%), Positives = 112/340 (32%), Gaps = 112/340 (32%)
Query: 93 RYRILSKMGEGTFGQV---VECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQR 144
+ +L +G G +G+V + ++ +L A+K+++ K E E VL+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 145 LARHDI----------------------GGT------RYRSFPIDLVRELGRQLLESVAF 176
+ + GG + F V+ +++ ++
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 177 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 236
+H+L +I+ D+K ENILL S +V + D+ + + + +
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGL------------------SKEFVADETER 186
Query: 237 FEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294
+ Y AP+++ G G + D WS+G ++ EL +G + F
Sbjct: 187 AYDFCGTI-----EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241
Query: 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 354
A + R + +P ++
Sbjct: 242 AEISRRILKSE--------------------PPYPQEMSA-------------------- 261
Query: 355 VDHSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 389
DL+Q LL DP +RL A E H FF
Sbjct: 262 ------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 2e-21
Identities = 50/337 (14%), Positives = 92/337 (27%), Gaps = 94/337 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEI------------- 139
+ +G+G FG+V + E VA+KI S + EI
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 140 -------------------------DVLQRLARHDIGGTRYRSFPIDLVRELGRQLLESV 174
+ L R+ + + L +E V
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
+ + H DLK +NIL+ + D R P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH---------- 171
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCSGEALFQTH 288
V T+ Y APEV+ D++++G + E+ ++ H
Sbjct: 172 ----------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
E+ + P M + + R + P+ S +++R
Sbjct: 222 EDYQLPYYDLVPSDPSVEEM-------RKVVCEQKLRPNIPNRWQSCEALR--------- 265
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385
+ +++ + A RL A +
Sbjct: 266 ------------VMAKIMRECWYANGAARLTALRIKK 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.9 bits (225), Expect = 2e-21
Identities = 42/327 (12%), Positives = 99/327 (30%), Gaps = 110/327 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLV 76
Query: 150 ---------------------------IGGTRYRSFPIDLVRELGRQLLESVAFMHELRL 182
+ + ++ + Q+ ++ ++ +
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 183 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD- 241
IH DL N L+ ++ +K+ DFG + D
Sbjct: 137 IHRDLAARNCLV-----------------GENHL----------VKVADFGLSRLMTGDT 169
Query: 242 ---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
H+ + APE + ++ D+W+ G +L E+ + +L + +
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL- 228
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 358
+ R++ P+G
Sbjct: 229 ---------------------LEKDYRMERPEGCPE------------------------ 243
Query: 359 AGDLIDLLQGLLRYDPAERLKAREALR 385
+ +L++ +++P++R E +
Sbjct: 244 --KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 7e-21
Identities = 59/327 (18%), Positives = 104/327 (31%), Gaps = 105/327 (32%)
Query: 99 KMGEGTFGQVVECFDNEKKE--LVAIKIVR--SINKYREAAMIEIDVLQRLARHDI---- 150
++G G FG V + +K+ VAIK+++ + E M E ++ +L I
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 151 ----------------GGT-------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 187
GG + P+ V EL Q+ + ++ E +H DL
Sbjct: 76 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 188 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 247
N+LLV+ Y K+ D+ D SY + S
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSY---------------------YTARSAGKW 174
Query: 248 TRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSGEALFQTHENLEHLAMMERVLGPLPH 306
+ APE I ++ D+WS G + E L G+ ++ + E +A +E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------- 226
Query: 307 HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 366
+G R++ P +L L+
Sbjct: 227 ---------------QGKRMECPPECPP--------------------------ELYALM 245
Query: 367 QGLLRYDPAERLKARE---ALRHPFFT 390
Y +R +R +++
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 1e-20
Identities = 47/353 (13%), Positives = 92/353 (26%), Gaps = 129/353 (36%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKEL-----VAIKIVR--SINKYREAAMIEIDVLQRL 145
+G G FG+V+ + VA+K+++ + + REA M E+ ++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 146 ARHD---------------------------------------------------IGGTR 154
H+
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
+ + Q+ + + F+ +H DL N+L+ + VK+ D+ D
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
+Y + APE + + D+WS G +
Sbjct: 218 SNYVV----------------------RGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
Query: 275 LVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 333
L E+ S G + + K + G ++D P AT
Sbjct: 256 LWEIFSLGVNPYPGIPVDANF----------------------YKLIQNGFKMDQPFYAT 293
Query: 334 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386
++ ++Q +D +R
Sbjct: 294 E--------------------------EIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-20
Identities = 59/346 (17%), Positives = 101/346 (29%), Gaps = 122/346 (35%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R +G G FG+VVE ++ VA+K+++ + REA M E+ VL L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 146 ARH----------DIGGTRY------------------------------------RSFP 159
H IGG +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 160 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219
++ + Q+ + +AF+ IH DL NILL K+ D+ D +Y
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279
+ APE I + + D+WS G L EL
Sbjct: 204 ----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
S + ++ K + G R+ P+ A +
Sbjct: 242 SLGSSPYPGMPVDSKFY---------------------KMIKEGFRMLSPEHAPA----- 275
Query: 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385
++ D+++ DP +R ++ ++
Sbjct: 276 ---------------------EMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 4e-20
Identities = 43/249 (17%), Positives = 87/249 (34%), Gaps = 58/249 (23%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVR----SINKYREAAMIEIDVLQRL 145
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 146 ARH----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFM 177
H D F + + Q+ E + ++
Sbjct: 69 -DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 178 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 237
R IH DL N+LL + + VK+ D+ + ++ +
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-------------------- 167
Query: 238 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 296
+ + + APE + +++ D W G L E+ + G+ + + L
Sbjct: 168 -YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
Query: 297 MERVLGPLP 305
+++ LP
Sbjct: 227 IDKEGERLP 235
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 5e-20
Identities = 50/323 (15%), Positives = 96/323 (29%), Gaps = 104/323 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH----- 148
L ++G G FG V + + VAIK+++ + + + E V+ L H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQ 63
Query: 149 ------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLIH 184
+ F + E+ + + E++ ++ + +H
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 185 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 244
DL N L+ VKV D+ LSR D Y +
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSS----------------------VG 160
Query: 245 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGP 303
+ PEV++ ++ D+W+ G ++ E+ S G+ ++ N E +
Sbjct: 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------ 214
Query: 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363
+G RL P A+ +
Sbjct: 215 -----------------AQGLRLYRPHLASE--------------------------KVY 231
Query: 364 DLLQGLLRYDPAERLKAREALRH 386
++ ER + L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.0 bits (212), Expect = 2e-19
Identities = 51/296 (17%), Positives = 100/296 (33%), Gaps = 56/296 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRS--INKYREAAMIEIDVL 142
E +I +G G FG+V +++ VAIK ++S K R + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 143 QRLARHDI---------------------GGT-------RYRSFPIDLVRELGRQLLESV 174
+ ++ G+ F + + + R + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 175 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 234
++ ++ +H DL NIL+ S KV D+ LSR +D + + K+
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFG-LSRFLEDDTSDPTYTSALGGKI----- 195
Query: 235 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 293
+ APE I + D+WS G ++ E+ S GE + N +
Sbjct: 196 -------------PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD- 241
Query: 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349
++ + + + + D + + K++R PN
Sbjct: 242 --VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 3e-19
Identities = 49/342 (14%), Positives = 89/342 (26%), Gaps = 121/342 (35%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ +GEG FGQV++ + + AIK ++ E++VL +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 149 --------------------------------------------DIGGTRYRSFPIDLVR 164
I + + +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 165 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224
+ + ++ + + IH DL NIL+ K+ D+ LSR +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF-GLSRGQEV---------- 179
Query: 225 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 284
+ + + A E + + D+WS G +L E+ S
Sbjct: 180 --------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 285 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 344
L + +G RL+ P
Sbjct: 226 PYCGMTCAELY----------------------EKLPQGYRLEKPLNCDD---------- 253
Query: 345 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386
++ DL++ R P ER + L
Sbjct: 254 ----------------EVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 5e-19
Identities = 48/327 (14%), Positives = 92/327 (28%), Gaps = 105/327 (32%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLAR 147
++ + +G G FG V + + E VAIK +R K + + E V+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69
Query: 148 H----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHE 179
+ D + + Q+ + + ++ +
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 180 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 239
RL+H DL N+L+ + ++VK+ D+ L++
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLGAEEK---------------------E 167
Query: 240 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299
+ A E IL + + D+WS G + EL + + ++
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---- 223
Query: 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 359
+G RL P T
Sbjct: 224 ------------------SILEKGERLPQPPICTI------------------------- 240
Query: 360 GDLIDLLQGLLRYDPAERLKAREALRH 386
D+ ++ D R K RE +
Sbjct: 241 -DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 9e-19
Identities = 44/298 (14%), Positives = 89/298 (29%), Gaps = 57/298 (19%)
Query: 93 RYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLA 146
+G G FG+V + +K+ VAIK ++ K R + E ++ + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 147 RH----------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMH 178
H + F + + + R + + ++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
+ +H DL NIL+ S KV D+ D
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT----------------- 170
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298
S + APE I + D+WS G ++ E+ + + + M+
Sbjct: 171 ----SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MK 224
Query: 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 356
+ + + + + + D + + KL+R P+ + D
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 1e-18
Identities = 47/323 (14%), Positives = 84/323 (26%), Gaps = 104/323 (32%)
Query: 99 KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH----- 148
+G G FG V + KK A+K + I + E +++ H
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 92
Query: 149 -------------------------DIGGTRYRSFPIDLVRELGRQLLESVAFMHELRLI 183
+ + + + G Q+ + + F+ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 184 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 243
H DL N +L VKV D+ L+R D + K+
Sbjct: 153 HRDLAARNCMLDEKFTVKVADF-GLARDMYDKEFDSVHNKTG------------------ 193
Query: 244 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 303
+ A E + + D+WS G +L EL + A N +
Sbjct: 194 -AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------- 244
Query: 304 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363
Y +G RL P ++ L
Sbjct: 245 --------------VYLLQGRRLLQP--------------------------EYCPDPLY 264
Query: 364 DLLQGLLRYDPAERLKAREALRH 386
+++ R E +
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 7e-18
Identities = 53/346 (15%), Positives = 94/346 (27%), Gaps = 121/346 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R ++ +G G FGQV+E VA+K+++ + + A M E+ +L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 146 ARHDI---------------------------------------------GGTRYRSFPI 160
H +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 161 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220
+ + Q+ + + F+ + IH DL NILL VK+ D+ KD Y +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR- 192
Query: 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 280
+ APE I + D+WS G +L E+ S
Sbjct: 193 ---------------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
Query: 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 340
A ++ + + G R+ PD T
Sbjct: 232 LGASPYPGVKIDEEFC---------------------RRLKEGTRMRAPDYTTP------ 264
Query: 341 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386
++ + +P++R E + H
Sbjct: 265 --------------------EMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 80.3 bits (197), Expect = 2e-17
Identities = 50/351 (14%), Positives = 89/351 (25%), Gaps = 128/351 (36%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ +GEG FG+V + E +VA+K+++ + + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 146 ---------------------------------------------------ARHDIGGTR 154
R +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 155 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214
+ RQ+ +A++ E + +H DL N L+ VK+ D+ LSR+
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF-GLSRNIYS 192
Query: 215 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274
Y+K + PE I + D+W+ G +
Sbjct: 193 ADYYKA---------------------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231
Query: 275 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 334
L E+ S E + Y R G L P+
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIY----------------------YVRDGNILACPENCPL 269
Query: 335 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385
+L +L++ PA+R R
Sbjct: 270 --------------------------ELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 3e-17
Identities = 49/347 (14%), Positives = 100/347 (28%), Gaps = 120/347 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ + ++G+G+FG V E +E + VAIK V + + R + E V++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 146 ARHDI---------------------GGT----------------RYRSFPIDLVRELGR 168
H + G + + ++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 169 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 228
++ + +A+++ + +H DL N ++ VK+ D+ + Y K
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--------- 191
Query: 229 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288
+ + +PE + + D+WS G +L E+ +
Sbjct: 192 -------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238
Query: 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 348
+ E + ++ G LD PD
Sbjct: 239 LSNEQVL----------------------RFVMEGGLLDKPDNCPD-------------- 262
Query: 349 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR------HPFF 389
L +L++ +Y+P R E + P F
Sbjct: 263 ------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 4e-17
Identities = 46/347 (13%), Positives = 96/347 (27%), Gaps = 123/347 (35%)
Query: 93 RYRILSKMGEGTFGQVVECFD-------NEKKELVAIKIVR--SINKYREAAMIEIDVLQ 143
R + +GEG FGQVV + VA+K+++ + K + E+++++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 144 RLARH--------------------------------------------DIGGTRYRSFP 159
+ +H +
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 160 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219
+ Q+ + ++ + IH DL N+L+ +K+ D+ Y K
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 279
+ + APE + + + D+WS G +L E+
Sbjct: 194 ----------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 280 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 339
+ +E L K + G R+D P T+
Sbjct: 232 TLGGSPYPGVPVEELF----------------------KLLKEGHRMDKPSNCTN----- 264
Query: 340 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386
+L +++ P++R ++ +
Sbjct: 265 ---------------------ELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.3 bits (135), Expect = 5e-10
Identities = 32/219 (14%), Positives = 58/219 (26%), Gaps = 64/219 (29%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-------------------INKYREA 134
I MGEG V C+ + E +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 135 AMIEIDVLQRLARHDI----------------GGTRYRSFPIDLVRELGRQLLESVAFMH 178
A E LQ+L + ++ E+ +LE VA +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 179 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 238
++H DL N+L+ I +IDF +
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152
Query: 239 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 277
++ + R R + D+ S +++
Sbjct: 153 GEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 405 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 94.9 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=398.40 Aligned_cols=224 Identities=27% Similarity=0.433 Sum_probs=188.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|+++.+++.||||++.+. ....+.+.+|+++++.+.|+|++...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999998643 23456788999999999999985422
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~---------------------- 143 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---------------------- 143 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------------------
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC----------------------
Confidence 24689999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.+||+|||+|...... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus 144 -----~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 218 (263)
T d2j4za1 144 -----ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218 (263)
T ss_dssp -----CEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred -----CEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 4677777777554433 2345799999999999999999999999999999999999999998877766655543
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
....+ ++.+++++.+||.+||+.||++|||
T Consensus 219 ~~~~~--------------------------------------------------p~~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 219 VEFTF--------------------------------------------------PDFVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp TCCCC--------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCC--------------------------------------------------CccCCHHHHHHHHHHccCCHhHCcC
Confidence 22111 1235678999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 015532 380 AREALRHPFFTRD 392 (405)
Q Consensus 380 a~elL~hp~f~~~ 392 (405)
++|+|+||||+.+
T Consensus 249 ~~eil~hp~~~~~ 261 (263)
T d2j4za1 249 LREVLEHPWITAN 261 (263)
T ss_dssp HHHHHTCHHHHHH
T ss_pred HHHHHcCcCcCCc
Confidence 9999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=395.80 Aligned_cols=230 Identities=22% Similarity=0.371 Sum_probs=181.8
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++|++++|+|++...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999999999999999996532 2345688999999999999985421
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~----------------------- 140 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----------------------- 140 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-----------------------
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-----------------------
Confidence 24689999999999999999999999999999999999997655
Q ss_pred CCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||+|+..... ....+||+.|||||++.+..+ +.++|||||||++|+|++|++||..........
T Consensus 141 ----~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~ 216 (271)
T d1nvra_ 141 ----NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216 (271)
T ss_dssp ----CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred ----CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH
Confidence 4677777777643221 234689999999999998876 578999999999999999999997655432222
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
........ .......+++++.+||.+||+.||+
T Consensus 217 ~~~~~~~~-----------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~ 249 (271)
T d1nvra_ 217 SDWKEKKT-----------------------------------------------YLNPWKKIDSAPLALLHKILVENPS 249 (271)
T ss_dssp HHHHTTCT-----------------------------------------------TSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred HHHhcCCC-----------------------------------------------CCCccccCCHHHHHHHHHHcCCChh
Confidence 11111000 0011234577899999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCC
Q 015532 376 ERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 376 ~Rpta~elL~hp~f~~~~~ 394 (405)
+|||++|+|+||||++..+
T Consensus 250 ~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 250 ARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp TSCCHHHHTTCTTTTCCCC
T ss_pred HCcCHHHHhcCHhhCcCCC
Confidence 9999999999999997654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=397.92 Aligned_cols=229 Identities=26% Similarity=0.394 Sum_probs=189.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.++|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.++|+|++...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 468999999999999999999999999999999996543 3456788999999999999985432
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~------------------------- 153 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------------------------- 153 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------------------------
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-------------------------
Confidence 24589999999999999999999999999999999999997655
Q ss_pred CCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 154 --~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 231 (293)
T d1yhwa1 154 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (293)
T ss_dssp --CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred --cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 4677777776544322 23457999999999999999999999999999999999999999988877666554332
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
..+. ...+..+++++++||.+||+.||++|||+
T Consensus 232 ~~~~-----------------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 264 (293)
T d1yhwa1 232 GTPE-----------------------------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSA 264 (293)
T ss_dssp CSCC-----------------------------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCC-----------------------------------------------CCCcccCCHHHHHHHHHHccCChhHCcCH
Confidence 1100 01123457789999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 015532 381 REALRHPFFTRDV 393 (405)
Q Consensus 381 ~elL~hp~f~~~~ 393 (405)
+|+|+||||+...
T Consensus 265 ~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 265 KELLQHQFLKIAK 277 (293)
T ss_dssp HHHTTCGGGGGCC
T ss_pred HHHhcCHhhCCCC
Confidence 9999999997644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-53 Score=398.14 Aligned_cols=239 Identities=27% Similarity=0.412 Sum_probs=183.3
Q ss_pred eCCccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 86 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
..+.+.++|++.+.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+|+.++|+|++...
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35667889999999999999999999999999999999996532 2345577899999999999985421
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++.++..++.||+.||+|||++||+||||||+|||+...
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------------- 143 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------------- 143 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-------------------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc-------------------
Confidence 2468999999999999999999999999999999999999642
Q ss_pred cccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
+.+..+||+|||++...... ....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+....+..
T Consensus 144 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 218 (307)
T d1a06a_ 144 -----DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218 (307)
T ss_dssp -----STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 23456889999988765433 23468999999999999999999999999999999999999999988777666
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.+....++ ......+++++.+||.+||+.||
T Consensus 219 ~~i~~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~L~~dP 252 (307)
T d1a06a_ 219 EQILKAEYEFD----------------------------------------------SPYWDDISDSAKDFIRHLMEKDP 252 (307)
T ss_dssp HHHHTTCCCCC----------------------------------------------TTTTTTSCHHHHHHHHHHSCSSG
T ss_pred HHHhccCCCCC----------------------------------------------CccccCCCHHHHHHHHHHccCCH
Confidence 55543221111 11123567899999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~ 394 (405)
++|||++|+|+||||++...
T Consensus 253 ~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 253 EKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp GGSCCHHHHHHSTTTTSSCC
T ss_pred hHCcCHHHHhcCHhhCCCCc
Confidence 99999999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=390.43 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=197.3
Q ss_pred CccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-------hhhHHHHHHHHHHHHHhhcCCCCCc------
Q 015532 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTR------ 154 (405)
Q Consensus 88 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~il~~l~~~~~~~~~------ 154 (405)
+.+.++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|++++|+|++...
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 446789999999999999999999999999999999996421 2356788999999999999985422
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~-------------- 151 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV-------------- 151 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS--------------
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC--------------
Confidence 246899999999999999999999999999999999999976552
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 152 ---------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 152 ---------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp ---------SSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------cccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 2346899999998765433 33468999999999999989999999999999999999999999998887
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+.+..+.+.....+.. .....++.+++||.+||+
T Consensus 223 ~~~~~i~~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~ 256 (293)
T d1jksa_ 223 ETLANVSAVNYEFEDE----------------------------------------------YFSNTSALAKDFIRRLLV 256 (293)
T ss_dssp HHHHHHHTTCCCCCHH----------------------------------------------HHTTSCHHHHHHHHTTSC
T ss_pred HHHHHHHhcCCCCCch----------------------------------------------hcCCCCHHHHHHHHHHcc
Confidence 7776665433322221 123457789999999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCCC
Q 015532 372 YDPAERLKAREALRHPFFTRDVR 394 (405)
Q Consensus 372 ~dP~~Rpta~elL~hp~f~~~~~ 394 (405)
.||++|||++|+|+||||+....
T Consensus 257 ~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 257 KDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp SSGGGSCCHHHHHHSTTTCC---
T ss_pred CChhHCcCHHHHhcCcccCCCCh
Confidence 99999999999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.7e-53 Score=399.19 Aligned_cols=233 Identities=29% Similarity=0.409 Sum_probs=195.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+++|++++|+|++...
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4468999999999999999999999999999999996533 3456788999999999999984321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++.+++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~----------------------- 160 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK----------------------- 160 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-----------------------
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-----------------------
Confidence 2458999999999999999999999999999999999999642
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
.+..+||+|||++....... ....||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 161 --~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 161 --RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp --TSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred --CCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 23468999999887655433 34689999999999999999999999999999999999999999988887777765
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
.....++. .....+++++++||.+||++||++||
T Consensus 239 ~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~ 272 (350)
T d1koaa2 239 SCDWNMDD----------------------------------------------SAFSGISEDGKDFIRKLLLADPNTRM 272 (350)
T ss_dssp HTCCCSCC----------------------------------------------GGGGGCCHHHHHHHHHHCCSSGGGSC
T ss_pred hCCCCCCc----------------------------------------------ccccCCCHHHHHHHHHHccCChhHCc
Confidence 54332221 11134577899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
|++|+|+||||+...
T Consensus 273 t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 273 TIHQALEHPWLTPGN 287 (350)
T ss_dssp CHHHHHHSTTTSCTT
T ss_pred CHHHHhcCcccCCCC
Confidence 999999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=397.30 Aligned_cols=267 Identities=29% Similarity=0.507 Sum_probs=210.9
Q ss_pred CCCceEeeCCc---cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCC
Q 015532 79 DGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGG 152 (405)
Q Consensus 79 ~~~~~~~~~~~---~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~ 152 (405)
.|++...++.. +.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+++|+.+.|++++.
T Consensus 2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~ 81 (346)
T d1cm8a_ 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81 (346)
T ss_dssp CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCC
T ss_pred CCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeE
Confidence 46777777776 789999999999999999999999999999999999743 234567889999999999998854
Q ss_pred Cc-------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccc
Q 015532 153 TR-------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 201 (405)
Q Consensus 153 ~~-------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k 201 (405)
.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~--- 158 (346)
T d1cm8a_ 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--- 158 (346)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---
T ss_pred EEEEeccCccccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc---
Confidence 21 24689999999999999999999999999999999999997554
Q ss_pred cCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHh
Q 015532 202 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 280 (405)
Q Consensus 202 ~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~llt 280 (405)
.+|++|||++.......+..+||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 159 ------------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~ 214 (346)
T d1cm8a_ 159 ------------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214 (346)
T ss_dssp ------------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH
T ss_pred ------------------------ccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH
Confidence 56778888887776666677899999999999875 56899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc-hhhhhhcccCch
Q 015532 281 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL-PNLIMQHVDHSA 359 (405)
Q Consensus 281 g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 359 (405)
|.+||.+.+..+.+..+....+.+|..+.............. ..... ...........+
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~s 274 (346)
T d1cm8a_ 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK--------------------GLPELEKKDFASILTNAS 274 (346)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH--------------------HSCCCCCCCGGGTCTTCC
T ss_pred CcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhc--------------------cCCcccccchHHhccCCC
Confidence 999999999999999999999999987654432221111110 00000 011112234567
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 360 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 360 ~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+.++|||.+||++||++||||+|+|+||||++-
T Consensus 275 ~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 275 PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 899999999999999999999999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=392.31 Aligned_cols=231 Identities=26% Similarity=0.475 Sum_probs=189.1
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch-hhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
+.|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|++++|+|++...
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4699999999999999999999999999999999653 34456788999999999999985422
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++.+++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~------------------------ 147 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG------------------------ 147 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------------------------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC------------------------
Confidence 24589999999999999999999999999999999999997654
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 294 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 294 (405)
.+||+|||+|...... ....+||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.+..+.+
T Consensus 148 ---~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~ 224 (288)
T d2jfla1 148 ---DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224 (288)
T ss_dssp ---CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred ---CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH
Confidence 5677888877544322 23468999999999985 446899999999999999999999999988776666
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.+...+. ...+..+++++.+||.+||+.||
T Consensus 225 ~~i~~~~~~~-----------------------------------------------~~~~~~~s~~~~~li~~~L~~dp 257 (288)
T d2jfla1 225 LKIAKSEPPT-----------------------------------------------LAQPSRWSSNFKDFLKKCLEKNV 257 (288)
T ss_dssp HHHHHSCCCC-----------------------------------------------CSSGGGSCHHHHHHHHHHSCSST
T ss_pred HHHHcCCCCC-----------------------------------------------CCccccCCHHHHHHHHHHccCCh
Confidence 5554321100 01123457789999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCCCCC
Q 015532 375 AERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 375 ~~Rpta~elL~hp~f~~~~~~~ 396 (405)
++|||++|+|+||||+.....|
T Consensus 258 ~~R~t~~ell~hp~~~~~~~~p 279 (288)
T d2jfla1 258 DARWTTSQLLQHPFVTVDSNKP 279 (288)
T ss_dssp TTSCCHHHHTTSGGGCCCCCHH
T ss_pred hHCcCHHHHhcCcccCCCCCCC
Confidence 9999999999999998765543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-53 Score=401.17 Aligned_cols=224 Identities=26% Similarity=0.395 Sum_probs=192.2
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+|+.+.|++++...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999996432 3346788999999999999985432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||.|||++|||||||||+|||++.+|
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g---------------------- 178 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---------------------- 178 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----------------------
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC----------------------
Confidence 24689999999999999999999999999999999999997554
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||+|+.........+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 179 -----~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 253 (350)
T d1rdqe_ 179 -----YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp -----CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred -----CEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC
Confidence 578888888877766666679999999999999999999999999999999999999999988877766665443
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC--
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-- 378 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-- 378 (405)
.... +..+++++.+||.+||+.||++|+
T Consensus 254 ~~~~--------------------------------------------------p~~~s~~~~~li~~~L~~dP~kR~~~ 283 (350)
T d1rdqe_ 254 KVRF--------------------------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGN 283 (350)
T ss_dssp CCCC--------------------------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTS
T ss_pred CCCC--------------------------------------------------CccCCHHHHHHHHHHhhhCHHhcccc
Confidence 2211 124577899999999999999995
Q ss_pred ---CHHHHHcCCCCCCC
Q 015532 379 ---KAREALRHPFFTRD 392 (405)
Q Consensus 379 ---ta~elL~hp~f~~~ 392 (405)
|++|+++||||++.
T Consensus 284 ~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 284 LKNGVNDIKNHKWFATT 300 (350)
T ss_dssp STTTTHHHHTSGGGTTC
T ss_pred ccccHHHHHcCccccCC
Confidence 99999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-52 Score=396.73 Aligned_cols=233 Identities=27% Similarity=0.439 Sum_probs=196.2
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+++.|+|++...
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999999999999999996543 3345678899999999999984321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++.+++.++.||+.||.|||++|||||||||+|||++..
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~------------------------ 163 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK------------------------ 163 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST------------------------
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc------------------------
Confidence 2358999999999999999999999999999999999999632
Q ss_pred CCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 299 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (405)
.++.+||+|||+|....... ....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+.+
T Consensus 164 -~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 164 -KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242 (352)
T ss_dssp -TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred -CCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 23468999999987665433 346899999999999999999999999999999999999999999888887777665
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
....+|. .....+++++.+||.+||++||++|||
T Consensus 243 ~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 243 CDWEFDE----------------------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp CCCCCCS----------------------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCCCCc----------------------------------------------ccccCCCHHHHHHHHHHccCChhHCcC
Confidence 4333221 112345789999999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015532 380 AREALRHPFFTRDVR 394 (405)
Q Consensus 380 a~elL~hp~f~~~~~ 394 (405)
++|+|+||||++...
T Consensus 277 ~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 277 VHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHTSTTTSSCCT
T ss_pred HHHHhcCHhhCCCcc
Confidence 999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=389.96 Aligned_cols=225 Identities=27% Similarity=0.394 Sum_probs=185.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
++|++.+.||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+++|++++|++++...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999996432 3346688999999999999985422
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~---------------------- 145 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---------------------- 145 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----------------------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc----------------------
Confidence 24689999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 146 -----~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 220 (288)
T d1uu3a_ 146 -----HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220 (288)
T ss_dssp -----CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -----eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH
Confidence 4667777776544321 123579999999999999999999999999999999999999999887777666
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
.+.+....+ +..+++++++||.+||+.||+
T Consensus 221 ~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~~L~~dP~ 250 (288)
T d1uu3a_ 221 KIIKLEYDF--------------------------------------------------PEKFFPKARDLVEKLLVLDAT 250 (288)
T ss_dssp HHHTTCCCC--------------------------------------------------CTTCCHHHHHHHHTTSCSSGG
T ss_pred HHHcCCCCC--------------------------------------------------CccCCHHHHHHHHHHccCCHh
Confidence 554321111 124577899999999999999
Q ss_pred CCCCHHH------HHcCCCCCCCC
Q 015532 376 ERLKARE------ALRHPFFTRDV 393 (405)
Q Consensus 376 ~Rpta~e------lL~hp~f~~~~ 393 (405)
+|||++| +++||||++-.
T Consensus 251 ~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 251 KRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp GSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999988 68999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=390.68 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=194.6
Q ss_pred CCCeEEEeeeecccceeEEEEEecCC-CcEEEEEEecch---hhhhHHHHHHHHHHHHH---hhcCCCCCc---------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSI---NKYREAAMIEIDVLQRL---ARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~-~~~vAiK~~~~~---~~~~~~~~~E~~il~~l---~~~~~~~~~--------- 154 (405)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ......+.+|+++|+.| .|+++....
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 678999998642 22234567888888877 588874321
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 ------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 ------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++..+.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~----------- 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----------- 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-----------
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC-----------
Confidence 235788999999999999999999999999999999999976654
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 288 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 288 (405)
+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 155 ----------------~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 155 ----------------IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp ----------------EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ----------------eeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 56666666544322 223468999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHH
Q 015532 289 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 368 (405)
Q Consensus 289 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~ 368 (405)
+..+.+..+.+..+.++.... +......... ................++.+++||.+
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~-------------------~~~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~dli~~ 275 (305)
T d1blxa_ 219 SDVDQLGKILDVIGLPGEEDW-------------------PRDVALPRQA----FHSKSAQPIEKFVTDIDELGKDLLLK 275 (305)
T ss_dssp SHHHHHHHHHHHHCCCCGGGS-------------------CTTCSSCGGG----SCCCCCCCGGGTCCSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHhhCCCchhcc-------------------cccccchhhh----hccccccchhhccccCCHHHHHHHHH
Confidence 999999999998887654321 1111000000 00001111223345678899999999
Q ss_pred ccccCCCCCCCHHHHHcCCCCCCC
Q 015532 369 LLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 369 ~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
||++||++||||+|+|+||||++-
T Consensus 276 mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 276 CLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HCcCChhHCcCHHHHhcChhhcCc
Confidence 999999999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-52 Score=392.34 Aligned_cols=224 Identities=26% Similarity=0.384 Sum_probs=191.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+|+.+.|++++...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4599999999999999999999999999999999643 23356788999999999999985422
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g---------------------- 141 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---------------------- 141 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS----------------------
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC----------------------
Confidence 24568889999999999999999999999999999999997654
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||+|+.........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 142 -----~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 216 (316)
T d1fota_ 142 -----HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216 (316)
T ss_dssp -----CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred -----CEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC
Confidence 578888888877766666789999999999999999999999999999999999999999998877776665442
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC--
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-- 378 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp-- 378 (405)
....| ..+++++.++|.+||+.||++|+
T Consensus 217 ~~~~p--------------------------------------------------~~~s~~~~~li~~~L~~dp~~R~~~ 246 (316)
T d1fota_ 217 ELRFP--------------------------------------------------PFFNEDVKDLLSRLITRDLSQRLGN 246 (316)
T ss_dssp CCCCC--------------------------------------------------TTSCHHHHHHHHHHTCSCTTTCTTS
T ss_pred CCCCC--------------------------------------------------CCCCHHHHHHHHHHhhhCHHhcccc
Confidence 22111 23467899999999999999996
Q ss_pred ---CHHHHHcCCCCCCC
Q 015532 379 ---KAREALRHPFFTRD 392 (405)
Q Consensus 379 ---ta~elL~hp~f~~~ 392 (405)
|++++|+||||++-
T Consensus 247 ~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 247 LQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp STTTTHHHHTSGGGSSC
T ss_pred chhhHHHHHcCcccccC
Confidence 99999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=383.28 Aligned_cols=227 Identities=23% Similarity=0.419 Sum_probs=181.1
Q ss_pred ccCCCe-EEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 89 NLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
...+|| ++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|+++|++++|+|++...
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 344566 6778999999999999999999999999998643 23456688999999999999985421
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++.+++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--------------- 149 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--------------- 149 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---------------
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---------------
Confidence 135788999999999999999999998 999999999999953
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.+..+||+|||+++..... ....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+..+
T Consensus 150 -----------~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~ 217 (270)
T d1t4ha_ 150 -----------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 217 (270)
T ss_dssp -----------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred -----------CCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence 2335778888887654433 334689999999999876 699999999999999999999999987655
Q ss_pred HHHHHH-HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 LEHLAM-MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 ~~~~~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
...+.. +.. +..|. ......++++.+||.+|
T Consensus 218 ~~~~~~~i~~--~~~~~----------------------------------------------~~~~~~~~~~~~li~~~ 249 (270)
T d1t4ha_ 218 AAQIYRRVTS--GVKPA----------------------------------------------SFDKVAIPEVKEIIEGC 249 (270)
T ss_dssp HHHHHHHHTT--TCCCG----------------------------------------------GGGGCCCHHHHHHHHHH
T ss_pred HHHHHHHHHc--CCCCc----------------------------------------------ccCccCCHHHHHHHHHH
Confidence 443322 211 11111 11123467899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFT 390 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~ 390 (405)
|+.||++|||++|+|+||||+
T Consensus 250 l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 250 IRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=399.81 Aligned_cols=270 Identities=22% Similarity=0.299 Sum_probs=185.6
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.++|+|++...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999999999999999999643 34456788999999999999985432
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||+ +||+||||||+|||++.+|
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--------------------- 142 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--------------------- 142 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC---------------------
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC---------------------
Confidence 2468999999999999999999997 5999999999999997654
Q ss_pred CCCCCCCceeccCCCCccccC-CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH-LAMM 297 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i 297 (405)
.+||+|||+|..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+. ...+
T Consensus 143 ------~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 216 (322)
T d1s9ja_ 143 ------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216 (322)
T ss_dssp ------CEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-
T ss_pred ------CEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 577888887765432 23446899999999999999999999999999999999999999987654332 2222
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
....+.......... ......... .................... ..+ .......+.+++|||.+||++||++|
T Consensus 217 ~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 217 CQVEGDAAETPPRPR-TPGRPLSSY--GMDSRPPMAIFELLDYIVNE-PPP---KLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp --------------------------------CCCCHHHHHHHHHTS-CCC---CCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHhcCCcccCCcccc-ccccccccc--ccccccchhHHHHHhhhhcc-CCc---cCccccCCHHHHHHHHHHcCCChhHC
Confidence 222222111100000 000000000 00000000000011110000 000 00112357899999999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDV 393 (405)
Q Consensus 378 pta~elL~hp~f~~~~ 393 (405)
|||+|+|+||||++..
T Consensus 290 ~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 290 ADLKQLMVHAFIKRSD 305 (322)
T ss_dssp CCHHHHHTSHHHHHHH
T ss_pred cCHHHHhhCHhhCcCC
Confidence 9999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=391.96 Aligned_cols=228 Identities=25% Similarity=0.370 Sum_probs=186.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
..+|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|++++|+|++...
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 346999999999999999999999999999999996432 3345688999999999999985432
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--------------------- 152 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--------------------- 152 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---------------------
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC---------------------
Confidence 24689999999999999999999999999999999999998765
Q ss_pred CCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+||+|||+|...... ...+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..
T Consensus 153 ------~~Kl~DFG~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~ 225 (309)
T d1u5ra_ 153 ------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (309)
T ss_dssp ------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ------CEEEeecccccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 4566677766654332 34589999999999975 3589999999999999999999999998877766655
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+...+.+ ....+++++.+||.+||+.||++
T Consensus 226 i~~~~~~~~------------------------------------------------~~~~~s~~~~~li~~~L~~dP~~ 257 (309)
T d1u5ra_ 226 IAQNESPAL------------------------------------------------QSGHWSEYFRNFVDSCLQKIPQD 257 (309)
T ss_dssp HHHSCCCCC------------------------------------------------SCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHhCCCCCC------------------------------------------------CCCCCCHHHHHHHHHHCcCChhH
Confidence 543211100 01235678999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCC
Q 015532 377 RLKAREALRHPFFTRDVR 394 (405)
Q Consensus 377 Rpta~elL~hp~f~~~~~ 394 (405)
|||++|+|+||||++...
T Consensus 258 Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 258 RPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp SCCHHHHTTCHHHHSCCC
T ss_pred CcCHHHHHhCHHhcCCCC
Confidence 999999999999987543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=392.87 Aligned_cols=224 Identities=25% Similarity=0.404 Sum_probs=187.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+|+.+.|++++...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5699999999999999999999999999999999753 22456688999999999999985422
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g---------------------- 142 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---------------------- 142 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----------------------
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC----------------------
Confidence 24689999999999999999999999999999999999997665
Q ss_pred CCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
.+||+|||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+
T Consensus 143 -----~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i 217 (337)
T d1o6la_ 143 -----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp -----CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -----CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 466667776654322 223468999999999999999999999999999999999999999998877666555
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
......+ +..+++++++||.+||++||++|
T Consensus 218 ~~~~~~~--------------------------------------------------p~~~s~~~~dli~~~L~~dP~~R 247 (337)
T d1o6la_ 218 LMEEIRF--------------------------------------------------PRTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp HHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHTCSSTTTS
T ss_pred hcCCCCC--------------------------------------------------CccCCHHHHHHHHhhccCCchhh
Confidence 4322111 23457789999999999999999
Q ss_pred C-----CHHHHHcCCCCCCC
Q 015532 378 L-----KAREALRHPFFTRD 392 (405)
Q Consensus 378 p-----ta~elL~hp~f~~~ 392 (405)
+ +++|+++||||++-
T Consensus 248 ~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 248 LGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTTC
T ss_pred cccccccHHHHHcCcccccC
Confidence 9 49999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=382.65 Aligned_cols=222 Identities=22% Similarity=0.378 Sum_probs=173.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
+.|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++|++++|+|++...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46999999999999999999999999999999996532 3346678999999999999985421
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEEecccccccCCcccccc
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDYKFLSR 210 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIli~~~~~~k~~df~~~~~ 210 (405)
...+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+||
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF----- 158 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF----- 158 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH-----
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec-----
Confidence 134789999999999999999999876 999999999999987665555555
Q ss_pred CCCCCCcccCCCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 211 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 211 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
|+++..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+
T Consensus 159 ----------------------G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 159 ----------------------GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp ----------------------HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----------------------cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 444432221 1235899999999999999999999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.+..+....+.... .+ ..+..+++++.+||.
T Consensus 217 ~~~~~~~~~i~~~~--~~-----------------------------------------------~~~~~~s~~l~~li~ 247 (269)
T d2java1 217 FSQKELAGKIREGK--FR-----------------------------------------------RIPYRYSDELNEIIT 247 (269)
T ss_dssp SSHHHHHHHHHHTC--CC-----------------------------------------------CCCTTSCHHHHHHHH
T ss_pred CCHHHHHHHHHcCC--CC-----------------------------------------------CCCcccCHHHHHHHH
Confidence 87766665543311 00 011345778999999
Q ss_pred HccccCCCCCCCHHHHHcCCCC
Q 015532 368 GLLRYDPAERLKAREALRHPFF 389 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~hp~f 389 (405)
+||+.||++|||++|+|+|||+
T Consensus 248 ~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 248 RMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=388.55 Aligned_cols=234 Identities=24% Similarity=0.376 Sum_probs=199.1
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+.++|++.+.||+|+||+||+|+++.+++.||||+++........+.+|+++|+.++|+|++...
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 356889999999999999999999999999999999987666667788999999999999984321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~---------------------- 139 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR---------------------- 139 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS----------------------
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC----------------------
Confidence 13589999999999999999999999999999999999996532
Q ss_pred CCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
...+||+|||++....... ....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 140 ---~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 140 ---SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp ---CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ---ceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3468899999987654433 34689999999999999999999999999999999999999999988888777776
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+....+|... +..+++++++||.+||+.||++||
T Consensus 217 ~~~~~~~~~~----------------------------------------------~~~~s~~~~~li~~~L~~dp~~R~ 250 (321)
T d1tkia_ 217 NAEYTFDEEA----------------------------------------------FKEISIEAMDFVDRLLVKERKSRM 250 (321)
T ss_dssp HTCCCCCHHH----------------------------------------------HTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred hCCCCCChhh----------------------------------------------ccCCCHHHHHHHHHHccCChhHCc
Confidence 5433333221 234577899999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q 015532 379 KAREALRHPFFTRDV 393 (405)
Q Consensus 379 ta~elL~hp~f~~~~ 393 (405)
|++|+|+||||++..
T Consensus 251 s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 251 TASEALQHPWLKQKI 265 (321)
T ss_dssp CHHHHHHSHHHHSCG
T ss_pred CHHHHhcCHhhccCc
Confidence 999999999998653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=388.17 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=189.1
Q ss_pred EEeeeecccceeEEEEEecCCCcEEEEEEecchhh------hhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 96 ~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
.+++||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+++|+.++|++++...
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 56899999999999999999999999999864322 234578999999999999985421
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~----------------------- 138 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV----------------------- 138 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-----------------------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc-----------------------
Confidence 245889999999999999999999999999999999999987664
Q ss_pred CCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 298 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (405)
+||+|||++...... ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.++.+++..|.
T Consensus 139 ----~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 139 ----LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp ----EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ----cccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 455555555433221 2235799999999999755 58999999999999999999999999999999999999
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccch-hhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
+.+|.++........ ........ ...+ ..........++++++||.+||++||++|
T Consensus 215 ~~~~~~~~~~~~~~~-----------~~~~~~~~------------~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 215 ETLGTPTEEQWPDMC-----------SLPDYVTF------------KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp HHHCCCCTTTSSSTT-----------SSTTCCCC------------CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred HhcCCCChhhccchh-----------ccchhhhh------------ccCCCCChHHhcccCCHHHHHHHHHHccCChhhC
Confidence 988876643211000 00000000 0000 01112234567899999999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q 015532 378 LKAREALRHPFFTRDV 393 (405)
Q Consensus 378 pta~elL~hp~f~~~~ 393 (405)
|||+|+|+||||++..
T Consensus 272 ~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 272 ITATQALKMKYFSNRP 287 (299)
T ss_dssp CCHHHHHTSGGGTSSS
T ss_pred cCHHHHhCCHhhCCCC
Confidence 9999999999998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=388.03 Aligned_cols=278 Identities=27% Similarity=0.409 Sum_probs=207.4
Q ss_pred CCceEeeCCc---cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCC
Q 015532 80 GHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (405)
Q Consensus 80 ~~~~~~~~~~---~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~ 153 (405)
.+|++.+|+. +.++|+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+|+++.|++++..
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~ 81 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 5788999993 448999999999999999999999999999999999653 2334567899999999999998542
Q ss_pred c------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 154 R------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 154 ~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~---- 157 (355)
T d2b1pa1 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---- 157 (355)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC----
T ss_pred EEEEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc----
Confidence 1 246789999999999999999999999999999999999977654
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccC--CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
++++|||.+..... .....+||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 158 -----------------------~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g 214 (355)
T d2b1pa1 158 -----------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_dssp -----------------------EEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred -----------------------eeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhC
Confidence 45556655543322 22335799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
++||.+.+......++....+..+...+.........+.......... .. ....... ............+++
T Consensus 215 ~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~-~~~~~~~~~~~~s~~ 286 (355)
T d2b1pa1 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL----TF---PKLFPDS-LFPADSEHNKLKASQ 286 (355)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCC----CH---HHHSCGG-GSCCSSHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccc----cc---ccccccc-cccccccccccCCHH
Confidence 999999999999999988888888777666555555544433211100 00 0000000 000001111234778
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
++|||++||++||++||||+|+|+||||+..
T Consensus 287 ~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 287 ARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=382.86 Aligned_cols=253 Identities=32% Similarity=0.504 Sum_probs=194.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|++++|++++...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999999999999999996432 2356788999999999999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~---------------------- 139 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG---------------------- 139 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----------------------
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC----------------------
Confidence 34589999999999999999999999999999999999997655
Q ss_pred CCCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+||+|||.|...... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus 140 -----~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 140 -----AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214 (298)
T ss_dssp -----CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -----cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH
Confidence 4566666665443222 23358999999999988776 57899999999999999999999999999999988
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+.+..+.+.+........ . ......++.. ............+.++++||.+||++||++
T Consensus 215 i~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~---------------~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 273 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTS-M-----PDYKPSFPKW---------------ARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273 (298)
T ss_dssp HHHHHCCCCTTTSTTGGG-S-----TTCCTTSCCC---------------CCCCHHHHSTTCCHHHHHHHHHHTCSSTTT
T ss_pred HHHhcCCCchhhcccccc-c-----cccccccccc---------------cccchhhhccCCCHHHHHHHHHHccCChhH
Confidence 888877765433211100 0 0000001000 000111222356789999999999999999
Q ss_pred CCCHHHHHcCCCCCCC
Q 015532 377 RLKAREALRHPFFTRD 392 (405)
Q Consensus 377 Rpta~elL~hp~f~~~ 392 (405)
|||++|+|+||||++-
T Consensus 274 R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 274 RISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCHHHHHTSGGGTTC
T ss_pred CcCHHHHhCCHhhccC
Confidence 9999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-51 Score=379.59 Aligned_cols=251 Identities=29% Similarity=0.473 Sum_probs=192.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|+++++||+|+||+||+|+++ +++.||||+++.. ....+.+.+|+.+|+++.|++++...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999985 7889999999653 23356788999999999999985421
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~---------------------- 138 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---------------------- 138 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----------------------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC----------------------
Confidence 356899999999999999999999999999999999999976654
Q ss_pred CCCCCceeccCCCCccccCC---ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 297 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 297 (405)
+||+|||.+...... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+++.++
T Consensus 139 -----~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i 213 (286)
T d1ob3a_ 139 -----LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (286)
T ss_dssp -----EEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred -----EEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 566666665433221 2234789999999999865 4689999999999999999999999999999999998
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+..+.++............ + ...... .............++.++|||++||++||++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~---------------~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 272 (286)
T d1ob3a_ 214 FRILGTPNSKNWPNVTELPK-Y-----DPNFTV---------------YEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272 (286)
T ss_dssp HHHHCCCCTTTSTTGGGSTT-C-----CTTCCC---------------CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTS
T ss_pred HHhhCCCChhhccchhhhhh-c-----cccccc---------------ccCcchhhhcccCCHHHHHHHHHHccCChhHC
Confidence 88888765432211100000 0 000000 00111122345567899999999999999999
Q ss_pred CCHHHHHcCCCCCC
Q 015532 378 LKAREALRHPFFTR 391 (405)
Q Consensus 378 pta~elL~hp~f~~ 391 (405)
|||+|+|+||||++
T Consensus 273 ~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 273 ITAKQALEHAYFKE 286 (286)
T ss_dssp CCHHHHHTSGGGGC
T ss_pred cCHHHHhcCcccCc
Confidence 99999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=381.30 Aligned_cols=263 Identities=25% Similarity=0.439 Sum_probs=191.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|+++++||+|+||+||+|++..+|+.||||++... ......+.+|+++|++++|+++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7899999999999999999999999999999998543 23456788999999999999874311
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 24578899999999999999999999999999999999998776555555554322111
Q ss_pred CCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
... .........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.++.+
T Consensus 170 ~~~--------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~ 229 (318)
T d3blha1 170 AKN--------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229 (318)
T ss_dssp -------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccc--------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence 000 000111235799999999999875 68999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.+..+.++.............. .+............... ....++.++|||.+||++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~dLl~~mL~~ 291 (318)
T d3blha1 230 QLALISQLCGSITPEVWPNVDNYELYE-------KLELVKGQKRKVKDRLK-----------AYVRDPYALDLIDKLLVL 291 (318)
T ss_dssp HHHHHHHHHCCCCTTTSTTCCCC--------------CCSSCCBCHHHHHH-----------HHHCCHHHHHHHHHHSCS
T ss_pred HHHHHHHhcCCCChhhccccchhhhhh-------hhcccccccccchhhhc-----------cccCCHHHHHHHHHHCcC
Confidence 999999998887754321110000000 00000000000000000 011256789999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~ 392 (405)
||++|+||+|+|+||||+..
T Consensus 292 dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 292 DPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp STTTSCCHHHHHHSGGGSSS
T ss_pred ChhHCcCHHHHHcChhhccC
Confidence 99999999999999999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-49 Score=381.27 Aligned_cols=286 Identities=30% Similarity=0.467 Sum_probs=217.1
Q ss_pred CceEeeCCccC-CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC---------
Q 015532 81 HYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI--------- 150 (405)
Q Consensus 81 ~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~--------- 150 (405)
+|++.+|+.+. +||+++++||+|+||+||+|+++.+|+.||||++++.....+...+|+++++.+.|+++
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 46677899887 57999999999999999999999999999999998776667788899999999987653
Q ss_pred --CCCc--------------------------------cccCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEe
Q 015532 151 --GGTR--------------------------------YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 195 (405)
Q Consensus 151 --~~~~--------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIli~ 195 (405)
.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 2111 2457889999999999999999998 8999999999999998
Q ss_pred cccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHH
Q 015532 196 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 275 (405)
Q Consensus 196 ~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 275 (405)
..+.. .....++++|||.+..........+||+.|+|||++.+..|+.++||||+||++
T Consensus 161 ~~~~~---------------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 219 (362)
T d1q8ya_ 161 IVDSP---------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 219 (362)
T ss_dssp EEETT---------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHH
T ss_pred ccCcc---------------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHH
Confidence 65421 112347999999998777666677899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh
Q 015532 276 VELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 349 (405)
Q Consensus 276 ~~lltg~~pf~~~~------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (405)
++|++|+.||.... ..+.+..+...+|.+|..+..........+........+...... .......
T Consensus 220 ~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------- 291 (362)
T d1q8ya_ 220 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW-PLEDVLT------- 291 (362)
T ss_dssp HHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC-CHHHHHH-------
T ss_pred HHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC-chhhhcc-------
Confidence 99999999997543 345677778889999987765544333322222211121111111 1111111
Q ss_pred hhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcCCCCCCCCCC
Q 015532 350 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 395 (405)
Q Consensus 350 ~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 395 (405)
.........+++++|||.+||++||++||||+|+|+||||++....
T Consensus 292 ~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 337 (362)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred cccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCc
Confidence 0112223457789999999999999999999999999999966443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-50 Score=369.53 Aligned_cols=230 Identities=30% Similarity=0.462 Sum_probs=186.3
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----------hhhHHHHHHHHHHHHHh-hcCCCCCc----
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTR---- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~il~~l~-~~~~~~~~---- 154 (405)
+.++|++.+.||+|+||+||+|++..+++.||||++++.. ...+.+.+|+.+++++. |++++...
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 3578999999999999999999999999999999986421 23456889999999997 88874321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccC
Q 015532 155 -----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 211 (405)
Q Consensus 155 -----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~ 211 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~------------- 147 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------------- 147 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------------
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-------------
Confidence 24689999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhC------CCCCCchhHHHHHHHHHHHHhCCC
Q 015532 212 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELCSGEA 283 (405)
Q Consensus 212 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~~lltg~~ 283 (405)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.
T Consensus 148 --------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 148 --------------NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp --------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 4667777776554332 233679999999999974 347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHH
Q 015532 284 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 363 (405)
Q Consensus 284 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 363 (405)
||.+.+..+....+.+..-.++ ......++++++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~----------------------------------------------~~~~~~~s~~~~ 247 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFG----------------------------------------------SPEWDDYSDTVK 247 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC----------------------------------------------TTTGGGSCHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCC----------------------------------------------CcccccCCHHHH
Confidence 9999887776665544211111 011234678999
Q ss_pred HHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 364 DLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 364 ~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+||.+||+.||++|||++|+|+||||++-
T Consensus 248 ~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 248 DLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 99999999999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=380.34 Aligned_cols=257 Identities=31% Similarity=0.552 Sum_probs=194.1
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
+.+||+++++||+|+||+||+|+++.+|+.||||+++... ...+.+++|+++|+.++|+++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4578999999999999999999999999999999997533 3456788999999999999875321
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~------------------ 147 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD------------------ 147 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC------------------
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC------------------
Confidence 246899999999999999999999999999999999999976664
Q ss_pred ccCCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+||+|||++...... ....+||+.|+|||++.. ..++.++||||+||++|+|++|..||.+.+.
T Consensus 148 ---------~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 148 ---------LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp ---------EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------EEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 555555555432211 233579999999999854 4678999999999999999999999999988
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhH-hhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
.+....+....+.+.......... ....+... ++. .............++++++||.+|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~---------------~~~~~~~~~~~~~s~~~~~li~~~ 278 (345)
T d1pmea_ 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLS-----LPH---------------KNKVPWNRLFPNADSKALDLLDKM 278 (345)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT-----SCC---------------CCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred HHHHHHHhhhccCCChhhhhhhhhhhhhccccc-----CCc---------------cCCCCHHHhCCCCCHHHHHHHHHH
Confidence 888888888777766543321100 00000000 000 000001122345677899999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCC
Q 015532 370 LRYDPAERLKAREALRHPFFTRDV 393 (405)
Q Consensus 370 L~~dP~~Rpta~elL~hp~f~~~~ 393 (405)
|++||++||||+|+|+||||++..
T Consensus 279 L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 279 LTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp SCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred ccCChhHCcCHHHHhcCHhhccCC
Confidence 999999999999999999999653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=384.08 Aligned_cols=249 Identities=29% Similarity=0.507 Sum_probs=197.5
Q ss_pred CeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 93 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
+|+.+++||+|+||+||+|+++.+|+.||||+++..... ..+|+++|++++|++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 599999999999999999999999999999999764432 34699999999999985421
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCC
Q 015532 155 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 216 (405)
Q Consensus 155 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~ 216 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~------------------ 159 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------------ 159 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT------------------
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC------------------
Confidence 12478999999999999999999999999999999999997543
Q ss_pred cccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 015532 217 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 293 (405)
Q Consensus 217 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 293 (405)
..+||+|||++...... ....+||+.|+|||.+.+. .|+.++||||+||++|||++|.+||...+..+.
T Consensus 160 --------~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~ 231 (350)
T d1q5ka_ 160 --------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231 (350)
T ss_dssp --------CCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred --------CceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH
Confidence 24788888887654332 3346899999999998764 689999999999999999999999999999999
Q ss_pred HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccC
Q 015532 294 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 373 (405)
Q Consensus 294 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 373 (405)
+..+.+.+|..+...+........ ...++... ............++++++||.+||++|
T Consensus 232 l~~i~~~~g~~~~~~~~~~~~~~~-------~~~~~~~~--------------~~~~~~~~~~~~s~~~~dLl~~mL~~d 290 (350)
T d1q5ka_ 232 LVEIIKVLGTPTREQIREMNPNYT-------EFKFPQIK--------------AHPWTKVFRPRTPPEAIALCSRLLEYT 290 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHCC----------CCCCCCCC--------------CCCGGGTSCTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHHhCCChHHhhhhhccchh-------hccccccc--------------cCchhhhcccCCCHHHHHHHHHHccCC
Confidence 999999999988766543321111 11111100 000111122346788999999999999
Q ss_pred CCCCCCHHHHHcCCCCCC
Q 015532 374 PAERLKAREALRHPFFTR 391 (405)
Q Consensus 374 P~~Rpta~elL~hp~f~~ 391 (405)
|++||||.|+|+||||++
T Consensus 291 P~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 291 PTARLTPLEACAHSFFDE 308 (350)
T ss_dssp GGGSCCHHHHHTSGGGGG
T ss_pred hhHCcCHHHHhcCHhhcc
Confidence 999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=376.60 Aligned_cols=221 Identities=25% Similarity=0.377 Sum_probs=177.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhh-------hhHHHHHHHHHHHHHh--hcCCCCCc------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLA--RHDIGGTR------ 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~il~~l~--~~~~~~~~------ 154 (405)
+.++|++.+.||+|+||+||+|++..+++.||||++++... ....+.+|+.+|+++. |+|++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 46789999999999999999999999999999999964321 1233568999999997 67774321
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 ----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 ----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~--------------- 146 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--------------- 146 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT---------------
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC---------------
Confidence 2457999999999999999999999999999999999999743
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
+..+||+|||+|...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.
T Consensus 147 -----------~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (273)
T d1xwsa_ 147 -----------RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215 (273)
T ss_dssp -----------TTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred -----------CCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH
Confidence 235778888887654433 244689999999999988765 5779999999999999999999975321
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
+.+. .. .....+++++.+||.+||
T Consensus 216 ------i~~~------------------------~~--------------------------~~~~~~s~~~~~li~~~L 239 (273)
T d1xwsa_ 216 ------IIRG------------------------QV--------------------------FFRQRVSSECQHLIRWCL 239 (273)
T ss_dssp ------HHHC------------------------CC--------------------------CCSSCCCHHHHHHHHHHT
T ss_pred ------Hhhc------------------------cc--------------------------CCCCCCCHHHHHHHHHHc
Confidence 1110 00 112345779999999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCC
Q 015532 371 RYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 371 ~~dP~~Rpta~elL~hp~f~~~ 392 (405)
+.||++|||++|+|+||||++.
T Consensus 240 ~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 240 ALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CSSGGGSCCHHHHHTSGGGSSC
T ss_pred cCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=379.62 Aligned_cols=265 Identities=27% Similarity=0.503 Sum_probs=204.6
Q ss_pred CceEeeCCc---cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc
Q 015532 81 HYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR 154 (405)
Q Consensus 81 ~~~~~~~~~---~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~ 154 (405)
+|....+.. +.+||+++++||+|+||+||+|++..+|+.||||++++.. ...+.+.+|+++|+.+.|++++...
T Consensus 4 ~~~~~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~ 83 (348)
T d2gfsa1 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83 (348)
T ss_dssp EEEEECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred cEEEecCCccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 444444432 3478999999999999999999999999999999996532 3345678999999999999875321
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~----- 158 (348)
T d2gfsa1 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----- 158 (348)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----
T ss_pred EEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-----
Confidence 24589999999999999999999999999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGE 282 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~ 282 (405)
.+|++|||.+...........||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 159 ----------------------~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~ 216 (348)
T d2gfsa1 159 ----------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216 (348)
T ss_dssp ----------------------CEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ----------------------cccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCC
Confidence 467777777766665556678999999999988764 689999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh-hhhhcccCchHH
Q 015532 283 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIMQHVDHSAGD 361 (405)
Q Consensus 283 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 361 (405)
+||.+.+.......+.+..+..+..+...........+... ....+. .........+++
T Consensus 217 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~s~~ 276 (348)
T d2gfsa1 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS--------------------LTQMPKMNFANVFIGANPL 276 (348)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTT--------------------SCCCCCCCHHHHSTTCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhh--------------------cccCCCcchhhhcCCCCHH
Confidence 99999999999999999888877665432211111111000 000000 011123456789
Q ss_pred HHHHHHHccccCCCCCCCHHHHHcCCCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALRHPFFTRD 392 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~hp~f~~~ 392 (405)
++|||.+||++||++||||+|+|+||||++.
T Consensus 277 ~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=376.93 Aligned_cols=223 Identities=25% Similarity=0.391 Sum_probs=182.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHH-HHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQ-RLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~-~l~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||+||+|+++.+++.||||++++. ....+.+..|+.++. .+.|++++...
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4699999999999999999999999999999999653 233455677877765 68999885422
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++..|
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--------------------- 140 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--------------------- 140 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---------------------
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC---------------------
Confidence 24689999999999999999999999999999999999997665
Q ss_pred CCCCCCCceeccCCCCccccC---CccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 296 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~ 296 (405)
.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....
T Consensus 141 ------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 214 (320)
T d1xjda_ 141 ------HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214 (320)
T ss_dssp ------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ------ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 456666666653322 22335799999999999999999999999999999999999999999887776665
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....... +..+++++.+||.+||+.||++
T Consensus 215 i~~~~~~~--------------------------------------------------p~~~s~~~~dli~~~L~~dP~~ 244 (320)
T d1xjda_ 215 IRMDNPFY--------------------------------------------------PRWLEKEAKDLLVKLFVREPEK 244 (320)
T ss_dssp HHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHcCCCCC--------------------------------------------------CccCCHHHHHHHHHhcccCCCC
Confidence 54321111 1235778999999999999999
Q ss_pred CCCHH-HHHcCCCCCC
Q 015532 377 RLKAR-EALRHPFFTR 391 (405)
Q Consensus 377 Rpta~-elL~hp~f~~ 391 (405)
|||+. |+++||||++
T Consensus 245 R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 245 RLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SBTTBSCGGGSGGGTT
T ss_pred CcCHHHHHHhCchhcc
Confidence 99995 8999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-50 Score=380.72 Aligned_cols=227 Identities=25% Similarity=0.380 Sum_probs=175.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh----hhhHHHHHH---HHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIE---IDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~~~~E---~~il~~l~~~~~~~~~---------- 154 (405)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .....+.+| +.+++.+.|++++...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 56999999999999999999999999999999996432 222334445 5555566788875421
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..++.++.||+.||.|||++|||||||||+|||++.+|
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g------------------- 144 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG------------------- 144 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-------------------
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-------------------
Confidence 23578899999999999999999999999999999999997655
Q ss_pred ccCCCCCCCceeccCCCCccccCC-ccceecCCCcchhHHHhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 295 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 295 (405)
.+||+|||+|...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+....+...
T Consensus 145 --------~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 216 (364)
T d1omwa3 145 --------HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216 (364)
T ss_dssp --------CEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH
T ss_pred --------cEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4677777776644332 334689999999999975 569999999999999999999999998755433222
Q ss_pred HHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCC
Q 015532 296 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 375 (405)
Q Consensus 296 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 375 (405)
........ ....+..+++++++||.+||+.||+
T Consensus 217 ~~~~~~~~-----------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~ 249 (364)
T d1omwa3 217 IDRMTLTM-----------------------------------------------AVELPDSFSPELRSLLEGLLQRDVN 249 (364)
T ss_dssp HHHHSSSC-----------------------------------------------CCCCCSSSCHHHHHHHHHHTCSSTT
T ss_pred HHHhcccC-----------------------------------------------CCCCCCCCCHHHHHHHHHHcccCHH
Confidence 21111110 0112235678999999999999999
Q ss_pred CCCC-----HHHHHcCCCCCCC
Q 015532 376 ERLK-----AREALRHPFFTRD 392 (405)
Q Consensus 376 ~Rpt-----a~elL~hp~f~~~ 392 (405)
+||| |+|+++||||++-
T Consensus 250 ~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 250 RRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp TSTTTSSSTHHHHHTSGGGTTC
T ss_pred HhCCCcccCHHHHHcCccccCC
Confidence 9999 8999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=374.53 Aligned_cols=260 Identities=26% Similarity=0.507 Sum_probs=189.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHh-hcCCCCC-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGT----------------- 153 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~-~~~~~~~----------------- 153 (405)
++|+++++||+|+||+||+|+++.+++.||||+++... .+.+.+|+++|+.+. |+++...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 68999999999999999999999999999999997533 456789999999996 7776321
Q ss_pred ---------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCC
Q 015532 154 ---------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 224 (405)
Q Consensus 154 ---------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~ 224 (405)
....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 113 ~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~-------------------------- 166 (328)
T d3bqca1 113 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-------------------------- 166 (328)
T ss_dssp CCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--------------------------
T ss_pred ecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--------------------------
Confidence 134689999999999999999999999999999999999998643
Q ss_pred CCceeccCCCCccccC--CccceecCCCcchhHHHhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHH
Q 015532 225 SAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH-ENLEHLAMMERV 300 (405)
Q Consensus 225 ~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~ 300 (405)
..+||+|||+|..... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||... +..++...+...
T Consensus 167 ~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~ 246 (328)
T d3bqca1 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246 (328)
T ss_dssp TEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred CeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence 2367777777654432 23345789999999999876 4799999999999999999999999654 455666667776
Q ss_pred hCCCChHHH-HHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchh-hhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 301 LGPLPHHMV-IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 301 ~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+|....... ..........+.. ... .... ..... .........+++++|||.+||++||++||
T Consensus 247 ~g~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~---------~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 247 LGTEDLYDYIDKYNIELDPRFND-----ILG-RHSR---------KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp HCHHHHHHHHHHTTCCCCGGGGG-----TCC-CCCC---------CCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred HCCchhhhhhhhcccccCcccch-----hcc-cccc---------cchhhcccccccccCCHHHHHHHHHHccCChhHCc
Confidence 664221111 0000000000000 000 0000 00000 01112234578899999999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q 015532 379 KAREALRHPFFTRDVR 394 (405)
Q Consensus 379 ta~elL~hp~f~~~~~ 394 (405)
||+|+|+||||+.-.+
T Consensus 312 ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 312 TAREAMEHPYFYTVVK 327 (328)
T ss_dssp CHHHHHTSGGGTTSCC
T ss_pred CHHHHhcCcccCCCCC
Confidence 9999999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=380.28 Aligned_cols=237 Identities=24% Similarity=0.446 Sum_probs=182.4
Q ss_pred cCCCeEEEe-eeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHH-hhcCCCCCc-------------
Q 015532 90 LTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTR------------- 154 (405)
Q Consensus 90 ~~~~y~~~~-~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l-~~~~~~~~~------------- 154 (405)
+.++|++++ .||+|+||+||+|++..+++.||||+++.. ....+|+.++.++ .|++++...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 456799886 599999999999999999999999999753 3466799987766 688874311
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCC
Q 015532 155 --------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 214 (405)
Q Consensus 155 --------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~ 214 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~---------------- 148 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR---------------- 148 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS----------------
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc----------------
Confidence 13589999999999999999999999999999999999997532
Q ss_pred CCcccCCCCCCCceeccCCCCccccCC--ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 215 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 215 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
....+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+...
T Consensus 149 --------~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 149 --------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp --------TTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred --------ccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 3456899999988754432 334689999999999999899999999999999999999999998765444
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+..... .....++. .....+++++.+||.+||++
T Consensus 221 ~~~~~~~~i~--------------------~~~~~~~~----------------------~~~~~~s~~~~~li~~~L~~ 258 (335)
T d2ozaa1 221 ISPGMKTRIR--------------------MGQYEFPN----------------------PEWSEVSEEVKMLIRNLLKT 258 (335)
T ss_dssp -------CCC--------------------SCSSSCCT----------------------THHHHSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHh--------------------cCCCCCCC----------------------cccccCCHHHHHHHHHHccC
Confidence 3322211100 00011110 01123577899999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCCCC
Q 015532 373 DPAERLKAREALRHPFFTRDVRRP 396 (405)
Q Consensus 373 dP~~Rpta~elL~hp~f~~~~~~~ 396 (405)
||++|||+.|+|+||||++....+
T Consensus 259 dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 259 EPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp STTTSCCHHHHHHSHHHHTTTSSC
T ss_pred ChhHCcCHHHHHcCHHhhCCCCCC
Confidence 999999999999999998765443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=366.26 Aligned_cols=253 Identities=30% Similarity=0.475 Sum_probs=192.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh---hhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+|+.++|++++...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999999999999999996432 3457788999999999999985422
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~----------------------- 138 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----------------------- 138 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-----------------------
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-----------------------
Confidence 35678999999999999999999999999999999999997654
Q ss_pred CCCCCceeccCCCCccccCCc---cceecCCCcchhHHHhCCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALF-QTHENLEHLAM 296 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~ 296 (405)
.+||+|||.+....... ....+++.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..+.+..
T Consensus 139 ----~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~ 214 (292)
T d1unla_ 139 ----ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp ----CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred ----ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 46677777665443322 2246788999999998765 689999999999999999998885 55666777777
Q ss_pred HHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCC
Q 015532 297 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 376 (405)
Q Consensus 297 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 376 (405)
+....+.++........... . . ...+. ..............++.+.+||.+||++||.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~----~-~--~~~~~--------------~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 273 (292)
T d1unla_ 215 IFRLLGTPTEEQWPSMTKLP----D-Y--KPYPM--------------YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGST----T-C--CCCCC--------------CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhhcCCCChhhhhhhhhcc----c-c--ccccc--------------ccccchhhhccccCCHHHHHHHHHHccCChhH
Confidence 87777765543211110000 0 0 00000 00011112223456788999999999999999
Q ss_pred CCCHHHHHcCCCCCCC
Q 015532 377 RLKAREALRHPFFTRD 392 (405)
Q Consensus 377 Rpta~elL~hp~f~~~ 392 (405)
||||+|+|+||||++-
T Consensus 274 R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 274 RISAEEALQHPYFSDF 289 (292)
T ss_dssp SCCHHHHTTSGGGSSC
T ss_pred CcCHHHHhcChhhcCC
Confidence 9999999999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-48 Score=357.83 Aligned_cols=227 Identities=24% Similarity=0.290 Sum_probs=175.3
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
.+.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++|+.++|++++...
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4678899999999999999999999999999999999643 23345688999999999999985421
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCC
Q 015532 155 ---------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 213 (405)
Q Consensus 155 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~ 213 (405)
...+++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d--------- 154 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD--------- 154 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECC---------
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeeh---------
Confidence 24689999999999999999999999999999999999998776555544
Q ss_pred CCCcccCCCCCCCceeccCCCCcccc------CCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015532 214 DGSYFKNLPKSSAIKLIDFGSTTFEH------QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 287 (405)
Q Consensus 214 ~~~~~~~~~~~~~~kl~Dfg~a~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 287 (405)
||.+.... ......+||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+
T Consensus 155 ------------------~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 155 ------------------FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp ------------------CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------------hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 44443221 112335899999999999999999999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 288 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 288 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
.+..+.+..+.+....+| ......+++++.+||.
T Consensus 217 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~s~~l~~li~ 250 (277)
T d1o6ya_ 217 DSPVSVAYQHVREDPIPP----------------------------------------------SARHEGLSADLDAVVL 250 (277)
T ss_dssp SSHHHHHHHHHHCCCCCG----------------------------------------------GGTSSSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhcCCCCC----------------------------------------------chhccCCCHHHHHHHH
Confidence 887766655433211111 1122456789999999
Q ss_pred HccccCCCCCC-CHHHHHcCCCC
Q 015532 368 GLLRYDPAERL-KAREALRHPFF 389 (405)
Q Consensus 368 ~~L~~dP~~Rp-ta~elL~hp~f 389 (405)
+||+.||++|| |+++++ |+|+
T Consensus 251 ~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 251 KALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp HHTCSSGGGSCSSHHHHH-HHHH
T ss_pred HHccCCHhHCHhHHHHHH-HHHH
Confidence 99999999999 566554 5554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-48 Score=357.65 Aligned_cols=218 Identities=17% Similarity=0.282 Sum_probs=175.9
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||+||+|+++.+++.||||+++......+.+.+|+++|++++|+|++...
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 579999999999999999999999999999999987666677899999999999999984421
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCC
Q 015532 155 ------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 222 (405)
Q Consensus 155 ------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~ 222 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~------------------------ 152 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH------------------------ 152 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------------
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC------------------------
Confidence 24578899999999999999999999999999999999997665
Q ss_pred CCCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHH
Q 015532 223 KSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ-THENLEHLAMM 297 (405)
Q Consensus 223 ~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i 297 (405)
.+||+|||+|+...... ....||+.|+|||++.+..|+.++|||||||++|||++|..||. +.+..+....+
T Consensus 153 ---~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 153 ---LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp ---CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred ---cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 46677777766543322 12468999999999999999999999999999999999666554 44433333222
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
... .+. ..+..+++++.+||.+||+.||++|
T Consensus 230 ~~~-----------------------~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~R 260 (287)
T d1opja_ 230 EKD-----------------------YRM--------------------------ERPEGCPEKVYELMRACWQWNPSDR 260 (287)
T ss_dssp HTT-----------------------CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hcC-----------------------CCC--------------------------CCCccchHHHHHHHHHHcCCCHhHC
Confidence 110 011 1123457789999999999999999
Q ss_pred CCHHHHHc
Q 015532 378 LKAREALR 385 (405)
Q Consensus 378 pta~elL~ 385 (405)
||++|+++
T Consensus 261 ps~~ei~~ 268 (287)
T d1opja_ 261 PSFAEIHQ 268 (287)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=357.08 Aligned_cols=223 Identities=23% Similarity=0.366 Sum_probs=179.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||+||+|+++ +++.||||+++......+.+.+|+++|.+++|+|++...
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 57999999999999999999985 567899999987666678899999999999999985422
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~------------------------- 146 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL------------------------- 146 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------------------------
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-------------------------
Confidence 12478999999999999999999999999999999999997655
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~ 298 (405)
.+||+|||+|+...... ....||+.|+|||++.+..|+.++|||||||++|||+|| .+||...+..+.+..+.
T Consensus 147 --~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~ 224 (272)
T d1qpca_ 147 --SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224 (272)
T ss_dssp --CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred --ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 45666666665443221 235789999999999988999999999999999999995 56666666555544432
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
... +.. .+..+++++.+||.+||+.||++||
T Consensus 225 ~~~-----------------------~~~--------------------------~p~~~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 225 RGY-----------------------RMV--------------------------RPDNCPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp TTC-----------------------CCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hcC-----------------------CCC--------------------------CcccChHHHHHHHHHHcCCCHhHCc
Confidence 211 011 1134567899999999999999999
Q ss_pred CHHHHHc--CCCCCC
Q 015532 379 KAREALR--HPFFTR 391 (405)
Q Consensus 379 ta~elL~--hp~f~~ 391 (405)
|++|+++ |+||+.
T Consensus 256 t~~ei~~~L~~~fts 270 (272)
T d1qpca_ 256 TFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhhhhc
Confidence 9999998 788854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=349.09 Aligned_cols=218 Identities=23% Similarity=0.347 Sum_probs=170.7
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||+||+|++. +++.||||+++......+.+.+|++++++++|+|++...
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46999999999999999999986 567899999987666778899999999999999985422
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~------------------------ 139 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV------------------------ 139 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC------------------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC------------------------
Confidence 245788999999999999999999999999999999999987664
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
+||+|||+++...... ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+.
T Consensus 140 ---~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~ 216 (263)
T d1sm2a_ 140 ---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216 (263)
T ss_dssp ---EEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred ---eEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 5666666654433221 22468999999999999999999999999999999999 577777766666555443
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
... +.. .+...++++.+||.+||+.||++||
T Consensus 217 ~~~-----------------------~~~--------------------------~p~~~~~~l~~li~~cl~~~p~~Rp 247 (263)
T d1sm2a_ 217 TGF-----------------------RLY--------------------------KPRLASTHVYQIMNHCWKERPEDRP 247 (263)
T ss_dssp HTC-----------------------CCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hcC-----------------------CCC--------------------------CccccCHHHHHHHHHHccCCHhHCc
Confidence 311 111 1123466899999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|++|+++|
T Consensus 248 s~~~il~~ 255 (263)
T d1sm2a_ 248 AFSRLLRQ 255 (263)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=351.84 Aligned_cols=222 Identities=22% Similarity=0.291 Sum_probs=171.9
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc-------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------- 154 (405)
.++|++.++||+|+||+||+|+.+ ..||||+++.. ....+.+.+|+.+|++++|+|++...
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEe
Confidence 367999999999999999999864 35999998642 33456788999999999999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--------------------- 142 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--------------------- 142 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS---------------------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC---------------------
Confidence 245889999999999999999999999999999999999987654
Q ss_pred CCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHENLE 292 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 292 (405)
+||+|||+|...... .....||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+...
T Consensus 143 ------~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~ 216 (276)
T d1uwha_ 143 ------VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216 (276)
T ss_dssp ------EEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred ------EEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH
Confidence 566666666543221 1235799999999999753 48999999999999999999999999877665
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
.+..+.......| ........+++++.+||.+||+.
T Consensus 217 ~~~~~~~~~~~~p--------------------------------------------~~~~~~~~~~~~l~~li~~cl~~ 252 (276)
T d1uwha_ 217 QIIFMVGRGYLSP--------------------------------------------DLSKVRSNCPKAMKRLMAECLKK 252 (276)
T ss_dssp HHHHHHHHTSCCC--------------------------------------------CGGGSCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCCCC--------------------------------------------cchhccccchHHHHHHHHHHcCC
Confidence 5443322111111 01112235677999999999999
Q ss_pred CCCCCCCHHHHHcC
Q 015532 373 DPAERLKAREALRH 386 (405)
Q Consensus 373 dP~~Rpta~elL~h 386 (405)
||++|||++|++++
T Consensus 253 dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 253 KRDERPLFPQILAS 266 (276)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=347.84 Aligned_cols=218 Identities=19% Similarity=0.305 Sum_probs=179.4
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
+.|++.++||+|+||+||+|+++ +++.||||+++......+.+++|+.++.+++|+|++...
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 45889999999999999999985 778899999987777778899999999999999985422
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~------------------------ 138 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV------------------------ 138 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC------------------------
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc------------------------
Confidence 245788899999999999999999999999999999999976654
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (405)
+||+|||++....... ....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+.
T Consensus 139 ---~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~ 215 (258)
T d1k2pa_ 139 ---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215 (258)
T ss_dssp ---EEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred ---EEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH
Confidence 5666666654332221 12468999999999999999999999999999999998 899999988877666554
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+... .. .+...++.+.+||.+||+.||++||
T Consensus 216 ~~~~-----------------------~~--------------------------~p~~~~~~l~~li~~cl~~dP~~RP 246 (258)
T d1k2pa_ 216 QGLR-----------------------LY--------------------------RPHLASEKVYTIMYSCWHEKADERP 246 (258)
T ss_dssp TTCC-----------------------CC--------------------------CCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred hCCC-----------------------CC--------------------------CcccccHHHHHHHHHHccCCHhHCc
Confidence 3211 11 1123466899999999999999999
Q ss_pred CHHHHHcC
Q 015532 379 KAREALRH 386 (405)
Q Consensus 379 ta~elL~h 386 (405)
|++++++|
T Consensus 247 t~~eil~~ 254 (258)
T d1k2pa_ 247 TFKILLSN 254 (258)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-46 Score=350.22 Aligned_cols=219 Identities=23% Similarity=0.314 Sum_probs=168.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc---EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.++||+|+||+||+|+++.+++ .||||++... ....+.+.+|+++|++++|+|++...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 579999999999999999999976654 5899988542 34456789999999999999985421
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~------------------- 166 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV------------------- 166 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-------------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc-------------------
Confidence 235899999999999999999999999999999999999977664
Q ss_pred cCCCCCCCceeccCCCCccccCCc--------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDH--------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 289 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 289 (405)
+||+|||+++...... ....||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus 167 --------~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 167 --------CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp --------EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred --------EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 5555555554332211 11357899999999999999999999999999999998 899999888
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+.+..+.+.. +.. .+..+++.+.+||.+|
T Consensus 239 ~~~~~~~i~~~~-----------------------~~~--------------------------~~~~~~~~l~~li~~c 269 (299)
T d1jpaa_ 239 NQDVINAIEQDY-----------------------RLP--------------------------PPMDCPSALHQLMLDC 269 (299)
T ss_dssp HHHHHHHHHTTC-----------------------CCC--------------------------CCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCC-----------------------CCC--------------------------CCccchHHHHHHHHHH
Confidence 776665543311 111 1124567899999999
Q ss_pred cccCCCCCCCHHHHHcC
Q 015532 370 LRYDPAERLKAREALRH 386 (405)
Q Consensus 370 L~~dP~~Rpta~elL~h 386 (405)
|+.||++|||+.|++++
T Consensus 270 l~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 270 WQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCSSTTTSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=346.87 Aligned_cols=225 Identities=24% Similarity=0.334 Sum_probs=178.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.+.||+|+||+||+|+++.+ +.||||+++......+.+.+|+.++++++|+|++...
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 5799999999999999999999755 5699999987666678899999999999999985422
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCC
Q 015532 155 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 223 (405)
Q Consensus 155 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~ 223 (405)
...+++.++..++.||+.||.|||++||+||||||+||||+.++
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~------------------------- 150 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------------- 150 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-------------------------
Confidence 13579999999999999999999999999999999999997765
Q ss_pred CCCceeccCCCCccccCCc----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 015532 224 SSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLEHLAMME 298 (405)
Q Consensus 224 ~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~ 298 (405)
.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++| .+||.+....+.+..+.
T Consensus 151 --~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 151 --VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp --CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred --cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 45666666665432221 225789999999999999999999999999999999995 55566666555555443
Q ss_pred HHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCC
Q 015532 299 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 378 (405)
Q Consensus 299 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rp 378 (405)
+.. +. .....+++++.+||.+||+.||++||
T Consensus 229 ~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rp 259 (285)
T d1fmka3 229 RGY-----------------------RM--------------------------PCPPECPESLHDLMCQCWRKEPEERP 259 (285)
T ss_dssp TTC-----------------------CC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hcC-----------------------CC--------------------------CCCcccCHHHHHHHHHHcccCHhHCc
Confidence 211 00 11234567899999999999999999
Q ss_pred CHHHHHc--CCCCCCCC
Q 015532 379 KAREALR--HPFFTRDV 393 (405)
Q Consensus 379 ta~elL~--hp~f~~~~ 393 (405)
|+++|++ |+||+...
T Consensus 260 s~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 260 TFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CHHHHHHHHHTTTSCSC
T ss_pred CHHHHHHHHhhhhcCCC
Confidence 9999998 99997653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=356.10 Aligned_cols=228 Identities=27% Similarity=0.371 Sum_probs=175.4
Q ss_pred CCeEEEeeeecccceeEEEEEec---CCCcEEEEEEecch-----hhhhHHHHHHHHHHHHHhhc-CCCCCc--------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARH-DIGGTR-------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vAiK~~~~~-----~~~~~~~~~E~~il~~l~~~-~~~~~~-------- 154 (405)
++|+++++||+|+||+||+|++. .+|+.||||++++. ....+.+.+|+++|+++.|+ ++....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999874 46899999998642 23345677899999999996 553211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCC
Q 015532 155 -------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 215 (405)
Q Consensus 155 -------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~ 215 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---------------- 167 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---------------- 167 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----------------
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC----------------
Confidence 245688999999999999999999999999999999999977654
Q ss_pred CcccCCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015532 216 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHE 289 (405)
Q Consensus 216 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~ 289 (405)
+||+|||++...... .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+
T Consensus 168 -----------vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 168 -----------VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp -----------EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred -----------EEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 566666655433221 2235799999999999865 46789999999999999999999998765
Q ss_pred hHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHc
Q 015532 290 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 369 (405)
Q Consensus 290 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 369 (405)
..+....+.+.... .....+...++++++||.+|
T Consensus 237 ~~~~~~~i~~~~~~----------------------------------------------~~~~~~~~~s~~~~~li~~~ 270 (322)
T d1vzoa_ 237 EKNSQAEISRRILK----------------------------------------------SEPPYPQEMSALAKDLIQRL 270 (322)
T ss_dssp SCCCHHHHHHHHHH----------------------------------------------CCCCCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccc----------------------------------------------CCCCCcccCCHHHHHHHHHH
Confidence 54433333221100 00011234678999999999
Q ss_pred cccCCCCCC-----CHHHHHcCCCCCCC
Q 015532 370 LRYDPAERL-----KAREALRHPFFTRD 392 (405)
Q Consensus 370 L~~dP~~Rp-----ta~elL~hp~f~~~ 392 (405)
|++||++|| ||+|+|+||||++-
T Consensus 271 l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 271 LMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999999 59999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-46 Score=347.34 Aligned_cols=236 Identities=22% Similarity=0.286 Sum_probs=180.9
Q ss_pred cCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 90 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
+.++|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+..|+++++.+.|++++...
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4568999999999999999999999999999999986543 334578899999999998874322
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~----------------------- 140 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK----------------------- 140 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-----------------------
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC-----------------------
Confidence 24689999999999999999999999999999999999986532
Q ss_pred CCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 015532 222 PKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 291 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 291 (405)
.+..++|+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 141 -~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 141 -KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp -GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred -CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 3445778888877654322 22357999999999999999999999999999999999999999876655
Q ss_pred HHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccc
Q 015532 292 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 371 (405)
Q Consensus 292 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 371 (405)
+....+.+... .............+++++.+||.+||+
T Consensus 220 ~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~p~~~~~li~~cl~ 257 (299)
T d1ckia_ 220 TKRQKYERISE------------------------------------------KKMSTPIEVLCKGYPSEFATYLNFCRS 257 (299)
T ss_dssp -----HHHHHH------------------------------------------HHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred HHHHHHHHhhc------------------------------------------ccCCCChhHhccCCCHHHHHHHHHHcc
Confidence 44333222100 000000111223567789999999999
Q ss_pred cCCCCCCCHH---HHHcCCCCCCC
Q 015532 372 YDPAERLKAR---EALRHPFFTRD 392 (405)
Q Consensus 372 ~dP~~Rpta~---elL~hp~f~~~ 392 (405)
.||++||+++ ++|+|+|.++.
T Consensus 258 ~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 258 LRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CChhHCcCHHHHHHHHHHHHHHcC
Confidence 9999999986 55778876544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=346.78 Aligned_cols=223 Identities=25% Similarity=0.349 Sum_probs=176.2
Q ss_pred CCeEEEe-eeecccceeEEEEEecC--CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILS-KMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~-~LG~G~fg~V~~a~~~~--~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|.+.+ +||+|+||+||+|.++. ++..||||+++.. ....+.+.+|+++|++++|+|++...
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 4688888 49999999999998764 4557999999643 33456788999999999999985421
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~------------------- 148 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA------------------- 148 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE-------------------
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCce-------------------
Confidence 2458999999999999999999999999999999999999877655
Q ss_pred CCCCCCCceeccCCCCccccCC------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 292 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 292 (405)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+
T Consensus 149 --------Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~ 220 (285)
T d1u59a_ 149 --------KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220 (285)
T ss_dssp --------EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred --------eeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 45555554432221 122468999999999999899999999999999999998 999999887766
Q ss_pred HHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcccc
Q 015532 293 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 372 (405)
Q Consensus 293 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 372 (405)
....+.+. .+.. .+..+++++.+||.+||+.
T Consensus 221 ~~~~i~~~-----------------------~~~~--------------------------~p~~~~~~l~~li~~cl~~ 251 (285)
T d1u59a_ 221 VMAFIEQG-----------------------KRME--------------------------CPPECPPELYALMSDCWIY 251 (285)
T ss_dssp HHHHHHTT-----------------------CCCC--------------------------CCTTCCHHHHHHHHHTTCS
T ss_pred HHHHHHcC-----------------------CCCC--------------------------CCCcCCHHHHHHHHHHcCC
Confidence 65544321 1111 1234567899999999999
Q ss_pred CCCCCCCHHHH---HcCCCCC
Q 015532 373 DPAERLKAREA---LRHPFFT 390 (405)
Q Consensus 373 dP~~Rpta~el---L~hp~f~ 390 (405)
||++|||+.++ |+|+|++
T Consensus 252 ~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 252 KWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHHH
Confidence 99999999888 5788874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=352.54 Aligned_cols=220 Identities=20% Similarity=0.285 Sum_probs=170.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc-----EEEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
++|++.++||+|+||+||+|++..+++ .||||++... ......+.+|+.+|.++ +|+|++...
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 579999999999999999999876543 6999998543 33456788999999999 788874311
Q ss_pred -----------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEE
Q 015532 155 -----------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 193 (405)
Q Consensus 155 -----------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 193 (405)
...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 123788899999999999999999999999999999999
Q ss_pred EecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhH
Q 015532 194 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL 268 (405)
Q Consensus 194 i~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 268 (405)
++.++.+ ||+|||+|+...... ....||+.|||||++.+..|+.++||
T Consensus 197 l~~~~~~---------------------------Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di 249 (325)
T d1rjba_ 197 VTHGKVV---------------------------KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249 (325)
T ss_dssp EETTTEE---------------------------EECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred cccCCeE---------------------------EEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceec
Confidence 9877655 455555544322211 23568999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccc
Q 015532 269 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 347 (405)
Q Consensus 269 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (405)
|||||++|||+| |.+||.+.+..+.+..+.+.- .+.+
T Consensus 250 wS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~----------------------~~~~-------------------- 287 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG----------------------FKMD-------------------- 287 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT----------------------CCCC--------------------
T ss_pred cchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------------------CCCC--------------------
Confidence 999999999998 899998876655444332211 0111
Q ss_pred hhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 348 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 348 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.+..+++++.+||.+||+.||++|||++||++|
T Consensus 288 ------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 288 ------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 123457789999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=351.50 Aligned_cols=224 Identities=21% Similarity=0.263 Sum_probs=170.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCc----EEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
..|+++++||+|+||+||+|++..+|+ .||||.++.. ....+.+.+|+.++++++|+|++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 359999999999999999999988776 5888887543 23457789999999999999985432
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 155 ----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 155 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++........
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~-- 166 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-- 166 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc--
Confidence 24578999999999999999999999999999999999998877655555554432211100
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 297 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 297 (405)
........||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+
T Consensus 167 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 167 --------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp ----------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred --------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 001112468999999999999999999999999999999998 89999887665544443
Q ss_pred HHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCC
Q 015532 298 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 377 (405)
Q Consensus 298 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 377 (405)
.+.. +.. .+..+++.+.+||.+||+.||++|
T Consensus 227 ~~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~cl~~dP~~R 257 (317)
T d1xkka_ 227 EKGE-----------------------RLP--------------------------QPPICTIDVYMIMVKCWMIDADSR 257 (317)
T ss_dssp HHTC-----------------------CCC--------------------------CCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred HcCC-----------------------CCC--------------------------CCcccCHHHHHHHHHhCCCChhhC
Confidence 3211 111 113456789999999999999999
Q ss_pred CCHHHHHcC
Q 015532 378 LKAREALRH 386 (405)
Q Consensus 378 pta~elL~h 386 (405)
||+.|+++|
T Consensus 258 Ps~~eil~~ 266 (317)
T d1xkka_ 258 PKFRELIIE 266 (317)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=346.25 Aligned_cols=216 Identities=25% Similarity=0.396 Sum_probs=168.8
Q ss_pred eeeecccceeEEEEEec--CCCcEEEEEEecch---hhhhHHHHHHHHHHHHHhhcCCCCCc------------------
Q 015532 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR------------------ 154 (405)
Q Consensus 98 ~~LG~G~fg~V~~a~~~--~~~~~vAiK~~~~~---~~~~~~~~~E~~il~~l~~~~~~~~~------------------ 154 (405)
++||+|+||+||+|.+. .+++.||||+++.. ....+.+.+|+++|++++|+|++...
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 47999999999999864 45678999999642 23456789999999999999985422
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCCCCCCC
Q 015532 155 --------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 226 (405)
Q Consensus 155 --------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~ 226 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~-------------------------- 146 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-------------------------- 146 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE--------------------------
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc--------------------------
Confidence 2458999999999999999999999999999999999999887755
Q ss_pred ceeccCCCCccccCC------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 015532 227 IKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 299 (405)
Q Consensus 227 ~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (405)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+.+
T Consensus 147 -kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~ 225 (277)
T d1xbba_ 147 -KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225 (277)
T ss_dssp -EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred -cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 45555555432211 122468999999999999899999999999999999998 8999998877665554432
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
. .+... +..+++++.+||.+||+.||++|||
T Consensus 226 ~-----------------------~~~~~--------------------------p~~~~~~~~~li~~cl~~dp~~RPs 256 (277)
T d1xbba_ 226 G-----------------------ERMGC--------------------------PAGCPREMYDLMNLCWTYDVENRPG 256 (277)
T ss_dssp T-----------------------CCCCC--------------------------CTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred C-----------------------CCCCC--------------------------CcccCHHHHHHHHHHcCCCHhHCcC
Confidence 1 11111 1345678999999999999999999
Q ss_pred HHHH---HcCCCC
Q 015532 380 AREA---LRHPFF 389 (405)
Q Consensus 380 a~el---L~hp~f 389 (405)
++++ |+|+|+
T Consensus 257 ~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 257 FAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHhhCHHh
Confidence 9998 456654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=339.53 Aligned_cols=218 Identities=22% Similarity=0.278 Sum_probs=165.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC----cEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc-----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR----------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~----------- 154 (405)
+.|++.+.||+|+||+||+|.++.++ ..||||+++.. ......+.+|+++|++++|+|++...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46999999999999999999987654 47999998642 33445688999999999999985422
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~------------------- 147 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------------------- 147 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------------------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-------------------
Confidence 24578999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~ 290 (405)
.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+.
T Consensus 148 --------~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 148 --------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp --------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --------eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence 45666666665432211 124689999999999999999999999999999999995 455555555
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+.+..+... .+.. .+..++..+.+||.+||
T Consensus 220 ~~~~~~i~~~-----------------------~~~~--------------------------~~~~~~~~l~~li~~cl 250 (283)
T d1mqba_ 220 HEVMKAINDG-----------------------FRLP--------------------------TPMDCPSAIYQLMMQCW 250 (283)
T ss_dssp HHHHHHHHTT-----------------------CCCC--------------------------CCTTCBHHHHHHHHHHT
T ss_pred HHHHHHHhcc-----------------------CCCC--------------------------CchhhHHHHHHHHHHHC
Confidence 4444333211 0111 11235678999999999
Q ss_pred ccCCCCCCCHHHHHc
Q 015532 371 RYDPAERLKAREALR 385 (405)
Q Consensus 371 ~~dP~~Rpta~elL~ 385 (405)
+.||++|||+.|+++
T Consensus 251 ~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 251 QQERARRPKFADIVS 265 (283)
T ss_dssp CSSTTTSCCHHHHHH
T ss_pred cCCHhHCcCHHHHHH
Confidence 999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=341.69 Aligned_cols=219 Identities=24% Similarity=0.320 Sum_probs=169.3
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC---cEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~---~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~------------ 154 (405)
++|++.+.||+|+||+||+|++..++ ..||||+++.. ....+.+.+|+.+|++++|+|++...
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 57999999999999999999986543 56899988643 33456788999999999999985422
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCccc
Q 015532 155 ---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 219 (405)
Q Consensus 155 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~ 219 (405)
...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~-------------------- 146 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-------------------- 146 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--------------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--------------------
Confidence 235789999999999999999999999999999999999987665
Q ss_pred CCCCCCCceeccCCCCccccCC----ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015532 220 NLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 294 (405)
Q Consensus 220 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 294 (405)
+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+..
T Consensus 147 -------~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~ 219 (273)
T d1mp8a_ 147 -------VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219 (273)
T ss_dssp -------EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred -------EEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH
Confidence 455555555443221 123468999999999999999999999999999999998 89999887776655
Q ss_pred HHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCC
Q 015532 295 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 374 (405)
Q Consensus 295 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 374 (405)
..+.... +. ..+..+++++.+||.+||+.||
T Consensus 220 ~~i~~~~-----------------------~~--------------------------~~~~~~~~~~~~li~~cl~~dp 250 (273)
T d1mp8a_ 220 GRIENGE-----------------------RL--------------------------PMPPNCPPTLYSLMTKCWAYDP 250 (273)
T ss_dssp HHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHcCC-----------------------CC--------------------------CCCCCCCHHHHHHHHHHcCCCH
Confidence 5443210 11 1123457789999999999999
Q ss_pred CCCCCHHHHHcC
Q 015532 375 AERLKAREALRH 386 (405)
Q Consensus 375 ~~Rpta~elL~h 386 (405)
++|||++||++|
T Consensus 251 ~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 251 SRRPRFTELKAQ 262 (273)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=341.14 Aligned_cols=220 Identities=23% Similarity=0.323 Sum_probs=163.4
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|++.++||+|+||.||+|++.. +++.||||+++.. ....+.+..|+.++.++.||+++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 579999999999999999999754 4578999998643 23455677899999998766531110
Q ss_pred -----------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccc
Q 015532 155 -----------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 199 (405)
Q Consensus 155 -----------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~ 199 (405)
...+++.++..++.||+.||.|||++|||||||||+|||++.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 123788999999999999999999999999999999999987665
Q ss_pred cccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHHH
Q 015532 200 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 274 (405)
Q Consensus 200 ~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 274 (405)
+ ||+|||+|+..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~---------------------------Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvi 225 (299)
T d1ywna1 173 V---------------------------KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225 (299)
T ss_dssp E---------------------------EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred E---------------------------EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHH
Confidence 5 55555555432211 123579999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhh
Q 015532 275 LVELCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 353 (405)
Q Consensus 275 l~~lltg-~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (405)
+|||++| .+||.+....+.+..+... +.+. .
T Consensus 226 l~ellt~~~~p~~~~~~~~~~~~~~~~----------------------~~~~--------------------------~ 257 (299)
T d1ywna1 226 LWEIFSLGASPYPGVKIDEEFCRRLKE----------------------GTRM--------------------------R 257 (299)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHHHHHHH----------------------TCCC--------------------------C
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhc----------------------CCCC--------------------------C
Confidence 9999986 5788776544433322211 0011 1
Q ss_pred cccCchHHHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 354 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 354 ~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
.++..++++.+||.+||+.||++|||++|+++|
T Consensus 258 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 258 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 123457789999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=333.71 Aligned_cols=219 Identities=20% Similarity=0.297 Sum_probs=166.8
Q ss_pred CCeEEEeeeecccceeEEEEEecCC-C--cEEEEEEecch----hhhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~-~--~~vAiK~~~~~----~~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|++++.||+|+||.||+|++... + ..||||+++.. ....+.+.+|+.+|++++|+|++...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 4699999999999999999986533 2 46899998642 23456788999999999999985422
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCc
Q 015532 155 -----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 217 (405)
Q Consensus 155 -----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~ 217 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~------------------ 149 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL------------------ 149 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE------------------
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc------------------
Confidence 245899999999999999999999999999999999999987664
Q ss_pred ccCCCCCCCceeccCCCCccccCCc------cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 015532 218 FKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 290 (405)
Q Consensus 218 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 290 (405)
+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||+| |..||.+.+.
T Consensus 150 ---------vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 150 ---------VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp ---------EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ---------eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 5666666655432221 22467889999999999999999999999999999998 8999999888
Q ss_pred HHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHcc
Q 015532 291 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 370 (405)
Q Consensus 291 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 370 (405)
.+.+..+.+..-. . .....+++.+.+||.+||
T Consensus 221 ~~~~~~i~~~~~~----------------------~--------------------------~~~~~~~~~l~~li~~cl 252 (273)
T d1u46a_ 221 SQILHKIDKEGER----------------------L--------------------------PRPEDCPQDIYNVMVQCW 252 (273)
T ss_dssp HHHHHHHHTSCCC----------------------C--------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCC----------------------C--------------------------CCcccccHHHHHHHHHHc
Confidence 7776655331100 0 112345678999999999
Q ss_pred ccCCCCCCCHHHHHc
Q 015532 371 RYDPAERLKAREALR 385 (405)
Q Consensus 371 ~~dP~~Rpta~elL~ 385 (405)
..||++|||+.||++
T Consensus 253 ~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 253 AHKPEDRPTFVALRD 267 (273)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhHCcCHHHHHH
Confidence 999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-45 Score=338.34 Aligned_cols=219 Identities=19% Similarity=0.253 Sum_probs=172.7
Q ss_pred CCCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecch--hhhhHHHHHHHHHHHHHhhcCCCCCc---------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR--------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~il~~l~~~~~~~~~--------- 154 (405)
.++|++.+.||+|+||+||+|+++. +++.||||+++.. ....+.+.+|+++|+.++|+++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 3579999999999999999999753 5678999999643 23456789999999999999984321
Q ss_pred ------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 015532 155 ------------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 192 (405)
Q Consensus 155 ------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 192 (405)
...+++..+..++.||+.||+|||++|||||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 12378889999999999999999999999999999999
Q ss_pred EEecccccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccC-----CccceecCCCcchhHHHhCCCCCCchh
Q 015532 193 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCD 267 (405)
Q Consensus 193 li~~~~~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (405)
|++.++. +||+|||+++.... ......||+.|+|||++.+..|+.++|
T Consensus 172 Lld~~~~---------------------------~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksD 224 (301)
T d1lufa_ 172 LVGENMV---------------------------VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224 (301)
T ss_dssp EECGGGC---------------------------EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHH
T ss_pred EECCCCc---------------------------EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhh
Confidence 9987654 56666666543221 112357889999999999999999999
Q ss_pred HHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhcc
Q 015532 268 LWSVGCILVELCSGE-ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 346 (405)
Q Consensus 268 iwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (405)
||||||++|||++|. +||.+.+..+.+..+... .. .
T Consensus 225 VwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~--~~---------------------~-------------------- 261 (301)
T d1lufa_ 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG--NI---------------------L-------------------- 261 (301)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CC---------------------C--------------------
T ss_pred hccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC--CC---------------------C--------------------
Confidence 999999999999984 788888777766544321 11 1
Q ss_pred chhhhhhcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 347 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 347 ~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
..+..+++++.+||.+||+.||++|||+.||++
T Consensus 262 ------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 262 ------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112345678999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=329.93 Aligned_cols=216 Identities=20% Similarity=0.314 Sum_probs=168.5
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc-----------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR----------------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~----------------- 154 (405)
++|++.++||+|+||.||+|+++ |..||||+++.. ...+.+.+|++++++++|+|++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46999999999999999999984 678999999754 3457789999999999999985422
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccCC
Q 015532 155 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 221 (405)
Q Consensus 155 -------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~~ 221 (405)
...+++..++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~----------------------- 140 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----------------------- 140 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-----------------------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-----------------------
Confidence 12378899999999999999999999999999999999997654
Q ss_pred CCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 015532 222 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERV 300 (405)
Q Consensus 222 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (405)
.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+..
T Consensus 141 ----~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~- 215 (262)
T d1byga_ 141 ----VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK- 215 (262)
T ss_dssp ----CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-
T ss_pred ----CEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-
Confidence 5677777777766555556678999999999999999999999999999999998 7999987766555444321
Q ss_pred hCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCCH
Q 015532 301 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 380 (405)
Q Consensus 301 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpta 380 (405)
+.+.. .+...++++.+||.+||..||++|||+
T Consensus 216 ----------------------~~~~~--------------------------~~~~~~~~~~~li~~cl~~dP~~Rps~ 247 (262)
T d1byga_ 216 ----------------------GYKMD--------------------------APDGCPPAVYEVMKNCWHLDAAMRPSF 247 (262)
T ss_dssp ----------------------TCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ----------------------CCCCC--------------------------CCccCCHHHHHHHHHHcccCHhHCcCH
Confidence 11111 123456789999999999999999999
Q ss_pred HHHHcC
Q 015532 381 REALRH 386 (405)
Q Consensus 381 ~elL~h 386 (405)
.+++++
T Consensus 248 ~~l~~~ 253 (262)
T d1byga_ 248 LQLREQ 253 (262)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-43 Score=329.28 Aligned_cols=229 Identities=18% Similarity=0.203 Sum_probs=174.5
Q ss_pred ccCCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc--------------
Q 015532 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-------------- 154 (405)
Q Consensus 89 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~-------------- 154 (405)
.+.++|++.++||+|+||+||+|++..+|+.||||++.... ..+.+.+|+++++.|.|++.....
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 35678999999999999999999999999999999986533 234567899999999885542211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||+|||++||+||||||+|||++....
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~--------------------- 139 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS--------------------- 139 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS---------------------
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc---------------------
Confidence 246889999999999999999999999999999999999975321
Q ss_pred CCCCCCceeccCCCCccccCC----------ccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 015532 221 LPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 290 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 290 (405)
.....++|+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||++|..||.+...
T Consensus 140 -~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 140 -KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp -TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred -ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 12345788888887653321 2235799999999999999999999999999999999999999986543
Q ss_pred HHH---HHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHH
Q 015532 291 LEH---LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 367 (405)
Q Consensus 291 ~~~---~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 367 (405)
... ...+....- .....+....+++++.+++.
T Consensus 219 ~~~~~~~~~i~~~~~---------------------------------------------~~~~~~l~~~~p~~l~~ii~ 253 (293)
T d1csna_ 219 ATNKQKYERIGEKKQ---------------------------------------------STPLRELCAGFPEEFYKYMH 253 (293)
T ss_dssp CCHHHHHHHHHHHHH---------------------------------------------HSCHHHHTTTSCHHHHHHHH
T ss_pred hhHHHHHHHHHhccC---------------------------------------------CCChHHhcCCCCHHHHHHHH
Confidence 222 222211100 00011112345678999999
Q ss_pred HccccCCCCCCCHHHHHc
Q 015532 368 GLLRYDPAERLKAREALR 385 (405)
Q Consensus 368 ~~L~~dP~~Rpta~elL~ 385 (405)
.|+..+|++||+.+.+.+
T Consensus 254 ~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 254 YARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCcccCcCHHHHHH
Confidence 999999999998776543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=328.63 Aligned_cols=218 Identities=20% Similarity=0.314 Sum_probs=167.0
Q ss_pred CCeEEEeeeecccceeEEEEEecCCC-------cEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc-------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~-------~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~------- 154 (405)
++|++.+.||+|+||.||+|++..++ ..||||+++... .....+.+|...+.++ .|++++...
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 67999999999999999999986554 479999996533 3456788899999999 688874321
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 ------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 ------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
...+++.+++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 13479999999999999999999999999999999999997766
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCC-----ccceecCCCcchhHHHhCCCCCCchhHHHHHH
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 273 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 273 (405)
. +||+|||++...... .....||+.|+|||.+.+..|+.++|||||||
T Consensus 173 ~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 173 V---------------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225 (299)
T ss_dssp C---------------------------EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred C---------------------------eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHH
Confidence 4 555666655433222 12257899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhh
Q 015532 274 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 352 (405)
Q Consensus 274 il~~llt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (405)
++|||++ |.+||.+.+..+....+... .+..
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~-----------------------~~~~------------------------- 257 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEG-----------------------HRMD------------------------- 257 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTT-----------------------CCCC-------------------------
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHcC-----------------------CCCC-------------------------
Confidence 9999998 79999887766554433221 0111
Q ss_pred hcccCchHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 353 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 353 ~~~~~~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.+..+++++.+||.+||+.||++|||+.||++
T Consensus 258 -~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 258 -KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 12345678999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=331.27 Aligned_cols=224 Identities=21% Similarity=0.326 Sum_probs=178.0
Q ss_pred CCeEEEeeeecccceeEEEEEecC-----CCcEEEEEEecchh--hhhHHHHHHHHHHHHHhhcCCCCCc----------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTR---------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l~~~~~~~~~---------- 154 (405)
++|++.++||+|+||+||+|.++. ++..||||+++... .....+.+|+++++++.|++++...
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 689999999999999999998853 35789999997532 3345678999999999999985422
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccc
Q 015532 155 ---------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 207 (405)
Q Consensus 155 ---------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~ 207 (405)
...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--------- 170 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--------- 170 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---------
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc---------
Confidence 12357788899999999999999999999999999999997654
Q ss_pred cccCCCCCCcccCCCCCCCceeccCCCCccccCCc-----cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC-
Q 015532 208 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG- 281 (405)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg- 281 (405)
.+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||+||
T Consensus 171 ------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 171 ------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp ------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred ------------------eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 56777777775443221 224789999999999999999999999999999999998
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHH
Q 015532 282 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 361 (405)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (405)
.+||.+.+..+.+..+.+. . ..+ .+..+++.
T Consensus 233 ~~p~~~~~~~~~~~~i~~~--~---------------------~~~--------------------------~p~~~~~~ 263 (308)
T d1p4oa_ 233 EQPYQGLSNEQVLRFVMEG--G---------------------LLD--------------------------KPDNCPDM 263 (308)
T ss_dssp CCTTTTSCHHHHHHHHHTT--C---------------------CCC--------------------------CCTTCCHH
T ss_pred CCCCCCCCHHHHHHHHHhC--C---------------------CCC--------------------------CcccchHH
Confidence 5888887776666544321 0 111 11245678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHc------CCCCCC
Q 015532 362 LIDLLQGLLRYDPAERLKAREALR------HPFFTR 391 (405)
Q Consensus 362 l~~ll~~~L~~dP~~Rpta~elL~------hp~f~~ 391 (405)
+.+||.+||+.||++|||++|+++ +|+|++
T Consensus 264 l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 264 LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 999999999999999999999997 777653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=330.20 Aligned_cols=219 Identities=21% Similarity=0.247 Sum_probs=169.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcE--EEEEEecch--hhhhHHHHHHHHHHHHH-hhcCCCCCc------------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTR------------ 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~--vAiK~~~~~--~~~~~~~~~E~~il~~l-~~~~~~~~~------------ 154 (405)
++|++.++||+|+||+||+|+++.++.. ||||.++.. ....+.+.+|+++|.++ +|+||+...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5699999999999999999999888764 677877532 23455688999999998 688884321
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccC
Q 015532 155 -------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 203 (405)
Q Consensus 155 -------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~ 203 (405)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~----- 164 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY----- 164 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-----
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-----
Confidence 14578899999999999999999999999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCceeccCCCCccccCCc--cceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhC
Q 015532 204 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 281 (405)
Q Consensus 204 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 281 (405)
.+||+|||++....... ....||..|+|||.+.+..|+.++|||||||++|||++|
T Consensus 165 ----------------------~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 165 ----------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp ----------------------CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred ----------------------ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhc
Confidence 45666666665433222 234689999999999999999999999999999999996
Q ss_pred -CCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchH
Q 015532 282 -EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 360 (405)
Q Consensus 282 -~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (405)
.+||.+.+..+....+.+. .+.. .+..+++
T Consensus 223 ~~~p~~~~~~~~~~~~i~~~-----------------------~~~~--------------------------~~~~~~~ 253 (309)
T d1fvra_ 223 GGTPYCGMTCAELYEKLPQG-----------------------YRLE--------------------------KPLNCDD 253 (309)
T ss_dssp SCCTTTTCCHHHHHHHGGGT-----------------------CCCC--------------------------CCTTBCH
T ss_pred CCCCCCCCCHHHHHHHHHhc-----------------------CCCC--------------------------CCccCCH
Confidence 4678877766654433211 0111 1234577
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHcC
Q 015532 361 DLIDLLQGLLRYDPAERLKAREALRH 386 (405)
Q Consensus 361 ~l~~ll~~~L~~dP~~Rpta~elL~h 386 (405)
++.+||.+||+.||++|||++||++|
T Consensus 254 ~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 254 EVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=323.75 Aligned_cols=224 Identities=24% Similarity=0.353 Sum_probs=170.6
Q ss_pred CCeEEEeeeecccceeEEEEEec-----CCCcEEEEEEecchh--hhhHHHHHHHHHHHHH-hhcCCCCCc---------
Q 015532 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTR--------- 154 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~il~~l-~~~~~~~~~--------- 154 (405)
++|++.++||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++++ +|++++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 67999999999999999999863 456789999996432 3455688999999999 588874321
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEeccc
Q 015532 155 ------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 198 (405)
Q Consensus 155 ------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~ 198 (405)
...+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 12478899999999999999999999999999999999998877
Q ss_pred ccccCCccccccCCCCCCcccCCCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHH
Q 015532 199 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 278 (405)
Q Consensus 199 ~~k~~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 278 (405)
.+|++|||++........ ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 183 ~~ki~DfG~~~~~~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~el 240 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSN----------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240 (311)
T ss_dssp EEEECCCGGGSCTTSCTT----------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccchheeccCCCc----------------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHH
Confidence 666666554432211000 0001224789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccC
Q 015532 279 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 357 (405)
Q Consensus 279 lt-g~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (405)
+| |.+||.+.+..+.+..+.+.-. +. .....
T Consensus 241 lt~g~p~~~~~~~~~~~~~~i~~~~----------------------~~--------------------------~~~~~ 272 (311)
T d1t46a_ 241 FSLGSSPYPGMPVDSKFYKMIKEGF----------------------RM--------------------------LSPEH 272 (311)
T ss_dssp HTTTCCSSTTCCSSHHHHHHHHHTC----------------------CC--------------------------CCCTT
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCC----------------------CC--------------------------CCccc
Confidence 98 7777777665554443322110 00 11123
Q ss_pred chHHHHHHHHHccccCCCCCCCHHHHHc
Q 015532 358 SAGDLIDLLQGLLRYDPAERLKAREALR 385 (405)
Q Consensus 358 ~~~~l~~ll~~~L~~dP~~Rpta~elL~ 385 (405)
.++.+.+||.+||+.||++|||++||++
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4678999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=319.30 Aligned_cols=229 Identities=17% Similarity=0.177 Sum_probs=167.1
Q ss_pred EEEeeeecccceeEEEEEecCCC---cEEEEEEecc--hhhhhHHHHHHHHHHHHHhhcCCCCCc---------------
Q 015532 95 RILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR--------------- 154 (405)
Q Consensus 95 ~~~~~LG~G~fg~V~~a~~~~~~---~~vAiK~~~~--~~~~~~~~~~E~~il~~l~~~~~~~~~--------------- 154 (405)
...++||+|+||+||+|++..++ ..||||+++. .....+.+.+|+++|.+++|+|++...
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 33678999999999999986543 3699999964 334457789999999999999986543
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcccC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 220 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~~~ 220 (405)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~---- 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---- 185 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC----
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc----
Confidence 12356778899999999999999999999999999999998777666666655432211110
Q ss_pred CCCCCCceeccCCCCccccCCccceecCCCcchhHHHhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 015532 221 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL-EHLAMMER 299 (405)
Q Consensus 221 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~ 299 (405)
..........||..|+|||.+.+..++.++|||||||++|||++|..||...... +....+.
T Consensus 186 ----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~- 248 (311)
T d1r0pa_ 186 ----------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 248 (311)
T ss_dssp ----------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-
T ss_pred ----------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-
Confidence 0001112246899999999999999999999999999999999977777553322 2221111
Q ss_pred HhCCCChHHHHHhhHhhHHhhhcCCcccCCCCCCchhhHHHHHHhccchhhhhhcccCchHHHHHHHHHccccCCCCCCC
Q 015532 300 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 379 (405)
Q Consensus 300 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~Rpt 379 (405)
.+.+.. .+..+++.+.+||.+||+.||++|||
T Consensus 249 ----------------------~g~~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 249 ----------------------QGRRLL--------------------------QPEYCPDPLYEVMLKCWHPKAEMRPS 280 (311)
T ss_dssp ----------------------TTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----------------------cCCCCC--------------------------CcccCcHHHHHHHHHHcCCCHhHCcC
Confidence 111111 11234678999999999999999999
Q ss_pred HHHHHcC------CCCCCC
Q 015532 380 AREALRH------PFFTRD 392 (405)
Q Consensus 380 a~elL~h------p~f~~~ 392 (405)
+.|+++| .|+.+.
T Consensus 281 ~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 281 FSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp HHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHHHHHHhhhhhh
Confidence 9999988 766654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=315.92 Aligned_cols=168 Identities=23% Similarity=0.237 Sum_probs=130.5
Q ss_pred CCCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCCCCCc----------------
Q 015532 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR---------------- 154 (405)
Q Consensus 91 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~~~~~---------------- 154 (405)
...|.+.++||+|+||.||+|++ +|+.||||+++...........|+..+..++|+|++...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35689999999999999999986 588999999976544333334455566678999985421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHH--------CCcEecCCCCCcEEEecccccccCCccccccCC
Q 015532 155 --------------YRSFPIDLVRELGRQLLESVAFMHE--------LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 212 (405)
Q Consensus 155 --------------~~~l~~~~~~~~~~qi~~aL~~LH~--------~givHrDlkp~NIli~~~~~~k~~df~~~~~~~ 212 (405)
...+++..+..++.|++.||.|||+ +|||||||||+|||++.++
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-------------- 145 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-------------- 145 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--------------
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--------------
Confidence 1356889999999999999999996 5999999999999997665
Q ss_pred CCCCcccCCCCCCCceeccCCCCccccCC-------ccceecCCCcchhHHHhCCC------CCCchhHHHHHHHHHHHH
Q 015532 213 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELC 279 (405)
Q Consensus 213 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~~ll 279 (405)
.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 146 -------------~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 146 -------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp -------------CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred -------------CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 4566666665443221 12357999999999997643 567899999999999999
Q ss_pred hCCCCCCC
Q 015532 280 SGEALFQT 287 (405)
Q Consensus 280 tg~~pf~~ 287 (405)
||..||..
T Consensus 213 tg~~~~~~ 220 (303)
T d1vjya_ 213 RRCSIGGI 220 (303)
T ss_dssp HTBCBTTB
T ss_pred hCCCCCCc
Confidence 99988754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.7e-24 Score=186.66 Aligned_cols=147 Identities=20% Similarity=0.182 Sum_probs=105.9
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-------------------hhhHHHHHHHHHHHHHhhcCCCCC-
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGGT- 153 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~E~~il~~l~~~~~~~~- 153 (405)
|.+.++||+|+||+||+|++. +|+.||||+++... ........|..++.++.+.++...
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 567899999999999999984 68899999875211 112334468888888888765331
Q ss_pred ---------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecccccccCCccccccCCCCCCcc
Q 015532 154 ---------------RYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 218 (405)
Q Consensus 154 ---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIli~~~~~~k~~df~~~~~~~~~~~~~ 218 (405)
....+++..+..++.||+.+|.|||++||+||||||+|||++..+
T Consensus 81 ~~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-------------------- 140 (191)
T d1zara2 81 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-------------------- 140 (191)
T ss_dssp EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE--------------------
T ss_pred EecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC--------------------
Confidence 123466778889999999999999999999999999999997543
Q ss_pred cCCCCCCCceeccCCCCccccCCccceecCCCcchh------HHHhCCCCCCchhHHHHHHHH
Q 015532 219 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAP------EVILGLGWNYPCDLWSVGCIL 275 (405)
Q Consensus 219 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwSlG~il 275 (405)
++|+|||.|......... .|... +. ....|+.++|+||+.--+
T Consensus 141 --------~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 --------IWIIDFPQSVEVGEEGWR-----EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp --------EEECCCTTCEETTSTTHH-----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred --------EEEEECCCcccCCCCCcH-----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 688899988655432211 11111 11 234688999999976443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.98 E-value=0.001 Score=59.58 Aligned_cols=44 Identities=16% Similarity=0.220 Sum_probs=34.6
Q ss_pred eeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 106 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
..||++.. .+|+.|++|+.+......+++..|+..+..|....+
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gi 79 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEV 79 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCC
Confidence 58999987 467779999987655556777889999999987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.82 E-value=0.0023 Score=56.76 Aligned_cols=54 Identities=11% Similarity=0.124 Sum_probs=33.7
Q ss_pred eEEEeeeecccceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 94 y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
..-.+.|..|---+.|+.... +|+ +++|++.... ..+....|++++..|....+
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~-~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~ 73 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT-KDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGL 73 (316)
T ss_dssp EEEEEEECC---EEEEEEEES-SCC-EEEEEECC----CCHHHHHHHHHHHHHHTTC
T ss_pred ceEeecCCCCcccCeEEEEEC-CCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccc
Confidence 344456777877889998764 344 7899986532 23445668888888887654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.76 E-value=0.0033 Score=53.92 Aligned_cols=54 Identities=17% Similarity=0.131 Sum_probs=35.6
Q ss_pred CCeEEEeeeecccceeEEEEEecCCCcEEEEEEecchh-hhhHHHHHHHHHHHHHhh
Q 015532 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 92 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~il~~l~~ 147 (405)
..|++.+..+-++.+.||+... +++.+.||+..... .......+|..++..+..
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~ 68 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG 68 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc
Confidence 4677777665556678998863 45567788875432 233446678888888754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.22 E-value=0.0061 Score=55.86 Aligned_cols=51 Identities=24% Similarity=0.345 Sum_probs=33.4
Q ss_pred EeeeecccceeEEEEEecCCCcEEEEEEecc----h----hhhhHHHHHHHHHHHHHhh
Q 015532 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS----I----NKYREAAMIEIDVLQRLAR 147 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~~~~----~----~~~~~~~~~E~~il~~l~~ 147 (405)
.+.||.|....||++.+..+++.|+||.-.. . ....++...|..+|+.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~ 89 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGE 89 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhh
Confidence 4579999999999999877788899996421 1 1122345668888887754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.98 E-value=0.055 Score=49.15 Aligned_cols=53 Identities=13% Similarity=0.206 Sum_probs=37.5
Q ss_pred EeeeecccceeEEEEEecC-------CCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 97 ~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
++.|+-|-.-.+|++.... ..+.|.+++.-... ......+|..+++.+...++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~idr~~E~~i~~~ls~~gl 106 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHL 106 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhhHHHHHHHHHHHHHhCCC
Confidence 4678889999999998653 24567777765322 23345679999999887765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=94.90 E-value=0.0082 Score=50.97 Aligned_cols=49 Identities=16% Similarity=0.036 Sum_probs=31.6
Q ss_pred eeeccc-ceeEEEEEecCCCcEEEEEEecchhhhhHHHHHHHHHHHHHhhcCC
Q 015532 99 KMGEGT-FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150 (405)
Q Consensus 99 ~LG~G~-fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~E~~il~~l~~~~~ 150 (405)
.+..|. -+.||+... .++..+.+|...... ...+..|...++.|....+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gv 66 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGV 66 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCC
Confidence 444554 367898876 455567889765432 2346678888888876544
|